Citrus Sinensis ID: 007256
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.538 | 0.464 | 0.430 | 5e-72 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.494 | 0.396 | 0.449 | 6e-72 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.474 | 0.389 | 0.452 | 6e-72 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.497 | 0.466 | 0.445 | 4e-71 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.468 | 0.397 | 0.448 | 2e-70 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.459 | 0.391 | 0.442 | 2e-69 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.500 | 0.426 | 0.439 | 3e-69 | |
| Q8RXC8 | 460 | Receptor-like cytosolic s | no | no | 0.500 | 0.665 | 0.44 | 6e-69 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.469 | 0.404 | 0.440 | 6e-69 | |
| Q5XF57 | 579 | Probable receptor-like se | no | no | 0.476 | 0.502 | 0.438 | 1e-68 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 272 bits (696), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 149/346 (43%), Positives = 211/346 (60%), Gaps = 17/346 (4%)
Query: 252 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 310
LF+Y++L+ AT+ F ENL+G+GG VYKG LPDG+ +AVK LK +EF E+E
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 311 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 370
++ +HH++++S++G C + LL+YD++S L +LHG K + W+ R K+A G
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEK---SVLDWATRVKIAAG 480
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
A L YLH R+IHRD+KSSNILL D+F+ ++SDFGLA+ A ++HIT T V GT
Sbjct: 481 AARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHIT-TRVIGT 539
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490
FGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV WA+P++S
Sbjct: 540 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAI 599
Query: 491 VTQ----LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA--DVTK 544
T+ L DP LG NY +M RM+ A+ C+R RP+M +++ A D+T
Sbjct: 600 ETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTN 659
Query: 545 WARLQVNASEESEMLDD-ESCPRSNLQSHLNLALLDVEDDSFSMSS 589
RL ESE+ + + L + + D FS SS
Sbjct: 660 GMRLG-----ESEVFNSAQQSAEIRLFRRMAFGSQNYSTDFFSHSS 700
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 6e-72, Method: Compositional matrix adjust.
Identities = 142/316 (44%), Positives = 203/316 (64%), Gaps = 14/316 (4%)
Query: 252 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 310
LF+Y++L+ AT+ F ENL+G+GG +VYKG LPD + +AVK LK +EF E++
Sbjct: 417 LFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEVD 476
Query: 311 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 370
I+ +HH+N++S++G+C +N LL+YD++ +L +LH W+ R K+A G
Sbjct: 477 TISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGT--PGLDWATRVKIAAG 534
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
A L YLH R+IHRD+KSSNILL ++F +SDFGLAK A ++HIT T V GT
Sbjct: 535 AARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT-TRVMGT 593
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG- 489
FGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV WA+P+LS+
Sbjct: 594 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNAT 653
Query: 490 ---KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR--GDADVTK 544
+ T L DP LG NY +M RM+ A+ CIR RP+MS +++ + D+T
Sbjct: 654 ETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAEEDLTN 713
Query: 545 WARLQ----VNASEES 556
RL +N++++S
Sbjct: 714 GMRLGESEIINSAQQS 729
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 6e-72, Method: Compositional matrix adjust.
Identities = 138/305 (45%), Positives = 201/305 (65%), Gaps = 15/305 (4%)
Query: 248 ATCRL----FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVI 302
ATC L F +L AT F A+ ++G+GG +VY+G + DG E+AVK+L + +++
Sbjct: 328 ATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRD 387
Query: 303 KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 362
+EF+ E+E+++ LHH+N++ L+G C E L+Y+ + GS+E +LH D W
Sbjct: 388 REFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHEGTLD-----WD 442
Query: 363 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422
R K+A+G A L YLH S RVIHRD K+SN+LL DDF P++SDFGLA+ A+ S HI
Sbjct: 443 ARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI 502
Query: 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482
+ T V GTFGY+APEY M G + K DVY++GVVLLELLTGR+P+ P G+E+LV WA
Sbjct: 503 S-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWA 561
Query: 483 KPILSSGK-VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV---LKLLRG 538
+P+L++ + + QL+DPAL Y++D M ++ + +C+ ++ RP M V LKL+
Sbjct: 562 RPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYN 621
Query: 539 DADVT 543
DAD T
Sbjct: 622 DADET 626
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (688), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 140/314 (44%), Positives = 204/314 (64%), Gaps = 10/314 (3%)
Query: 235 LPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKI 294
LP GL +S + F Y++L AT+ F NL+G+GG V+KG LP GKE+AVK
Sbjct: 252 LPPPSPGLVLGFSKST--FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQ 309
Query: 295 LKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK 353
LK S +EF E+EII+ +HH++++SL+G+C LLVY+F+ +LE +LHG
Sbjct: 310 LKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG-- 367
Query: 354 KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413
K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DFGLAK
Sbjct: 368 KGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK 427
Query: 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473
AS +++H++ T V GTFGYLAPEY GK+ +K DV++FGVVLLEL+TGR+P+ ++
Sbjct: 428 IASDTNTHVS-TRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVY 486
Query: 474 GQESLVMWAKPILS----SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 529
+SLV WA+P+L+ G L D +GN YD ++M RMV + C+R R RP+M
Sbjct: 487 VDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRM 546
Query: 530 SLVLKLLRGDADVT 543
S +++ L G+ ++
Sbjct: 547 SQIVRALEGNVSLS 560
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 267 bits (683), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 132/294 (44%), Positives = 197/294 (67%), Gaps = 8/294 (2%)
Query: 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 311
F+Y++L T F +N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 312 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 371
I+ +HH++++SL+G+C D + LL+Y+++S +LE +LHG K WS+R ++A+G
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGS 476
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
A+ L YLH ++IHRD+KS+NILL D++E Q++DFGLA+ T+ +H++ T V GTF
Sbjct: 477 AKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVS-TRVMGTF 535
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 487
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P+L
Sbjct: 536 GYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIE 595
Query: 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541
+G +++L+D L Y ++ RM+ + C+R RP+M V++ L D D
Sbjct: 596 TGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGD 649
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 263 bits (673), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 128/289 (44%), Positives = 192/289 (66%), Gaps = 8/289 (2%)
Query: 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP-SEDVIKEFVLEIEI 311
F Y++L T F ++G+GG VYKG L +GK +A+K LK S + +EF E+EI
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 312 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 371
I+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+ WS R ++A+G
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRVRIAIGA 475
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T+ SHI+ T V GTF
Sbjct: 476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIS-TRVMGTF 534
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 487
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P L
Sbjct: 535 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIE 594
Query: 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
G +++++DP L N+Y ++ +M+ + C+R RP+M V++ L
Sbjct: 595 KGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 138/314 (43%), Positives = 199/314 (63%), Gaps = 8/314 (2%)
Query: 231 DSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKEL 290
D + LP GL FNY++L AT+ F NL+G+GG V+KG L +GKE+
Sbjct: 320 DQSVLPPPSPGLALGLGIYQGTFNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEV 379
Query: 291 AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 349
AVK LK S +EF E+ II+ +HH+++++L+G+C D LLVY+F+ +LE +L
Sbjct: 380 AVKQLKEGSSQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHL 439
Query: 350 HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409
HG K WS R K+A+G A+ L YLH ++IHRD+K+SNIL+ FE +++DF
Sbjct: 440 HG--KGRPTMEWSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADF 497
Query: 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 469
GLAK AS +++H++ T V GTFGYLAPEY GK+ +K DV++FGVVLLEL+TGR+PI
Sbjct: 498 GLAKIASDTNTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDV 556
Query: 470 DHPKGQESLVMWAKPILSS----GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA 525
++ SLV WA+P+L+ G ++D L N YD ++M RMV + C+R
Sbjct: 557 NNVHADNSLVDWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPR 616
Query: 526 RPQMSLVLKLLRGD 539
RP+M V ++L G+
Sbjct: 617 RPRMDQVARVLEGN 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 143/325 (44%), Positives = 197/325 (60%), Gaps = 19/325 (5%)
Query: 242 LHEKYSATCRLFNYQ--DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK--- 296
LH+ Y L N+ D+ AT NF EN+IG+GG + VY+G LP+GK +AVK L
Sbjct: 118 LHDIYDFQSSLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGT 177
Query: 297 PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 356
P E EF+ E+ II + H N +G C E + LV+ GSL LHG K
Sbjct: 178 PDEQT-AEFLSELGIIAHVDHPNTAKFIGCCIE-GGMHLVFRLSPLGSLGSLLHGPSK-- 233
Query: 357 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416
WS RY VA+G A+ L YLH G +R+IHRD+K+ NILL++DF+PQ+ DFGLAKW
Sbjct: 234 YKLTWSRRYNVALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLP 293
Query: 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 476
+H + GTFGY APEYFM+G V++K DV+AFGV+LLEL+TG + + Q+
Sbjct: 294 KQLTHHNVSKFEGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALD----ESQQ 349
Query: 477 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
SLV+WAKP+L + +L+DP+LG+ Y+ +++ R+ + LCI + RP+MS V++LL
Sbjct: 350 SLVLWAKPLLERKAIKELVDPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELL 409
Query: 537 RGDADVTKWAR------LQVNASEE 555
G DV R +Q SEE
Sbjct: 410 LGHEDVVMTPREAKIKMMQRTYSEE 434
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (670), Expect = 6e-69, Method: Compositional matrix adjust.
Identities = 130/295 (44%), Positives = 195/295 (66%), Gaps = 8/295 (2%)
Query: 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIEI 311
F Y++L T F N++G+GG VYKG L DGK +AVK LK S +EF E+EI
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 312 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 371
I+ +HH++++SL+G+C D+ LL+Y+++ +LE +LHG K W+ R ++A+G
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG--KGRPVLEWARRVRIAIGS 458
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
A+ L YLH ++IHRD+KS+NILL D+FE Q++DFGLAK ++ +H++ T V GTF
Sbjct: 459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVS-TRVMGTF 517
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----S 487
GYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ESLV WA+P+L
Sbjct: 518 GYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIE 577
Query: 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADV 542
+G ++L+D L +Y +++ RM+ + C+R RP+M V++ L + D+
Sbjct: 578 TGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDM 632
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 133/303 (43%), Positives = 195/303 (64%), Gaps = 12/303 (3%)
Query: 251 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPSEDVIKE--FVL 307
+ F Y ++ AT++F N++G GG S+VY+G L DG+ +AVK L K S D+ KE F+
Sbjct: 253 QCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLT 312
Query: 308 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 367
E+ II+ + H N LLG C E L LV+ F G+L LH N+ + W RYK+
Sbjct: 313 ELGIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHENEN--GSLDWPVRYKI 369
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 427
A+GVA L YLH R+IHRD+KSSN+LL D+EPQ++DFGLAKW +H V
Sbjct: 370 AVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPV 429
Query: 428 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 487
GTFGYLAPE M G +++K D+YAFG++LLE++TGR+P++ Q+ +++WAKP +
Sbjct: 430 EGTFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVN----PTQKHILLWAKPAME 485
Query: 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR--GDADVTKW 545
+G ++L+DP L + YD QM ++VL + C+++ P RP M+ VL+LL +A++ K
Sbjct: 486 TGNTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEIAKS 545
Query: 546 ARL 548
R+
Sbjct: 546 WRM 548
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | ||||||
| 255558560 | 758 | ATP binding protein, putative [Ricinus c | 0.957 | 0.771 | 0.726 | 0.0 | |
| 224082346 | 697 | predicted protein [Populus trichocarpa] | 0.872 | 0.764 | 0.763 | 0.0 | |
| 302141759 | 732 | unnamed protein product [Vitis vinifera] | 0.918 | 0.766 | 0.694 | 0.0 | |
| 224066793 | 738 | predicted protein [Populus trichocarpa] | 0.939 | 0.777 | 0.697 | 0.0 | |
| 356547275 | 736 | PREDICTED: uncharacterized protein LOC10 | 0.921 | 0.764 | 0.666 | 0.0 | |
| 449523137 | 756 | PREDICTED: uncharacterized LOC101203034 | 0.944 | 0.763 | 0.665 | 0.0 | |
| 449463428 | 756 | PREDICTED: uncharacterized protein LOC10 | 0.944 | 0.763 | 0.665 | 0.0 | |
| 356515943 | 743 | PREDICTED: probable receptor-like serine | 0.936 | 0.769 | 0.641 | 0.0 | |
| 356507630 | 750 | PREDICTED: probable receptor-like serine | 0.937 | 0.764 | 0.644 | 0.0 | |
| 351727927 | 649 | protein kinase family protein [Glycine m | 0.733 | 0.690 | 0.728 | 0.0 |
| >gi|255558560|ref|XP_002520305.1| ATP binding protein, putative [Ricinus communis] gi|223540524|gb|EEF42091.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2241), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/600 (72%), Positives = 499/600 (83%), Gaps = 15/600 (2%)
Query: 14 GTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLG-GSVMNLEQALV 72
G+ED +R +++ HRSIS+SK NSKV+++ G I P +G G+ QALV
Sbjct: 172 GSEDDQRKGFVNIFHRSISLSK-----NSKVISESG--INEAPKYVVGEGNEQTFHQALV 224
Query: 73 KARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAAST 132
KAR + GS K+NC++CG V N D SC+QS E+S D G ++SLA+VPV VE S+
Sbjct: 225 KARPNSLGSIMKQNCTVCGAVGNSLDESCNQSAEKSSGDNGGDNKSLALVPVSKVEGRSS 284
Query: 133 SITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQ-PSYLANSD 191
S L+ Q+PE +PGWPLLRRAI P +A DRSSLR+ISVVQWA+RLP+RQ S ++N D
Sbjct: 285 SFRSLIAQVPELKPGWPLLRRAILPGGQASDRSSLRQISVVQWAMRLPSRQLSSSISNLD 344
Query: 192 VKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCR 251
KQ G+ + +L+G+SGAIV VG + ++ P S DH++ +LP ELEG HEKYSATCR
Sbjct: 345 HKQ----NGEGQP-SLDGESGAIVAVGTDALTIPPSPDHNA-KLPIELEGFHEKYSATCR 398
Query: 252 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI 311
LF YQ+LLSATSNFLAE L+GKGGSSQVYKGCLPDGKELAVKILKPSEDV+KEFVLEIEI
Sbjct: 399 LFQYQELLSATSNFLAEYLVGKGGSSQVYKGCLPDGKELAVKILKPSEDVLKEFVLEIEI 458
Query: 312 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 371
ITTL+HKNIISLLGFCFE N LLLVYDFLSRGSLEENLHGN+KDP AF W ERYKVA+GV
Sbjct: 459 ITTLNHKNIISLLGFCFEYNKLLLVYDFLSRGSLEENLHGNRKDPLAFNWYERYKVAVGV 518
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
AEAL YLH+G+AQ VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI CTDVAGTF
Sbjct: 519 AEALNYLHTGTAQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIICTDVAGTF 578
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491
GYLAPEYFMYGKVN+KIDVYAFGVVLLELL+GRKPISND PKGQESLVMWAKPIL GK
Sbjct: 579 GYLAPEYFMYGKVNEKIDVYAFGVVLLELLSGRKPISNDLPKGQESLVMWAKPILDDGKF 638
Query: 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVN 551
QLLDP+LG++YD DQMERMVLA+ LC++R PRARPQMSLVLKLL GDA+VTKWARLQVN
Sbjct: 639 CQLLDPSLGDDYDQDQMERMVLAATLCVKRSPRARPQMSLVLKLLHGDAEVTKWARLQVN 698
Query: 552 ASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 611
EES+MLDDE+CPRSN+QSHLNLA LDVEDDS S+SSIEQ+VSLEDYL GR SRSSSFD
Sbjct: 699 KVEESDMLDDETCPRSNIQSHLNLAFLDVEDDSLSISSIEQTVSLEDYLQGRCSRSSSFD 758
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082346|ref|XP_002306655.1| predicted protein [Populus trichocarpa] gi|222856104|gb|EEE93651.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 812 bits (2098), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/536 (76%), Positives = 462/536 (86%), Gaps = 3/536 (0%)
Query: 78 CS-GSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSITM 136
CS S K NCS+CG V D SC+QS E S D D+SLA+VPV VE ++S++
Sbjct: 163 CSLASIMKENCSVCGSVMKPADDSCNQSAEASCGDRDGDDKSLALVPVPRVEEPTSSVST 222
Query: 137 LVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSY-LANSDVKQI 195
L+ Q+PE +PGWPLLR ++ P+R+ +RS +R+ISVVQWA+RLP+RQ S NSD KQ
Sbjct: 223 LIGQVPELKPGWPLLRSSVLPNRKTSNRSLVRQISVVQWAMRLPSRQLSLSTVNSDHKQD 282
Query: 196 TYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNY 255
D G+ E +NL+G+SGAIV VG E ++PLS DH+S LPKELEGLHEKYSATCRLF
Sbjct: 283 VSDKGE-EQLNLDGESGAIVAVGMETATAPLSPDHNSRSLPKELEGLHEKYSATCRLFQC 341
Query: 256 QDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL 315
Q+LLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV+KEFV EIEIITTL
Sbjct: 342 QELLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVLKEFVQEIEIITTL 401
Query: 316 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 375
HKNIISLLGFCFE NLLLVYDFLSRGSLEENLHGNKKDP AFGW+ERYKVA+G+AEAL
Sbjct: 402 SHKNIISLLGFCFEGKNLLLVYDFLSRGSLEENLHGNKKDPRAFGWNERYKVALGIAEAL 461
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
+YLHS SAQ VIHRDVKSSNILLSDDFEPQLSDFGLAKWA TSSSHI C DVAGTFGYLA
Sbjct: 462 DYLHSCSAQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWAPTSSSHIICNDVAGTFGYLA 521
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495
PEYFMYGKVN+KIDVYAFGVVLLELL+G+KPISND PKGQESLVMWAKPIL+ GKV+QLL
Sbjct: 522 PEYFMYGKVNNKIDVYAFGVVLLELLSGKKPISNDLPKGQESLVMWAKPILNGGKVSQLL 581
Query: 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEE 555
DP LG++ D DQMERMVLA+ LC+RR PRARPQMSLV+KLL+GDA+VT+WARLQVNA EE
Sbjct: 582 DPILGDSCDRDQMERMVLAATLCVRRAPRARPQMSLVVKLLQGDAEVTRWARLQVNAVEE 641
Query: 556 SEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 611
S++LDDE+CPRSNLQSHLNLALLDVE+DS S SS+EQS+SL+DYL GRWSRSSS D
Sbjct: 642 SDVLDDEACPRSNLQSHLNLALLDVENDSLSSSSLEQSISLQDYLQGRWSRSSSLD 697
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302141759|emb|CBI18962.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2035), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/596 (69%), Positives = 476/596 (79%), Gaps = 35/596 (5%)
Query: 16 EDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVKAR 75
E+HRRN LL I +S+S K + N V ++ S+I
Sbjct: 172 EEHRRNGLLGGIQQSVS--KKSKALNHGKVNEEPSTI----------------------- 206
Query: 76 SDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAASTSIT 135
C SA + L SCSQS E S D D+SLAIVPVQ +EA+S+SI+
Sbjct: 207 --CDPSACQS--------LELGLNSCSQSIEGSSGDSHHEDDSLAIVPVQKLEASSSSIS 256
Query: 136 MLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQI 195
+L+R+LPE RPGWPLLRRAI PDR+ +SS+R+ISVVQWA+RLP+R A+ D +
Sbjct: 257 LLIRELPELRPGWPLLRRAILPDRQTSTKSSVRQISVVQWAMRLPSRNFPSAASLDNIES 316
Query: 196 TYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNY 255
+ D ++ S NL+G+SGAIVPVG S+P S ST+L KELEGLHEKYSATCRLF +
Sbjct: 317 SCDGDEDLSTNLDGESGAIVPVGTVNASAPPSPSRSSTKLAKELEGLHEKYSATCRLFKF 376
Query: 256 QDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL 315
Q+L SATSNF+ ENLIGKGGSS+VY+GCL DGKELAVKILK S+D++KEF+LEIEII+TL
Sbjct: 377 QELFSATSNFMPENLIGKGGSSRVYRGCLSDGKELAVKILKQSDDILKEFLLEIEIISTL 436
Query: 316 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 375
HHKNIISLLGFCFE+NNLLLVYDFLSRGSLEENL+GNKKD AFGWSERYKVA+GVAEAL
Sbjct: 437 HHKNIISLLGFCFENNNLLLVYDFLSRGSLEENLYGNKKDLFAFGWSERYKVAVGVAEAL 496
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
+YLH GSAQ VIH DVKSSNILL+DDFEPQLSDFGLAKWASTSSSHITC+DVAGTFGY+A
Sbjct: 497 DYLHCGSAQAVIHGDVKSSNILLADDFEPQLSDFGLAKWASTSSSHITCSDVAGTFGYMA 556
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495
PEYFMYGKVN+KIDVYAFGVVLLELL+GRKPIS+D+PKGQESLVMWAKPIL GKV++LL
Sbjct: 557 PEYFMYGKVNEKIDVYAFGVVLLELLSGRKPISSDYPKGQESLVMWAKPILYGGKVSELL 616
Query: 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEE 555
DP+LG+NYD QMERMV A+ILCIRR PRARPQMSLVLKLL+GDA+ TKWARLQVNA E
Sbjct: 617 DPSLGSNYDSSQMERMVWAAILCIRRAPRARPQMSLVLKLLQGDAEATKWARLQVNACEG 676
Query: 556 SEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 611
S+ DDE+ P SNLQSHLNLALLDVE+DS SMSSIEQSVSLEDYL GRWSRSSSFD
Sbjct: 677 SDTPDDEAFPHSNLQSHLNLALLDVEEDSLSMSSIEQSVSLEDYLQGRWSRSSSFD 732
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066793|ref|XP_002302218.1| predicted protein [Populus trichocarpa] gi|222843944|gb|EEE81491.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2029), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/591 (69%), Positives = 481/591 (81%), Gaps = 17/591 (2%)
Query: 13 AGTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALV 72
+GT+DH + SLL V+HR+IS K + + N + +G S + D + LE+AL+
Sbjct: 158 SGTKDHSK-SLLSVVHRTISSEKKSRELNES--SANGGSKDDQDSDQI------LEKALM 208
Query: 73 KARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAAST 132
KARS+ S K NCS+CG D S ++S E S SD G D+SLA+VPV +E ++
Sbjct: 209 KARSNSLESIMKENCSVCGSATIFADDSSNESAEASSSDNGGDDKSLALVPVPRLEEPTS 268
Query: 133 SITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQW-ALRLPTRQPSYLANSD 191
S++ L+RQ+PE +PGWPLL RA+ PD++ + S +R++ VVQW L L T NSD
Sbjct: 269 SVSTLIRQVPELKPGWPLLCRAVLPDKKESNISLVRQVCVVQWEQLSLST------VNSD 322
Query: 192 VKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCR 251
KQ D G+++ NL+G+SGAIV VG E ++P + H+S PKELEGLHEKYSATCR
Sbjct: 323 HKQDGSDKGEDK-FNLDGESGAIVAVGMETATAPHTPHHNSRSPPKELEGLHEKYSATCR 381
Query: 252 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI 311
LF YQ+LLSATSNFLAENLIGKGGSSQVYKGCL DGKELAVKILKPSEDV+KEFVLEIEI
Sbjct: 382 LFQYQELLSATSNFLAENLIGKGGSSQVYKGCLSDGKELAVKILKPSEDVLKEFVLEIEI 441
Query: 312 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 371
ITTLHHKNIISLLGFCFED NLLLVYDFL RGSLE+NL+GNKKDP FGW+ERYKVA+GV
Sbjct: 442 ITTLHHKNIISLLGFCFEDKNLLLVYDFLPRGSLEDNLYGNKKDPLTFGWNERYKVALGV 501
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
AEAL+YLHS SAQ VIHRDVKSSNILLSDDFEPQLSDFGLAKWA TSSSHI CTDVAGTF
Sbjct: 502 AEALDYLHSCSAQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWAPTSSSHIICTDVAGTF 561
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491
GYLAPEYFMYGKVN KIDVYAFGVVLLELL+G+KPISND PKGQESLVMWAKPIL+ GKV
Sbjct: 562 GYLAPEYFMYGKVNKKIDVYAFGVVLLELLSGKKPISNDLPKGQESLVMWAKPILNGGKV 621
Query: 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVN 551
+QLLD +LG++YD DQMERMVLA+ LC++R PRARPQMSLV+KLL+GDA+ TKWARLQVN
Sbjct: 622 SQLLDSSLGDSYDLDQMERMVLAANLCVKRAPRARPQMSLVVKLLQGDAEATKWARLQVN 681
Query: 552 ASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLG 602
A+EES++LDDE+CPRSNL SHLNLALLDVEDD S+SSIE S+SLEDYL G
Sbjct: 682 AAEESDVLDDEACPRSNLLSHLNLALLDVEDDLLSLSSIEHSISLEDYLAG 732
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547275|ref|XP_003542041.1| PREDICTED: uncharacterized protein LOC100797280 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/600 (66%), Positives = 459/600 (76%), Gaps = 37/600 (6%)
Query: 12 FAGTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQAL 71
G + + LL IHR+IS K SKV+ DDG+ I K G+ + +L
Sbjct: 174 LKGLDQDHKTRLLGSIHRTIS-------KGSKVLDDDGTGIHEKGC----GNGEYSDHSL 222
Query: 72 VKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAAS 131
KA D K+ CSIC SEEES D + LAIVPVQ +AAS
Sbjct: 223 AKAFLDSKEFVEKKRCSICA------------SEEESCGDASDENNPLAIVPVQTNDAAS 270
Query: 132 TSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTRQPSYLANSD 191
+PGWPLLR+ I D++ ++S LR+ISVVQWA++LP+R SY A+ D
Sbjct: 271 -------------KPGWPLLRKTIASDKKCSEKSLLRQISVVQWAMQLPSRDLSYAAHQD 317
Query: 192 VKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCR 251
K D ++ + L+ SGA+VPV EI ++ S + +S +PKELEGLHEKYS+TCR
Sbjct: 318 HKANNCDQNKDQFLALDSKSGALVPVDAEIGTAS-SPERNSRSIPKELEGLHEKYSSTCR 376
Query: 252 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI 311
LF YQ+L+ ATSNFL ENLIGKGGSSQVY+GCLPDGKELAVKILKPS+DV+KEFVLEIEI
Sbjct: 377 LFEYQELVLATSNFLPENLIGKGGSSQVYRGCLPDGKELAVKILKPSDDVLKEFVLEIEI 436
Query: 312 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 371
ITTL+HKNIISLLGFCFED NLLLVYDFLSRGSLEENLHGNKK+P FGW+ERYKVAMGV
Sbjct: 437 ITTLNHKNIISLLGFCFEDGNLLLVYDFLSRGSLEENLHGNKKNPLVFGWTERYKVAMGV 496
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
AEALEYLH+ Q VIHRDVKSSN+LLS+DFEPQLSDFGLAKWASTSSSHI CTDVAGTF
Sbjct: 497 AEALEYLHNNEGQSVIHRDVKSSNVLLSEDFEPQLSDFGLAKWASTSSSHIICTDVAGTF 556
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491
GY+APEYFMYGKVNDKIDVYAFGVVLLELL+GRKPIS D+PKGQESLVMWA PIL+SGKV
Sbjct: 557 GYMAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISGDYPKGQESLVMWASPILNSGKV 616
Query: 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVN 551
Q+LDP+LG NYD+++MERMVLA+ LCIRR PRARP MSL+ KLL GD DV KWARL+ N
Sbjct: 617 LQMLDPSLGENYDHEEMERMVLAATLCIRRAPRARPLMSLISKLLGGDPDVIKWARLEAN 676
Query: 552 ASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 611
A E EMLD E+CP SNLQSHLNLALLDVEDDS SM S+EQ+VSLEDYL GRWSRSSSFD
Sbjct: 677 ALEAPEMLDGEACPPSNLQSHLNLALLDVEDDSLSMCSVEQNVSLEDYLRGRWSRSSSFD 736
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449523137|ref|XP_004168581.1| PREDICTED: uncharacterized LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 767 bits (1981), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/603 (66%), Positives = 477/603 (79%), Gaps = 26/603 (4%)
Query: 14 GTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDG-SSITSKPVDDLGGSVMNLEQALV 72
G E+ R ++LL ++ S S KV + + S+ ++ D+LG N +Q
Sbjct: 175 GNEEQRHSNLLAAVYGSAGSSP-------KVQSGESFGSLLARDRDNLGIG-KNSDQEFE 226
Query: 73 KARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAAST 132
KA S K+NCSICG + + QS E S SDG DESLA+VPVQ VE AS+
Sbjct: 227 KA---LSVGTDKQNCSICGSESSFVE----QSAEISSSDGEKHDESLALVPVQIVEVASS 279
Query: 133 SITMLVRQLPESRPGWPLLR---RAIFPDRRAP-DRSSLRKISVVQWALRLPTRQPSYLA 188
SIT L++QLPE +PGWPLLR ++ R+A DRS ++ISVVQWA++LP+R P Y A
Sbjct: 280 SITKLIKQLPEVKPGWPLLRHVDQSCESGRQASSDRSLAKQISVVQWAMKLPSRSPLYPA 339
Query: 189 NSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSA 248
D K T D +S+ L+G++GA+V VG+E V SPLS+D D+ LPKELEG HEKYS+
Sbjct: 340 ALDYKSNTSD----QSLGLDGENGAMVLVGSEPVPSPLSSDSDTETLPKELEGFHEKYSS 395
Query: 249 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLE 308
TCRLFNY +LL+ATSNFL ENLIGKGGSSQV++GCLPDGKE+AVKILK SEDV+KEFV+E
Sbjct: 396 TCRLFNYHELLTATSNFLPENLIGKGGSSQVFRGCLPDGKEVAVKILKTSEDVLKEFVME 455
Query: 309 IEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVA 368
+EIIT+L HKNIISLLGFCFE++ LLVYDFLSRG LEE LHGN+K+P FGWSERYKVA
Sbjct: 456 VEIITSLSHKNIISLLGFCFENSKFLLVYDFLSRGCLEEILHGNRKNPNTFGWSERYKVA 515
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 428
+GVAEAL+YLH AQ VIHRDVKSSNILLSDDFEPQLSDFGLAK S++SSH+TCTDVA
Sbjct: 516 VGVAEALDYLHL-DAQHVIHRDVKSSNILLSDDFEPQLSDFGLAK-RSSNSSHVTCTDVA 573
Query: 429 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 488
GTFGYLAPEYFMYGKVNDKIDVYA+GVVLLEL++GRKPIS ++PKGQESLVMWA+PIL
Sbjct: 574 GTFGYLAPEYFMYGKVNDKIDVYAYGVVLLELISGRKPISTEYPKGQESLVMWARPILID 633
Query: 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARL 548
GKV++LLDP LG NY+ D+MER+VLA+ LCIRR PRARP MSLVLKLL+GDADVTKWAR
Sbjct: 634 GKVSRLLDPTLGGNYNQDEMERVVLAASLCIRRAPRARPPMSLVLKLLQGDADVTKWARQ 693
Query: 549 QVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSS 608
Q+NA +S LDDE CPRS++QSHLNLALLDV+DDS S+SSIE S+SLEDYL GRWSRSS
Sbjct: 694 QINALGDSNTLDDEVCPRSDIQSHLNLALLDVDDDSLSLSSIEHSISLEDYLQGRWSRSS 753
Query: 609 SFD 611
SFD
Sbjct: 754 SFD 756
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463428|ref|XP_004149436.1| PREDICTED: uncharacterized protein LOC101203034 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 767 bits (1980), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/603 (66%), Positives = 476/603 (78%), Gaps = 26/603 (4%)
Query: 14 GTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDG-SSITSKPVDDLGGSVMNLEQALV 72
G E+ R ++LL ++ S S KV + + S+ ++ D+LG N +Q
Sbjct: 175 GNEEQRHSNLLAAVYGSAGSSP-------KVQSGESFGSLLARDRDNLGIG-KNSDQEFE 226
Query: 73 KARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQNVEAAST 132
KA S K+NCSICG + + QS E S SDG DESLA+VPVQ VE AS+
Sbjct: 227 KA---LSVGTDKQNCSICGSESSFVE----QSAEISSSDGEKHDESLALVPVQIVEVASS 279
Query: 133 SITMLVRQLPESRPGWPLLR---RAIFPDRRAP-DRSSLRKISVVQWALRLPTRQPSYLA 188
SIT L++QLPE +PGWPLLR ++ R+A DRS ++ISVVQWA++LP+R P Y A
Sbjct: 280 SITKLIKQLPEVKPGWPLLRHVDQSCESGRQASSDRSLAKQISVVQWAMKLPSRSPLYPA 339
Query: 189 NSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSA 248
D K T D +S+ L+G++GA+V VG+E V SPLS+D D+ LPKELEG HEKYS+
Sbjct: 340 ALDYKSNTSD----QSLGLDGENGAMVLVGSEPVPSPLSSDSDTETLPKELEGFHEKYSS 395
Query: 249 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLE 308
TCRLFNY +LL+ATSNFL ENLIGKGGSSQV++GCLPDGKE+AVKILK SEDV+KEFV+E
Sbjct: 396 TCRLFNYHELLTATSNFLPENLIGKGGSSQVFRGCLPDGKEVAVKILKTSEDVLKEFVME 455
Query: 309 IEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVA 368
+EIIT+L HKNIISLLGFCFE++ LLVYDFLSRG LEE LHGN+K+P FGWSERYKVA
Sbjct: 456 VEIITSLSHKNIISLLGFCFENSKFLLVYDFLSRGCLEEILHGNRKNPNTFGWSERYKVA 515
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 428
+GVAEAL+YLH AQ VIHRDVKSSNILLSDDFEPQLSDFGLAK S++SSH+TCTDVA
Sbjct: 516 VGVAEALDYLHL-DAQHVIHRDVKSSNILLSDDFEPQLSDFGLAK-RSSNSSHVTCTDVA 573
Query: 429 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 488
GTFGYLAPEYFMYGKVNDKIDVYA+GVVLLEL++GRKPIS +PKGQESLVMWA+PIL
Sbjct: 574 GTFGYLAPEYFMYGKVNDKIDVYAYGVVLLELISGRKPISTKYPKGQESLVMWARPILID 633
Query: 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARL 548
GKV++LLDP LG NY+ D+MER+VLA+ LCIRR PRARP MSLVLKLL+GDADVTKWAR
Sbjct: 634 GKVSRLLDPTLGGNYNQDEMERVVLAASLCIRRAPRARPPMSLVLKLLQGDADVTKWARQ 693
Query: 549 QVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSS 608
Q+NA +S LDDE CPRS++QSHLNLALLDV+DDS S+SSIE S+SLEDYL GRWSRSS
Sbjct: 694 QINALGDSNTLDDEVCPRSDIQSHLNLALLDVDDDSLSLSSIEHSISLEDYLQGRWSRSS 753
Query: 609 SFD 611
SFD
Sbjct: 754 SFD 756
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356515943|ref|XP_003526656.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 755 bits (1950), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/606 (64%), Positives = 459/606 (75%), Gaps = 34/606 (5%)
Query: 12 FAGTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSI-----TSKPVDDLGGSVMN 66
G + H RN LL IH ++ KN KV++DD S + + P+ D
Sbjct: 166 LQGVDRHNRNGLLGSIHWTLG-------KNRKVLSDDSSGMDADEKKTGPISD------- 211
Query: 67 LEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPVQN 126
+L K + + +CSICG LPD S QS E D G + SLA+VPVQ
Sbjct: 212 --HSLAKFFLESKETVRNPSCSICGTTLALPDPSFYQSAEGVSGDEGR-ENSLAMVPVQP 268
Query: 127 VEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLR-KISVVQWALRLPTRQPS 185
AA T E +PGWPLL I DR++ RS +ISVVQWA+RLP+R S
Sbjct: 269 TVAAKT----------ELKPGWPLLDGRILSDRQSAGRSLFHLQISVVQWAMRLPSRNLS 318
Query: 186 YLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEK 245
Y + D K D G ++ L+ +SGA+V V E+ ++ S +++S +PKELEGLHEK
Sbjct: 319 YAVDRDEKSKICDQGQDQPAALDSESGALVLVDAELGTAS-SPENNSGNIPKELEGLHEK 377
Query: 246 YSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEF 305
YS+TCRLF YQ+L+SATSNFL ENLIGKGGSSQVY+GCLPDGKELAVKIL PS+DV+ EF
Sbjct: 378 YSSTCRLFEYQELVSATSNFLHENLIGKGGSSQVYRGCLPDGKELAVKILNPSDDVLSEF 437
Query: 306 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 365
+LEIEIITTLHHKNIISLLGFCFE+ LLLVYDFLSRGSLEENLHGNKK+ FGWSERY
Sbjct: 438 LLEIEIITTLHHKNIISLLGFCFENGKLLLVYDFLSRGSLEENLHGNKKNSLVFGWSERY 497
Query: 366 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425
KVA+GVAEAL+YLHS Q VIHRDVKSSN+LLS++FEPQLSDFGLAKWAST SSHITCT
Sbjct: 498 KVAVGVAEALDYLHSKDDQPVIHRDVKSSNVLLSENFEPQLSDFGLAKWASTLSSHITCT 557
Query: 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485
DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL+GRKPIS D+PKGQESLVMWA PI
Sbjct: 558 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISRDYPKGQESLVMWASPI 617
Query: 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKW 545
L+SGKV QLLDP+LG+NYD+++ME++VLA+ LCI+R PRARPQM+L+ KLL+GDA+ KW
Sbjct: 618 LNSGKVLQLLDPSLGDNYDHEEMEKIVLAATLCIKRAPRARPQMNLISKLLQGDAEAIKW 677
Query: 546 ARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWS 605
ARLQVNA + EMLDDE+CP SNLQSH+NLALLDVEDD SM S+EQ ++LEDYL GRWS
Sbjct: 678 ARLQVNALDPPEMLDDEACPPSNLQSHINLALLDVEDDLLSMCSVEQGLTLEDYLRGRWS 737
Query: 606 RSSSFD 611
R+SSFD
Sbjct: 738 RASSFD 743
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507630|ref|XP_003522567.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/605 (64%), Positives = 462/605 (76%), Gaps = 32/605 (5%)
Query: 12 FAGTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQAL 71
G + H RN L+ I ++ K++KV++DD S + + + G V + +L
Sbjct: 173 LQGIDRHNRNGLIGSIQWTLG-------KSTKVLSDDNSGMEAD--EKKTGQVS--DHSL 221
Query: 72 VKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDE----SLAIVPVQNV 127
K + + +CSICG LPD SC QS +DG +GD+ SLAIVPVQ
Sbjct: 222 AKLFLESKETVRNPSCSICGTTLALPDSSCYQS-----ADGVSGDDGRENSLAIVPVQPS 276
Query: 128 EAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLR-KISVVQWALRLPTRQPSY 186
AA T E +PGWPLL R I DR++ DR + +ISVVQWA+RLP+R SY
Sbjct: 277 VAAIT----------EMKPGWPLLHRGILLDRQSADRLLMHPQISVVQWAMRLPSRNLSY 326
Query: 187 LANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKY 246
+ + K D G ++ L+ +SGA+VPV E+ ++ L +H+S +PKELEGLHEKY
Sbjct: 327 AVDCNEKPNICDQGQDQHAALDSESGALVPVDAELGTASLP-EHNSGNIPKELEGLHEKY 385
Query: 247 SATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV 306
S+TCRLF YQ+L+ ATSNFL NLIGKGGSSQVY+GCLPDGKELAVKILKPS++V+ EF+
Sbjct: 386 SSTCRLFEYQELVLATSNFLPGNLIGKGGSSQVYRGCLPDGKELAVKILKPSDNVLSEFL 445
Query: 307 LEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 366
LEIEIITTLHHKNIISLLGFCFE+ LLLVYDFLSRGSLEENLHGNKK FGWSERYK
Sbjct: 446 LEIEIITTLHHKNIISLLGFCFENGKLLLVYDFLSRGSLEENLHGNKKISLVFGWSERYK 505
Query: 367 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 426
VA+G+AEAL+YLHS Q VIHRDVKSSN+LLS+DFEPQL DFGLAKWAST SSHITCTD
Sbjct: 506 VAVGIAEALDYLHSKDDQPVIHRDVKSSNVLLSEDFEPQLCDFGLAKWASTLSSHITCTD 565
Query: 427 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486
VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL+GRKPIS D+PKGQESLVMWA PIL
Sbjct: 566 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISPDYPKGQESLVMWATPIL 625
Query: 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWA 546
+SGKV QLLDP+LG NYD+ +ME+MVLA+ LCI+R PRARPQMSL+ KLL+GDA+ K A
Sbjct: 626 NSGKVLQLLDPSLGENYDHGEMEKMVLAATLCIKRAPRARPQMSLISKLLQGDAEAIKRA 685
Query: 547 RLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSR 606
RLQVNA + EMLDDE+CP SNLQSH+NLALLDVEDDS SM S+EQ ++LEDYL GRWSR
Sbjct: 686 RLQVNALDAPEMLDDEACPPSNLQSHINLALLDVEDDSLSMCSVEQGLTLEDYLRGRWSR 745
Query: 607 SSSFD 611
+SSFD
Sbjct: 746 ASSFD 750
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727927|ref|NP_001238713.1| protein kinase family protein [Glycine max] gi|223452363|gb|ACM89509.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1866), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 359/493 (72%), Positives = 403/493 (81%), Gaps = 45/493 (9%)
Query: 119 LAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALR 178
LAIVPVQ +AAS +PGWPLLR+ I DR+ RS L +ISVVQWA+
Sbjct: 202 LAIVPVQTNDAAS-------------KPGWPLLRKTIVSDRKCSQRSLLCQISVVQWAMH 248
Query: 179 LPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKE 238
SGA+VPV EI ++P ST+H+S +PKE
Sbjct: 249 -------------------------------KSGALVPVDAEIGTAP-STEHNSRSIPKE 276
Query: 239 LEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS 298
LEGLHEKYS+TCRLF YQ+L+ ATSNFL ENLIGKGGSSQVY+GCLPDGKELAVKILKPS
Sbjct: 277 LEGLHEKYSSTCRLFKYQELVLATSNFLPENLIGKGGSSQVYRGCLPDGKELAVKILKPS 336
Query: 299 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 358
+DV+KEFVLEIEIITTL+HK++ISLLGFCFED NLLLVYDFLSRGSLEENLHGNKK+P
Sbjct: 337 DDVLKEFVLEIEIITTLNHKSLISLLGFCFEDGNLLLVYDFLSRGSLEENLHGNKKNPLM 396
Query: 359 FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418
FGW+ERYKVA+GVAEALEYLH+ Q VIHRDVKSSN+LLS+DFEPQLSDFGLAKWAST+
Sbjct: 397 FGWTERYKVAIGVAEALEYLHNNDGQSVIHRDVKSSNVLLSEDFEPQLSDFGLAKWASTT 456
Query: 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 478
SSHI CTDVAGTFGY+APEYFMYGKVNDKIDVYAFGVVLLELL+GRKPIS D+PKGQESL
Sbjct: 457 SSHIICTDVAGTFGYMAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPISGDYPKGQESL 516
Query: 479 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538
VMWA PIL+SGKV QLLDP+LG+NY++++MERMVLA+ LC RR PRARPQMSL+ KLL G
Sbjct: 517 VMWASPILNSGKVLQLLDPSLGDNYNHEEMERMVLAATLCTRRAPRARPQMSLISKLLGG 576
Query: 539 DADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLED 598
D DV KWARL+VNA E EMLDDE+CP SNLQSHLNLALLDVEDDS SM S+EQ+VSLED
Sbjct: 577 DPDVIKWARLEVNALEAPEMLDDEACPPSNLQSHLNLALLDVEDDSLSMCSVEQNVSLED 636
Query: 599 YLLGRWSRSSSFD 611
YL GRWSRSSSFD
Sbjct: 637 YLRGRWSRSSSFD 649
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 611 | ||||||
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.905 | 0.696 | 0.616 | 3.5e-178 | |
| TAIR|locus:2026957 | 756 | AT1G21590 [Arabidopsis thalian | 0.949 | 0.767 | 0.560 | 1.8e-167 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.867 | 0.751 | 0.556 | 1.4e-149 | |
| TAIR|locus:2059919 | 617 | AT2G16750 [Arabidopsis thalian | 0.549 | 0.544 | 0.556 | 2.4e-106 | |
| TAIR|locus:2156050 | 552 | AT5G37790 [Arabidopsis thalian | 0.707 | 0.782 | 0.399 | 1.9e-74 | |
| TAIR|locus:2044420 | 392 | AT2G18890 [Arabidopsis thalian | 0.549 | 0.857 | 0.433 | 2.3e-71 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.618 | 0.526 | 0.387 | 4.7e-70 | |
| TAIR|locus:2028967 | 467 | AT1G66460 [Arabidopsis thalian | 0.540 | 0.706 | 0.450 | 5.5e-70 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.592 | 0.325 | 0.388 | 1.6e-69 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.494 | 0.396 | 0.449 | 3.3e-69 |
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1730 (614.0 bits), Expect = 3.5e-178, P = 3.5e-178
Identities = 356/577 (61%), Positives = 429/577 (74%)
Query: 44 VVTDDGSSITSKPVDDLGGSVMNLEQALVKARSDCSGSAAKRNCSICG-----PVRNLPD 98
V + + + S +D +QA + +A NCS+CG P
Sbjct: 233 VTLNKTTKVVSHSEEDSNSKEEEEDQACGQNLRQVLAAARLENCSVCGFDSLSPNDTTTP 292
Query: 99 GSCS-QSEEESPSDGGAGDESLAIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFP 157
G S S+ + D ++++ IVPV E + S+TMLVR+LPE RPGWPLLRRA+
Sbjct: 293 GKLSGASDFDRSEDDDECNKAMEIVPVNGSEDSGGSVTMLVRKLPEPRPGWPLLRRAV-- 350
Query: 158 DRRAPDRSSLRKISVVQWALRLPTRQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPV 217
+ KI VVQWAL+LP R D KQ+ YD ++ LN A+VP
Sbjct: 351 -STLGQSVTPHKIPVVQWALKLPPR--------DTKQLGYDSSEDNLSTLN----ALVPF 397
Query: 218 GNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS 277
G +++ D+ +LP+ELEGL+E++S+TCR F Y++L+S TSNF A+N IGKGGSS
Sbjct: 398 GINSITNKSIPDNSPRKLPEELEGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSS 457
Query: 278 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337
+V++GCL +G+ +AVKILK +EDV+ +FV EIEIITTLHHKNIISLLGFCFED+NLLLVY
Sbjct: 458 RVFRGCLSNGRVVAVKILKQTEDVLNDFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVY 517
Query: 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 397
++LSRGSLEENLHGNKKDP AF WSERYKVA+GVAEAL+YLH+ ++Q VIHRDVKSSNIL
Sbjct: 518 NYLSRGSLEENLHGNKKDPLAFCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNIL 577
Query: 398 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 457
LSDDFEPQLSDFGLA+WAS S++HI C+DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL
Sbjct: 578 LSDDFEPQLSDFGLARWASISTTHIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 637
Query: 458 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL--GNNYDYDQMERMVLAS 515
LELL+GRKPIS+ PKGQESLVMWAKPIL GK +QLLDP+L NN + DQM+RM LA+
Sbjct: 638 LELLSGRKPISSGCPKGQESLVMWAKPILDDGKYSQLLDPSLRDNNNNNDDQMQRMALAA 697
Query: 516 ILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNAS-EESEMLDDESCPRSNLQSHLN 574
LCIRR P+ARP+MS+VLKLL+GD D +WA QVN+S EESEML DE C RSNLQSHLN
Sbjct: 698 TLCIRRSPQARPKMSIVLKLLKGDEDTLEWAMQQVNSSSEESEMLKDEQCQRSNLQSHLN 757
Query: 575 LALLDVEDDSFSMSSIEQSVSLEDYLLGRWSRSSSFD 611
LALLDVEDDS SM SIEQ VS+EDYL GR SRSSSFD
Sbjct: 758 LALLDVEDDSISMGSIEQGVSVEDYLKGRTSRSSSFD 794
|
|
| TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1629 (578.5 bits), Expect = 1.8e-167, P = 1.8e-167
Identities = 341/608 (56%), Positives = 441/608 (72%)
Query: 14 GTEDHRRNSLLDVIHRSISMSKITGQKNSKVVTDDGSSITSKPVDDLGGSVMNLEQALVK 73
G D RRN+L S +T +KN+KVV S + + ++ + +L ++LV
Sbjct: 167 GKSDARRNTL-----SSFFQMPVTLRKNTKVVNH--SEVEEEEAEEDHSNGQSLRRSLVY 219
Query: 74 ARSDCSGSAAKRNCSICGPVRNLPD-GSCSQSEE-ESPSDGGAG-DESLAIVPVQNVEAA 130
A C G NCS+ + +LP G+ S+S D A +++A+VP + E
Sbjct: 220 A---CLG-----NCSV-RDMNSLPTPGNLSRSSSCNGDQDDNADLHKAMALVPAKFPEDL 270
Query: 131 STSITMLVRQLPESRPGWPLLRRAIFPD--RRAPDRSSLRKISVVQWALRLPTRQPSYLA 188
+ ITMLV++LPE RPGWPLL R D AP SS RKI VVQW L+LP R S +
Sbjct: 271 TPFITMLVKELPEFRPGWPLLCRVASSDVLASAPRSSSFRKIPVVQWVLKLPARTNSVVG 330
Query: 189 NSDVKQITYDPGDNES----INLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHE 244
+SD KQI +D ++E + N + AIVP + IV L DH S P+ +EGL
Sbjct: 331 SSDTKQIGFDSSESEENDKLSSSNVERQAIVPDESMIVKCSL--DHSSGRFPENVEGLQA 388
Query: 245 KYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE 304
+ S +C+ F Y++L+S TSNF A+N IGKGGSS+V++G LP+G+E+AVKILK +E V+K+
Sbjct: 389 RISTSCQFFTYKELVSVTSNFCADNFIGKGGSSRVFRGYLPNGREVAVKILKRTECVLKD 448
Query: 305 FVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 364
FV EI+IITTLHHKN+ISLLG+CFE+NNLLLVY++LSRGSLEENLHGNKKD AF W+ER
Sbjct: 449 FVAEIDIITTLHHKNVISLLGYCFENNNLLLVYNYLSRGSLEENLHGNKKDLVAFRWNER 508
Query: 365 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424
YKVA+G+AEAL+YLH+ + Q VIHRDVKSSNILLSDDFEPQLSDFGLAKWAS S++ I C
Sbjct: 509 YKVAVGIAEALDYLHNDAPQPVIHRDVKSSNILLSDDFEPQLSDFGLAKWASESTTQIIC 568
Query: 425 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 484
+DVAGTFGYLAPEYFMYGK+N+KIDVYA+GVVLLELL+GRKP++++ PK Q+SLVMWAKP
Sbjct: 569 SDVAGTFGYLAPEYFMYGKMNNKIDVYAYGVVLLELLSGRKPVNSESPKAQDSLVMWAKP 628
Query: 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTK 544
IL + +QLLD +L ++ + DQME+M LA+ LCIR +P+ RP M +VL+LL+GD ++ K
Sbjct: 629 ILDDKEYSQLLDSSLQDDNNSDQMEKMALAATLCIRHNPQTRPTMGMVLELLKGDVEMLK 688
Query: 545 WARLQV-NASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGR 603
WA+LQV N E+S +L DE RSNLQSHLNLA LD+EDDS SM S+EQ +S+E+YL GR
Sbjct: 689 WAKLQVSNPLEDSMLLKDEKLRRSNLQSHLNLAFLDMEDDSLSMGSMEQGISVEEYLKGR 748
Query: 604 WSRSSSFD 611
SRSSSF+
Sbjct: 749 TSRSSSFN 756
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1460 (519.0 bits), Expect = 1.4e-149, P = 1.4e-149
Identities = 309/555 (55%), Positives = 397/555 (71%)
Query: 62 GSVMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGS-CSQSEE-ESPSDGGAGDESL 119
G MN+ +LV D + AAK S P R + S+S +SP G D L
Sbjct: 169 GPQMNIP-SLVCGSPDIAIEAAKIGNSF-SPARTSSRWTRTSRSSSLQSPDSLGV-DNLL 225
Query: 120 AIVPVQNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRL 179
A+VPVQ E S S+ ES PGW LR +R++ + S +K +V+QW RL
Sbjct: 226 ALVPVQTNETDSGSL--------ESGPGWHFLRGLYGNNRKSWTKVSAKK-AVLQWVSRL 276
Query: 180 PTRQPSYLANSDVKQITYDPGDNE--SINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPK 237
R + D K+ D G +E S +++G+ +I G+E++ SPLS S +P+
Sbjct: 277 RGRHSETVIYLDRKRS--DSGCDEDCSSSIDGEDVSISRFGSELMQSPLSPFIGSNNIPE 334
Query: 238 ELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP 297
ELEGLHEKYS+TCRLF Y+++LS TSNF +ENL+G+GG+S VY+G LPDG+ELAVKILKP
Sbjct: 335 ELEGLHEKYSSTCRLFTYEEVLSITSNFASENLVGEGGNSYVYRGDLPDGRELAVKILKP 394
Query: 298 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 357
DV+KEF+LEIE+IT++HHKNI+SL GFCFE+NNL+LVYD+L RGSLEENLHGN+KD
Sbjct: 395 CLDVLKEFILEIEVITSVHHKNIVSLFGFCFENNNLMLVYDYLPRGSLEENLHGNRKDAK 454
Query: 358 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417
FGW ERYKVA+GVAEAL+YLH+ VIHRDVKSSN+LL+DDFEPQLSDFG A AS+
Sbjct: 455 KFGWMERYKVAVGVAEALDYLHNTHDPEVIHRDVKSSNVLLADDFEPQLSDFGFASLASS 514
Query: 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 477
+S H+ D+AGTFGYLAPEYFM+GKV DKIDVYAFGVVLLEL++GRKPI D KGQES
Sbjct: 515 TSQHVAGGDIAGTFGYLAPEYFMHGKVTDKIDVYAFGVVLLELISGRKPICVDQSKGQES 574
Query: 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
LV+WA PIL SGK QLLDP+L N+ D +E+++LA+ LCI+R P RPQ+ LVLK+L+
Sbjct: 575 LVLWANPILDSGKFAQLLDPSLENDNSNDLIEKLLLAATLCIKRTPHDRPQIGLVLKILQ 634
Query: 538 GDADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIE-QSVSL 596
G+ + T+W + QV ASE D S +N++SH+NLALLD+EDD+ S SS E S+S+
Sbjct: 635 GEEEATEWGKQQVRASE------DVSAYLTNIESHINLALLDLEDDAASDSSPEASSISV 688
Query: 597 EDYLLGRWSRSSSFD 611
E+YL GRWSR++SF+
Sbjct: 689 EEYLKGRWSRTASFN 703
|
|
| TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 2.4e-106, Sum P(2) = 2.4e-106
Identities = 192/345 (55%), Positives = 250/345 (72%)
Query: 251 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEI 309
R F+Y L +ATS+F ENLIGKGG ++VYKG L DGK +AVKILKPS ++ +KEFV E+
Sbjct: 263 RWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKILKPSVKEAVKEFVHEV 322
Query: 310 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 369
I+++L H NI L+G C N+L+ VY+ S+GSLEE L G W ER K+A+
Sbjct: 323 SIVSSLSHSNISPLIGVCVHYNDLISVYNLSSKGSLEETLQGKH----VLRWEERLKIAI 378
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
G+ EAL+YLH+ + VIHRDVKSSN+LLSD+FEPQLSDFGL+ W S S + DV G
Sbjct: 379 GLGEALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLSMWGSKSCRYTIQRDVVG 438
Query: 430 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489
TFGYLAPEYFMYGKV+DK+DVYAFGVVLLEL++GR IS+D P+GQESLVMWAKP++ G
Sbjct: 439 TFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSPRGQESLVMWAKPMIEKG 498
Query: 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQ 549
+LLDP + +D DQ +MVLA+ C+ R RP + +LKLLRG+ DV+KW +++
Sbjct: 499 NAKELLDPNIAGTFDEDQFHKMVLAATHCLTRAATYRPNIKEILKLLRGEDDVSKWVKIE 558
Query: 550 VNASEESEMLDDESCPRSNLQSHLNLALLDVED-DSFSMSSIEQS 593
++ + DDE P SN + HL+LA++DVED DS S SS+E+S
Sbjct: 559 ---EDDEDGFDDEVYPNSNTELHLSLAMVDVEDNDSVSNSSLERS 600
|
|
| TAIR|locus:2156050 AT5G37790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 751 (269.4 bits), Expect = 1.9e-74, P = 1.9e-74
Identities = 185/463 (39%), Positives = 260/463 (56%)
Query: 143 ESRPGWPLLRRAIFPDRRAPD----RSSLRKISVVQWAL-RLPTRQPSYLANSDVKQITY 197
E+ W L A P+ PD SS R Q L ++ +PS A+S + ++
Sbjct: 93 ENNKAWLLAETA--PENMNPDPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSV 150
Query: 198 DPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQD 257
G + +N ++G GN +TD + LE + T F+Y +
Sbjct: 151 SGGSTTVLMVNLENGVKETTGN-------ATDDLRWTRARSLEKSISPVANTLVRFSYGE 203
Query: 258 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKE-LAVKIL-KPSEDVIKEFVLEIEIITTL 315
+++AT NF ++G+G S V++G + + LA+K L K ++ K F E+ I ++L
Sbjct: 204 IVAATRNFSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSL 263
Query: 316 HHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFG--WSERYKVAM 369
H NI+ LLGFC + + L LVY ++S GSLE LH KK AAFG WS RYKVA+
Sbjct: 264 HSSNIVPLLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVAL 323
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
G+A+A+ YLH+G+ Q V+HRD+K SNILLS P+L DFGLA W + S C V G
Sbjct: 324 GIADAIAYLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKG 383
Query: 430 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489
TFGYLAPEYF +GK++DK DVYAFGVVLLEL+TGRKPI GQE+LV+WAKP+L G
Sbjct: 384 TFGYLAPEYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRASGQENLVVWAKPLLDRG 443
Query: 490 --KVTQLLDPALG-NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADV---T 543
+ +LLDP L + QMERM+ A+ C+ + RP M ++ +L+G+ V T
Sbjct: 444 IEAIVELLDPRLKCTRKNSVQMERMIRAAAACVINEESRRPGMEEIVSILKGEEGVEPET 503
Query: 544 KWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDV---EDD 583
+R N S + +S ++ HL+LA+L V EDD
Sbjct: 504 HSSRKTTNISGMIDSYTQLQQTKSEMKCHLDLAMLGVTEFEDD 546
|
|
| TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 722 (259.2 bits), Expect = 2.3e-71, P = 2.3e-71
Identities = 154/355 (43%), Positives = 222/355 (62%)
Query: 223 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 282
SSPL+ ST+ + + + + F++Q++ AT+ F +ENL+G+GG ++VYKG
Sbjct: 28 SSPLAAS--STKCVEGFQETDQFQRPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKG 85
Query: 283 CL-PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337
L +G+E+AVK + + E KEF++EI I + H N++SLLG C DN L LV+
Sbjct: 86 ILGKNGEEIAVKRITRGGRDDERREKEFLMEIGTIGHVSHPNVLSLLGCCI-DNGLYLVF 144
Query: 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 397
F SRGSL LH + P W RYK+A+G A+ L YLH G +R+IHRD+KSSN+L
Sbjct: 145 IFSSRGSLASLLHDLNQAPLE--WETRYKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVL 202
Query: 398 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 457
L+ DFEPQ+SDFGLAKW + SH + + GTFG+LAPEY+ +G V++K DV+AFGV L
Sbjct: 203 LNQDFEPQISDFGLAKWLPSQWSHHSIAPIEGTFGHLAPEYYTHGIVDEKTDVFAFGVFL 262
Query: 458 LELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL 517
LEL++G+KP+ H +SL WAK I+ G++ +L+DP +G +D Q+ R+ A+ L
Sbjct: 263 LELISGKKPVDASH----QSLHSWAKLIIKDGEIEKLVDPRIGEEFDLQQLHRIAFAASL 318
Query: 518 CIRRDPRARPQMSLVLKLLRG-DADVTKWARLQVNASEES----EMLDDESCPRS 567
CIR RP M VL++L+G D + KW + +E E L+D C S
Sbjct: 319 CIRSSSLCRPSMIEVLEVLQGEDIEKEKWKMEEEEEVKEEFWGYEDLEDCECDSS 373
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 4.7e-70, Sum P(2) = 4.7e-70
Identities = 152/392 (38%), Positives = 233/392 (59%)
Query: 182 RQPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLST-DHDSTELPKELE 240
R+ +S + Y P N S+N G GN S+ S+ D +S PK
Sbjct: 284 RRKQKKGSSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKHGR 343
Query: 241 GLHEK-YSATCRL-FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP- 297
G + T ++ F Y++L T F ++G+GG VYKG L +GK +A+K LK
Sbjct: 344 GTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSV 403
Query: 298 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 357
S + +EF E+EII+ +HH++++SL+G+C + + L+Y+F+ +L+ +LHG K+
Sbjct: 404 SAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLP 461
Query: 358 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417
WS R ++A+G A+ L YLH ++IHRD+KSSNILL D+FE Q++DFGLA+ T
Sbjct: 462 VLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDT 521
Query: 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 477
+ SHI+ T V GTFGYLAPEY GK+ D+ DV++FGVVLLEL+TGRKP+ P G+ES
Sbjct: 522 AQSHIS-TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEES 580
Query: 478 LVMWAKPIL----SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 533
LV WA+P L G +++++DP L N+Y ++ +M+ + C+R RP+M V+
Sbjct: 581 LVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVV 640
Query: 534 KLL--RGD-ADVTKWARLQVNASEESEMLDDE 562
+ L R D +D+T ++ + +S +E
Sbjct: 641 RALDTRDDLSDLTNGVKVGQSRVYDSGQYSNE 672
|
|
| TAIR|locus:2028967 AT1G66460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 5.5e-70, P = 5.5e-70
Identities = 155/344 (45%), Positives = 215/344 (62%)
Query: 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDG-KELAVKIL-KPSEDVIKEFVLEIE 310
F+Y++LL+AT NF ++G+G S V+KG + K +A+K L K ++ K F E+
Sbjct: 117 FSYRELLTATRNFSKRRVLGRGACSYVFKGRIGIWRKAVAIKRLDKKDKESPKSFCRELM 176
Query: 311 IITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKD-----PAAFGWSER 364
I ++L+ N++ LLGFC + D L LVY ++S GSLE LH KK P WS R
Sbjct: 177 IASSLNSPNVVPLLGFCIDPDQGLFLVYKYVSGGSLERFLHDKKKKKSRKTPLNLPWSTR 236
Query: 365 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424
YKVA+G+A+A+ YLH+G+ Q V+HRD+K SNILLS + P+L DFGLA W + S C
Sbjct: 237 YKVALGIADAIAYLHNGTEQCVVHRDIKPSNILLSSNKIPKLCDFGLATWTAAPSVPFLC 296
Query: 425 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 484
V GTFGYLAPEYF +GK++DK DVYAFGVVLLEL+TGRKPI P G+E+LV+WAKP
Sbjct: 297 KTVKGTFGYLAPEYFQHGKISDKTDVYAFGVVLLELITGRKPIEARRPSGEENLVVWAKP 356
Query: 485 ILSSG-KVTQ-LLDPALG-NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541
+L G + T+ LLDP L + MERM+ A+ C+ + RP M +L +L+G
Sbjct: 357 LLHRGIEATEELLDPRLKCTRKNSASMERMIRAAAACVINEESRRPGMKEILSILKGGEG 416
Query: 542 V---TKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVED 582
+ T +R + N + +S ++SHL LA+L V +
Sbjct: 417 IELRTLSSRKKSNLPGIMDCYPQLQRTKSEMKSHLTLAMLGVTE 460
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 1.6e-69, Sum P(2) = 1.6e-69
Identities = 145/373 (38%), Positives = 223/373 (59%)
Query: 246 YSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-IKE 304
++ + + F +++ AT+NF ++G+GG +VY+G DG ++AVK+LK + +E
Sbjct: 704 FTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSRE 763
Query: 305 FVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 364
F+ E+E+++ LHH+N+++L+G C ED N LVY+ + GS+E +LHG K + W R
Sbjct: 764 FLAEVEMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSVESHLHGIDKASSPLDWDAR 823
Query: 365 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA--STSSSHI 422
K+A+G A L YLH S+ RVIHRD KSSNILL +DF P++SDFGLA+ A + HI
Sbjct: 824 LKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHI 883
Query: 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482
+ T V GTFGY+APEY M G + K DVY++GVVLLELLTGRKP+ P GQE+LV W
Sbjct: 884 S-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVSWT 942
Query: 483 KPILSSGK-VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV---LKLLRG 538
+P L+S + + ++D +LG +D + ++ + +C++ + RP M V LKL+
Sbjct: 943 RPFLTSAEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQALKLVSN 1002
Query: 539 DADVTKWARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLED 598
+ D K + S++ + DD S S +A + + S E+ +S +
Sbjct: 1003 ECDEAKELNSLTSISKD-DFRDDTQAESSCGDSSARMARYPLLPNYDSEPDTERGLSTSE 1061
Query: 599 YLLG--RWSRSSS 609
G R+ R S+
Sbjct: 1062 MYTGSGRFERQSN 1074
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 682 (245.1 bits), Expect = 3.3e-69, Sum P(2) = 3.3e-69
Identities = 142/316 (44%), Positives = 203/316 (64%)
Query: 252 LFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK-PSEDVIKEFVLEIE 310
LF+Y++L+ AT+ F ENL+G+GG +VYKG LPD + +AVK LK +EF E++
Sbjct: 417 LFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEVD 476
Query: 311 IITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 370
I+ +HH+N++S++G+C +N LL+YD++ +L +LH W+ R K+A G
Sbjct: 477 TISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHA--AGTPGLDWATRVKIAAG 534
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
A L YLH R+IHRD+KSSNILL ++F +SDFGLAK A ++HIT T V GT
Sbjct: 535 AARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT-TRVMGT 593
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490
FGY+APEY GK+ +K DV++FGVVLLEL+TGRKP+ P G ESLV WA+P+LS+
Sbjct: 594 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNAT 653
Query: 491 VTQ----LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG--DADVTK 544
T+ L DP LG NY +M RM+ A+ CIR RP+MS +++ + D+T
Sbjct: 654 ETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLAEEDLTN 713
Query: 545 WARLQ----VNASEES 556
RL +N++++S
Sbjct: 714 GMRLGESEIINSAQQS 729
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_Genewise1_v1.C_LG_V0045 | hypothetical protein (697 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 611 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-44 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-39 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-30 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-22 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-16 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-14 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-04 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 2e-51
Identities = 87/268 (32%), Positives = 127/268 (47%), Gaps = 36/268 (13%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---EIEIITTLHHKNIISLLGF 326
+G G VYK GK +AVKILK + K+ EI I+ L H NI+ L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
+ ++L LV ++ G L + L E K+A+ + LEYLHS +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFMYG 442
IHRD+K NILL ++ +++DFGLAK SSS T GT Y+APE YG
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS--LTTFVGTPWYMAPEVLLGGNGYG 177
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL---VMWAKPILSSGKVTQLLDPAL 499
K+DV++ GV+L ELLTG+ P S ++ Q L ++ K + + A
Sbjct: 178 P---KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234
Query: 500 GNNYDYDQMERMVLASILCIRRDPRARP 527
D +++ C+ +DP RP
Sbjct: 235 ------DLIKK-------CLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 72/195 (36%), Positives = 114/195 (58%), Gaps = 13/195 (6%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G+GG VY GK++A+KI+K S +++E + EIEI+ L+H NI+ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
++N+L LV ++ GSL++ L N+ E ++ + + E LEYLHS +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHS---NGII 114
Query: 388 HRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVN 445
HRD+K NILL SD+ + +L+DFGL+K +S + GT Y+APE + G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 446 DKIDVYAFGVVLLEL 460
+K D+++ GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 2e-47
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 269 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDV--IKEFVLEIEIITTLHHKNIISLLG 325
+G+G +VY GK +A+K++K + + + EI+I+ L H NI+ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHSGS 382
+++ L LV ++ G L + L + A F + + ALEYLHS
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQ-------ILSALEYLHS-- 115
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
+ ++HRD+K NILL +D +L+DFGLA+ T GT Y+APE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISNDH 471
+D+++ GV+L ELLTG+ P D
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPPFPGDD 200
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 9e-45
Identities = 88/277 (31%), Positives = 131/277 (47%), Gaps = 36/277 (12%)
Query: 271 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 323
+G+G +VYKG L DGKE+ AVK LK SE I+EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
LG C E+ L++V +++ G L + L K P S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+ IHRD+ + N L+ ++ ++SDFGL++ + ++APE GK
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 444 VNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499
K DV++FGV+L E+ T G +P +SN L G L P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE----------VLEYLKKGYR--LPKPPN 228
Query: 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
Y M + C DP RP S ++++L
Sbjct: 229 CPPELYKLMLQ-------CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 5e-44
Identities = 71/206 (34%), Positives = 110/206 (53%), Gaps = 15/206 (7%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 328
IGKGG +VYK GKE+A+K++K KE ++ EI+I+ H NI+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 386
+ + L +V +F S GSL++ L + +E V + + LEYLHS +
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHS---NGI 119
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 446
IHRD+K++NILL+ D E +L DFGL+ S + + T + GT ++APE +
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVINGKPYDY 176
Query: 447 KIDVYAFGVVLLELLTGRKPISNDHP 472
K D+++ G+ +EL G+ P S P
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 84/278 (30%), Positives = 128/278 (46%), Gaps = 39/278 (14%)
Query: 271 IGKGGSSQVYKGCL----PDGKEL-AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 323
+G+G +VYKG L K AVK LK SE I+EF+ E I+ L H N++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
LG C E+ L +V +++ G L L N+ S+ A+ +A +EYL S
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLES--- 120
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYG 442
+ IHRD+ + N L+ ++ ++SDFGL++ + ++APE G
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178
Query: 443 KVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498
K K DV++FGV+L E+ T G +P +SN+ L +G L P
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----------VLEYLKNGYR--LPQPP 226
Query: 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
YD M + C DP RP S ++++L
Sbjct: 227 NCPPELYDLMLQ-------CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 79/272 (29%), Positives = 124/272 (45%), Gaps = 41/272 (15%)
Query: 269 NLIGKGGSSQVYKGCLPD-GKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLL 324
L+G+G VY D G+ +AVK + SE+ ++ EI I+++L H NI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 325 GFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE----RYKVAMGVAEALEYL 378
G E N L + +++S GSL L K P E +Y + E L YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP------EPVIRKY-TRQ-ILEGLAYL 117
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
HS ++HRD+K +NIL+ D +L+DFG AK + V GT ++APE
Sbjct: 118 HS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL---L 495
+ D+++ G ++E+ TG+ P S G ++ I SSG+ ++ L
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSE---LGNPMAALYK--IGSSGEPPEIPEHL 229
Query: 496 DPALGNNYDYDQMERMVLASILCIRRDPRARP 527
D + + C+RRDP+ RP
Sbjct: 230 SEEA-----KDFLRK-------CLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 37/284 (13%)
Query: 269 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 322
+G+G +VYKG L DGK AVK LK SE+ K+F+ E ++ L H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 323 LLGFCFEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
LLG C E+ L LV +++ G L + + + + A+ +A+ +EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
L S ++ +HRD+ + N L+ +D ++SDFGL++ + T ++APE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPILSSGKVTQ 493
G K DV++FGV+L E+ T G P +SN+ V+ L G +
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VL---EYLRKGY--R 225
Query: 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
L P + Y+ M C + DP RP S +++ L
Sbjct: 226 LPKPEYCPDELYELMLS-------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-39
Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 38/216 (17%)
Query: 271 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 323
+G+G +VYKG L +G E AVK LK SE+ +EF+ E I+ L H NI+ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
LG C + L +V +++ G L + L + + + ++A+ +A+ +EYL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLES--- 120
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY---------- 433
+ +HRD+ + N L++++ ++SDFGL++ D+ Y
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSR------------DIYEDDYYRKRGGGKLPI 168
Query: 434 --LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+APE GK K DV++FGV+L E+ T G +P
Sbjct: 169 KWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 16/200 (8%)
Query: 270 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 329
IGKG V G G+++AVK LK + F+ E ++TTL H N++ LLG +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 330 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 389
N L +V +++++GSL + L + A +++ A+ V E +EYL + +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 390 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDK 447
D+ + N+L+S+D ++SDFGLAK AS +G + APE K + K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQD-------SGKLPVKWTAPEALREKKFSTK 179
Query: 448 IDVYAFGVVLLELLT-GRKP 466
DV++FG++L E+ + GR P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 1e-32
Identities = 80/286 (27%), Positives = 127/286 (44%), Gaps = 27/286 (9%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHK 318
++ +G+G +VY D K +A+K+L ++ F+ EI+I+ +L H
Sbjct: 1 SYRILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
NI+ L F ++ +L LV +++ GSLE+ L SE + + ALEYL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 379 HSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH----ITCTDVAGTFGY 433
HS + +IHRD+K NILL D +L DFGLAK S + GT GY
Sbjct: 118 HS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 434 LAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490
+APE + + D+++ G+ L ELLTG P + S + I+
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL---KIILELP 231
Query: 491 VTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLK 534
L P + ++ + +L + +DP+ R S L
Sbjct: 232 TPSLASP---LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 73/276 (26%), Positives = 129/276 (46%), Gaps = 25/276 (9%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN 319
+ IGKG +VY DGK +K + SE ++ + E++I+ L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
II E L +V ++ G L + + KK+ F + + + AL+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
S ++++HRD+K NI L+ + +L DFG++K S++ V GT YL+PE
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL--AKTVVGTPYYLSPELC 175
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499
N K D+++ G VL EL T + P ++ L + K+ + P +
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELAL---------KILKGQYPPI 223
Query: 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535
+ Y + + +V + +++DP RP ++ +L+
Sbjct: 224 PSQYSSE-LRNLVSS---LLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 19/208 (9%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 329
IG+G S +VYK GKE+A+K ++ + + + EI I+ H NI+ +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYL 85
Query: 330 DNNLL-LVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
+ L +V +++ GSL + + N A+ V V + LEYLHS Q
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLHS---Q 135
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
VIHRD+KS NILLS D +L+DFG A A + V GT ++APE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFA--AQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 445 NDKIDVYAFGVVLLELLTGRKPISNDHP 472
K+D+++ G++ +E+ G P + P
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 26/226 (11%)
Query: 264 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 319
N+ +LIG+G VYKG L G +A+K + E+ +K + EI+++ L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
I+ +G ++L ++ ++ GSL + + F S V + L YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESLVAVYVYQVLQGLAYLH 116
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
Q VIHRD+K++NIL + D +L+DFG+A + V GT ++APE
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVI 171
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKP-------------ISNDHP 472
+ D+++ G ++ELLTG P + +DHP
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 37/278 (13%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
IG G ++ VY CLP+ +++A+K + K V E E++ ++ +H N++
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNVVKYYTS 67
Query: 327 CFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAM--GVAEALEYLHSGSA 383
+ L LV +LS GSL + + + G E + V + LEYLHS
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRG----GLDEAIIATVLKEVLKGLEYLHS--- 120
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVAGTFGYLAPEYFMY 441
IHRD+K+ NILL +D +++DFG++ + + GT ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 442 GK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500
+ K D+++FG+ +EL TG P S P + L++ L + P+L
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLML----TLQNDP------PSLE 228
Query: 501 NNYDYDQ----MERMVLASILCIRRDPRARPQMSLVLK 534
DY + +M+ LC+++DP RP +LK
Sbjct: 229 TGADYKKYSKSFRKMI---SLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 83/292 (28%), Positives = 128/292 (43%), Gaps = 42/292 (14%)
Query: 269 NLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNII 321
+G+G +V G+++AVK L S E +F EIEI+ TL H+NI+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 322 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
G C + +L L+ ++L GSL + L ++ + + + ++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG 126
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPE 437
S QR IHRD+ + NIL+ + ++SDFGLAK + + + F Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496
K + DV++FGV L EL T G + P E L M VT+LL+
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDP---SQSPP-AEFLRMIG-IAQGQMIVTRLLE 237
Query: 497 ----------PALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLKLLR 537
P + YD M+ C +P+ RP + L+L + R
Sbjct: 238 LLKEGERLPRPPSCPDEVYDLMKL-------CWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-29
Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 36/222 (16%)
Query: 271 IGKGGSSQVYKG-----CLPDGKEL-AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 322
+G+G +V+ G + KEL AVK LK S D K+F E E++T H+NI+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENL--HG--------NKKDPAAFGWSERYKVAMGVA 372
G C E + ++V++++ G L + L HG S+ ++A+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD---VAG 429
+ YL ++Q +HRD+ + N L+ D ++ DFG+ S + TD V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM-------SRDVYTTDYYRVGG 182
Query: 430 T----FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
++ PE MY K + DV++FGVVL E+ T G++P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 31/276 (11%)
Query: 269 NLIGKGGSSQVYKGC-LPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 324
N IG G +VY L G+ +AVK ++ IKE E++++ L H N++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
G + + ++ S G+LEE L + Y + + E L YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVYTLQL--LEGLAYLHS---H 118
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYLAPEYFMYG 442
++HRD+K +NI L + +L DFG A +T++ +AGT Y+APE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 443 KVNDK---IDVYAFGVVLLELLTGRKPISN-DHPKGQESLVMWAKPILSSGKVTQLLDPA 498
K D+++ G V+LE+ TG++P S D+ E +M+ + +G + D
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIMFH---VGAGHKPPIPDSL 231
Query: 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ D ++R C+ DP+ RP S +L+
Sbjct: 232 QLSPEGKDFLDR-------CLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 15/212 (7%)
Query: 265 FLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 321
F IGKG +VYK + +A+K+ L+ +ED I++ EI+ ++ I
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
G + + L ++ ++ GS + L K D + R V LEYLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILRE-----VLLGLEYLHE- 116
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFM 440
+ IHRD+K++NILLS++ + +L+DFG++ + ST S T GT ++APE
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT---FVGTPFWMAPEVIK 171
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
++K D+++ G+ +EL G P+S+ HP
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHP 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 71/232 (30%), Positives = 107/232 (46%), Gaps = 39/232 (16%)
Query: 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKE----FVL-EIEIITTL- 315
+F +IG+G S V KE A+KIL + +IKE +V E E++T L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLN 59
Query: 316 HHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVA 372
H II L + F+D NL V ++ G L + +G+ + R+ A +
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT-----RFYAAE-IL 112
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA---- 428
ALEYLHS + +IHRD+K NILL D +++DFG AK +SS + A
Sbjct: 113 LALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 429 --------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
GT Y++PE D++A G ++ ++LTG+ P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 71/211 (33%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 271 IGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIIS 322
+GKG +V K GK A+K+LK + + ++ V E I++ ++H I+
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 323 LLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYL 378
L + F+ L LV ++ G L +L + + Y AE ALEYL
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE--ERARFY-----AAEIVLALEYL 109
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
HS +I+RD+K NILL D +L+DFGLAK S+ S GT YLAPE
Sbjct: 110 HS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEV 164
Query: 439 FM---YGKVNDKIDVYAFGVVLLELLTGRKP 466
+ YGK +D ++ GV+L E+LTG+ P
Sbjct: 165 LLGKGYGKA---VDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 59/209 (28%), Positives = 108/209 (51%), Gaps = 10/209 (4%)
Query: 265 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL 323
F +G+G VYK G+ +A+K++ P E+ ++E + EI I+ I+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
G F++ +L +V ++ GS+ + + K E + + LEYLHS
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+ IHRD+K+ NILL+++ + +L+DFG++ + + + V GT ++APE
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR--NTVIGTPFWMAPEVIQEIG 175
Query: 444 VNDKIDVYAFGVVLLELLTGRKPISNDHP 472
N+K D+++ G+ +E+ G+ P S+ HP
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 35/283 (12%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEII 312
NF E IGKG S VYK CL DG+ +A+K + K +D +KE I+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56
Query: 313 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 372
L H N+I L E+N L +V + G L + KK +K + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGT 430
ALE++HS +R++HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGT 169
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490
Y++PE N K D+++ G +L E+ + P D + +L K K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------K 219
Query: 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 533
+ + P L ++ Y + R +++ CI DP RP +S VL
Sbjct: 220 IEKCDYPPLPADH-YSEELRDLVS--RCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNI 320
F E +G G +V++G + +A+KILK S+D++K +F E++ + L HK++
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHL 64
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
ISL C + ++ + + +GSL L + + +A VAE + YL
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-----WASTSSSHITCTDVAGTFGYLA 435
Q IHRD+ + NIL+ +D +++DFGLA+ +S I + + A
Sbjct: 123 ---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-------PYKWTA 172
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLT 462
PE +G + K DV++FG++L E+ T
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 80/284 (28%), Positives = 139/284 (48%), Gaps = 35/284 (12%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 313
+NF E IG+G S+VY+ CL D K +A+K + K +D +KE I+++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE----IDLLK 57
Query: 314 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 373
L+H N+I L EDN L +V + G L + + KK +K + +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTF 431
A+E++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491
Y++PE N K D+++ G +L E+ + P D + +L + K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLFSLCQ------KI 220
Query: 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535
Q P L + Y + R +++ +CI DP RP + V ++
Sbjct: 221 EQCDYPPLPTEH-YSEKLRELVS--MCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 5e-25
Identities = 82/296 (27%), Positives = 137/296 (46%), Gaps = 30/296 (10%)
Query: 247 SATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF 305
S + D+LS+ EN+I +G YKG + +G + VK + +
Sbjct: 677 SKVSKSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSE 733
Query: 306 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 365
+ ++ L H NI+ L+G C + L+++++ +L E L W R
Sbjct: 734 IADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRR 783
Query: 366 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425
K+A+G+A+AL +LH + V+ ++ I++ EP L S + CT
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---------LSLPGLLCT 834
Query: 426 DVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 483
D Y+APE + +K D+Y FG++L+ELLTG+ P ++ S+V WA+
Sbjct: 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVHGSIVEWAR 893
Query: 484 PILSSGKVTQLLDPALGNNYDYDQ---MERMVLASILCIRRDPRARPQMSLVLKLL 536
S + +DP++ + +Q +E M LA + C DP ARP + VLK L
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA-LHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 51/274 (18%)
Query: 271 IGKGGSSQVYKGCL-PDGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G+G S VYK P GK A+K + E+ K+ + E++ + + ++ G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 385
+++ + +V +++ GSL + L KK E +A + + L+YLH+
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL---KKVG---KIPEPVLAYIARQILKGLDYLHTKR--H 120
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV-----AGTFGYLAPEYF- 439
+IHRD+K SN+L++ E +++DFG+ S + T GT Y++PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGI-------SKVLENTLDQCNTFVGTVTYMSPERIQ 173
Query: 440 --MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ----ESLVMWAKPILSSGKVTQ 493
Y D+++ G+ LLE G+ P +++ P L + + +
Sbjct: 174 GESYSY---AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230
Query: 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARP 527
+ + C+++DP+ RP
Sbjct: 231 -------------EFRDFI---SACLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 46/272 (16%)
Query: 271 IGKGGSSQVYKGCL--PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
+G G S V K L P GK +AVK L+ +E + K+ + E++I+ + I+ G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW-SERY--KVAMGVAEALEYLHSGSA 383
+ + ++ + +++ GSL++ L G ER K+A+ V + L YLH
Sbjct: 68 FYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE--K 119
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
++IHRDVK SNIL++ + +L DFG++ S + T V GT Y+APE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---LAKTFV-GTSSYMAPERIQGND 175
Query: 444 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD------- 496
+ K D+++ G+ L+EL TGR P + + +LL
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFP--------------YPPENDPPDGIFELLQYIVNEPP 221
Query: 497 PALGN-NYDYDQMERMVLASILCIRRDPRARP 527
P L + + D LC+ +DPR RP
Sbjct: 222 PRLPSGKFSPD----FQDFVNLCLIKDPRERP 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 34/278 (12%)
Query: 271 IGKGGSSQVYKGC--LPDGKEL--AVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL 324
+G G V KG + GKE+ AVK LK KEF+ E ++ L H I+ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
G C + L+LV + G L + L ++ P S+ ++A VA + YL S +
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPV----SDLKELAHQVAMGMAYLES---K 114
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYG 442
+HRD+ + N+LL + + ++SDFG+++ S + T AG + + APE YG
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPECINYG 173
Query: 443 KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501
K + K DV+++GV L E + G KP KG E + M L SG+ +L P
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGE--MKGAEVIAM-----LESGE--RLPRPEECP 224
Query: 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539
Y M C + P RP S + R D
Sbjct: 225 QEIYSIMLS-------CWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 81/286 (28%), Positives = 139/286 (48%), Gaps = 35/286 (12%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL--------KPSEDVIKEFVLEIEIIT 313
+NF E IG+G S+VY+ CL DG +A+K + K D IKE I+++
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLK 57
Query: 314 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 373
L+H N+I EDN L +V + G L + KK +K + +
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTDVAGTF 431
ALE++HS +RV+HRD+K +N+ ++ +L D GL ++ S T+++H + GT
Sbjct: 118 ALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491
Y++PE N K D+++ G +L E+ + P D + +L K K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------KI 220
Query: 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
Q P L +++ +++ ++V +CI DP RP ++ V + +
Sbjct: 221 EQCDYPPLPSDHYSEELRQLV---NMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 82/276 (29%), Positives = 132/276 (47%), Gaps = 39/276 (14%)
Query: 271 IGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 328
+G G +VYK + A KI++ SE+ +++F++EI+I++ H NI+ L F
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 329 EDNNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
+N L ++ +F G+L E G + + V + EAL +LHS
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEALNFLHS---H 122
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+VIHRD+K+ NILL+ D + +L+DFG+ AK ST T GT ++APE
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACET 179
Query: 444 VND-----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498
D K D+++ G+ L+EL P +P V+ IL S T L P+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNP----MRVLLK--ILKSEPPT-LDQPS 232
Query: 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
++ D ++ C+ +DP RP + +LK
Sbjct: 233 KWSSSFNDFLKS-------CLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 71/270 (26%), Positives = 131/270 (48%), Gaps = 30/270 (11%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330
IG G V+ G + +++A+K ++ ++F+ E +++ L H ++ L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 390
+ + LV++F+ G L + L + F + + V E + YL S + VIHRD
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 391 VKSSNILLSDDFEPQLSDFGLAKWA---STSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 447
+ + N L+ ++ ++SDFG+ ++ +SS T V + +PE F + K + K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSSPEVFSFSKYSSK 181
Query: 448 IDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 506
DV++FGV++ E+ + G+ P N + +V +++G +L P L + Y+
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYEN---RSNSEVV----ETINAG--FRLYKPRLASQSVYE 232
Query: 507 QMERMVLASILCIRRDPRARPQMSLVLKLL 536
M+ C + P RP SL+L L
Sbjct: 233 LMQH-------CWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHHK 318
+F +IGKG +V D K++ A+K + + ++ + E I+ L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 319 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEA 374
+++L + F+D N+ LV D L G L +L K + F E + A
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-------IVLA 112
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
LEYLHS + +IHRD+K NILL + ++DF +A + + T +GT GY+
Sbjct: 113 LEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYM 166
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
APE + +D ++ GV E L G++P
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 7e-23
Identities = 70/205 (34%), Positives = 115/205 (56%), Gaps = 20/205 (9%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-FVLEIEIITTLHHKNIISLLGFCFE 329
IG+G V +G G+++AVK +K DV + F+ E ++T LHHKN++ LLG
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 330 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 389
N L +V + +S+G+L L + A + + ++ VAE +EYL S ++++HR
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124
Query: 390 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKID 449
D+ + NIL+S+D ++SDFGLA+ + + V T APE + K + K D
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 450 VYAFGVVLLELLT-GRKPISNDHPK 473
V+++GV+L E+ + GR P +PK
Sbjct: 180 VWSYGVLLWEVFSYGRAP----YPK 200
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 7e-23
Identities = 68/182 (37%), Positives = 101/182 (55%), Gaps = 13/182 (7%)
Query: 287 GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYDFLSR 342
G+++AVK LKP + I + EIEI+ L+H+NI+ G C ED N + L+ +FL
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402
GSL+E L NK ++ K A+ + + ++YL GS Q V HRD+ + N+L+ +
Sbjct: 93 GSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYL--GSRQYV-HRDLAARNVLVESEH 146
Query: 403 EPQLSDFGLAKWASTSSSHITCTD--VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 460
+ ++ DFGL K T + T D + F Y APE + K DV++FGV L EL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205
Query: 461 LT 462
LT
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 50/290 (17%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHH---KNIIS 322
LIG+G VY+G +P G+ +A+KI+ P +DV + E+ +++ L NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNITK 66
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMGVAEALEYLHS 380
G + L ++ ++ GS+ + E+Y + V AL+Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-------EKYISVIIREVLVALKYIHK 119
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYF 439
VIHRD+K++NIL+++ +L DFG+ A SS T GT ++APE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST---FVGTPYWMAPEVI 173
Query: 440 MYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498
GK D K D+++ G+ + E+ TG P S+ L+ +KP P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP------------PR 221
Query: 499 L-GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWAR 547
L N Y E + C+ +P+ R +LK +KW +
Sbjct: 222 LEDNGYSKLLREFVA----ACLDEEPKERLSAEELLK--------SKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 67/223 (30%), Positives = 117/223 (52%), Gaps = 26/223 (11%)
Query: 265 FLAENLIGKGGSSQVYKGCL--PDGKE----LAVKILKPSE--DVIKEFVLEIEIITTLH 316
FL E +G+G +VYKG L P+ + +A+K LK + V +EF E E+++ L
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 317 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYK-------- 366
H NI+ LLG C ++ +++++L+ G L E L + D A E K
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 367 --VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424
+A+ +A +EYL S+ +HRD+ + N L+ + ++SDFGL++ ++ +
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 425 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ ++ PE +YGK + D+++FGVVL E+ + G +P
Sbjct: 184 SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 63/212 (29%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISLL 324
IG+G QVYK G+ +A+K ++ + KE + EI+++ L H NI+ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 325 GFCFED--NNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
++ +V++++ G L+ K F S+ + E L+YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVK----FTESQIKCYMKQLLEGLQYLH 117
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
S ++HRD+K SNIL+++D +L+DFGLA+ T + T+ T Y PE
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPELL 173
Query: 440 M----YGKVNDKIDVYAFGVVLLELLTGRKPI 467
+ YG ++D+++ G +L EL G KPI
Sbjct: 174 LGATRYGP---EVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 37/275 (13%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNIIS 322
L+G G VY+G L DG AVK + + ++ +K+ EI +++ L H NI+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
LG E++NL + + + GSL + L +G+ +P ++ + + LEYLH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHD 120
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+ +HRD+K +NIL+ + +L+DFG+AK S G+ ++APE
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIA 174
Query: 441 -YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499
G D+++ G +LE+ TG+ P S ++ I S ++ P +
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----AVFK--IGRSKEL-----PPI 223
Query: 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
++ D+ + +L C++RDP RP + +L+
Sbjct: 224 PDHLS-DEAKDFIL---KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 56/180 (31%), Positives = 88/180 (48%), Gaps = 10/180 (5%)
Query: 291 AVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 348
AVK LK D++ +F+ E I+ +L H+N+I L G + L++V + GSL +
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDR 85
Query: 349 LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 408
L + Y A+ +A + YL S +R IHRD+ + NILL+ D + ++ D
Sbjct: 86 LRKDALGHFLISTLCDY--AVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGD 140
Query: 409 FGLAKWASTSSSHITCT-DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
FGL + + H + F + APE + DV+ FGV L E+ T G +P
Sbjct: 141 FGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 4e-22
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 15/213 (7%)
Query: 266 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 323
L E GK ++ Y C K L AVK LK S++ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---------PAAFGWSERYKVAMGVAEA 374
G C E + L++V++++ G L + L + D PA S+ +A +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
+ YL S Q +HRD+ + N L+ ++ ++ DFG+++ ++ + ++
Sbjct: 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
PE MY K + DV++ GVVL E+ T G++P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 65/199 (32%), Positives = 109/199 (54%), Gaps = 16/199 (8%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++ LLG E+
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 331 N-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHR 389
L +V +++++GSL + L + + G K ++ V EA+EYL + + +HR
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 390 DVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVNDKI 448
D+ + N+L+S+D ++SDFGL K AS++ D + APE K + K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKS 180
Query: 449 DVYAFGVVLLELLT-GRKP 466
DV++FG++L E+ + GR P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 35/280 (12%)
Query: 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKN 319
+F N IGKG V+K D + A+K + K + +E + E ++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--YKVAMGVAEALEY 377
II + L +V ++ G L + L + P E ++ + + L +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPL----PEDQVWRFFIQILLGLAH 116
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LHS ++++HRD+KS N+ L ++ D G+AK S ++ + GT YL+PE
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPE 171
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497
N+K DV+A GVVL E TG+ P ++ Q +L++ K+ + + P
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALIL---------KIIRGVFP 219
Query: 498 ALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 535
+ Y LA ++ C+ +D R RP +L+
Sbjct: 220 PVSQMYSQQ------LAQLIDQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 32/223 (14%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 327
+IG+G +VYK G+ +A+KI+ ED +E E I+ +H NI + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-A 71
Query: 328 F-------EDNNLLLVYDFLSRGS---LEENLH--GNKKDPAAFGWSERYKVAMGVAEAL 375
F D+ L LV + GS L + L G + + R L
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGL 126
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYL 434
YLH +VIHRD+K NILL+ + E +L DFG+ A+ ST T GT ++
Sbjct: 127 AYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWM 180
Query: 435 APEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 472
APE + D + DV++ G+ +EL G+ P+ + HP
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 270 LIGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 324
++G+G V K C G+ +A+K K SED +K+ L E++++ L H+NI++L
Sbjct: 8 VVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
L LV++++ R LE + P + +A+ Y HS
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCHS---H 119
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFM 440
+IHRD+K NIL+S+ +L DFG A+ A + TD T Y APE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 441 YGKVNDKIDVYAFGVVLLELLTGR 464
YGK +DV+A G ++ ELL G
Sbjct: 179 YGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330
+G G +V++G + +AVK LKP K+F+ E +I+ L H +I L C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 390
+ +V + + GSL E L G A + +A VA + YL AQ IHRD
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 391 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKI 448
+ + N+L+ ++ +++DFGLA+ I F + APE +Y + + K
Sbjct: 129 LAARNVLVGENNICKVADFGLAR---VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 449 DVYAFGVVLLELLT-GRKP 466
DV++FG++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-22
Identities = 78/267 (29%), Positives = 125/267 (46%), Gaps = 29/267 (10%)
Query: 271 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IGKG +VYKG KE+ A+KI L+ +ED I++ EI +++ I G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
+ L ++ ++L GS + L P + + + + L+YLHS +R I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS---ERKI 123
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 447
HRD+K++N+LLS+ + +L+DFG+A + + I GT ++APE + K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 448 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 507
D+++ G+ +EL G P S+ HP L+ P P L Y
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------PTLEGQYS-KP 228
Query: 508 MERMVLASILCIRRDPRARPQMSLVLK 534
+ V A C+ +DPR RP +LK
Sbjct: 229 FKEFVEA---CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 8e-22
Identities = 76/286 (26%), Positives = 129/286 (45%), Gaps = 43/286 (15%)
Query: 269 NLIGKGGSSQVYKGCLPDGKELAVK--ILKPS-----EDVIKEFVLEIEIITTLHHKNII 321
++GKG VY G G+ +AVK L S E ++ E++++ +L H NI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 379
LG C +DN + + +F+ GS+ L N+ P +Y ++ GVA YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA----YLH 119
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHIT-CTDVAGTFGYLA 435
+ V+HRD+K +N++L + +L DFG A+ W +H + GT ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK--VTQ 493
PE K D+++ G + E+ TG+ P+++ + A + + + + +
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRGLMPR 229
Query: 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539
L D D+ C+ RD RP L+LLR D
Sbjct: 230 LPDSFSAAAIDFVTS---------CLTRDQHERPS---ALQLLRHD 263
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF 328
IG G VYK + G+ +A+K++K D + EI ++ H NI++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL---EYLHSGSAQR 385
+ L +V ++ GSL++ + G ++A E L YLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHE---TG 121
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYF---MY 441
IHRD+K +NILL++D + +L+DFG+ A+ +T + + GT ++APE
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS---FIGTPYWMAPEVAAVERK 178
Query: 442 GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
G + K D++A G+ +EL + P+ + HP
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHP 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 1e-21
Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 29/267 (10%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
+D L ++ ++L GS + L +P ++ + + + L+YLHS ++ I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS---EKKI 123
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 447
HRD+K++N+LLS+ E +L+DFG+A + + I GT ++APE + K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 448 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 507
D+++ G+ +EL G P S HP L+ P P L NY
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------PTLEGNYS-KP 228
Query: 508 MERMVLASILCIRRDPRARPQMSLVLK 534
++ V A C+ ++P RP +LK
Sbjct: 229 LKEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 27/232 (11%)
Query: 308 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 367
EI I++ L H NII+ +DN LL+ ++ + G+L + + ++ F E +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLF--EEEMVL 104
Query: 368 AM--GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425
+ A+ Y+H ++HRD+K+ NI L+ +L DFG++K + S
Sbjct: 105 WYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AE 159
Query: 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485
V GT Y++PE K N K D++A G VL ELLT ++ +P
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----------LN 208
Query: 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
L V P + Y ++ S +++DP RP VL
Sbjct: 209 LVVKIVQGNYTPVVSV---YSSELISLVHS--LLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 35/278 (12%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 320
+ + +G+G V K L + + A+K + P+ D+ K+ + E+EI + I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 321 ISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
+ G + +++ + ++ GSL+ KK G K+A V + L YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG----YL 434
HS +++IHRD+K SNILL+ + +L DFG++ S +AGTF Y+
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--------LAGTFTGTSFYM 170
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI-----LSSG 489
APE + DV++ G+ LLE+ R P P+G+ L PI + +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG----PIELLSYIVNM 223
Query: 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 527
+L D GN + + + + C+ +DP RP
Sbjct: 224 PNPELKD-EPGNGIKWSEEFKDFIKQ--CLEKDPTRRP 258
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-21
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 321
++ ++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYL 378
LLG C + ++ +F++ G+L + L + + +A ++ A+EYL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL-----LYMATQISSAMEYL 120
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT---FGYLA 435
+ IHRD+ + N L+ ++ +++DFGL++ + T T AG + A
Sbjct: 121 EKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTA 173
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLT 462
PE Y K + K DV+AFGV+L E+ T
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 64/203 (31%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 270 LIGKGGSSQVYKGC---LPD--GKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISL 323
+GKG V L D G+ +AVK L+ S + +++F EIEI+ +L H NI+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 324 LGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
G C+ NL LV ++L GSL + L ++ + A + + +EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYL--- 124
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYF 439
++R +HRD+ + NIL+ + ++ DFGL K + + + F Y APE
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 440 MYGKVNDKIDVYAFGVVLLELLT 462
K + DV++FGVVL EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-21
Identities = 77/290 (26%), Positives = 123/290 (42%), Gaps = 60/290 (20%)
Query: 265 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNII 321
FL E +G G V+ G ++A+K+++ SED +F+ E +++ L H N++
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLV 62
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L G C + + +V ++++ G L L K G + V EA+EYL S
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN 119
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA----STSSSHITCTDVAGT---FGYL 434
IHRD+ + N L+ +D ++SDFGLA++ TSS GT +
Sbjct: 120 G---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--------GTKFPVKWA 168
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT- 492
PE F Y + + K DV++FGV++ E+ + G+ P S+ +V
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER----------------FSNSEVVE 212
Query: 493 ------QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
+L P L Y M C P RP +L L
Sbjct: 213 SVSAGYRLYRPKLAPTEVYTIMY-------SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 328
IG+G S VY + G+E+A+K + + KE ++ EI ++ H NI++ L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 388
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 138
Query: 389 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 448
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 449 DVYAFGVVLLELLTGRKPISNDHP 472
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 74/286 (25%), Positives = 132/286 (46%), Gaps = 34/286 (11%)
Query: 266 LAENLIGKGGSSQVYKGCLPDGKEL-AVKILK-PSEDVIKEFVLEIEIITTLHHKNIISL 323
L E GK ++ Y K L AVK LK P+ K+F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------------AAFGWSERYKVAMGV 371
G C + + L++V++++ G L + L + D G S+ +A +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
A + YL S Q +HRD+ + N L+ + ++ DFG+++ ++ +
Sbjct: 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 490
++ PE MY K + DV++FGV+L E+ T G++P + V+ ++ G+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----TEVI---ECITQGR 242
Query: 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
V L P + YD M + C +R+P+ R + + K+L
Sbjct: 243 V--LERPRVCPKEVYDIM-------LGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 271 IGKGGSSQVYKGC-LPDGK----ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL 323
+G G VYKG +P+G+ +A+K+L+ KE + E ++ ++ H +++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHS 380
LG C + L+ + G L + + +K + + W + +A+ + YL
Sbjct: 75 LGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL-- 125
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+R++HRD+ + N+L+ +++DFGLAK ++A E +
Sbjct: 126 -EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 441 YGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ K DV+++GV + EL+T G KP
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLGF 326
IG+G VYK G+ +A+K +K + I + L EI+++ L+H NII LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYLHSGSA 383
+L LV++F+ + +L+ KD G E + + + + L + HS
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKD-RQRGLPESLIKSYLYQ-LLQGLAFCHS--- 116
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF---- 439
++HRD+K N+L++ + +L+DFGLA+ S S T T Y APE
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGR 464
Y +D+++ G + ELL+ R
Sbjct: 175 GYST---PVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L C E+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 390
+ +V +++S+GSL + L + + +A +AE + YL S + IHRD
Sbjct: 74 EPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRD 128
Query: 391 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKI 448
+ + NIL+ ++ +++DFGLA+ F + APE YG+ K
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDD---EYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 449 DVYAFGVVLLELLT-GRKP 466
DV++FG++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 78/291 (26%), Positives = 132/291 (45%), Gaps = 42/291 (14%)
Query: 270 LIGKGGSSQVYKGCL--PDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 324
L+G+G V K C G+ +A+K SED V K + EI ++ L H+N+++L+
Sbjct: 8 LVGEGSYGMVMK-CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
L LV++F+ L++ +K P S K + +E+ HS
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHS---H 119
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---- 440
+IHRD+K NIL+S +L DFG A+ + ++ TD T Y APE +
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 441 YGKVNDKIDVYAFGVVLLELLTGR----------------KPISNDHPKGQESLVMWAKP 484
YG+ +D++A G ++ E+LTG K + N P+ QE + P
Sbjct: 178 YGR---AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE--IFQKNP 232
Query: 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASI-LCIRRDPRARPQMSLVLK 534
+ + ++ ++ + + ++ +VL C+R DP RP S +L
Sbjct: 233 LFAGMRLPEVKEIE-PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 264 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-----DVIKEFVL-EIEIITTLH 316
+ +G+G + VYK G+ +A+K +K E D I L EI+++ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 317 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA-EAL 375
H NII LL +N+ LV++F+ LE+ + KD + K M + L
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVI----KDKSIVLTPADIKSYMLMTLRGL 115
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
EYLHS ++HRD+K +N+L++ D +L+DFGLA+ + + +T V T Y A
Sbjct: 116 EYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRA 170
Query: 436 PEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 467
PE YG +D+++ G + ELL R P
Sbjct: 171 PELLFGARHYGV---GVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 270 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
IGKG VYKG L E+AVK + P + K F+ E EI+ H NI+ L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
C + + +V + + GSL L K + ++++ A +EYL S +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNC 114
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAK----WASTSSSHITCTDVAGTFGYLAPEYFMYG 442
IHRD+ + N L+ ++ ++SDFG+++ T S + + T APE YG
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYG 170
Query: 443 KVNDKIDVYAFGVVLLELLT-GRKPISN 469
+ + DV+++G++L E + G P
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVK-------ILKPSEDVIKEFV----LEIEIITTLHH 317
LIGKG +VY + G+ +AVK I + K+ V EIE + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
NI+ LGF + L + +++ GS+ L + F V E L Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL----RTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LHS + ++HRD+K+ N+L+ D ++SDFG++K + + + G+ ++APE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 438 YF-MYGK-VNDKIDVYAFGVVLLELLTGRKPISND 470
Y + + K+D+++ G V+LE+ GR+P S++
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-20
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 16/216 (7%)
Query: 287 GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 342
G+ +AVK LK + + EI I+ TL+H+NI+ G C E L L+ +++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402
GSL + L +K ++ A + E + YLHS Q IHRD+ + N+LL +D
Sbjct: 93 GSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDR 144
Query: 403 EPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 460
++ DFGLAK + + + F Y A E K + DV++FGV L EL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYEL 203
Query: 461 LTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496
LT PK E ++ + ++ ++ +LL+
Sbjct: 204 LTHCDS-KQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 9e-20
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 270 LIGKGGSSQVYKGC--LPDGKELAVKIL------KPSEDVIKEFVLEIEIITTLHHKNII 321
L+G+G +VY C + G+ELAVK + ++ + EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 322 SLLGFCFEDNNLLLVY-DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
G C D+ L ++ +++ GS+++ L K A + K + E +EYLHS
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHS 122
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYLAPEYF 439
++HRD+K +NIL +L DFG +K T S T V GT +++PE
Sbjct: 123 ---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179
Query: 440 M---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
YG+ K DV++ G ++E+LT + P +
Sbjct: 180 SGEGYGR---KADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 9e-20
Identities = 57/188 (30%), Positives = 99/188 (52%), Gaps = 26/188 (13%)
Query: 289 ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345
++A+K++K SED EF+ E +++ L H+ ++ L G C + + +V +++S G L
Sbjct: 30 DVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405
L + K S+ ++ V E + YL S ++ IHRD+ + N L+ D +
Sbjct: 87 LNYLREHGKRFQP---SQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVK 140
Query: 406 LSDFGLAKWA----STSSSHITCTDVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLE 459
+SDFGL+++ TSS V F + PE +Y K + K DV+AFGV++ E
Sbjct: 141 VSDFGLSRYVLDDEYTSS-------VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193
Query: 460 LLT-GRKP 466
+ + G+ P
Sbjct: 194 VYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHKNIISLLGF 326
+G+G VYK G+ +A+K ++ E+ I L EI ++ L H NI+ LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHG--NKKDPAAFGWSERY-KVAMG-VAEALEYLHSGS 382
+ L LV+++ + +L +K+ S K M + L Y HS
Sbjct: 67 IHTERKLYLVFEYC-----DMDLKKYLDKRPGPL---SPNLIKSIMYQLLRGLAYCHS-- 116
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 440
R++HRD+K NIL++ D +L+DFGLA+ A T T T Y APE +
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLAR-AFGIPLR-TYTHEVVTLWYRAPEILLGS 173
Query: 441 --YGKVNDKIDVYAFGVVLLELLTGR 464
Y +D+++ G + E++TG+
Sbjct: 174 KHYST---AVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
E +IG G +V +G L P KE+ A+K LK S+ +F+ E I+ H NII
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L G + ++++ +++ GSL++ L N F + + G+A ++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYL--- 122
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------YLA 435
S +HRD+ + NIL++ + ++SDFGL++ S + T T G + A
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTA 176
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
PE Y K DV++FG+V+ E+++ G +P
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 72/253 (28%), Positives = 126/253 (49%), Gaps = 28/253 (11%)
Query: 286 DGKELAVK---ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342
DGK+ +K I K S +E E+ +++ + H NI+ E+ NL +V D+
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83
Query: 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402
G L + + N + F + + + AL+++H ++++HRD+KS NI L+ D
Sbjct: 84 GDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDG 138
Query: 403 EPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 461
+L DFG+A+ ST TC GT YL+PE N+K D++A G VL E+
Sbjct: 139 TIKLGDFGIARVLNSTVELARTCI---GTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
Query: 462 TGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 521
T + + K +LV+ K+ + P + ++Y YD R +++ + +R
Sbjct: 196 TLKHAFEAGNMK---NLVL---------KIIRGSYPPVSSHYSYDL--RNLVSQLF--KR 239
Query: 522 DPRARPQMSLVLK 534
+PR RP ++ +L+
Sbjct: 240 NPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 61/204 (29%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 328
IG+G S V+ + G+E+A+K + + KE ++ EI ++ L + NI++ L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 388
+ L +V ++L+ GSL + + D A V +ALE+LH A +VIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLH---ANQVIH 138
Query: 389 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 448
RD+KS N+LL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 449 DVYAFGVVLLELLTGRKPISNDHP 472
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 73/265 (27%), Positives = 110/265 (41%), Gaps = 26/265 (9%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKNIISLLGF 326
IGKG V K DGK L K + KE V E+ I+ L H NI+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 327 CFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA- 383
+ +N L +V ++ G L + + KK+ +++ + AL H+ S
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 384 -QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
V+HRD+K +NI L + +L DFGLAK SS GT Y++PE +
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHM 185
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502
++K D+++ G ++ EL P + Q L K GK ++ P
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPF---TARNQLQLASKIK----EGKFRRI--P----- 231
Query: 503 YDYDQMERMVLASILCIRRDPRARP 527
Y Y V+ S + DP RP
Sbjct: 232 YRYSSELNEVIKS--MLNVDPDKRP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 271 IGKGGSSQVY----KGCLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 323
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-----------PAAFGWSERYKVAMGVA 372
G C E LL+V++++ G L L + D P + +A +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 432
+ YL S +HRD+ + N L+ ++ DFG+ S I TD G
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGM-------SRDIYSTDYYRVGG 182
Query: 433 -------YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
++ PE +Y K + D+++FGVVL E+ T G++P
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 6e-19
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 328
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 388
+ L +V ++L+ GSL + + D V +ALE+LHS +VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHS---NQVIH 139
Query: 389 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 448
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 449 DVYAFGVVLLELLTGRKPISNDHP 472
D+++ G++ +E++ G P N++P
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 60/208 (28%), Positives = 111/208 (53%), Gaps = 16/208 (7%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
+ +IG G +V++G L P KE +A+K LKP +E ++F+ E I+ H NII
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L G + +++ +++ G+L++ L + + +++ + + G+A ++YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY---QLVGMLRGIAAGMKYL--- 123
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG--YLAPEYF 439
S +HRD+ + NIL++ + E ++SDFGL++ T T G + APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 440 MYGKVNDKIDVYAFGVVLLELLT-GRKP 466
Y K DV++FG+V+ E+++ G +P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330
+G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE 73
Query: 331 NNLLLVYDFLSRGSLEENLHGNK----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
+ +V +++S+GSL + L G + P + + M E + Y
Sbjct: 74 P-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY--------- 123
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 446
+HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 447 KIDVYAFGVVLLELLT-GRKP 466
K DV++FG++L EL T GR P
Sbjct: 183 KSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 40/222 (18%)
Query: 270 LIGKGGSSQVYKG------CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNI 320
+G+G QV K + +AVK+LK E + + V E+E++ + HKNI
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK--------------------KDPAAFG 360
I+LLG C ++ L +V ++ + G+L + L + KD +F
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 361 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420
+ VA +E+L S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 139 YQ--------VARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY 187
Query: 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 462
+ T+ ++APE + DV++FGV+L E+ T
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 17/199 (8%)
Query: 270 LIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
L+GKG +V+KG L D +AVK K P E IK F+ E I+ H NI+ L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
C + + +V + + G L K + + K A+ A + YL S +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWAST---SSSHITCTDVAGTFGYLAPEYFMYGK 443
IHRD+ + N L+ ++ ++SDFG+++ SSS + + T APE YG+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGR 170
Query: 444 VNDKIDVYAFGVVLLELLT 462
+ + DV+++G++L E +
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 71/270 (26%), Positives = 128/270 (47%), Gaps = 35/270 (12%)
Query: 271 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IGKG +V+KG +++ A+KI L+ +ED I++ EI +++ + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQ 384
+ L ++ ++L GS + L D +++A + E L+YLHS +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFD--------EFQIATMLKEILKGLDYLHS---E 120
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
+ IHRD+K++N+LLS+ + +L+DFG+A + + I GT ++APE
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 445 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 504
+ K D+++ G+ +EL G P S+ HP L+ P +G+ ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSK----------- 227
Query: 505 YDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ + A C+ +DP RP +LK
Sbjct: 228 --PFKEFIDA---CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 22/236 (9%)
Query: 243 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 297
HE++ A +L + D +F+ IG+G + V C+ GK++AVK +
Sbjct: 4 HEQFRAALQLVVSPGDPREYLDSFIK---IGEGSTGIV---CIATEKHTGKQVAVKKMDL 57
Query: 298 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 356
+ +E + E+ I+ HH+N++ + + L +V +FL G+L + + + +
Sbjct: 58 RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE 117
Query: 357 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416
V + V AL YLH+ Q VIHRD+KS +ILL+ D +LSDFG A
Sbjct: 118 EQIA-----TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQ 167
Query: 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
S + GT ++APE ++D+++ G++++E++ G P N+ P
Sbjct: 168 VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 269 NLIGKGGSSQVYKGCL--PDGKEL--AVKILKPSEDV--IKEFVLEIEIITTLHHKNIIS 322
+IGKG VY G L DG+++ AVK L D+ +++F+ E I+ H N++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 323 LLGFCFEDNNL-LLVYDFLSRGSLEENLHGNKKDPA-----AFGWSERYKVAMGVAEALE 376
LLG C L+V ++ G L + +P FG + VA+ +E
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--------LQVAKGME 112
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYL 434
YL S ++ +HRD+ + N +L + F +++DFGLA+ + S T ++
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLT 462
A E K K DV++FGV+L EL+T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 328
IG+G S VY + G+E+A+K + + KE ++ EI ++ + NI++ L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 388
+ L +V ++L+ GSL + + D V +AL++LHS +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALDFLHS---NQVIH 138
Query: 389 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 448
RD+KS NILL D +L+DFG A + + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 449 DVYAFGVVLLELLTGRKPISNDHP 472
D+++ G++ +E++ G P N++P
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 72/248 (29%), Positives = 117/248 (47%), Gaps = 27/248 (10%)
Query: 242 LHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSED 300
L+ + + + L T + IGKG +VYK DG AVKIL P D
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 301 VIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-----LLLVYDFLSRGSLEENLHG--- 351
V +E E I+ +L +H N++ G ++ + L LV + + GS+ E + G
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 352 --NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409
+ D A + + G L++LH+ R+IHRDVK +NILL+ + +L DF
Sbjct: 121 CGQRLDEAMISY-----ILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-----KIDVYAFGVVLLELLTGR 464
G++ A +S+ + GT ++APE + D + DV++ G+ +EL G
Sbjct: 173 GVS--AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
Query: 465 KPISNDHP 472
P+ + HP
Sbjct: 231 PPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 56/197 (28%), Positives = 104/197 (52%), Gaps = 8/197 (4%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330
+G+G +V+ G ++A+K LKP + + F+ E +I+ L H ++ L E+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE 73
Query: 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 390
+ +V +F+ +GSL + L + D + +A +A+ + Y+ IHRD
Sbjct: 74 P-IYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRD 127
Query: 391 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 450
++++NIL+ D+ +++DFGLA+ + + + APE +YG+ K DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 451 YAFGVVLLELLT-GRKP 466
++FG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 29/204 (14%)
Query: 271 IGKGGSSQVYK------GCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 324
+G G +VYK G L K + K SE+ ++++++EIEI+ T +H I+ LL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 325 GFCFEDNNLLLVYDFLSRGSLEE---NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
G + D L ++ +F G+++ L +P + + + EAL+YLHS
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP------QIQVICRQMLEALQYLHS- 128
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
++IHRD+K+ N+LL+ D + +L+DFG++ A + GT ++APE M
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 442 GKVND-----KIDVYAFGVVLLEL 460
+ D K D+++ G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 16/209 (7%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKE--LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
E +IG G +V +G L P +E +A+K LK +E ++F+ E I+ H NII
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L G + ++++ +F+ G+L+ L N F + + G+A ++YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYL--- 122
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG---TFGYLAPEY 438
S +HRD+ + NIL++ + ++SDFGL+++ +S T T G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 439 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
Y K DV+++G+V+ E+++ G +P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 70/274 (25%), Positives = 124/274 (45%), Gaps = 27/274 (9%)
Query: 264 NFLAENLIGKGGSSQVYK-GCLPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN 319
+F +GKG VYK L D + A+K + KE V EI I+ +++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
IIS + N L +V ++ G L + + KK E +++ + + L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
Q+++HRD+KS+NILL + ++ D G++K ++ T + GT Y+APE +
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYMAPEVW 173
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499
+ K D+++ G +L E+ T P + + L KV + P +
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFEA---RSMQDL---------RYKVQRGKYPPI 221
Query: 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 533
Y D ++ + + ++ P+ RP +L
Sbjct: 222 PPIYSQD-LQNFIRS---MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330
+G G +V+ G ++AVK LKP + F+ E +I+ L H ++ L E+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 390
+ +V +++S+GSL + L + A +A VA + Y+ IHRD
Sbjct: 74 P-IYIVTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127
Query: 391 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 450
++S+NIL+ D +++DFGLA+ + + + APE +YG+ K DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 451 YAFGVVLLELLT-GRKP 466
++FG++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 8e-18
Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 24/194 (12%)
Query: 287 GKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341
GK A+KIL ++K E VL E I+ ++ H +++L G +D+NL LV +++
Sbjct: 26 GKYYALKILS-KAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP 84
Query: 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 401
G L +L + + P + Y A V ALEYLHS +++RD+K N+LL D
Sbjct: 85 GGELFSHLRKSGRFPE--PVARFY--AAQVVLALEYLHS---LDIVYRDLKPENLLLDSD 137
Query: 402 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLL 458
+++DFG AK T T + GT YLAPE + YGK +D +A G+++
Sbjct: 138 GYIKITDFGFAKRVKGR----TYT-LCGTPEYLAPEIILSKGYGK---AVDWWALGILIY 189
Query: 459 ELLTGRKPISNDHP 472
E+L G P +D+P
Sbjct: 190 EMLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 42/288 (14%)
Query: 264 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTL 315
+L +G G S Y+ + G +AVK + E+V++ EI ++ L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 316 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 375
+H +II +LG ED++ L ++++ GS+ L AF + + L
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGL 116
Query: 376 EYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTD-----VAG 429
YLH ++IHRDVK +N+L+ S +++DFG A+ ++ T + G
Sbjct: 117 SYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGA---AARLAAKGTGAGEFQGQLLG 170
Query: 430 TFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486
T ++APE YG+ DV++ G V++E+ T + P + + +L+
Sbjct: 171 TIAFMAPEVLRGEQYGR---SCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
++ + + L P L R V + C+ P RP +LK
Sbjct: 228 TAPSIPEHLSPGL----------RDVT--LRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 83/297 (27%), Positives = 129/297 (43%), Gaps = 50/297 (16%)
Query: 272 GKGGSSQVYKGCLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE 329
G GGS K +P G +A K+ + V K+ + E++I+ I+S G
Sbjct: 16 GNGGSVSKVKH-IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74
Query: 330 DNNLLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 388
+NN+ + +F+ GSL+ G G K+A+ V E L YL++ R++H
Sbjct: 75 ENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRIMH 127
Query: 389 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKI 448
RD+K SNIL++ + +L DFG++ S I T V GT Y++PE GK K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFV-GTSTYMSPERIQGGKYTVKS 183
Query: 449 DVYAFGVVLLELLTGRKPI--SNDHPKGQES----------LVMWAKPILSSGKVTQLLD 496
DV++ G+ ++EL G+ P SN GQ+ +V P L S +
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED-- 241
Query: 497 PALGNNYDYDQMERMVLASILCIRRDP--RARPQ-----MSLVLKLLRGDADVTKWA 546
+ V A C+ +DP R PQ + L + D+ WA
Sbjct: 242 -----------LRDFVDA---CLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAWA 284
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 266 LAENLIGKGGSSQVYKGCLPDGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISL 323
L E GK +Y + + +A+K LK + EF E ++ LHH NI+ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENL-----H---GNKKD-----PAAFGWSERYKVAMG 370
LG ++ + +++++L++G L E L H G D ++ + +A+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
+A +EYL S+ +H+D+ + NIL+ + ++SD GL++ ++ +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
++ PE MYGK + D+++FGVVL E+ + G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 271 IGKGGSSQVY---KGCLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISL 323
I KG +V+ K G A+K++K + ++ + + + E +I++ ++ L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 324 LGFCFE-DNNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
+ F+ NL LV ++L G SL EN+ +D A +E + ALEYLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAE-------IVLALEYLH 110
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT------CTDVAGTFGY 433
S +IHRD+K NIL+ + +L+DFGL+K + GT Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 434 LAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
+APE + + K +D ++ G +L E L G P + P
Sbjct: 168 IAPEVILGQGHSK---TVDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 70/268 (26%), Positives = 124/268 (46%), Gaps = 35/268 (13%)
Query: 290 LAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 347
+AVKIL+P +++ +F+ E++I++ L NII LLG C +++ L ++ +++ G L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 348 NL----------HGNKKDPAA-----FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 392
L +GN P A +S VA+ +A ++YL S+ +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 393 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 452
+ N L+ ++ +++DFG+++ + ++A E + GK DV+A
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 453 FGVVLLELLTGRKPISNDHPKGQ---ESLVMWAKPIL-SSGKVTQLLDPALGNNYDYDQM 508
FGV L E+L + + P G+ E ++ A G+ L P Y+ M
Sbjct: 226 FGVTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELM 281
Query: 509 ERMVLASILCIRRDPRARPQMSLVLKLL 536
+ C RD R RP S + L
Sbjct: 282 LQ-------CWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 58/218 (26%), Positives = 113/218 (51%), Gaps = 21/218 (9%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330
+G G +V+ G + ++AVK LKP ++ F+ E ++ TL H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 331 NNLLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
+ ++ +++++GSL + L ++ P +S + +AE + Y+ +
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KNY 124
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVN 445
IHRD++++N+L+S+ +++DFGLA+ + T + A + APE +G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 446 DKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 482
K DV++FG++L E++T G+ P +P S VM A
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIP----YPGMSNSDVMSA 216
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 66/273 (24%), Positives = 119/273 (43%), Gaps = 26/273 (9%)
Query: 265 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 324
F+ E +G G V+ G ++A+K + ++F+ E +++ L H ++ L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
G C + L +V +F+ G L L+ ++ + V E +EYL S
Sbjct: 66 GVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS-- 120
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
IHRD+ + N L+S ++SDFG+ ++ + + + + PE F + K
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 445 NDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 503
+ K DV++FGV++ E+ T G+ P E + M +S G +L P L +
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKK--SNYEVVEM-----ISRGF--RLYRPKLASMT 229
Query: 504 DYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
Y+ M C P RP + +L+ +
Sbjct: 230 VYEVMYS-------CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 32/222 (14%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 327
++G G QVYKG + G+ A+K++ +ED +E LEI ++ HH+NI + G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 328 FE------DNNLLLVYDFLSRGS---LEENLHGN--KKDPAAFGWSERYKVAMGVAEALE 376
+ D+ L LV +F GS L +N GN K+D A+ + + L
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-------ICREILRGLA 135
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLA 435
+LH A +VIHRD+K N+LL+++ E +L DFG+ A+ T T GT ++A
Sbjct: 136 HLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMA 189
Query: 436 PEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 472
PE + D + D+++ G+ +E+ G P+ + HP
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK--PSEDVIKEFVL-EIEIITTLHHK 318
+ F N IG+G VY+ G+ +A+K ++ D I L EI ++ L H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 319 NIISLLGFCFED--NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 374
NI+ L +++ LV ++ + SL +N+ P F S+ + + +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQLLRG 120
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
L+YLH +IHRD+K SN+LL+D +++DFGLA+ + +T V T Y
Sbjct: 121 LQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYR 175
Query: 435 APEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 467
APE + ID++A G +L ELL KP+
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 30/295 (10%)
Query: 243 HEKYSATCRLF-NYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED 300
HE++ A ++ + D + NF+ IG+G + V + GK +AVK + +
Sbjct: 2 HEQFRAALQMVVDPGDPRTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ 58
Query: 301 VIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAF 359
+E + E+ I+ H+N++ + + L +V +FL G+L + + + +
Sbjct: 59 QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI 118
Query: 360 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419
V + V +AL LH AQ VIHRD+KS +ILL+ D +LSDFG A S
Sbjct: 119 A-----AVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSK 168
Query: 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479
+ GT ++APE ++D+++ G++++E++ G P N+
Sbjct: 169 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------- 219
Query: 480 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
P+ + + L P L N + + L +L RDP R + +LK
Sbjct: 220 ---PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV--RDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 269 NLIGKGGSSQVYKGC----LPDGKE---LAVKILK--PSEDVIKEFVLEIEIITTLHHKN 319
N +G G +VY+G L G +AVK L+ ++ KEF+ E +++ +H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---PAAFGWSERYKVAMGVAEALE 376
I+ LLG C + ++ + + G L L + + P E + + VA+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 377 YLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
YL IHRD+ + N L+S+ D ++ DFGLA+ S + +
Sbjct: 121 YLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
++APE + GK + DV++FGV++ E+LT G++P
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 18/189 (9%)
Query: 289 ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345
++AVK+LK +E + + + E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 346 EENLHGNKKDPAAFGWS------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 393
E L + + ++ + A VA +EYL S ++ IHRD+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAA 168
Query: 394 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 453
N+L+++D +++DFGLA+ + T+ ++APE + DV++F
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 454 GVVLLELLT 462
GV+L E+ T
Sbjct: 229 GVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 64/218 (29%), Positives = 112/218 (51%), Gaps = 34/218 (15%)
Query: 268 ENLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 321
E++IG+G QV + + DG ++ A+K+LK SE+ ++F E+E++ L HH NII
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 369
+LLG C L + ++ G+L + L ++ DPA + + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
VA ++YL S ++ IHRD+ + N+L+ ++ +++DFGL++ V
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--------VKK 175
Query: 430 TFG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 462
T G ++A E Y K DV++FGV+L E+++
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 59/223 (26%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 271 IGKGGSSQVYK----GCLPDGKEL--AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 322
IG+G +V++ G LP AVK+LK S D+ +F E ++ H NI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK------------------KDPAAFGWSER 364
LLG C + L++++++ G L E L +P +E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 365 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++ ++ +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 425 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ A ++ PE Y + + DV+A+GVVL E+ + G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 65/205 (31%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 271 IGKGGSSQVYKGC--LPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLG 325
IG+G V+K C G+ +A+K SED VIK+ L EI ++ L H N+++L+
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 326 FCFEDNNLLLVYDFLSR---GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
L LV+++ LE+N G + K+ +A+ + H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCH--- 117
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 440
IHRDVK NIL++ + +L DFG A+ + TD T Y APE +
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGD 175
Query: 441 --YGKVNDKIDVYAFGVVLLELLTG 463
YG +DV+A G V ELLTG
Sbjct: 176 TQYGP---PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 271 IGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 325
IG+G + V C+ G+++AVK + + +E + E+ I+ H NI+ +
Sbjct: 27 IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 326 FCFEDNNLLLVYDFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
+ L +V +FL G+L + + H + V + V +AL +LH+ Q
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI------ATVCLAVLKALSFLHA---Q 134
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
VIHRD+KS +ILL+ D +LSDFG A S + GT ++APE
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192
Query: 445 NDKIDVYAFGVVLLELLTGRKPISNDHP 472
++D+++ G++++E++ G P N+ P
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 22/190 (11%)
Query: 290 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346
+AVK+LK ++ + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 347 ENLHGNKKDPAAFGWS--------------ERYKVAMGVAEALEYLHSGSAQRVIHRDVK 392
E L + P +S + A VA +EYL S Q+ IHRD+
Sbjct: 107 EYLRARR--PPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLA 161
Query: 393 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 452
+ N+L+++D +++DFGLA+ + T+ ++APE + DV++
Sbjct: 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 453 FGVVLLELLT 462
FGV+L E+ T
Sbjct: 222 FGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 328
+G G +VYK + LA I SE+ ++++++EI+I+ + H NI+ LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 388
+NNL ++ +F + G+++ + ++ + V EAL YLH ++IH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHE---NKIIH 126
Query: 389 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND-- 446
RD+K+ NIL + D + +L+DFG++ A + + GT ++APE M D
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 447 ---KIDVYAFGVVLLEL 460
K DV++ G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 271 IGKGGSSQVYKGCLPDGK---ELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 325
+G G V KG K ++A+K+LK + V E + E EI+ L + I+ ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 384
C E L+LV + S G L + L G K + E ++V+MG ++YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMG----MKYLEG---K 114
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----YLAPEYF 439
+HRD+ + N+LL + ++SDFGL+K S+ A + G + APE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAGKWPLKWYAPECI 170
Query: 440 MYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ K + + DV+++G+ + E + G+KP
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 50/272 (18%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G G VYK L + LAVK+ L + ++ K+ + E+EI+ II G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
F +N + + +F+ GSL+ ++ + G ++A+ V + L YL S +++
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIPEHV-LG-----RIAVAVVKGLTYLWS---LKIL 117
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 447
HRDVK SN+L++ + +L DFG+ ST + GT Y+APE +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGV----STQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 448 IDVYAFGVVLLELLTGRKPISNDHPKGQ------------ESLVMWAKPILSSGKVTQLL 495
DV++ G+ +EL GR P +P+ Q + +V P+L G+ +
Sbjct: 174 SDVWSLGISFMELALGRFP----YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS--- 226
Query: 496 DPALGNNYDYDQMERMVLASILCIRRDPRARP 527
E+ V C+R+ P+ RP
Sbjct: 227 -------------EKFVHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 26/270 (9%)
Query: 271 IGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IG+G +V+ G L D +AVK + + D+ +F+ E I+ H NI+ L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
+ + +V + + G L + + E ++ A +EYL S + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 447
HRD+ + N L+++ ++SDFG+++ T + APE YG+ + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 448 IDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 506
DV++FG++L E + G P +N + + + +L P L + Y
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---------QGVRLPCPELCPDAVYR 227
Query: 507 QMERMVLASILCIRRDPRARPQMSLVLKLL 536
MER C DP RP S V + L
Sbjct: 228 LMER-------CWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 22/228 (9%)
Query: 269 NLIGKGGSSQVYKGCL----PDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNI 320
+G G +VY+G D EL V + SE +F++E I++ +H+NI
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEY 377
+ L+G FE ++ + ++ G L+ L N+ + P++ + A VA+ +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGY 433
L IHRD+ + N LL+ P ++DFG+A+ +S + +
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 434 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 480
+ PE F+ G K DV++FGV+L E+ + G P QE +
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFC 327
L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+NI + G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 328 FE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
+ D+ L LV +F GS+ + + K + W + + L +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ- 129
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+VIHRD+K N+LL+++ E +L DFG+ A+ T T GT ++APE
Sbjct: 130 --HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVIA 184
Query: 441 YGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 472
+ D K D+++ G+ +E+ G P+ + HP
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 51/188 (27%), Positives = 98/188 (52%), Gaps = 18/188 (9%)
Query: 290 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346
+AVK+LK ++ + + + E+E++ + HKNII+LLG C ++ L ++ ++ ++G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 347 ENLH------------GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 394
E L K + + A VA +EYL S +R IHRD+ +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAAR 163
Query: 395 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFG 454
N+L+++D +++DFGLA+ + ++ ++APE + DV++FG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 455 VVLLELLT 462
+++ E+ T
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 271 IGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNIISLL 324
+GKGG +V C GK A K L ++ + E +I+ + + I+SL
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 325 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
+ FE ++L LV ++ G L+ H F + A + LE+LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+R+++RD+K N+LL D ++SD GLA AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEV 170
Query: 444 VNDKIDVYAFGVVLLELLTGRKP 466
+ +D +A G L E++ GR P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 57/192 (29%), Positives = 102/192 (53%), Gaps = 26/192 (13%)
Query: 290 LAVKILK--PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346
+AVK+LK +E + + V E+E++ + HKNII+LLG C +D L ++ ++ S+G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 347 ENLHGNKKDPAAFGW----------------SERYKVAMGVAEALEYLHSGSAQRVIHRD 390
E L + + + S Y+VA G +EYL S Q+ IHRD
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARG----MEYLAS---QKCIHRD 162
Query: 391 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDV 450
+ + N+L++++ +++DFGLA+ + + T+ ++APE + DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 451 YAFGVVLLELLT 462
++FGV++ E+ T
Sbjct: 223 WSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-16
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 19/229 (8%)
Query: 290 LAVKILKPSEDVIKEFVL------------EIEIITTLHHKNIISLLGFCFEDNNLLLVY 337
+A + P E V+ +FV+ E+ + H I+ D+ LLL+
Sbjct: 85 VATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144
Query: 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 397
++ S G L + + K+ F E + + AL+ +HS ++++HRD+KS+NI
Sbjct: 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIF 201
Query: 398 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVL 457
L +L DFG +K S S S + GT YLAPE + + + K D+++ GV+L
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261
Query: 458 LELLTGRKPISNDHPKGQESLVMWAK----PILSSGKVTQLLDPALGNN 502
ELLT +P + V++ K P S + LLDP L N
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKN 310
|
Length = 478 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 6e-16
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 34/217 (15%)
Query: 269 NLIGKGGSSQVYKGCLP-DGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNIIS 322
++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA-------AFGWSER--YKVAMG 370
LLG C L L ++ G+L + L ++ DPA A S + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ V T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKKT 169
Query: 431 FG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 462
G ++A E Y DV+++GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 21/236 (8%)
Query: 293 KILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 351
K + + I + V E+ II L H NI+ E++ L +V D + L E+ +
Sbjct: 43 KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102
Query: 352 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411
K+ F + + + + AL YLH +R++HRD+ +NI+L +D + ++DFGL
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL 160
Query: 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 471
AK S T V GT Y PE +K DV+AFG +L ++ T + P +
Sbjct: 161 AKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF---Y 214
Query: 472 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 527
SL V + +P Y + V+ S C+ D ARP
Sbjct: 215 STNMLSLATKI--------VEAVYEPL--PEGMYSEDVTDVITS--CLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 64/293 (21%), Positives = 121/293 (41%), Gaps = 58/293 (19%)
Query: 271 IGKGGSSQVYKGCLPD------GKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 322
+G+G VY+G +A+K + S EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 323 LLGFCFEDNNLLLVYDFLSRGSL--------EENLHGNKKDPAAFGWSERYKVAMGVAEA 374
LLG L+V + +++G L E + P + ++A +A+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP--TLQKFIQMAAEIADG 131
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-- 432
+ YL A++ +HRD+ + N ++++D ++ DFG+ + I TD G
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-------DIYETDYYRKGGKG 181
Query: 433 -----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAK 483
++APE G K DV++FGVVL E+ T +P +SN+ V+ K
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VL--K 232
Query: 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
++ G + P + + M C + +P+ RP ++ L
Sbjct: 233 FVIDGGHLDL---PENCPDKLLELMRM-------CWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 51/290 (17%)
Query: 268 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILK--PSEDVIKEFVLEIEIITTL-HHKNII 321
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPA---------AFGWSERYKVAM 369
+LLG C L L ++ G+L + L ++ DPA + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ V
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKK 180
Query: 430 TFG-----YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 483
T G ++A E Y DV+++GV+L E+++ G P G ++ K
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELYEK 235
Query: 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 533
L G +L P ++ YD M + C R P RP + +L
Sbjct: 236 --LPQG--YRLEKPLNCDDEVYDLMRQ-------CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 328
IGKG +V+K +G + AVKIL P D+ +E E I+ L H N++ G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 329 EDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK---VAMGVAEALEYLHS 380
+ + L LV + + GS+ + + G K ER + +A + EAL L
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR------GERMEEPIIAYILHEALMGLQH 139
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF- 439
+ IHRDVK +NILL+ + +L DFG++ A +S+ + GT ++APE
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 440 ----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
+ + + DV++ G+ +EL G P+++ HP
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 22/236 (9%)
Query: 243 HEKYSATCRLFNYQ-DLLSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP 297
HE++ A R+ Q D S N++ IG+G + V C+ G+++AVK++
Sbjct: 3 HEQFKAALRMVVDQGDPRSLLENYIK---IGEGSTGIV---CIAREKHSGRQVAVKMMDL 56
Query: 298 SEDVIKEFVL-EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP 356
+ +E + E+ I+ H+N++ + L ++ +FL G+L + + + +
Sbjct: 57 RKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNE 116
Query: 357 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416
V V +AL YLHS Q VIHRD+KS +ILL+ D +LSDFG A
Sbjct: 117 EQIA-----TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQ 166
Query: 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
S + GT ++APE ++D+++ G++++E++ G P +D P
Sbjct: 167 ISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 270 LIGKGGSSQVYKGCLPDGK----ELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISL 323
IG+G VY+G + +AVK K S V ++F+ E I+ H +I+ L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
+G +N + +V + G L L NK + + + ++ AL YL S
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLES--- 125
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+R +HRD+ + N+L+S +L DFGL+++ S+ + ++APE + +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRR 184
Query: 444 VNDKIDVYAFGVVLLELLT-GRKP 466
DV+ FGV + E+L G KP
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 78/279 (27%), Positives = 123/279 (44%), Gaps = 40/279 (14%)
Query: 271 IGKGGSSQVYKG---CLPDGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLL 324
+G G V KG K +AVKILK + + E + E ++ L + I+ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
G C E + +LV + G L + L NK ++V+MG ++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEETN-- 115
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----YLAPEYF 439
+HRD+ + N+LL ++SDFGL+K ++ A T G + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECM 170
Query: 440 MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498
Y K + K DV++FGV++ E + G+KP KG E M + SG+ ++ P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG--MKGNEVTQM-----IESGE--RMECPQ 221
Query: 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
YD M+ LC RP ++V LR
Sbjct: 222 RCPPEMYDLMK-------LCWTYGVDERPGFAVVELRLR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 78/283 (27%), Positives = 130/283 (45%), Gaps = 39/283 (13%)
Query: 265 FLAENLIGKGGSSQVYKGCLPDGKEL-AVKIL----KPSEDVIKEFVLEIEIITTLHHKN 319
F+ + IG G VY E+ AVK + K + + ++ + E++ + L H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
I G +++ LV ++ GS + L +KK E + G + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLH 138
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
S +IHRD+K+ NILL++ + +L+DFG A +S ++S + GT ++APE
Sbjct: 139 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVI 189
Query: 440 MY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496
+ G+ + K+DV++ G+ +EL + P+ N M A L + Q
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------MNAMSALY--HIAQNDS 237
Query: 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539
P L +N D V C+++ P+ RP +LLR D
Sbjct: 238 PTLQSNEWTDSFRGFV---DYCLQKIPQERPAS---AELLRHD 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 50/283 (17%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLG 325
IG G QVYK G +AVK ++ + ++ K +++++++ H I+ G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 326 FCFEDNNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 375
+ D+++ + + +S +G + E++ G K+ + + +AL
Sbjct: 82 YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG--------------KMTVAIVKAL 127
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
YL VIHRDVK SNILL +L DFG++ S + T AG Y+A
Sbjct: 128 HYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMA 182
Query: 436 PEYFMYGKVNDKI----DVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491
PE N K DV++ G+ L+EL TG+ P N + + +L+ K+
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE---------VLT--KI 231
Query: 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
Q P+L N + + LC+ +D R RP+ +L+
Sbjct: 232 LQEEPPSLPPNEGFSPDFCSFV--DLCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 325
IG G VY + + +A+K + K S + ++ + E+ + L H N I G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
++ LV ++ GS + L +KK E + G + L YLHS
Sbjct: 83 CYLREHTAWLVMEY-CLGSASDILEVHKK---PLQEVEIAAICHGALQGLAYLHS---HE 135
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY---G 442
IHRD+K+ NILL++ +L+DFG A S ++S + GT ++APE + G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVILAMDEG 189
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISN 469
+ + K+DV++ G+ +EL + P+ N
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 67/217 (30%), Positives = 110/217 (50%), Gaps = 33/217 (15%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 322
NFL ++GKG +V EL A+KILK +DVI + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVI---IQDDDVECTMVEKRVLA 55
Query: 323 LLG---------FCFED-NNLLLVYDFLSRGSLEENLH--GNKKDP-AAFGWSERYKVAM 369
L G CF+ + L V ++++ G L ++ G K+P A F +E
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAE------ 109
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
+A L +LHS + +I+RD+K N++L + +++DFG+ K + T T G
Sbjct: 110 -IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRT-FCG 163
Query: 430 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
T Y+APE Y +D +AFGV+L E+L G+ P
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)
Query: 263 SNFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITT 314
S+F +G G +V +KG G+ A+K LK E + ++ E I+
Sbjct: 18 SDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILME 74
Query: 315 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGV 371
L H I++++ ++N + + +F+ G L +L + P A F +E +
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE-------L 127
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
A EYLHS + +I+RD+K N+LL + +++DFG AK + C GT
Sbjct: 128 VLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTLC----GTP 179
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
YLAPE +D + GV+L E + G P +D P
Sbjct: 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 65/262 (24%), Positives = 119/262 (45%), Gaps = 28/262 (10%)
Query: 290 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345
+AVK+L+ DV K +F+ EI+I++ L + NII LLG C D+ L ++ +++ G L
Sbjct: 47 VAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 346 EENL----------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 395
+ L H N + + + +A+ +A ++YL S +HRD+ + N
Sbjct: 105 NQFLSQREIESTFTHAN--NIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159
Query: 396 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGV 455
L+ + + +++DFG+++ + + ++A E + GK DV+AFGV
Sbjct: 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 456 VLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLAS 515
L E+ T K ++ + + + G+ L L + + M R
Sbjct: 220 TLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR----- 274
Query: 516 ILCIRRDPRARPQMSLVLKLLR 537
C RD + RP + + LR
Sbjct: 275 --CWSRDIKDRPTFNKIHHFLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 32/272 (11%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 325
IG G VYK + G+ A+K++K P ED V+++ EI ++ H NI++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSNIVAYFG 73
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
+ L + +F GSL++ H S+ V+ + L YLHS
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY---G 442
+HRD+K +NILL+D+ +L+DFG++ A +++ GT ++APE G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502
N D++A G+ +EL + P+ + HP +L + K S+ + +L D +N
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHP--MRALFLMTK---SNFQPPKLKDKMKWSN 239
Query: 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ +M L ++P+ RP +L+
Sbjct: 240 -SFHHFVKMALT------KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 63/252 (25%), Positives = 119/252 (47%), Gaps = 24/252 (9%)
Query: 289 ELAVKILKPSEDVIKEFVL--EIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345
++AVK+LKP+ + L E++I++ L +H+NI++LLG C +L++ ++ G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405
L ++ + + VA+ + +L S + IHRD+ + N+LL+ +
Sbjct: 127 LNFLRRKRESFLTL--EDLLSFSYQVAKGMAFLASKNC---IHRDLAARNVLLTHGKIVK 181
Query: 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GR 464
+ DFGLA+ S+++ + ++APE + DV+++G++L E+ + G
Sbjct: 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241
Query: 465 KPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPR 524
P +P G + K I ++ Q P YD M+ C DP
Sbjct: 242 NP----YP-GMPVDSKFYKLIKEGYRMAQ---PEHAPAEIYDIMKT-------CWDADPL 286
Query: 525 ARPQMSLVLKLL 536
RP +++L+
Sbjct: 287 KRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 22/203 (10%)
Query: 287 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 341
GK A+KILK ++D + + E ++ H + SL + F+ + L V ++++
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVN 78
Query: 342 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398
G L +L + +D F +E + AL+YLHSG ++++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRTRFYGAE-------IVSALDYLHSG---KIVYRDLKLENLML 128
Query: 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 458
D +++DFGL K T ++ T GT YLAPE +D + GVV+
Sbjct: 129 DKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 459 ELLTGRKPISN-DHPKGQESLVM 480
E++ GR P N DH K E ++M
Sbjct: 187 EMMCGRLPFYNQDHEKLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 33/271 (12%)
Query: 270 LIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL----EIEIITTLHHKNIISL 323
++G+G V+ C D K + +K + P E + K+ L E +++ L H NII
Sbjct: 7 VVGRGAFGIVHL-CRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
ED L++V ++ G+L E + K+ + + + AL ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVH---T 119
Query: 384 QRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
+ ++HRD+K+ NILL ++ DFG++K S+ S T V GT Y++PE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGK 176
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502
N K D++A G VL EL + ++ + +LV+ K+ + +
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVL---------KIMSGTFAPISDR 224
Query: 503 YDYDQMERMVLASILCIRRDPRARPQMSLVL 533
Y D R ++ S+L DP RPQ+S ++
Sbjct: 225 YSPDL--RQLILSML--NLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 270 LIGKGGSSQVY----KGCLPDGKEL--AVKIL--KPSEDVIKEFVLEIEIITTLHHKNII 321
+G+G +V+ KG +G E VK L E++ EF E+++ L HKN++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-----DPAAFGWSERYKVAMGVAEALE 376
LLG C E ++ ++ G L++ L K P ++ + +A ++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
+L S R +HRD+ + N L+S E ++S L+K S + + +LAP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 437 EYFMYGKVNDKIDVYAFGVVLLELLT 462
E + K DV++FGV++ E+ T
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 54/204 (26%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 328 FEDNNLLLVYDFLSRGSLEENL---HGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSA 383
++ + ++ +F+++GSL + L G+K+ P +S + +AE + ++
Sbjct: 71 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ--- 120
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+ IHRD++++NIL+S +++DFGLA+ + + + APE +G
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 444 VNDKIDVYAFGVVLLELLT-GRKP 466
K DV++FG++L+E++T GR P
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 37/214 (17%)
Query: 269 NLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLG 325
N IG G VYK P G+ A+K++ + V ++ EIEI+ ++H N++
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 383
+ + ++ +F+ GSLE E++ VA + + YLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE----------GTHIADEQFLADVARQILSGIAYLHR--- 186
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYG 442
+ ++HRD+K SN+L++ +++DFG+++ A T C GT Y++PE
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPE----- 238
Query: 443 KVNDKI----------DVYAFGVVLLELLTGRKP 466
++N + D+++ GV +LE GR P
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 270 LIGKGGSSQVYKGC-LPDGKEL----AVKILK----PSEDVIKEFVLEIEIITTLHHKNI 320
++G G VYKG +P+G+ + A+KIL P +V EF+ E I+ ++ H ++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPHL 71
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
+ LLG C + LV + G L + +H +K + G + +A+ + YL
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLEE 127
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+R++HRD+ + N+L+ +++DFGLA+ ++A E
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 441 YGKVNDKIDVYAFGVVLLELLT-GRKP 466
Y K + DV+++GV + EL+T G KP
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-15
Identities = 64/249 (25%), Positives = 114/249 (45%), Gaps = 23/249 (9%)
Query: 290 LAVKILKPSEDVIK----EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345
+AVK+L+ ED K +F+ EI+I++ L NII LL C + L ++ +++ G L
Sbjct: 49 VAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 346 EENL-------HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398
+ L K D +S +A +A ++YL S+ +HRD+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 458
++ +++DFG+++ + + +++ E + GK DV+AFGV L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 459 ELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILC 518
E+LT K ++ + + G+ L PAL + Y M + C
Sbjct: 224 EILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLM-------LSC 276
Query: 519 IRRDPRARP 527
RR+ + RP
Sbjct: 277 WRRNAKERP 285
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 271 IGKGGSSQVYKGCLPDGKEL-AVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLG 325
+G+GG QV+ D E+ A+K +K S + ++ + E +I+TT + ++ LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 326 FCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
+ F+D L L +++ G +L NL +D A F Y M EA++ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-----YMAEM--FEAVDALHEL 120
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
IHRD+K N L+ +L+DFGL+K + ++ V G+ Y+APE
Sbjct: 121 G---YIHRDLKPENFLIDASGHIKLTDFGLSK-GIVTYAN----SVVGSPDYMAPEVLRG 172
Query: 442 GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
+ +D ++ G +L E L G P S P
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 270 LIGKGGSSQVYKGCLPDGKE-LAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISL 323
+G G +V+ + A+K++ +VI+ + V E ++ + H II L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIP-EVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
+ L ++ +++ G L L + + F S A + ALEYLHS
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHS--- 119
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+ +++RD+K NILL + +L+DFG AK T T + GT YLAPE
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWT-LCGTPEYLAPEVIQSKG 174
Query: 444 VNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474
N +D +A G+++ E+L G P +D+P G
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 21/214 (9%)
Query: 270 LIGKGGSSQVYKGC-LPDGKEL----AVKIL--KPSEDVIKEFVLEIEIITTLHHKNIIS 322
L+G G V+KG +P+G + A+K + + +E + + +L H I+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--DPAAF-GWSERYKVAMGVAEALEYLH 379
LLG C +L LV GSL +++ ++ DP W + +A+ + YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
R++HR++ + NILL D Q++DFG+A ++ ++A E
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 440 MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 472
++G+ + DV+++GV + E+++ G +P + P
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 270 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 323
++GKG +V L EL AVK+LK +DVI + + ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLK--KDVI---LQDDDVECTMTEKRVLALAGKHP 56
Query: 324 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEAL 375
L CF+ + L V ++++ G L ++ + + A F Y A + L
Sbjct: 57 FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF-----Y--AAEIVLGL 109
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
++LH + +I+RD+K N+LL + +++DFG+ K +T + GT Y+A
Sbjct: 110 QFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIA 164
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470
PE Y +D +A GV+L E+L G+ P D
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 287 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 341
G+ A+KIL+ ++D + V E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP-FLTALKYAFQTHDRLCFVMEYAN 78
Query: 342 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398
G L +L + ++ A F +E + ALEYLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFTEERARFYGAE-------IVSALEYLHS---RDVVYRDIKLENLML 128
Query: 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 458
D +++DFGL K + + T GT YLAPE +D + GVV+
Sbjct: 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 459 ELLTGRKPISN-DHPKGQESLVM 480
E++ GR P N DH + E ++M
Sbjct: 187 EMMCGRLPFYNQDHERLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVK---ILKPSED-------VIKEFVLEIEIITTLHHK 318
LIG G VY G G+ +AVK + S ++ EI ++ L H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALE 376
NI+ LG + ++L + +++ GS+ N +G ++ + + + + L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------ILKGLN 120
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT----DVAGTFG 432
YLH+ + +IHRD+K +NIL+ + ++SDFG++K +S + G+
Sbjct: 121 YLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177
Query: 433 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 469
++APE K D+++ G +++E+LTG+ P +
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 271 IGKGGSSQVYKGCL-PDGKELAVKILKPSEDV---IKEFV-LEIEIITTLHHKNIISLLG 325
+G GG +V + + A+K +K V +E + E EI+ +H I+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 326 FCFEDNN---LLL-------VYDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 374
F+D +L+ ++ L RG +E ++ R+ +A V A
Sbjct: 61 -TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-------------YTARFYIAC-VVLA 105
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
EYLH+ + +I+RD+K N+LL + +L DFG AK S T T GT Y+
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFC-GTPEYV 159
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470
APE + + +D ++ G++L ELLTGR P D
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 270 LIGKGGSSQVYKGCLPDGKEL----AVKILKPSEDVIKE-----FVLEIEIITTLHHKNI 320
++GKGG +V++ G + A+K+LK + V + E I+ + H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 321 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALE 376
+ L+ + F+ L L+ ++LS G L +L +D A F SE ++ ALE
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISLALE 114
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
+LH Q +I+RD+K NILL +L+DFGL K S +T T GT Y+AP
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHT-FCGTIEYMAP 169
Query: 437 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473
E M +D ++ G ++ ++LTG P + ++ K
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK 206
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 319
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD--PAAFGWSERYKVAMGVAEALEY 377
I+ LL +N L LV++FL + L++ + + P S +++ G+A +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----F 115
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
HS RV+HRD+K N+L++ + +L+DFGLA+ T T T Y APE
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPE 170
Query: 438 YFMYGKV-NDKIDVYAFGVVLLELLTGR 464
+ K + +D+++ G + E++T R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 72/222 (32%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE-----FVLEIEIITTLHHKNIISL 323
IG+G QVYK D EL V + K D KE + EI+I+ L+H+NI++L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGEL-VALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 324 ----------LGFCFEDNNLLLVYDFLSR---GSLEENL-HGNKKDPAAFGWSERYKVAM 369
L F + LV++++ G LE L H ++ +F K +
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF-----MKQLL 126
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
E L Y H + +HRD+K SNILL++ + +L+DFGLA+ ++ S V
Sbjct: 127 ---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179
Query: 430 TFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPI 467
T Y PE YG IDV++ G +L EL T +KPI
Sbjct: 180 TLWYRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 37/240 (15%)
Query: 270 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLG--- 325
++GKG +V+ L + A+K LK +DV+ +++ ++ T+ K ++SL
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK--KDVV---LMDDDVECTMVEKRVLSLAWEHP 56
Query: 326 -----FC-FE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
+C F+ NL V ++L+ G L ++ K F A + L++L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFL 112
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
HS + +++RD+K NILL D +++DFG+ K + TCT GT Y+APE
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCT-FCGTPDYIAPEI 167
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKP------------ISNDHPKGQESLVMWAKPIL 486
+ K N +D ++FGV+L E+L G+ P I D+P L AK IL
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330
+G G +V+ G ++A+K LK + F+ E ++ L H ++ L ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAEALEYLHSGSAQRVIH 388
+ ++ +++ GSL + L K P + + M +AE + ++ + IH
Sbjct: 74 P-IYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 389 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG-TFGYLAPEYFMYGKVNDK 447
RD++++NIL+S+ +++DFGLA+ + T + A + APE YG K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 448 IDVYAFGVVLLELLT-GRKP 466
DV++FG++L E++T GR P
Sbjct: 184 SDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 69/274 (25%), Positives = 126/274 (45%), Gaps = 38/274 (13%)
Query: 271 IGKGGSSQVY--------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 322
IG+G ++Y + C+ +L +K E KE +L + + H NI++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVIL----LAKMKHPNIVT 63
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
E+ L +V ++ G L + + N++ F + + ++ L+++H
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIHD-- 119
Query: 383 AQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFM 440
++++HRD+KS NI LS + +L DFG+A+ + S TC GT YL+PE
Sbjct: 120 -RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYYLSPEICQ 175
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500
N+K D+++ G VL EL T + P ++ LV+ K+ Q +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVL---------KICQGYFAPIS 223
Query: 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
N+ D R +++ + + PR RP ++ +LK
Sbjct: 224 PNFSRDL--RSLISQLF--KVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 71/249 (28%), Positives = 111/249 (44%), Gaps = 46/249 (18%)
Query: 264 NFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKP--------------SEDVIKEF 305
NF ++G G +V+ G GK A+K+LK +E + E
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 306 VLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 364
V + TLH + F+ D L L+ D+++ G L +L+ + F SE
Sbjct: 61 VRRCPFLVTLH---------YAFQTDTKLHLILDYVNGGELFTHLYQREH----FTESE- 106
Query: 365 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421
V + +AE AL++LH +I+RD+K NILL + L+DFGL+K
Sbjct: 107 --VRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE 161
Query: 422 ITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479
GT Y+APE G + +D ++ GV+ ELLTG P + D + +S +
Sbjct: 162 RA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
Query: 480 MWAKPILSS 488
++ IL S
Sbjct: 221 --SRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 57/227 (25%), Positives = 108/227 (47%), Gaps = 26/227 (11%)
Query: 261 ATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDVI--KEFVLEIEII 312
+T F+ E +G+ +VYKG L + +A+K LK + +EF E +
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 313 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFG 360
+ L H NI+ LLG ++ L +++ + S L E L +K +
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 361 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420
++ + +A +E+L S+ V+H+D+ + N+L+ D ++SD GL + +
Sbjct: 123 PADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ + +++PE MYGK + D++++GVVL E+ + G +P
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILK--PSED--VIKEFVLEIEIITTLHHKNIISLLG 325
+G G VYK L G+ AVKI+K P +D +I++ EI ++ H NI++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHCNIVAYFG 73
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE---YLHSGS 382
L + ++ GSL++ H G ++A E L+ YLHS
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY- 441
+HRD+K +NILL+D+ + +L+DFG+A A +++ GT ++APE
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 442 --GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
G N D++A G+ +EL + P+ + HP
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 29/193 (15%)
Query: 366 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425
K+A+ + +ALEYLHS VIHRDVK SN+L++ + + +L DFG++ + S + T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKT 161
Query: 426 DVAGTFGYLAPEYF---MYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW 481
AG Y+APE + K D K DV++ G+ ++EL TGR P + W
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------W 210
Query: 482 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP------QMSLVLKL 535
P +V + P L + + V C++++ + RP Q
Sbjct: 211 KTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPELLQHPFFELH 267
Query: 536 LRGDADVTKWARL 548
L + DV + L
Sbjct: 268 LSKNTDVASFVSL 280
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 71/269 (26%), Positives = 110/269 (40%), Gaps = 65/269 (24%)
Query: 271 IGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEF----VLEIEIITTLHHKNIISL 323
IG+G +VYK DGKE A+K K ++ EI ++ L H+N++SL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 324 LGFCFEDNN--LLLVYDFLSRGSLEENL---------HGNKKDPAAFGWSERYKVAMGVA 372
+ E + + L++D+ E +L P + S +++ GV
Sbjct: 68 VEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLA-KWASTSSSHITCTDV 427
YLHS V+HRD+K +NIL+ + + + D GLA + + V
Sbjct: 123 ----YLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 428 AGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 483
T Y APE + Y K ID++A G + ELLT PI KG+E+
Sbjct: 176 VVTIWYRAPELLLGARHYTKA---IDIWAIGCIFAELLTLE-PIF----KGREA------ 221
Query: 484 PILSSGKVTQLLDPALGNNYDYDQMERMV 512
N + DQ+ER+
Sbjct: 222 ------------KIKKSNPFQRDQLERIF 238
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 50/193 (25%), Positives = 84/193 (43%), Gaps = 20/193 (10%)
Query: 287 GKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFLS 341
G A+K+LK S+ + + E I+ ++ L + F+ + L LV ++L+
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80
Query: 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSD 400
G + W+++Y V +E LH QR +IHRD+K N+L+
Sbjct: 81 GGDCASLI--KTLGGLPEDWAKQY--IAEVVLGVEDLH----QRGIIHRDIKPENLLIDQ 132
Query: 401 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 460
+L+DFGL++ + GT YLAPE + + D ++ G V+ E
Sbjct: 133 TGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 461 LTGRKPISNDHPK 473
L G P + P
Sbjct: 187 LFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 68/239 (28%), Positives = 110/239 (46%), Gaps = 35/239 (14%)
Query: 299 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 358
+D+IKE + + L H N I G ++ LV ++ GS + L +KK
Sbjct: 60 QDIIKE----VRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQE 114
Query: 359 FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418
E V G + L YLHS +IHRDVK+ NILLS+ +L DFG A + +
Sbjct: 115 V---EIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 419 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 475
+ + GT ++APE + G+ + K+DV++ G+ +EL + P+ N
Sbjct: 169 NXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN------ 216
Query: 476 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
M A L + Q PAL + + + V + C+++ P+ RP ++LK
Sbjct: 217 ----MNAMSALY--HIAQNESPALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 14/212 (6%)
Query: 263 SNFLAENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLH 316
S E +IG G +V G L P +E+ A+K LK +E ++F+ E I+
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 317 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376
H NII L G + +++V +++ GSL+ L +K F + + G+A ++
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMK 120
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLA 435
YL S +HRD+ + NIL++ + ++SDFGL++ + T + A
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 177
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
PE Y K DV+++G+V+ E+++ G +P
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 285 PDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340
P G +A K++ KP+ + + + E++++ + I+ G + D + + + +
Sbjct: 28 PSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85
Query: 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 400
GSL++ L K+ P KV++ V L YL +++HRDVK SNIL++
Sbjct: 86 DGGSLDQVLKEAKRIPEEI----LGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNS 139
Query: 401 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 460
E +L DFG++ S ++ GT Y++PE + + D+++ G+ L+EL
Sbjct: 140 RGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 461 LTGRKPISNDHPKGQESLVMWAKPILSSG 489
GR PI P +E ++ +P++
Sbjct: 196 AIGRYPIPP--PDAKELEAIFGRPVVDGE 222
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 67/227 (29%), Positives = 116/227 (51%), Gaps = 28/227 (12%)
Query: 270 LIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFV---LEIEIITTLHHKNIIS 322
++G+G +V+ K PD +L A+K+LK + +++ V +E +I+ ++H I+
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 323 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYL 378
L + F+ + L L+ DFL G L L ++ F +E +A AL++L
Sbjct: 63 L-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHL 114
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA--STSSSHITCTDVAGTFGYLAP 436
HS +I+RD+K NILL ++ +L+DFGL+K + ++ C GT Y+AP
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAP 167
Query: 437 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 483
E D ++FGV++ E+LTG P K ++++ AK
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 4e-14
Identities = 70/235 (29%), Positives = 92/235 (39%), Gaps = 52/235 (22%)
Query: 259 LSATSNFLAE-------NLI-GKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIE 310
LS FL LI GK G V K P K KI+K K F IE
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKH-KPTQKLFVQKIIKA-----KNFN-AIE 58
Query: 311 I-ITTL--HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 367
+ L + N I L +L+ D++ G L + L K +E K+
Sbjct: 59 PMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKI 114
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCT 425
+ EAL LH +IH D+K N+L D + + L D+GL K T S +
Sbjct: 115 IRQLVEALNDLHK---HNIIHNDIKLENVLY-DRAKDRIYLCDYGLCKIIGTPSCY---- 166
Query: 426 DVAGTFGYLAPEYFMYGKVNDKI---------DVYAFGVVLLELLTGRKPISNDH 471
D GT Y +PE KI D +A GV+ ELLTG+ P D
Sbjct: 167 D--GTLDYFSPE---------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 31/242 (12%)
Query: 296 KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD 355
K S + ++ + E++ + + H N I G ++ LV ++ GS + L +KK
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVHKKP 121
Query: 356 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415
E + G + L YLHS +IHRD+K+ NILL++ + +L+DFG A A
Sbjct: 122 LQEV---EIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175
Query: 416 STSSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
S ++S + GT ++APE + G+ + K+DV++ G+ +EL + P+ N
Sbjct: 176 SPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--- 226
Query: 473 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 532
M A L + Q P L +N D V + C+++ P+ RP +
Sbjct: 227 -------MNAMSALY--HIAQNESPTLQSNEWSDYFRNFVDS---CLQKIPQDRPTSEEL 274
Query: 533 LK 534
LK
Sbjct: 275 LK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 270 LIGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIIS 322
++G+G V +G L DG +L AVK +K + I+EF+ E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 323 LLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEA 374
L+G CFE ++L +++ F+ G L L ++ P K + +A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS----SHITCTDVAGT 430
+EYL S + IHRD+ + N +L +D ++DFGL+K + I V
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 180
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
++A E K DV+AFGV + E+ T G+ P
Sbjct: 181 --WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 271 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--------- 320
IGKG QVY+ D + A+K+L KE V + E+ T+ +NI
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK-----KEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 321 --ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
I L F F+ D++L LV D++S G L +L + ++ +A V ALE+
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVL-ALEH 111
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LH +++RD+K NILL L DFGL+K A+ + + T T GT YLAPE
Sbjct: 112 LHK---YDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNT-FCGTTEYLAPE 166
Query: 438 YFM----YGKVNDKIDVYAFGVVLLELLTGRKP 466
+ Y K +D ++ GV++ E+ G P
Sbjct: 167 VLLDEKGYTK---HVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 326
IG+G VYKG G+ +A+K I SE+ V + EI ++ L H NI+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 327 CFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
+++ L L+++FLS L+ ++L + A S Y++ G+ + HS
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCHS--- 119
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG- 442
+RV+HRD+K N+L+ + +L+DFGLA+ T V T Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSP 177
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPI 467
+ + +D+++ G + E+ T +KP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 76/298 (25%), Positives = 122/298 (40%), Gaps = 60/298 (20%)
Query: 265 FLAENL-----IGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLH 316
F AE+L IG+G V K G +AVK ++ + D K +++++++
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS 60
Query: 317 H-KNIISLLG---------FCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 360
I+ G C E D VY+ L + + E + G
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILG--------- 110
Query: 361 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420
K+A+ +AL YL ++IHRDVK SNILL + +L DFG++ S
Sbjct: 111 -----KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-- 161
Query: 421 HITCTDVAGTFGYLAPEY---FMYGKVNDKIDVYAFGVVLLELLTGRKPISN-DHPKGQE 476
I T AG Y+APE + + DV++ G+ L E+ TG+ P + Q
Sbjct: 162 -IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
Query: 477 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ V+ P P L N+ + + V LC+ +D RP+ +L+
Sbjct: 221 TQVVKGDP------------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 64/220 (29%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 322
NFL ++GKG +V EL A+KILK +DV+ + + ++ T+ K +++
Sbjct: 3 NFLM--VLGKGSFGKVMLAERKGTDELYAIKILK--KDVV---IQDDDVECTMVEKRVLA 55
Query: 323 LLG---------FCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMG 370
L G CF+ + L V ++++ G L + G K+P A + A
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAE 109
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
+A L +LHS + +I+RD+K N++L + +++DFG+ K +T GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470
Y+APE Y +D +AFGV+L E+L G+ P +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 54/229 (23%), Positives = 108/229 (47%), Gaps = 35/229 (15%)
Query: 264 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILK----PSEDVIKEFVLEIEIIT 313
N + +G+G +V K +AVK+LK SE +++ + E ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSE--LRDLLSEFNLLK 58
Query: 314 TLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYK------ 366
++H ++I L G C +D LLL+ ++ GSL L ++K P+ G
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 367 -----VAMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413
+ MG ++ ++YL + +++HRD+ + N+L+++ + ++SDFGL++
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 462
S++ + ++A E + DV++FGV+L E++T
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 271 IGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNIISLL 324
IGKG +V DGK AVK+L+ + K+ I ++ + H ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 325 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEALEYLHS 380
+ F+ + L V D+++ G L +L + P A F +E +A AL YLHS
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE-------IASALGYLHS 114
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+I+RD+K NILL L+DFGL K S T + GT YLAPE
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLR 169
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKPI-SNDH 471
+ +D + G VL E+L G P S D
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-13
Identities = 47/133 (35%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 394
LV D+ + G L + + K F E + + V A+ ++HS + +IHRD+KS+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSA 172
Query: 395 NILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 453
NILL + +L DFG +K +A+T S + T GT Y+APE + + K D+++
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 454 GVVLLELLTGRKP 466
GV+L ELLT ++P
Sbjct: 232 GVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 66/239 (27%), Positives = 116/239 (48%), Gaps = 35/239 (14%)
Query: 299 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNK----K 354
ED KE VL + + H NI++ D +L +V ++ G L + + +
Sbjct: 43 EDSRKEAVL----LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFP 98
Query: 355 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414
+ W ++ +GV +++H +RV+HRD+KS NI L+ + + +L DFG A+
Sbjct: 99 EDTILQWF--VQMCLGV----QHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
Query: 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474
++ ++ CT V GT Y+ PE + N+K D+++ G +L EL T + P +
Sbjct: 150 LTSPGAY-ACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--- 204
Query: 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 533
W IL KV Q L ++Y Y+ R ++ + +R+PR+RP + +L
Sbjct: 205 ------WKNLIL---KVCQGSYKPLPSHYSYEL--RSLIKQMF--KRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 262 TSNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKP----SEDVIKEFVLEIEIITTLH 316
NFL ++GKG +V EL A+KILK +D ++ ++E ++
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 317 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAE 373
++ L CF+ + L V ++++ G L ++ G K+P A + A ++
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISV 112
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 433
L +LH + +I+RD+K N++L + +++DFG+ K +T GT Y
Sbjct: 113 GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDY 167
Query: 434 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470
+APE Y +D +A+GV+L E+L G+ P +
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 270 LIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLL 324
++GKG +V L G+ AVK+LK +D ++ + E I++ + ++ L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 325 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 380
CF+ + L V +F++ G L ++ +++ A F +E + AL +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-------ITSALMFLHD 114
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+ +I+RD+K N+LL + +L+DFG+ K + T + GT Y+APE
Sbjct: 115 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQ 169
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKP 466
+D +A GV+L E+L G P
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 271 IGKGGSSQVY------KGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 324
+GKGG +V G L K+L K LK + V E I+ +H + I+SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSL- 58
Query: 325 GFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
+ F+ +L LV ++ G L +++ ++ F + LE+LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--- 115
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+R+I+RD+K N+LL +D ++SD GLA AGT G++APE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAPELLQGEE 173
Query: 444 VNDKIDVYAFGVVLLELLTGRKP 466
+ +D +A GV L E++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 49/206 (23%)
Query: 287 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLLV 336
G+++A+K I +D+I K + EI+++ L H+NII LL F D + +V
Sbjct: 25 GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND--VYIV 82
Query: 337 YDFL---------SRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 386
+ + S L + + + + + L+YLHS + V
Sbjct: 83 TELMETDLHKVIKSPQPLTD---------------DHIQYFLYQILRGLKYLHSAN---V 124
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-TDVAGTFGYLAPEYFM----Y 441
IHRD+K SNIL++ + + ++ DFGLA+ T+ T Y APE + Y
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184
Query: 442 GKVNDKIDVYAFGVVLLELLTGRKPI 467
K ID+++ G + ELLT RKP+
Sbjct: 185 TK---AIDIWSVGCIFAELLT-RKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 269 NLIGKGGSSQVYKGC-LPDGKELAVK-ILKP-SEDVIKEFVL-EIEI---ITTLHHKNII 321
IG+G VYK L G+ +A+K + P SE+ I L EI + + + H NI+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 322 SLLGFC-----FEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMG-VAEA 374
LL C + L LV++ + +++L K P E K M +
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
+++LHS R++HRD+K NIL++ D + +++DFGLA+ S + T V T Y
Sbjct: 120 VDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWYR 173
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
APE + +D+++ G + EL R+P+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 53/165 (32%), Positives = 86/165 (52%), Gaps = 35/165 (21%)
Query: 316 HHKNIISLLGFCFEDNN--LLLVYDFLS-------RGSLEENLHGNKKDPAAFGWSERYK 366
H NI+ LL +N+ + LV++++ R ++ E++H +RY
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------------KRY- 111
Query: 367 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST---SSSHIT 423
+ + +AL+Y+HSG VIHRD+K SNILL+ D +L+DFGLA+ S + +
Sbjct: 112 IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 424 CTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 464
TD T Y APE + Y K +D+++ G +L E+L G+
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTK---GVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 270 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLG-- 325
++GKG +V L E A+K LK K+ VLE + + T+ + +++L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEH 55
Query: 326 ------FC-FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
FC F+ +L V ++L+ G L ++ + + F + A + L++
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----FDEARARFYAAEIICGLQF 111
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LH + +I+RD+K N+LL D +++DFG+ K + GT Y+APE
Sbjct: 112 LHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPE 166
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470
K N+ +D ++FGV+L E+L G+ P +
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 270 LIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTLHHKNIIS 322
L+G+G +VY D G+ELA K ++ S + KE EI+++ L H+ I+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 323 LLGFCFEDN---NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
G C D L + +++ GS+++ L K A S K + E + YLH
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLH 123
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST-SSSHITCTDVAGTFGYLAPEY 438
S ++HRD+K +NIL +L DFG +K T S V GT +++PE
Sbjct: 124 S---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKP 466
K DV++ G ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 271 IGKGGSSQVYKGCLPDGKEL-AVKILK---PS-EDVIKEFVLEIEIITTL-HHKNIISLL 324
+G G VY + EL A+K +K S E+ + + E++ + L H NI+ L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYL 378
E++ L V++++ E NL+ KD +SE Y++ G L ++
Sbjct: 65 EVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQG----LAHI 115
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC----TDVAGTFGYL 434
H HRD+K N+L+S +++DFGLA+ I TD T Y
Sbjct: 116 HK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYR 165
Query: 435 APEYFMY-GKVNDKIDVYAFGVVLLELLTGR 464
APE + + +D++A G ++ EL T R
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 271 IGKGGSSQVYK-GCLPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 326
IG+G V+K G+ +A+K L+ E I L EI+ + H ++ LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
+ +LV +++ L E L +++ P + Y + + + Y+H A +
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLR-DEERPLPEAQVKSY--MRMLLKGVAYMH---ANGI 120
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KV 444
+HRD+K +N+L+S D +++DFGLA+ S + VA T Y APE +YG K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPE-LLYGARKY 178
Query: 445 NDKIDVYAFGVVLLELLTGR 464
+ +D++A G + ELL G
Sbjct: 179 DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 287 GKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 341
GK A+KILK + K+ V E ++ H + +L + F+ ++ L V ++ +
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYAN 78
Query: 342 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398
G L +L + +D A F +E + AL YLHS V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALGYLHS---CDVVYRDLKLENLML 128
Query: 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGV 455
D +++DFGL K + + T GT YLAPE YG+ +D + GV
Sbjct: 129 DKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRA---VDWWGLGV 183
Query: 456 VLLELLTGRKPISN-DHPKGQESLVM 480
V+ E++ GR P N DH K E ++M
Sbjct: 184 VMYEMMCGRLPFYNQDHEKLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 287 GKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLS 341
G+ A+KILK ++D + + E ++ H ++ L + F+ ++ L V ++ +
Sbjct: 20 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYAN 78
Query: 342 RGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398
G L +L + +D A F +E + AL+YLHS + V++RD+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALDYLHS--EKNVVYRDLKLENLML 129
Query: 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 458
D +++DFGL K + T GT YLAPE +D + GVV+
Sbjct: 130 DKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 187
Query: 459 ELLTGRKPISN-DHPKGQESLVM 480
E++ GR P N DH K E ++M
Sbjct: 188 EMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 55/250 (22%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE-----FVLEIEIITTLH 316
+F +IG+G +V+ D ++ A+K+L+ S D+IK E +I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKS-DMIKRNQIAHVRAERDILADAD 59
Query: 317 HKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-- 373
I+ L + F+D +L LV +++ G L L +KD + Y +AE
Sbjct: 60 SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFY-----IAELV 111
Query: 374 -ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------------------- 413
AL+ +H IHRD+K NIL+ D +L+DFGL K
Sbjct: 112 LALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 414 --------WASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLT 462
+ GT Y+APE YG + D ++ GV+L E+L
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL---ECDWWSLGVILYEMLY 225
Query: 463 GRKPISNDHP 472
G P +D
Sbjct: 226 GFPPFYSDTL 235
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTL 315
+N+ L+G+G +VY D G+ELAVK ++ S + KE EI+++ L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 316 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 373
H+ I+ G + + L + + + GS+++ L K A + K + E
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILE 117
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS-SHITCTDVAGTFG 432
+ YLHS ++HRD+K +NIL +L DFG +K T S V GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 433 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
+++PE K D+++ G ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 270 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 323
++GKG +V L E+ A+K+LK +DVI + + ++ T+ K I++L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLK--KDVI---LQDDDVDCTMTEKRILALAAKHP 56
Query: 324 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
L CF+ + L V ++++ G L + ++K F A V AL +L
Sbjct: 57 FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFL 112
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
H VI+RD+K NILL + +L+DFG+ K + +T T GT Y+APE
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEI 167
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 471
+ +D +A GV++ E++ G+ P D+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 287 GKELAVKILKPSEDVI---KEFVLEIEIITTLHHKNIISLL------GFCFEDNNLLLVY 337
GK++A+K + + DV K + E++I+ H NII++ G F+D + +V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD--VYVVM 87
Query: 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 397
D L L +H ++ Y++ G L+Y+HS + VIHRD+K SN+L
Sbjct: 88 D-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG----LKYIHSAN---VIHRDLKPSNLL 139
Query: 398 LSDDFEPQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPE-YFMYGKVNDKIDVYAFG 454
+++D E ++ DFG+A+ S+S + T+ T Y APE + ID+++ G
Sbjct: 140 VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG 199
Query: 455 VVLLELLTGRKPI-SNDHPKGQESLVM 480
+ E+L GR+ + + Q L++
Sbjct: 200 CIFAEML-GRRQLFPGKNYVHQLKLIL 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVK-ILKPSED--VIKEFVLEIEIITTLHHKNIISLLGF 326
IG+G VYK G+ +A+K I +ED V + EI ++ L+H NI+ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
+N L LV++FL L+ + + + + + Y HS RV
Sbjct: 67 VHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRV 120
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN 445
+HRD+K N+L+ + +L+DFGLA+ T V T Y APE + + +
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQYS 178
Query: 446 DKIDVYAFGVVLLELLTGRKPI 467
+D+++ G + E++ R+P+
Sbjct: 179 TPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 287 GKELAVKILKPSEDVIKEFV-----LEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFL 340
GK A+K+LK + V K E +++ + + L + F+ D L L+ D++
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 400
+ G L +L ++ F E + + ALE+LH +I+RD+K NILL
Sbjct: 88 NGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDS 140
Query: 401 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDK-IDVYAFGVVLL 458
+ L+DFGL+K GT Y+AP+ G +DK +D ++ GV++
Sbjct: 141 NGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMY 199
Query: 459 ELLTGRKPISNDHPKGQES 477
ELLTG P + D K ++
Sbjct: 200 ELLTGASPFTVDGEKNSQA 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 26/221 (11%)
Query: 270 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 321
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 322 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 378
+ + F + L + D ++ G L +L HG F E A + LE++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHM 113
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 439 FMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESL 478
G D D ++ G +L +LL G P K + +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILK---PSEDVIKE---FVLEIEIITTLH 316
N+ L+G+G +VY D G+ELAVK + S++ KE EI+++ L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 317 HKNIISLLGFCFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 373
H I+ G C D L + +++ GS+++ L K A + + + +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST-SSSHITCTDVAGTFG 432
+ YLHS ++HRD+K +NIL +L DFG +K T S V GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 433 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
+++PE K DV++ ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
+ E L YLH AQR+IHRDVK+ NI ++D + + D G A++ + + + +AGT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAGT 219
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 476
APE K N K D+++ G+VL E+L I D P E
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV--LEIEIITTL-HHKNIISLLGF 326
IG+G S+V K GK A+K +K +++ EI+ + L H NI+ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 327 CFE--DNNLLLVYDFLSRGSLEENLH---GNKKDPAAFGWSERYKVAM-GVAEALEYLHS 380
F+ L LV++ + + NL+ +K P +R K M + ++L+++H
Sbjct: 67 LFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHMH- 117
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+ HRD+K NIL+ DD +L+DFG + S T+ T Y APE +
Sbjct: 118 --RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLL 171
Query: 441 Y-GKVNDKIDVYAFGVVLLELLT 462
G K+D++A G V E+L+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 67/237 (28%), Positives = 99/237 (41%), Gaps = 53/237 (22%)
Query: 270 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDV----IKEFVLEIEIITTLHHKNII 321
L+GKG +V+ KG GK A+K+L E + +K + E EI+ TL H +
Sbjct: 8 LLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLH---GN--KKDPAAFGWSERYKVAMGVAEALE 376
+L + L LV D+ G L L G ++ A F +E V ALE
Sbjct: 65 TLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-------VLLALE 117
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA---------------STSSSH 421
YLH +++RD+K NILL + LSDF L+K + SS +
Sbjct: 118 YLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 422 ITCTDVA------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
++ GT Y+APE +D + G++L E+L G P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 37/219 (16%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEIITTLHHKNIISL 323
IG+G +V+K + +A+K +L +E KE F + EI+I+ L H+N+++L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENE---KEGFPITALREIKILQLLKHENVVNL 76
Query: 324 LGFCFED----NN----LLLVYDFLSRGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEA 374
+ C N LV++F E +L G + F SE KV +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS-SSHITC-TDVAGTFG 432
L Y+H +++HRD+K++NIL++ D +L+DFGLA+ S S +S T+ T
Sbjct: 132 LYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 433 YLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 467
Y PE + YG ID++ G ++ E+ T R PI
Sbjct: 189 YRPPELLLGERDYGP---PIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 29/246 (11%)
Query: 270 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKE---FVLEIEIITTLHHKN---II 321
+IG+GG +VY GC GK A+K L +K+ L I+ +L I
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 322 SLLGFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 378
+ + F + L + D ++ G L +L HG F +E A + LE++
Sbjct: 60 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHM 113
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 439 FMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQ---ESLVMWAKPILSSGKVTQL 494
G D D ++ G +L +LL G P K + + + + L +L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226
Query: 495 LDPALG 500
G
Sbjct: 227 RSLLEG 232
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 264 NFLAENLIGKGGSSQV----YKGCLPDGKELAVKILKPSEDVIKEFVLE----------- 308
LA ++G+G +V YK G+ A+K LK K ++
Sbjct: 2 RCLA--VLGRGHFGKVLLAEYK---KTGELYAIKALK------KGDIIARDEVESLMCEK 50
Query: 309 --IEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 365
E + H +++L CF+ ++++ V ++ + G L ++H + +SE
Sbjct: 51 RIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV-------FSEPR 102
Query: 366 KV--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSS 420
V A V L+YLH ++++RD+K N+LL + +++DFGL K +S
Sbjct: 103 AVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159
Query: 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470
C GT +LAPE +D + GV++ E+L G P D
Sbjct: 160 TF-C----GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
++GKG VY L +A+K + + S V + EI + + L H+NI+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGS 73
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
E+ + + + GSL L +K P + E L+YLH ++
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQI 129
Query: 387 IHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDV-AGTFGYLAPEYF----- 439
+HRD+K N+L++ ++SDFG +K + + CT+ GT Y+APE
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPR 186
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKP 466
YG D+++ G ++E+ TG+ P
Sbjct: 187 GYGA---PADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 57/220 (25%), Positives = 107/220 (48%), Gaps = 19/220 (8%)
Query: 271 IGKGGSSQVYK-GCLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLLG 325
+G G V+K P G +A K++ KP+ + + + E++++ + I+ G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYG 70
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
+ D + + + + GSL++ L + P KV++ V + L YL +
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE--KHK 124
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 445
++HRDVK SNIL++ E +L DFG++ S ++ GT Y++PE +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYS 180
Query: 446 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485
+ D+++ G+ L+E+ GR PI P +E +M+ P+
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPV 218
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 9/92 (9%)
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 433
L+Y+HS +IHRD+K SNI +++D E ++ DFGLA+ T T Y
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 181
Query: 434 LAPE-YFMYGKVNDKIDVYAFGVVLLELLTGR 464
APE + N +D+++ G ++ ELLTG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 8e-12
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 271 IGKGGSSQVYKGCLPDGKEL-AVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G+G + VYKG E+ A+K L E + EI ++ L H+NI+ L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 328 FEDNNLLLVYDFLSRGSLEE--NLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
+N L+LV++++ L++ + HG + S Y++ G+A + H
Sbjct: 68 HTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FCHE---N 119
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKW----ASTSSSHITCTDVAGTFGYLAPEYFM 440
RV+HRD+K N+L++ E +L+DFGLA+ +T S+ + T Y AP+ +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV------TLWYRAPDVLL 173
Query: 441 YGKV-NDKIDVYAFGVVLLELLTGR 464
+ + ID+++ G ++ E++TGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 58/192 (30%), Positives = 92/192 (47%), Gaps = 22/192 (11%)
Query: 287 GKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL--GFCFEDNNLLLVYDFL 340
G E+A+K+L+ E F E + L+H NI++LL G L V++++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS- 399
+L E L + PA E ++ + V +AL H Q ++HRD+K NI++S
Sbjct: 62 PGRTLREVLAADGALPAG----ETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 400 DDFEP--QLSDFGLAKWAS----TSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYA 452
P ++ DFG+ + +T T+V GT Y APE V D+YA
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 453 FGVVLLELLTGR 464
+G++ LE LTG+
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 44/280 (15%)
Query: 264 NFLAENLIGKGGSSQVY---KGCLPD-GKELAVKILKPSEDVIKEFVLE-----IEIITT 314
NF ++G G +V+ K D GK A+K+L+ + V K +E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 315 LHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMG 370
+ + L + F+ + L L+ D++S G + +L+ +D F E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGE------- 113
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
+ ALE+LH +++RD+K NILL + L+DFGL+K + T + GT
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGT 169
Query: 431 FGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486
Y+APE +GK +D ++ G+++ ELLTG P + + + +S V ++ IL
Sbjct: 170 IEYMAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRIL 224
Query: 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR 526
K +G + +L +L +DP+ R
Sbjct: 225 ---KCDPPFPSFIG------PEAQDLLHKLLR--KDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 21/206 (10%)
Query: 270 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVI------KEFVLEIEII-TTLHHKNII 321
+IGKG +V DGK AVK+L+ + ++ K + E ++ + H ++
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQ--KKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 322 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
L + F+ L V DF++ G L +L + P R+ A +A AL YLHS
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAE-IASALGYLHS 114
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+++RD+K NILL L+DFGL K S T T GT YLAPE
Sbjct: 115 ---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIR 169
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKP 466
++ +D + G VL E+L G P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 64/227 (28%), Positives = 107/227 (47%), Gaps = 44/227 (19%)
Query: 263 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 317
+ + IG+G V P G ++A+K + P E F EI+I+ H
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT--FCQRTLREIKILRRFKH 62
Query: 318 KNIISLLGF----CFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER-------- 364
+NII +L FE N++ +V + + E +L+ K ++
Sbjct: 63 ENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLYKLIK-------TQHLSNDHIQY 110
Query: 365 --YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH- 421
Y++ G L+Y+HS + V+HRD+K SN+LL+ + + ++ DFGLA+ A H
Sbjct: 111 FLYQILRG----LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163
Query: 422 ITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 467
T+ T Y APE + K K ID+++ G +L E+L+ R P+
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 26/191 (13%)
Query: 295 LKPSEDVIKEFVLEIEIITTLHHKN---IISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 351
+KP+ + + + E+++ LH N I+ G + D + + + + GSL++ L
Sbjct: 38 IKPA--IRNQIIRELKV---LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 92
Query: 352 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409
+ P E K+++ V L YL +++HRDVK SNIL++ E +L DF
Sbjct: 93 AGRIP------ENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 144
Query: 410 GLAKWA--STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
G++ S ++S + GT Y++PE + D+++ G+ L+E+ GR PI
Sbjct: 145 GVSGQLIDSMANSFV------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
Query: 468 SNDHPKGQESL 478
K E++
Sbjct: 199 PPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 265 FLAENLIGKGGSSQVYKGCLPDGK-----ELAVKILK--PSEDVIKEFVLEIEIITTLHH 317
+L+ +G +++ G L D K E+ VK +K SE + + E ++ L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 318 KNIISLLGFCFEDNNLLLV-YDFLSRGSLEENL----HGNKKDPAAFGWSERYKVAMG-- 370
+NI+ +L C ED V Y +++ G+L+ L G +P A S + V M
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQ 125
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
+A + YLH + VIH+D+ + N ++ ++ + +++D L++ H +
Sbjct: 126 IACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 462
++A E + + + DV++FGV+L EL+T
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 70/296 (23%), Positives = 128/296 (43%), Gaps = 45/296 (15%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFC 327
+GKG VYK P G +A+K ++ D K + ++E++I+ I+ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
F + + + +++ GSL++ L+ ++ V + L++L +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 445
HRDVK +N+L++ + + +L DFG++ AS + ++I C Y+APE G N
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS------YMAPERIKSGGPN 179
Query: 446 DKI------DVYAFGVVLLELLTGRKPI---SNDHPKGQESLVMWAKPILSSGKVTQLLD 496
DV++ G+ +LE+ GR P + + Q S ++ P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------------ 227
Query: 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL------KLLRGDADVTKWA 546
P L + Y D + + C+ + P RP + +L K D D+ +W
Sbjct: 228 PTLPSGYSDDAQDFVA----KCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWV 279
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 52/213 (24%), Positives = 102/213 (47%), Gaps = 31/213 (14%)
Query: 271 IGKGGSSQVY----KGCLPDGKE--LAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 322
+G+G VY KG + D E +A+K + + + + EF+ E ++ + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP------AAFGWSERYKVAMGVAEALE 376
LLG + L++ + ++RG L+ L + + A + ++A +A+ +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG---- 432
YL +A + +HRD+ + N ++++DF ++ DFG+ + I TD G
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYETDYYRKGGKGLL 183
Query: 433 ---YLAPEYFMYGKVNDKIDVYAFGVVLLELLT 462
+++PE G DV++FGVVL E+ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEF--VLEIEIITTLHHKNIISLLGFC 327
+G+G + VYKG +GK +A+K+++ E+ F + E ++ L H NI+ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
L LV++++ + K P + L Y+H + ++
Sbjct: 73 HTKETLTLVFEYVHTDLCQYM----DKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYIL 125
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVND 446
HRD+K N+L+SD E +L+DFGLA+ A + SH +V T Y P+ + + +
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYST 183
Query: 447 KIDVYAFGVVLLELLTG 463
+D++ G + +E++ G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 49/206 (23%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
E ++G G ++ +GCL P +EL A+ L+ S+ + F+ E + H NI+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L G N +++V +++S G+L+ L +K + + G+A ++YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL--- 123
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
S +H+ + + +L++ D ++S F + + + + T + + + APE Y
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-WAAPEAIQY 182
Query: 442 GKVNDKIDVYAFGVVLLELLT-GRKP 466
+ DV++FG+V+ E+++ G +P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 31/215 (14%)
Query: 270 LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISL----- 323
++GKG +V L G+ AVK LK +DV+ +++ ++ T+ K +++L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALK--KDVV---LIDDDVECTMVEKRVLALAWENP 56
Query: 324 ----LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---AL 375
L F+ +L V +FL+ G L ++ +D F + Y+ AE L
Sbjct: 57 FLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRF---DLYRATFYAAEIVCGL 109
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
++LHS + +I+RD+K N++L D +++DFG+ K + + GT Y+A
Sbjct: 110 QFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIA 164
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470
PE K +D ++FGV+L E+L G+ P D
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 270 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSE--DVIKEFVL-EIEIITTLHHKNIISLLG 325
++G+G V K + KE+ A+K K SE + +KE L E++++ TL +NI+ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 326 FCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
L LV++++ + LE E +G + KV + + ++ +H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE----------KVRSYIYQLIKAIHWCH 117
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
++HRD+K N+L+S + +L DFG A+ S S+ T+ T Y +PE +
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGA 176
Query: 443 KVNDKIDVYAFGVVLLELLTGR 464
+D+++ G +L EL G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 52/212 (24%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 263 SNFLAENLIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTL 315
+ F ++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 316 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 375
+ ++ LLG C + + L+ + G L + + +K + G + +A+ +
Sbjct: 67 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 122
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
YL +R++HRD+ + N+L+ +++DFGLAK ++A
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
E ++ + DV+++GV + EL+T G KP
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 15/205 (7%)
Query: 270 LIGKGGSSQVYKGC-LPDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNIIS 322
++G G VYKG +PDG+ + A+K+L+ S KE + E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
LLG C + + LV + G L + + NK G + + +A+ + YL
Sbjct: 74 LLGICLT-STVQLVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
R++HRD+ + N+L+ +++DFGLA+ + ++A E ++
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 443 KVNDKIDVYAFGVVLLELLT-GRKP 466
+ + DV+++GV + EL+T G KP
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 76/307 (24%), Positives = 121/307 (39%), Gaps = 61/307 (19%)
Query: 270 LIGK----GGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-LEIEIITT--LHHKNIIS 322
LIGK + K P +AVK + ++ L+ EIIT+ L H NI+
Sbjct: 5 LIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 323 LLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 378
+ F D+ L +V ++ GS E+ L + + G E + + V AL+Y+
Sbjct: 64 YV-TSFIVDSELYVVSPLMAYGSCEDLLKTHFPE----GLPELAIAF-ILKDVLNALDYI 117
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG-----Y 433
HS + IHR VK+S+ILLS D + LS + +
Sbjct: 118 HS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 434 LAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490
L+PE + G N+K D+Y+ G+ EL G P + M + + G
Sbjct: 175 LSPEVLQQNLQG-YNEKSDIYSVGITACELANGHVPFKDMPA-----TQMLLEKV--RGT 226
Query: 491 VTQLLD---------------PALGNNYDYDQMERMVLASI---------LCIRRDPRAR 526
V LLD + + + D ++ + LC++RDP +R
Sbjct: 227 VPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESR 286
Query: 527 PQMSLVL 533
P S +L
Sbjct: 287 PSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 54/187 (28%), Positives = 91/187 (48%), Gaps = 24/187 (12%)
Query: 291 AVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 348
AVK+L+P ++F+ E++I++ L NI LLG C D L ++ +++ G L +
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 349 LHGNKKDPAAFGWSERYK-------VAMGV--AEALEYLHSGSAQRVIHRDVKSSNILLS 399
L K G + K + M A + YL S +HRD+ + N L+
Sbjct: 110 LQ--KHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVG 164
Query: 400 DDFEPQLSDFGLAKWASTSSSHITCTDVAGT----FGYLAPEYFMYGKVNDKIDVYAFGV 455
++ +++DFG+++ +S + V G ++A E + GK K DV+AFGV
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 456 VLLELLT 462
L E+LT
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 37/222 (16%)
Query: 270 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLE---IEIITTLHH-----KNI 320
+IG+G ++V L + + A+K++K KE V + I+ + T H N
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK------KELVNDDEDIDWVQTEKHVFETASNH 55
Query: 321 ISLLGF--CFE-DNNLLLVYDFLSRGSLEENLHGNKKDP---AAFGWSERYKVAMGVAEA 374
L+G CF+ ++ L V +F+S G L ++ +K P A F +E ++ A
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAE-------ISLA 108
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
L +LH +I+RD+K N+LL + +L+D+G+ K T + GT Y+
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYI 163
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI----SNDHP 472
APE +D +A GV++ E++ GR P +D+P
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 50/166 (30%), Positives = 84/166 (50%), Gaps = 16/166 (9%)
Query: 327 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
CF+ + L LV ++++ G L ++ +K P R+ A + AL +LH +
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA---RFYAAE-ICIALNFLHE---RG 116
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 445
+I+RD+K N+LL D +L+D+G+ K T + GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYG 174
Query: 446 DKIDVYAFGVVLLELLTGRKP--ISNDHP--KGQESL--VMWAKPI 485
+D +A GV++ E++ GR P I D+P ++ L V+ KPI
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 59/192 (30%), Positives = 99/192 (51%), Gaps = 22/192 (11%)
Query: 287 GKELAVK-ILKP-SEDVI-KEFVLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSR 342
G+ +A+K I+KP S V+ K E++++ L H+NIISL F ++ V + L
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402
L L + F Y++ G L+Y+HS V+HRD+K SNIL++++
Sbjct: 95 -DLHRLLTSRPLEKQ-FIQYFLYQILRG----LKYVHSAG---VVHRDLKPSNILINENC 145
Query: 403 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL 461
+ ++ DFGLA+ + T T Y APE + + K + ++D+++ G + E+L
Sbjct: 146 DLKICDFGLAR---IQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
Query: 462 TGRKPI--SNDH 471
G KP+ DH
Sbjct: 201 EG-KPLFPGKDH 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 42/201 (20%)
Query: 287 GKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLLGFC-------FEDNNLLLV 336
+++A+K I ++ I K + EI+++ L H+N+I++ F D + +V
Sbjct: 30 NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND--VYIV 87
Query: 337 YDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRD 390
Y+ + + +LH + S+ Y++ G L+Y+HS + V+HRD
Sbjct: 88 YELM-----DTDLHQIIRSSQTL--SDDHCQYFLYQLLRG----LKYIHSAN---VLHRD 133
Query: 391 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----YGKVND 446
+K SN+LL+ + + ++ DFGLA+ +TS T+ T Y APE + Y
Sbjct: 134 LKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTA-- 189
Query: 447 KIDVYAFGVVLLELLTGRKPI 467
IDV++ G + ELL GRKP+
Sbjct: 190 -IDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 327 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
CF+ ++ L V ++++ G L ++ +K P R+ A ++ AL YLH +
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSAE-ISLALNYLHE---RG 116
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 445
+I+RD+K N+LL + +L+D+G+ K T + GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYG 174
Query: 446 DKIDVYAFGVVLLELLTGRKPI----SNDHP 472
+D +A GV++ E++ GR P S+D+P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 271 IGKGGSSQVYKG--CLPDGKELAVKI-LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G+G + VYKG L D +I L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 328 FEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
+ +L LV+++L + L++ L GN + + V + + + L L+ ++
Sbjct: 74 HTEKSLTLVFEYLDK-DLKQYLDDCGNSIN--------MHNVKLFLFQLLRGLNYCHRRK 124
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKV 444
V+HRD+K N+L+++ E +L+DFGLA+ S + T ++ T Y P+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDY 182
Query: 445 NDKIDVYAFGVVLLELLTGR 464
+ +ID++ G + E+ TGR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 271 IGKGGSSQV------YKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLL 324
+GKGG +V G + K+L K LK K +LE EI+ ++ I++L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGE-KMALLEKEILEKVNSPFIVNL- 58
Query: 325 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
+ FE +L LV ++ G L+ H + + + +LHS
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+++RD+K N+LL D +LSD GLA T T AGT GY+APE
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEP 170
Query: 444 VNDKIDVYAFGVVLLELLTGRKPISNDHPK 473
+ +D +A G + E++ GR P + K
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 308 EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 367
E +I+ ++H ++L G +++ L LV +F+ G L NK+ P G ++
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 427
+ EYL S +++RD+K N+LL D +++DFG AK T ++ C
Sbjct: 141 VL----IFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-RTYTLC--- 189
Query: 428 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
GT Y+APE + D + G+ + E+L G P + P
Sbjct: 190 -GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA-STSSSHITCTDVAGTFG 432
AL+Y+H+ + V HRD+K NIL + D + ++ DFGLA+ A + + + I TD T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 433 YLAPEY--FMYGKVNDKIDVYAFGVVLLELLTGR 464
Y APE + K ID+++ G + E+LTG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 26/189 (13%)
Query: 287 GKELAVKIL-KPSEDVI--KEFVLEIEIITTLHHKNIISLLGF-----CFEDNNLLLVYD 338
G +AVK L +P + +I K E+ ++ + H+N+I LL E+ N + +
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101
Query: 339 FLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 396
L L + K D F + + L+Y+HS +IHRD+K SN+
Sbjct: 102 HLMGADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSAD---IIHRDLKPSNL 151
Query: 397 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGV 455
+++D E ++ DFGLA+ T T Y APE + + N +D+++ G
Sbjct: 152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 456 VLLELLTGR 464
++ ELLTGR
Sbjct: 207 IMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 50/252 (19%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVL----EIEIITTLHH 317
+F + +IG+G +V D G A+K L+ SE + KE V E +I+ +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 318 KNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376
++ L + F+D N L L+ ++L G + L KKD + Y +AE +
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFY-----IAETIL 112
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL----------------AKWASTSSS 420
+ S IHRD+K N+LL +LSDFGL + ++
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 421 HITCT--------------------DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 460
GT Y+APE F+ N + D ++ GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 461 LTGRKPISNDHP 472
L G P +D+P
Sbjct: 233 LVGYPPFCSDNP 244
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-10
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 36/207 (17%)
Query: 288 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYDFLSRGSL 345
K ++ + LK E + V+E+ ++ L HKNI+ + N L ++ +F G L
Sbjct: 44 KAISYRGLKEREK--SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL 101
Query: 346 EENLHGNKKDPAAFGWSERY---KVAMGVAEALEYLHS----GSAQRVIHRDVKSSNILL 398
N+ K FG E + + + AL Y H+ + +RV+HRD+K NI L
Sbjct: 102 SRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
Query: 399 SDDFE-----------------PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
S ++ DFGL+K S +C GT Y +PE ++
Sbjct: 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLH 215
Query: 442 --GKVNDKIDVYAFGVVLLELLTGRKP 466
+DK D++A G ++ EL +G+ P
Sbjct: 216 ETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 53/169 (31%), Positives = 75/169 (44%), Gaps = 22/169 (13%)
Query: 321 ISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
I L + F+D+ L +V +++ G L NL N P W+ Y V AL+ +H
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEK--WARFY--TAEVVLALDAIH 159
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEY 438
S IHRDVK N+LL +L+DFG K + C GT Y++PE
Sbjct: 160 S---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR--CDTAVGTPDYISPEV 214
Query: 439 FM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480
YG+ + D ++ GV L E+L G P D G S +M
Sbjct: 215 LKSQGGDGYYGR---ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 10/167 (5%)
Query: 308 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 366
E +I+ ++ + ++SL + +E + L LV ++ G L+ H A F
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEEGRAVF 106
Query: 367 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 426
A + LE LH +R+++RD+K NILL D ++SD GLA T
Sbjct: 107 YAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKG 160
Query: 427 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473
GT GY+APE + D +A G +L E++ G+ P K
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 66/272 (24%), Positives = 119/272 (43%), Gaps = 44/272 (16%)
Query: 271 IGKGGSSQVYKGCL---PD------GKELAV--KILKPSEDVIKEFVLEIEIITTLHHKN 319
+G+G + +YKG L D G+E++V K+L F +++ L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
++ L G C D N ++V +++ G L+ LH K + + W + VA +A AL YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSL-HW--KLDVAKQLASALHYLE 118
Query: 380 SGSAQRVIHRDVKSSNILL---SDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFG 432
++++H +V NIL+ + LSD G+ + +
Sbjct: 119 D---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------RIP 169
Query: 433 YLAPEYFMYGKVNDKI--DVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK----PI 485
++APE G+ + I D ++FG LLE+ + G +P+S E + P+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQDQHRLPM 227
Query: 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASIL 517
++ L++ + YD +R +IL
Sbjct: 228 PDCAELANLIN----QCWTYDPTKRPSFRAIL 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 28/223 (12%)
Query: 264 NFLAENLIGKG--GSSQVYKGCLPDGKELAVKILKPSEDVIKEFVL----EIEIITTLHH 317
+F ++L+G+G G QV + G A+K++K S + +E V E +I++ +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVRE-KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 318 KNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376
I L + F+D NL LV ++ G L +L +D ++ Y +AE +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLL-SLLNRYEDQFDEDMAQFY-----LAELVL 113
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
+HS +HRD+K N+L+ +L+DFG A T++ + GT Y+AP
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAP 172
Query: 437 EYF---------MYGKVNDKIDVYAFGVVLLELLTGRKPISND 470
E YG + D ++ GV+ E++ GR P
Sbjct: 173 EVLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 52/199 (26%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 271 IGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G+G + V+KG + L A+K L+ E + E+ ++ L H NI++L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRV 386
D +L LV+++L +++L D K+ + + L Y H ++V
Sbjct: 74 HTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVN 445
+HRD+K N+L+++ E +L+DFGLA+ S + T ++ T Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYS 183
Query: 446 DKIDVYAFGVVLLELLTGR 464
+ID++ G + E+ +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 37/99 (37%), Positives = 58/99 (58%), Gaps = 11/99 (11%)
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS----SSHITCTDVAG 429
L+Y+HS + V+HRD+K N+L++ D E ++ DFGLA+ S + + + T+
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM--TEYVA 171
Query: 430 TFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPI 467
T Y APE + + IDV++ G +L ELL GRKP+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 44/124 (35%), Positives = 62/124 (50%), Gaps = 25/124 (20%)
Query: 369 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 420
M AE ALEYLH+ ++HRD+K N+L++ +L+DFGL+K S +
Sbjct: 105 MYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE 161
Query: 421 -HITC-------TDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISN 469
HI V GT Y+APE + YGK +D +A G++L E L G P
Sbjct: 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVGCVPFFG 218
Query: 470 DHPK 473
D P+
Sbjct: 219 DTPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 271 IGKGGSSQVYKGCLPDGKELA----VKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
IG+G V+K + E+ V++ E V + EI ++ L HKNI+ L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 327 CFEDNNLLLVYDFLSRG--SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
D L LV+++ + ++ +G DP S +++ G+A + HS
Sbjct: 68 LHSDKKLTLVFEYCDQDLKKYFDSCNG-DIDPEIVK-SFMFQLLKGLA----FCHS---H 118
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
V+HRD+K N+L++ + E +L+DFGLA+ + V T Y P+ K+
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKL 176
Query: 445 ND-KIDVYAFGVVLLELLTGRKPI 467
ID+++ G + EL +P+
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 271 IGKGGSSQVYKGCLPD-GKELA---VKILKPSEDVIKEFVLEIEIITTLH---HKNIISL 323
IG G VYK P G +A V++ + + V E+ ++ L H NI+ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 324 LGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEY 377
+ C + + LV++ + + L L K P +E K M L++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL---DKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LH A ++HRD+K NIL++ + +L+DFGLA+ S + T V T Y APE
Sbjct: 124 LH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRAPE 177
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
+ +D+++ G + E+ RKP+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 326
+G+G VYK DGK+ LK E + EI ++ L H N+I+L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 327 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
D + L++D+ NKK P S + + + + YLH
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKK-PMQLPRSMVKSLLYQILDGIHYLH-- 125
Query: 382 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAP 436
A V+HRD+K +NIL+ + +++D G A+ ++ + D V TF Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 437 EYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 467
E + + K ID++A G + ELLT +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 269 NLIGKGGSSQVYKGC-LPDGKELAVKILKPSE---DVIKE----------FVL--EIEII 312
+G+G +V K GK +A+K +K E DV K+ F E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 313 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK--VAMG 370
+ H+NI+ L+ E + + LV D ++ L++ + + +E + +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR------LTESQVKCILLQ 127
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG- 429
+ L LH +HRD+ +NI ++ +++DFGLA+ T +
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 430 -----------TFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPI 467
T Y APE M K + +D+++ G + ELLTG KP+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 27/253 (10%)
Query: 286 DGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL-GFCFEDNNLLLVYDFLS 341
DGK+ +K L S K E ++++ L H NI++ + ED L +V F
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83
Query: 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 401
G L L K ++ + + +A AL+YLH + ++HRD+K+ N+ L+
Sbjct: 84 GGDLYHKLKEQKGK--LLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRT 138
Query: 402 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 461
++ D G+A+ + + + GT Y++PE F N K DV+A G + E+
Sbjct: 139 NIIKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196
Query: 462 TGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 521
T + + K SLV + GK+ + P DY ++A++L +
Sbjct: 197 TLKHAFN---AKDMNSLVYR----IIEGKLPPM--PK-----DYSPELGELIATMLS--K 240
Query: 522 DPRARPQMSLVLK 534
P RP + +L+
Sbjct: 241 RPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 271 IGKGGSSQVYKG--CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
+G+G + VYKG L G+ +A+K L+ E + E ++ L H NI++L
Sbjct: 13 LGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 327 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPA---AFGWSERYKVAMGVAEALEYLHSG 381
L LV+++L L++ + G F +++ G L Y H
Sbjct: 72 IHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLF----LFQLLRG----LAYCHQ- 121
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
+RV+HRD+K N+L+S+ E +L+DFGLA+ A + S +V T Y P+ +
Sbjct: 122 --RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV-TLWYRPPDVLL- 176
Query: 442 GKVN--DKIDVYAFGVVLLELLTGR 464
G +D++ G + E+ TGR
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 17/213 (7%)
Query: 271 IGKGGSSQVYKGCLPDGKELA---VKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 325
IG G +V G G A VK L+ S ++ F+ E++ L+H N++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE-RYKVAMGVAEALEYLHSGSAQ 384
C E LLV +F G L+ L N+ A + ++A VA L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY------ 438
IH D+ N L+ D ++ D+GLA +IT A +LAPE
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 439 -FMYGKVNDKIDVYAFGVVLLELLT-GRKPISN 469
+ K ++++ GV + EL T +P +
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 270 LIGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFVLEIE-----IITTLHHKNII 321
+IGKG +V + DG AVK+L+ + K+ I ++ L H ++
Sbjct: 2 VIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 322 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYL 378
L + F+ L V D+++ G L +L + +P A R+ A VA A+ YL
Sbjct: 60 GL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA-----RFYAAE-VASAIGYL 112
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
HS +I+RD+K NILL L+DFGL K T + GT YLAPE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEV 167
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKP 466
+ +D + G VL E+L G P
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 306 VLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 365
+ E+ ++ L H NI++L + L LV+++L + +L +
Sbjct: 51 IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNV 105
Query: 366 KVAM-GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424
K+ M + L Y H ++++HRD+K N+L+++ E +L+DFGLA+ S + T
Sbjct: 106 KIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TY 160
Query: 425 TDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGR 464
++ T Y P+ + + + ID++ G +L E+ TGR
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISL--LGF 326
+G+G VYK DGK+ LK E + EI ++ L H N+ISL +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 327 CFEDNNLLLVYDFLSRG-----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
D + L++D+ NKK P + + + + YLH
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKK-PVQLPRGMVKSLLYQILDGIHYLH-- 125
Query: 382 SAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAP 436
A V+HRD+K +NIL+ + +++D G A+ ++ + D V TF Y AP
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 437 EYFMYGKVNDK-IDVYAFGVVLLELLTGRKPI 467
E + + K ID++A G + ELLT +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 271 IGKGGSSQVYKGC-LPDGKELA----VKILKPSEDVIKEFVLEIEII---TTLHHKNIIS 322
IG+G +V+K L +G V++ E + + E+ ++ T H N++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 323 LLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALE 376
L C + L LV++ + + L L K P +E K M + L+
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
+LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V T Y AP
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRAP 178
Query: 437 EYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
E + +D+++ G + E+ RKP+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 40/173 (23%), Positives = 82/173 (47%), Gaps = 8/173 (4%)
Query: 288 KELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 347
KE+ V L P+E V + E ++++ L H I+ E + ++ ++ L+
Sbjct: 34 KEIPVGELNPNETV--QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC 91
Query: 348 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407
L K ++ + + + + Y+H +R++HRD+K+ NI L ++ ++
Sbjct: 92 KLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIG 147
Query: 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 460
DFG+++ S T GT Y++PE + + K D+++ G +L E+
Sbjct: 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 64/291 (21%), Positives = 125/291 (42%), Gaps = 48/291 (16%)
Query: 271 IGKGGSSQVYKGCLPD------GKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIIS 322
+G+G VY+G D +AVK + S + + EF+ E ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA------AFGWSERYKVAMGVAEALE 376
LLG + L+V + ++ G L+ L + + E ++A +A+ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG---- 432
YL +A++ +HRD+ + N +++ DF ++ DFG+ + I TD G
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYETDYYRKGGKGLL 183
Query: 433 ---YLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 488
++APE G D+++FGVVL E+ + +P LS+
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG----------------LSN 227
Query: 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539
+V + + + + ER+ +C + +P+ RP ++ LL+ D
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 308 EIEIITTLHHKNIISLLGFCFEDN--NLLLVYDFLSRGSLEENLHG---NKKDPAAFGWS 362
EI I+ L H NI+++ N + +V +++ E +L K P F S
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-----EHDLKSLMETMKQP--FLQS 106
Query: 363 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422
E + + + + +LH ++HRD+K+SN+LL++ ++ DFGLA+ +
Sbjct: 107 EVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163
Query: 423 TCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPI 467
T V T Y APE + K + ID+++ G + ELLT +KP+
Sbjct: 164 TQLVV--TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 71/264 (26%), Positives = 111/264 (42%), Gaps = 28/264 (10%)
Query: 237 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKG--GSSQVYKGCLPDGKELAVKI 294
K ++ +Y T + +DL ++ +IG+G G Q+ + K A+K+
Sbjct: 19 KNIDNFLNRYKDT--INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKL 75
Query: 295 LKPSEDVIKE---FVLEIEIITTLHHKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLH 350
L E + + F E I + + L + F+D+ L +V +++ G L NL
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLM 134
Query: 351 GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410
N P W+ Y V AL+ +HS IHRDVK N+LL +L+DFG
Sbjct: 135 SNYDVPEK--WARFYTAE--VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187
Query: 411 LAKWASTSSSHITCTDVAGTFGYLAPEYF-------MYGKVNDKIDVYAFGVVLLELLTG 463
+ C GT Y++PE YG+ + D ++ GV L E+L G
Sbjct: 188 TCM-KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 243
Query: 464 RKPISNDHPKGQESLVMWAKPILS 487
P D G S +M K L+
Sbjct: 244 DTPFYADSLVGTYSKIMNHKNSLT 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKI--LKPSEDVIKEFVLEIEIITTLHH 317
A +++L +G+G + VYKG +G+ +A+K+ +K E V + E ++ L H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
NI+ L L V++++ L + + + P + L Y
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAY 118
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
+H Q ++HRD+K N+L+S E +L+DFGLA+ S S + V T Y P+
Sbjct: 119 IHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 438 YFMYG-KVNDKIDVYAFGVVLLELLTGR 464
+ + +D++ G + +E+L G+
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 270 LIGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNII 321
++GKG V + L +++AVK+LK S D I+EF+ E + H N+I
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVI 64
Query: 322 SLLGFCFEDNNL------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAE 373
L+G +++ F+ G L L ++ ++P + + +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 433
+EYL S++ IHRD+ + N +L+++ ++DFGL+K + + +
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 434 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
LA E DV+AFGV + E++T G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 45/232 (19%)
Query: 270 LIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVI------KEFVLEIEIITTLHHKNIIS 322
LIGKGG +VY P + +A+K K ED+ K F+ E +I L H I+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALK--KIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKVAMG 370
+ C + + + ++ +L+ L K AF S +K+
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-LSIFHKICAT 125
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW---------------- 414
+ EY+HS + V+HRD+K NILL E + D+G A +
Sbjct: 126 I----EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
SS + GT Y+APE + ++ D+YA GV+L ++LT P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 34/211 (16%)
Query: 271 IGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNI--------I 321
IGKG +V + D + + A+K ++ + V + E+ TL + + I
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRS-----EVTHTLAERTVLAQVNCPFI 55
Query: 322 SLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEY 377
L F F+ L LV F++ G L +L G + + AE ALE
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-------GRFDLSRARFYTAELLCALEN 108
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFGYLA 435
LH + VI+RD+K NILL L DFGL K ++ C GT YLA
Sbjct: 109 LHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC----GTPEYLA 161
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
PE + +D + GV+L E+LTG P
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 54/242 (22%)
Query: 260 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKE-FVL----EIEII 312
S ++ +G+G +VYK + G+ +A+K IL +E K+ F + EI+I+
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKIL 61
Query: 313 TTLHHKNIISLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 367
L H N++ L+ E VY ++ +L G ++P K+
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENP-------SVKL 112
Query: 368 AMG--------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA------- 412
+ E + YLH ++HRD+K++NIL+ + +++DFGLA
Sbjct: 113 TESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 413 ---KWASTSSSHITCTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRK 465
K + T++ T Y PE + Y +D++ G V E+ T R+
Sbjct: 170 PNPKGGGGGGTR-KYTNLVVTRWYRPPELLLGERRYTT---AVDIWGIGCVFAEMFT-RR 224
Query: 466 PI 467
PI
Sbjct: 225 PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 35/174 (20%)
Query: 303 KEFVLEIEIITTLHHKNIISLLGFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKD 355
+E VL + ++HKNII LL F E ++ LV + + +L + + +
Sbjct: 64 RELVL----MKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLD- 116
Query: 356 PAAFGWSER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFG
Sbjct: 117 ------HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163
Query: 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 464
LA+ A TS T T Y APE + + +D+++ G ++ E++ G
Sbjct: 164 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 49/146 (33%), Positives = 70/146 (47%), Gaps = 14/146 (9%)
Query: 324 LGFCFED-NNLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHS 380
L F F+ + L V D+++ G L +L + +P A R+ A +A AL YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-----RFYAAE-IASALGYLHS 114
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+++RD+K NILL L+DFGL K + T + GT YLAPE
Sbjct: 115 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLH 169
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKP 466
+ +D + G VL E+L G P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 69/256 (26%), Positives = 109/256 (42%), Gaps = 47/256 (18%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFV----LEIEIITTLHHK 318
+F + +IG+G +V D G A+KIL+ ++ + KE V E +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 319 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
++ + + F+D NL L+ +FL G + L KKD ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFY-----IAETVLA 113
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHITCTD--- 426
+ S IHRD+K N+LL +LSDFGL K A + +H +D
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173
Query: 427 ----------------------VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 464
GT Y+APE FM N D ++ GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 465 KPISNDHPKGQESLVM 480
P ++ P+ VM
Sbjct: 234 PPFCSETPQETYKKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 63/222 (28%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 271 IGKGGSSQVYKGCLPD-----------GKELAV--KILKPSE-DVIKEFVLEIEIITTLH 316
+G+G +Q+Y G L KE+ V K+L PS D+ F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 317 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376
HK+I+ L G C D ++V +F+ G L+ +H K D W ++KVA +A AL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPW--KFKVAKQLASALS 119
Query: 377 YLHSGSAQRVIHRDVKSSNILLS-----DDFEP--QLSDFGLAKWASTSSSHITCTDVAG 429
YL + ++H +V + NILL+ + P +LSD G+ T S C +
Sbjct: 120 YLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI---PITVLSRQECVE--- 170
Query: 430 TFGYLAPEYFMYGKV-NDKIDVYAFGVVLLEL-LTGRKPISN 469
++APE K + D ++FG L E+ G P+ +
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 68/256 (26%), Positives = 111/256 (43%), Gaps = 47/256 (18%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEI----EIITTLHHK 318
+F + +IG+G +V D G A+KIL+ ++ + KE V I +I+
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 319 NIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
++ + + F+D NL L+ +FL G + L KKD + ++ Y +AE +
Sbjct: 62 WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFY-----IAETVLA 113
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHITCTDVA- 428
+ + IHRD+K N+LL +LSDFGL K A + +H +D +
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 429 ------------------------GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 464
GT Y+APE FM N D ++ GV++ E+L G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 465 KPISNDHPKGQESLVM 480
P ++ P+ VM
Sbjct: 234 PPFCSETPQETYRKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 54/165 (32%), Positives = 76/165 (46%), Gaps = 23/165 (13%)
Query: 326 FC-FEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
FC F+D+ L +V +++ G L NL N P W++ Y V AL+ +HS
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEK--WAKFYTAE--VVLALDAIHS--- 160
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYF--- 439
+IHRDVK N+LL +L+DFG K T C GT Y++PE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR--CDTAVGTPDYISPEVLKSQ 218
Query: 440 ----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480
YG+ + D ++ GV L E+L G P D G S +M
Sbjct: 219 GGDGYYGR---ECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 70/239 (29%)
Query: 288 KELAVKILK----PSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN-LLLVYDFLS 341
+ +AVK+LK SE K + E++I+ + HH N+++LLG C + L+++ ++
Sbjct: 38 RTVAVKMLKEGATASEY--KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCK 95
Query: 342 RGSLEENLHGNK--------------------------------KDPAAFGW-------- 361
G+L L + + A+ G+
Sbjct: 96 FGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155
Query: 362 -------SERYKV----------AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 404
E YK + VA +E+L S ++ IHRD+ + NILLS++
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVV 212
Query: 405 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLT 462
++ DFGLA+ ++ D ++APE ++ KV + DV++FGV+L E+ +
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPES-IFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 308 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 366
E +I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNP---GFDEERA 104
Query: 367 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-- 422
V A + LE LH +R+++RD+K NILL D ++SD GLA I
Sbjct: 105 VFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA-------VEIPE 154
Query: 423 --TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
T GT GY+APE + D + G ++ E++ G+ P
Sbjct: 155 GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 29/167 (17%)
Query: 308 EIEIITTLHHKNIISLLGFCF------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW 361
E+ ++ ++HKNIISLL E ++ LV + + +L + +H
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELD------- 121
Query: 362 SER-----YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416
ER Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+
Sbjct: 122 HERMSYLLYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--- 171
Query: 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 463
T+ ++ T T Y APE + + +D+++ G ++ EL+ G
Sbjct: 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 27/265 (10%)
Query: 287 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 343
G ++A+K L +P SE K E+ ++ + H+N+I LL D +L +DF
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99
Query: 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 403
G + + + L+Y+H+ +IHRD+K N+ +++D E
Sbjct: 100 PFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCE 156
Query: 404 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLT 462
++ DFGLA+ + T T Y APE + + +D+++ G ++ E+LT
Sbjct: 157 LKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
Query: 463 GRKPI--SNDH-PKGQESLVMWAKPILSSGKVTQLLDPALGNNY--DYDQMERMVLASIL 517
G KP+ +DH + E + + P S + Q L NY + + S+L
Sbjct: 212 G-KPLFKGHDHLDQLMEIMKVTGTP---SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLL 267
Query: 518 CIRRDPRARPQMSLVL-KLLRGDAD 541
P A P VL K+L DA+
Sbjct: 268 -----PNANPLAVNVLEKMLVLDAE 287
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 79/352 (22%), Positives = 144/352 (40%), Gaps = 46/352 (13%)
Query: 271 IGKGGSSQVYKGCLPD-GKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNII------- 321
+G G + V+ D K +AVK + ++ +K + EI+II L H NI+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 322 -------SLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGV 371
+G E N++ +V +++ LE+ + Y++ G
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM-----YQLLRG- 126
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSH---ITCTDV 427
L+Y+HS + V+HRD+K +N+ ++ +D ++ DFGLA+ SH ++ V
Sbjct: 127 ---LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 428 AGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486
T Y +P + ID++A G + E+LTG+ + H Q L++ + P++
Sbjct: 181 --TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238
Query: 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWA 546
+LL+ + R L +L +P A + + ++L +
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLP-GVNPEA---LDFLEQILTFN----PMD 290
Query: 547 RLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLED 598
RL + + SCP S + D DD M+ I + D
Sbjct: 291 RLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSIIYNWD 342
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 286 DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGF-------CFEDNNLLL 335
DGK +A+K + K E++++ H N++S L FE+ + +
Sbjct: 24 DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE--IYV 81
Query: 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLHSGSAQRVIHRDVKSS 394
V + + + +LH P S+ KV + + L+YLHS ++HRD+K
Sbjct: 82 VTELM-----QSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSA---GILHRDIKPG 132
Query: 395 NILLSDDFEPQLSDFGLA-KWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYA 452
N+L++ + ++ DFGLA S H+T V T Y APE M + +D+++
Sbjct: 133 NLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWS 190
Query: 453 FGVVLLELLTGR 464
G + ELL R
Sbjct: 191 VGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 14/162 (8%)
Query: 308 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 366
E +I+ ++ + +++L + +E + L LV ++ G L+ +++ N +P G+ E
Sbjct: 50 EKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFEEERA 104
Query: 367 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424
+ A + LE LH + ++RD+K NILL D ++SD GLA S
Sbjct: 105 LFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---I 158
Query: 425 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
GT GY+APE + D + G ++ E++ G+ P
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 9/91 (9%)
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
L+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ A T T Y
Sbjct: 131 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYR 182
Query: 435 APEYFM-YGKVNDKIDVYAFGVVLLELLTGR 464
APE + + N +D+++ G ++ ELL G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 308 EIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 366
E I+ ++ + ++SL + +E + L LV ++ G L+ +++ N +P G+ E+
Sbjct: 50 EKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNP---GFDEQRA 104
Query: 367 V--AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424
+ A + LE L +R+++RD+K NILL D ++SD GLA T
Sbjct: 105 IFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TV 158
Query: 425 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
GT GY+APE K D + G ++ E++ G+ P
Sbjct: 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 271 IGKGGSSQVYKGCLPDGKE-LAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
IG+G VYK E +A+K ++ E V + EI ++ + H NI+ L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHS 380
+ L LV+++ L+ +L + F + R Y++ G+A Y HS
Sbjct: 70 VHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHS 120
Query: 381 GSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
RV+HRD+K N+L+ +L+DFGLA+ T V T Y APE
Sbjct: 121 ---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEIL 175
Query: 440 MYGK-VNDKIDVYAFGVVLLELLTGRKPI 467
+ + + +D+++ G + E++ +KP+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN-QKPL 203
|
Length = 294 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 18/211 (8%)
Query: 271 IGKGGSSQVYKGCLPDGK---ELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 324
+G+G V +G L ++AVK +K + +++F+ E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 325 GFCFEDN------NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALE 376
G C + + +++ F+ G L L ++ P K +A +E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
YL S++ IHRD+ + N +L+++ ++DFGL+K + ++A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 437 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
E K DV++FGV + E+ T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 62/272 (22%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHH 317
S F+ IG G +V D L A+K L+ ++ +++ E +I+ +
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN 60
Query: 318 KNIISLLGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAE 373
+ ++ L + F+D +NL V D++ G SL L ++D A F +E +
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAE-------LTC 112
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA--------------------- 412
A+E +H IHRD+K NIL+ D +L+DFGL
Sbjct: 113 AIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQD 169
Query: 413 ------KWASTSSS------------HITCT--DVAGTFGYLAPEYFMYGKVNDKIDVYA 452
+W+ H C + GT Y+APE + D ++
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229
Query: 453 FGVVLLELLTGRKPISNDHPKG-QESLVMWAK 483
GV+L E+L G+ P D P Q ++ W
Sbjct: 230 VGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 308 EIEIITTLHHKNIISLLGFCFEDNNLLLV-----YDFLSRGSLEENLHGNKKDPAAFGWS 362
EI+I+ T+ H+ II+L+ + + +V D + + ++ P
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFT--------YVDRSGPLPL--E 185
Query: 363 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422
+ + + EAL YLH + +IHRDVK+ NI L + L DFG A
Sbjct: 186 QAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
C +GT +PE K D+++ G+VL E+ +
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 22/161 (13%)
Query: 312 ITTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 370
ITTLH + F+D N L LV D+ G L L +D + Y
Sbjct: 63 ITTLH---------YAFQDENYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY----- 107
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
+AE + +HS +HRD+K N+LL + +L+DFG + + + GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166
Query: 431 FGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 466
Y++PE GK + D ++ GV + E+L G P
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 21/186 (11%)
Query: 287 GKELAVKIL-KP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF-LSR 342
G+++A+K L +P SE K E+ ++ + H+N+I LL + DF L
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLS 399
++ +L P SE KV V + L+Y+HS +IHRD+K N+ ++
Sbjct: 100 PYMQTDLQKIMGHP----LSED-KVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVN 151
Query: 400 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLL 458
+D E ++ DFGLA+ A T T Y APE + + N +D+++ G ++
Sbjct: 152 EDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 459 ELLTGR 464
E+LTG+
Sbjct: 207 EMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 271 IGKGGSSQVYKGCLPDG---KELAVKILKPSEDVIKE--FVLEIEIITTLHHKNIISLLG 325
IG G +V G + G ++ VK L+ S V ++ F+ E + +L H N++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKK------DPAAFGWSERYKVAMGVAEALEYLH 379
C E LLV +F G L+ L +K DP ++A +A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTL-----QRMACEIALGLLHLH 117
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
+ IH D+ N LL+ D ++ D+GL+ ++T + ++APE
Sbjct: 118 KNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 440 --MYGK--VNDKI---DVYAFGVVLLELLT-GRKP 466
++G V D+ +V++ GV + EL G +P
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 4/97 (4%)
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
VA+ +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+ ++ D
Sbjct: 188 VAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
++APE + DV++FGV+L E+ + G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
VA +E+L S ++ IHRD+ + NILLS++ ++ DFGLA+ ++
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 489
++APE + DV++FGV+L E+ + G P +P Q + + L G
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP----YPGVQINEEFCQR--LKDG 293
Query: 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
T++ P ++ R++LA C + DP+ RP S ++++L
Sbjct: 294 --TRMRAP----ENATPEIYRIMLA---CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 17/163 (10%)
Query: 306 VLEIEIITTLHHKNIISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 364
E I+ ++H +II L G F + L++ + + L L + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAIC----DI 184
Query: 365 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424
+ V A++YLH R+IHRD+K+ NI ++ + L DFG A+ I
Sbjct: 185 LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG----AACFPVDINA 237
Query: 425 TDV---AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 464
AGT APE +D+++ G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 15/158 (9%)
Query: 308 EIEIITTLHHKNIISLLGFCFEDNNLLLVYD-FLSRGSLEENLHG---NKKDPAAFGWSE 363
E+ ++ ++HKNIISLL +L D +L ++ NL + D +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL- 124
Query: 364 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 423
Y++ G+ ++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS
Sbjct: 125 LYQMLCGI----KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FM 174
Query: 424 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 461
T T Y APE + + +D+++ G ++ E++
Sbjct: 175 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 28/97 (28%), Positives = 56/97 (57%), Gaps = 4/97 (4%)
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
VA+ +++L +++ IHRDV + N+LL+D ++ DFGLA+ S+++ +
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
++APE + DV+++G++L E+ + G+ P
Sbjct: 278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 433
+++LHS +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYY 191
Query: 434 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 464
APE + + +D+++ G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 9e-07
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 22/153 (14%)
Query: 271 IGKGGSSQVY---KGCLPDGKELAVKILKPSEDVIKEFV----LEIEIITTLHHKNIISL 323
I +G +VY K + K AVK++K ++ + K V E + + I+ L
Sbjct: 12 ISRGAFGKVYLGRKKN--NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLH--GNKKDPAAFGW-SERYKVAMGVAEALEYLHS 380
NN+ LV ++L G ++ LH G + A + SE VA AL+YLH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE-------VALALDYLHR 122
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413
+IHRD+K N+L+S++ +L+DFGL+K
Sbjct: 123 HG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 51/216 (23%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 272 GKGGSSQVYKGCLPDGKELAVKILKPSEDVIK--EFVLEIEIITTLHHKNIISLLGFCFE 329
GK S++Y + VK LK + + EF+ + + L H NI+ LG C E
Sbjct: 9 GKVLLSEIYTD--TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE 66
Query: 330 DNNLLLVYDFLSRGSL------EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
LLV+++ G L E+ N + ++A +A + ++H
Sbjct: 67 AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL------LLLQRMACEIAAGVTHMHK--- 117
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+H D+ N L+ D ++ D+G+ T D +LAPE + G+
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE--LVGE 175
Query: 444 VNDKI---------DVYAFGVVLLELL-TGRKPISN 469
+ + +V+A GV L EL +P S+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
N++ L + ++++ LV G L ++ P +R+ M VA L+ L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE--ECVKRWAAEMVVA--LDAL 101
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
H + ++ RD+ +NILL D QL+ F +W+ S C A Y APE
Sbjct: 102 HR---EGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDS---CDGEAVENMYCAPEV 153
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474
+ + D ++ G +L ELLTG K + HP G
Sbjct: 154 GGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 46/210 (21%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 270 LIGKGGSSQVYKGCLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 325
LI + + +YKG + KE+ ++ K + +I EI+ + + NI+ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 326 FCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
F + + L L+ ++ +RG L E L K + + +A+ + L L+
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKY 141
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF-- 439
+ + ++++ S + L++++++ ++ GL K S+ +V Y + +
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK----NV-NFMVYFSYKMLND 194
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKPISN 469
++ + K D+Y+ GVVL E+ TG+ P N
Sbjct: 195 IFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 49/169 (28%), Positives = 73/169 (43%), Gaps = 38/169 (22%)
Query: 312 ITTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 370
IT LH + F+D NNL LV D+ G L L + F +R M
Sbjct: 63 ITNLH---------YAFQDENNLYLVMDYYVGGDLLTLL-------SKFE--DRLPEDMA 104
Query: 371 ---VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG----LAKWASTSSSHIT 423
+AE + + S +HRD+K N+LL + +L+DFG L + S+
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN--- 161
Query: 424 CTDVA-GTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKP 466
VA GT Y++PE G+ + D ++ GV + E+L G P
Sbjct: 162 ---VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDG-KELAVKILKPSEDVIKE----FVLEIEIITTLHHK 318
+F +IG+G +V L + K A+KIL E + + F E +++ ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA-EALEY 377
I +L ++NNL LV D+ G L L +D + Y M +A +++
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LH +HRD+K NIL+ + +L+DFG + + + GT Y++PE
Sbjct: 121 LH------YVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 438 YFMY-----GKVNDKIDVYAFGVVLLELLTGRKP 466
GK + D ++ GV + E+L G P
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 367 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 426
VA + A++Y+H + +IHRD+K+ N+L++ + L DFG A +A S S
Sbjct: 265 VARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 427 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 459
+AGT APE +D+++ G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 66/271 (24%), Positives = 108/271 (39%), Gaps = 60/271 (22%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSE----DVIKEFVLEIEIITTLHH 317
S F+ +G G +V C D L A+K L+ + + + E +I+ +
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN 60
Query: 318 KNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376
+ ++ L + F+D +NL V D++ G + L + P R+ +A + A+E
Sbjct: 61 EWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIAE-LTLAIE 115
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTSS-----SHI------ 422
+H IHRD+K NIL+ D +L+DFGL +W S SHI
Sbjct: 116 SVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 423 -----------TCTD--------------------VAGTFGYLAPEYFMYGKVNDKIDVY 451
C D + GT Y+APE + D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 452 AFGVVLLELLTGRKPISNDHP-KGQESLVMW 481
+ GV+L E+L G+ P P + Q ++ W
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 28/97 (28%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S+++ +
Sbjct: 223 VAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
++APE + DV+++G++L E+ + G P
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 27/92 (29%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
VA +E+L S + +HRD+ + N+L+ + ++ DFGLA+ S++I+
Sbjct: 248 VANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 462
++APE DV++FG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 16/140 (11%)
Query: 268 ENLIGKGGSSQVYKGC---LPDGKEL-----AVKILKPSEDVIKEFVLE-IEIITTLHHK 318
E+L G+G ++++KG + D EL +K+L S E E +++ L HK
Sbjct: 1 ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
+++ G C + ++V +++ GSL+ L KK+ S + +VA +A AL +L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYL---KKNKNLINISWKLEVAKQLAWALHFL 116
Query: 379 HSGSAQRVIHRDVKSSNILL 398
+ + H +V + N+LL
Sbjct: 117 ED---KGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 52/208 (25%), Positives = 81/208 (38%), Gaps = 60/208 (28%)
Query: 324 LGFCFED-NNLLLVYDFLSRG---SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
L + F+D +NL V D++ G SL + +D A F +E + A+E +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE-------LTCAVESVH 118
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA---KWASTS------------------ 418
IHRD+K NIL+ D +L+DFGL +W S
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 419 ----SSHITCTD--------------------VAGTFGYLAPEYFMYGKVNDKIDVYAFG 454
++ C D + GT Y+APE + D ++ G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 455 VVLLELLTGRKPISNDHP-KGQESLVMW 481
V+L E+L G+ P P + Q ++ W
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 50/189 (26%), Positives = 81/189 (42%), Gaps = 21/189 (11%)
Query: 298 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 357
+ +++ E+ + +H NI+ DN L +V F++ GS ++ + + D
Sbjct: 39 TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD-- 96
Query: 358 AFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415
G SE + GV +AL+Y+H +HR VK+S+IL+S D + LS GL
Sbjct: 97 --GMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNL 149
Query: 416 STSSS-------HITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKP 466
S + H +L+PE + K D+Y+ G+ EL G P
Sbjct: 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
Query: 467 ISNDHPKGQ 475
D P Q
Sbjct: 210 F-KDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 27/210 (12%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVK--ILKPSEDVIKEFVL-EIEIITTLHHKN-IISLLG 325
IG+G +VYK GK +A+K L+ E+ I L EI ++ L I+ LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 326 FCFEDNN-----LLLVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEAL 375
+ L LV+++L L++ + N + PA S Y++ GVA
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA--- 124
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEP-QLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
+ H V+HRD+K N+L+ +++D GL + S T V T Y
Sbjct: 125 -HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYR 178
Query: 435 APEYFMYGK-VNDKIDVYAFGVVLLELLTG 463
APE + + +D+++ G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 33/148 (22%), Positives = 57/148 (38%), Gaps = 15/148 (10%)
Query: 270 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS--LLGFC 327
L+ G +++VY D +KI E E+ I+ L K + +L
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKINPSREKGAD-REREVAILQLLARKGLPVPKVLASG 62
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
D L+ +++ +L+E K+D +A +AE L LH +
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED-----------IAEQLAELLAKLHQLPLLVLC 111
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWA 415
H D+ NIL+ D + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 55/204 (26%), Positives = 82/204 (40%), Gaps = 22/204 (10%)
Query: 285 PDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341
P G + V+I +E+ +K E+ + H NI++ + L ++ F++
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 342 RGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 399
GS L K G SE + G L YLH IHR++K+S+IL+S
Sbjct: 83 YGSANSLL----KTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILIS 135
Query: 400 DDFEPQLSDFG-LAKWASTSSSHITCTDV----AGTFGYLAPEYF---MYGKVNDKIDVY 451
D LS L D +L+PE +YG N K D+Y
Sbjct: 136 GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIY 194
Query: 452 AFGVVLLELLTGRKPISNDHPKGQ 475
+ G+ EL TGR P D + Q
Sbjct: 195 SVGITACELATGRVPFQ-DMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 67/265 (25%), Positives = 101/265 (38%), Gaps = 69/265 (26%)
Query: 264 NFLAENLIGKGGSSQV---YKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLH 316
+F +IGKG +V K GK A+K L SE D + E +++
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD 59
Query: 317 HKNIISLLGFCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVA 372
++SL + F+D L L+ +FL G L L K D +SE R+ +A V
Sbjct: 60 SPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML--IKYDT----FSEDVTRFYMAECVL 112
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK------------------- 413
A+E +H IHRD+K NIL+ +LSDFGL+
Sbjct: 113 -AIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 414 ----------------WASTSSSHITCT----------DVAGTFGYLAPEYFMYGKVNDK 447
+ SS T GT Y+APE F+ +
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 448 IDVYAFGVVLLELLTGRKPISNDHP 472
D ++ G ++ E L G P +++
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENS 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 25/92 (27%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
VA +E+L S + +HRD+ + N+LL+ ++ DFGLA+ S++++
Sbjct: 246 VARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 431 FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 462
++APE DV+++G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 26/189 (13%)
Query: 285 PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLV--YDFLS 341
P + L K +K + EI + L+H+NI+ + E N ++ YDF
Sbjct: 190 PKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-- 247
Query: 342 RGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 395
+L+ D AF W +R + + A+EY+H +++IHRD+K N
Sbjct: 248 ------DLYSFMYD-EAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLEN 297
Query: 396 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--GTFGYLAPEYFMYGKVNDKIDVYAF 453
I L+ D + L DFG A D GT +PE + D+++
Sbjct: 298 IFLNCDGKIVLGDFGT---AMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354
Query: 454 GVVLLELLT 462
G++LL++L+
Sbjct: 355 GLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.003
Identities = 18/70 (25%), Positives = 35/70 (50%), Gaps = 7/70 (10%)
Query: 278 QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337
QV++ L DG+E+AVK+ +P V K +++++ K + +L F +L +
Sbjct: 26 QVHRAVLKDGEEVAVKVQRP--GVKKRIRSDLKLL-----KFLAKILKKFFPGFDLDWLV 78
Query: 338 DFLSRGSLEE 347
D + +E
Sbjct: 79 DEFRKSLPQE 88
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.51 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.01 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.7 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.61 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.49 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.4 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.35 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.34 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.22 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.21 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.05 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.03 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.96 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.87 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.87 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.8 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.74 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.68 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.38 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.37 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.32 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.15 | |
| PLN02236 | 344 | choline kinase | 97.08 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.97 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.94 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.91 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.76 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.63 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.59 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.56 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.56 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.53 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.38 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.29 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.17 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.1 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.08 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.52 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.45 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.29 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.15 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.81 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 93.84 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 91.75 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-56 Score=480.02 Aligned_cols=288 Identities=49% Similarity=0.878 Sum_probs=259.8
Q ss_pred cccccCHHHHHHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhH-HHHHHHHHHHHHhcCCcceeEEeeEE
Q 007256 249 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV-IKEFVLEIEIITTLHHKNIISLLGFC 327 (611)
Q Consensus 249 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~ 327 (611)
..+.|++.++..+|++|...+.||+|+||.||+|...+|..||||++...... .++|.+|++++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999998875544 66799999999999999999999999
Q ss_pred EecCc-eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEE
Q 007256 328 FEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 406 (611)
Q Consensus 328 ~~~~~-~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL 406 (611)
.+.+. .+||||||++|+|.++|+..... .++|..|++|+.++|+||+|||+.+...||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 99994 99999999999999999876543 7899999999999999999999988778999999999999999999999
Q ss_pred eecCccccccC-CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 407 SDFGLAKWAST-SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 407 ~DFGla~~~~~-~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
+|||+|+.... ....... ..||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+.....++.|..+.
T Consensus 219 sDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 99999976665 2222111 17999999999999999999999999999999999999999877666777799999999
Q ss_pred cccCccccccCcccC-CCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 486 LSSGKVTQLLDPALG-NNYDY-DQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 486 ~~~g~l~~lld~~l~-~~~~~-~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
+..+.+.+++|+.+. ..+.. .++.+++.+|..|++.+|.+||+|.+|+++|+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 999999999999997 55554 68999999999999999999999999999995443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=380.73 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=205.2
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEec--CChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-eEEEEeeC
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILK--PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVYDFL 340 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~--~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~-~~LV~Ey~ 340 (611)
....+.||+|..|+|||+.++ +++.+|+|++. .+....+++.+|+++++..+|||||.+||.|..+.. ..|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 345688999999999999975 78899999994 456778899999999999999999999999999995 99999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|++++...+ .+++...-+|+.+|++||.|||+. ++||||||||+|||++..|++||||||.++.+..+
T Consensus 161 DgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999998654 488999999999999999999952 88999999999999999999999999999887765
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCC--cchhhHHHhhccccccCccccccCcc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP--KGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~--~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.+..++||..|||||.++++.|+.++||||||++++|+.+|+.||....+ .....+..+. . .-..|.
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v------~~ppP~ 301 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---V------DEPPPR 301 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---h------cCCCCC
Confidence 34568999999999999999999999999999999999999999977521 1222222111 0 001123
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
++...-.+ .+..++..||++||.+||++.+++++
T Consensus 302 lP~~~fS~---ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 302 LPEGEFSP---EFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCcccCCH---HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 33321222 34445556999999999999999873
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=383.88 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=202.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh--------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 331 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~--------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~ 331 (611)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++++.. .......+|++||++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 345688999999999999999985 589999999997532 12223468999999999999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC---CceEEee
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSD 408 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~---~~vKL~D 408 (611)
..||||||++||+|.+.+-.++. +.+..-..++.|++.|+.|||+ +||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999977653 6667778899999999999999 999999999999999766 7899999
Q ss_pred cCccccccCCCCCccccccccccccCChhhhccCC---CCCcceehhhhHHHHHHHhCCCCCCCCCCcc-hhhHHHhhcc
Q 007256 409 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKP 484 (611)
Q Consensus 409 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~-~~~lv~~~~~ 484 (611)
||+|+...... .+.+.||||.|.|||++.++. +..++|+||+|||||-+|+|.+||....... ....+..++.
T Consensus 323 FGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 323 FGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred cchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 99999887543 334589999999999998664 3348899999999999999999998765433 2122211111
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+. | .....-.++...++.+||..||++|||+.|+|++
T Consensus 400 ~f~---------p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 400 AFG---------P----LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ccc---------C----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 110 0 0111223566677888999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=386.98 Aligned_cols=250 Identities=32% Similarity=0.519 Sum_probs=204.8
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-ceEEEEeeCCCC
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDFLSRG 343 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~-~~~LV~Ey~~gg 343 (611)
.+.||.|+||+||+|.+.....||||++.... ...+.|.+|+.+|.+++|||||+++|+|.+.. .+++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 34599999999999998655559999998643 23668999999999999999999999999887 799999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc-EEeeccCccceeeCCCC-ceEEeecCccccccCCCCC
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g-IiHrDIKp~NILLd~~~-~vKL~DFGla~~~~~~~~~ 421 (611)
+|.++++.. ....+++..++.++.+||+||.|||+ ++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 126 sL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 126 SLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred cHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 999999874 23469999999999999999999999 66 99999999999999998 99999999998776543
Q ss_pred ccccccccccccCChhhhc--cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 422 ITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~--~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||....+......+..... -+.+
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~-----------Rp~~ 267 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL-----------RPPI 267 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-----------CCCC
Confidence 1222368999999999999 56999999999999999999999999988776322222211111 1111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.. .....+..++..||+.||..||++.+++..|+..
T Consensus 268 p~----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 268 PK----ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred Cc----cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 11 1223455566669999999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=391.05 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=210.2
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~----~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
..|...+.||+|||+++|++.+ .+|..||+|++.+ .....+...+||+|.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688999999999999999998 7899999999976 4566778899999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
|+|.+++|.++++..+ .+++.+++.++.||+.||.|||+ ++|||||||-.|+||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krrk----~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK----PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcC----CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999998544 59999999999999999999999 9999999999999999999999999999988875
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.... ..+.+|||.|+|||++.....+..+||||+|||||-||.|++||+...-.+....+......+. .
T Consensus 171 ~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P-----~---- 239 (592)
T KOG0575|consen 171 DGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP-----S---- 239 (592)
T ss_pred cccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc-----c----
Confidence 4322 2348999999999999999999999999999999999999999988765554444433222111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.-..+. ..++..+|++||.+|||+++|+.
T Consensus 240 -----~ls~~A---~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 -----HLSAEA---KDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----ccCHHH---HHHHHHHhcCCcccCCCHHHHhc
Confidence 111222 33445589999999999999996
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=374.95 Aligned_cols=206 Identities=30% Similarity=0.518 Sum_probs=185.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
..+|...+.||.|+||+||+|.++ ++..||||.+... ....+.+..|+.+|+.++|||||.+++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888999999999999999975 6899999998653 466778899999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC------CceEEeecCc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD------FEPQLSDFGL 411 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~------~~vKL~DFGl 411 (611)
|||.||+|.++|+..+ .+++..++.++.||+.||++||+ ++||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999998775 48999999999999999999999 999999999999999765 4689999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhh
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 477 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~ 477 (611)
|+.+..... ..+.+|+|.|||||+++.++|+.|+|+||+|+|||+|++|+.||....+.+-..
T Consensus 162 AR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 162 ARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred hhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 998875432 334899999999999999999999999999999999999999998776655433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=369.12 Aligned_cols=241 Identities=29% Similarity=0.417 Sum_probs=201.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.++||+|+||+||.++.+ +++.||+|++++.. ...+....|..||.+++||+||+++-.|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 467999999999999999999865 68999999998643 4566788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
+||+.||.|...|+..+ .|++..++.++.+|+.||.|||+ ++||||||||+|||||.+|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~eg----~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG----RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcC----CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999998665 48999999999999999999999 999999999999999999999999999998554
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.... ...+++||+.|||||++....|+..+|+||||+++|||++|.+||...+.......+...+.
T Consensus 177 ~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~------------ 242 (357)
T KOG0598|consen 177 KDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL------------ 242 (357)
T ss_pred cCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC------------
Confidence 4322 22348999999999999999999999999999999999999999998776554443332220
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARP 527 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP 527 (611)
.....+...+ ...++...|.+||++|-
T Consensus 243 -~~~p~~ls~~---ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -PLPPGYLSEE---ARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCccCCHH---HHHHHHHHhccCHHHhc
Confidence 0011111222 33344458899999996
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=362.06 Aligned_cols=259 Identities=27% Similarity=0.392 Sum_probs=211.4
Q ss_pred cCceeeeeEeecCcEEEEEEE-eCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEee-EEEecCc-eEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLG-FCFEDNN-LLLV 336 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g-~~~~~~~-~~LV 336 (611)
.+|.+.+.||+|.||+|||+. ..+|..+|.|.++-. ......+..|+.+|++|+|||||++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 468888999999999999997 569999999998743 355667899999999999999999999 5656655 8999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA-QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~-~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||.+|+|...++..+.....+++..+|+++.|++.||.++|+.-. .-|+||||||.||+|+.+|.+||+|||+++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999998877777889999999999999999999998442 23899999999999999999999999999998
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
...... ....+|||.||+||.+...+|+.|+||||+||++|||+.-+.||.++.-......+ ..++...+.
T Consensus 179 ~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI-------~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI-------EQGDYPPLP 249 (375)
T ss_pred cchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH-------HcCCCCCCc
Confidence 876543 33579999999999999999999999999999999999999999887322111111 122221111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+.-....+.+++..|+..||+.||+...++..+..
T Consensus 250 --------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 --------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 12234556667777999999999996555554443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=367.89 Aligned_cols=251 Identities=27% Similarity=0.451 Sum_probs=207.1
Q ss_pred eeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 266 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 266 ~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
..++.||+|-||.||.|.++....||+|.++......+.|.+|+.+|++|+|+|||+++++|..+..++||||||+.|+|
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 45678999999999999998888999999998777778999999999999999999999999998899999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccc
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~ 425 (611)
.++|+... ...+...+.+.++.|||+|++||++ +++|||||-..||||+++..+||+|||||+....+.... ..
T Consensus 289 l~yLr~~~--~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~-~~ 362 (468)
T KOG0197|consen 289 LDYLRTRE--GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA-SE 362 (468)
T ss_pred HHHhhhcC--CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceee-cC
Confidence 99998632 3468889999999999999999999 999999999999999999999999999999544433222 11
Q ss_pred ccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCC
Q 007256 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 504 (611)
Q Consensus 426 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~ 504 (611)
...-..-|.|||.+..+.++.|||||||||+|+||+| |+.|+......+....+........ |.. -
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------P~~----C 429 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------PEG----C 429 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------CCC----C
Confidence 1223457999999999999999999999999999999 9999877665544444433222211 111 1
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 505 YDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 505 ~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+ ..+..++..||+.+|++|||++.+...|..
T Consensus 430 P---~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 430 P---DEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred C---HHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 2 234456667999999999999988777754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.32 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=207.4
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChh---HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.|....++|+|+||+|||++++ +|+.||||++..+++ ..+-.++||++|++++|+|+|.|+++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4667789999999999999975 699999999986543 455678999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
|+. ++.+-|.... ..++.+.+.+++.|++.|+.|+|+ +++|||||||+||||+.++.+||||||+|+.+....
T Consensus 83 ~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 83 CDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred cch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 998 4444444333 357889999999999999999999 889999999999999999999999999999887532
Q ss_pred CCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcc--------cc-ccC
Q 007256 420 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP--------IL-SSG 489 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~--------~~-~~g 489 (611)
..+++.+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+.|.+....++..++..... ++ .++
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 23456889999999999987 6899999999999999999999999999888777666543221 11 111
Q ss_pred ccccccCcccC------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 490 KVTQLLDPALG------NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 490 ~l~~lld~~l~------~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+..+.-|... ..+ .....-++.++..||+.||.+|++.++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111 111 112234556777799999999999999885
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.20 Aligned_cols=259 Identities=24% Similarity=0.427 Sum_probs=202.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec-C
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-N 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~-~ 331 (611)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ....+.+.+|+.++..+ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999973 24578999999753 23456789999999999 899999999998764 4
Q ss_pred ceEEEEeeCCCCChhhhhccCCCC--------------------------------------------------------
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKD-------------------------------------------------------- 355 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~-------------------------------------------------------- 355 (611)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 589999999999999998643210
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccccccccccc
Q 007256 356 --PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 433 (611)
Q Consensus 356 --~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y 433 (611)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1347888999999999999999999 89999999999999999999999999999865443322222234567899
Q ss_pred CChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHH
Q 007256 434 LAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 512 (611)
Q Consensus 434 ~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~ 512 (611)
+|||++.+..++.++|||||||+||||++ |..||............ ...+... .... .....+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~------~~~~~~~-----~~~~----~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR------LKDGTRM-----RAPE----NATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH------HhcCCCC-----CCCC----CCCHHHH
Confidence 99999998999999999999999999997 99999765432211110 0111100 0111 1123455
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 513 LASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 513 ~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.++..||+.||.+|||+.+|++.|+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 67778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=351.18 Aligned_cols=261 Identities=28% Similarity=0.417 Sum_probs=208.2
Q ss_pred hcCceeeeeEeecCcEEEEEEE-eCCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||.|..++||+|. .+.+..||||++.-+ ....+.+.+|+..++.++||||++++..|..++.+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678999999999999999997 467899999999754 3457889999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
||.+|++.+++...-. ..+.+..+..|++++++||.|||+ +|.||||||+.||||+.+|.+||+|||.+..+-..
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999986654 348999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCC-ccc-cccccccccCChhhhcc--CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 419 SSH-ITC-TDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 419 ~~~-~~~-~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
... ... .+++||+.|||||+++. ..|+.|+||||||++.+||.+|..||....+.....+.....+.... ...
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~---t~~ 256 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL---TSG 256 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc---ccc
Confidence 221 111 45799999999999653 37999999999999999999999999887665433222222111000 111
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
++..-.. .....+...+-.||++||.+|||++++++
T Consensus 257 ~~~d~~k----~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LDKDEDK----KFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CChHHhh----hhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111111 11124444555699999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=362.11 Aligned_cols=252 Identities=27% Similarity=0.370 Sum_probs=207.0
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 333 (611)
...++|.+.+.||+|+|++||+|... ++++||||++.+. +...+....|-++|.+| .||.|++|+-.|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34578999999999999999999864 7999999999753 33445677899999999 799999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
|+|+||+++|+|.++|++.+ .|++.-.+.++.+|+.||+|||+ +|||||||||+|||||.++++||+|||.|+
T Consensus 150 YFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccc
Confidence 99999999999999999876 48999999999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCC---------cc--ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 007256 414 WASTSSSH---------IT--CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 414 ~~~~~~~~---------~~--~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 482 (611)
.+...... .. ...++||..|.+||++..+..+..+|+|+||||||+|+.|.+||.+.+.--.-..++-.
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 87653222 11 14489999999999999999999999999999999999999999876543222222211
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+-.+...++ .....++...|..||.+|+|..+|-++
T Consensus 303 -------------~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 -------------DYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -------------cccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 111222222 233344455789999999999888764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.58 Aligned_cols=263 Identities=24% Similarity=0.395 Sum_probs=202.2
Q ss_pred cCceeeeeEeecCcEEEEEEEeCC-----------------CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 323 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~-----------------g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l 323 (611)
++|.+.+.||+|+||.||++.+++ +..||+|+++.. ......|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 346999999763 3456689999999999999999999
Q ss_pred eeEEEecCceEEEEeeCCCCChhhhhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEe
Q 007256 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 388 (611)
Q Consensus 324 ~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~---------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiH 388 (611)
++++.+.+..++||||+++|+|.+++..... ....++|..++.++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999998854321 11347888999999999999999999 89999
Q ss_pred eccCccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh--CCCC
Q 007256 389 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKP 466 (611)
Q Consensus 389 rDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt--G~~P 466 (611)
|||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986544332222233456889999999998999999999999999999987 5667
Q ss_pred CCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 467 ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 467 f~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
|........ ................ ... .......+..++..||+.+|.+|||+.+|.+.|+
T Consensus 242 ~~~~~~~~~---~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQV---IENAGEFFRDQGRQVY--LFR----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHH---HHHHHHHhhhcccccc--ccC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 765433221 1111111111000000 000 1111235666778899999999999999998885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=336.06 Aligned_cols=206 Identities=28% Similarity=0.419 Sum_probs=186.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|...+.||.|+||.|.+++.+ +|..||+|++...+ ...+...+|..+|+.+.||+++++++.|.+.+.++||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 357889999999999999999875 68899999998654 3345677899999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||++||.|..++++.+ .|++..++.++.+|+.||+|||+ ++|++|||||+|||||.+|++||+|||+|+...
T Consensus 123 meyv~GGElFS~Lrk~~----rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG----RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcC----CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999998765 48999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv 479 (611)
.. +.+.||||.|+|||+++...|+.++|+|||||++|||+.|.+||.+..+......+
T Consensus 196 ~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI 253 (355)
T KOG0616|consen 196 GR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI 253 (355)
T ss_pred Cc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH
Confidence 63 23489999999999999999999999999999999999999999988875444433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=357.72 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=204.8
Q ss_pred cCHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEE
Q 007256 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFC 327 (611)
Q Consensus 253 f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~ 327 (611)
...+......++|.+.+.||+|+||.||++..+ +|..+|+|+++++. ..++....|-++|....+|+||+|+-.|
T Consensus 131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 344444567889999999999999999999865 69999999999864 4456778899999999999999999999
Q ss_pred EecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 328 ~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
++.+.+||||||++||++..+|.... .|++..++.++.+++.|+..||+ .|+|||||||+|+|||..|++||+
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLS 283 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLS 283 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeec
Confidence 99999999999999999999997654 58999999999999999999999 999999999999999999999999
Q ss_pred ecCccccccCC--------------------CCC-c-------c-----------------ccccccccccCChhhhccC
Q 007256 408 DFGLAKWASTS--------------------SSH-I-------T-----------------CTDVAGTFGYLAPEYFMYG 442 (611)
Q Consensus 408 DFGla~~~~~~--------------------~~~-~-------~-----------------~~~~~GT~~Y~APE~l~~~ 442 (611)
||||+.-+... ... . . ....+|||.|+|||++.+.
T Consensus 284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k 363 (550)
T KOG0605|consen 284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK 363 (550)
T ss_pred cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence 99998532210 000 0 0 0114799999999999999
Q ss_pred CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhh-HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhccc
Q 007256 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRR 521 (611)
Q Consensus 443 ~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~ 521 (611)
.|+..+|+||||||+||||.|.+||..+.+..... ++.|...+..... ....++. ..++..|+.
T Consensus 364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~-----------~~~s~eA---~DLI~rll~- 428 (550)
T KOG0605|consen 364 GYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE-----------VDLSDEA---KDLITRLLC- 428 (550)
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc-----------CcccHHH---HHHHHHHhc-
Confidence 99999999999999999999999999998876544 4455432211111 0011233 334445666
Q ss_pred CCCCCCC
Q 007256 522 DPRARPQ 528 (611)
Q Consensus 522 dP~~RPt 528 (611)
||.+|--
T Consensus 429 d~~~RLG 435 (550)
T KOG0605|consen 429 DPENRLG 435 (550)
T ss_pred CHHHhcC
Confidence 9999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=360.07 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=213.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHH--HHHHHHHHhcC-CcceeEEeeEEEecC-ceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEF--VLEIEIITTLH-HKNIISLLGFCFEDN-NLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f--~~Ei~iL~~l~-HpnIv~l~g~~~~~~-~~~LV 336 (611)
-++|.+.+.||.|.||.||+|.. .+|..||||.++..-...++. ++|+..|++++ |||||+|.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 46788999999999999999985 479999999998755444443 47999999999 999999999999988 99999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
||||+. +|+++++.+. ..|++..++.|+.||++||+|+|+ +|+.|||+||+|||+.....+||+|||+|+...
T Consensus 89 fE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999987 9999998763 479999999999999999999999 999999999999999988899999999999876
Q ss_pred CCCCCccccccccccccCChhhhc-cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC------
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG------ 489 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g------ 489 (611)
.... ++..+.|.+|.|||++. .+.|+.+.|+||+|||++|+.+-++.|.+.+..++...+..........
T Consensus 162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 6544 34578999999999875 6789999999999999999999999999887777666553322111110
Q ss_pred ccccccCcccCCC-------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNN-------YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~-------~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
++...++=.+... .-.......+.++..|+..||.+|||+.+.+++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111111100 011244566777778999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=354.01 Aligned_cols=250 Identities=25% Similarity=0.332 Sum_probs=204.5
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC----h--hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecC
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----E--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 331 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~--~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~ 331 (611)
...+.|.+.+.||+|+||+|+.|.. .+|..||||++... . ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3467899999999999999999976 47899999987653 1 23456778999999999 999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC-CceEEeecC
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFG 410 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~-~~vKL~DFG 410 (611)
.+++||||+.||+|.+++...+ .+.+.++..++.|++.|++|||+ +||+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g----~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG----RLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC----CCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999998743 58889999999999999999999 999999999999999999 999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCC-CC-CcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-VN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 488 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 488 (611)
++..... ......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.........+....
T Consensus 167 ~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~----- 239 (370)
T KOG0583|consen 167 LSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE----- 239 (370)
T ss_pred cccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC-----
Confidence 9987741 112334579999999999999877 86 68999999999999999999998854333222211110
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 489 g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
-.+...++ ...+..++..||..||.+|+++.++++
T Consensus 240 ~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 FKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 01122111 234555666799999999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=337.30 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=199.3
Q ss_pred CceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.|...+.||+|+||.||++.. .+|+.||||.+.... .....+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378889999999999999986 479999999987432 233467889999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++|+|.+.+..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999988754322 258899999999999999999999 89999999999999999999999999999875432
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... + ....
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~--~-~~~~-------- 221 (285)
T cd05631 156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR--V-KEDQ-------- 221 (285)
T ss_pred Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH--h-hccc--------
Confidence 21 12357999999999999999999999999999999999999999865443221111100 0 0000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~~ 535 (611)
..+.......+..++..||+.||.+||+ ++++++.
T Consensus 222 --~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 --EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0011111234555667799999999997 7887763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=353.75 Aligned_cols=264 Identities=26% Similarity=0.343 Sum_probs=208.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~L 335 (611)
.+.|..++.||+|.||.||+|++ .+|+.||+|.++.. +....-..+||.||++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34677788999999999999985 58999999998753 34566778999999999999999999998876 68999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
|+|||+. +|.-++.... ..|+..++..++.||+.||.|+|. +||+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999988 8988887543 369999999999999999999999 99999999999999999999999999999988
Q ss_pred cCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc--
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT-- 492 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~-- 492 (611)
....... .+..+-|.+|.|||++.+. .|+.++|+||.||||.||++|++.|.+....+|...+-..-.-+.+..+.
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 7755442 4557889999999998865 79999999999999999999999999888777766653211111111111
Q ss_pred cc-----cC------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 493 QL-----LD------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 493 ~l-----ld------~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+ +. ..+...+ .......+.++-.+|..||.+|.|+.++|+
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11 11 1111100 011123344445578889999999999986
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=346.28 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=203.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||+|.+. +|+.||||+++... .....+.+|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999976 68999999997532 34567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999997543 47889999999999999999999 8999999999999999999999999999976544
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH-HhhccccccCccccccC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWAKPILSSGKVTQLLD 496 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv-~~~~~~~~~g~l~~lld 496 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .|... ... ....+
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~---~~~~~ 224 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET-LQR---PVYDD 224 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-ccC---CCCCc
Confidence 122367999999999999999999999999999999999999999876543322221 12111 000 00000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+. ......+..++..||..+|.+||++.++++.
T Consensus 225 ~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PR------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cc------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00 1112344556667999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=338.90 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=201.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|+||+||++.++ +++.||||+++.. ....+.+.+|+.+++.++||||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999975 6889999998753 2345678899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|++++.+..+.... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99997776554322 258899999999999999999999 89999999999999999999999999999876443
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh-cccc--------ccC
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPIL--------SSG 489 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~-~~~~--------~~g 489 (611)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .+.. ...
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 221 122357999999999999889999999999999999999999999865433222111111 0000 000
Q ss_pred ccccccCcccCCCCC------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 490 KVTQLLDPALGNNYD------YDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 490 ~l~~lld~~l~~~~~------~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.......+....... ......+..++..||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000011000000 011234667777899999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.44 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=197.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC--ceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~--~~~LV~E 338 (611)
.+|...+.||+|+||+||++... +|...|||.+.... ...+.+.+|+.+|++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777889999999999999975 49999999987542 22667899999999999999999999855444 6999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-CCceEEeecCccccccC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 417 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-~~~vKL~DFGla~~~~~ 417 (611)
|+++|+|.+++...+. .+++..+..++.||++||.|||+ +|||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999987653 48999999999999999999999 99999999999999999 79999999999987764
Q ss_pred CCC-CccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCC-CCcchhhHHHhhccccccCccccc
Q 007256 418 SSS-HITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISND-HPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 418 ~~~-~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~-~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
... ........||+.|||||++..+.. ..++|||||||+++||+||+.||... ........+ .......
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i------g~~~~~P-- 242 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI------GREDSLP-- 242 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH------hccCCCC--
Confidence 111 112234789999999999996433 35999999999999999999999764 111111111 1111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.+... -.++ ...+...|+..+|.+|||+.++|++..
T Consensus 243 ---~ip~~-ls~~---a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 243 ---EIPDS-LSDE---AKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---CCCcc-cCHH---HHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 11111 1122 233444599999999999999998643
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.66 Aligned_cols=255 Identities=22% Similarity=0.429 Sum_probs=207.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.++|.+.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 35789999999999999999998888999999988766667789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++..... ..+++..++.++.+++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 85 KGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999875432 357889999999999999999999 89999999999999999999999999999876543221
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......++..|+|||++..+.++.++|||||||++|+|++ |+.||...........+ ..... . +..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~~~~~---~-----~~~- 226 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL---QRGYR---M-----PRM- 226 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH---HcCCC---C-----CCC-
Confidence 1122346778999999998899999999999999999998 99999765433221111 10000 0 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.. ....+..++..|+..+|++||+++++++.|+.
T Consensus 227 ~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 EN----CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CC----CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 12345667778999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=325.61 Aligned_cols=263 Identities=26% Similarity=0.363 Sum_probs=214.0
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.+|...+.||+|.||.||+|++ ++|+.||||.++..+ .......+||..|+.++|+||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4577788999999999999996 589999999998643 335578899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
||+. +|+..++... ..++...+..++.++++||+|||. +.|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9987 9999997654 368889999999999999999999 89999999999999999999999999999988765
Q ss_pred CCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC---ccccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---KVTQL 494 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---~l~~l 494 (611)
..... ..+-|.+|.|||.+.+. .|+..+|+||.|||+.||+-|.+-|.++...+|...+-.+....... ++..+
T Consensus 155 ~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Ccccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 54433 24789999999988754 79999999999999999999999998888877776654333222221 22222
Q ss_pred cC---------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 LD---------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 ld---------~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.| +.+. ..-.......+.+...++..||.+|.++.+++++
T Consensus 233 pdY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 22 1111 1222334455667777999999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.65 Aligned_cols=251 Identities=23% Similarity=0.417 Sum_probs=204.3
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
++|.+.+.||+|+||.||++..+++..+|+|.++........|.+|+++++.++||||++++++|...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 46888999999999999999988888999999886655567899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.++++.... .+++..+..++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 84 GCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999875432 48899999999999999999999 89999999999999999999999999998765432211
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...........+.. +. ....+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-------~~--~~~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-------GF--RLYRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------CC--CCCCCC---
Confidence 1112345678999999998899999999999999999999 8999976543322111110 00 000111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
. ....+..++..|++.+|.+||++.++++.|
T Consensus 225 -~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 -L---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -C---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 123466777789999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.05 Aligned_cols=244 Identities=25% Similarity=0.292 Sum_probs=200.2
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999875 68999999987532 34556889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999997543 48889999999999999999999 8999999999999999999999999999986643
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....
T Consensus 154 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~------------- 215 (291)
T cd05612 154 RT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL------------- 215 (291)
T ss_pred Cc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc-------------
Confidence 21 235799999999999988999999999999999999999999977554332221111110
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~~ 535 (611)
.+.... ...+..++..||+.||.+||+ +.+++++
T Consensus 216 ~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011111 123455667799999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=345.56 Aligned_cols=244 Identities=25% Similarity=0.360 Sum_probs=199.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57899999999999999999875 68999999997532 34567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999997543 47888999999999999999999 8999999999999999999999999999986644
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+......+. .+.+
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-------~~~~------ 232 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-------AGRL------ 232 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh-------cCCc------
Confidence 22 13579999999999999999999999999999999999999997654322211111 1110
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~~ 535 (611)
.+...+ ...+..++..||+.||.+||+ +.+++.+
T Consensus 233 ~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 KFPNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 001111 123455667799999999997 5777654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=337.02 Aligned_cols=264 Identities=20% Similarity=0.324 Sum_probs=201.0
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||.|+||+||+|... ++..||+|+++... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999865 78999999987532 3345678999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++ +|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 986 8998886543 247889999999999999999999 899999999999999999999999999997654322
Q ss_pred CCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC---------
Q 007256 420 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG--------- 489 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g--------- 489 (611)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..........
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 1 1223578999999999875 568999999999999999999999998765544332221111110000
Q ss_pred ccccccCcccCCCC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~----~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+...+.+...... ..........++..||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111111100000 00112345567778999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=352.84 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=202.0
Q ss_pred cCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 333 (611)
++|.+.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.++..+ +||||++++++|..++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4688899999999999999863 346789999997543 3456788999999999 899999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC-----------------------------------------------------------
Q 007256 334 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 354 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~----------------------------------------------------------- 354 (611)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999864321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 355 ------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 355 ------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 11257889999999999999999999 899999999999999999999999999998665433222
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
......++..|+|||++.+..++.++|||||||++|||++ |..||........ ...+.. .+.. +.. .
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~~~----~~~~-----~~~-~ 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKMIK----EGYR-----MLS-P 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHHHH----hCcc-----CCC-C
Confidence 2222345678999999999999999999999999999998 8889865432221 111111 1100 000 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.... ..+..++..||+.||++||++.+|++.|+.
T Consensus 340 ~~~~---~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ECAP---SEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1112 245566777999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.91 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=206.7
Q ss_pred CceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHH-HHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 264 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVI-KEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~-~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.|.....||+|+.|.||.+.. .+++.||||++....+.. +-+.+|+.+|+..+|+|||++++.|...+++|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 466678899999999999985 478999999998765444 457799999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
||+|.+.+... .+++.++..|+.+++.||+|||. ++|||||||.+|||++.+|.+||+|||++..+......
T Consensus 354 ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 354 GGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 99999999754 38899999999999999999999 99999999999999999999999999999887765543
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
....+|||.|||||++....|++|+||||||++++||+-|.+||-.+.+.....++.-... |.+..
T Consensus 426 --R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~------------P~lk~ 491 (550)
T KOG0578|consen 426 --RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT------------PKLKN 491 (550)
T ss_pred --cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC------------CCcCC
Confidence 3357999999999999999999999999999999999999999988777655555432211 11110
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......+-.+..+||+.|+++||++.|+|++
T Consensus 492 --~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 --PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred --ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 00111122233445999999999999999974
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=334.99 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=195.3
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceEEEEeeC
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLVYDFL 340 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~LV~Ey~ 340 (611)
..||+|++|.||+|.. +|+.||||.++... ...+.|.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999988 78999999997542 235678899999999999999999999977 34689999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.+++.... .+++.....++.+++.||.|||+. .+++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999997643 488999999999999999999972 378899999999999999999999999998654322
Q ss_pred CccccccccccccCChhhhcc--CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 421 HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
....||..|+|||++.+ +.++.++|||||||++|||++|+.||...........+.... .. +.
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~-----~~------~~ 242 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN-----NS------LK 242 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC-----CC------CC
Confidence 12468999999999976 689999999999999999999999998654332221111000 00 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+. ......+..++..||+.||.+|||+.+|++.|+.
T Consensus 243 ~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 243 LP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred CC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11 1112245566677999999999999999998864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=344.06 Aligned_cols=241 Identities=25% Similarity=0.357 Sum_probs=195.0
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
+.||+|+||.||++... +|+.||||+++.. ......+.+|+.+++.++||||++++++|..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 7899999999753 234456788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcc
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 423 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 423 (611)
+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 151 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence 9999987543 48899999999999999999999 8999999999999999999999999999875432221 1
Q ss_pred ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCC
Q 007256 424 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 503 (611)
Q Consensus 424 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 503 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... . ..+....
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------~------~~~p~~~ 218 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------E------IRFPRTL 218 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-------C------CCCCCCC
Confidence 22367999999999999999999999999999999999999999765432221111100 0 0111111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 504 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 504 ~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
...+..++..||+.||++|| ++.+++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 219 ----SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ----CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 22345566679999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=328.12 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=207.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..++|.+.+.||+|++|.||+|...+++.||||.++......+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34679999999999999999999888889999999876655678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++.... ...+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999997543 2358999999999999999999999 8999999999999999999999999999987753221
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.||...........+. . ....
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~--~----~~~~-------- 223 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD--Q----GYRM-------- 223 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--c----CCCC--------
Confidence 1 1111223457999999998899999999999999999999 999997654322111111 0 0000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.........+..++..|++.+|.+||++.++++.|+
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 001112245666778899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=358.84 Aligned_cols=243 Identities=23% Similarity=0.380 Sum_probs=202.9
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCce
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 333 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~ 333 (611)
...++|.+.++||+|.||+|+++..+ +++.||||++++. ++.++..+.|.+|+.... ||.+++|+.+|+..+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 35578999999999999999999976 6889999999974 577888999999999886 99999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
|+||||+.||++..+.+.. .|++..+..++.+|+.||+|||+ ++|||||||.+|||||.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999955444422 48999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
....... .+.+++|||.|||||++..+.|+..+|+|||||+|||||.|..||.+++..+.-.-+...
T Consensus 517 e~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------- 583 (694)
T KOG0694|consen 517 EGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------- 583 (694)
T ss_pred ccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 6553222 334599999999999999999999999999999999999999999987755432222111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 529 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm 529 (611)
|+. |+.......+.+....|.++|++|.-+
T Consensus 584 --~~~----yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 --EVR----YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCC----CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 222233444555666899999999987
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=352.22 Aligned_cols=258 Identities=24% Similarity=0.413 Sum_probs=202.1
Q ss_pred cCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 333 (611)
++|.+.+.||+|+||.||+|.. .++..||||+++.. ......+.+|+++++.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4688999999999999999874 23468999999753 34456788999999999 899999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC-----------------------------------------------------------
Q 007256 334 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 354 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~----------------------------------------------------------- 354 (611)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999998854210
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccccc
Q 007256 355 -------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 427 (611)
Q Consensus 355 -------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~ 427 (611)
....+++..+++++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 11247889999999999999999999 89999999999999999999999999999866543322222223
Q ss_pred ccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChH
Q 007256 428 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 506 (611)
Q Consensus 428 ~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~ 506 (611)
.++..|+|||++..+.++.++|||||||++|||++ |+.||.............. .+ ........ .
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~------~~-----~~~~~~~~-~-- 340 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK------RG-----YQMSRPDF-A-- 340 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH------cc-----cCccCCCC-C--
Confidence 45678999999998999999999999999999997 9999976543221111110 00 00000011 1
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 507 QMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 507 ~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
...+..++..||+.||.+||++.+|++.|+.
T Consensus 341 -~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 341 -PPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred -CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1345566677999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.37 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=205.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeCC------CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
++|.+.+.||+|+||.||+|.... ...||+|.++.. ......|.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998642 257999998753 344567899999999999999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC
Q 007256 335 LVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~ 402 (611)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 99999999999999865421 11357889999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 007256 403 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 481 (611)
Q Consensus 403 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 481 (611)
.+||+|||++................+++.|+|||++..+.++.++|||||||++|||++ |..||...........+..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999976544332222233567889999999998999999999999999999998 9999976554332222111
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 482 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 482 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+.... ........+..++..||+.||.+||++.+|++.|+.
T Consensus 242 -------~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 242 -------RQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -------CCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11110 111122456667778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=328.53 Aligned_cols=254 Identities=20% Similarity=0.368 Sum_probs=201.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||.||+|.++ .+..||+|.++.. ......|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357899999999999999999753 4668999999864 3445678999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+|||++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999987543 258899999999999999999999 89999999999999999999999999987654
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
...... ......++..|+|||++.++.++.++|||||||++|||++ |..||...........+. .+..
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~~--- 226 (266)
T cd05064 158 KSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-------DGFR--- 226 (266)
T ss_pred cccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCCC---
Confidence 322111 1112345678999999999999999999999999999775 999997654332211111 1100
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..... .....+..++..||+.+|.+||++.+|++.|..
T Consensus 227 --~~~~~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 --LPAPR----NCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CCCCC----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 00111 112345666777999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.91 Aligned_cols=201 Identities=26% Similarity=0.418 Sum_probs=177.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||.||++... +|..+|+|++... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999875 6889999998753 3455679999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.+++.... .+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999997543 478899999999999999999971 35999999999999999999999999998765432
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred c----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 1235799999999999988999999999999999999999999975443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=343.35 Aligned_cols=204 Identities=26% Similarity=0.395 Sum_probs=177.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||++... +++.||||+++.. ......+.+|+.++..++|+||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999865 6899999999753 234456788999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999997543 48899999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCC---------------------------------ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCC
Q 007256 418 SSSH---------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 464 (611)
Q Consensus 418 ~~~~---------------------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~ 464 (611)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCCCc
Q 007256 465 KPISNDHPK 473 (611)
Q Consensus 465 ~Pf~~~~~~ 473 (611)
.||......
T Consensus 234 ~Pf~~~~~~ 242 (363)
T cd05628 234 PPFCSETPQ 242 (363)
T ss_pred CCCCCCCHH
Confidence 999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=343.22 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=202.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||+|... +|+.||||+++... .....+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999975 79999999997532 44567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999997652 58899999999999999999999 9999999999999999999999999999986654
Q ss_pred CC---------------------------CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCC
Q 007256 418 SS---------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470 (611)
Q Consensus 418 ~~---------------------------~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~ 470 (611)
.. .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 001122357999999999999999999999999999999999999999876
Q ss_pred CCcchhhHH-HhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 007256 471 HPKGQESLV-MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKL 535 (611)
Q Consensus 471 ~~~~~~~lv-~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-m~eVL~~ 535 (611)
........+ .|.... . +..... ....+..++..|++ +|.+||+ +.++++.
T Consensus 234 ~~~~~~~~i~~~~~~~----~--------~p~~~~--~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKESL----R--------FPPDPP--VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCCcc----c--------CCCCCC--CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 543222211 111100 0 000000 12234445556887 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.55 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=204.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.+++.+...||+|.||+||+|.+.. .||||+++. +.+..+.|.+|+..+++-+|.||+-+.|||..... .||.-
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 3455678899999999999998743 499999984 45678899999999999999999999999987766 99999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
+|+|-+|+.+||-.. ..|.....+.|+.||++|+.|||. ++|||||||+.||+|.+++.|||+|||++.....-
T Consensus 468 wCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred hccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999998665 469999999999999999999999 99999999999999999999999999998654443
Q ss_pred CCCccccccccccccCChhhhcc---CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
..........|...|||||+++- .+|+..+||||||+|+|||+||..||...........+ |.-.-..
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV---------GrG~l~p 612 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV---------GRGYLMP 612 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe---------cccccCc
Confidence 33333344568889999999974 37899999999999999999999999843332222111 1111111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
|.......-. +.|..+...||..++++||.+.+|+..|....
T Consensus 613 d~s~~~s~~p---k~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 613 DLSKIRSNCP---KAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred cchhhhccCH---HHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 2221111122 34444555699999999999999999776544
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=329.07 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=204.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||.||+|... ++..||||+++... ...+.+.+|+++++.++|+||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 356888899999999999999763 34789999997643 3467899999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc
Q 007256 334 LLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 403 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~----------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~ 403 (611)
++||||+++++|.+++..... ....+++..+..++.+++.||.|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999975431 22457899999999999999999999 89999999999999999999
Q ss_pred eEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhh
Q 007256 404 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 404 vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~ 482 (611)
+||+|||++................+++.|+|||++.++.++.++|||||||++|||++ |..||...........+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-- 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-- 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--
Confidence 99999999976543322222223456788999999999999999999999999999998 999997654332211111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.+..... .......+..++..||+.||.+||++.||++.|+
T Consensus 239 -----~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 -----QGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -----cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111110 0111234556677799999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=356.40 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=202.2
Q ss_pred CceeeeeEeecCcEEEEEEEeC-C-CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-D-GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~-g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.|.+.+.||+|+||.||+|... + +..||+|.+.... .....+.+|+.+|+.++||||++++++|..++.++|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3889999999999999999854 3 6788888775433 44456778999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.+++.........+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999999886543334468899999999999999999999 8999999999999999999999999999987655433
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
.......+||++|+|||++.+..++.++|||||||++|||++|+.||...........+... ... + +.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-------~~~----~-~~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-------KYD----P-FP 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CCC----C-CC
Confidence 22233467999999999999999999999999999999999999999765432221111111 100 0 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
. .....+..++..||+.||.+||++.+++.
T Consensus 293 ~----~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 C----PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred c----cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 11124556667799999999999999875
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=339.64 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=196.2
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----ceE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 334 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~-----~~~ 334 (611)
+|.+.+.||+|+||.||+|.+. +|..||||+++.. ......+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4889999999999999999865 7899999998742 234457889999999999999999999886432 489
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 58998886543 48899999999999999999999 8999999999999999999999999999976
Q ss_pred ccCCCC-CccccccccccccCChhhhcc--CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc-----
Q 007256 415 ASTSSS-HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL----- 486 (611)
Q Consensus 415 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~----- 486 (611)
...... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+.......
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533221 122234679999999999875 678999999999999999999999997654332211111000000
Q ss_pred ---ccCccccccCc---ccCCCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 487 ---SSGKVTQLLDP---ALGNNYD---YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 487 ---~~g~l~~lld~---~l~~~~~---~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
........++. ....... ......+..++..||+.||++|||+.++++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 0000000 0011234567778999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=327.86 Aligned_cols=258 Identities=21% Similarity=0.390 Sum_probs=203.1
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
.+++|.+.+.||+|+||.||+|... ++..||||.+.... ....+|.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999998753 35679999986432 345678899999999999999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEE
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 406 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~------~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL 406 (611)
.++||||+++++|.+++...... ...+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653221 2346788999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccc
Q 007256 407 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
+|||++................+++.|+|||++.++.++.++|||||||++|||++ |..||...........+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~---- 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME---- 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----
Confidence 99999876544322222222356788999999998899999999999999999999 7889876543222111110
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
+.... +... ....+..++..|++.+|++|||+.++++.|+
T Consensus 237 ---~~~~~-----~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 ---GGLLD-----KPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ---CCcCC-----CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11100 0111 1234566777899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=330.27 Aligned_cols=263 Identities=22% Similarity=0.329 Sum_probs=195.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC--CCCEEEEEEecCC---hhHHHHHHHHHHHHHhc---CCcceeEEeeEEEe-----
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFE----- 329 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~~----- 329 (611)
++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ......+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999863 4788999998743 22334566788877766 69999999999852
Q ss_pred cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeec
Q 007256 330 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409 (611)
Q Consensus 330 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DF 409 (611)
...+++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999997 589998865432 248899999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
|++....... ......||+.|+|||++....++.++|||||||++|||++|+.||...........+..........
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 9998665432 1223578999999999998899999999999999999999999998765443322221111111111
Q ss_pred ccccc---cCcccCC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 490 KVTQL---LDPALGN-------NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 490 ~l~~l---ld~~l~~-------~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..... ....+.. .........+..++..||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 11000 0000000 000011233456777899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=337.24 Aligned_cols=238 Identities=26% Similarity=0.336 Sum_probs=191.1
Q ss_pred EeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 271 IGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
||+|+||.||+|.+. +++.||+|+++.. ......+.+|+.++.+++||||++++++|...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 6889999998742 34456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccc
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~ 425 (611)
.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 99997543 48899999999999999999999 8999999999999999999999999999975433222 123
Q ss_pred ccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCCh
Q 007256 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505 (611)
Q Consensus 426 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 505 (611)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .. . ..+...++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~------~~-~------~~~~~~~~- 217 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL------QE-P------LRFPDGFD- 217 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH------cC-C------CCCCCcCC-
Confidence 3679999999999999999999999999999999999999997654322111111 00 0 00111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 007256 506 DQMERMVLASILCIRRDPRARPQ---MSLVLK 534 (611)
Q Consensus 506 ~~~~~l~~la~~CL~~dP~~RPt---m~eVL~ 534 (611)
..+..++..||+.||.+||+ +.+++.
T Consensus 218 ---~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 218 ---RDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ---HHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 23445566799999999986 556554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=324.47 Aligned_cols=254 Identities=24% Similarity=0.415 Sum_probs=205.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.+|.+.+.||+|+||.||+|... +++.||+|+++........+.+|+++++.++|+||+++++++..++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 46889999999999999999865 58899999998776667789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++..... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999865432 358899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||...........+. . + ..+...
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~----~-----~~~~~~ 227 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---K----G-----YRMERP 227 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---C----C-----CCCCCC
Confidence 1 111234678999999999999999999999999999998 999997654322211111 0 0 001111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.. ....+..++..||+.+|.+||++.++++.|+.
T Consensus 228 ~~----~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 228 EG----CPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CC----CCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 11 12345556677999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=342.78 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=197.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||+|... +|+.||||+++.. ......+.+|++++..++||||++++++|.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999875 6899999999753 234456788999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999987543 48899999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCc------------------------------------cccccccccccCChhhhccCCCCCcceehhhhHHHHHHH
Q 007256 418 SSSHI------------------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 461 (611)
Q Consensus 418 ~~~~~------------------------------------~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELl 461 (611)
..... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 21100 011246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcchhhH-HHhhccccccCccccccCcccCCC-CChHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 007256 462 TGRKPISNDHPKGQESL-VMWAKPILSSGKVTQLLDPALGNN-YDYDQMERMVLASILCIRRDPRARPQ---MSLVLKL 535 (611)
Q Consensus 462 tG~~Pf~~~~~~~~~~l-v~~~~~~~~~g~l~~lld~~l~~~-~~~~~~~~l~~la~~CL~~dP~~RPt---m~eVL~~ 535 (611)
+|+.||........... ..|..... +... ...+.+.. ++..|+. +|.+|++ +.+++++
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~~~~------------~~~~~~~s~~~~~---li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKETLQ------------FPDEVPLSPEAKD---LIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCccC------------CCCCCCCCHHHHH---HHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999987654332211 11211100 0000 11123333 3344775 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=339.12 Aligned_cols=241 Identities=26% Similarity=0.366 Sum_probs=195.2
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
+.||+|+||.||++... +|+.||||+++.. ......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 7899999999753 244567889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcc
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 423 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 423 (611)
+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 151 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T 151 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence 9998886543 48899999999999999999999 8999999999999999999999999999875433221 1
Q ss_pred ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCC
Q 007256 424 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 503 (611)
Q Consensus 424 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 503 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... . ..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-------~------~~~p~~~ 218 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------D------IKFPRTL 218 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-------C------ccCCCCC
Confidence 22367999999999999899999999999999999999999999765433221111110 0 0111111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 504 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 504 ~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
...+..++..||+.||.+|| ++.+++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 ----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12345566679999999997 88888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=324.09 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=203.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
++|.+.+.||+|+||.||+|...++..+|||.++......+.|.+|+.++++++||||++++++|...+..++||||+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46888999999999999999887777899999886655567899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++..... .+++..++.++.+|+.||.|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 84 ~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 84 GCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999875432 58899999999999999999999 89999999999999999999999999998765443221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
......++..|+|||++.++.++.++|||||||++|+|++ |..||...........+... ... ....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-------~~~-----~~~~ 224 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-------LRL-----YRPH 224 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-------CCC-----CCCC
Confidence 1112345678999999998899999999999999999998 99999754432211111110 000 0000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.....+..++..||+.+|.+||++.++++.|+
T Consensus 225 ----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 ----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11245566777899999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.64 Aligned_cols=253 Identities=21% Similarity=0.346 Sum_probs=196.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.|.+.+.||+|+||+||+|.+. +++.||||++... ......+.+|+++++.++||||+++++++.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 6889999999999999999864 6889999999753 2345678899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999987543 47888899999999999999999 89999999999999999999999999997543210
Q ss_pred CC---------------------------------------------CccccccccccccCChhhhccCCCCCcceehhh
Q 007256 419 SS---------------------------------------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 453 (611)
Q Consensus 419 ~~---------------------------------------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSl 453 (611)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123579999999999998899999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCcchh-hHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 007256 454 GVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 532 (611)
Q Consensus 454 GvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eV 532 (611)
||++|||++|+.||....+.... ..+.|..... +. + ...+. .+...++.- +.|+..+|..||++.++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----~~----~--~~~~s-~~~~dli~~-ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENTLH----IP----P--QVKLS-PEAVDLITK-LCCSAEERLGRNGADDI 302 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC----CC----C--CCCCC-HHHHHHHHH-HccCcccccCCCCHHHH
Confidence 99999999999999876543221 1222211110 00 0 00111 222222221 23777888889999999
Q ss_pred HHH
Q 007256 533 LKL 535 (611)
Q Consensus 533 L~~ 535 (611)
+++
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=334.25 Aligned_cols=254 Identities=22% Similarity=0.403 Sum_probs=201.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.+|...+.||+|+||.||+|.+. +|. .||||+++.. ....+++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 57999999999999999999853 343 4899998753 34567899999999999999999999999764 6789
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997643 247889999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
.............++..|+|||++.+..++.++|||||||++|||++ |+.||................ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~------~~--- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------RL--- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC------CC---
Confidence 65433322222345678999999999999999999999999999998 999997644322211111100 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
..+ ... ...+..++..||..+|.+||++.+++..|...
T Consensus 231 ~~~---~~~----~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 PQP---PIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CCC---CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 011 12455677789999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=341.45 Aligned_cols=245 Identities=23% Similarity=0.306 Sum_probs=199.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCC--CCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||.||+|.+.+ +..||+|++... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3579999999999999999998543 468999998643 2345678899999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999997543 48899999999999999999999 89999999999999999999999999999865
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+......+.. +..
T Consensus 182 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-------~~~---- 245 (340)
T PTZ00426 182 DTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE-------GII---- 245 (340)
T ss_pred CCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc-------CCC----
Confidence 4321 235799999999999988899999999999999999999999986554322111110 000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
.+....+ ..+..++..||+.||.+|+ ++++++++
T Consensus 246 --~~p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 --YFPKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCCCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0111111 2344566679999999995 88888765
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=357.64 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=205.6
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC----
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN---- 331 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~---- 331 (611)
...++|.+.+.||+|+||+||+|.. .+|+.||||++... ......+.+|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999985 47999999998643 345667889999999999999999998775432
Q ss_pred ----ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 332 ----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 332 ----~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999997654444568999999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 487 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~ 487 (611)
|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~------- 258 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL------- 258 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-------
Confidence 9999987654333323334679999999999999999999999999999999999999997654322111111
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 488 ~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.. ++ +... ....+..++..||+.||.+||++.+++++
T Consensus 259 ~~~~----~~-~~~~----~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGRY----DP-LPPS----ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCCC----CC-CCCC----CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0111 11 1111 12345566777999999999999998863
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=322.88 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=204.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||+||+|.+. +...||||.++.. ......|.+|+.+++.++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357899999999999999999864 2457999998753 3445678999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++++|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999975432 58999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
.............+++.|+|||++.+..++.++||||||+++|+|++ |..||...........+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~------~~--- 227 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY------RL--- 227 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC------CC---
Confidence 53222222222345678999999998899999999999999999998 999996543322111111000 00
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+ ........+..++..|++.+|.+||++.+|++.|..
T Consensus 228 --~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 228 --P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred --C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 001112345677778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=345.81 Aligned_cols=247 Identities=28% Similarity=0.443 Sum_probs=206.8
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.|.....||+|.||.||+|.+. +++.||+|++... ++..+++.+|+.+|.+++++||.++|+.|..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4556688999999999999864 7899999999754 466788999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
.||++.+.+.... .+.+..+..|+.+++.||.|||. ++.+|||||+.|||+..+|.+||+|||++........
T Consensus 94 ~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999997543 24667777899999999999999 8999999999999999999999999999988876554
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
.. .+++|||.|||||++....|+.|+||||||++.+||++|.+|+...++.....++-.. .-|.+.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~------------~PP~L~ 232 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS------------APPRLD 232 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC------------CCCccc
Confidence 43 4689999999999999889999999999999999999999999988774433332211 123333
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+.+. ..+.+++-.||.+||+.||++.++|++
T Consensus 233 ~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFS----PPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccC----HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 3221 223334445999999999999999973
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=338.26 Aligned_cols=241 Identities=26% Similarity=0.373 Sum_probs=194.4
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
+.||+|+||.||++... +|+.||+|+++.. ......+.+|+.+++.++||||++++++|..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 7899999999753 234556788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcc
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 423 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 423 (611)
+|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 9998886543 48899999999999999999999 8999999999999999999999999999875432211 1
Q ss_pred ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCC
Q 007256 424 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 503 (611)
Q Consensus 424 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 503 (611)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||...........+.... ..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-------------~~~p~~~ 218 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-------------IRFPRTL 218 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-------------CCCCCCC
Confidence 223679999999999999999999999999999999999999997654432221111100 0111111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 504 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 504 ~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
+ ..+..++..||+.||.+|| ++.++++.
T Consensus 219 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 219 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C----HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 1 2344566679999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=338.76 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=199.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||++... +|+.||||+++... ...+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47899999999999999999865 78999999998532 34567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997652 258899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCccccccccccccCChhhhc------cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~------~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...........+.... ..
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~------~~ 227 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ------RF 227 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC------Cc
Confidence 3222 222357999999999987 4567899999999999999999999997655432222111110 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+ .... .....+..++..|++ +|.+||++.++++.
T Consensus 228 ~~~-----~~~~--~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 LKF-----PEDP--KVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cCC-----CCCC--CCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 0000 111233445556887 99999999998863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=323.31 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=202.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
.+|.+.+.||+|+||.||+|..+++..+|+|++.........|.+|+++++.++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 35778899999999999999988888899999876555556788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999875432 58999999999999999999999 899999999999999999999999999987654322111
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...........+.. + .....
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------~-----~~~~~-- 222 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-------G-----YRLYR-- 222 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-------C-----CcCCC--
Confidence 111234567999999998999999999999999999999 8999976543322111110 0 00000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
+......+..++..|+..+|++|||+.++++.|
T Consensus 223 --~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 --PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111233566777889999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.54 Aligned_cols=260 Identities=26% Similarity=0.467 Sum_probs=206.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
..+|.+.+.||+|+||.||++.. .++..+|+|.+... ....+.+.+|++++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35789999999999999999974 23456899998754 345668999999999999999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 335 LVYDFLSRGSLEENLHGNK---------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~---------~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
+||||+++++|.+++.... .....+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999986543 122358999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhcc
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKP 484 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~ 484 (611)
|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~---- 236 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT---- 236 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----
Confidence 999999986644332222233456789999999998899999999999999999998 999987654322211111
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.+.... .....+ ..+..++..||+.||.+|||+.+|++.|+...
T Consensus 237 ---~~~~~~-----~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 237 ---QGRVLQ-----RPRTCP----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred ---cCCcCC-----CCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111111 111111 34667778899999999999999999886433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.17 Aligned_cols=257 Identities=25% Similarity=0.434 Sum_probs=202.8
Q ss_pred cCceeeeeEeecCcEEEEEEEe-----CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
++|++.+.||+|+||.||+|.. .++..+|+|.++.. ......+.+|+++++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688899999999999999974 35678999999753 3445678899999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC
Q 007256 336 VYDFLSRGSLEENLHGNKK-------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~-------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~ 402 (611)
||||+++++|.+++..... ....+++..+..++.+++.||.|||+ ++|+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999853321 12347889999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 007256 403 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 481 (611)
Q Consensus 403 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 481 (611)
.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||...........+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999986644322222223456778999999998899999999999999999998 9999976443221111110
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 482 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 482 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..... ..... ...+..++..|++.||.+||++.+|++.|.+
T Consensus 242 -------~~~~~-----~~~~~----~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 -------RQLLP-----CSEDC----PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -------CCcCC-----CCCCC----CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 00000 11111 2345566778999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=325.18 Aligned_cols=250 Identities=34% Similarity=0.541 Sum_probs=193.5
Q ss_pred eeeeeEeecCcEEEEEEEeC-----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 266 LAENLIGKGGSSQVYKGCLP-----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 266 ~~~~~LG~G~fG~Vyk~~~~-----~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.+.+.||.|.||.||+|.+. .+..|+||.++.. ....+.|.+|++++++++||||++++|+|...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 35688999999999999876 3578999999753 3457899999999999999999999999998888999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++|+|.++|.... ...+++..+..|+.||+.||.|||+ ++++|+||+++|||++.++.+||+|||++......
T Consensus 82 ~~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999998762 2358999999999999999999999 88999999999999999999999999999877333
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
..........+...|+|||.+....++.++||||||+++|||++ |+.||...........+..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------~~---- 225 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------LP---- 225 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-------TT----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ce----
Confidence 22222233457789999999999999999999999999999999 7899866533221111111110 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
.+......+..++..||..+|++||++.++++.|
T Consensus 226 -----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111123455667779999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.05 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=196.1
Q ss_pred CceeeeeEeecCcEEEEEEEe----CCCCEEEEEEecCC-----hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCce
Q 007256 264 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPS-----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 333 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~-----~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~ 333 (611)
+|.+.+.||+|+||.||++.. .+|+.||+|+++.. ....+.+..|+.++..++ |+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999875 36889999998742 233456788999999995 99999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999987543 48899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.. .+..
T Consensus 154 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--~~~~----- 225 (332)
T cd05614 154 EFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--RILK----- 225 (332)
T ss_pred cccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--HHhc-----
Confidence 654332221 2236799999999999865 478899999999999999999999975433221111110 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
.++.+...++ ..+..++..||+.||.+|| ++.++++.
T Consensus 226 --~~~~~~~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 --CDPPFPSFIG----PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCCCCCCCC----HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0111111111 2334556679999999999 67777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.27 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=195.9
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
+.||+|+||.||+|.+. +|+.||+|.+... .+....+.+|+++++.++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999875 7899999988643 45567899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccc
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~ 425 (611)
.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99986543 257899999999999999999999 899999999999999999999999999987654322111111
Q ss_pred ccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCC
Q 007256 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 504 (611)
Q Consensus 426 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~ 504 (611)
...++..|+|||++.++.++.++|||||||++|||++ |..||...........+....+ . ...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~------------~----~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR------------L----PCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC------------C----CCc
Confidence 1233567999999999999999999999999999998 8888865443222111111000 0 001
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 505 YDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 505 ~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
......+..++..|++.+|.+||++.+|++.|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 111234566777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.25 Aligned_cols=203 Identities=27% Similarity=0.374 Sum_probs=175.0
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||++... +|+.||||++... ....+.+.+|+++++.++||||++++++|.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47899999999999999999864 7899999998653 234567888999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999987543 47889999999999999999999 8999999999999999999999999999863321
Q ss_pred CCCC---------------------------------------------ccccccccccccCChhhhccCCCCCcceehh
Q 007256 418 SSSH---------------------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYA 452 (611)
Q Consensus 418 ~~~~---------------------------------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwS 452 (611)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCCC
Q 007256 453 FGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 453 lGvvL~ELltG~~Pf~~~~~ 472 (611)
|||++|||++|+.||.....
T Consensus 234 lGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH
Confidence 99999999999999976554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=326.48 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=205.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 331 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 331 (611)
..++|.+.+.||+|+||.||++... +...+|+|.+... ......+.+|++++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3467889999999999999999853 2367999998753 34456788999999999 7999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC
Q 007256 332 NLLLVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 399 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~------------~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd 399 (611)
..+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+ .+|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence 9999999999999999986432 223468999999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhH
Q 007256 400 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 478 (611)
Q Consensus 400 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l 478 (611)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999987654332222222345678999999998899999999999999999998 9999876543222111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 479 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 479 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+. .+.. ...+......+..++..|++.+|.+|||+.++++.|..
T Consensus 247 ~~-------~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 247 LK-------EGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred HH-------cCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 11 0000 00111223356667788999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.17 Aligned_cols=201 Identities=24% Similarity=0.428 Sum_probs=172.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 578999999999999999999976 78999999987532 233467789999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+. ++|.+++.... ..+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 57877776433 247889999999999999999999 89999999999999999999999999998754332
Q ss_pred CCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCC
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDH 471 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 471 (611)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 157 SH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred Cc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 21 1223578999999999875 458889999999999999999999997643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.31 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=207.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChh-HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..+|.+.+.||.|+||.||+|...++..+|+|++..... ....+..|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 456888999999999999999988899999999986544 5677899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++..... ..+++..++.++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999975432 358999999999999999999999 8999999999999999999999999999976644322
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. ....++..|+|||++..+.++.++||||||+++|+|++ |+.||...........+. . +. ...
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~----~~-----~~~- 224 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---A----GY-----RMP- 224 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---h----CC-----cCC-
Confidence 11 12346778999999998899999999999999999998 899997654322211111 0 00 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
........+..++..|++.+|.+|||+.++++.|+.
T Consensus 225 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 ---CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 011112346677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=319.46 Aligned_cols=259 Identities=28% Similarity=0.425 Sum_probs=206.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~----~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||+|... +++.||||.++. .......+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999865 789999998754 2344567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++.........+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886443333457889999999999999999999 8999999999999999999999999999886654
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
... ......|++.|+|||++.+..++.++|+||||+++|||++|+.||........ ........ .. .+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~----~~-----~~ 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLCQKIEQ----CD-----YP 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHHHHHhc----CC-----CC
Confidence 322 11235688999999999988899999999999999999999999965433211 11111110 00 01
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
... .......+..++..||+.+|.+||++.+|++.|+..
T Consensus 227 ~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PLP---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 110 111224456667789999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=348.54 Aligned_cols=245 Identities=30% Similarity=0.427 Sum_probs=203.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+. +...+.+.+|++|++.++|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999865 6889999998753 4556778899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+.| +|..+|...+ .++++.++.|+.+++.||.|||+ .+|+|||+||.||||+.++.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d~----~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG----KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9988 9999998665 48999999999999999999999 99999999999999999999999999999988774
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.... +.+.|||.|||||++.++.|+..+|.||+|||+|||.+|++||....-. .++ +.+.. |+.
T Consensus 154 t~vl--tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~---~Lv---~~I~~--------d~v 217 (808)
T KOG0597|consen 154 TSVL--TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT---QLV---KSILK--------DPV 217 (808)
T ss_pred ceee--eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH---HHH---HHHhc--------CCC
Confidence 4332 3478999999999999999999999999999999999999999754321 111 11111 111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
. .+......+..+..-.|.+||..|.|-.+++.
T Consensus 218 ~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 K---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred C---CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 11122233444455578999999999888775
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.28 Aligned_cols=240 Identities=23% Similarity=0.330 Sum_probs=192.9
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCc-ceeEEeeEEEecCceEEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~Hp-nIv~l~g~~~~~~~~~LV~ 337 (611)
+|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+..|++++..++|+ +|+++++++...+.+++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999875 5789999999753 34456788899999999764 6888999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999986543 47899999999999999999999 8999999999999999999999999999875322
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... . .
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------~------~ 218 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------N------V 218 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------C------C
Confidence 211 122357999999999999999999999999999999999999999765433222111100 0 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 529 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm 529 (611)
.+.... ...+..++..||+.||.+|++.
T Consensus 219 ~~~~~~----~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKSL----SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHHHcCCC
Confidence 111111 2244556677999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.23 Aligned_cols=241 Identities=27% Similarity=0.387 Sum_probs=193.2
Q ss_pred eeEeecCcEEEEEEEe----CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 269 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+.||+|+||.||++.. .+++.||||+++... .....+..|+++++.++||||++++++|..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 368899999997532 2345677899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999987543 47788889999999999999999 899999999999999999999999999987543322
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. +.. .+
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~-------~~~------~~ 219 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-------GKL------NL 219 (323)
T ss_pred C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------CCC------CC
Confidence 2 12235799999999999988899999999999999999999999976553322111110 000 01
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
.... ...+..++..||+.+|++|| ++.++++.
T Consensus 220 ~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYL----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCC----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111 12345566779999999999 78887764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.84 Aligned_cols=257 Identities=21% Similarity=0.393 Sum_probs=205.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... .....+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457899999999999999999864 24689999987543 4456788999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 334 LLVYDFLSRGSLEENLHGNKKD------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~------~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
++||||+++|+|.+++...... ...+.+..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEEC
Confidence 9999999999999998654321 1247889999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhcccc
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 486 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 486 (611)
|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||...........+.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------ 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence 9999876554332222223457889999999998899999999999999999998 999997654332211111
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 487 ~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.+.... +.... ...+..++..||+.+|.+|||+.++++.|+
T Consensus 236 -~~~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGGHLD-----LPENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCCCCC-----CCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111000 11111 345666777899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=320.05 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=203.2
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
++|.+.+.||+|+||.||+|..+++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 468889999999999999999888889999999876555677999999999999999999999885 4568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|.+++..... ..+++..++.++.+++.||.|||+ ++|+||||||+||++++++.++|+|||++..........
T Consensus 85 ~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 85 GSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999975432 347899999999999999999999 899999999999999999999999999997664432211
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
.....++..|+|||++.+..++.++||||||+++|+|++ |..||...........+. . ... .
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~--~----~~~------~---- 222 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE--R----GYR------M---- 222 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--c----CCC------C----
Confidence 112345678999999998899999999999999999999 899997654322111111 0 000 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.........+..++..|+..+|.+|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111122346667778999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=338.74 Aligned_cols=258 Identities=24% Similarity=0.425 Sum_probs=201.7
Q ss_pred cCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe-cCc
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-DNN 332 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~-~~~ 332 (611)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.. ....+.+..|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4788999999999999999963 23578999998753 33456788999999999 79999999998865 457
Q ss_pred eEEEEeeCCCCChhhhhccCCCC---------------------------------------------------------
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKD--------------------------------------------------------- 355 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~--------------------------------------------------------- 355 (611)
++++|||+++++|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 89999999999999988542210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccccccccccccCC
Q 007256 356 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435 (611)
Q Consensus 356 ~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~A 435 (611)
...++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1258999999999999999999999 8999999999999999999999999999987654333333333456788999
Q ss_pred hhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHH
Q 007256 436 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLA 514 (611)
Q Consensus 436 PE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~l 514 (611)
||++.+..++.++|||||||+||||++ |..||.......... .. +..+... .. +......+..+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~--~~----~~~~~~~-----~~----~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC--RR----LKEGTRM-----RA----PEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH--HH----HhccCCC-----CC----CccCCHHHHHH
Confidence 999999999999999999999999998 999997643322111 00 0111000 00 11112346677
Q ss_pred HHHhcccCCCCCCCHHHHHHHhhC
Q 007256 515 SILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 515 a~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+..||+.+|++||++.+|+++|..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHH
Confidence 778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.70 Aligned_cols=240 Identities=24% Similarity=0.329 Sum_probs=193.3
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
+|.+.+.||+|+||.||+|... +++.||||+++.. ....+.+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999875 6789999998753 23345577788888877 5899999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999886543 48899999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
... ......||+.|+|||++.++.++.++|||||||++|||++|+.||...........+... . .
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------~------~ 218 (323)
T cd05616 154 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------N------V 218 (323)
T ss_pred CCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------C------C
Confidence 221 223467999999999999999999999999999999999999999765543222211110 0 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 529 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm 529 (611)
.+... ....+..++..||+.+|.+|++.
T Consensus 219 ~~p~~----~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPKS----MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCc----CCHHHHHHHHHHcccCHHhcCCC
Confidence 01111 12345566777999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.60 Aligned_cols=203 Identities=24% Similarity=0.344 Sum_probs=174.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.|.+.+.||+|+||+||+|... +++.||||++.... .....+.+|++++++++|+||++++++|.+++.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 6889999999999999999864 68899999997532 345678899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999987543 47888899999999999999999 89999999999999999999999999997532110
Q ss_pred C---------------------------------------------CCccccccccccccCChhhhccCCCCCcceehhh
Q 007256 419 S---------------------------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAF 453 (611)
Q Consensus 419 ~---------------------------------------------~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSl 453 (611)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000112579999999999999999999999999
Q ss_pred hHHHHHHHhCCCCCCCCCCc
Q 007256 454 GVVLLELLTGRKPISNDHPK 473 (611)
Q Consensus 454 GvvL~ELltG~~Pf~~~~~~ 473 (611)
||++|||++|+.||....+.
T Consensus 235 Gvil~elltG~~Pf~~~~~~ 254 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPL 254 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=324.70 Aligned_cols=265 Identities=26% Similarity=0.381 Sum_probs=200.8
Q ss_pred ceeeeeEeecCcEEEEEEEe-----CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEE
Q 007256 265 FLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 335 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~L 335 (611)
|.+.+.||+|+||+||++.. .++..||+|+++... .....|.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988642 468899999997542 3567788999999999999999999998754 35899
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++++|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999998653 38999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcc-ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
........ .....++..|+|||++..+.++.++|||||||++|||++|..|+........ ....+.........+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhh
Confidence 54322111 1123456779999999988999999999999999999999999865432211 111111101111111122
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
++.......+......+..++..|++.+|.+|||+.+|++.|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 22111111122223456667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=333.00 Aligned_cols=243 Identities=23% Similarity=0.361 Sum_probs=193.1
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHH---HhcCCcceeEEeeEEEecCceEEE
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEII---TTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL---~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999865 6899999999753 23345666776665 466799999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|...+... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999888642 48999999999999999999999 899999999999999999999999999987543
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 153 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~------------ 218 (324)
T cd05589 153 GFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV------------ 218 (324)
T ss_pred CCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 2221 12346799999999999999999999999999999999999999976544322221111110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~ 534 (611)
.....+ ...+..++..||+.||.+|| ++.++++
T Consensus 219 -~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -RYPRFL----SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCCC----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011111 23345567779999999999 4666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=325.91 Aligned_cols=258 Identities=24% Similarity=0.442 Sum_probs=206.3
Q ss_pred cCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.+|.+.+.||+|+||.||+|... ++..+++|.++... ...+.+.+|+++++.++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46889999999999999999742 45678999987543 345678899999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc
Q 007256 336 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 403 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~ 403 (611)
||||+++++|.+++..... ....+++..++.++.+|+.||.|||+ ++|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999965431 12358999999999999999999999 89999999999999999999
Q ss_pred eEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhh
Q 007256 404 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 404 vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~ 482 (611)
++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.||............
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~--- 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI--- 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 99999999976554332222233567889999999999999999999999999999999 99998765443221111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
..+..... .......+..++..||+.+|.+||++.+|++.|...
T Consensus 239 ----~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 239 ----TQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred ----hCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11111110 001123456677789999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=341.54 Aligned_cols=204 Identities=25% Similarity=0.350 Sum_probs=175.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||++... +++.||||++.... .....+.+|+++|+.++|+||+++++.|.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999864 68999999997532 23456889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|..+..
T Consensus 81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999997643 47888889999999999999999 8999999999999999999999999999753211
Q ss_pred CC-----------------------------------------CCccccccccccccCChhhhccCCCCCcceehhhhHH
Q 007256 418 SS-----------------------------------------SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVV 456 (611)
Q Consensus 418 ~~-----------------------------------------~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvv 456 (611)
.. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000113579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCc
Q 007256 457 LLELLTGRKPISNDHPK 473 (611)
Q Consensus 457 L~ELltG~~Pf~~~~~~ 473 (611)
+|||++|+.||....+.
T Consensus 234 lyell~G~~Pf~~~~~~ 250 (376)
T cd05598 234 LYEMLVGQPPFLADTPA 250 (376)
T ss_pred eeehhhCCCCCCCCCHH
Confidence 99999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=316.24 Aligned_cols=259 Identities=28% Similarity=0.415 Sum_probs=208.1
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||+|... +|+.||+|.++.. ....+.+.+|++++++++|+|++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999976 8999999988642 234667899999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++.........+++..++.++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986544444568999999999999999999999 8999999999999999999999999999876644
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||......... +... . ..+....
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~---~-~~~~~~~---- 227 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKK---I-EKCDYPP---- 227 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH-HHhh---h-hcCCCCC----
Confidence 3221 12356899999999999889999999999999999999999999654322111 1100 0 0011100
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.. .......+..++..||..+|.+||++.+|+++|+..
T Consensus 228 -~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 -LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00 011223455667779999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=318.56 Aligned_cols=253 Identities=22% Similarity=0.389 Sum_probs=204.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.++|.+.++||+|+||.||+|..++++.||+|.+.........+.+|+.+++.++|+||+++++++. .+..+++|||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 4578999999999999999999889999999999876666678999999999999999999999874 567899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++..... ..+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 84 NGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999865432 358899999999999999999999 89999999999999999999999999999766532221
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......++..|+|||++..+.++.++|||||||++|||++ |+.||............ ..... ....
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~---------~~~~ 225 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL---ERGYR---------MPRP 225 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---HcCCC---------CCCC
Confidence 1122346778999999998899999999999999999999 99999765432211111 00000 0001
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
. .....+..++..|++.+|++||+++++++.|+
T Consensus 226 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 226 D----NCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 1 11234666777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=320.80 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=204.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.++|.+.+.||+|+||.||+|.++++..||+|+++......+.|.+|+.+++.++||||+++++++. ....++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 3568999999999999999998877778999999875555678999999999999999999999874 456899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+|+|.+++..... ..+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999975422 357899999999999999999999 89999999999999999999999999999766543221
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......++..|+|||+..++.++.++|||||||++|||++ |..||...........+.... .. .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------~~------~-- 223 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------RM------P-- 223 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC------CC------C--
Confidence 1122456778999999998899999999999999999999 888887654332221111100 00 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
........+..++..|++.+|.+||++.++++.|+.
T Consensus 224 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred --CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 011223456678888999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=324.98 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=202.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
+|.+.+.||+|+||.||+|... ....+++|.+.... .....+.+|+.+++.++||||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999753 23578999887543 345678999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccc
Q 007256 336 VYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 395 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~--------------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~N 395 (611)
||||+.+++|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 9999999999998864321 12357899999999999999999999 899999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcc
Q 007256 396 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 474 (611)
Q Consensus 396 ILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~ 474 (611)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976544332222222456778999999998899999999999999999998 999997654332
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 475 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
... ...... .... +......+..++..|++.+|.+||++.++++.|+..
T Consensus 238 ~~~---~~~~~~---------~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 LFN---LLKTGY---------RMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHH---HHhCCC---------CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 111 111000 0000 111123566777889999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.08 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=194.4
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
+.||+|+||.||++... +|+.||+|+++.. ......+..|++++..++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 7899999999753 234567788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcc
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 423 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 423 (611)
+|.+++.... .+++..+..++.||+.||.|||+ .++|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-- 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence 9999886543 48899999999999999999995 158999999999999999999999999998754332221
Q ss_pred ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCC
Q 007256 424 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 503 (611)
Q Consensus 424 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 503 (611)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||...........+.... ..+...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~-------------~~~p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------IRFPRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-------------CCCCCCC
Confidence 223579999999999999999999999999999999999999997654432222221110 0011111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 504 DYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 504 ~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
+ ..+..++..||+.||.+|+ ++.++++.
T Consensus 220 ~----~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 S----PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 2344556679999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=322.46 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=202.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
.+++|.+.+.||+|+||.||+|.+. .+..||+|.+... ......|.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567999999999999999999874 3567899988743 3345678999999999999999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC---ceEE
Q 007256 333 LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQL 406 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~---~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~---~vKL 406 (611)
.++||||+++++|.+++..... ....+++..+..++.+|+.||.|||+ ++++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865432 22358999999999999999999999 8999999999999998654 5999
Q ss_pred eecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccc
Q 007256 407 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||...........+.-
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---- 236 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG---- 236 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----
Confidence 99999987643222111112234568999999999999999999999999999997 9999976544332221110
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.... ...... ...+..++..|++.+|++||++.+|++.|+
T Consensus 237 --~~~~------~~~~~~----~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 --GGRL------DPPKGC----PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --CCcC------CCCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0010 001111 234556677799999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=333.02 Aligned_cols=201 Identities=25% Similarity=0.428 Sum_probs=176.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||.||++.+. +|..+|+|++... ......+.+|+++++.++|+||++++++|..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999876 6888999988753 3445678999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++|+|.+++.... .+++..+..++.+++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999997543 478889999999999999999971 36999999999999999999999999998765432
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 1 1235789999999999988999999999999999999999999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.63 Aligned_cols=255 Identities=22% Similarity=0.268 Sum_probs=200.4
Q ss_pred HHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 259 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 259 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
....++|.+.+.||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345678999999999999999999875 68999999996422 3345577899999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 9999999999999998643 36778888999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCCccccccccccccCChhhhccC----CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
....... .......||+.|+|||++... .++.++|||||||++|||++|+.||...........+.....
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----- 264 (370)
T cd05596 191 KMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN----- 264 (370)
T ss_pred eccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-----
Confidence 6643322 122346799999999998753 478899999999999999999999987654322222111100
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~--RPtm~eVL~~ 535 (611)
.+ .+.... .....+..++..||+.+|.+ ||++.++++.
T Consensus 265 ~~------~~~~~~--~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 SL------TFPDDI--EISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred cC------CCCCcC--CCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 001110 11123444556699999987 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=339.32 Aligned_cols=209 Identities=24% Similarity=0.332 Sum_probs=179.3
Q ss_pred HHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec
Q 007256 256 QDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330 (611)
Q Consensus 256 ~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~ 330 (611)
..+....++|.+.+.||+|+||.||++... +++.||+|++... ......+.+|+.+++.++||||+++++++..+
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD 115 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 344456688999999999999999999875 6889999998642 23345678899999999999999999999999
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
+..++||||+++|+|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG 187 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG 187 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecc
Confidence 9999999999999999998643 37788899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccC----CCCCcceehhhhHHHHHHHhCCCCCCCCCCc
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 473 (611)
++........ .......||+.|+|||++... .++.++|||||||++|||++|+.||......
T Consensus 188 ~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~ 253 (370)
T cd05621 188 TCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV 253 (370)
T ss_pred cceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH
Confidence 9987643221 122346799999999999754 3788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=331.67 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=193.2
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|... +++.||||+++.. ......+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999875 5889999999753 34456678899999876 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|...+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 99999886543 48899999999999999999999 8999999999999999999999999999875433222
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... . ......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~-------~------~~~p~~ 218 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-------D------VLYPVW 218 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-------C------CCCCCC
Confidence 123467999999999999999999999999999999999999999876543322111100 0 000001
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARP-------QMSLVLKL 535 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RP-------tm~eVL~~ 535 (611)
. ...+..++..||+.||.+|| ++.++++.
T Consensus 219 ~----~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 L----SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C----CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 12345566679999999999 77877764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=324.06 Aligned_cols=246 Identities=26% Similarity=0.351 Sum_probs=193.8
Q ss_pred EeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 271 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
||+|+||+||++.+. +|+.||+|.+.... ...+.+..|+++++.++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 78999999987432 2345678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccc
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~ 425 (611)
...+.........+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 98875443333468999999999999999999999 89999999999999999999999999999766543222 22
Q ss_pred ccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCCh
Q 007256 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505 (611)
Q Consensus 426 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 505 (611)
...||+.|+|||++.++.++.++|||||||++|||++|+.||............ ....... . . .+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~-~--------~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRILND-S--------V--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHhhccc-C--------C--CCcc
Confidence 357999999999999999999999999999999999999999764432211111 0011000 0 0 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007256 506 DQMERMVLASILCIRRDPRARP-----QMSLVLK 534 (611)
Q Consensus 506 ~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~ 534 (611)
.....+..++..||+.||.+|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1123445566679999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=349.27 Aligned_cols=265 Identities=20% Similarity=0.272 Sum_probs=195.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--------C
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED--------N 331 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--------~ 331 (611)
...+|.+.+.||+|+||.||+|... +++.||||++..... ...+|+.+++.++||||+++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 3568999999999999999999874 689999998865432 234799999999999999999987532 2
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-ceEEeecC
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFG 410 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-~vKL~DFG 410 (611)
.+++||||+++ +|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999986 7777765433333468999999999999999999999 8999999999999998664 69999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc-
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS- 488 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~- 488 (611)
+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|++||...........+.........
T Consensus 217 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99876543222 235789999999998754 6899999999999999999999999876543332222111000000
Q ss_pred ------Cc-----cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 489 ------GK-----VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 489 ------g~-----l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.. +.......+...++......+..++..||+.||.+|||+.+++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 000000001001111112345667778999999999999999864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.24 Aligned_cols=246 Identities=24% Similarity=0.399 Sum_probs=190.8
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
+|...+.||+|+||.||+|.+. +|+.||||++... ......+.+|+++++.++|+||+++++++..++.+++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456688999999999999865 7899999998653 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.... ...+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986532 24567788899999999999999 8999999999999999999999999999987654321
Q ss_pred CccccccccccccCChhhhcc-----CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+...... ..
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~----- 292 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----SQ----- 292 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc----cC-----
Confidence 1223579999999998743 2345689999999999999999999974333222111111000 00
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.. .......+..++..||+.||++||++.++++.
T Consensus 293 ~~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEA----PATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001 11112345566677999999999999999874
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=318.62 Aligned_cols=255 Identities=22% Similarity=0.359 Sum_probs=197.2
Q ss_pred ceeeeeEeecCcEEEEEEEeCC-CC--EEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------Cc
Q 007256 265 FLAENLIGKGGSSQVYKGCLPD-GK--ELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NN 332 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~~-g~--~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~------~~ 332 (611)
|.+.+.||+|+||.||+|.+.+ +. .+|+|.++.. ....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998754 33 5899998753 45567889999999999999999999987542 24
Q ss_pred eEEEEeeCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 333 LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~--~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
.+++|||+++|+|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999998874322 223458999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccC
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||...........+. .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-------QG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cC
Confidence 9987654332211222346778999999998999999999999999999999 889997644322111111 11
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.... . .......+..++..||+.+|++|||+.+|++.|..
T Consensus 231 ~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1000 0 11112345667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=343.96 Aligned_cols=259 Identities=23% Similarity=0.390 Sum_probs=203.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~ 332 (611)
.++|.+.++||+|+||.||+|.+. .+..||||+++.. ....+.+.+|+++++.+. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 457889999999999999999752 2357999999753 234567899999999996 9999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCC----------------------------------------------------------
Q 007256 333 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 354 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~---------------------------------------------------------- 354 (611)
.+|||||+++|+|.++++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864321
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC
Q 007256 355 ----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 400 (611)
Q Consensus 355 ----------------------------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~ 400 (611)
....+++..+..++.|++.||.|||+ .+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01247888999999999999999999 89999999999999999
Q ss_pred CCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHH
Q 007256 401 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLV 479 (611)
Q Consensus 401 ~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv 479 (611)
++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999999986654333222233457789999999998899999999999999999997 99998754322111100
Q ss_pred HhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 480 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 480 ~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
. ..+. ...... .....+..++..||+.+|++||++.+|.++|+.
T Consensus 353 --~----~~~~-----~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 353 --I----KSGY-----RMAKPD----HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred --H----hcCC-----CCCCCc----cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 0 0010 000011 112345667778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=324.53 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=201.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
.+|.+.+.||+|+||.||+|... ++..||||+++... .....+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 34677889999999999999853 35789999997543 34567889999999999999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC
Q 007256 335 LVYDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~------------~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~ 402 (611)
+++||+.+++|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||+++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999985321 112357888999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 007256 403 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 481 (611)
Q Consensus 403 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 481 (611)
.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||...........+..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999886544332222223456789999999998999999999999999999998 8888876543322211111
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 482 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 482 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
+.... ... .....+..++..|++.+|.+||++.+|+..|+
T Consensus 242 -------~~~~~-----~~~----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 242 -------RQVLP-----CPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred -------CCcCC-----CCC----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 11100 011 11233556777799999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=316.77 Aligned_cols=253 Identities=25% Similarity=0.437 Sum_probs=203.0
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
++|.+.+.||+|+||.||+|.++++..+|+|.+.......+.+.+|+.+++.++|+|++++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 468899999999999999999887778999998876656678899999999999999999999885 4568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|.+++..... ..+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 85 GSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 999999975432 347899999999999999999999 89999999999999999999999999999766433221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
......++..|+|||++.++.++.++|||||||++|||++ |+.||.......... +..... . ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~~~~---~------~~~-- 224 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE---QVERGY---R------MPC-- 224 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCC---C------CCC--
Confidence 1122346778999999998899999999999999999999 899997654332211 111000 0 000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.......+..++..||+.+|.+||++.+|++.|+.
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 --PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122345666677999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=323.26 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=199.6
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
+|.+.+.||+|+||.||++... +++.||||++.... .....+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788999999999999999864 78999999987532 223457789999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988864332 358899999999999999999999 89999999999999999999999999999765432
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... + ....
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~--~-~~~~-------- 221 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR--V-KEDQ-------- 221 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH--h-hhcc--------
Confidence 22 12357899999999999889999999999999999999999999865432221111100 0 0000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
..+.......+..++..||+.||.+|| ++.++++.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 011111223455667779999999999 78888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=317.74 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=199.5
Q ss_pred ceeeeeEeecCcEEEEEEEeC-C---CCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-----
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 332 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~---g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~----- 332 (611)
|.+.+.||+|+||.||+|... + +..||||+++.. ......+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567789999999999999864 2 467999998753 3445688999999999999999999999876554
Q ss_pred -eEEEEeeCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeec
Q 007256 333 -LLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409 (611)
Q Consensus 333 -~~LV~Ey~~ggsL~~~L~~~~--~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DF 409 (611)
.++||||+++|+|..++.... .....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 799999999999999885432 223468999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhcccccc
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 488 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 488 (611)
|+++...............++..|+|||++....++.++|||||||++|||++ |..||........ ..+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~---~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI---YDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH----c
Confidence 99987654333222222345678999999988899999999999999999999 8899866443221 11111 0
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 489 g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+... .. .......+..++..||+.||.+||++.+|++.|+.
T Consensus 231 ~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNRL-----KQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCC-----CC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0000 01 11122356667777999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=316.36 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=207.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..++|.+.+.||+|+||.||+|..++++.+|||.+.......+++.+|+.++++++|+||+++++++......++||||+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 34689999999999999999999888889999999876666778999999999999999999999999889999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++..... ..+++..+..++.+++.||.|||+ ++++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999999976432 358999999999999999999999 8999999999999999999999999999876653211
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
. ......++..|+|||.+.++.++.++|||||||++|+|++ |+.||...........+... . . ...
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~---~---~------~~~ 225 (261)
T cd05034 159 T-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG---Y---R------MPR 225 (261)
T ss_pred h-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---C---C------CCC
Confidence 1 1112234678999999998899999999999999999998 99999654432211111100 0 0 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
... ....+..++..|++.+|.+||++.++++.|+
T Consensus 226 ~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 226 PPN----CPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred CCC----CCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 001 1234566777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=322.92 Aligned_cols=264 Identities=24% Similarity=0.387 Sum_probs=204.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCC-----------------CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPD-----------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIIS 322 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~-----------------g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~ 322 (611)
..+|.+.+.||+|+||.||+|...+ +..||+|.+... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999987542 245899998754 345678999999999999999999
Q ss_pred EeeEEEecCceEEEEeeCCCCChhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccc
Q 007256 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 395 (611)
Q Consensus 323 l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~-------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~N 395 (611)
++++|..++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 99999999999999999999999999876541 12258999999999999999999999 899999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh--CCCCCCCCCCc
Q 007256 396 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPK 473 (611)
Q Consensus 396 ILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt--G~~Pf~~~~~~ 473 (611)
|+++.++.++|+|||++................+++.|+|||++..+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876544332222233456789999999998899999999999999999998 67787654322
Q ss_pred chhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 474 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 474 ~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
. ................... ........+..++..|++.||.+|||+.+|++.|+
T Consensus 241 ~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q---VIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 1111111111111000000 01111245677888899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=359.03 Aligned_cols=258 Identities=27% Similarity=0.479 Sum_probs=212.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
+.+-...+.||+|+||.||+|... +...||||.++... +...+|.+|++++..++|||||+|+|+|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 445677889999999999999843 34679999998643 4678999999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC---------C-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc
Q 007256 334 LLVYDFLSRGSLEENLHGNKK---------D-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 403 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~---------~-~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~ 403 (611)
+||+|||..|+|.++|..... . +.+++..+.+.|+.|||.|+.||-+ +.+|||||-+.|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 999999999999999964331 1 3448899999999999999999999 88999999999999999999
Q ss_pred eEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhh
Q 007256 404 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 404 vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~ 482 (611)
|||+||||++..-....+.......-...|||||-+++++|+.+||||||||||||+++ |+.|+.+....+....+..
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~- 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA- 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc-
Confidence 99999999986655444433222334578999999999999999999999999999999 9999988766554444332
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
|++-. .+..-...+..+++.||+.+|.+||++.+|-..|+.
T Consensus 721 ------g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 721 ------GQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred ------CCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 22211 112223456667778999999999999999998863
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=331.87 Aligned_cols=235 Identities=25% Similarity=0.373 Sum_probs=189.1
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||+||+|..+ +++.||||+++.. ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 6889999999753 23456778899998876 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-- 151 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-- 151 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence 99999887543 48899999999999999999999 8999999999999999999999999999875432221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. +.. .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------~~~------~~~~~ 218 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------DEV------VYPTW 218 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-------CCC------CCCCC
Confidence 12236799999999999988999999999999999999999999976554322211110 000 00111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQM 529 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm 529 (611)
. ...+..++..||+.||.+||++
T Consensus 219 ~----~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 L----SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred C----CHHHHHHHHHHcccCHHHCCCC
Confidence 1 1234556667999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=325.42 Aligned_cols=262 Identities=23% Similarity=0.378 Sum_probs=200.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeCC---------------CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPD---------------GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLG 325 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~---------------g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g 325 (611)
++|.+.+.||+|+||.||++.... ...||+|.++.. ......|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999987532 235899998753 344567999999999999999999999
Q ss_pred EEEecCceEEEEeeCCCCChhhhhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCcccee
Q 007256 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKK--------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 397 (611)
Q Consensus 326 ~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~--------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NIL 397 (611)
++...+..++||||+++++|.+++..... ....+++..++.++.+++.||.|||+ ++++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 99999999999999999999999864321 11246889999999999999999999 89999999999999
Q ss_pred eCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh--CCCCCCCCCCcch
Q 007256 398 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKGQ 475 (611)
Q Consensus 398 Ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt--G~~Pf~~~~~~~~ 475 (611)
++.++.+||+|||++................++..|+|||++..+.++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999976543322222222345778999999998999999999999999999998 5667765433221
Q ss_pred hhHHHhhcccccc-CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 476 ESLVMWAKPILSS-GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 476 ~~lv~~~~~~~~~-g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.... ...... +....... .......+..++..|++.+|.+||++.+|++.|+
T Consensus 242 ~~~~---~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENT---GEFFRNQGRQIYLSQ-------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH---HHhhhhccccccCCC-------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111 000000 00000000 0011236777888899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=329.84 Aligned_cols=240 Identities=24% Similarity=0.377 Sum_probs=189.3
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|... +++.||||+++.. ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 6889999999753 23345566777777654 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-- 151 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence 99999887543 48889999999999999999999 8999999999999999999999999999976533221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... +.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------------~~~~~~ 218 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR-------------PHFPRW 218 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------CCCCCC
Confidence 2234679999999999998899999999999999999999999997654322211111100 111111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMS-LVLK 534 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~-eVL~ 534 (611)
+ ...+..++..||+.+|.+||++. ++++
T Consensus 219 ~----~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 I----SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred C----CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 12334556679999999999975 4544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=320.77 Aligned_cols=253 Identities=23% Similarity=0.422 Sum_probs=199.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
++|.+.+.||+|+||+||+|.+. +|. .+++|.+... .....++..|+.+++.+.||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 46788899999999999999863 454 4778887543 234567888999999999999999999885 456789
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
++||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997543 258999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
.............++..|+|||++.++.++.++|||||||++|||++ |+.||....+.....++. .+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~-- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGERL-- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCcC--
Confidence 54433333334567889999999998999999999999999999998 999997655433222221 11100
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..+.. . ...+..++..|+..+|.+|||+.++++.|..
T Consensus 231 ~~~~~---~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 231 AQPQI---C----TIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CCCCC---C----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 01111 1 1234556678999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.19 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=203.3
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.+.+.||+|++|.||+|... +|+.|++|.+... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5788999999999999999875 7899999998642 35567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++..... ..+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999976422 358899999999999999999999 899999999999999999999999999988665432
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. .....|++.|+|||++.++.++.++|||||||++++|++|+.||....... ...... .+.... +
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~~~~-----~ 221 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKII----RGVFPP-----V 221 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cCCCCC-----C
Confidence 22 123568999999999999999999999999999999999999997655221 111110 011100 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......+..++..|++.+|++||++.++++.
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11122345667778999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=319.61 Aligned_cols=259 Identities=23% Similarity=0.405 Sum_probs=206.4
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCC-----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCc
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNN 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-~~~ 332 (611)
..++|.+.+.||+|+||.||+|.+.+ +..|++|+++.. ....+.+.+|+.+++.++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999998765 788999998753 3446778899999999999999999998876 567
Q ss_pred eEEEEeeCCCCChhhhhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEee
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKD----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 408 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~----~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~D 408 (611)
.++++||+++++|.+++...... ...+++..++.++.+++.||.|||+ .+++||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 1468999999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccc
Q 007256 409 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 487 (611)
Q Consensus 409 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 487 (611)
||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||....+.. +..+....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~-- 235 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKDG-- 235 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHcC--
Confidence 999986644333222223456778999999998889999999999999999999 999997654322 11111110
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 488 ~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..+. ..... ...+..++..|++.+|++|||+.+|++.|..
T Consensus 236 -~~~~------~~~~~----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 275 (280)
T cd05043 236 -YRLA------QPINC----PDELFAVMACCWALDPEERPSFSQLVQCLTD 275 (280)
T ss_pred -CCCC------CCCcC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0000 00011 1245667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.21 Aligned_cols=237 Identities=26% Similarity=0.362 Sum_probs=190.5
Q ss_pred eeEeecCcEEEEEEEe----CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 269 NLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
+.||+|+||.||++.. .+|+.||+|+++... .....+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 368999999997532 234467789999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 999999986543 48899999999999999999999 89999999999999999999999999998765443221
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ... .+..
T Consensus 155 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~-------~~~------~~p~ 219 (318)
T cd05582 155 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-------AKL------GMPQ 219 (318)
T ss_pred --eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc-------CCC------CCCC
Confidence 2236799999999999988899999999999999999999999976543222111110 000 0111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSL 531 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~e 531 (611)
.+ ...+..++..||+.||.+||++.+
T Consensus 220 ~~----~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FL----SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC----CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 123445666799999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=341.10 Aligned_cols=195 Identities=22% Similarity=0.321 Sum_probs=169.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..+|.+.+.||+|+||.||++.+. +++.||+|.... ..+.+|++++++++||||++++++|..+...++|||++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 467999999999999999999874 789999997542 35678999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
. ++|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 6 58888886543 47899999999999999999999 8999999999999999999999999999975433221
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~ 470 (611)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 238 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 238 N-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred c-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 1 122367999999999999999999999999999999999999887543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=317.60 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=205.7
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||++.. .+|+.+|||.+... ......+.+|+.+++.++|+||++++++|..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999986 48999999988642 234567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++.........+++..++.++.+|+.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999887543333468999999999999999999999 8999999999999999999999999999876654
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.... .....|+..|+|||++.+..++.++||||||+++|+|++|..||......... ... .+ .....+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~---~~------~~~~~~ 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCK---KI------EQCDYP 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-Hhh---hh------hcCCCC
Confidence 3221 12356899999999999889999999999999999999999999654332111 110 00 000111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.+... .....+..++..|++.+|.+||||.+|++.++.
T Consensus 227 ~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PLPSD---HYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCcc---cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 11111 122345566667999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=320.91 Aligned_cols=269 Identities=26% Similarity=0.362 Sum_probs=199.2
Q ss_pred cCceeeeeEeecCcEEEEEEEe-----CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLL 334 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~ 334 (611)
.+|.+.+.||+|+||.||++.. .++..||+|.++.. ....+.|.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788999999999999999874 36889999998754 3456788999999999999999999998754 34689
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999996543 258899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccc-cccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcc-ccccCccc
Q 007256 415 ASTSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP-ILSSGKVT 492 (611)
Q Consensus 415 ~~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~-~~~~g~l~ 492 (611)
.......... ....++..|+|||++.++.++.++|||||||++|||++|..|+........ ........ ......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM-RMMGNDKQGQMIVYHLI 236 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh-hhcccccccccchHHHH
Confidence 6543322111 112334569999999988999999999999999999999877643221100 00000000 00000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+.+...............+..++..||..+|++|||+.+|++.|..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 1111000000111122456677778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=330.50 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=190.1
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|.+. +|+.||||+++.. ......+..|..++..+ +||||+++++++..++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999875 6899999999753 23445667788888764 899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|..++.... .+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 99999886543 47889999999999999999999 8999999999999999999999999999874322111
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... .+.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-------------~~~~~~~ 218 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-------------TPHYPRW 218 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------CCCCCCC
Confidence 223467999999999999999999999999999999999999999765432221111110 0111111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMS-LVLK 534 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~-eVL~ 534 (611)
. ...+..++..||+.||.+||++. ++++
T Consensus 219 ~----~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 219 I----TKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred C----CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 12344566679999999999974 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.51 Aligned_cols=246 Identities=26% Similarity=0.427 Sum_probs=197.4
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChh
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
++||+|+||.||+|...++..+|+|.++.. ......+.+|+++++.++||||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888999999998753 334457889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccccc
Q 007256 347 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 426 (611)
Q Consensus 347 ~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~ 426 (611)
+++.... ..+.+..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++.......... ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~ 153 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGL 153 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCC
Confidence 9986543 247899999999999999999999 899999999999999999999999999987544322111 111
Q ss_pred cccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCCh
Q 007256 427 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505 (611)
Q Consensus 427 ~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 505 (611)
..++..|+|||++.++.++.++|||||||++|+|++ |..||...........+. . +. ... ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~----~~-----~~~----~~~ 217 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---K----GY-----RMS----CPQ 217 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c----CC-----CCC----CCC
Confidence 344678999999998999999999999999999998 999997553322111111 0 00 000 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 506 DQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 506 ~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.....+..++..|+..+|++||++.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 12245667778899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=325.37 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=201.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 331 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 331 (611)
++|.+.+.||+|+||.||++... ++..+|+|.++.. ......+.+|+++++.+ +||||++++++|..++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57899999999999999999742 2357999999854 34456788999999999 7999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 399 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd 399 (611)
..++||||+++|+|.+++..... ....+++.++..++.|++.||+|||+ ++++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 99999999999999999975432 12358899999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhH
Q 007256 400 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 478 (611)
Q Consensus 400 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l 478 (611)
.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999876543221111111234578999999998899999999999999999998 8889865433221111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 479 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 479 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
+.. +.... ........+..++..|++.+|.+||++.+|++.|...
T Consensus 255 ~~~-------~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 255 LKE-------GHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred HHc-------CCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 110 00000 0111123445567779999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=331.06 Aligned_cols=248 Identities=21% Similarity=0.324 Sum_probs=191.8
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||++... +++.||||+++.. ....+.+..|..++..+ +||||++++++|...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999865 6899999999753 23456688899999998 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-- 151 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence 99998886543 48999999999999999999999 8999999999999999999999999999875322111
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc--hhhHHHhhccccccCccccccCcccC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG--QESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~--~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+......... ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~p 225 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ------IRIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC------CCCC
Confidence 2223679999999999999999999999999999999999999996422111 0000001000000000 0111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQ------MSLVLKL 535 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPt------m~eVL~~ 535 (611)
..+ ...+..++..||+.||.+||+ +.++++.
T Consensus 226 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 226 RSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 111 223455667799999999998 5666653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.61 Aligned_cols=252 Identities=26% Similarity=0.508 Sum_probs=204.1
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
.+|.+.+.||+|+||.||+|.+.++..+|+|.++........|.+|++++++++|||++++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 47888999999999999999887788999999986655566899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|.+++.... ..+++..++.++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 84 GCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999987543 247899999999999999999999 88999999999999999999999999998765432211
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
......++.+|+|||++.++.++.++|||||||++|||++ |+.||...........+. .+ .....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~--~~~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-------AG--FRLYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-------CC--CCCCCCCC--
Confidence 1112335678999999998899999999999999999998 999997654322111110 00 01111111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
....+..++..||+.+|.+||++.++++.|.
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1245667788899999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.27 Aligned_cols=263 Identities=22% Similarity=0.368 Sum_probs=201.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-----------------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-----------------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISL 323 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-----------------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l 323 (611)
++|.+.+.||+|+||.||++... ++..+|+|+++.. ......|.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 2446899999753 3455789999999999999999999
Q ss_pred eeEEEecCceEEEEeeCCCCChhhhhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccce
Q 007256 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 396 (611)
Q Consensus 324 ~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~-------~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NI 396 (611)
++++..++..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999998754321 1347888999999999999999999 8999999999999
Q ss_pred eeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh--CCCCCCCCCCcc
Q 007256 397 LLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKG 474 (611)
Q Consensus 397 LLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt--G~~Pf~~~~~~~ 474 (611)
|++.++.++|+|||++................+++.|+|||+...+.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999976544322222222345678999999988899999999999999999998 778886543322
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 475 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
..... ........ .....+. .......+..++..||+.||.+||++.+|++.|+
T Consensus 242 ~~~~~---~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIENT---GEFFRDQG-RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHH---HHHHhhcc-ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11110 00000000 0000000 0111245666777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=326.94 Aligned_cols=263 Identities=19% Similarity=0.327 Sum_probs=198.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||+|+||.||+|..+ +++.||+|.++... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57999999999999999999875 68889999987432 3345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++ +|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 986 8888876543 247889999999999999999999 899999999999999999999999999987654322
Q ss_pred CCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc----
Q 007256 420 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL---- 494 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l---- 494 (611)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..............+
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 2 1223468999999998865 46889999999999999999999999876544333222211110000000000
Q ss_pred --cCcccCCC-------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 495 --LDPALGNN-------YDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 495 --ld~~l~~~-------~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+...... ...........++..||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 00001123455667799999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=316.27 Aligned_cols=251 Identities=33% Similarity=0.491 Sum_probs=199.2
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHH---HHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIK---EFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~---~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
|++.+.||+|+||+||++... +++.||+|++........ ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 678999999999999999976 567899999987653332 3456999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++.... .+++..+..++.|+++||.|||+ .+|+|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-- 151 (260)
T PF00069_consen 81 PGGSLQDYLQKNK----PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-- 151 (260)
T ss_dssp TTEBHHHHHHHHS----SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--
T ss_pred ccccccccccccc----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--
Confidence 9999999998332 48999999999999999999999 89999999999999999999999999998764221
Q ss_pred CccccccccccccCChhhhc-cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
........+|..|+|||++. +..++.++||||||+++++|++|..||.................. . +....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-------~-~~~~~ 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-------P-LPSSS 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-------H-HHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-------c-ccccc
Confidence 12333467899999999998 888999999999999999999999999876222222211111000 0 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.........+..++..||+.||++||++.++++
T Consensus 224 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 --QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011156666777899999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=329.53 Aligned_cols=240 Identities=24% Similarity=0.382 Sum_probs=190.7
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHh-cCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITT-LHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~-l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|.+. +++.||||+++.. ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 5889999999753 2344567778888876 4899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 99999987543 47889999999999999999999 8999999999999999999999999999875432221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... +.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-------------~~~~~~ 218 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-------------PCYPRW 218 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------CCCCcc
Confidence 1223579999999999999899999999999999999999999997654332221111111 111111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMS-LVLK 534 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~-eVL~ 534 (611)
. ...+..++..||+.||.+||++. ++++
T Consensus 219 ~----~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 L----TREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred C----CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1 12344556679999999999996 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=311.88 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=202.2
Q ss_pred eeEeecCcEEEEEEEeCC----CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLPD----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|.... +..|++|+++.... ..+.+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998753 88999999986543 367899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 343 GSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 343 gsL~~~L~~~~~~-----~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
++|.+++...... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765221 2468999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
...........+++.|+|||.+....++.++|||||||++|||++ |..||...........+. .+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-------KGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCCC-----
Confidence 432222334567899999999998899999999999999999999 699997764322111111 0000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
... .......+..++..|++.+|.+||++.++++.|+
T Consensus 226 ~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 LPK----PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCC----CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 000 1111235566777899999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=344.56 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=203.8
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.-|.+++.||.|+.|.|-+|.+ .+|+.+|||++... ......+.+||-||+.+.||||+++|+++....++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4578899999999999999986 58999999999754 234456788999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||++||.|++++...+ ++.+.++.+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|.....
T Consensus 92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999997665 48899999999999999999999 8999999999999999999999999999976655
Q ss_pred CCCCccccccccccccCChhhhccCCCC-CcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
+.- -.+.||+|.|.|||++++.+|+ .++||||.|||||.||||+.||++++.......+..+.. .+..
T Consensus 165 gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f-----~MPs--- 233 (786)
T KOG0588|consen 165 GKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF-----EMPS--- 233 (786)
T ss_pred Ccc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc-----cCCC---
Confidence 432 2346999999999999999985 589999999999999999999987654443333322211 1111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.-..+.+. ++..|+..||.+|.|+++|+++
T Consensus 234 ------~Is~eaQd---LLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 234 ------NISSEAQD---LLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ------cCCHHHHH---HHHHHhccCccccccHHHHhhC
Confidence 11223333 3445899999999999999984
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.20 Aligned_cols=256 Identities=23% Similarity=0.416 Sum_probs=202.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
++|...+.||+|+||.||++... ++..+|+|.++.. ......|.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788899999999999999632 4668999988754 3556789999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCce
Q 007256 336 VYDFLSRGSLEENLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 404 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~-----------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~v 404 (611)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+ ++++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999875432 11357899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 007256 405 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 483 (611)
||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||...........+....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR 241 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence 9999999976544322222223446788999999999999999999999999999998 999986544332221111110
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 484 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
+. ...... ...+..++..||+.||.+||++.+|++.|+
T Consensus 242 ~~------------~~~~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 EL------------ERPRTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cC------------CCCCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 000111 123556667799999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=342.45 Aligned_cols=239 Identities=31% Similarity=0.502 Sum_probs=198.0
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChhh
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 347 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~ 347 (611)
.+-||.|+.|.||+|.+ .++.||||.++.-+ ..+|..|++|+||||+.+.|+|.....++||||||..|-|.+
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 35699999999999998 56789999876322 247889999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccccc
Q 007256 348 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 427 (611)
Q Consensus 348 ~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~ 427 (611)
.|+... .+.-.....+..+||.|+.|||. +.|||||||.-||||..+..+||+|||-++......+ .-.+
T Consensus 202 VLka~~----~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST---kMSF 271 (904)
T KOG4721|consen 202 VLKAGR----PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST---KMSF 271 (904)
T ss_pred HHhccC----ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhhh---hhhh
Confidence 997654 46778888999999999999999 8999999999999999999999999999987766432 2348
Q ss_pred ccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHH
Q 007256 428 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQ 507 (611)
Q Consensus 428 ~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~ 507 (611)
+||..|||||++.+.+.++|+|||||||||||||||..||.+-+. ..+.|.-. . +.-.+ ..+..-
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVG---s-NsL~L-------pvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVG---S-NSLHL-------PVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEecc---C-Ccccc-------cCcccC
Confidence 999999999999999999999999999999999999999976443 22334311 1 11111 112223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 508 MERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 508 ~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..-+.+++.+||+..|++||++.+++.+|.-
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 3456777888999999999999999988764
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.22 Aligned_cols=247 Identities=20% Similarity=0.330 Sum_probs=190.2
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|... +++.||+|+++.. ....+.+..|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6889999999753 23455678899988877 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|..++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 99998886543 48899999999999999999999 8999999999999999999999999999875432211
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcch--hhHHHhhccccccCccccccCcccC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ--ESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+......... ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~~p 225 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IRIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------CCCC
Confidence 12236799999999999999999999999999999999999999963211110 000000000000000 0111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQ------MSLVLK 534 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPt------m~eVL~ 534 (611)
. .....+..++..||+.||.+||+ +.++++
T Consensus 226 ~----~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 226 R----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred C----CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 1 11234456667799999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.17 Aligned_cols=257 Identities=25% Similarity=0.474 Sum_probs=203.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||.||+|..+ ++..||+|++... ......|.+|+.+++.++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467999999999999999999853 4678999998754 34456799999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKK------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 395 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~------------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~N 395 (611)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 999999999999999864321 12347888999999999999999999 899999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcc
Q 007256 396 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKG 474 (611)
Q Consensus 396 ILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~ 474 (611)
||++.++.++|+|||++................++..|+|||++.++.++.++|||||||++|||++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999876543322211222345678999999998999999999999999999998 888986544322
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 475 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
. ..... .+.... ... .....+..++.+||+.+|.+|||+.|+++.|+
T Consensus 241 ~---~~~~~----~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 V---IYYVR----DGNVLS-----CPD----NCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H---HHHHh----cCCCCC-----CCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 11111 111110 001 11245666778899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=345.34 Aligned_cols=269 Identities=17% Similarity=0.220 Sum_probs=197.8
Q ss_pred HHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCC------cceeEEeeEE
Q 007256 255 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH------KNIISLLGFC 327 (611)
Q Consensus 255 ~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H------pnIv~l~g~~ 327 (611)
.+++...+++|.+.+.||+|+||+||+|.+. +++.||||+++........+..|+.++..++| .++++++++|
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3444456789999999999999999999864 68889999997655555566778888887765 4589999988
Q ss_pred Eec-CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC----
Q 007256 328 FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---- 402 (611)
Q Consensus 328 ~~~-~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~---- 402 (611)
..+ ...++|||++ +++|.+++.... .+++..+..|+.||+.||.|||+. .+||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence 764 4688999988 668888886543 588999999999999999999961 4899999999999998765
Q ss_pred ------------ceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCC
Q 007256 403 ------------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470 (611)
Q Consensus 403 ------------~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~ 470 (611)
.+||+|||++...... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4999999987543221 22468999999999999999999999999999999999999999876
Q ss_pred CCcchhhHHHhhccccc------------------cCccccccCcc-----cCCCC--ChHHHHHHHHHHHHhcccCCCC
Q 007256 471 HPKGQESLVMWAKPILS------------------SGKVTQLLDPA-----LGNNY--DYDQMERMVLASILCIRRDPRA 525 (611)
Q Consensus 471 ~~~~~~~lv~~~~~~~~------------------~g~l~~lld~~-----l~~~~--~~~~~~~l~~la~~CL~~dP~~ 525 (611)
.......++......+. .+.+....++. ..... .......+..++..||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 54433322211110000 00000000000 00000 0001234556778899999999
Q ss_pred CCCHHHHHHH
Q 007256 526 RPQMSLVLKL 535 (611)
Q Consensus 526 RPtm~eVL~~ 535 (611)
|||+.|++++
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999973
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=335.47 Aligned_cols=261 Identities=23% Similarity=0.279 Sum_probs=201.4
Q ss_pred CHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEE
Q 007256 254 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCF 328 (611)
Q Consensus 254 ~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~ 328 (611)
.+.++....++|.+.+.||+|+||.||++... +++.||+|++... ......+.+|+.+++.++||||+++++++.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35556667789999999999999999999875 6889999998642 233456788999999999999999999999
Q ss_pred ecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEee
Q 007256 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 408 (611)
Q Consensus 329 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~D 408 (611)
.++..++||||+++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999998643 36788889999999999999999 9999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccccccCChhhhccC----CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 007256 409 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 484 (611)
Q Consensus 409 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 484 (611)
||++........ .......||+.|+|||++... .++.++|||||||++|||++|+.||...........+....
T Consensus 186 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~- 263 (371)
T cd05622 186 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK- 263 (371)
T ss_pred CCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-
Confidence 999987644322 122346799999999998754 37889999999999999999999998765433222221110
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHh
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKLL 536 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~--RPtm~eVL~~L 536 (611)
....+.+ . ......+..++..||..++.+ ||++.+++++.
T Consensus 264 -----~~~~~~~-----~--~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 264 -----NSLTFPD-----D--NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----CcccCCC-----c--CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0000100 0 011123334455688744433 78999988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.08 Aligned_cols=250 Identities=25% Similarity=0.352 Sum_probs=210.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-eEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-LLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~-~~LV~ 337 (611)
++|...+.+|+|+||.++....+ +++.|++|.+.-. ....+...+|+.++++++|||||.+++.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999998865 6889999998743 3445578899999999999999999999999888 99999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
+|++||+|.+.|...+ ...|+++.+..++.|++.|+.|||+ ..|+|||||+.|||++.++.+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998765 3578999999999999999999998 8899999999999999999999999999999887
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.... ...++||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+.......+... .++|
T Consensus 159 ~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~-----------~~~P 225 (426)
T KOG0589|consen 159 EDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG-----------LYSP 225 (426)
T ss_pred chhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc-----------cCCC
Confidence 6532 23478999999999999999999999999999999999999999887655433322211 1111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+......+..++..||+.+|+.||++.++|..
T Consensus 226 -----lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 -----LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122233345555667999999999999999975
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=320.55 Aligned_cols=265 Identities=25% Similarity=0.386 Sum_probs=206.2
Q ss_pred cCHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEE--
Q 007256 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF-- 328 (611)
Q Consensus 253 f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~-- 328 (611)
+.++.+....++|.+.+.||+|+||.||++... +++.+|+|++.........+.+|+.+++.+ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 344566667899999999999999999999864 688999999876555556788999999999 6999999999884
Q ss_pred ---ecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 329 ---EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 329 ---~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence 3456899999999999999886433333468889999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhcc-----CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~ 480 (611)
|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+..... .
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--~ 240 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--K 240 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh--h
Confidence 999999876643221 1223569999999999853 457889999999999999999999997654322111 1
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 481 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 481 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
... .....+.++. . ....+..++..||+.||++||++.+|++.+
T Consensus 241 ~~~-----~~~~~~~~~~---~----~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 IPR-----NPPPTLHQPE---L----WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccc-----cCCCcccCCC---C----cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 0000111111 0 112455667779999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.80 Aligned_cols=254 Identities=22% Similarity=0.415 Sum_probs=204.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.++|.+.+.||+|+||.||++...++..+|+|.++........+.+|+.+++.++|+||+++++++.. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 45789999999999999999998888889999998766667789999999999999999999999887 78899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++.... ...+++..+..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 84 KGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999997543 2357889999999999999999999 89999999999999999999999999999765432221
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......++..|+|||++..+.++.++|+|||||++|+|++ |+.||...........+. .+.... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~~~~~-----~- 224 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRMP-----R- 224 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------CCCCCC-----C-
Confidence 1112345678999999998899999999999999999999 999997654322211111 000000 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.......+..++..|++.+|++||++.++++.|+.
T Consensus 225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112345566778999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.40 Aligned_cols=262 Identities=24% Similarity=0.297 Sum_probs=202.8
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----ceEEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLLLVY 337 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~-----~~~LV~ 337 (611)
.|...+++|.|+||.||+|... +++.||||....+... -.+|+.+|+.+.|||||+|.-+|.... .+.+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 4677899999999999999864 6799999998765432 346999999999999999999886532 356899
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC-CceEEeecCcccccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWAS 416 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~-~~vKL~DFGla~~~~ 416 (611)
|||+. +|.+.++........++...+.-+..||++||.|||+ .+|+||||||.|||+|.+ |.+||||||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99988 9999998543334457777888899999999999999 999999999999999976 899999999999887
Q ss_pred CCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC------
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG------ 489 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g------ 489 (611)
....... ...|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+++...+..++..........
T Consensus 178 ~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 KGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred cCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7665543 4679999999988754 79999999999999999999999999988777665543322211111
Q ss_pred -ccccccCcccCCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 -KVTQLLDPALGNN-----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 -~l~~lld~~l~~~-----~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+..+...+.+... +........+.+...+|+.+|.+|.++.+++.+
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111222111 111222345666677999999999999998863
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=313.98 Aligned_cols=255 Identities=25% Similarity=0.451 Sum_probs=202.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCC---EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGK---ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~---~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|...+.||+|+||.||+|... ++. .+|+|.++.. ......+..|+++++.++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888999999999999999875 333 7999998754 3445678999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++++|.+++.... ..+++..+..++.+++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999986533 258899999999999999999999 89999999999999999999999999998766
Q ss_pred cCCCCCccc-cccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 416 STSSSHITC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 416 ~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
......... .....++.|+|||++.++.++.++|||||||++|||++ |+.||...........+.. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~------~~~~~~ 231 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND------GFRLPA 231 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc------CCCCCC
Confidence 543222111 11223467999999998899999999999999999997 9999976543222111110 000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.......+..++..|++.+|.+||++.+|++.|.+
T Consensus 232 ----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 232 ----------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 01112345677788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.48 Aligned_cols=260 Identities=26% Similarity=0.411 Sum_probs=204.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEe--------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 330 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~--------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~ 330 (611)
.++|.+.+.||+|+||.||+|.. .++..||+|.++.. ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45788899999999999999963 13457999998753 34457789999999999 799999999999999
Q ss_pred CceEEEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
...++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+ ++|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 999999999999999999975422 12357889999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhh
Q 007256 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 477 (611)
Q Consensus 399 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 477 (611)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999987654333222223456788999999998899999999999999999998 788886543322211
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.+. .+... .. .......+..++..||+.+|.+||++.+|++.|+...
T Consensus 251 ~~~-------~~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 251 LLK-------EGHRM-----DK----PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHH-------cCCcC-----CC----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 111 00000 00 1111234555667799999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.77 Aligned_cols=263 Identities=23% Similarity=0.314 Sum_probs=198.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----ceE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 334 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~-----~~~ 334 (611)
+|.+.+.||+|+||.||++.+. +|+.||||++... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5788999999999999999864 7999999998643 234567889999999999999999999998776 789
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+.+ +|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~~-~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeecccc-CHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999974 7888775432 58899999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc--
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV-- 491 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l-- 491 (611)
....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+..+...+...........+
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 5443222 12235689999999998864 5789999999999999999999999876654332222111000000000
Q ss_pred -----cc-ccC-----cccCC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 492 -----TQ-LLD-----PALGN--NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 492 -----~~-lld-----~~l~~--~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.. +.. +.... .........+..++..||+.||.+|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00 000 00000 0011112345567778999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=333.80 Aligned_cols=205 Identities=25% Similarity=0.396 Sum_probs=177.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||++... +++.||||+++.. ......+.+|+.++..++||||+++++.+.+++.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999865 6899999999743 234567888999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999987543 48889999999999999999999 9999999999999999999999999999875432
Q ss_pred CCC---------------------------------CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCC
Q 007256 418 SSS---------------------------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 464 (611)
Q Consensus 418 ~~~---------------------------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~ 464 (611)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 00011357999999999999999999999999999999999999
Q ss_pred CCCCCCCCcc
Q 007256 465 KPISNDHPKG 474 (611)
Q Consensus 465 ~Pf~~~~~~~ 474 (611)
.||....+..
T Consensus 234 ~Pf~~~~~~~ 243 (360)
T cd05627 234 PPFCSETPQE 243 (360)
T ss_pred CCCCCCCHHH
Confidence 9998765543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=328.47 Aligned_cols=241 Identities=22% Similarity=0.338 Sum_probs=193.5
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||+||+|.+. +++.||||+++.. ......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 5889999999753 23456678899999888 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|...+.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 99999887543 48999999999999999999999 8999999999999999999999999999875332221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. .. ..+...
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------~~------~~~~~~ 218 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------DE------VRYPRW 218 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-------CC------CCCCCc
Confidence 12235799999999999999999999999999999999999999976543222111110 00 001111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQM-----SLVLKL 535 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm-----~eVL~~ 535 (611)
....+..++..||+.||.+||++ .++++.
T Consensus 219 ----~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 219 ----LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 12345566777999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.54 Aligned_cols=254 Identities=23% Similarity=0.415 Sum_probs=200.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~----~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
.++|.+.+.||+|+||+||+|.. .+|. .||+|+++.. ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 46789999999999999999985 3554 4899998743 3456678899999999999999999999975 4678
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999987543 258899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
..............+++.|+|||++.++.++.++|||||||++|||++ |..||...........+.. +....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-------GERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------CCcCC
Confidence 754333222222345678999999998899999999999999999998 9999875443222111110 00000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
... .....+..++..||+.||++||++.++++.|..
T Consensus 232 -----~~~----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 232 -----QPP----ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267 (279)
T ss_pred -----CCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 000 112245566778999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.83 Aligned_cols=257 Identities=28% Similarity=0.344 Sum_probs=200.6
Q ss_pred HHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---------------hHHHHHHHHHHHHHhcCCcceeE
Q 007256 259 LSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------------DVIKEFVLEIEIITTLHHKNIIS 322 (611)
Q Consensus 259 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---------------~~~~~f~~Ei~iL~~l~HpnIv~ 322 (611)
.+..++|.+.+.||+|.||.|-+|... +++.||||++.+.+ ...+...+||.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345688999999999999999999865 79999999996531 12357889999999999999999
Q ss_pred EeeEEEe--cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC
Q 007256 323 LLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 400 (611)
Q Consensus 323 l~g~~~~--~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~ 400 (611)
|+++..+ .+.+|||+|||..|.+...-.. ...++..++++++.+++.||.|||. +|||||||||+|+||+.
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcC
Confidence 9999865 4579999999999887654321 1228999999999999999999999 99999999999999999
Q ss_pred CCceEEeecCccccccCCCCC---ccccccccccccCChhhhccCC----CCCcceehhhhHHHHHHHhCCCCCCCCCCc
Q 007256 401 DFEPQLSDFGLAKWASTSSSH---ITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPK 473 (611)
Q Consensus 401 ~~~vKL~DFGla~~~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~----~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 473 (611)
+|++||+|||.+.....+... ......+|||.|+|||.+.++. .+.+.||||+||+||-|+.|+.||.++...
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999999877443221 1112268999999999998743 356899999999999999999999876543
Q ss_pred chhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 474 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 474 ~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.....+ ++..+.-....+.-+.+-.+++.+|.+||+.|.+..+|..+..
T Consensus 326 ~l~~KI---------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 326 ELFDKI---------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHH---------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 322222 1111211111123345555677799999999999999877654
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.63 Aligned_cols=260 Identities=22% Similarity=0.383 Sum_probs=202.9
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
..++|.+.+.||+|+||.||+|..+ .+..||+|.++... .....+.+|+.+++.++||||+++++++..++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999743 24589999987543 334568899999999999999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEE
Q 007256 333 LLLVYDFLSRGSLEENLHGNKK------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 406 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL 406 (611)
.++||||+++|+|.+++..... ....+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 11345677889999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccc
Q 007256 407 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||...........+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~----- 235 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM----- 235 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----
Confidence 99999886544332222222345778999999998999999999999999999999 788886543322111110
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
. +.... .. ......+..++..||+.+|++||++.++++.|+..
T Consensus 236 -~-~~~~~-----~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 236 -D-GGYLD-----QP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -c-CCCCC-----CC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 0 00000 00 11123566677789999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.93 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=200.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999986 478899999987542 3455688899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.++++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 99999999986543 47899999999999999999999 899999999999999999999999999998664322
Q ss_pred CCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 420 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.. .....|++.|+|||.+. ...++.++|||||||++|||++|+.||....+....... ... . +..
T Consensus 161 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~-----~---~~~ 228 (267)
T cd06646 161 AK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKS-----N---FQP 228 (267)
T ss_pred cc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecC-----C---CCC
Confidence 11 12356899999999884 445788999999999999999999999654432211110 000 0 000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
+.... .......+..++..||+.+|++||+++++++.|
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11110 011123455667789999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.22 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=200.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CC---CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g---~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
++|.+.+.||+|+||.||+|... ++ ..||||+++.. ......|..|+.+++.++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 45889999999999999999864 33 36999998753 44567899999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999987543 258899999999999999999999 899999999999999999999999999987665
Q ss_pred CCCCCccccc-cc--cccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 417 TSSSHITCTD-VA--GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 417 ~~~~~~~~~~-~~--GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
.......... .. .+..|+|||++.++.++.++|||||||++|||++ |..||......... .+..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~---~~i~~~~---~~~ 231 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---NAIEQDY---RLP 231 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH---HHHHcCC---cCC
Confidence 4332211111 11 2457999999999999999999999999999886 99999765433211 1111000 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..... ...+..++..|++.+|.+||++.+|+..|+.
T Consensus 232 ------~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 232 ------PPMDC----PTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ------CcccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 00111 1234556677999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.97 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=200.2
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
++|.+.+.||+|++|.||++... +++.||+|.+.... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999864 68999999986432 234568899999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++++|.+.+.... .+++..+..++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999987543 47889999999999999999999 89999999999999999999999999998765
Q ss_pred cCCCCCcc-ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
........ .....|+..|+|||++.+..++.++||||||+++|||++|+.||............. . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~---~~~---- 224 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---T---QPT---- 224 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh---c---cCC----
Confidence 43221111 123568899999999998889999999999999999999999997653322111110 0 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.+... ....+..++..||..+|.+|||+.++++.
T Consensus 225 -~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 -NPQLPSH----VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCcc----CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0111111 12234556667999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.53 Aligned_cols=264 Identities=28% Similarity=0.411 Sum_probs=208.2
Q ss_pred cCHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec
Q 007256 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 330 (611)
Q Consensus 253 f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~ 330 (611)
+.+.++...+++|.+.+.||+|+||.||++... +++.+|+|++.........+.+|+.++.++ +|||+++++++|...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 556677778899999999999999999999874 789999999986655567788999999999 799999999998754
Q ss_pred -----CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 331 -----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 331 -----~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
+..++||||+++++|.++++........+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEE
Confidence 35899999999999999886543333468999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhccC-----CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~ 480 (611)
|+|||++......... .....|+..|+|||++..+ .++.++|||||||++|||++|+.||......... ..
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~--~~ 244 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL--FK 244 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--HH
Confidence 9999998765432221 1235689999999998644 3688999999999999999999999765432221 11
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 481 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 481 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+... ....+.++ ......+..++..|++.+|++||++.++++.
T Consensus 245 ~~~~-----~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 245 IPRN-----PPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HhcC-----CCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1110 00011111 1112346667778999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=317.93 Aligned_cols=246 Identities=25% Similarity=0.314 Sum_probs=191.7
Q ss_pred EeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 271 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
||+|+||.||++..+ +|+.||+|.+.... .....+..|++++++++||||+++++++..+...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 69999999986422 2234556799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccc
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~ 425 (611)
.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~ 152 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---IT 152 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---ee
Confidence 988865432 348899999999999999999999 8999999999999999999999999999876654321 22
Q ss_pred ccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCCh
Q 007256 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505 (611)
Q Consensus 426 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 505 (611)
...||+.|+|||++.++.++.++|||||||++|||++|+.||...........+. ..... ..... ....+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~-~~~~~-----~~~~~-- 222 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK--RRTLE-DEVKF-----EHQNF-- 222 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH--HHhhc-ccccc-----ccccC--
Confidence 3578999999999998899999999999999999999999997543322111111 11100 00000 00111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 506 DQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 506 ~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
...+..++..||+.||.+||++.++++.+
T Consensus 223 --~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 --TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred --CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 12345566679999999999997766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=318.14 Aligned_cols=262 Identities=21% Similarity=0.317 Sum_probs=193.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhc---CCcceeEEeeEEEec-----C
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFED-----N 331 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~~~-----~ 331 (611)
+|.+.+.||+|+||+||+|.+. +|+.||+|.++.. ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4888999999999999999875 6899999998753 22234556777777665 699999999998642 4
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++||||+++ +|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 58999999985 88888865432 348899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|++||...........+............
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 986654322 12356899999999999889999999999999999999999999765443322111100000000000
Q ss_pred cc-------ccCcccCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 492 TQ-------LLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 492 ~~-------lld~~l~~---~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.. .+.+.... .........+..++..||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000000 000111234556777899999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.59 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=198.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCC--EEEEEEecC--ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~--~vAVK~l~~--~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV 336 (611)
++|.+.+.||+|+||.||+|... ++. .+++|.++. .....+.|.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57899999999999999999875 343 478888874 234566789999999999 799999999999999999999
Q ss_pred EeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCce
Q 007256 337 YDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 404 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~v 404 (611)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 999999999999965431 12358899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 007256 405 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 483 (611)
||+|||++........ ......+..|+|||++....++.++|||||||++|||++ |..||...........+.
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~--- 232 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 232 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---
Confidence 9999999864322111 111223567999999998899999999999999999997 999997654332111110
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 484 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.+ ........ ....+..++..|++.+|.+||++.++++.|..
T Consensus 233 ----~~-----~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 233 ----QG-----YRMEKPRN----CDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred ----cC-----CCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00 00001111 12345567778999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=323.98 Aligned_cols=256 Identities=23% Similarity=0.390 Sum_probs=202.7
Q ss_pred cCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 333 (611)
++|.+.+.||+|+||.||++.. .++..+|||+++.. ....+.+.+|+.+++++ +||||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4689999999999999999974 23567999998754 34456789999999999 799999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++|+|.++++.... ..+++..+..++.+++.||.|||+ ++|+|+||||+|||++.++.++|+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999975432 248999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
...............++..|+|||++..+.++.++|||||||++|||++ |..||......... ..... .+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~~~----~~~-- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKLIK----EGY-- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHHHH----cCC--
Confidence 6654332222222456788999999998999999999999999999998 99998765432211 11110 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
...... .....+..++..|+..+|++||++.+|++.|..
T Consensus 262 ---~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ---RMAQPE----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---cCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 000000 112345667777999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.89 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=199.9
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec------C
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED------N 331 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~------~ 331 (611)
.+++.|.+.+.||+|+||.||+|... +++.||+|++.........+..|+.++.++ +|+||++++++|... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 35677888999999999999999865 688999999986655567788999999998 699999999998753 4
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 58999999999999999875432 358899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 486 (611)
+......... .....|++.|+|||++. ...++.++|||||||++|||++|+.||....+........ .
T Consensus 158 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~-~---- 230 (272)
T cd06637 158 SAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-R---- 230 (272)
T ss_pred ceeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-c----
Confidence 9765432221 22367899999999986 3468889999999999999999999997544332221110 0
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 487 ~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.......+ ..+ ...+..++..||..+|.+|||+.++++
T Consensus 231 --~~~~~~~~----~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 --NPAPRLKS----KKW----SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --CCCCCCCC----CCc----CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00001111 111 123455667799999999999999876
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=320.08 Aligned_cols=265 Identities=22% Similarity=0.248 Sum_probs=206.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChh---HHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~L 335 (611)
.++|...+.|++|.||.||+|.++ +++.||+|+++-+.+ .--.-++||.+|.+++|||||.+..+..- -+.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 457888899999999999999975 688899999986432 22346789999999999999999988764 356999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
|||||+. +|..+++... .+|...+...+..|+++||+|||. +.|+||||||+|+|++..|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999988 9999998776 368999999999999999999999 88999999999999999999999999999988
Q ss_pred cCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
...... .+..+-|.+|.|||.+.+. .|+..+|+||+|||+.||+++++.|.+.....+...+-.......+..+..+
T Consensus 228 gsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 875433 3457789999999998865 6999999999999999999999999988777666554322211111111111
Q ss_pred --------------cCcccCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 --------------LDPALGNNYDYD-QMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 --------------ld~~l~~~~~~~-~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.-..+...+... ..+.-..+....|..||.+|-|+++.|+.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111111222111 11223334445788999999999998864
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.64 Aligned_cols=199 Identities=27% Similarity=0.360 Sum_probs=170.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 331 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~----- 331 (611)
..++|.+.+.||+|+||.||++.+. +|+.||||++... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999864 6899999998643 344567889999999999999999999986543
Q ss_pred -ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 332 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 332 -~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence 47999999976 56666642 37788899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 169 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 169 LARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred CccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9975543221 2235789999999999999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.33 Aligned_cols=236 Identities=28% Similarity=0.344 Sum_probs=186.6
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHH-HHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~-iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||+||+|.+. +|+.||||++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 78999999997532 23344555555 56789999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-- 151 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence 99999887543 47889999999999999999999 8999999999999999999999999999875432221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. +. ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------~~------~~~~~~ 218 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------KP------LRLKPN 218 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc-------CC------CCCCCC
Confidence 22346799999999999999999999999999999999999999976543222111110 00 001111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMS 530 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~ 530 (611)
. ...+..++..||+.||.+||++.
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 I----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 23345566679999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=320.54 Aligned_cols=263 Identities=22% Similarity=0.355 Sum_probs=201.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||+|+||.||++... +|..+|+|.++.. ......+.+|++++++++||||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47899999999999999999865 6888999998753 34456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.... .+++..+..++.|++.||.|||+ ..+++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999997543 47889999999999999999996 1479999999999999999999999999987553321
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC----------
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---------- 489 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---------- 489 (611)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||......................
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 123578999999999988889999999999999999999999997544322211111000000000
Q ss_pred -------ccccccCcccC---CCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 -------KVTQLLDPALG---NNYDY-DQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 -------~l~~lld~~l~---~~~~~-~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
...++.+.... ...+. .....+..++.+||..+|.+||++.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 00000 012245677778999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.53 Aligned_cols=240 Identities=23% Similarity=0.337 Sum_probs=192.3
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~ 337 (611)
+|...+.||+|+||.||+|... +|+.||||+++.. ....+.+..|..++..+. |++|+++++++...+.+++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999865 6899999999753 234456788999998886 577888999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999986543 48899999999999999999999 8999999999999999999999999999875432
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
... ......||+.|+|||++.++.++.++|||||||++|||++|+.||...........+... ..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-------~~------ 218 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-------NV------ 218 (323)
T ss_pred CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------CC------
Confidence 221 122357999999999999999999999999999999999999999765433221111110 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQM 529 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm 529 (611)
.+.... ...+..++..||+.+|.+|++.
T Consensus 219 ~~p~~~----~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPKSL----SKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCccC----CHHHHHHHHHHcccCHhhCCCC
Confidence 011111 2244556677999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=310.93 Aligned_cols=248 Identities=28% Similarity=0.438 Sum_probs=196.1
Q ss_pred eeEeecCcEEEEEEEeC--C--CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP--D--GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~--~--g~~vAVK~l~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|... + +..+|+|.+..... ..+.+.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46899999999999753 2 37899999986543 5678999999999999999999999875 5578999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++.... .+++..+..++.|++.||.|||. .+++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997654 48899999999999999999999 899999999999999999999999999998765433221
Q ss_pred c-ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 423 T-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 423 ~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |+.||...........+....+ . ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~------~------~~- 219 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------L------PR- 219 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc------C------CC-
Confidence 1 111224568999999998999999999999999999998 9999976543222111111100 0 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.......+..++..|+..+|.+||++.+|++.|+...
T Consensus 220 ---~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 ---PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0111234556777899999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.27 Aligned_cols=250 Identities=30% Similarity=0.463 Sum_probs=204.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.++|.+.+.||.|+||.||+|... |+.||+|.++......+++.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 357888999999999999999874 7889999998766567789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++..... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999975432 258999999999999999999999 8999999999999999999999999999986643221
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
...++..|+|||++..+.++.++||||||++++||++ |+.||...........+ .. +.. ....
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~----~~~-----~~~~ 221 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV---EK----GYR-----MEAP 221 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---hc----CCC-----CCCc
Confidence 1335678999999998899999999999999999997 99999765432211111 00 000 0000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
. .....+..++..||..+|.+||++.++++.|+.
T Consensus 222 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 E----GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred c----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1 112345566777999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=325.38 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=195.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||++... +++.||||++... ....+.+.+|+.++..++|+||++++++|.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999865 6899999999742 234456889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999996532 258889999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCCccccccccccccCChhhhcc-----CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
.... ......||+.|+|||++.. +.++.++|||||||++|||++|+.||...........+... ....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~------~~~~ 227 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH------KEHF 227 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC------CCcc
Confidence 3221 1122469999999999873 46788999999999999999999999765433222111100 0000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+ .+. ... -.+....++.. ++|...++..||++.++++.
T Consensus 228 ~~-~~~-~~~-~~~~~~~li~~-ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 QF-PPD-VTD-VSEEAKDLIRR-LICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cC-CCc-cCC-CCHHHHHHHHH-HccCcccccCCCCHHHHhcC
Confidence 00 000 001 12233333332 23556666668999998875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.59 Aligned_cols=241 Identities=27% Similarity=0.336 Sum_probs=187.4
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHH-HHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~-iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||+||+|.+. +++.||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999875 67889999997532 22334444544 56789999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++.... .+.+..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 99999987543 47788888999999999999999 8999999999999999999999999999875433221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..+ . .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-~~~------~------~~~~~ 218 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL-NKP------L------QLKPN 218 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH-hCC------c------CCCCC
Confidence 2234679999999999999999999999999999999999999997654332211111 000 0 01111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. ...+..++..||+.||.+||++.+.+..
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 219 I----TNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred C----CHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 1 1234455667999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.75 Aligned_cols=239 Identities=26% Similarity=0.323 Sum_probs=185.4
Q ss_pred EeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc---CCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 271 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
||+|+||+||+|... +|+.||||++.... .....+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 68999999986432 2334456677777765 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 99999887543 48899999999999999999999 8999999999999999999999999999875433222
Q ss_pred cccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+... . ..+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-------~------~~~~~ 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-------K------VRFPK 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-------C------CCCCC
Confidence 12346799999999999755 4899999999999999999999999765433221111111 0 00111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARP----QMSLVLK 534 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RP----tm~eVL~ 534 (611)
..- ...+..++..||+.||.+|| ++.++++
T Consensus 219 ~~~---~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVL---SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccC---CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 111 12334556679999999998 5666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=320.61 Aligned_cols=264 Identities=21% Similarity=0.341 Sum_probs=199.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||+|+||.||+|... +++.||+|.++.. ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999875 6889999998743 23345677899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++ +|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LDK-DLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred ccc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 975 8988886543 247889999999999999999999 899999999999999999999999999987654322
Q ss_pred CCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC--
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD-- 496 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld-- 496 (611)
. ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+..............+++
T Consensus 159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 1 11234678999999998754 578899999999999999999999987654333222211111111111111110
Q ss_pred -------cccCCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 -------PALGNN----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 -------~~l~~~----~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+..... ........+..++..||+.||.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 000112234567778999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.62 Aligned_cols=236 Identities=28% Similarity=0.361 Sum_probs=186.0
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHH-HHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~-iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|.+. +|+.||+|++.... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 68899999987532 23344555554 67889999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|...+.... .+.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-- 151 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence 99998886543 47888889999999999999999 8999999999999999999999999999875432221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. ..+. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~-~~~~------------~---- 214 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL-HKPL------------Q---- 214 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh-cCCC------------C----
Confidence 2234679999999999998899999999999999999999999997654322111110 0000 0
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMS 530 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~ 530 (611)
.+......+..++..||+.||.+||++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111223455667779999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.85 Aligned_cols=242 Identities=21% Similarity=0.312 Sum_probs=188.2
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|... +++.||||+++.. ....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999865 6889999999853 23456688999999888 599999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 151 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-- 151 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence 99998886543 48999999999999999999999 8999999999999999999999999999875332211
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+......... ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~p~~ 225 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP------IRIPRF 225 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC------CCCCCC
Confidence 12236799999999999999999999999999999999999999964322211111101000000000 001111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQM 529 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm 529 (611)
. ...+..++..||+.||.+||++
T Consensus 226 ~----~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 L----SVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred C----CHHHHHHHHHHhccCHHHcCCC
Confidence 1 1234556667999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=313.99 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=190.8
Q ss_pred eeEeecCcEEEEEEEeC---CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 269 NLIGKGGSSQVYKGCLP---DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
+.||+|+||.||+|... ++..+|+|.++... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 35899999999999854 34679999987543 33457889999999999999999999999999999999999999
Q ss_pred ChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 344 SLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 344 sL~~~L~~~~~-~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
+|.+++..... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975432 22346778888999999999999999 899999999999999999999999999997554333222
Q ss_pred cccccccccccCChhhhccC-------CCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 423 TCTDVAGTFGYLAPEYFMYG-------KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~-------~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
......|+..|+|||++... .++.++|||||||++|||++ |+.||............ +. +....+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~------~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VR------EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-hh------cccCCC
Confidence 22335678899999998642 35789999999999999996 99999764432211110 00 111111
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.++.+... ..+ .+..++..|+ .+|.+|||+.+|+..|.
T Consensus 231 ~~~~~~~~-~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP-LSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC-CCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22222111 112 2333445688 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=313.20 Aligned_cols=255 Identities=24% Similarity=0.426 Sum_probs=202.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-C---CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~---g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||.||+|... + +..+|+|.++.. ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357889999999999999999863 2 337999998753 3445688999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++++|.+++.... ..+++.+++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999997543 257899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcc-ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 416 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 416 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
........ .....++..|+|||++.++.++.++|||||||++||+++ |..||...........+ .... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~---~~~~---~~-- 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI---EEGY---RL-- 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHH---hCCC---cC--
Confidence 54332211 111234568999999998899999999999999999886 99999765433211111 1000 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+ . .......+..++..|++.+|.+||++.++++.|..
T Consensus 229 ---~-~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 ---P-A----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---C-C----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 0 01112345667778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=321.56 Aligned_cols=258 Identities=24% Similarity=0.429 Sum_probs=201.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 331 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 331 (611)
++|.+.+.||+|+||.||++... .+..+|+|+++.. ......+..|+.+++.+ +||||++++++|..++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57889999999999999999742 3457899998753 34456788999999999 5999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 399 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd 399 (611)
..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+ +||+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999965321 12358899999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhH
Q 007256 400 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 478 (611)
Q Consensus 400 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l 478 (611)
.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999986654322211111234568999999998899999999999999999999 8999966543222111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 479 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 479 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
+. .+.... . .......+..++..|++.+|.+||++.++++.|...
T Consensus 249 ~~-------~~~~~~-----~----~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 249 LR-------EGHRMD-----K----PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HH-------cCCCCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11 010000 0 111122455667789999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=328.16 Aligned_cols=239 Identities=28% Similarity=0.342 Sum_probs=187.9
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHH-HHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~-iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||+||+|... +|+.||||++... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999864 7899999999753 233445566665 46779999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 151 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-- 151 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence 99998886543 48899999999999999999999 8999999999999999999999999999875432211
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
......||+.|+|||++.++.++.++|||||||++|||++|+.||...........+.. +.+ .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------~~~------~~~~~ 218 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------KPL------VLRPG 218 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc-------CCc------cCCCC
Confidence 12346799999999999999999999999999999999999999976543322111110 000 00111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMSLVL 533 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL 533 (611)
....+..++..|++.+|.+||++.+.+
T Consensus 219 ----~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 219 ----ASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ----CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 122344566679999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=310.51 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=206.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|-||.||.|+.+ ++-.||+|++.++. ....++.+|++|-+.|+||||+++|++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467899999999999999999864 67889999998654 4456788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
+||..+|+|...|..... ..+++.....++.|+|.||.|+|. ++||||||||+|+|++.++.+||+|||-+...+
T Consensus 101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999985443 357888888999999999999999 899999999999999999999999999987665
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.. ...+.+||..|++||+..+..++.++|+|++|++.||++.|.+||......+....+... ++.+
T Consensus 176 ~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----------~~~~ 241 (281)
T KOG0580|consen 176 SN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----------DLKF 241 (281)
T ss_pred CC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc----------cccC
Confidence 32 223479999999999999999999999999999999999999999877633322222211 1111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
| ..-......++..|+..+|.+|.+..+|+.+
T Consensus 242 p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 P-------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred C-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1 1112234456667999999999999999875
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=321.05 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=198.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCC--EEEEEEecC--ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~--~vAVK~l~~--~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||.||+|.+. +|. .+|+|.++. .......+.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457899999999999999999864 454 457777764 234566888999999999 89999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc
Q 007256 336 VYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 403 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~ 403 (611)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 9999999999999975431 12357899999999999999999999 89999999999999999999
Q ss_pred eEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhh
Q 007256 404 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 404 vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~ 482 (611)
+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||......... ...
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKL 236 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH---HHH
Confidence 9999999986332111 1111234678999999988889999999999999999998 99999754432211 111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.. + ........ ....+..++..|++.+|++||++.++++.|..
T Consensus 237 ~~----~-----~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 237 PQ----G-----YRLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred hc----C-----CcCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00 0 00000011 12245667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.85 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=197.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 330 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~------ 330 (611)
..++|.+.+.||+|+||.||++.+. .++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 6889999998753 34456788999999999999999999988643
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCc
Confidence 347999999976 67666642 37888899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc--c----
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK--P---- 484 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~--~---- 484 (611)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... +
T Consensus 165 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9986544322 223578999999999998899999999999999999999999997654322211110000 0
Q ss_pred ----------ccc-cCc-----ccccc-CcccC--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 485 ----------ILS-SGK-----VTQLL-DPALG--NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 485 ----------~~~-~g~-----l~~ll-d~~l~--~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
... ... +.... +.... ..........+..++..||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 000 00000 00000 00011112355677788999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=308.66 Aligned_cols=247 Identities=26% Similarity=0.456 Sum_probs=197.7
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChh
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
++||+|+||.||++.+.+++.||+|.+.... .....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 4689999999999998779999999987543 35678999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccccc
Q 007256 347 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 426 (611)
Q Consensus 347 ~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~ 426 (611)
+++..... .+++..+..++.+++.||.|||+ ++++||||||+|||++.++.+||+|||++..............
T Consensus 81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99865432 47889999999999999999999 8999999999999999999999999999976543222111112
Q ss_pred cccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCCh
Q 007256 427 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505 (611)
Q Consensus 427 ~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 505 (611)
..++..|+|||++.++.++.++|||||||++|||++ |..||...........+.... .. . .+.
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~------~~------~----~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY------RM------P----APQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC------CC------C----CCc
Confidence 334667999999998899999999999999999999 888887654332222111000 00 0 011
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 506 DQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 506 ~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.....+..++..|++.+|.+||++.+|++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11234566777899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=316.28 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=197.2
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.|...+.||+|+||+||+|... +++.||+|.+.... .....+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 3677899999999999999864 78999999987532 234457889999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999988865432 358999999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.. .....|+..|+|||++.+..++.++|+|||||++|||++|..||...........+.. .. ..+. ..
T Consensus 156 ~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~--~~-~~~~------~~ 223 (285)
T cd05632 156 ES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR--RV-LETE------EV 223 (285)
T ss_pred Cc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hh-hccc------cc
Confidence 21 1235799999999999989999999999999999999999999976543322111111 00 0000 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 534 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~ 534 (611)
....+ ...+..++..|++.||.+||+ +.++++
T Consensus 224 ~~~~~----~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKF----SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccC----CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11111 123455666799999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=315.10 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=195.9
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||+|+||.||+|.+ .+++.||+|++... ......+.+|++++++++||||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999986 47899999998653 34456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999997542 36788889999999999999999 899999999999999999999999999997654322
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchh-hHHHhhccccccCccccccCcc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||......... .......... .. ..+.
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~-----~~~~ 219 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DE-----DPPV 219 (279)
T ss_pred ----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-cc-----CCCC
Confidence 22357899999999999889999999999999999999999999653321110 0000000000 00 0011
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+.. ......+..++..|++.+|.+||++.++++.
T Consensus 220 ~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPV---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111 1112245566677999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=311.47 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=194.0
Q ss_pred eEeecCcEEEEEEEe---CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 270 LIGKGGSSQVYKGCL---PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~~---~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
.||+|+||.||+|.+ .++..+|+|+++.. ....+.+.+|+.+++.+.||||+++++++. ++..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 36788999998753 244678899999999999999999999885 55789999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcc
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 423 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 423 (611)
+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||.||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999986543 48899999999999999999999 8999999999999999999999999999987654432211
Q ss_pred -ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 424 -CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 424 -~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
.....++..|+|||.+..+.++.++|||||||++|||++ |+.||...........+.. +... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-------~~~~-----~~~~ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-------GERM-----ECPQ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-------CCCC-----CCCC
Confidence 112334678999999988889999999999999999998 9999976543322222111 1100 0111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.. ...+..++..|++.||++||++.+|.+.|+.
T Consensus 222 ~~----~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 RC----PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CC----CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11 1334556777999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=326.88 Aligned_cols=246 Identities=23% Similarity=0.367 Sum_probs=206.7
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.+|.+.+.||+|.||.|-+|.. ..|+.||||.++++ +++.-.+.+||+||..|+||||+.+|.+|...+.++|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999985 68999999999864 456667889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||..+|.|++++...+ .+++.+++.++.||..|+.|+|+ ++++|||||.+|||||.++++||+|||++.++..
T Consensus 133 EYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999998765 48999999999999999999999 8999999999999999999999999999988876
Q ss_pred CCCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
... -.++||+|-|.+||++.+.+| .+.+|-|||||+||-|+.|..||++.+... ++.. +..|...+-
T Consensus 206 ~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQ----Is~GaYrEP-- 273 (668)
T KOG0611|consen 206 KKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQ----ISRGAYREP-- 273 (668)
T ss_pred ccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHH----hhcccccCC--
Confidence 543 235899999999999999888 568999999999999999999998765332 2211 112221111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
+......-++.+||..||++|.|+.+|..+.
T Consensus 274 ---------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ---------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1112233456689999999999999998754
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=308.70 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=201.1
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
+|.+.+.||+|+||.||++... +++.+|+|.++. .....+.+.+|+.+++.++|+||+++++++..++.+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5788999999999999999865 689999999864 3345677889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++..... ..+++..++.++.+++.||.|||+ ++|+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998864332 347889999999999999999999 8999999999999999999999999999876644322
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
. .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...........+. .+.... +.
T Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~-----~~ 221 (255)
T cd08219 156 Y--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-------QGSYKP-----LP 221 (255)
T ss_pred c--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-------cCCCCC-----CC
Confidence 1 223578999999999998899999999999999999999999997654322211111 011110 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
... ...+..++..||+.||.+||++.+++..
T Consensus 222 ~~~----~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 SHY----SYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccc----CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111 1234556677999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=316.62 Aligned_cols=270 Identities=26% Similarity=0.363 Sum_probs=203.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-----CCCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-----DGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-----~g~~vAVK~l~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~ 333 (611)
++|.+.+.||+|+||.||+|... ++..+|||+++.... ..+.|.+|+++++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677899999999999999853 478899999986554 47789999999999999999999999877 5679
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++++|.+++..... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999976542 58999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcc-ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
.......... .....++..|+|||++....++.++||||||++++||++|+.|+............. .........+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~ 236 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLL 236 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHH
Confidence 7763322111 112345667999999998899999999999999999999999986533211000000 00000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
..+...............+..++.+|++.+|.+||++.+|+++|...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111000000111124566778889999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.45 Aligned_cols=266 Identities=28% Similarity=0.398 Sum_probs=200.3
Q ss_pred cCceeeeeEeecCcEEEEEEEe-----CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--Cce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~ 333 (611)
..|.+.+.||+|+||.||++.. .++..||+|.++.. ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999973 36788999998754 34456799999999999999999999999775 568
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++++|.+++.... ..+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 99999999999999986543 258999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc-cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
......... ......|+..|+|||++.++.++.++|||||||++|||++++.|.......... . ..+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~---~~~~~~~~~~~ 233 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-M---IGPTHGQMTVT 233 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-h---cccccccccHH
Confidence 765433221 112345777899999999889999999999999999999988765332110000 0 00000000000
Q ss_pred ---cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 493 ---QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 493 ---~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..+...............+..++..||+.+|.+||++.++++.|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 0000000000111123467778888999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=339.45 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=202.1
Q ss_pred cCceeeeeEeecCcEEEEEEEeC--CC--CE-EEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP--DG--KE-LAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~--~g--~~-vAVK~l~~----~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
++-.+.++||+|+||.||+|.+. ++ .. ||||..+. ......+|++|++++++++|||||++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34456689999999999999864 23 23 89999984 356788999999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++|||+|.||+|.++|...+. .++..++..++.+.|.||+|||+ +++|||||-..|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999987764 58999999999999999999999 899999999999999999999999999987
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
....-..... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+.. ++...
T Consensus 311 ~~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~------~~~r~ 382 (474)
T KOG0194|consen 311 AGSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK------NGYRM 382 (474)
T ss_pred CCcceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh------cCccC
Confidence 5542111110 1123468999999999999999999999999999999 8889987655433222211 11000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
. .....+.+ +..+...|+..+|++||+|.++.+.|+..
T Consensus 383 ~------~~~~~p~~---~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 383 P------IPSKTPKE---LAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred C------CCCCCHHH---HHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 0 01123333 33344479999999999999999988643
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=309.16 Aligned_cols=248 Identities=29% Similarity=0.445 Sum_probs=197.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEE-ecCceEEEEeeCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLLVYDFLS 341 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~~~LV~Ey~~ 341 (611)
.+|.+.+.||+|+||.||++.. .|..+|+|.++... ..+.+.+|+.++++++|+|++++++++. .++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4788999999999999999976 47889999987543 3567899999999999999999999765 4567899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++..... ..+++..+..++.+++.||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999875432 347899999999999999999999 899999999999999999999999999987554322
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
....++..|+|||++....++.++|||||||++|||++ |+.||........ ..... .+. .+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~----~~~-----~~~~~ 221 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVE----KGY-----KMDAP 221 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh----cCC-----CCCCC
Confidence 12345678999999998899999999999999999998 9999865433221 11110 000 00111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.. ....+..++..|++.+|.+|||+.++++.|+.
T Consensus 222 ~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DG----CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11 12344556677999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=328.99 Aligned_cols=262 Identities=21% Similarity=0.259 Sum_probs=197.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 330 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~------ 330 (611)
..++|.+.+.||+|+||.||++.+. .++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999865 6889999999753 34456788999999999999999999987543
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
...++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999976 77777642 37788899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc-------
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK------- 483 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~------- 483 (611)
+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+....
T Consensus 172 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9986544322 223578999999999999999999999999999999999999997665433222111100
Q ss_pred ---------------cccccCccccccCccc-C--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 484 ---------------PILSSGKVTQLLDPAL-G--NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 484 ---------------~~~~~g~l~~lld~~l-~--~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+.........+....+ . ..........+..++..||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000000 0 00000112345567778999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=313.84 Aligned_cols=250 Identities=26% Similarity=0.475 Sum_probs=196.3
Q ss_pred eeEeecCcEEEEEEEeCC-------CCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 269 NLIGKGGSSQVYKGCLPD-------GKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~-------g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+.||+|+||.||+|...+ +..+|||.+.... .....+.+|+.+++.++||||++++++|......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999886543 4567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-----ceEEeecCc
Q 007256 340 LSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-----EPQLSDFGL 411 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~---~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-----~vKL~DFGl 411 (611)
+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999965322 22357899999999999999999998 8899999999999999877 899999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
+................++..|+|||++.++.++.++|||||||++|||++ |+.||........ ..... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~~~---~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQHVT---AGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHHHh---cCCc
Confidence 976544322222222356788999999999999999999999999999998 9999975433221 11110 0000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 491 l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
. .. .......+..++..||..+|.+||++.+|++.|+
T Consensus 232 ~------~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 L------QK----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c------CC----cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 00 1111234566777899999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=333.00 Aligned_cols=199 Identities=23% Similarity=0.329 Sum_probs=173.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
..+|.+.+.||+|+||.||++... .+..||+|.+.... .+.+|+++|+.++||||+++++++......++|||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 357999999999999999998753 46789999987542 34679999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
++. ++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++......
T Consensus 167 ~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 167 KYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 996 5888888433 358999999999999999999999 89999999999999999999999999999876554
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 333333346799999999999999999999999999999999999999976543
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=326.47 Aligned_cols=258 Identities=24% Similarity=0.409 Sum_probs=199.1
Q ss_pred cCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe-cCc
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-DNN 332 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~-~~~ 332 (611)
++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ......+.+|+.++.++ +||||++++++|.. +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5789999999999999999973 35788999999753 34456788999999999 68999999998865 456
Q ss_pred eEEEEeeCCCCChhhhhccCCC----------------------------------------------------------
Q 007256 333 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 354 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~---------------------------------------------------------- 354 (611)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 8999999999999999864321
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccccccc
Q 007256 355 -----DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429 (611)
Q Consensus 355 -----~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~G 429 (611)
....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 01246888899999999999999999 8999999999999999999999999999986543322222222345
Q ss_pred ccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHH
Q 007256 430 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQM 508 (611)
Q Consensus 430 T~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~ 508 (611)
++.|+|||++.+..++.++|||||||++|+|++ |..||............. ..+... ...... .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------~~~~~~-----~~~~~~----~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------KEGTRM-----RAPDYT----T 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH------hccCCC-----CCCCCC----C
Confidence 678999999998899999999999999999997 999986543322111100 011000 000111 1
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 509 ERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 509 ~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..+..++..||+.+|.+||++.+|++.|+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 245666778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=308.50 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=203.0
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
++|.+.+.||+|+||.||+|... +++.+++|.+..... .+.+.+|+++++.++|+||+++++++..+...+++|||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 57888999999999999999976 489999999986544 6789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++.... ..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999986543 358999999999999999999999 8999999999999999999999999999987654332
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+......+ .. .. .+.+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--~~-----~~-----~~~~~- 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--PN-----KP-----PPTLS- 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--cc-----CC-----CCCCC-
Confidence 122356899999999999889999999999999999999999999765433221110 00 00 00000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+......+..++..|++.+|.+||++.+|++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 01111234556667799999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=310.88 Aligned_cols=250 Identities=25% Similarity=0.418 Sum_probs=199.6
Q ss_pred CceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC-------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~-------~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
+|.+.+.||+|+||.||+|...+|+.+|||.++.. ......+.+|+++++.++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999999888999999998643 12345688999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999996543 47889999999999999999999 889999999999999999999999999987653
Q ss_pred CCCCC----ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 417 TSSSH----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 417 ~~~~~----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
..... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+... .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~-- 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH-----RGL-- 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhc-----cCC--
Confidence 21111 1112356899999999999889999999999999999999999999764432211111100 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+.+... ....+..++..||+.+|.+||++.++++
T Consensus 227 ---~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ---MPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111111 1234556677799999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=323.47 Aligned_cols=203 Identities=24% Similarity=0.303 Sum_probs=175.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||++... +++.||+|++... ......+.+|+.++..++|+||+++++++..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999865 6889999998752 233455788999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||++||+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997532 257889999999999999999999 9999999999999999999999999999976654
Q ss_pred CCCCccccccccccccCChhhhcc-----CCCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
.... ......||+.|+|||++.. +.++.++|||||||+||||++|+.||.....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 3221 1223579999999999875 5688999999999999999999999976554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.61 Aligned_cols=266 Identities=24% Similarity=0.308 Sum_probs=205.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChh---HHHHHHHHHHHHHhcCCcc-eeEEeeEEEecC------c
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---VIKEFVLEIEIITTLHHKN-IISLLGFCFEDN------N 332 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---~~~~f~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~------~ 332 (611)
.|...++||+|+||+||+|..+ +|+.||+|.++.+.+ ......+|+.+|+.++|+| |++|++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4555677999999999999964 789999999986533 4566789999999999999 999999998877 7
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
+++||||++. +|.+++.........++...+..++.||+.||+|||+ ++|+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchH
Confidence 9999999977 9999997665322346668899999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
+...-... ..+..++|.+|.|||++.+. .|+...||||+|||+.||++++..|.++....+...+-.......+..+
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 86653322 23456899999999999876 7999999999999999999999999888775554443222111111111
Q ss_pred ---ccccCc--ccCCCC-C-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 492 ---TQLLDP--ALGNNY-D-------YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 492 ---~~lld~--~l~~~~-~-------~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+.+- .+.... . .........++..||+.+|.+|.|+..++++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111110 010000 0 0111355667778999999999999998875
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=315.86 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=197.8
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.|...+.||+|+||.||++... +++.||||.+.... .....+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677899999999999999865 78999999986532 234567789999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999998864432 358899999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.............. ... ... ..
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~---~~~--~~~----~~ 223 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVK--EVQ----EE 223 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh---hhh--hhh----hh
Confidence 22 1235799999999999999999999999999999999999999976443211111100 000 000 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~~ 535 (611)
....+. ..+..++..||+.||.+||| +.+++++
T Consensus 224 ~~~~~~----~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 YSEKFS----PDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCccCC----HHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111111 23445566799999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=309.63 Aligned_cols=238 Identities=25% Similarity=0.416 Sum_probs=191.0
Q ss_pred eeEeecCcEEEEEEEeCCCC-----------EEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 269 NLIGKGGSSQVYKGCLPDGK-----------ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~-----------~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
+.||+|+||.||+|.+.+.. .+++|++.........|.+|+.+++.++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 36899999999999976432 57888887655447789999999999999999999999988 7889999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-------ceEEeecC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-------EPQLSDFG 410 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-------~vKL~DFG 410 (611)
||+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999976542 58899999999999999999999 8999999999999999887 79999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccC--CCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccc
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 487 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 487 (611)
++...... ....++..|+|||++... .++.++|||||||++|||++ |..||.................
T Consensus 154 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~--- 224 (259)
T cd05037 154 IPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR--- 224 (259)
T ss_pred cccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCC---
Confidence 98765431 124567889999999876 78999999999999999999 5777766543222211110000
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 488 ~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
. .......+..++..||..+|.+|||+.+|++.|.
T Consensus 225 -----------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 -----------L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0001145666777899999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=323.10 Aligned_cols=203 Identities=25% Similarity=0.324 Sum_probs=174.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||++..+ +++.+|+|++... ......+..|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999875 5788999998642 223445788999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999975332 58889999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCCccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
.... ......||+.|+|||++. .+.++.++|||||||++|||++|+.||.....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~ 213 (332)
T cd05623 155 DGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (332)
T ss_pred CCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH
Confidence 2221 122357999999999986 34688999999999999999999999976554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=311.99 Aligned_cols=253 Identities=28% Similarity=0.379 Sum_probs=188.0
Q ss_pred eEeecCcEEEEEEEeCC---CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCC
Q 007256 270 LIGKGGSSQVYKGCLPD---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 344 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~~~~---g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggs 344 (611)
.||+|+||.||+|...+ ...+|+|.+... ......|.+|+.+++.++|+||++++++|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 356888887643 3445678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcc
Q 007256 345 LEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 423 (611)
Q Consensus 345 L~~~L~~~~~~-~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 423 (611)
|.+++...... ...+.+.....++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764421 2335678888999999999999999 8999999999999999999999999999875433222222
Q ss_pred ccccccccccCChhhhcc-------CCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 424 CTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 424 ~~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
.....+++.|+|||++.. ..++.++|||||||++|||++ |..||....+........ .. ....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~------~~-~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV------RE-QDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh------hc-cCccCC
Confidence 223456778999999753 356789999999999999999 788886543322111110 00 111112
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
++.+...+. ..+..+...|+ .||.+||++.+|++.|.
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDLKYS----DRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccccCC----HHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222222212 22333445577 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=335.79 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=201.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~ 333 (611)
++|.+.+.||+|+||.||+|.+. .++.||||+++.. ......+.+|+++|.++. ||||++++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 35778899999999999999853 3568999999854 233457889999999998 99999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC-----------------------------------------------------------
Q 007256 334 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 354 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~----------------------------------------------------------- 354 (611)
++||||+++|+|.++++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999965321
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC
Q 007256 355 -----------------------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 399 (611)
Q Consensus 355 -----------------------------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd 399 (611)
....+++..+..++.|++.||.|||+ .+|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence 11246788889999999999999998 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhH
Q 007256 400 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 478 (611)
Q Consensus 400 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l 478 (611)
.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||...........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 999999999999986543322222223457889999999998889999999999999999998 8999865443222111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 479 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 479 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
... .+. .+.. +......+..++..||..+|.+||++.+|++.|+.
T Consensus 354 ~~~------~~~-----~~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 354 AIK------RGY-----RMAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred HHH------cCC-----CCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 100 000 0000 11112345566677999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=309.52 Aligned_cols=245 Identities=26% Similarity=0.408 Sum_probs=192.7
Q ss_pred EeecCcEEEEEEEeC---CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 271 IGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
||+|+||.||+|.+. ++..||+|++... ....+.+.+|+.++++++||||+++++++. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999753 4567999998754 244567999999999999999999999885 4578999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcc-c
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-C 424 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~-~ 424 (611)
.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........... .
T Consensus 82 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGKK---DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99986533 258899999999999999999999 8999999999999999999999999999986544322211 1
Q ss_pred cccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCC
Q 007256 425 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 503 (611)
Q Consensus 425 ~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 503 (611)
....+++.|+|||++.++.++.++|||||||++|||++ |+.||...........+.. +.. +.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~-----~~~---- 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-------GKR-----LDC---- 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-------CCC-----CCC----
Confidence 11234578999999998899999999999999999996 9999976544332222111 100 001
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 504 DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 504 ~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+......+..++..||..+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 11112344456677999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=337.37 Aligned_cols=205 Identities=30% Similarity=0.441 Sum_probs=184.2
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-C-----cceeEEeeEEEecCceEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-H-----KNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-H-----pnIv~l~g~~~~~~~~~LV 336 (611)
+|.+.+.||+|.||.|.+|.+. +++.||||++++......+...|+.||..|+ | -|+|+++++|...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 7899999999999999999864 7999999999999999999999999999998 4 4899999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC--CceEEeecCcccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKW 414 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~--~~vKL~DFGla~~ 414 (611)
+|.+.. +|+++|+.+.-. .++...++.++.||+.||.+||+ .+|||+||||+||||.+. ..+||+|||.|.+
T Consensus 267 fELL~~-NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhhhh-hHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999966 999999877654 48899999999999999999999 999999999999999643 4799999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv 479 (611)
...... ..+-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+++..++...+
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I 400 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI 400 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence 765322 356789999999999999999999999999999999999999888777666554
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=329.09 Aligned_cols=194 Identities=25% Similarity=0.387 Sum_probs=166.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
...+|.+.+.||+|+||.||+|... ++..||+|+.... ....|+.++++++|+||+++++++...+..++||||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3457999999999999999999875 5788999986533 234699999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+. ++|.+++.... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 YS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 96 48888876433 358999999999999999999999 899999999999999999999999999997543322
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCC
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 469 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 469 (611)
. .....||+.|+|||++.+..++.++|||||||++|||+++..|+..
T Consensus 212 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 212 A---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred c---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 1 1235799999999999999999999999999999999996665533
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=311.28 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=199.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999864 68999999987543 3445688899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 99999999986543 48899999999999999999999 899999999999999999999999999987654322
Q ss_pred CCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 420 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
. ......|++.|+|||++. .+.++.++|||||||++|+|++|..||....+........... .. .
T Consensus 161 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~--~~--------~ 228 (267)
T cd06645 161 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN--FQ--------P 228 (267)
T ss_pred c--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC--CC--------C
Confidence 2 122357899999999984 4568899999999999999999999987654332221111100 00 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+.+...... ...+..++..||+.+|++||++.+|+++
T Consensus 229 ~~~~~~~~~--~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKDKMKW--SNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CcccccCCC--CHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 111111111 1235566777999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=310.69 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=203.2
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC------
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN------ 331 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~------ 331 (611)
..+++|.+.+.||+|+||.||+|... +++.+++|++.......+.+.+|+++++++ .|+||++++++|....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35689999999999999999999975 688999999987766667899999999999 6999999999997654
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987544333568999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhcc-----CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 486 (611)
+......... .....|+..|+|||++.. ..++.++|||||||++|+|++|+.||...........+ ..
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~--- 232 (275)
T cd06608 160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI--PR--- 232 (275)
T ss_pred ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh--hc---
Confidence 8765433221 223568999999998853 34678999999999999999999999754332211110 00
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 487 ~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+.. +.+. ........+..++..||..||++|||+.++++
T Consensus 233 --~~~-----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 --NPP-----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred --cCC-----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 0111 01112345566777899999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.55 Aligned_cols=249 Identities=26% Similarity=0.397 Sum_probs=200.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
..+|.+.+.||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.+++.+.|+||++++++|..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35899999999999999999986 478999999887533 3456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 9999999998642 37889999999999999999999 899999999999999999999999999987654322
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....+..... .+.. .+. .. +
T Consensus 171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~~~~----~~~-~~-----~ 236 (296)
T cd06654 171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--LIAT----NGT-PE-----L 236 (296)
T ss_pred cc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--HHhc----CCC-CC-----C
Confidence 11 123468999999999998889999999999999999999999997655432211 1110 000 00 0
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
. ........+..++..||..+|++||++.++++
T Consensus 237 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 Q--NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred C--CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 01111234555667899999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=323.27 Aligned_cols=268 Identities=23% Similarity=0.331 Sum_probs=210.9
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-----c
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-----D 330 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-----~ 330 (611)
.....|...+.||+|+||.|..+.+. +|+.||||.+.. .....++..+|+.+|+.++|+||+.+++.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34556777899999999999999865 799999998863 44667888999999999999999999998865 4
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
+.+|+|+|+|+. +|...++... .++......++.|+++||.|+|+ .+|+||||||+|+|++.+..+||+|||
T Consensus 99 ~DvYiV~elMet-DL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELMET-DLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHHhh-HHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccc
Confidence 579999999954 9999997654 38888999999999999999999 889999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhc-cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
+|+...........+..+.|.+|.|||++. ...|+...||||.||||.||++|++.|.+.+...+..++....+.....
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 999886543333445678999999999876 5589999999999999999999999999988888777776554433322
Q ss_pred ccccccCcc-------cC--CCCChHH-----HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPA-------LG--NNYDYDQ-----MERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~-------l~--~~~~~~~-----~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+..+-... +. ...++.. ....+.+.-.||..||.+|+|++|.|++
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 222221100 00 0011111 1122334445999999999999998864
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=328.67 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=207.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~ 334 (611)
....|.+.+.||.|.||.||++..+ +|+.+|+|++++.. .....+.+|+.||+++. |||||.++++|.....++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3457888899999999999999976 59999999997643 24568899999999999 999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC----CceEEeecC
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFG 410 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~----~~vKL~DFG 410 (611)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+ .||+||||||+|+|+... +.+|++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999765 28999999999999999999999 999999999999999533 579999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
++...... ......+||++|+|||++....|+..+||||+||++|.|++|..||...........+.....
T Consensus 185 la~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------ 255 (382)
T KOG0032|consen 185 LAKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------ 255 (382)
T ss_pred CceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC------
Confidence 99988762 223458999999999999999999999999999999999999999988775554443332221
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 491 l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. +....-.......-.++..|+..||.+|+|+.++|++
T Consensus 256 --~-----f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 --D-----FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --C-----CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 1111111122334445556999999999999999984
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=322.36 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=203.2
Q ss_pred cCceeeeeEeecCcEEEEEEEeC--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 331 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 331 (611)
.+|.+.+.||+|+||.||++... .+..||+|.++.. ....+.+.+|+.+++++ +||||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 1236899998753 34567899999999999 7999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 399 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd 399 (611)
..+++|||+++|+|.+++..... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 99999999999999999875321 12358899999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhH
Q 007256 400 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESL 478 (611)
Q Consensus 400 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~l 478 (611)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999986654332222222344678999999999999999999999999999998 8899876543222111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 479 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 479 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
+. .+.... ........+..++..|++.+|.+||++.++++.|....
T Consensus 249 ~~-------~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 249 LK-------EGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HH-------cCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 11 000000 01111234566777899999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=311.15 Aligned_cols=248 Identities=26% Similarity=0.437 Sum_probs=193.0
Q ss_pred eeEeecCcEEEEEEEeC-CCC--EEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGK--ELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~--~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|.+. +|. .+++|.++.. ....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999875 444 4688988742 44566889999999999 799999999999999999999999999
Q ss_pred CChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 343 GSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 343 gsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
|+|.+++..... ....+++..+..++.+++.||+|||+ ++++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999875431 12347899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccC
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
++....... .......+..|+|||++....++.++|||||||++|||++ |..||...........+ . ...
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~---~---~~~ 228 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---P---QGY 228 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH---h---CCC
Confidence 985322111 1111234667999999998899999999999999999997 99999654332211111 0 000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.. .. .......+..++..|++.+|.+|||+.++++.|..
T Consensus 229 ~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 229 RL------EK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CC------CC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 00 00 01112345677778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=308.57 Aligned_cols=248 Identities=28% Similarity=0.462 Sum_probs=197.3
Q ss_pred eeEeecCcEEEEEEEeCC--CC--EEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLPD--GK--ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~--g~--~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|++|.||+|.+.+ ++ .||||.+.... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 33 68999998643 456789999999999999999999999988 889999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|.+++..... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976542 358999999999999999999999 899999999999999999999999999998775533221
Q ss_pred cc-cccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 423 TC-TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 423 ~~-~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
.. ....++..|+|||++....++.++|||||||++|||++ |+.||...........+.. .+. .+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------~~~--~~~~---- 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK------EGE--RLER---- 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------cCC--cCCC----
Confidence 11 12457889999999998899999999999999999999 9999965433221111110 000 0000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.......+..++..|++.+|.+||++.+|++.|.
T Consensus 223 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 ---PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111234556777899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=311.95 Aligned_cols=264 Identities=25% Similarity=0.329 Sum_probs=200.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|+||.||+|.+. +|+.||+|++.... ...+.+.+|+.+++.++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999876 68999999986432 234567899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|++++.|..++.... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988888765432 48999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh-ccc-------cccC
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPI-------LSSG 489 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~-~~~-------~~~g 489 (611)
... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ... ....
T Consensus 154 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 321 123467899999999876 45789999999999999999999999865543322211100 000 0000
Q ss_pred c-cccccCcccCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 K-VTQLLDPALGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~-l~~lld~~l~~~~~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. ......+....... ......+..++..||+.+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 00000000000000 0112456677788999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=310.14 Aligned_cols=254 Identities=23% Similarity=0.412 Sum_probs=201.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCC----EEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.+|.+.+.||+|+||.||+|..+ +|. .+|+|.++... .....+.+|+.+++.++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888999999999999999864 343 58999887543 455688999999999999999999999987 78999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++..... .+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999975432 48899999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
.............++..|+|||.+..+.++.++|||||||++|||++ |+.||...........+..... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------~ 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER---------L 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC---------C
Confidence 54333222222234678999999988899999999999999999999 9999976544322221111000 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
..+ ......+..++..||..+|.+||++.++++.|...
T Consensus 231 ~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 PQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 01112355566779999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=310.83 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=202.0
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||.|+||.||+|.+. +++.||+|++... ......+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999865 6899999998753 34456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++... .+++..++.++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998753 58899999999999999999999 899999999999999999999999999998776542
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....+......+. .+. .+.+
T Consensus 153 ~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------~~~-----~~~~ 218 (274)
T cd06609 153 SK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-------KNN-----PPSL 218 (274)
T ss_pred cc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-------hcC-----CCCC
Confidence 21 223578999999999998889999999999999999999999997655322211111 000 1111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.... ....+..++..||..+|++||++.++++.
T Consensus 219 ~~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 EGNK---FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cccc---cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1110 11234556667999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=338.10 Aligned_cols=196 Identities=24% Similarity=0.324 Sum_probs=170.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
...+|.+.+.||+|+||.||++.+. +++.||||... ...+.+|+++|++++|+|||++++++..++..++|||+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3558999999999999999999875 58889999643 23467899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+. ++|.+++.... ..++|..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 58888876433 258999999999999999999999 899999999999999999999999999998765433
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCC
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 468 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~ 468 (611)
.........||+.|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2222234679999999999999999999999999999999999887654
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.60 Aligned_cols=254 Identities=26% Similarity=0.371 Sum_probs=202.2
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVY 337 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~LV~ 337 (611)
+|.+.+.||.|+||.||++... +|..+|+|+++.. ....+.+..|+.+++.++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999864 7889999998643 3455678899999999999999999998864 44689999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~--~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||+++++|.+++.........+++..++.++.+++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765443456899999999999999999999321 289999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
...... .....|++.|+|||++....++.++||||||+++++|++|+.||....... +.... ..+..
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~~---- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKI----KEGKF---- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHH----hcCCC----
Confidence 553321 223578999999999998889999999999999999999999997654221 11111 11111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+.+ .......+..++..|++.+|.+||++.+|+++
T Consensus 228 -~~~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -RRI----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCC----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111 11223455667778999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.10 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=203.3
Q ss_pred CceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|++.+.||.|+||.||.+.. .+++.+++|.+.. +....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999999999885 4689999998764 345567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.... ...+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997543 2358899999999999999999999 899999999999999999999999999998765433
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
. ......|++.|+|||++.+..++.++||||||++++||++|..||...........+. .+......
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-------~~~~~~~~---- 222 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-------QGNYTPVV---- 222 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCCCCCCc----
Confidence 2 1223578999999999988889999999999999999999999997654332221111 11111110
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
......+..++..|++.+|.+||++.++++.+
T Consensus 223 -----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 -----SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -----cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123455666679999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=311.42 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=188.8
Q ss_pred eEeecCcEEEEEEEeCCC---CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCC
Q 007256 270 LIGKGGSSQVYKGCLPDG---KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 344 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~~~~g---~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggs 344 (611)
.||+|+||.||+|...++ ..+++|.++.. ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 34667776643 3456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccc
Q 007256 345 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424 (611)
Q Consensus 345 L~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~ 424 (611)
|.+++.........+.+..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997654333346677788999999999999999 89999999999999999999999999998643222111122
Q ss_pred cccccccccCChhhhcc-------CCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 425 TDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 425 ~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||...........+. .+....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-------~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI-------KDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------hhcccccCC
Confidence 23568899999998753 245789999999999999997 566876543322211111 111222333
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
+.+...+. ..+..+...|+ .+|++||++.+|++.|.
T Consensus 232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33332222 23333445688 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.94 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=202.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||+||++... +|+.||+|++... ....+.+.+|+++++.++||||+++++++...+.+++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356888899999999999999865 6899999988643 3456789999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.+++...+ .+++..+..++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999886543 488999999999999999999961 47999999999999999999999999998654332
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcch-----hhHHHhhccccccCcccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-----ESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~-----~~lv~~~~~~~~~g~l~~ 493 (611)
.. ....|+..|+|||++.++.++.++|||||||++|+|++|+.||........ ..+..+....... .
T Consensus 158 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 229 (284)
T cd06620 158 IA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P--- 229 (284)
T ss_pred cc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c---
Confidence 11 235789999999999888999999999999999999999999986543211 1111111111100 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
.+.+... .....+..++..|++.||.+|||+.+|+++.
T Consensus 230 --~~~~~~~---~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 --PPRLPSS---DFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCCCCch---hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111111 1123455667789999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.02 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=196.6
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.+.+.||+|++|.||+|... +|..||||.++.. ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5888999999999999999875 7899999998753 22346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
++ ++|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 588888865432 2358899999999999999999999 899999999999999999999999999987554322
Q ss_pred CCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH--Hhhccc---cc----cC
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV--MWAKPI---LS----SG 489 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv--~~~~~~---~~----~g 489 (611)
. ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||............ .+..+. +. ..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1 11224678999999988754 5788999999999999999999999765432211110 000000 00 00
Q ss_pred ccc----cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 490 KVT----QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 490 ~l~----~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
... ......+.. ........+..++..||+.||.+|||+.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRS-AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHH-hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 000000000 00001234456777899999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=318.26 Aligned_cols=199 Identities=26% Similarity=0.432 Sum_probs=162.7
Q ss_pred eeeEeecCcEEEEEEEeC---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEEEEeeCCC
Q 007256 268 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 342 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~LV~Ey~~g 342 (611)
.++||+|+||+||+|... +++.||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 467999999999999864 56789999997543 23457789999999999999999999864 4568999999865
Q ss_pred CChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee----CCCCceEEeecCccc
Q 007256 343 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 413 (611)
Q Consensus 343 gsL~~~L~~~~-----~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL----d~~~~vKL~DFGla~ 413 (611)
+|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 8887765322 122358899999999999999999999 899999999999999 456789999999998
Q ss_pred cccCCCCC-ccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCC
Q 007256 414 WASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 471 (611)
Q Consensus 414 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 471 (611)
........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76543221 122346789999999999764 58999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.26 Aligned_cols=248 Identities=25% Similarity=0.424 Sum_probs=197.5
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
+|.+.+.||+|+||.||+|... +++.+|+|.+.... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999864 68899999886421 223568899999999999999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.++||||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999997543 47888999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc----cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 007256 413 KWASTSSSHI----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 488 (611)
Q Consensus 413 ~~~~~~~~~~----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 488 (611)
+......... ......|+..|+|||++.++.++.++|||||||++|+|++|+.||...........+ .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~------ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--G------ 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH--h------
Confidence 8765321111 111246889999999999889999999999999999999999999764322111100 0
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 489 g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
....+.+.. .....+..++..||+.+|.+||++.+|++
T Consensus 226 ----~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 ----ENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----ccCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011111111 11234555666799999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=303.60 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=199.1
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~~LV~E 338 (611)
+|.+.+.||+|++|.||++... +++.||+|.+... ....+.+.+|++++++++|+|++++++.+.. +..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999865 5789999998643 2445678899999999999999999998764 446899999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.+++..... ..+++.++..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999875332 358899999999999999999999 89999999999999999999999999999866443
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
... .....|++.|+|||++.++.++.++|||||||++++|++|+.||............. .+.+..
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-------~~~~~~----- 221 (257)
T cd08223 156 CDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-------EGKLPP----- 221 (257)
T ss_pred CCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------hcCCCC-----
Confidence 221 223568999999999999999999999999999999999999997544322111110 111110
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+ .......+..++..|++.+|++||++.++++.
T Consensus 222 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 M----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred C----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 11122345667778999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=364.34 Aligned_cols=261 Identities=29% Similarity=0.528 Sum_probs=214.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
...|...+.||+|+||.||+|.. .+|..||||.++..... ...|++++++++|||||+++++|.+++..++||||+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 34577788999999999999986 58999999998754322 234688999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.++++ .++|..+..|+.|+++||+|||..+..+|+||||||+||+++.++.+++. ||.+......
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 9999999995 27899999999999999999996555899999999999999999888876 6655433221
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....++.|............++|+.+.
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 123689999999999999999999999999999999999999954332 233456666655555556667777765
Q ss_pred CC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 501 NN--YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 501 ~~--~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.. ....++..+..++..|++.+|++||+|.+|++.|+...
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 43 34566778888999999999999999999999997543
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.52 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=203.7
Q ss_pred CHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe--
Q 007256 254 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-- 329 (611)
Q Consensus 254 ~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~-- 329 (611)
++.++....+.|.+.+.||.|+||.||+|.+. +++.+|+|++.........+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 45555667788999999999999999999874 688999999987666667788999999998 69999999999863
Q ss_pred ----cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 330 ----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 330 ----~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
++..+++|||+++|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+|+||||+||+++.++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 4578999999999999999865432 347788889999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~ 480 (611)
|+|||++........ ......|++.|+|||++. ...++.++|||||||++|||++|+.||....+......+.
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence 999999876543221 122357899999999876 3468889999999999999999999997654332222111
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 481 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 481 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+.. .+.+... .....+..++..||+.||.+||++.++++
T Consensus 240 ~~~------------~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 RNP------------PPKLKSK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hCC------------CCCCccc---ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 100 0111100 11234556677799999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.68 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=200.6
Q ss_pred CceeeeeEeecCcEEEEEEEeCC--CCEEEEEEecC-----------ChhHHHHHHHHHHHHHh-cCCcceeEEeeEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKP-----------SEDVIKEFVLEIEIITT-LHHKNIISLLGFCFE 329 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~-----------~~~~~~~f~~Ei~iL~~-l~HpnIv~l~g~~~~ 329 (611)
+|.+.+.||+|+||.||+|.... ++.+|+|.+.. ......++.+|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999764 78899998753 22345667889998875 799999999999999
Q ss_pred cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeec
Q 007256 330 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409 (611)
Q Consensus 330 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DF 409 (611)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999886433333468999999999999999999995 157999999999999999999999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
|++....... ......|+..|+|||++.++.++.++||||||+++|+|++|+.||...........+. .+
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~-------~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIV-------EA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHh-------hc
Confidence 9998665433 2233578999999999998889999999999999999999999997544322111111 01
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
... +.....+ ...+..++.+|++.||++||++.+|..++.
T Consensus 229 ~~~----~~~~~~~----~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE----PLPEGMY----SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC----cCCcccC----CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 100 1000011 134556667799999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.41 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=200.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||.||+|.+.+ ...||||..... ....+.+.+|+.+++.++||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3468889999999999999998643 246899988754 3456689999999999999999999999865 56789
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++.... ..+++..++.++.+++.||.|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999997543 248999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
....... .....++..|+|||++....++.++|||||||++|||++ |..||...........+..... .
T Consensus 158 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------~--- 227 (270)
T cd05056 158 EDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER------L--- 227 (270)
T ss_pred cccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc------C---
Confidence 5442221 122345678999999988889999999999999999996 9999976544322111111100 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
...... ...+..++..|+..+|.+|||+.++++.|..
T Consensus 228 ---~~~~~~----~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 228 ---PMPPNC----PPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred ---CCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 011111 1345566778999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.63 Aligned_cols=248 Identities=26% Similarity=0.423 Sum_probs=189.6
Q ss_pred eeEeecCcEEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEE-ecCceEEEEeeCC
Q 007256 269 NLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLLLVYDFLS 341 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~~~LV~Ey~~ 341 (611)
+.||+|+||.||+|.+. ++..+|+|.+... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2457999998642 345678899999999999999999999876 4556899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+|+|.+++..... .+.+..+..++.+++.||.|||+ .+++||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999975432 36778888999999999999999 89999999999999999999999999998755332111
Q ss_pred --ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhC-CCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 422 --ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 422 --~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.......+++.|+|||++....++.++|||||||++|||++| ..||....... +..... .+. .+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~----~~~-----~~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLL----QGR-----RLL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh----cCC-----CCC
Confidence 111123567789999999988999999999999999999995 55665433221 111110 000 000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.... ....+..++..||+.+|++||++.+|++.|+.
T Consensus 223 ~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 223 QPEY----CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CCCc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0011 12345667778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.66 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=203.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
++|.+.+.||.|+||.||+|... +++.+++|++.... ...+.+.+|+++++.++||||+++++++..++..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57999999999999999999874 67889999987543 35678899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999887542 258899999999999999999999 8999999999999999999999999999876544221
Q ss_pred CccccccccccccCChhhhccC---CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~---~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
......++..|+|||++... .++.++|||||||++|||++|+.||....+........ ..... .+
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~~--------~~ 224 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNFP--------PP 224 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCC--------Cc
Confidence 11235688999999999876 88999999999999999999999997655433222111 10000 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+. ........+..++.+|+..+|.+|||+.+|+.
T Consensus 225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 110 11222345667788899999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.89 Aligned_cols=251 Identities=25% Similarity=0.373 Sum_probs=193.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHH-HHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~i-L~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|+||.||++.+. +|+.||+|+++... .....+..|+.+ ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47899999999999999999875 69999999987542 334456667765 666789999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-cEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~-gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
|++ |+|.+++.........+++..++.++.|++.||.|||+ + +++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 58888876543333568999999999999999999998 5 899999999999999999999999999876643
Q ss_pred CCCCccccccccccccCChhhhcc----CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMY----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
... .....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||....... ..+..... +.
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~-----~~--- 224 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQVVE-----EP--- 224 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHHHh-----cC---
Confidence 221 122568999999998864 456889999999999999999999996432211 11111000 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+.+... .....+..++..||..+|.+||++.++++
T Consensus 225 --~~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 --SPQLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111100 01234556677799999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.56 Aligned_cols=247 Identities=29% Similarity=0.480 Sum_probs=198.1
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
++|.+.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.+++.++|||++++++++..+ ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4688999999999999999864 77889999987543 346788999999999999999999998654 57999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999975432 357899999999999999999999 899999999999999999999999999987543321
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
.....+..|+|||++.++.++.++|+|||||++|||++ |+.||...........+.. +.. .+ ...
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~~---~~--~~~ 220 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-------GYR---ME--PPE 220 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-------CCC---CC--CCC
Confidence 11334678999999998899999999999999999998 9999976554322111111 000 00 001
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.....+..++..|++.+|.+||++.+|++.|+.
T Consensus 221 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 ----GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112345567778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=325.80 Aligned_cols=260 Identities=22% Similarity=0.286 Sum_probs=194.4
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEec------
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 330 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~------ 330 (611)
..++|.+.+.||+|+||+||+|.+. +++.||||++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4578999999999999999999864 78899999997532 3345678899999999999999999987543
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
...+++++++ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCc
Confidence 3578999988 67998887532 48899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc---
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL--- 486 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~--- 486 (611)
+++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......
T Consensus 164 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 998654421 23578999999999876 568999999999999999999999997654322111110000000
Q ss_pred -----ccCccccccCcccCCCCC--h-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 487 -----SSGKVTQLLDPALGNNYD--Y-----DQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 487 -----~~g~l~~lld~~l~~~~~--~-----~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
........+. .+..... . .....+..++..||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0000000 0 001124566778999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=312.71 Aligned_cols=246 Identities=28% Similarity=0.420 Sum_probs=199.0
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.|...+.||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3566778999999999999864 6889999998743 345567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++... .+.+..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKPG-----PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999988642 47899999999999999999999 8999999999999999999999999999876654321
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....+..... +. ..+ ..+.+.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~----~~~-----~~~~~~ 222 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---LI----PKN-----SPPTLE 222 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---hh----hcC-----CCCCCC
Confidence 1123568999999999998899999999999999999999999987544322111 10 000 011111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
......+..++..|++.+|.+||++.+|++.
T Consensus 223 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122345566777999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.58 Aligned_cols=264 Identities=24% Similarity=0.338 Sum_probs=210.1
Q ss_pred hhcCceeeeeEeecCcEEEEEEE-eCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-----e
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN-----L 333 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~-----~ 333 (611)
..++|.+.+.||+|||+.||++. ..++..||+|++.... +..+..++|++..++++|||+++++++...+.. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999998 4688999999988655 778889999999999999999999998865544 9
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
||+++|...|+|.+.+......+..+++.++++|+.+|++||.+||... .++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999877766678999999999999999999999943 359999999999999999999999999987
Q ss_pred cccCCCCCcc-------ccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 007256 414 WASTSSSHIT-------CTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 414 ~~~~~~~~~~-------~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~ 483 (611)
...-...... ...-..|..|.|||.+. +...++++|||||||+||+|+.|..||+.....+.......
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv-- 255 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV-- 255 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee--
Confidence 5542211100 01124689999999986 44678999999999999999999999976544332211111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 484 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.++++.-. . .....+.+.+++..|++.||.+||++.+++..+..
T Consensus 256 ---~n~q~s~P------~--~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 256 ---QNAQISIP------N--SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ---eccccccC------C--CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 11111111 1 11134577788889999999999999999988753
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.13 Aligned_cols=258 Identities=22% Similarity=0.327 Sum_probs=199.0
Q ss_pred HHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 258 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 258 l~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
++.+++++.....||+|+||.||+|.+. ++..||+|.+... ....+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445677777789999999999999864 6788999988754 3456788999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-CCceEEeecCcccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKW 414 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-~~~vKL~DFGla~~ 414 (611)
||||+++++|.+++..... ....++..+..++.||+.||.|||+ .+|+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999875422 1112778888999999999999999 89999999999999976 67999999999876
Q ss_pred ccCCCCCccccccccccccCChhhhccCC--CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
....... .....|++.|+|||++.... ++.++|||||||++|+|++|+.||........ ..+......
T Consensus 159 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~----- 228 (268)
T cd06624 159 LAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK----- 228 (268)
T ss_pred cccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc-----
Confidence 5432221 12246899999999987654 78899999999999999999999965432111 111111000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+.+. ......+..++..||+.+|.+|||+.++++.
T Consensus 229 --~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 --IHPEIP----ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --cCCCCC----cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 001111 1112345566778999999999999998863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=307.53 Aligned_cols=254 Identities=26% Similarity=0.418 Sum_probs=197.8
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-----------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-----------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 331 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-----------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~ 331 (611)
+|...+.||.|+||.||+|... +|+.||+|.++... ...+.+..|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999864 68999999886321 12356788999999999999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999997652 58889999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCC--CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
+................|+..|+|||++.... ++.++|+||||+++++|++|..||.......... .... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~-----~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF--KLGN-----K 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH--Hhhc-----c
Confidence 97654432222223356899999999988654 8899999999999999999999996543221111 1000 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.....+...... .....+..++..|++.+|.+||++.+|++.
T Consensus 228 ~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000111111111 112344556667999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.93 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=202.3
Q ss_pred cCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
++|.....||+|+||.||+|..+ +.+.+++|.+.... ...+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999853 34679999987543 24678999999999999999999999999989999
Q ss_pred EEEeeCCCCChhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeec
Q 007256 335 LVYDFLSRGSLEENLHGNKKD-----PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~-----~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DF 409 (611)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999755421 1258999999999999999999999 88999999999999999999999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhcccccc
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 488 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 488 (611)
|++......... ......++..|+|||.+.++.++.++|||||||++|+|++ |..||........ +.... .
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~~~~----~ 233 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LNRLQ----A 233 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HHHHH----c
Confidence 998754332211 1223456788999999998889999999999999999999 8889865433221 11111 0
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 489 g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
+.+... ... .....+..++..||+.+|.+||++.+++..|.
T Consensus 234 ~~~~~~----~~~----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELP----VPE----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCC----CCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111000 001 11235666777899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.46 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=196.9
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
|.+.+.||+|+||.||+|... ++..+++|.+... ....+.+.+|+++++.++||||++++++|..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567788999999999999876 5788899998753 45567889999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|..++.... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 99998876432 258999999999999999999999 8999999999999999999999999999876543221
Q ss_pred cccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 423 TCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
......||+.|+|||++. +..++.++|||||||++|||++|+.||....+........... ......+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-------PPTLAQP 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC-------CCCCCCc
Confidence 122357899999999984 3457889999999999999999999997654332211111000 0000001
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+ ...+..++..||+.+|.+||++.++++.
T Consensus 232 ---~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 ---SRW----SSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1244556677999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=307.20 Aligned_cols=238 Identities=25% Similarity=0.450 Sum_probs=186.9
Q ss_pred eeEeecCcEEEEEEEeCC-------------CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 269 NLIGKGGSSQVYKGCLPD-------------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~-------------g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
+.||+|+||.||+|...+ ...+++|.+.... .....|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997432 2358999887543 34557888999999999999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc-------eEEe
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-------PQLS 407 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~-------vKL~ 407 (611)
+||||+++|+|..++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999998886533 258899999999999999999999 89999999999999986654 8999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhc-cCCCCCcceehhhhHHHHHHH-hCCCCCCCCCCcchhhHHHhhccc
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELL-TGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELl-tG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
|||++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|+.||........... +..
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~--~~~-- 224 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF--YEG-- 224 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH--Hhc--
Confidence 99998655321 1245788999999887 467899999999999999998 58888865433221111 110
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
.. ... ......+..++..||+.||.+||++.+|++.+
T Consensus 225 ----~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 ----QC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----Cc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 000 01123456677789999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=302.54 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=204.0
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||.|+||+||+|... ++..+|+|++... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999864 6889999998743 23567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++..... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975432 1358899999999999999999999 899999999999999999999999999987765543
Q ss_pred CCc--cccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 420 SHI--TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 420 ~~~--~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
... ......|+..|+|||++... .++.++|+|||||++++|++|+.||.......... ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~--~~~~~----------~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM--LTLQN----------DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH--HHhcC----------CC
Confidence 221 12235689999999999877 78999999999999999999999997654432111 11110 00
Q ss_pred cccCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 PALGNNYD-YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~-~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+.+..... ......+..++..|++.||.+||++.+|++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111000 1122345566677999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.22 Aligned_cols=256 Identities=24% Similarity=0.430 Sum_probs=200.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCC----EEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
.++|...+.||+|+||.||+|.+. +|. .+|+|.+.... .....+.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999863 444 57899887543 3345788999999999999999999998654 578
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+++||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence 9999999999999987543 257899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
..............++..|+|||++.+..++.++|||||||++|||++ |+.||..........++.... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~------~~-- 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE------RL-- 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC------CC--
Confidence 654333222223456788999999998899999999999999999997 999997653322212111100 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.. ... ....+..++..|+..+|++||++.++++.|....
T Consensus 231 -~~---~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 -PQ---PPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred -CC---CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 011 1134556677799999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=354.02 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=198.1
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--Cce
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 333 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~ 333 (611)
...++|.+.+.||+|+||+||++.+. ++..+|+|++... ......|..|+.+++.++|||||+++++|... ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34578999999999999999999875 5778999998742 34567789999999999999999999988653 468
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCcEEeeccCccceeeCC---------
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS----AQRVIHRDVKSSNILLSD--------- 400 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~----~~gIiHrDIKp~NILLd~--------- 400 (611)
||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+ ..+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999764333346899999999999999999999832 145999999999999964
Q ss_pred --------CCceEEeecCccccccCCCCCccccccccccccCChhhhcc--CCCCCcceehhhhHHHHHHHhCCCCCCCC
Q 007256 401 --------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISND 470 (611)
Q Consensus 401 --------~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~ 470 (611)
.+.+||+|||++........ .....||+.|+|||++.. ..++.++||||||||||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 23489999999986644322 123579999999999864 45889999999999999999999999754
Q ss_pred CCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 471 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 471 ~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
............. +.+..... ...+..++..||+.+|.+||++.++|.
T Consensus 247 ~~~~qli~~lk~~-------------p~lpi~~~---S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFSQLISELKRG-------------PDLPIKGK---SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHHHHHHHHhcC-------------CCCCcCCC---CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 4322111110000 00100001 133555667799999999999999984
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=310.51 Aligned_cols=264 Identities=22% Similarity=0.348 Sum_probs=196.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|++|.||+|..+ +++.||||.+.... .....+.+|+++++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367999999999999999999875 68999999987532 223457789999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+.+ +|.+++..... .+.+..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9985 99998865432 57899999999999999999999 89999999999999999999999999998754322
Q ss_pred CCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCc-chhhHHHhhccccccCcccc---
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQ--- 493 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~-~~~~lv~~~~~~~~~g~l~~--- 493 (611)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .+...+..............
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 11 1122357889999999875 45889999999999999999999999755421 11111100000000000000
Q ss_pred -----------ccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 494 -----------LLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 494 -----------lld~~l~~~~-~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.....+.... .......+..++..||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 0111244556777899999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=302.69 Aligned_cols=250 Identities=30% Similarity=0.497 Sum_probs=199.7
Q ss_pred ceeeeeEeecCcEEEEEEEeCC-----CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 265 FLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
|.+.+.||.|+||.||++...+ +..||+|+++.... ..+.+..|++++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999998753 48899999986543 5678999999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999975432 128999999999999999999999 8999999999999999999999999999987655
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
....... ...+++.|+|||.+....++.++||||||+++++|++ |+.||...........+... ....
T Consensus 156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-------~~~~--- 224 (258)
T smart00219 156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKG-------YRLP--- 224 (258)
T ss_pred ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------CCCC---
Confidence 4222111 2337789999999988889999999999999999998 88888764332221111110 0000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
.... ....+..++..|+..+|++|||+.++++.|
T Consensus 225 --~~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 --KPEN----CPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCc----CCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011 123455577789999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=304.83 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=200.2
Q ss_pred CceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
+|+..+.||+|++|.||+|.. .+++.||+|++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 578999999986432 245788999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-ceEEeecCcccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 414 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-~vKL~DFGla~~ 414 (611)
||||+++++|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999987543 47889999999999999999999 8999999999999998776 599999999877
Q ss_pred ccCCCCC--ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 415 ASTSSSH--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 415 ~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
....... .......||..|+|||++.+..++.++||||||+++++|++|..||...........+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 228 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT----- 228 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-----
Confidence 6543211 111235689999999999888899999999999999999999999975543322222111100000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+ ..+......+..++..|++.+|.+||++.++++
T Consensus 229 ---~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ---AP----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CC----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01 111122244556777899999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=312.69 Aligned_cols=264 Identities=26% Similarity=0.361 Sum_probs=199.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|+||.||+|.++ +++.||+|++.... ...+.+.+|+++++.++||||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47889999999999999999975 68999999986432 245678899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.++..... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999988765432 48899999999999999999999 89999999999999999999999999998866443
Q ss_pred CCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh-ccccccC-------
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPILSSG------- 489 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~-~~~~~~g------- 489 (611)
.. ......++..|+|||++.+ ..++.++|||||||+++||++|+.||...........+... .......
T Consensus 154 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 GE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred cc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 32 1223568999999999875 45788999999999999999999999765432221111110 0000000
Q ss_pred c-cccccCcccCCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 K-VTQLLDPALGNN-----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~-l~~lld~~l~~~-----~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. ......+..... ........+..++..||+.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 000000000000 001123456667778999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=303.16 Aligned_cols=246 Identities=27% Similarity=0.430 Sum_probs=198.6
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~------~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
+|...+.||+|+||.||+|... ++..|++|.+... ....+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999976 7999999988643 23567899999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999997543 47899999999999999999999 899999999999999999999999999987654
Q ss_pred CCCCCccccccccccccCChhhhccCC-CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
... ......|++.|+|||.+.... ++.++|+|||||++|+|++|+.||......... ..+.. .....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~----~~~~~--- 221 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--FKIGR----SKELP--- 221 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--HHHHh----cccCC---
Confidence 432 122356899999999998776 899999999999999999999999765422211 11111 00010
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+.. .....+..++..||+.+|.+||++.++++
T Consensus 222 --~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 --PIPD----HLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CcCC----CcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111 11233455667799999999999999885
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=342.30 Aligned_cols=260 Identities=25% Similarity=0.328 Sum_probs=204.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCC-CEEEEEEecC-ChhHHHHHHHHHHHHHhcC-CcceeEEeeE-EEe---c---
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDG-KELAVKILKP-SEDVIKEFVLEIEIITTLH-HKNIISLLGF-CFE---D--- 330 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g-~~vAVK~l~~-~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~-~~~---~--- 330 (611)
...++.+.+.|.+|||+.||+|.+..+ ..||+|++-. ++...+.+.+||++|++|+ |+|||.+++. ... +
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345678999999999999999998765 9999998764 5677888999999999998 9999999993 321 1
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
-+++|.||||.||.|-+++..+... .|++.++++|+.++++|+++||... .+|||||||-+||||+.+++.||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 2578999999999999999866553 4999999999999999999999843 579999999999999999999999999
Q ss_pred ccccccCCCCC-cccc------ccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 007256 411 LAKWASTSSSH-ITCT------DVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480 (611)
Q Consensus 411 la~~~~~~~~~-~~~~------~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~ 480 (611)
.|......... .... ...-|+.|.|||++. +...++|+|||+|||+||-|+....||+......
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------ 265 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------ 265 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------
Confidence 98643332211 0000 023589999999875 5688999999999999999999999997653221
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCccc
Q 007256 481 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADV 542 (611)
Q Consensus 481 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~~~ 542 (611)
+++....-........++..++..||+.||.+||++-+|++.+......
T Consensus 266 -------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 -------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111111111134566777788889999999999999999877654433
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=307.83 Aligned_cols=259 Identities=27% Similarity=0.390 Sum_probs=202.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~LV~ 337 (611)
++|...+.||.|++|.||++.+. +++.+|+|.+.... .....+.+|+++++.++||||++++++|... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46889999999999999999975 68899999987543 3567789999999999999999999998654 4689999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876443334568899999999999999999999 8999999999999999999999999999865543
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCC--cchhhHHHhhccccccCcccccc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP--KGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~--~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .....+..+.... ....+.
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 229 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPELK 229 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchhhc
Confidence 221 134678899999999999999999999999999999999999986532 1111222221110 000110
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+ .... .......+..++..||+.+|.+|||+.+|++.
T Consensus 230 ~-~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 D-EPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred c-CCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 0000 11223456677788999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=304.84 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=193.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~------~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~ 333 (611)
.+|...+.||+|+||.||+|... +|..||+|++... ......+.+|+.+++.++||||+++++++.. +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999874 6899999988642 2345678899999999999999999999875 3568
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
+++|||+++++|.+++.... .+++...+.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999997543 37889999999999999999998 899999999999999999999999999987
Q ss_pred cccCCCCC-ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
........ .......++..|+|||++.+..++.++|||||||++|||++|+.||............. ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~------~~~--- 225 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA------TQP--- 225 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh------cCC---
Confidence 65432111 11122468999999999998889999999999999999999999997654322111100 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..+.+....+ ..+.. .+.|+..+|.+||++.+|++
T Consensus 226 --~~~~~~~~~~-~~~~~----li~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 --TNPQLPSHIS-EHARD----FLGCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCCchhcC-HHHHH----HHHHhcCChhhCcCHHHHhc
Confidence 0111111111 12222 23588899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.61 Aligned_cols=198 Identities=27% Similarity=0.433 Sum_probs=161.9
Q ss_pred eeeEeecCcEEEEEEEeC---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEEEEeeCCC
Q 007256 268 ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLVYDFLSR 342 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~LV~Ey~~g 342 (611)
.+.||+|+||.||+|... ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 367999999999999864 45789999987543 23467889999999999999999999854 4578999999876
Q ss_pred CChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee----CCCCceEEeecCccc
Q 007256 343 GSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLAK 413 (611)
Q Consensus 343 gsL~~~L~~~~-----~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL----d~~~~vKL~DFGla~ 413 (611)
+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7777764221 122358899999999999999999999 899999999999999 566789999999998
Q ss_pred cccCCCCC-ccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCC
Q 007256 414 WASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISND 470 (611)
Q Consensus 414 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~ 470 (611)
........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76543221 112235789999999998764 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=316.83 Aligned_cols=199 Identities=23% Similarity=0.321 Sum_probs=166.2
Q ss_pred eeeeEeec--CcEEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 267 AENLIGKG--GSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 267 ~~~~LG~G--~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
+.++||+| +|++||++.. .+|+.||||+++.. ....+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999986 47999999999753 344556778999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999865432 248899999999999999999999 8999999999999999999999999986543321111
Q ss_pred C-----ccccccccccccCChhhhcc--CCCCCcceehhhhHHHHHHHhCCCCCCCC
Q 007256 421 H-----ITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISND 470 (611)
Q Consensus 421 ~-----~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~ 470 (611)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 01112357788999999976 46899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.07 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=198.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
+.|.+.+.||.|+||.||+|... +++.+++|++... ....+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999875 5899999998754 355678899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|..++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999998875433 258899999999999999999999 8999999999999999999999999999865433211
Q ss_pred CccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 421 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
......+++.|+|||++. ...++.++|||||||++|||++|+.||....+... ....... ......
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-----~~~~~~ 236 (292)
T cd06644 166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKS-----EPPTLS 236 (292)
T ss_pred --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHhcC-----CCccCC
Confidence 122356899999999885 34578899999999999999999999976543221 1111110 000000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. .......+..++..||+.+|++||++.++++.
T Consensus 237 ~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 Q-------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred C-------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 11112245556777999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=307.10 Aligned_cols=246 Identities=26% Similarity=0.419 Sum_probs=201.3
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.|...+.||.|+||.||+|.+. ++..||+|++... ......+.+|+.+++.++|+||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999875 6889999998753 345678899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988642 47888999999999999999999 8999999999999999999999999999976644322
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
. .....++..|+|||++.+..++.++|+|||||++|||++|..||....+......+. .+. .
T Consensus 157 ~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-------~~~---------~ 218 (277)
T cd06640 157 K--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-------KNN---------P 218 (277)
T ss_pred c--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-------cCC---------C
Confidence 1 123468899999999998889999999999999999999999997654432211110 000 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..........+..++..||+.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122233456677778999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=351.59 Aligned_cols=258 Identities=26% Similarity=0.462 Sum_probs=207.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC--CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP--DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~--~g~----~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
.+-...+.||+|+||.||.|... +|. .||||.++.. .....+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34567789999999999999854 343 4899999864 677889999999999999999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 335 LVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~---~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
|++|||+||+|..+|+.... .+..++....+.++.+||+|+.||++ +++|||||...|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999986521 24568999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
|+.............-.-...|||||.++.+.++.|+|||||||+|||++| |..||.+.+..+....+. ..|+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~------~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL------EGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH------hCCc
Confidence 995444333322211122357999999999999999999999999999999 999998776554333222 1221
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 491 l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
+.. +..-...+..++..||+.+|++||++..+++.+...
T Consensus 923 L~~----------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 923 LDP----------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred cCC----------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 111 111223455777789999999999999999966543
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.81 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=200.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
..+|.+.+.||+|+||.||+|.. .+|+.||+|.+.... ...+.+.+|+.+++.++|+||++++++|..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36799999999999999999986 479999999987533 3446688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++... .+++..+..++.+++.||.|||+ .+++||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998642 47888999999999999999999 899999999999999999999999999987654432
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....+....... + ..+ ...+..
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-~-----~~~-~~~~~~--- 237 (297)
T cd06656 170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-A-----TNG-TPELQN--- 237 (297)
T ss_pred cC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-c-----cCC-CCCCCC---
Confidence 21 12356899999999999888999999999999999999999999765442221110 0 000 000000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.......+..++..||+.+|.+||++.+|++
T Consensus 238 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 ----PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111123445667799999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.52 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=198.3
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||+|+||.||++... +|..||+|.++. .......+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999875 789999998875 334457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|..++.... ....+++..+..++.+++.||.|||+ ..+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999886532 12358999999999999999999996 1489999999999999999999999999987654322
Q ss_pred CCccccccccccccCChhhhccC------CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
. ....|++.|+|||++.+. .++.++|||||||++|+|++|+.||.............. + ..+..
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---~-~~~~~-- 227 (286)
T cd06622 158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA---I-VDGDP-- 227 (286)
T ss_pred c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH---H-hhcCC--
Confidence 1 234688999999998544 358899999999999999999999975433221111100 0 00000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+.+ .......+..++..||+.+|.+||++.+++.
T Consensus 228 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ---PTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ---CCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111 1112234556667799999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=309.70 Aligned_cols=238 Identities=24% Similarity=0.417 Sum_probs=186.2
Q ss_pred eEeecCcEEEEEEEeCC-------------------------CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEE
Q 007256 270 LIGKGGSSQVYKGCLPD-------------------------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISL 323 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~~~~-------------------------g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l 323 (611)
.||+|+||.||+|.... ...|++|++.... .....|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 1358999987543 334578899999999999999999
Q ss_pred eeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-
Q 007256 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF- 402 (611)
Q Consensus 324 ~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~- 402 (611)
+++|.++...++||||+++|+|..++.... ..+++..+..++.||++||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 999999999999999999999999886533 257899999999999999999999 8999999999999997643
Q ss_pred ------ceEEeecCccccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHH-hCCCCCCCCCCcc
Q 007256 403 ------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELL-TGRKPISNDHPKG 474 (611)
Q Consensus 403 ------~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELl-tG~~Pf~~~~~~~ 474 (611)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999987543221 12357888999998875 56899999999999999995 6999997654432
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 475 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
......... .+... ....+..++..||+.+|.+||++.+|++.|.
T Consensus 230 ~~~~~~~~~--------------~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYEKKH--------------RLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHhcc--------------CCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 211111000 00000 1124566777899999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=349.85 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=199.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....++|.+|+++++.++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999875 6899999998753 234567999999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 338 DFLSRGSLEENLHGNKK-------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~-------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
||++||+|.+++..... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 12346678889999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCC----------------CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc
Q 007256 411 LAKWASTSSS----------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474 (611)
Q Consensus 411 la~~~~~~~~----------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 474 (611)
+++....... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 011122579999999999999999999999999999999999999997643221
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhhC
Q 007256 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKLLRG 538 (611)
Q Consensus 475 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-m~eVL~~L~~ 538 (611)
.. ........... .+ .... ...+..++..|++.||++||+ ++++++.|+.
T Consensus 239 i~----~~~~i~~P~~~----~p--~~~i----P~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 IS----YRDVILSPIEV----AP--YREI----PPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hh----hhhhccChhhc----cc--cccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 11100000000 00 0011 123455667799999999976 5666665543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.68 Aligned_cols=264 Identities=27% Similarity=0.382 Sum_probs=201.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|+||.||+|.++ +++.||||.++.. ....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46899999999999999999875 6889999998753 3345678999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|++++.+..+.... ..+++..+..++.+|+.||.|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655432 247899999999999999999999 89999999999999999999999999999876654
Q ss_pred CCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc-ccc--------cc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-PIL--------SS 488 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-~~~--------~~ 488 (611)
... ......++..|+|||++... .++.++||||||+++|+|++|+.||................ ... ..
T Consensus 154 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 321 22335789999999999888 88999999999999999999999997654322211111100 000 00
Q ss_pred C-----ccccccCcc-cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 489 G-----KVTQLLDPA-LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 489 g-----~l~~lld~~-l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
. ......++. +...++......+..++..||..+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 000000000 000011111345667778899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=300.70 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=201.1
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.+.+.||+|+||.||++... +|+.||+|.+... ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4888999999999999999864 7899999998642 34456889999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+.+..... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999998875432 247889999999999999999999 899999999999999999999999999997654422
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. .....|++.|+|||++.++.++.++|+|||||++++|++|+.||...........+.. +... ..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-------~~~~-----~~ 221 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-------GSYP-----PV 221 (256)
T ss_pred hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc-------CCCC-----CC
Confidence 11 1234688999999999988999999999999999999999999976543322111110 1100 01
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. ......+..++..||+.+|.+||++.+|++.
T Consensus 222 ~----~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 S----SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred c----ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 1112345566777999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.67 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=198.3
Q ss_pred ceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 007256 265 FLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 331 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~------ 331 (611)
|.+.+.||+|+||.||+|... +++.||||+++.. ....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999753 4788999998753 345667889999999999999999999886532
Q ss_pred ceEEEEeeCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeec
Q 007256 332 NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~--~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DF 409 (611)
..+++++|+.+|+|.+++.... .....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875322 222357889999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhcccccc
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSS 488 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~ 488 (611)
|+++...............+++.|++||.+..+.++.++|||||||++|||++ |+.||...........+. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~------~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI------KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH------cC
Confidence 99986644332222222345678999999998889999999999999999999 889987654322111111 00
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 489 g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.... ........+..++..|++.+|.+||++.++++.|+.
T Consensus 232 ~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 232 NRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0000 001122456777888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=308.85 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=203.2
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecC------C---hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP------S---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN 331 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~------~---~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~ 331 (611)
+.|...+.||.|..++|-+.+. ++|+++|+|++.. + ....+.-.+|+.||+++. ||+|+++.++|..+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4566778899999999998875 4799999999853 1 123445668999999986 999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
.+++|+|.|+.|.|.++|... ..+++.+.+.|+.|+++|+.|||. ++|+||||||+|||++++.++||+|||+
T Consensus 97 F~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999754 368999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhcc------CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
|..+..+..- ...+|||+|+|||.+.. ..|+..+|+|++|||+|-||.|.+||......-...+++..+..
T Consensus 170 a~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 170 ACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred eeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 9888765432 34899999999998863 36888999999999999999999999765444444444444443
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+.+..+.++ ......++..||+.||.+|.|+.|+|.
T Consensus 247 F~speWadi-------------s~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 247 FRSPEWADI-------------SATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cCCcchhhc-------------cccHHHHHHHHHeeCchhcccHHHHhc
Confidence 333222222 122344666799999999999999986
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.11 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=200.9
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.+.+.||+|+||.||+|.+. +|+.||||++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999874 7899999998753 23456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+ +++|.+++.... ..+++..++.++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999986543 358999999999999999999999 899999999999999999999999999998665432
Q ss_pred CCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc---------C
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS---------G 489 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~---------g 489 (611)
. .......|+..|+|||++.+. .++.++|||||||+++||++|++||...........+......... .
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 2 112235689999999998654 4688999999999999999998888665432221111100000000 0
Q ss_pred ccccccCcccC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALG----NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~----~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
....+..+.-. .....+....+..++..||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00001122566677788999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.33 Aligned_cols=248 Identities=25% Similarity=0.418 Sum_probs=200.7
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.+|.+.+.||.|+||.||+|.. .+|+.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999986 478999999886433 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988642 47899999999999999999999 8999999999999999999999999999876544322
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+......+.-. . ...+..+
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~------~~~~~~~--- 238 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G------TPELQNP--- 238 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C------CcccCCc---
Confidence 1 12346899999999999888999999999999999999999999776543322221100 0 0000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..+ ...+..++..||..+|.+||++.++++
T Consensus 239 ~~~----~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKL----SPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccC----CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 111 123445667799999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=302.87 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=193.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--Cce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~------~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~ 333 (611)
++|.+.+.||+|+||.||+|... +|..||||.+... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999875 6899999988532 23456788999999999999999999998763 468
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999987543 37888899999999999999999 899999999999999999999999999987
Q ss_pred cccCCCCC-ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||.............. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~------~~--- 225 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------QP--- 225 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc------CC---
Confidence 65432111 112235689999999999988899999999999999999999999975432221111100 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+.+ +......+..++..|+ .+|.+||++++|++.
T Consensus 226 --~~~~~----~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 --TNPVL----PPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred --CCCCC----chhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 01111 1122223344445577 489999999998863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=311.96 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=199.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||++... +++.||+|.+.... .....+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999875 68899999987542 33457889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||++|++|.+++.... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999996543 47899999999999999999999 8999999999999999999999999999874221
Q ss_pred CCCC-------------ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 007256 418 SSSH-------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 484 (611)
Q Consensus 418 ~~~~-------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 484 (611)
.... .......|+..|+|||++....++.++|+|||||++|||++|..||.+.............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~-- 231 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-- 231 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Confidence 1100 0111246788999999999889999999999999999999999999765432211111110
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
. ...+.... .....+..++..||+.+|++||+..++++.|..
T Consensus 232 -----~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 -----D---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -----c---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 00011101 112234566777999999999997767766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=308.50 Aligned_cols=252 Identities=27% Similarity=0.409 Sum_probs=199.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||.|+||.||+|... ++..+|+|++... ....+.|..|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999874 6899999998754 34567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999986543 258999999999999999999999 899999999999999999999999999987554322
Q ss_pred CCccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
.. .....||+.|+|||++. ...++.++|||||||++|||++|+.||......... ..+.. +..
T Consensus 158 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~-----~~~--- 225 (280)
T cd06611 158 QK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LKILK-----SEP--- 225 (280)
T ss_pred cc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HHHhc-----CCC---
Confidence 21 12356899999999985 345778999999999999999999999765433211 11111 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+.+.. +......+..++..||+.+|.+||++.+|++.
T Consensus 226 --~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 --PTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000 00111234456667999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.98 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=199.6
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|...+.||+|+||.||++... +++.+|||.+... ....+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888999999999999999864 7889999998653 34467889999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC-CceEEeecCccccccCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWASTS 418 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~-~~vKL~DFGla~~~~~~ 418 (611)
+++++|.+++..... ..+++..+..++.+++.||.|||+ ++++|+||||+||+++.+ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999975432 357899999999999999999999 899999999999999855 46899999999876543
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
... ....|+..|+|||.+....++.++||||||+++++|++|+.||...........+.. +....+.+
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-- 223 (256)
T cd08220 156 SKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------GTFAPISD-- 223 (256)
T ss_pred ccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-------cCCCCCCC--
Confidence 221 225689999999999988899999999999999999999999976544322111110 01111111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.....+..++..||+.+|.+|||+.++++.
T Consensus 224 -------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 -------RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -------CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 112345566677999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=308.11 Aligned_cols=244 Identities=27% Similarity=0.375 Sum_probs=199.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||.||++... +++.+|+|++.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999865 68999999987532 34567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999987653 58899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+. .+. .
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~------~ 215 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-------EGK------V 215 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCC------c
Confidence 3 123578999999999998889999999999999999999999997655221111111 010 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
.+.... ...+..++..||..+|.+|| ++.++++.
T Consensus 216 ~~~~~~----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 RFPSFF----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCccC----CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111111 23445566679999999999 77777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=308.62 Aligned_cols=263 Identities=21% Similarity=0.261 Sum_probs=194.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.+.+.||+|+||.||+|... +|+.||+|.++... .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999875 78999999987532 2345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++ +|.+++.... ..+++..++.++.||++||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 7888776432 258999999999999999999999 899999999999999999999999999997654322
Q ss_pred CCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcc-hhhHHHhhccccccC---ccccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKPILSSG---KVTQL 494 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~-~~~lv~~~~~~~~~g---~l~~l 494 (611)
.. .....+++.|+|||++.+. .++.++|||||||++|+|++|+.|+....... ....+.......... .+.+.
T Consensus 154 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 21 1234678999999998765 47899999999999999999999865433221 111110000000000 00000
Q ss_pred cCc----ccCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 LDP----ALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 ld~----~l~~~~-----~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+. ...... .......+..++..||+.||.+|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 000000 01112345567778999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.91 Aligned_cols=266 Identities=24% Similarity=0.281 Sum_probs=207.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||.|.-|+||++.+. ++..+|+|++.+. .....+...|-+||+.+.||.++.||+.|..++..++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 356778899999999999999986 4689999999764 34456677899999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
||||+||+|..+++++.. ..|++..++.++.+++.||+|||. .|||+|||||+||||-++|++.|+||.|+....
T Consensus 156 meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999987654 469999999999999999999999 999999999999999999999999999875332
Q ss_pred CC---------------------------------CCC---------------------ccccccccccccCChhhhccC
Q 007256 417 TS---------------------------------SSH---------------------ITCTDVAGTFGYLAPEYFMYG 442 (611)
Q Consensus 417 ~~---------------------------------~~~---------------------~~~~~~~GT~~Y~APE~l~~~ 442 (611)
.. ... .....++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 000 001125799999999999999
Q ss_pred CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccC
Q 007256 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRD 522 (611)
Q Consensus 443 ~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~d 522 (611)
..+.++|+|+|||+|||||.|..||.+.........+...... +.+. ......+..++...|.+|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~-------------Fp~~--~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK-------------FPEE--PEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc-------------CCCC--CcchhHHHHHHHHHhccC
Confidence 9999999999999999999999999887765543333221111 1111 122234445566689999
Q ss_pred CCCCCC----HHHHHHHhhCCccchhhHhhh
Q 007256 523 PRARPQ----MSLVLKLLRGDADVTKWARLQ 549 (611)
Q Consensus 523 P~~RPt----m~eVL~~L~~~~~~~~~~~~~ 549 (611)
|.+|-- +.||-++- -..-.+|+-+.
T Consensus 376 P~kRlg~~rGA~eIK~Hp--FF~gVnWaLir 404 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRHP--FFEGVNWALIR 404 (459)
T ss_pred hhhhhccccchHHhhcCc--cccCCChhhee
Confidence 999998 55554320 11223577443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.46 Aligned_cols=252 Identities=27% Similarity=0.349 Sum_probs=200.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||++... +++.||+|.+.... ...+.+..|+++++.++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47899999999999999999876 58999999997542 34567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+.+++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999875432 358899999999999999999999 8999999999999999999999999999875533
Q ss_pred CCCCc---------------------------cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCC
Q 007256 418 SSSHI---------------------------TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470 (611)
Q Consensus 418 ~~~~~---------------------------~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~ 470 (611)
..... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 21110 111246899999999999888999999999999999999999999765
Q ss_pred CCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 007256 471 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ----MSLVLK 534 (611)
Q Consensus 471 ~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt----m~eVL~ 534 (611)
........+. .... .+.. .......+..++..||+.+|++||+ +.+++.
T Consensus 236 ~~~~~~~~~~-~~~~------------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETFSNIL-KKEV------------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHHHHHh-cCCc------------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 4332211111 0000 0000 1112345666777899999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=307.35 Aligned_cols=265 Identities=20% Similarity=0.240 Sum_probs=195.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCc-----
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN----- 332 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~----- 332 (611)
++|.+.+.||+|+||.||+|.+. +|+.||||.++... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47899999999999999999865 68999999986532 23457888999999995 6999999999987665
Q ss_pred eEEEEeeCCCCChhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-CCceEEeecC
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFG 410 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~-~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-~~~vKL~DFG 410 (611)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 888887654322 3468999999999999999999999 89999999999999998 8899999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
++......... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..........
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 98765432221 122357889999998865 457899999999999999999999997654332211110000000000
Q ss_pred c---c---------ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 490 K---V---------TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 490 ~---l---------~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
. . .......+. .........+..++..||+.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0 000000000 000112234566777899999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=293.84 Aligned_cols=249 Identities=31% Similarity=0.465 Sum_probs=203.6
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChh-HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
+|...+.||+|++|.||++... +++.+++|++..... ..+.+.+|+++++.++|+|++++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999975 789999999986543 66789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++.... ..+++..+..++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987643 358999999999999999999999 8999999999999999999999999999877655432
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
.....|+..|+|||++....++.++||||||+++|+|++|+.||............. . .....+.++
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~-----~~~~~~~~~---- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA--T-----NGPPGLRNP---- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--h-----cCCCCcCcc----
Confidence 223578999999999998889999999999999999999999997654322211111 0 001111111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.. ....+..++..||+.||.+|||+.++++.
T Consensus 221 -~~--~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 -EK--WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -cc--cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 12345666778999999999999998863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=308.23 Aligned_cols=263 Identities=23% Similarity=0.291 Sum_probs=199.4
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
+|.+.+.||+|+||.||+|... +|+.||||.++... .....+..|+++++.++|+||+++++++..++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999865 68999999997542 2345677899999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+ ++|+|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999997543 258999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC------
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG------ 489 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g------ 489 (611)
..... .....+++.|+|||++.+ ..++.++|||||||++|||++|..||...........+..........
T Consensus 154 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 43222 122457889999999864 467899999999999999999988887654322111110000000000
Q ss_pred ccccccCcccCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~-----~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.............. .......+..++..||+.+|.+|||+.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 11123456677888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.48 Aligned_cols=251 Identities=29% Similarity=0.411 Sum_probs=204.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVY 337 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~LV~ 337 (611)
+|...+.||+|++|.||+|... +++.|++|++.... ...+.+.+|++++++++|+||+++++.+... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999976 79999999987654 4577899999999999999999999999988 8899999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999987553 58999999999999999999999 8999999999999999999999999999987766
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
...........++..|+|||.+....++.++||||||+++++|++|+.||........ ..+. .........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~--~~~~~~~~~---- 224 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYK--IGSSGEPPE---- 224 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHh--ccccCCCcC----
Confidence 5432112335789999999999988899999999999999999999999976551111 1111 000001111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+......+..++..|+..+|.+||++.++++.
T Consensus 225 -----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 -----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111113456667778999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.14 Aligned_cols=239 Identities=22% Similarity=0.380 Sum_probs=187.3
Q ss_pred eeEeecCcEEEEEEEeCC--------CCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 269 NLIGKGGSSQVYKGCLPD--------GKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+.||+|+||.||+|.... ...+|+|.+.... ...+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 358999999999997532 2348888886543 4456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc--------eEEeecCc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------PQLSDFGL 411 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~--------vKL~DFGl 411 (611)
+++|+|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999976542 57899999999999999999999 89999999999999987765 69999998
Q ss_pred cccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCC-CCCCCCCCcchhhHHHhhccccccC
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGR-KPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~-~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
+...... ....+++.|+|||++.+. .++.++|||||||++|||++|. .||....+........ . ..
T Consensus 155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~-----~~ 222 (258)
T cd05078 155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-D-----RH 222 (258)
T ss_pred ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-c-----cc
Confidence 8654321 225688999999999864 5799999999999999999985 5655433322111110 0 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
. .+......+..++..||+.+|++|||+.++++.|.
T Consensus 223 --------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 --------Q----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------c----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 11111134566777799999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.80 Aligned_cols=203 Identities=24% Similarity=0.423 Sum_probs=170.9
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++++|.+.+.||+|+||.||+|... +|..||+|++.... .....+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999864 68999999987532 33346778999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+. ++|.+.+.... ..+.+..+..++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 57777665432 246788889999999999999999 8999999999999999999999999999875433
Q ss_pred CCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
.... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 156 PSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 2211 1234678999999998754 578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=310.16 Aligned_cols=205 Identities=27% Similarity=0.419 Sum_probs=171.4
Q ss_pred CceeeeeEeecCcEEEEEEEeC---CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP---DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLL 334 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~ 334 (611)
.|.+.+.||+|+||.||+|... ++..||+|.+... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999974 4789999999863 23346678899999999999999999999988 7899
Q ss_pred EEEeeCCCCChhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC----CCceEEeec
Q 007256 335 LVYDFLSRGSLEENLHGNKKD-PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 409 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~-~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~----~~~vKL~DF 409 (611)
+||||+++ +|.+.+...... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 677766433222 2368899999999999999999999 89999999999999999 899999999
Q ss_pred CccccccCCCC-CccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 410 GLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 410 Gla~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
|++........ ........+|+.|+|||++.+. .++.++|||||||++++|++|+.||.....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99986644322 1122335789999999988764 578999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.97 Aligned_cols=246 Identities=28% Similarity=0.446 Sum_probs=198.9
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
-|...+.||.|+||.||+|... ++..||||++... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667889999999999999864 7899999998643 244567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++... .+++..+..++.+++.|+.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999998642 47899999999999999999999 8999999999999999999999999999876644221
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||....+......+. .+.. +.+.
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~~-----~~~~ 222 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-------KNNP-----PTLE 222 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh-------cCCC-----CCCC
Confidence 1123568899999999998889999999999999999999999997544322111111 0000 1111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. .....+..++..|++.+|.+||++.++++.
T Consensus 223 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 G----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred c----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 112345566777999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.51 Aligned_cols=267 Identities=24% Similarity=0.323 Sum_probs=196.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~------ 331 (611)
.++|.+.+.||+|+||.||+|... +++.||||.+... ......+.+|+.++++++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999875 6899999988642 223345678999999999999999999987654
Q ss_pred --ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeec
Q 007256 332 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409 (611)
Q Consensus 332 --~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DF 409 (611)
..++||||+.+ +|.+.+.... ..+++.+++.++.||+.||.|||+ ++++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence 35999999975 8888876443 258999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCC--ccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 007256 410 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486 (611)
Q Consensus 410 Gla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 486 (611)
|++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||...........+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999866443221 111234678899999988754 47889999999999999999999998765443322222111000
Q ss_pred ccCccccc-----cCc-ccCCCC---------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 487 SSGKVTQL-----LDP-ALGNNY---------DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 487 ~~g~l~~l-----ld~-~l~~~~---------~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
........ .+. .+.... .......+..++..||+.||.+|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000 000 000000 00011234567778999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=297.17 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=199.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.+.+.||+|+||.||+|... +++.|++|.++... ...+.+..|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999864 78999999987643 3677899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987542 47889999999999999999999 899999999999999999999999999988765433
Q ss_pred CCcc--ccccccccccCChhhhccCC---CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 420 SHIT--CTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 420 ~~~~--~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
.... .....+++.|+|||++.... ++.++||||||+++++|++|+.||.......... +... .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~---~~~~---~~~---- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM---FHVG---AGH---- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH---HHHh---cCC----
Confidence 2211 11256889999999998766 8899999999999999999999997543221111 1000 000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+.+.... .....+..++..||+.+|.+||++.+++.
T Consensus 224 -~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -KPPIPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCccc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111 01223445667899999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.28 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=200.6
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
+|.+.+.||.|+||.||+|.+. +++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999875 68999999997532 456789999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+.+++|.+++... ..+++..+..++.++++||.|||+ ++++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998754 258899999999999999999999 89999999999999999999999999998766543
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
. ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||................. . .+.
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~--------~~~ 220 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--A--------DVL 220 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--c--------ccc
Confidence 2 12235688999999999988899999999999999999999999987654322222111100 0 001
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQM--SLVL 533 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm--~eVL 533 (611)
. +......+..++..||+.||.+||++ .+++
T Consensus 221 ~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 Y----PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred C----cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1 11112455566777999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.21 Aligned_cols=263 Identities=23% Similarity=0.316 Sum_probs=198.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 336 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~LV 336 (611)
++|.+.+.||.|+||.||+|..+ +++.+|+|.++... .....+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999976 68899999997532 2334677899999999999999999999877 889999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++ +|.+++..... .+++..+..++.||+.||.|||+ .+++|+||||+|||++.++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999985 99988865432 58999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHH----------hhc--
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------WAK-- 483 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~----------~~~-- 483 (611)
.... ......+++.|+|||++.+. .++.++|+||||+++++|++|+.||...........+. |..
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 4322 12234678999999998754 46889999999999999999999998654432211111 000
Q ss_pred --cccccCccccccCcccCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 484 --PILSSGKVTQLLDPALGNNYDYD-QMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 484 --~~~~~g~l~~lld~~l~~~~~~~-~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+..............+...+... ....+..++..||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000001111111111111111 1334556677799999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=305.71 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=200.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
+++|.+.+.||+|.|+.||+... ++|+.+|+|++.. +....+++.+|+.|-+.|+||||++|.+.+.+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46778888999999999999865 5899999998864 2346778899999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC---CCceEEeecCcccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKW 414 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---~~~vKL~DFGla~~ 414 (611)
|+|.|++|..-|-.. ..+++..+-..+.||+++|.|+|. ++|||||+||.|+||.. .--+||+|||+|+.
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999998766543 247888888999999999999999 99999999999999953 34599999999998
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
+.... ....++|||+|||||++...+|+..+|||+.|||||-||.|++||.+.+.......++....-.....+.
T Consensus 163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~-- 237 (355)
T KOG0033|consen 163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWD-- 237 (355)
T ss_pred eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccC--
Confidence 87332 2335899999999999999999999999999999999999999998865443322222211111100000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.-.++.+. ++..||..||.+|.|+.|.|++
T Consensus 238 --------~is~~Ak~---LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 238 --------TVTPEAKS---LIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred --------cCCHHHHH---HHHHHhccChhhhccHHHHhCC
Confidence 01122333 4455999999999999998863
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.56 Aligned_cols=264 Identities=21% Similarity=0.333 Sum_probs=198.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
+|.+.+.||.|++|.||+|.+. +|..||||+++... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999975 68999999987542 33567788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++ +|.+++..... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 86 88888765432 2358999999999999999999999 8999999999999999999999999999976543222
Q ss_pred CccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC-cc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD-PA 498 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld-~~ 498 (611)
. .....+|+.|++||++.+. .++.++|||||||++|+|++|+.||...........+...........+..+.+ +.
T Consensus 156 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 T--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred c--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 1224678999999998754 578899999999999999999999987654332221110000000000000000 00
Q ss_pred cCCC-----------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 499 LGNN-----------YDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 499 l~~~-----------~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+... ........+..++..|++.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 00011234556677799999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=295.40 Aligned_cols=253 Identities=23% Similarity=0.393 Sum_probs=205.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||+|++|.||+|... +|+.|+||++.... .....+.+|+.++..++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47889999999999999999876 59999999987654 4567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++... ..+++..++.++.|+++||.|||+. .+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999754 2588999999999999999999962 679999999999999999999999999998765433
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
... ....++..|+|||.+....++.++|+||||+++|+|++|+.||..........+..+... .. .+.+
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~-----~~~~ 223 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GP-----PPSL 223 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CC-----CCCC
Confidence 322 235688999999999988999999999999999999999999977653222222222110 00 0111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.... ....+..++..||..+|.+||++.++++.
T Consensus 224 ~~~~---~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEE---FSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred Cccc---CCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1110 22456667777999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=332.09 Aligned_cols=201 Identities=20% Similarity=0.227 Sum_probs=161.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC--CCCEEEE------------------EEecCChhHHHHHHHHHHHHHhcCCccee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP--DGKELAV------------------KILKPSEDVIKEFVLEIEIITTLHHKNII 321 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vAV------------------K~l~~~~~~~~~f~~Ei~iL~~l~HpnIv 321 (611)
.++|.+.+.||+|+||+||++..+ ++...++ |.++........+.+|+.+|+.++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998643 2222222 22223334556788999999999999999
Q ss_pred EEeeEEEecCceEEEEeeCCCCChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC
Q 007256 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 400 (611)
Q Consensus 322 ~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~-~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~ 400 (611)
++++++...+..|+|++++.+ +|.+++..... .........+..|+.||+.||.|||+ ++||||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 999999999999999999965 77776643321 11223456677899999999999999 89999999999999999
Q ss_pred CCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCC
Q 007256 401 DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467 (611)
Q Consensus 401 ~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf 467 (611)
++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999998765432221 22367999999999999999999999999999999999987644
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=314.75 Aligned_cols=266 Identities=22% Similarity=0.337 Sum_probs=197.4
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----c
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----N 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~-----~ 332 (611)
.+++|.+.+.||+|+||.||+|.+. +|+.||||++... ......+.+|+.+++.++|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999864 7899999998742 344567889999999999999999999876543 5
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.++||||+.+ +|.+.+... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccce
Confidence 8999999976 888777542 48899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc-cccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 413 KWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 413 ~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 7654432211 1223578999999998764 4688999999999999999999999976443221111100000000001
Q ss_pred cccccCcc-------c--CCCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 491 VTQLLDPA-------L--GNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 491 l~~lld~~-------l--~~~~~~-----~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+..+.+.. + ...... .....+..++..||+.+|.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11101000 0 000000 112346677778999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=313.47 Aligned_cols=248 Identities=25% Similarity=0.381 Sum_probs=208.6
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
|.+.++||+|.||.||++.++ +|..+|||.+.. +.+..++..|+.|++++..|++|++||.|..+..+++|||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 566788999999999999865 799999999875 456788999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcc
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 423 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 423 (611)
++.++++.+.+ ++++.++..|+...++||+|||. ..-||||||..||||+.+|++||+|||.|-.+...-. .
T Consensus 114 SiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--K 185 (502)
T KOG0574|consen 114 SISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--K 185 (502)
T ss_pred cHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--h
Confidence 99999976553 79999999999999999999999 8889999999999999999999999999977655332 2
Q ss_pred ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCC
Q 007256 424 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY 503 (611)
Q Consensus 424 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~ 503 (611)
..++.|||.|||||++..-.|+.++||||||++..||..|++||.+-.+......+--. ..|.+. .
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~------------PPPTF~--K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK------------PPPTFK--K 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC------------CCCCCC--C
Confidence 33588999999999999999999999999999999999999999887764432221110 011111 1
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 504 DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 504 ~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+......+..++..||-++|++|-|+.+++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 23344556667778999999999999998874
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.72 Aligned_cols=253 Identities=29% Similarity=0.437 Sum_probs=205.5
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
..++.|.+.+.||+|++|.||+|.++ ++..+++|++.........+.+|+++++.++|+|++++++++..++..++|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 35677888899999999999999976 68999999998665566788999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.+++.... ..+++..+..++.+++.||.|||+ .|++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998654 358999999999999999999999 99999999999999999999999999998655432
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.. ......++..|+|||++.+..++.++|||||||++|+|++|+.||....+......+. . .....+.++
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~--~-----~~~~~~~~~- 239 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT--T-----KGIPPLKNP- 239 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h-----cCCCCCcch-
Confidence 21 1122457899999999998889999999999999999999999997654432211111 0 000111000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
......+..++..|++.+|.+||++.+|++
T Consensus 240 ------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 ------EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ------hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001134556677799999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=300.35 Aligned_cols=246 Identities=26% Similarity=0.432 Sum_probs=197.9
Q ss_pred CceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.|...+.||+|+||.||+|.+ .+++.||+|.++.. ......+.+|+.+++.++ |||+++++++|..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999996 57899999998653 345667889999999997 999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++... .+++..+..++.+++.||.|||+ .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988643 48899999999999999999999 8999999999999999999999999999987655
Q ss_pred CCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.... .....|+..|+|||++..+ .++.++|||||||++|+|++|+.||.......... ... .. ..
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~~~----~~-----~~ 219 (277)
T cd06917 154 NSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM---LIP----KS-----KP 219 (277)
T ss_pred Cccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh---ccc----cC-----CC
Confidence 4322 2235789999999998754 46889999999999999999999997654322111 100 00 01
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+.+.... ....+..++..||+.||.+||++.++++
T Consensus 220 ~~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 PRLEDNG---YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111110 1234555667799999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.14 Aligned_cols=262 Identities=22% Similarity=0.279 Sum_probs=198.3
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------ 330 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~------ 330 (611)
..++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++|+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 7899999998642 34456788899999999999999999998644
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
...++||||+.+ +|.+.+... +++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999965 888877532 7788899999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHh--hc-----
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW--AK----- 483 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~--~~----- 483 (611)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.. ..
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9986654322 2235689999999999999999999999999999999999999976543221111100 00
Q ss_pred ---------------cccccCccccccCcccC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 484 ---------------PILSSGKVTQLLDPALG----NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 484 ---------------~~~~~g~l~~lld~~l~----~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+......+.++....+. ..........+..++..||+.||++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000001111111100 00011123345677788999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.75 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=200.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|...+.||.|+||.||++.+. +++.+|+|++... ......+.+|+++++.++||||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36778889999999999999876 6899999998754 34556789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.... ..+++..+..++.+++.||.|||+ ..+++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997643 358889999999999999999997 3579999999999999999999999999987654322
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. ...|+..|+|||++.+..++.++||||||+++++|++|+.||......... ........... ..+.+
T Consensus 156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~------~~~~~ 224 (265)
T cd06605 156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVNE------PPPRL 224 (265)
T ss_pred hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhcC------CCCCC
Confidence 11 157899999999999889999999999999999999999999755321111 11111111000 00111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.... ....+..++..||..+|.+|||+.+++..
T Consensus 225 ~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGK---FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred Chhh---cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1110 22335566677999999999999998853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.28 Aligned_cols=263 Identities=24% Similarity=0.318 Sum_probs=200.0
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEEEe
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLVYD 338 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~LV~E 338 (611)
|.+.+.||.|+||.||+|... +|+.+|+|++... ......+.+|+++++.++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 677899999999999999875 5899999999865 33456788999999999999999999999888 88999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++ +|.+++.... ..+++..++.++.+|+.||.|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 8888886542 358999999999999999999999 89999999999999999999999999999876554
Q ss_pred CCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc---
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL--- 494 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l--- 494 (611)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+..............+
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 321 1223467889999998764 46789999999999999999999999776543322221111000000000000
Q ss_pred -----------cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 -----------LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 -----------ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
....+...+.......+..++..||+.+|.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000001113456778888999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.82 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=194.4
Q ss_pred eeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 268 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
...||+|+||.||++... ++..||||.+... ....+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456999999999999864 6889999998653 34456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccc
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~ 425 (611)
.+++... .+++..+..++.+|+.||.|||+ ++|+||||||+||+++.++.++|+|||++......... ..
T Consensus 107 ~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~ 176 (292)
T cd06658 107 TDIVTHT-----RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RK 176 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Cc
Confidence 9988532 47889999999999999999999 89999999999999999999999999998765432221 12
Q ss_pred ccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCCh
Q 007256 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505 (611)
Q Consensus 426 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 505 (611)
...|++.|+|||++....++.++|||||||++|||++|+.||...........+.. .+.+.+.....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~------------~~~~~~~~~~~- 243 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD------------NLPPRVKDSHK- 243 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------cCCCccccccc-
Confidence 35689999999999988999999999999999999999999976543322111110 01111111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 506 DQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 506 ~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
....+..++..|+..||.+|||+.++++.
T Consensus 244 -~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 -VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11233445556999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=296.65 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=203.9
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.+.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5888999999999999999754 7889999998753 34456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.........+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999987644334568999999999999999999999 899999999999999999999999999998776541
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.....|++.|+|||++.+..++.++|+||||+++++|++|+.||...........+. .+....+
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~~----- 221 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-------RGKYPPI----- 221 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------cCCCCCC-----
Confidence 122468899999999998899999999999999999999999997654332211111 1111111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......+..++..|++.+|.+||++.++++.
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11223446667778999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.64 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=195.9
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
|.....||+|+||.||++... +++.||+|.+... ....+.+.+|+.++..++||||++++++|..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 344457999999999999865 7899999998643 23456788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|..++... .+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 103 ~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~- 173 (297)
T cd06659 103 GALTDIVSQT-----RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK- 173 (297)
T ss_pred CCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-
Confidence 9999877542 47899999999999999999999 89999999999999999999999999998755433221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....+......+. . . . .+....
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--~-~----~-----~~~~~~- 239 (297)
T cd06659 174 -RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR--D-S----P-----PPKLKN- 239 (297)
T ss_pred -ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--c-c----C-----CCCccc-
Confidence 123568999999999998899999999999999999999999997654332221111 0 0 0 000000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......+..++..||+.+|.+||++.++++.
T Consensus 240 -~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 -AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00111234556667999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=296.89 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=199.0
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.+.+.||+|+||.||+|..+ +|..+|+|.+... ....+.+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5888999999999999999875 6889999998653 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-ceEEeecCccccccCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 418 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-~vKL~DFGla~~~~~~ 418 (611)
+++++|.+++..... ..+++..+..++.+++.||.|||+ .+++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999875432 357899999999999999999999 8999999999999998875 4699999998766543
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
... .....|++.|+|||++....++.++|+|||||+++||++|+.||.......... ... .+....+
T Consensus 156 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~-----~~~~~~~---- 222 (257)
T cd08225 156 MEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL--KIC-----QGYFAPI---- 222 (257)
T ss_pred ccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHh-----cccCCCC----
Confidence 221 122468999999999998889999999999999999999999997544322111 000 0111110
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......+..++..|+..+|.+|||+.+|++.
T Consensus 223 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 -----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01112345566677999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.31 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=196.3
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|...+.||.|++|.||+|... +|+.||||.++... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999875 78999999987432 2345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+. ++|..++..... ..+++..+..++.+++.||+|||+ .+++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 589888865432 358899999999999999999999 899999999999999999999999999987654332
Q ss_pred CCccccccccccccCChhhhccCC-CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhh-HHHhhccccc----------
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKPILS---------- 487 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~~~~~---------- 487 (611)
.. .....+++.|+|||++.+.. ++.++|||||||++|||+||+.||.......... ...+......
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 21 12345789999999887544 5889999999999999999999997654322111 1111000000
Q ss_pred --cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 488 --SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 488 --~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
...+.......+.. ........+..++..|++.||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000000 000011234556778999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.67 Aligned_cols=265 Identities=25% Similarity=0.326 Sum_probs=197.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~L 335 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||+|.++... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999875 69999999987432 2233567899999999999999999998765 46899
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 8888876543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
...... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..............+
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 543221 122346888999999865 46789999999999999999999999876554433222211110000000000
Q ss_pred c-----Cc-ccCCC-C-C-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 L-----DP-ALGNN-Y-D-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 l-----d~-~l~~~-~-~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
- .. .+... . . .........++..||+.||++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00 00000 0 0 0012334557778999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=303.49 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=200.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
++|.+.+.||+|+||.||++... ++..||+|.+... ....+.+.+|+.+++.++||||++++++|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67899999999999999999864 7889999998643 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++... .+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998643 37889999999999999999999 8999999999999999999999999999876544322
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
. .....|++.|+|||++..+.++.++|||||||++|+|++|+.||...........+. ..+. +.+.
T Consensus 171 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~~~~------~~~~ 236 (293)
T cd06647 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNGT------PELQ 236 (293)
T ss_pred c--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------cCCC------CCCC
Confidence 2 123468899999999998889999999999999999999999997654432211110 0000 0000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
........+..++..||..+|.+||++.+++.+
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112234556677999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=291.81 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=204.5
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.+.+.||.|+||.||++.+. +++.+|+|++.... ...+.+.+|+++++.++|+|++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888999999999999999975 68999999997542 4566788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.........+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997654333568999999999999999999999 899999999999999999999999999998765543
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
. ......|++.|+|||.+....++.++|+||||+++++|++|+.||............. . ..... +
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~-----~~~~~-----~ 223 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL--K-----GQYPP-----I 223 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh--c-----CCCCC-----C
Confidence 1 2223578999999999998899999999999999999999999997654322111110 0 01111 1
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.. .....+..++..||..+|.+||++.++++.
T Consensus 224 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 PS----QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 112345556677999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=321.53 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=205.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV 336 (611)
....|.+++.||.||.+.||++...+.+.||+|.+.. +.....-|.+|+..|.+|+ |.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3457899999999999999999988888888887653 4567788999999999997 99999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||=+- +|..+|...... ...| .++.+..|++.|+.++|+ .||||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 439 mE~Gd~-DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECGDI-DLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eecccc-cHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 998644 999999876542 2345 677899999999999999 99999999999999975 489999999999999
Q ss_pred CCCCCccccccccccccCChhhhccC-----------CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
.+.+.+.....+||+.||+||.+... +.+.++||||||||||+|+.|++||..... .|+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a--- 580 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA--- 580 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH---
Confidence 88888777778999999999988633 356799999999999999999999964321 122
Q ss_pred cccCccccccCcccCCCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 486 LSSGKVTQLLDPALGNNYDY-DQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~-~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
++..+.||.-.-+|+. ..-..++.++..||.+||.+||+..|+|+.
T Consensus 581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2334444432222211 111126777778999999999999999974
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=298.98 Aligned_cols=260 Identities=23% Similarity=0.292 Sum_probs=193.0
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEec--CceEEEEe
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLVYD 338 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~--~~~~LV~E 338 (611)
|.+.+.||+|+||.||+|... +++.||+|+++.. ........+|+.++.++. |+|++++++++.++ +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 677899999999999999864 7899999998753 222334557999999886 99999999999987 88999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++ +|.+.+.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMDM-NLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCCc-cHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9975 8888776533 258999999999999999999999 89999999999999999 99999999999866443
Q ss_pred CCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHh-hcc-------ccccC
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW-AKP-------ILSSG 489 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~-~~~-------~~~~g 489 (611)
... ....++..|+|||++.. +.++.++|||||||++|||++|..||...+..+......- ... .....
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 222 22468899999997754 5578899999999999999999999976543221111100 000 00000
Q ss_pred ccccccCcc-cCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPA-LGNN---YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~-l~~~---~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......+. .... ........+..++..||+.+|.+||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 0000 001123566777788999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=302.02 Aligned_cols=264 Identities=21% Similarity=0.300 Sum_probs=195.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|++|.||+|.++ +|+.||+|.+.... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999875 78999999986532 334678899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-CCceEEeecCccccccC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 417 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-~~~vKL~DFGla~~~~~ 417 (611)
|+++ +|.+.+..... ..+++..+..++.||+.||.|||+ ++++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLDL-DLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cccc-cHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9965 78887754332 236788888999999999999999 89999999999999985 55799999999976543
Q ss_pred CCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc------
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK------ 490 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~------ 490 (611)
... ......+++.|+|||++.+. .++.++|||||||++|+|+||+.||......+....+...........
T Consensus 156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Ccc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 221 11234678999999998764 578999999999999999999999976544322211110000000000
Q ss_pred cccccC--cccCC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 491 VTQLLD--PALGN----NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 491 l~~lld--~~l~~----~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+..... +.... .........+..++..|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00000 000111234566777899999999999999986
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.20 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=192.4
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|...+.||+|+||.||++... +|+.+|+|.+... ......+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999865 6899999998753 244567889999999997 99999999999999999999999
Q ss_pred CCCCChhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 340 LSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 340 ~~ggsL~~~L~~~-~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
+.. +|.++.... ......+++..+..++.+++.||+|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 875 555443211 11123588999999999999999999961 48999999999999999999999999999765443
Q ss_pred CCCccccccccccccCChhhhccC---CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYG---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~---~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
... ....|++.|+|||++... .++.++|||||||++|||++|+.||....... ..+. .... +.
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~-~~----- 227 (288)
T cd06616 162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-DQLT----QVVK-GD----- 227 (288)
T ss_pred Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-HHHh----hhcC-CC-----
Confidence 221 224689999999999866 68999999999999999999999997543110 0100 0000 00
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.+...........+..++..||+.+|.+|||+.+|++.
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111111223356667778999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=304.03 Aligned_cols=245 Identities=27% Similarity=0.398 Sum_probs=194.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
..|...+.||+|+||+||+|... +|+.||+|.+... ....+.+.+|+++++.++||||++++++|..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999865 6899999998632 234567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+.+ +|.+.+.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~g-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCLG-SASDILEVHK---KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhCC-CHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99975 7777765332 258999999999999999999999 8999999999999999999999999999876543
Q ss_pred CCCCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
. ....|++.|+|||++. .+.++.++||||||+++|||++|+.||...........+.+.. .
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~-------~--- 231 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-------S--- 231 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCC-------C---
Confidence 2 1256889999999874 4568899999999999999999999997654322211111100 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+.+. .......+..++..||+.+|.+||++.+|+..
T Consensus 232 --~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 --PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0010 11122345666778999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.29 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=196.8
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
|.+.+.||.|++|.||+|.+. +|..||+|++.... .....+.+|+++++.++|||++++++++..++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999865 79999999987532 33467889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
+ ++|.+++..... ..+++..+..++.|+++||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 589998875542 358999999999999999999999 8999999999999999999999999999875543221
Q ss_pred CccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH-Hhhcccc--------ccCc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWAKPIL--------SSGK 490 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv-~~~~~~~--------~~g~ 490 (611)
. .....+++.|+|||++.++ .++.++|||||||++|+|++|+.||...........+ .+..... ....
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1 1223578999999988754 5788999999999999999999999765432221111 0000000 0000
Q ss_pred ----cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 491 ----VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 491 ----l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
......... ..........+..++..|++.+|.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0001112245667788899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=316.03 Aligned_cols=263 Identities=25% Similarity=0.427 Sum_probs=210.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
+...+.++||+|-||.|.++....+..||||.++... ...++|.+|+++|.+|+||||+.|+|+|..++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 3456789999999999999998888999999999754 44678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.+++....... +.-.....|+.||+.|++||.+ .++|||||.+.|+|++.++++||+|||+++-+-....
T Consensus 618 EnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred hcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999998664321 3334556799999999999999 8999999999999999999999999999986655555
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh--CCCCCCCCCCcchhhHHHhhccccccC-ccccccCc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT--GRKPISNDHPKGQESLVMWAKPILSSG-KVTQLLDP 497 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt--G~~Pf~~~~~~~~~~lv~~~~~~~~~g-~l~~lld~ 497 (611)
+......+-...|||||.+..++++.++|||+|||++||+++ ...||...... ..+.....++..+ .-.-+..|
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceeccCC
Confidence 544444556789999999999999999999999999999876 78888654332 2232222222222 11112222
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.. -...+.++++.||+.+-.+||+++++...|+.+.
T Consensus 770 ~~-------cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 770 PA-------CPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred Cc-------CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 21 1234557778899999999999999999887543
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.35 Aligned_cols=243 Identities=27% Similarity=0.404 Sum_probs=196.0
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
|.-.+.||.|+||.||-|.+. +...||||.+.-+ .....+++.|+..|.+++|||++.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 344567899999999999864 7788999998743 34456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
|-| +-.+++.-.+ .++-+.++..|+.+.+.||+|||+ ++.||||||..||||++.|.|||+|||.|.......
T Consensus 108 ClG-SAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN 180 (948)
T ss_pred Hhc-cHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence 976 7777775433 368889999999999999999999 889999999999999999999999999987665532
Q ss_pred CCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 420 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.++|||.|||||++. .|.|+.|+||||||++..||...++|+.+.+... .+...+. --.
T Consensus 181 ------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--ALYHIAQ----------Nes 242 (948)
T KOG0577|consen 181 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQ----------NES 242 (948)
T ss_pred ------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HHHHHHh----------cCC
Confidence 478999999999985 6799999999999999999999999976544322 1211111 111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
|.|. ..++...+..++-.||++-|.+|||.++++++
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2222 22334445556667999999999999998873
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=301.47 Aligned_cols=265 Identities=25% Similarity=0.342 Sum_probs=197.3
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 331 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~----- 331 (611)
..++|.+.+.||+|+||.||+|..+ +|+.||||+++.. ......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 5678999999999999999999975 6899999999743 233456778999999999999999999987655
Q ss_pred -----ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEE
Q 007256 332 -----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 406 (611)
Q Consensus 332 -----~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL 406 (611)
..++|+||+++ +|...+.... ..+++..++.++.|++.||.|||+ .+|+||||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999987 7777765432 358999999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 407 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
+|||++......... ......++..|+|||++.+. .++.++|||||||+++||++|+.||...........+......
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999876543321 11223568889999988643 5788999999999999999999999765433222111111000
Q ss_pred cccCccccc--------cCc------ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 486 LSSGKVTQL--------LDP------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 486 ~~~g~l~~l--------ld~------~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
........+ .++ ....... .....+..++..||+.+|.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 000 0000000 01234566777799999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.32 Aligned_cols=266 Identities=23% Similarity=0.326 Sum_probs=200.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~ 333 (611)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.+++.++||||++++++|.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999865 69999999987532 345677889999999999999999998763 3468
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 58998886543 48999999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCC--ccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc--
Q 007256 414 WASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS-- 488 (611)
Q Consensus 414 ~~~~~~~~--~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~-- 488 (611)
........ .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...........+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 66443221 11123578999999999865 46889999999999999999999999776543332222111100000
Q ss_pred ------CccccccCccc-CCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 489 ------GKVTQLLDPAL-GNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 489 ------g~l~~lld~~l-~~~~~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+....+..- ..... ......+..++..||+.+|.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 00011 1123456777788999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=289.53 Aligned_cols=246 Identities=29% Similarity=0.472 Sum_probs=201.2
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.+.+.||+|++|.||++... +++.|++|.+.... .....+.+|++++++++|+|++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788999999999999999865 68899999997654 4667899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.... .+++..+..++.+++.||.|||+ .+|+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999987552 58999999999999999999999 899999999999999999999999999998765543
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. .....|+..|+|||++....++.++||||||+++++|++|+.||........ .+.... ... +.+
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~~~~~---~~~-----~~~ 219 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LFRIVQ---DDH-----PPL 219 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHhc---cCC-----CCC
Confidence 32 1235689999999999888889999999999999999999999975442211 111100 000 111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
... ....+..++..||..+|++||++.+++.
T Consensus 220 ~~~----~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 PEG----ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCC----CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 111 1234456667799999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.01 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=197.3
Q ss_pred ceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 265 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
|...+.||+|++|.||++.. .+++.+++|.+.... ...+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999986 478899999886433 3455688999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|.+++... .+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 101 GALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 9999998752 47889999999999999999999 89999999999999999999999999988755443221
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....+......+.... .+.+...
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~------------~~~~~~~ 238 (285)
T cd06648 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL------------PPKLKNL 238 (285)
T ss_pred -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC------------CCCCccc
Confidence 123568999999999998889999999999999999999999997654432222111110 0011000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
......+..++..||+.+|++||++.++++
T Consensus 239 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 --HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 001134566677799999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.03 Aligned_cols=268 Identities=25% Similarity=0.433 Sum_probs=222.3
Q ss_pred ccccCHHHHHHhhcCc---------eeeeeEeecCcEEEEEEEeC-C---CCEEEEEEecCC--hhHHHHHHHHHHHHHh
Q 007256 250 CRLFNYQDLLSATSNF---------LAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITT 314 (611)
Q Consensus 250 ~~~f~~~el~~~t~~f---------~~~~~LG~G~fG~Vyk~~~~-~---g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~ 314 (611)
...++|++-..+..+| .++++||.|.||.||+|.++ . ...||||.+|.. +....+|+.|+.||.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 3456677666665554 57899999999999999975 2 356999999964 5667889999999999
Q ss_pred cCCcceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCcc
Q 007256 315 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 394 (611)
Q Consensus 315 l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~ 394 (611)
+.||||++|.|+.......+||.|||++|+|+.+|+.+.. .|.+.+..-++.+|+.|+.||-+ .++|||||-..
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAAR 760 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAAR 760 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhh
Confidence 9999999999999999999999999999999999987654 48999999999999999999999 99999999999
Q ss_pred ceeeCCCCceEEeecCccccccCCCCCcccccccc--ccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCC
Q 007256 395 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG--TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH 471 (611)
Q Consensus 395 NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~G--T~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~ 471 (611)
|||++.+...|++|||+++.+..+. ...++..-| ...|.|||.+.+.+++.++|||||||||||.++ |.+||.+..
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred heeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 9999999999999999999876654 222222223 357999999999999999999999999999887 999998877
Q ss_pred CcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 472 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 472 ~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
..+....++....+ .. +.+-...+.++++.||++|-.+||++.+|+..|.+..
T Consensus 840 NQdVIkaIe~gyRL------Pp----------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 840 NQDVIKAIEQGYRL------PP----------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred hHHHHHHHHhccCC------CC----------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 66655544432221 11 2233456778888999999999999999999987543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=298.42 Aligned_cols=261 Identities=22% Similarity=0.290 Sum_probs=200.0
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
|.+.+.||.|++|.||++... +|+.+++|.++... .....+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999875 78999999987543 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++ +|.+.+.... ..+++..+..++.+++.||.|||+ .+|+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 76 8888876543 358999999999999999999999 8999999999999999999999999999987755431
Q ss_pred CccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC---
Q 007256 421 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD--- 496 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld--- 496 (611)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+..............+.+
T Consensus 154 --~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 --PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred --cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 12234688899999999876 789999999999999999999999976554332211110000000000000000
Q ss_pred ---cccC-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 497 ---PALG-------NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 497 ---~~l~-------~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..+. ..........+..++..||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0001122346677888899999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.51 Aligned_cols=241 Identities=24% Similarity=0.314 Sum_probs=193.1
Q ss_pred EeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 271 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
||.|+||.||++... +++.+|+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 58999999987532 3456789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccc
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~ 425 (611)
.+++.... .+++..+..++.+++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~ 150 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TW 150 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---cc
Confidence 99997643 37889999999999999999999 8999999999999999999999999999987654321 12
Q ss_pred ccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCCh
Q 007256 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505 (611)
Q Consensus 426 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 505 (611)
...|++.|+|||++....++.++|+||||+++|+|++|..||............... .... .. .++.
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~-----~~----~~~~ 217 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL----KGNG-----KL----EFPN 217 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh----ccCC-----CC----CCCc
Confidence 356899999999998888999999999999999999999999766531111111100 0000 00 0111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007256 506 DQMERMVLASILCIRRDPRARPQ-----MSLVLK 534 (611)
Q Consensus 506 ~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~ 534 (611)
.....+..++..||+.+|.+||+ +.++++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11235666777799999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.39 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=185.0
Q ss_pred eEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHH---hcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 270 LIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIIT---TLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~---~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.||+|+||.||++... +|+.+|+|.+.... .....+.+|..++. ..+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999874 68999999886532 22233445554444 3479999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 999999886543 48999999999999999999999 8999999999999999999999999999875543221
Q ss_pred ccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
....||+.|+|||.+.. ..++.++|||||||++|+|++|+.||..........+.... . ..+..+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~---------~~~~~~~ 219 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-L---------TVNVELP 219 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-h---------cCCcCCc
Confidence 22468999999999874 46899999999999999999999999765433222111110 0 0011111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
.. ....+..++..||+.||.+|| ++.+++++
T Consensus 220 ~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 DS----FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cc----cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11 123445566679999999999 59998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.26 Aligned_cols=266 Identities=24% Similarity=0.314 Sum_probs=198.3
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec--Cce
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED--NNL 333 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~--~~~ 333 (611)
..++|.+.+.||+|+||.||+|.+. +|+.+|||.+.. .......+.+|+.+++++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888999999999999999875 688999998854 223445677899999999 999999999998654 368
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++ +|..++... .+.+..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEeccccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 999999975 998888643 47889999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC---ccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 414 WASTSSSH---ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 414 ~~~~~~~~---~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
........ .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||....+......+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 66543321 12233578999999998764 467889999999999999999999997655433222211111100000
Q ss_pred c--------cccccCcccCC------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 K--------VTQLLDPALGN------NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~--------l~~lld~~l~~------~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. ...+++..... .........+..++..|++.+|.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 00011100000 0000112456677788999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=311.37 Aligned_cols=246 Identities=20% Similarity=0.325 Sum_probs=205.7
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.-|.+++.||+|.|..|-+|.+ -+|..||||++.+.+ -....+.+|++.|+.++|||||+||++......+|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4577888999999999999875 489999999997643 345578899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC-CCCceEEeecCccccccC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd-~~~~vKL~DFGla~~~~~ 417 (611)
+=++|+|+++|-+... .+.+....+++.||+.|+.|+|+ ..+|||||||+||++- .-|-+||+|||++..+..
T Consensus 98 LGD~GDl~DyImKHe~---Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE---GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhhc---cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999976543 58999999999999999999999 8899999999999875 557899999999976665
Q ss_pred CCCCccccccccccccCChhhhccCCCC-CcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
+.. -++.+|+..|-|||++.+..|+ +++||||||||||.|++|+.||...+..+....++--+.
T Consensus 172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY------------ 236 (864)
T KOG4717|consen 172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY------------ 236 (864)
T ss_pred cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc------------
Confidence 432 2347999999999999999887 479999999999999999999987665544333332111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..+.-....+..++..||.+||++|.+.+||..
T Consensus 237 -----tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 -----TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 123334456677778899999999999999875
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=308.89 Aligned_cols=263 Identities=21% Similarity=0.315 Sum_probs=197.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~ 332 (611)
.++|.+.+.||+|+||+||+|... +|+.||||.+... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999864 7899999998752 33455678899999999999999999988654 35
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 899999996 58988886443 48899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc-c------
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-P------ 484 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-~------ 484 (611)
........ ......++..|+|||++.. ..++.++|||||||++|+|++|+.||...........+.... .
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 86654321 1223568899999998875 468899999999999999999999997654322111111000 0
Q ss_pred -ccccCcccccc-------CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 485 -ILSSGKVTQLL-------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 485 -~~~~g~l~~ll-------d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
....+.....+ ++.+.. ........+..++..||+.+|.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000 000000 001122445677788999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=293.47 Aligned_cols=261 Identities=23% Similarity=0.327 Sum_probs=195.4
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhc---CCcceeEEeeEEEecCc-----
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFEDNN----- 332 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~~~~~----- 332 (611)
|.+.+.||+|+||.||+|..+ +++.||+|+++.. ......+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999976 5899999999743 22334566788877766 59999999999988776
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.+++|||+.+ +|.+++..... ..+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 9999999975 89888865432 258999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc-
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV- 491 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l- 491 (611)
......... ....++..|+|||++.+..++.++|||||||++|||++|+.||...........+............
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 776443221 2245789999999999999999999999999999999999999765543322211110000000000
Q ss_pred ------ccccCcccCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 492 ------TQLLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 492 ------~~lld~~l~~---~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
...+...... .........+..++..||+.||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 001112344556777899999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.82 Aligned_cols=243 Identities=25% Similarity=0.331 Sum_probs=190.3
Q ss_pred EeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 271 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
||+|+||+||++... +|+.||+|.+.... .....+..|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 68999999986432 2345677899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccc
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~ 425 (611)
.+++..... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 152 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK 152 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cc
Confidence 999875543 358899999999999999999999 8999999999999999999999999999876544221 12
Q ss_pred ccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCCh
Q 007256 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505 (611)
Q Consensus 426 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 505 (611)
...++..|+|||++.++.++.++|||||||++|+|++|+.||...........+... ... ....+...+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~~-- 221 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR--TLE-------MAVEYPDKF-- 221 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc--ccc-------ccccCCccC--
Confidence 346788999999999888999999999999999999999999765432111111100 000 000011111
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007256 506 DQMERMVLASILCIRRDPRARP-----QMSLVLK 534 (611)
Q Consensus 506 ~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~ 534 (611)
...+..++..||+.+|.+|| ++.+++.
T Consensus 222 --~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 --SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 22345566679999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.73 Aligned_cols=244 Identities=26% Similarity=0.411 Sum_probs=193.7
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
|...+.||+|+||.||+|... +|..+|+|.+... ......+.+|+++++.++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666788999999999999864 6899999998642 24456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+.+ +|.+.+.... ..+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 975 7877775432 258999999999999999999999 89999999999999999999999999998654332
Q ss_pred CCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 420 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||...........+. .. + .
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~--~~----~-~----- 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--QN----E-S----- 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--hc----c-C-----
Confidence 2356899999999974 4578999999999999999999999987653322211111 10 0 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
+... .......+..++..||+.+|.+||++.+|++.+
T Consensus 242 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 PTLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0000 111123455667789999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=296.24 Aligned_cols=248 Identities=27% Similarity=0.376 Sum_probs=201.3
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV 336 (611)
++|.+.+.||+|+||.||+|... +|+.||+|++..+ ....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999875 7999999998752 234567889999999999 99999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997653 58999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCC------------------ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhH
Q 007256 417 TSSSH------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 478 (611)
Q Consensus 417 ~~~~~------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l 478 (611)
..... .......|+..|+|||++....++.++||||||+++++|++|+.||...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 43321 112235688999999999988899999999999999999999999976542111111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 007256 479 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM----SLVLK 534 (611)
Q Consensus 479 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm----~eVL~ 534 (611)
+. . . .. .+.......+..++..||+.+|.+||++ .++++
T Consensus 234 ~~---~------~----~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 IL---K------L----EY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH---h------c----CC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 0 0 00 0111113446667778999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.77 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=194.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--Cce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~------~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~ 333 (611)
.+|.+.+.||+|+||.||+|.+. +|+.||+|.+... ......+.+|++++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999864 6999999987532 23456788999999999999999999998764 458
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999987543 37888899999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCC-ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
........ .......|+..|+|||++.+..++.++|||||||++++|++|+.||.......... .... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~----~~--- 225 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF--KIAT----QP--- 225 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH--HHHc----CC---
Confidence 65432111 11123568999999999998889999999999999999999999997643322111 1100 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+.+. ......+..++..|++ +|..||+..+++.+
T Consensus 226 --~~~~~p----~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 --TKPMLP----DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --CCCCCC----cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 011111 1122345555566888 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.25 Aligned_cols=255 Identities=17% Similarity=0.188 Sum_probs=182.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCC----CCEEEEEEecCChhH------------HHHHHHHHHHHHhcCCcceeEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIISLLG 325 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~~------------~~~f~~Ei~iL~~l~HpnIv~l~g 325 (611)
.++|.+.++||+|+||+||+|...+ +..+|+|+....... ......++..+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3689999999999999999998654 456677764322111 011223444566678999999999
Q ss_pred EEEecC----ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC
Q 007256 326 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 401 (611)
Q Consensus 326 ~~~~~~----~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~ 401 (611)
++.... ..+++++++.. ++.+.+.... ..++..+..++.|++.||.|||+ ++|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence 776543 34677887654 6666665332 25678889999999999999999 899999999999999999
Q ss_pred CceEEeecCccccccCCCCC-----ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchh
Q 007256 402 FEPQLSDFGLAKWASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 476 (611)
Q Consensus 402 ~~vKL~DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~ 476 (611)
+.++|+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999876432211 1112246999999999999999999999999999999999999999766332211
Q ss_pred -hH--HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 477 -SL--VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 477 -~l--v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
.. ..+...+. .+. +..... ...+..++..|++.+|++||++.++++.|
T Consensus 243 ~~~~~~~~~~~~~-~~~--------~~~~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLH-EGK--------IKIKNA---NKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhh-hhh--------hccCCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 10 11111111 111 100011 23355566669999999999999999876
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=293.56 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=194.8
Q ss_pred EeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 271 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
||.|+||.||++... +|+.+++|++.... ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 59999999997543 3456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC-----
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----- 420 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~----- 420 (611)
.+++.... .+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997543 48899999999999999999999 8999999999999999999999999999875543321
Q ss_pred -CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 -HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 -~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
........++..|+|||++....++.++||||||+++|+|++|..||...........+.. +... .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-------~~~~------~ 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-------GKIE------W 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------CCcC------C
Confidence 1122235688999999999988899999999999999999999999976553322111111 0000 0
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.... .....+..++..|++.+|.+|||+..+.+.|+
T Consensus 221 ~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred Cccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000 01234556667799999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=301.42 Aligned_cols=266 Identities=21% Similarity=0.284 Sum_probs=195.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~------ 331 (611)
.++|.+.+.||+|+||.||+|... +++.+|||++... ......+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 6899999988642 222346778999999999999999999875543
Q ss_pred --ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeec
Q 007256 332 --NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409 (611)
Q Consensus 332 --~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DF 409 (611)
.+++||||+.+ +|...+.... ..+++..+..++.|+++||.|||+ ++|+|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999976 6777765432 258999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCCc---------cccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH
Q 007256 410 GLAKWASTSSSHI---------TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479 (611)
Q Consensus 410 Gla~~~~~~~~~~---------~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv 479 (611)
|++.......... ......|++.|+|||++.+. .++.++|||||||++|||++|+.||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9997654332111 11234678999999988654 5889999999999999999999999765543322221
Q ss_pred Hhhcccccc------CccccccCcccCCCCC-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 480 MWAKPILSS------GKVTQLLDPALGNNYD-------YDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 480 ~~~~~~~~~------g~l~~lld~~l~~~~~-------~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
......... ..+....+........ ......+..++..||+.+|.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111000000 0001110000000000 111245667788899999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.73 Aligned_cols=245 Identities=26% Similarity=0.369 Sum_probs=199.2
Q ss_pred eeEeecCcEEEEEEEeCC-CCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChh
Q 007256 269 NLIGKGGSSQVYKGCLPD-GKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
-+||+|.||+||-|++.+ ...+|||-+... .....-+..||.+.+.|+|.|||+++|.|.+++.+-|.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999764 557899988743 345566889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC-CCCceEEeecCccccccCCCCCcccc
Q 007256 347 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCT 425 (611)
Q Consensus 347 ~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd-~~~~vKL~DFGla~~~~~~~~~~~~~ 425 (611)
.+|...-. +..-.+.+.-.+.+||++||.|||+ +.|||||||-+|||++ ..|.+||+|||-++.+...... +.
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--TE 734 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--TE 734 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCcc--cc
Confidence 99975322 2223778888999999999999999 8899999999999996 5789999999999988765443 33
Q ss_pred ccccccccCChhhhccC--CCCCcceehhhhHHHHHHHhCCCCCCCCCCc-chhhHHHhhccccccCccccccCcccCCC
Q 007256 426 DVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 426 ~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~-~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
++.||..|||||++..| .|..++|||||||++.||.||++||..-... ..+..+..-+ ....
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK---------------vHP~ 799 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK---------------VHPP 799 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee---------------cCCC
Confidence 58899999999999876 5889999999999999999999999653322 2222211111 0123
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
++.+.......+++.|+.++|.+||++.++|+
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 34455566677888899999999999999986
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.73 Aligned_cols=251 Identities=26% Similarity=0.414 Sum_probs=201.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCC-CEEEEEEecC-ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDG-KELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g-~~vAVK~l~~-~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
+.|.++..||-|+||.||+|..++. -..|.|++.. +....++|+-||+||..+.||+||+|++.|..++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4577889999999999999987654 4456787763 5677889999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
.||-++.++-.-+. .|.+.++..++.+++.||.|||+ ++|||||||..|||++-+|.++|+|||.+..... .
T Consensus 112 ~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred CCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 99999988765443 68999999999999999999999 9999999999999999999999999998743322 1
Q ss_pred CccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 421 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
....+.+.|||+|||||+++ ..+|+.++||||||++|.||..+.+|-..-++......+.... ..-++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-------PPTLl 256 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-------PPTLL 256 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-------CCccc
Confidence 12234589999999999876 4589999999999999999999999987655533222222111 11122
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.| ..+...+..+...||.+||+.||++.+++++
T Consensus 257 qP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 QP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred Cc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 21 2233344455567999999999999999874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=308.59 Aligned_cols=259 Identities=21% Similarity=0.326 Sum_probs=193.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~------ 331 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999864 7899999998743 233456889999999999999999999987543
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++|+||+.. +|..++. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999975 7776552 147889999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc--
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS-- 488 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~-- 488 (611)
++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....+....
T Consensus 164 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 87653321 23467899999999876 46889999999999999999999999865433222221111100000
Q ss_pred ------CccccccC--cccC-CCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 489 ------GKVTQLLD--PALG-NNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 489 ------g~l~~lld--~~l~-~~~---~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
........ +... ... .......+..++..||+.||.+||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000 000 00112345567778999999999999999863
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.76 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=196.7
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChh--HHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeeC
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--VIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
|.+.+.||.|+||+||+|... +++.|+||.+..... ......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677899999999999999975 588999999875432 2234567999999999 999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
+|+|.+.+.... ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 779999887544 2358999999999999999999999 8999999999999999999999999999976654322
Q ss_pred CccccccccccccCChhhhc-cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHH----------hhccccccC
Q 007256 421 HITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------WAKPILSSG 489 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~----------~~~~~~~~g 489 (611)
. ....|+..|+|||++. ...++.++|+||||++++||++|+.||............. |........
T Consensus 155 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 Y---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred c---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1 2356889999999885 4457899999999999999999999997654433221110 000000000
Q ss_pred ccccccC----cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLD----PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld----~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+...+. ..+..... .....+..++..|++.+|++|||+.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00000000 112456677888999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=290.98 Aligned_cols=243 Identities=22% Similarity=0.261 Sum_probs=187.4
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHH-HhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEII-TTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL-~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||.||+|... +|+.||||++.... .....+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999864 68999999997542 2223344555444 455899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 99999997543 47889999999999999999999 8999999999999999999999999999875433
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||...........+..... .. ....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~----~~~~--- 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI-----NW----PEEV--- 216 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-----CC----CCcc---
Confidence 1235688999999999988899999999999999999999999976543322111111000 00 0000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.......+..++..||+.+|.+||++.++.+.|.
T Consensus 217 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 -KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred -cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 0011234566777899999999998766655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.11 Aligned_cols=264 Identities=22% Similarity=0.267 Sum_probs=195.4
Q ss_pred cCce-eeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhH---------------HHHHHHHHHHHHhcCCcceeEEee
Q 007256 263 SNFL-AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV---------------IKEFVLEIEIITTLHHKNIISLLG 325 (611)
Q Consensus 263 ~~f~-~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~---------------~~~f~~Ei~iL~~l~HpnIv~l~g 325 (611)
++|. +.+.||.|+||+||+|.+. +++.||||.++..... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 4577999999999999865 7999999998753211 124778999999999999999999
Q ss_pred EEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 326 ~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
++..++..++||||+. |+|.+++.... .+++.....++.|++.||.|||+ .+|+|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEE
Confidence 9999999999999997 58998886432 48889999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCC------------CccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 406 LSDFGLAKWASTSSS------------HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 406 L~DFGla~~~~~~~~------------~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
|+|||++........ ........+++.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999976652110 0111123578899999998764 468899999999999999999999987654
Q ss_pred cchhhHHHhhccccccCcccccc------------CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 473 KGQESLVMWAKPILSSGKVTQLL------------DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 473 ~~~~~lv~~~~~~~~~g~l~~ll------------d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
......+...........+.... .+.+.. ........+..++..||+.+|.+||++.+++..
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 43322211110000000000000 000000 001112345567778999999999999999863
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=297.93 Aligned_cols=252 Identities=27% Similarity=0.413 Sum_probs=193.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCC-CCEEEEEEecCCh--hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.++|.+.+.||+|+||.||+|..++ ++.||||+++... .....+..|+.++.+.. |+||++++++|......++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3578899999999999999999864 8999999997542 34456777888777775 999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+.+ +|.+++.... ..+++..+..++.+++.||.|||+. .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 94 e~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99865 7777765432 2689999999999999999999961 4899999999999999999999999999876544
Q ss_pred CCCCccccccccccccCChhhhccCC----CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~----~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
.... ....++..|+|||++.... ++.++||||||+++|+|++|+.||....... ..+...... ....
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~-----~~~~ 238 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTKILQE-----EPPS 238 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHHHhcC-----CCCC
Confidence 3222 2245788999999987543 8889999999999999999999996532211 111111110 0000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+... ......+..++..||+.||.+||++.+++++
T Consensus 239 -----~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 -----LPPN--EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0112346667778999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=294.24 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=193.3
Q ss_pred CceeeeeEeecCcEEEEEEEe----CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 007256 264 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~-----~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 333 (611)
+|.+.+.||+|+||.||++.. .+|..||+|+++... ...+.+.+|+.++..+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999986 378999999997532 2346788899999999 599999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999987543 47888999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCCccccccccccccCChhhhccC--CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
........ ......|+..|+|||++..+ .++.++||||||+++|+|++|+.||...........+ ...+...
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--~~~~~~~--- 227 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKS--- 227 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH--HHHhhcc---
Confidence 65443221 11235689999999998753 4678999999999999999999999754322111111 1111100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLK 534 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~ 534 (611)
.+.... .....+..++..|++.+|.+|| ++.+++.
T Consensus 228 ----~~~~~~----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ----EPPYPQ----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCCCCc----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 000111 1112445566679999999997 5666655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=294.84 Aligned_cols=255 Identities=26% Similarity=0.352 Sum_probs=197.8
Q ss_pred CceeeeeEeecCcEEEEEEEe----CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 007256 264 NFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~-----~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 333 (611)
+|.+.+.||+|++|.||++.. .+++.||||+++... ...+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999874 367889999987432 3345688999999999 599999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++|+|.+++.... .+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999986532 47889999999999999999999 899999999999999999999999999987
Q ss_pred cccCCCCCccccccccccccCChhhhccCC--CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
......... .....|+..|+|||++.+.. .+.++||||||+++|||++|..||............ .......
T Consensus 154 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKS--- 227 (288)
T ss_pred ccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH--HHHHHcc---
Confidence 654432221 12256899999999987665 788999999999999999999999654322111111 1111000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.+.....++ ..+..++..||+.+|++|||+.++.+.|...
T Consensus 228 ----~~~~~~~~~----~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 ----KPPFPKTMS----AEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----CCCCCcccC----HHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 011111111 2344566679999999999998888777643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.87 Aligned_cols=262 Identities=23% Similarity=0.292 Sum_probs=191.6
Q ss_pred eeEeec--CcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKG--GSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G--~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
..||+| +||+||++.+. +|+.||||++... ....+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 99999999874 7999999998743 33457788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++++|||.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999876532 248889999999999999999999 899999999999999999999999998654332211110
Q ss_pred --c---ccccccccccCChhhhccC--CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc--------
Q 007256 423 --T---CTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS-------- 487 (611)
Q Consensus 423 --~---~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~-------- 487 (611)
. .....++..|+|||++.++ .++.++|||||||++|||++|+.||................+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 0 0112356779999999764 478999999999999999999999976543221110000000000
Q ss_pred ----------------------cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 488 ----------------------SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 488 ----------------------~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+......+..+...........+..++..||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000111111111112234456778888999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.82 Aligned_cols=268 Identities=23% Similarity=0.287 Sum_probs=199.7
Q ss_pred cCHHHHHHhhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEE
Q 007256 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCF 328 (611)
Q Consensus 253 f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~ 328 (611)
....++...+++|.+.+.||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34556667889999999999999999999986 478999999997532 23466888999999999999999999886
Q ss_pred ec------CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC
Q 007256 329 ED------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402 (611)
Q Consensus 329 ~~------~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~ 402 (611)
.. ...+++++++ +++|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCC
Confidence 43 3467888876 77998887532 48899999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHh
Q 007256 403 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMW 481 (611)
Q Consensus 403 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~ 481 (611)
.+||+|||++...... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus 158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999998754332 123568999999999875 5688999999999999999999999976543222111111
Q ss_pred hccccccCcc---------------ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 482 AKPILSSGKV---------------TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 482 ~~~~~~~g~l---------------~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......... .......+.. ........+..++..|++.||.+||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000 0000000000 000112345667778999999999999998864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=297.84 Aligned_cols=261 Identities=25% Similarity=0.295 Sum_probs=192.3
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
+.+.+|.|+++.||++.. +|+.||||+++.. ....+.+.+|+++++.++|+||+++++++..++..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344456666666666654 7999999998753 455678999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC---
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--- 420 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~--- 420 (611)
+|.+++..... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999975432 247888999999999999999999 8999999999999999999999999998865532211
Q ss_pred --CccccccccccccCChhhhcc--CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc----ccccc----
Q 007256 421 --HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK----PILSS---- 488 (611)
Q Consensus 421 --~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~----~~~~~---- 488 (611)
........++..|+|||++.. ..++.++|||||||+++||++|+.||........ +..... ..+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchh
Confidence 111123457889999999875 3588999999999999999999999976543221 111000 00000
Q ss_pred ---Ccccc----ccCcccC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 489 ---GKVTQ----LLDPALG----NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 489 ---g~l~~----lld~~l~----~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..... ..++... ..........+..++..||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 1111100 01111223456667778999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.17 Aligned_cols=243 Identities=26% Similarity=0.425 Sum_probs=194.8
Q ss_pred eeeeEeecCcEEEEEEEeC-CCCEEEEEEec-----CChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc--eEEEEe
Q 007256 267 AENLIGKGGSSQVYKGCLP-DGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN--LLLVYD 338 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~-----~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~--~~LV~E 338 (611)
...+||+|+|-+||+|.+. +|.+||--.++ .+....++|..|+++|+.|+||||+++|.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3456999999999999975 68888743332 345667899999999999999999999999987665 889999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-CCceEEeecCccccccC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWAST 417 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-~~~vKL~DFGla~~~~~ 417 (611)
.|..|+|..++.+.+. .+...+..|+.||++||.|||+.. .+|||||||.+||+|+. .|.|||+|+|||.....
T Consensus 124 L~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999987764 777889999999999999999976 68999999999999975 58999999999998876
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
... ..++|||.|||||++. ..|++.+||||||++++||+|+..||..-....+.... ...|.-...+
T Consensus 199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKK------V~SGiKP~sl-- 265 (632)
T KOG0584|consen 199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKK------VTSGIKPAAL-- 265 (632)
T ss_pred ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHH------HHcCCCHHHh--
Confidence 433 2378999999999988 89999999999999999999999999765544433221 1112111111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
......+++. ++-.||.. ..+|||+.|+|+
T Consensus 266 ---~kV~dPevr~---fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 266 ---SKVKDPEVRE---FIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---hccCCHHHHH---HHHHHhcC-chhccCHHHHhh
Confidence 1222334444 44459999 999999999997
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=298.85 Aligned_cols=209 Identities=28% Similarity=0.383 Sum_probs=182.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
-++|...++||+|.||.|.+++.+ +|+.||||++++. ++.+..-+.|-++|+..+||.+..|.-.|+.++.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467888999999999999998855 7999999999864 34455567799999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||..||.|.-+|.... .+++...+.+..+|+.||.|||+ ++||.||||.+|+|||.+|++||+|||+++..-
T Consensus 247 MeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999998887543 58888889999999999999999 999999999999999999999999999998543
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv 479 (611)
... .+..+++|||.|+|||++....|...+|+|.+|||+|||++|+.||...+....-.++
T Consensus 320 ~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 320 KYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI 380 (516)
T ss_pred ccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence 322 2345699999999999999999999999999999999999999999877655443333
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=303.41 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=201.3
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----ceE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-----NLL 334 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~-----~~~ 334 (611)
+|.+.+.||.|+||.||+|... +|+.||||.+... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999975 5899999998753 344567899999999999999999999998775 789
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+++ +|.+++.... .+++..+..++.+++.||.|||+ ++|+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999985 8988886543 58999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-ccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC---
Q 007256 415 ASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG--- 489 (611)
Q Consensus 415 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g--- 489 (611)
....... .......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+.-........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 7654310 112235689999999999877 78999999999999999999999997765433222221111110000
Q ss_pred -----ccccccCcc-cCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 -----KVTQLLDPA-LGNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 -----~l~~lld~~-l~~~~~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.....+... ...... ......+..++..||+.+|.+||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 000000 0112345567777999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=290.90 Aligned_cols=250 Identities=20% Similarity=0.333 Sum_probs=194.5
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC------ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP------SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~------~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
+|.+.+.||+|+||.||++... .+..+++|+++. .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999865 345566666653 123344677899999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.........+++..++.++.|++.||.|||+ .+++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999887543334568999999999999999999999 89999999999999975 569999999987664
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
..... .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||........ ..... .+. .
T Consensus 157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~~~~~----~~~-----~ 222 (260)
T cd08222 157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV---VLRIV----EGP-----T 222 (260)
T ss_pred CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHH----cCC-----C
Confidence 43221 1235688999999999888899999999999999999999999965432211 11100 011 1
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+.+. ......+..++..|++.+|++||++.++++.
T Consensus 223 ~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 PSLP----ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCc----chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1111 1122345566777999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=290.09 Aligned_cols=264 Identities=26% Similarity=0.412 Sum_probs=202.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++......||.|..|.|++.... +|..+|||.+... ....++++..++++...+ +|+||+.+|||..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34456678999999999999865 6899999999864 456678888888887776 8999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
.|.- -++.++..... ++++..+-++...++.||.||.+. ++|||||+||+|||+|+.|++||||||++-.+..+
T Consensus 172 lMs~-C~ekLlkrik~---piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKG---PIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHHhcC---CchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9854 66666655443 578888889999999999999983 78999999999999999999999999999887765
Q ss_pred CCCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcch-hhHHHhhccccccCccccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g~l~~l 494 (611)
..+. ..+|-+.|||||.+. ..+|+-++||||||+.|+||.||+.||...+..-. ...+....
T Consensus 246 kAht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e----------- 311 (391)
T KOG0983|consen 246 KAHT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE----------- 311 (391)
T ss_pred cccc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC-----------
Confidence 5443 357999999999986 34789999999999999999999999987554322 22221111
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh--h----CCccchhhHhhh
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL--R----GDADVTKWARLQ 549 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L--~----~~~~~~~~~~~~ 549 (611)
.|.|..... ....+..+...||++|+++||...+++++- . ...++..|-...
T Consensus 312 -PP~L~~~~g--FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV 369 (391)
T KOG0983|consen 312 -PPLLPGHMG--FSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDV 369 (391)
T ss_pred -CCCCCcccC--cCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHH
Confidence 133332221 112233445569999999999999998741 1 134556676543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=291.17 Aligned_cols=241 Identities=25% Similarity=0.331 Sum_probs=185.1
Q ss_pred eEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHH---HHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 270 LIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIE---IITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~---iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
+||+|+||.||++... +++.||+|.+.... .....+..|.. +++...||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 68999999986432 11223444444 4444579999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
|++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 999999886432 58999999999999999999999 8999999999999999999999999999875543221
Q ss_pred ccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
....|+..|+|||++.++ .++.++|||||||++|||++|+.||............ .... .....+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~---------~~~~~~~ 219 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-RMTL---------TMAVELP 219 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-HHhh---------ccCCCCC
Confidence 235789999999999755 6899999999999999999999999765332221111 0000 0011111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
... ...+..++..|+..+|.+|| ++.++++.
T Consensus 220 ~~~----s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 DSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CcC----CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111 23455566679999999999 99998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=306.71 Aligned_cols=212 Identities=26% Similarity=0.336 Sum_probs=185.2
Q ss_pred HHHHHHhhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEe
Q 007256 255 YQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFE 329 (611)
Q Consensus 255 ~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~ 329 (611)
++-.....+.|..-++||+||||.||-+.. .+|+.||.|.+.+.. ......++|-.||.+++.+.||.+--.|..
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 333344557799999999999999998875 479999999886432 333456789999999999999999999999
Q ss_pred cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeec
Q 007256 330 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409 (611)
Q Consensus 330 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DF 409 (611)
.+.+++|+..|.||+|.-+|...+. ..|++..+..++.+|+.||++||+ .+||+||+||+|||||+.|+++|+|.
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeecc
Confidence 9999999999999999998876654 469999999999999999999999 99999999999999999999999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 474 (611)
|+|..+....... ..+||.||||||+++++.|+...|+|||||+||||+.|+.||.....+.
T Consensus 332 GLAvei~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv 393 (591)
T KOG0986|consen 332 GLAVEIPEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV 393 (591)
T ss_pred ceEEecCCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh
Confidence 9999887765443 2589999999999999999999999999999999999999997665443
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=302.94 Aligned_cols=264 Identities=22% Similarity=0.325 Sum_probs=197.7
Q ss_pred HHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cC
Q 007256 257 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DN 331 (611)
Q Consensus 257 el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-~~ 331 (611)
++...+++|.+.+.||.|+||.||++... +|+.||||++... ....+.+..|+++++.++||||++++++|.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44567889999999999999999999865 7999999987542 2345678899999999999999999999876 56
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++||||+ +++|.+++... .+.+..+..++.|++.||.|||+ ++|+||||+|+|||++.++.++|+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999998 45898888642 36788888999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH-Hhh-------
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV-MWA------- 482 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv-~~~------- 482 (611)
+....... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+ ...
T Consensus 155 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 155 ARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred ccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 87543211 22467889999998765 56899999999999999999999999765432211111 000
Q ss_pred -ccccccCccccccCcc-cCCCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 483 -KPILSSGKVTQLLDPA-LGNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 483 -~~~~~~g~l~~lld~~-l~~~~~~-----~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
...... ....++... .....+. .....+..++..||+.+|++||++.+++..
T Consensus 230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 230 INTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000000 0001111 112456667778999999999999998763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=295.53 Aligned_cols=244 Identities=29% Similarity=0.412 Sum_probs=192.8
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~----~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.|...+.||+|+||.||+|... ++..+|+|.+.. ......++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 4666788999999999999965 688999998863 23445678899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+. |+|.+.+.... ..+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 997 58877775432 247889999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
....|++.|+|||++. .+.++.++|||||||++|+|++|+.||........... +.. +..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~~~-----~~~---- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--IAQ-----NES---- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH--Hhh-----cCC----
Confidence 2356899999999985 35688899999999999999999999866433221111 111 000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+... .......+..++..||+.+|.+||++.+|++.
T Consensus 232 -~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 -PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0110 11122345566777999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=288.14 Aligned_cols=248 Identities=23% Similarity=0.254 Sum_probs=188.5
Q ss_pred HHHHhhcCceeeeeE--eecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCc
Q 007256 257 DLLSATSNFLAENLI--GKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 332 (611)
Q Consensus 257 el~~~t~~f~~~~~L--G~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~ 332 (611)
+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +||||++++++|..++.
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 333445667777766 99999999999864 78899999987532111 123222222 69999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-ceEEeecCc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGL 411 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-~vKL~DFGl 411 (611)
.++||||+++++|.+++.... .+++..+..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||+
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 999999999999999997543 58999999999999999999999 8999999999999999988 999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
+....... ...|+..|+|||++.+..++.++|||||||++|||++|+.||........ ....+..... ..
T Consensus 157 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~--~~- 226 (267)
T PHA03390 157 CKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQQ--KK- 226 (267)
T ss_pred ceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhhc--cc-
Confidence 87664322 24689999999999988999999999999999999999999975433221 1111111100 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLK 534 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-m~eVL~ 534 (611)
... .. .....+..++..||+.+|.+||+ ++++++
T Consensus 227 ~~~-----~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 LPF-----IK----NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCc-----cc----ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 00 11234455566799999999996 588874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=333.98 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=190.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-------
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------- 330 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~------- 330 (611)
..++|...++||+||||.||+++.+ ||+.||||++... ......+.+|+..|++|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4467888899999999999999977 9999999998754 56667889999999999999999987332100
Q ss_pred --------------------------------------------------------------------------------
Q 007256 331 -------------------------------------------------------------------------------- 330 (611)
Q Consensus 331 -------------------------------------------------------------------------------- 330 (611)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 007256 331 --------------------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378 (611)
Q Consensus 331 --------------------------------~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 378 (611)
..+||-||||+.-.|.++++.+.... .-...++++.+|++||.|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHH
Confidence 01578899999977777776554211 3567889999999999999
Q ss_pred hcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc----------------CCCCCccccccccccccCChhhhccC
Q 007256 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----------------TSSSHITCTDVAGTFGYLAPEYFMYG 442 (611)
Q Consensus 379 H~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~----------------~~~~~~~~~~~~GT~~Y~APE~l~~~ 442 (611)
|+ +|||||||||.||+|++++.+||+|||+|.... .+......+..+||.-|+|||++.+.
T Consensus 714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99 999999999999999999999999999998621 01111123447899999999999755
Q ss_pred ---CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhc
Q 007256 443 ---KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCI 519 (611)
Q Consensus 443 ---~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL 519 (611)
+|+.|+|+||||||||||+. ||.... +....+.. ++.+.+... ..+..+....-..++.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~----LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTN----LRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHh----cccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999994 564322 12222221 122222222 1122333444556677899
Q ss_pred ccCCCCCCCHHHHHH
Q 007256 520 RRDPRARPQMSLVLK 534 (611)
Q Consensus 520 ~~dP~~RPtm~eVL~ 534 (611)
+.||.+|||+.|+|+
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999986
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=318.73 Aligned_cols=203 Identities=31% Similarity=0.435 Sum_probs=174.6
Q ss_pred CceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------CceE
Q 007256 264 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLL 334 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~~ 334 (611)
.|...+.||+||||.||+|++ .+|+.||||.++.. ....+...+|+++|++++|+|||++++.-... ...+
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 355667899999999999995 58999999999863 35567788999999999999999999875443 3578
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC--CCC--ceEEeecC
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDF--EPQLSDFG 410 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd--~~~--~vKL~DFG 410 (611)
+|||||.||+|+..+..... ...|++.+.+.++..+..||.|||+ +||+||||||.||++- .+| ..||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999975443 3469999999999999999999999 8999999999999993 334 47999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhc-cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCc
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 473 (611)
.|+...... .+..++||+.|++||++. .+.|+..+|.|||||++|+.+||..||......
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999887765 344589999999999998 488999999999999999999999999765443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=334.08 Aligned_cols=222 Identities=25% Similarity=0.297 Sum_probs=195.5
Q ss_pred CHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEE
Q 007256 254 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCF 328 (611)
Q Consensus 254 ~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~ 328 (611)
...++....++|.+.++||+|+||.|..+..+ +++.||+|++++. ......|..|-++|...+.+-|++++-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35677777889999999999999999999875 6889999999863 234557889999999999999999999999
Q ss_pred ecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEee
Q 007256 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 408 (611)
Q Consensus 329 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~D 408 (611)
+++++|+|||||+||+|..++.... .+++.-++.++.+|+.||.-||+ .|+|||||||+|||||..|++||+|
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999997664 47888899999999999999999 9999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccccccCChhhhc----c-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 007256 409 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----Y-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 409 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~----~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~ 483 (611)
||.+..+..+ +...+...+|||.|++||++. + +.|+..+|+||+||++||||.|..||..+...+....++..+
T Consensus 219 FGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk 297 (1317)
T KOG0612|consen 219 FGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK 297 (1317)
T ss_pred chhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh
Confidence 9999877654 334455679999999999986 3 579999999999999999999999999988777777766543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=294.38 Aligned_cols=242 Identities=26% Similarity=0.389 Sum_probs=192.8
Q ss_pred eeEeecCcEEEEEEEe-CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChh
Q 007256 269 NLIGKGGSSQVYKGCL-PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
..||+|+||.||++.. .+|..||||.+... ......+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5689999999999986 47899999998643 234567889999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccccc
Q 007256 347 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 426 (611)
Q Consensus 347 ~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~ 426 (611)
+++... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~ 175 (292)
T cd06657 106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175 (292)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence 987532 47889999999999999999999 89999999999999999999999999998765443221 123
Q ss_pred cccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChH
Q 007256 427 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 506 (611)
Q Consensus 427 ~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~ 506 (611)
..|++.|+|||++....++.++|+|||||++|+|++|..||................ .+.+... ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~------------~~~~~~~--~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPKLKNL--HK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC------------CcccCCc--cc
Confidence 568999999999988889999999999999999999999997644322211111100 0111000 00
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 507 QMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 507 ~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
....+..++..||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1123445566799999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=302.43 Aligned_cols=260 Identities=21% Similarity=0.295 Sum_probs=194.7
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 331 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~----- 331 (611)
..++|.+.+.||+|+||.||++... +|..||||++... ......+.+|+++++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999854 7999999998642 234557889999999999999999999987654
Q ss_pred -ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 332 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 332 -~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
..++||||+ +++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 67998887532 48899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc---
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL--- 486 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~--- 486 (611)
++....... ....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...........+.......
T Consensus 164 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 997654321 23467899999999875 458899999999999999999999997654322211111000000
Q ss_pred -----ccCccccccCc--ccC-C---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 487 -----SSGKVTQLLDP--ALG-N---NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 487 -----~~g~l~~lld~--~l~-~---~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
........... ... . .........+..++..|++.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 000 0 000011223556777899999999999999885
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=299.03 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=191.3
Q ss_pred CceeeeeEeecCcEEEEEEEeC-C--CCEEEEEEecCC---hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec----Cc
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-D--GKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED----NN 332 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~--g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~----~~ 332 (611)
+|.+.+.||+|+||.||++... + +..||||.+... ....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999864 3 789999998742 23356788999999999 499999999976433 45
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.++++||+. ++|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899886 58998886433 58899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--ccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 413 KWASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 413 ~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
+........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865532221 11123578999999998765 468999999999999999999999997654322111111100000000
Q ss_pred ccccccC---------------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 490 KVTQLLD---------------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 490 ~l~~lld---------------~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+..+.+ ..+.. ........+..++..|++.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000 00001234566777899999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=310.40 Aligned_cols=245 Identities=25% Similarity=0.403 Sum_probs=202.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
....|.+.+.||+|.|+.|.+|.+. +|..||||++.++. .....+.+|+++|+.++|||||+++.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4568999999999999999999864 79999999998643 3344588999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+.+|.+++++..... ....++..++.|+..|++|||+ ++|+|||||++||||+.+.++||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999987764 4457788899999999999999 899999999999999999999999999999887
Q ss_pred CCCCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
.... ..+.+|++.|.|||++++.+| .+.+|+||+|++||-|+.|..||++....+-..-
T Consensus 207 ~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r----------------- 266 (596)
T KOG0586|consen 207 YGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR----------------- 266 (596)
T ss_pred cccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch-----------------
Confidence 4332 234899999999999998876 5689999999999999999999987654332211
Q ss_pred CcccCCCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 DPALGNNY--DYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 d~~l~~~~--~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+.+.+ ++.....+-.++..+|-.+|.+|++++++.+
T Consensus 267 --vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 --VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111111 1222223444555578899999999998865
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=302.96 Aligned_cols=265 Identities=22% Similarity=0.338 Sum_probs=194.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEec---------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFED--------- 330 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--------- 330 (611)
..+|.+.+.||.|+||.||+|... +|+.||+|.+.... ...+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999874 68999999986543 4456788999999999999999999876543
Q ss_pred -----CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC-CCCce
Q 007256 331 -----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 404 (611)
Q Consensus 331 -----~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd-~~~~v 404 (611)
...++||||+++ +|.+++... .+++..++.++.||+.||.|||+ .+|+||||||+||+++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYMET-DLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeecccc-cHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence 357899999975 888887532 47899999999999999999999 8999999999999997 45678
Q ss_pred EEeecCccccccCCCCCc-cccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 007256 405 QLSDFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 482 (611)
||+|||++.......... ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999997654322211 1122467889999998764 46788999999999999999999999765543322222111
Q ss_pred ccccccCccccccC---ccc-----CCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 483 KPILSSGKVTQLLD---PAL-----GNNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 483 ~~~~~~g~l~~lld---~~l-----~~~~~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.........+.+ ... ..... ......+..++..||+.||.+|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11111100000000 000 00000 0112345567778999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.24 Aligned_cols=243 Identities=26% Similarity=0.426 Sum_probs=191.8
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
|...+.||+|+||+||+|... +|..|++|++... ......+.+|+++++.++|||++++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999864 6889999998642 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+.+ +|.+.+.... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 965 7877775433 258899999999999999999999 8999999999999999999999999999864322
Q ss_pred CCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 420 SHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||............... .......
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~ 242 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------DSPTLQS 242 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------CCCCCCc
Confidence 12357899999999984 456888999999999999999999999765433222211110 0111111
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+ ...+..++..||+.+|.+||++.+++..
T Consensus 243 ----~~~----~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 ----NEW----TDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----ccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1234556667999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=289.11 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=198.5
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
|...+.||+|++|.||+|... +++.||+|++... ....+.+..|+.+++.++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999875 5999999999864 344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++ +|.+++.... ..+++..+..++.+++.||.|||+ ++|+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 DM-DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred Cc-CHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 85 8999997643 258999999999999999999999 8999999999999999999999999999976654322
Q ss_pred CccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc------------
Q 007256 421 HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS------------ 487 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~------------ 487 (611)
. .....++..|+|||++... .++.++|||||||+++||++|+.||...........+........
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 T--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred c--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 1 1224567889999998866 889999999999999999999999977553322111100000000
Q ss_pred -cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 488 -SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 488 -~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
............... .......+..++..||+.+|.+||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000000 0011345677778899999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=303.46 Aligned_cols=261 Identities=23% Similarity=0.309 Sum_probs=197.7
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc----
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~---- 332 (611)
..++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 6889999998753 2344667889999999999999999998876554
Q ss_pred --eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 333 --LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 333 --~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5699998864 248999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc--
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS-- 487 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~-- 487 (611)
++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99765432 123468899999999865 3678899999999999999999999976554322111111000000
Q ss_pred ------cCccccccCcccC-CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 488 ------SGKVTQLLDPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 488 ------~g~l~~lld~~l~-~~~~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
......++..... .... ......+..++..||+.+|.+|||+.+|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000000 0000 0113456777888999999999999998863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.22 Aligned_cols=255 Identities=23% Similarity=0.393 Sum_probs=208.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..+.....+||.|-||.||.|.++ -...||||.++.+....++|+.|..+|+.++|||+|+|+|+|..+..+|||.|||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345667789999999999999986 4678999999988888999999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
..|+|.++|+.... ..++-...++++.||..|+.||.. +++|||||-..|.|+.++..+|++||||++++..+..
T Consensus 346 ~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 99999999986554 245667788999999999999999 8999999999999999999999999999999877543
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.... ...-..-|.|||-+.+..++.|+|||+|||+|||+.| |..||.+.+......++. +..
T Consensus 421 TAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE----------------kgy 483 (1157)
T KOG4278|consen 421 TAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE----------------KGY 483 (1157)
T ss_pred eccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh----------------ccc
Confidence 2211 1122457999999999999999999999999999999 999997654333322222 111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.-+.+..-...+..++..||+.+|.+||++.|+-+.++.
T Consensus 484 RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 484 RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 111122223355666777999999999999988776653
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=304.72 Aligned_cols=254 Identities=28% Similarity=0.461 Sum_probs=204.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC---CCC--EEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP---DGK--ELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~---~g~--~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
........++||+|-||.||+|... .|+ .||||..+. ..+..+.|+.|.-+|++++|||||+|+|.|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 3344556688999999999999853 233 478999986 34668899999999999999999999999965 578
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
|||||+++-|.|..+|+.++. .++......++.||+.||+|||+ .++|||||-..|||+....-+||+|||+++
T Consensus 466 WivmEL~~~GELr~yLq~nk~---sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD---SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eEEEecccchhHHHHHHhccc---cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhh
Confidence 999999999999999987654 58888889999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
++......... ...-..-|||||-+....++.++|||.|||.+||++. |..||.+-...+....+. +|.
T Consensus 540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE-------nGe-- 609 (974)
T KOG4257|consen 540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE-------NGE-- 609 (974)
T ss_pred hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec-------CCC--
Confidence 98876655432 2333567999999999999999999999999999988 999998755443322221 111
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.+. .+... .-.+..+...||..+|.+||++.++...|..
T Consensus 610 RlP---~P~nC----Pp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 610 RLP---CPPNC----PPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCC---CCCCC----ChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 000 11111 2245567778999999999999998877754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=320.44 Aligned_cols=145 Identities=31% Similarity=0.447 Sum_probs=131.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||+||+|.+. +++.||||+++.. ......+..|+.++..++||||+++++++...+..+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 368999999999999999999976 7899999999753 23456788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
|||+.+++|.+++.... .+++..++.|+.||+.||.|||. ++||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997543 47888999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=279.32 Aligned_cols=235 Identities=29% Similarity=0.353 Sum_probs=190.4
Q ss_pred EeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 271 IGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
||.|+||.||++... +++.+|+|++.... .....+..|+.+++.++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 58999999987542 3456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccc
Q 007256 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425 (611)
Q Consensus 346 ~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~ 425 (611)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN 151 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence 99997553 48899999999999999999999 8999999999999999999999999999876654321 122
Q ss_pred ccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCCh
Q 007256 426 DVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505 (611)
Q Consensus 426 ~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 505 (611)
...++..|+|||.+.+...+.++|+||||+++|+|++|+.||....... ...... . +. ..+ +.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~---~-~~------~~~----~~ 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKIL---K-DP------LRF----PE 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHh---c-CC------CCC----CC
Confidence 3578999999999998888999999999999999999999996654311 111110 0 00 001 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH
Q 007256 506 DQMERMVLASILCIRRDPRARPQMSL 531 (611)
Q Consensus 506 ~~~~~l~~la~~CL~~dP~~RPtm~e 531 (611)
.....+..++..||..||++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11234556677799999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=297.06 Aligned_cols=242 Identities=24% Similarity=0.345 Sum_probs=197.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~L 335 (611)
..+|....+||+|+||.|.+|..+ +.+.||||++++. .++.+--+.|-++|.... -|.+++++.+|+.-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457899999999999999999865 4677999999863 455566677888888764 6899999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+.||+|-..+++.+. +.+..+..++.+||-||-+||+ +|||.||||.+||||+.+|++||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999987664 6677888899999999999999 99999999999999999999999999999754
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
--. ..++.+++|||.|+|||++.+++|+..+|+|||||+||||+.|++||++++..+.-..++-.+
T Consensus 501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn------------ 566 (683)
T KOG0696|consen 501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN------------ 566 (683)
T ss_pred ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc------------
Confidence 322 234456899999999999999999999999999999999999999999877655433332211
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQM 529 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm 529 (611)
-.++.......+.+....|.+.|.+|.-.
T Consensus 567 -----vsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 567 -----VSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred -----CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 01222233344455555688899988654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.54 Aligned_cols=245 Identities=27% Similarity=0.417 Sum_probs=201.2
Q ss_pred eeeEeecCcEEEEEEEeC--CCC--EEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 268 ENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~--~g~--~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.++||+|.||.|++|.+. +|+ .||||.++... ....+|.+|+.+|.+|+|+|+++|||+..+ ....||||+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 356899999999999864 465 47999998653 367899999999999999999999999987 78899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
.|+|.+.|+... ...|-......++.|||.|+.||.. +++|||||-..||||-..-.+||+||||.+.+.....+
T Consensus 194 lGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 194 LGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999998733 3468888999999999999999999 99999999999999998889999999999988776655
Q ss_pred ccccc-cccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 422 ITCTD-VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 422 ~~~~~-~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
..+.. ..-.+.|+|||.+...+++.++|||+|||+||||+| |..||-+-........+. .. .+|
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~-------------erL 334 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AG-------------ERL 334 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-cc-------------ccC
Confidence 44322 233567999999999999999999999999999999 888987654433222222 00 111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
. -+..-.+++..+++.||..+|.+|||+..|.+
T Consensus 335 p--RPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 P--RPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred C--CCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 1 12334567788888999999999999999864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=304.64 Aligned_cols=260 Identities=26% Similarity=0.416 Sum_probs=216.5
Q ss_pred HHHHHHhhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEe---
Q 007256 255 YQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--- 329 (611)
Q Consensus 255 ~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~--- 329 (611)
++.+..-++-|.+.+.||.|.+|.||++.. ++|+..|+|++....+..+++..|.+||+.+. |||++.++|+|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 444445577899999999999999999985 57899999999988888888999999999885 9999999999864
Q ss_pred --cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 330 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 330 --~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
++.+|||||||.||+..+++++.. ...+.|..+..|+.+++.||.+||+ ..+||||||-.|||++.++.+||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEe
Confidence 467999999999999999998766 4579999999999999999999999 889999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhccC-----CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 482 (611)
|||++..+....... .+.+|||.|||||++... .|+..+|+||||++..||.-|.+|+.+..+.....++-
T Consensus 166 DFGvSaQldsT~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-- 241 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-- 241 (953)
T ss_pred eeeeeeeeecccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC--
Confidence 999998776654433 347899999999998643 47789999999999999999999998877644322221
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
++. .|.+ .-+....+.+...+..||.+|-++||++.++|++
T Consensus 242 ----RNP------PPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 ----RNP------PPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----CCC------Cccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111 1111 1234556777778888999999999999999874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=327.69 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=196.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
+-+|.-...||.|.||.||-|.. .+|...|||-++-.. ...+...+|+.+|..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34677788999999999999986 478889999887533 34556789999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
|||++|+|.+.+.... ..++.....+..|++.|++|||+ +|||||||||.||+|+.+|.+|++|||.|.....
T Consensus 1314 EyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence 9999999999997543 35566667788999999999999 9999999999999999999999999999987765
Q ss_pred CCC--CccccccccccccCChhhhccCC---CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 418 SSS--HITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 418 ~~~--~~~~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
... .......+||+.|||||++.+.+ -.-+.||||||||.+||+||+.||...+.. ..+|+.- ..|...
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~V---~~gh~P 1460 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYHV---AAGHKP 1460 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhHH---hccCCC
Confidence 421 11223468999999999998543 455899999999999999999999765543 2233221 112222
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
++... . ..+- ..++-.||..||..|-++.+++++-
T Consensus 1461 q~P~~-----l-s~~g---~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1461 QIPER-----L-SSEG---RDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred CCchh-----h-hHhH---HHHHHHHHhcCchhhhHHHHHHHhh
Confidence 22111 1 1111 2233459999999998888887753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=278.92 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=193.7
Q ss_pred hhcCceee-eeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe----cCce
Q 007256 261 ATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE----DNNL 333 (611)
Q Consensus 261 ~t~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~----~~~~ 333 (611)
.|++|.+. .+||-|-.|.|..+..+ +|+.+|+|++..+.. ..+|+++.-.. .|||||.++++|.. ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 46677665 57999999999988765 789999999986543 45677765555 49999999998853 3468
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC---CCceEEeecC
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFG 410 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---~~~vKL~DFG 410 (611)
.+|||.|+||.|+..++..+. ..|++.++-.|+.||+.|+.|||+ .+|.||||||+|+|... +..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 899999999999999987664 469999999999999999999999 99999999999999964 4579999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc----hhhHHHhhcccc
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG----QESLVMWAKPIL 486 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~----~~~lv~~~~~~~ 486 (611)
+|+...... ...+.+-||.|.|||++...+|+..+|+||+||++|-||+|.+||....... ....+..+...+
T Consensus 210 FAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 210 FAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 998665422 2234678999999999999999999999999999999999999998765321 112222111111
Q ss_pred ccCccccccCcccCCCCChHHHHH-HHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 487 SSGKVTQLLDPALGNNYDYDQMER-MVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 487 ~~g~l~~lld~~l~~~~~~~~~~~-l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. +..++.+.. ...++...|+.+|.+|.|+.+++..
T Consensus 287 P--------------~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 P--------------EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred C--------------ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1 112333333 3334555799999999999999863
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=282.51 Aligned_cols=206 Identities=28% Similarity=0.473 Sum_probs=173.7
Q ss_pred CHHHHHHhhcCceeeeeEeecCcEEEEEEE-eCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcC-CcceeEEeeEEEec
Q 007256 254 NYQDLLSATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFED 330 (611)
Q Consensus 254 ~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~ 330 (611)
+|+++.+.|+ +.||+|+++.|--+. ..+|.+||||++.+.. ....+..+|++++.+.+ |+||++|++||.++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4777777765 569999999998876 5799999999997654 45678899999999997 99999999999999
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc---eEEe
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLS 407 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~---vKL~ 407 (611)
..+|||||.|.||+|...|++.. .|++.++.++..+|+.||.|||. +||.||||||+|||.....+ +|||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence 99999999999999999998765 59999999999999999999999 99999999999999976554 7999
Q ss_pred ecCcccccc--CCCCC---ccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCC
Q 007256 408 DFGLAKWAS--TSSSH---ITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDH 471 (611)
Q Consensus 408 DFGla~~~~--~~~~~---~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 471 (611)
||.++.-.. .+.+. ..-.+.+|+..|||||+.. ...|+.++|.||||||||-||+|.+||.+..
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 998764322 11111 1122368999999999764 2368889999999999999999999998654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.39 Aligned_cols=215 Identities=26% Similarity=0.378 Sum_probs=180.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
..-|..++.||-|+||.|.+++.. +...||+|.+++.+ ........|-+||.....+-||+||-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 346888999999999999999854 46679999998643 2334566799999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc-
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA- 415 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~- 415 (611)
|||++||++-.+|.+.+ .|.+..++.++.++..|+++.|. .|+|||||||+|||||.+|++||+||||+.-+
T Consensus 708 MdYIPGGDmMSLLIrmg----IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG----IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHhc----cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999987665 48888999999999999999999 99999999999999999999999999998521
Q ss_pred --------cCCCCC-------------------------------ccccccccccccCChhhhccCCCCCcceehhhhHH
Q 007256 416 --------STSSSH-------------------------------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVV 456 (611)
Q Consensus 416 --------~~~~~~-------------------------------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvv 456 (611)
.....+ +.....+||+.|+|||++....|+..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 111000 00112469999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCcc-hhhHHHhhc
Q 007256 457 LLELLTGRKPISNDHPKG-QESLVMWAK 483 (611)
Q Consensus 457 L~ELltG~~Pf~~~~~~~-~~~lv~~~~ 483 (611)
||||+.|+.||..+.+.+ +..++.|..
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~ 888 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRN 888 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhh
Confidence 999999999999888765 344455543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=274.12 Aligned_cols=220 Identities=21% Similarity=0.185 Sum_probs=174.6
Q ss_pred cCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChhhhhccC
Q 007256 274 GGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 352 (611)
Q Consensus 274 G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~ 352 (611)
|.+|.||++.+. +|+.||+|.++... .+.+|...+....||||+++++++...+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999875 78999999997653 2334555666667999999999999999999999999999999998654
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccccccccccc
Q 007256 353 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 432 (611)
Q Consensus 353 ~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~ 432 (611)
. .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++....... ....++..
T Consensus 80 ~----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 80 L----NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred c----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 3 48899999999999999999999 899999999999999999999999999876554321 12456788
Q ss_pred cCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHH
Q 007256 433 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 512 (611)
Q Consensus 433 Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~ 512 (611)
|+|||++..+.++.++|||||||++|||++|+.|+........ .. ....+...+ ...+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----~~------------~~~~~~~~~----~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----TH------------TTLNIPEWV----SEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----cc------------cccCCcccC----CHHHH
Confidence 9999999888899999999999999999999988754221100 00 000011111 12345
Q ss_pred HHHHHhcccCCCCCCCHH
Q 007256 513 LASILCIRRDPRARPQMS 530 (611)
Q Consensus 513 ~la~~CL~~dP~~RPtm~ 530 (611)
.++..|++.||.+||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 566679999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=286.34 Aligned_cols=265 Identities=26% Similarity=0.371 Sum_probs=192.5
Q ss_pred eeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCcceeEEeeEEEecC----ceEEEEee
Q 007256 266 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----NLLLVYDF 339 (611)
Q Consensus 266 ~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~--l~HpnIv~l~g~~~~~~----~~~LV~Ey 339 (611)
...++||+|.||.||||.+. ++.||||++. ......|.+|-+|.+. ++|+||++++++-.... .++||++|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp--~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP--EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecC--HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 34567899999999999984 5999999997 4556788888888775 57999999999876555 79999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG------SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~------~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
.+.|+|.++|..+ .++|....+|+.-+++||+|||+. ...+|+|||||+.||||.+|+...|+|||+|.
T Consensus 290 h~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999865 489999999999999999999973 23579999999999999999999999999999
Q ss_pred cccCCCCCccccccccccccCChhhhccC-CCC-----CcceehhhhHHHHHHHhCCCCCCCCCCcc-hhhHHHhhcccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYG-KVN-----DKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKPIL 486 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s-----~ksDVwSlGvvL~ELltG~~Pf~~~~~~~-~~~lv~~~~~~~ 486 (611)
.+..+.........+||..|||||++.+. .+. .+.||||+|.|||||++...-+....... +.-........+
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 88765554444447899999999999754 222 25999999999999999755443111111 000000000000
Q ss_pred ccCc-----cccccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 487 SSGK-----VTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 487 ~~g~-----l~~lld~~l~~~~-~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.-+. +.+-..|.+.... ....+.-+...+-.||..||+.|.|+.=|-+.+..
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~ 502 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAE 502 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHH
Confidence 0000 0000111221111 11234445555566999999999999877776643
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-34 Score=280.71 Aligned_cols=253 Identities=26% Similarity=0.332 Sum_probs=192.5
Q ss_pred eeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCC
Q 007256 266 LAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 266 ~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
+-...||.|+||+|+|-.+ +.|+..|||+++.. +...+++..|.+...+- +.||||++||.+..++..|+.||+|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 3457799999999999765 58999999999854 35667888999876554 68999999999999999999999996
Q ss_pred CCChhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 342 RGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 342 ggsL~~~L~~~-~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
- +|+.+...- ......+++...-.|......||.||-. ...||||||||+||||+..|.+||||||++-.+..+..
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA 223 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA 223 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence 5 776654311 1122357888888999999999999987 36799999999999999999999999999876654322
Q ss_pred CccccccccccccCChhhhcc--CCCCCcceehhhhHHHHHHHhCCCCCCCCCCc-chhhHHHhhccccccCccccccCc
Q 007256 421 HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~-~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.+..+|-..|||||.+.. ..|+-++||||||++|||+.||+.|+...+.. ++...+. .|....++.+
T Consensus 224 ---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv-------~gdpp~l~~~ 293 (361)
T KOG1006|consen 224 ---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV-------IGDPPILLFD 293 (361)
T ss_pred ---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-------cCCCCeecCc
Confidence 233578899999999863 35899999999999999999999999765431 1111111 1222222222
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. ........|+..+-.||.+|-..||...++.++
T Consensus 294 ~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 K----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred c----cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1 122234456666677999999999999988763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=261.50 Aligned_cols=237 Identities=30% Similarity=0.409 Sum_probs=191.1
Q ss_pred CcEEEEEEEeC-CCCEEEEEEecCChh-H-HHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChhhhhcc
Q 007256 275 GSSQVYKGCLP-DGKELAVKILKPSED-V-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 351 (611)
Q Consensus 275 ~fG~Vyk~~~~-~g~~vAVK~l~~~~~-~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~ 351 (611)
+||.||+|... +|+.+|+|++..... . .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 589999999976432 2 57899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccccccccc
Q 007256 352 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431 (611)
Q Consensus 352 ~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~ 431 (611)
... +++..++.++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 432 7889999999999999999999 899999999999999999999999999998766543 222356889
Q ss_pred ccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHH
Q 007256 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERM 511 (611)
Q Consensus 432 ~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l 511 (611)
.|++||.+....++.++||||||+++++|++|..||....... ....+... +.... ..........+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~~~----~~~~~-------~~~~~~~~~~~ 217 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKIGK----PKPPF-------PPPEWKISPEA 217 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHhc----cCCCC-------ccccccCCHHH
Confidence 9999999998889999999999999999999999997632211 11111110 00000 00000022456
Q ss_pred HHHHHHhcccCCCCCCCHHHHHH
Q 007256 512 VLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 512 ~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..++..|+..+|.+||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 66778899999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=276.97 Aligned_cols=205 Identities=28% Similarity=0.420 Sum_probs=172.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC---C--CCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP---D--GKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~---~--g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-~~~ 332 (611)
...|...+.||+|.||.||+|..+ + .+.+|||.++.+. ..-....+|+.+++.++||||+.|..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346888899999999999999643 2 3479999998653 234567899999999999999999999988 778
Q ss_pred eEEEEeeCCCCChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC----CceEEe
Q 007256 333 LLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLS 407 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~-~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~----~~vKL~ 407 (611)
++|++||.+. +|..+|+-... ....++-..+..|+.||+.|+.|||+ +-|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEee
Confidence 9999999988 99998864332 22457888899999999999999999 779999999999999877 899999
Q ss_pred ecCccccccCCCCCc-cccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCC
Q 007256 408 DFGLAKWASTSSSHI-TCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISND 470 (611)
Q Consensus 408 DFGla~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~ 470 (611)
|||+++.+...-... ..+.++-|.+|.|||.+.+. .|+.+.|||+.|||+.||+|-.+.|...
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 999999887654333 33447889999999998865 6999999999999999999988887643
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-33 Score=295.35 Aligned_cols=208 Identities=27% Similarity=0.363 Sum_probs=184.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCC-EEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGK-ELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~-~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.++..+..||-||||.|=+++.++.. .+|+|++++. ....+....|-+||..++.|.||++|.-|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667788999999999998875443 4899999863 344566888999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
|-|-||.|+..+...+ .|.......++..+++|++|||+ ++||+|||||+|.+|+.+|.+||.|||+|+....
T Consensus 500 EaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 9999999999998765 48888889999999999999999 9999999999999999999999999999998877
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~ 480 (611)
.... .+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++.....++.
T Consensus 573 g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 573 GRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred CCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 5433 34899999999999999999999999999999999999999999988877666654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=296.89 Aligned_cols=241 Identities=27% Similarity=0.347 Sum_probs=191.1
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEe
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++.|.+...+|.|+|+.|-++.. .+++..+||++.... .+-.+|+.++... +||||+++++.|.++.+.|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 356788888899999999988875 478999999997652 2334577666655 59999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee-CCCCceEEeecCccccccC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL-d~~~~vKL~DFGla~~~~~ 417 (611)
++.|+-|.+.+..... +. .++..|+.+|+.|+.|||. +|||||||||+|||+ +..++++|+|||.++....
T Consensus 397 ~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999988888765432 33 7778899999999999999 999999999999999 6899999999999987766
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
. +...+-|..|.|||++....|++++||||||++||+||+|+.||...... ..+.. .+..+...+
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~----~i~~~~~s~---- 533 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT----RIQMPKFSE---- 533 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----hhcCCcccc----
Confidence 4 33356789999999999999999999999999999999999999765443 11111 111112111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.-.+..+ .++.+||+.||.+||+|.++...
T Consensus 534 -----~vS~~AK---dLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 534 -----CVSDEAK---DLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----ccCHHHH---HHHHHhccCChhhCcChhhhccC
Confidence 1122333 34456999999999999998753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=283.60 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=196.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--------hhHHHHHHHHHHHHHhcCCcceeEEeeEEE-ecC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--------EDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDN 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--------~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~ 331 (611)
.++|....+||+|||+.||+|.+- ..+.||||+-... ....+...+|.+|.+.|.||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 446888999999999999999864 5778899986432 234566789999999999999999999986 556
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC---CCCceEEee
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSD 408 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd---~~~~vKL~D 408 (611)
.++-|+|||+|.+|+-+|...+ .+++.+++.|++||+.||.||.... .+|||-||||.||||. .-|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 7899999999999999998665 4899999999999999999999865 6899999999999995 447899999
Q ss_pred cCccccccCCCCCc-----cccccccccccCChhhhccC----CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH
Q 007256 409 FGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYG----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479 (611)
Q Consensus 409 FGla~~~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv 479 (611)
||+++.+..+.... .+...+||.+|++||.|.-+ +.+.|+||||.|||+|..+.|++||..+..... ++
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--IL 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--IL 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HH
Confidence 99999887654331 22346899999999988644 578899999999999999999999976543322 11
Q ss_pred HhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 480 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 480 ~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.. ..++....+.--..|. -..+... ++..||+..-++|....++..
T Consensus 695 qe-NTIlkAtEVqFP~KPv-----VsseAka---FIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 QE-NTILKATEVQFPPKPV-----VSSEAKA---FIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hh-hchhcceeccCCCCCc-----cCHHHHH---HHHHHHHhhhhhhhhHHHHcc
Confidence 11 1121111111111111 1122333 345699999999988776543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=287.34 Aligned_cols=196 Identities=29% Similarity=0.451 Sum_probs=170.9
Q ss_pred eeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 267 AENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
.+++||.|-||+||-|.+ ++|+.||||++.+- .....++.+|+.||++++||.||.+...|+..+..++|||.+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 358899999999999986 58999999998652 23446788999999999999999999999999999999999977
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC---CceEEeecCccccccCCC
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~---~~vKL~DFGla~~~~~~~ 419 (611)
.-|+-+|...+ ..+++.....++.||+.||.|||. ++|+|+||||+||||... .++||||||+|+..+...
T Consensus 648 DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSSEK---GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 55555554433 368888888999999999999999 999999999999999543 479999999999988765
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCC
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 471 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 471 (611)
.. ..++|||.|+|||+++...|+..-|+||.|||+|--|+|..||+.+.
T Consensus 722 FR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 722 FR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred hh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 43 34799999999999999999999999999999999999999997654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=296.77 Aligned_cols=262 Identities=18% Similarity=0.220 Sum_probs=169.1
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-C----CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeE------EEe
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-D----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF------CFE 329 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~----g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~------~~~ 329 (611)
..++|.+.+.||+|+||.||+|.+. + +..||||++...... +.+..| .+....+.++..++.. +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 5679999999999999999999975 4 689999998643221 111111 1122222222222211 245
Q ss_pred cCceEEEEeeCCCCChhhhhccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCc
Q 007256 330 DNNLLLVYDFLSRGSLEENLHGNKKD----------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 393 (611)
Q Consensus 330 ~~~~~LV~Ey~~ggsL~~~L~~~~~~----------------~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp 393 (611)
+...++||||+.+++|.+++...... ........+..++.||+.||.|||+ ++|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 66899999999999999988643210 0011233456799999999999999 8999999999
Q ss_pred cceeeCC-CCceEEeecCccccccCCCCCccccccccccccCChhhhccC----------------------CCCCccee
Q 007256 394 SNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG----------------------KVNDKIDV 450 (611)
Q Consensus 394 ~NILLd~-~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----------------------~~s~ksDV 450 (611)
+|||++. ++.+||+|||+|+........ ......||+.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 579999999999866443322 22346899999999966422 24456799
Q ss_pred hhhhHHHHHHHhCCCCCCCCCCcc-------hhhHHHhhccccccCccccccCcccCCCCC--hHHHHHHHHHHHHhccc
Q 007256 451 YAFGVVLLELLTGRKPISNDHPKG-------QESLVMWAKPILSSGKVTQLLDPALGNNYD--YDQMERMVLASILCIRR 521 (611)
Q Consensus 451 wSlGvvL~ELltG~~Pf~~~~~~~-------~~~lv~~~~~~~~~g~l~~lld~~l~~~~~--~~~~~~l~~la~~CL~~ 521 (611)
|||||+||||+++..|+......- ...+..|....... ..+.+...+. .........++..||+.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999877654321000 00111221111000 0000000000 00011223566779999
Q ss_pred CCCCCCCHHHHHHH
Q 007256 522 DPRARPQMSLVLKL 535 (611)
Q Consensus 522 dP~~RPtm~eVL~~ 535 (611)
||++|||+.+++++
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999974
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=296.90 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=205.1
Q ss_pred ceeeeeEeecCcEEEEEEEe-CCC----CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 265 FLAENLIGKGGSSQVYKGCL-PDG----KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~-~~g----~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
...+++||+|+||+||+|.+ +.| -+||||++... .....+++.|+-+|.++.|||+++|+++|.... +.||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34568899999999999985 444 36899988753 355788999999999999999999999997655 89999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
+||+.|+|.++++..+. .+.-...+.|..|||+|+.|||. ++++||||-..|||+..-.++||.|||+++....
T Consensus 777 q~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987553 67888999999999999999999 9999999999999999999999999999998887
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
+..........-.+-|||=|.+....|+.++|||||||++||++| |..|+......+...+...... +. .
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR------Ls---q 921 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER------LS---Q 921 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc------CC---C
Confidence 766655444444667999999999999999999999999999999 9999987665544333332211 11 1
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+..-...+..+++.||..|+..||+++++...+..
T Consensus 922 -------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 922 -------PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -------CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 11122345556677999999999999998876654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=276.17 Aligned_cols=263 Identities=21% Similarity=0.300 Sum_probs=205.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--c----ceeEEeeEEEecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH--K----NIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H--p----nIv~l~g~~~~~~~~~ 334 (611)
+++|.+..++|+|.||.|-...+. .+..||||+++.-....+..+-|+++|.++.+ | -+|++.++|.-.++.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 788999999999999999998764 57899999999888888888899999999952 2 3888999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC--------------
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------------- 400 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-------------- 400 (611)
||+|.+ |-|+.+++..+.- .+++...++.++.|++++++|||+ .+++|.||||+|||+..
T Consensus 168 ivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 5599999987654 468889999999999999999999 99999999999999842
Q ss_pred ------CCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc
Q 007256 401 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474 (611)
Q Consensus 401 ------~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 474 (611)
+..++|+|||.|.+-.... ..++.|..|.|||++.+-.++..+||||+||||+||.||...|...+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3458999999998765543 23678999999999999999999999999999999999999998766443
Q ss_pred hhhHHHhhc-ccc-------------ccC-----------ccccccCcccC--C--CCChHHHHHHHHHHHHhcccCCCC
Q 007256 475 QESLVMWAK-PIL-------------SSG-----------KVTQLLDPALG--N--NYDYDQMERMVLASILCIRRDPRA 525 (611)
Q Consensus 475 ~~~lv~~~~-~~~-------------~~g-----------~l~~lld~~l~--~--~~~~~~~~~l~~la~~CL~~dP~~ 525 (611)
...+..... |++ ..+ ++....++... . .....+...++.++..||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 221111100 110 001 00111111100 0 012234556788888899999999
Q ss_pred CCCHHHHHHH
Q 007256 526 RPQMSLVLKL 535 (611)
Q Consensus 526 RPtm~eVL~~ 535 (611)
|+|+.|+|.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999998863
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=296.64 Aligned_cols=256 Identities=28% Similarity=0.440 Sum_probs=200.1
Q ss_pred CceeeeeEeecCcEEEEEEEeC----C----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCc
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP----D----GKELAVKILKPS--EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 332 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~----~----g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~ 332 (611)
+..+.+.||+|+||.|++|... . ...||||.++.. ....+.+..|+++|+.+. |+||+.++|+|...+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3455568999999999999742 1 457899999864 355778999999999985 9999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC
Q 007256 333 LLLVYDFLSRGSLEENLHGNK---KD-------P--AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 400 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~---~~-------~--~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~ 400 (611)
.++|+||+..|+|.++++..+ .. . ..++....+.++.|||.|++||++ .++|||||-..|||+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecC
Confidence 999999999999999998665 00 0 238889999999999999999999 89999999999999999
Q ss_pred CCceEEeecCccccccCCCCCccccccccc--cccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhh
Q 007256 401 DFEPQLSDFGLAKWASTSSSHITCTDVAGT--FGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 477 (611)
Q Consensus 401 ~~~vKL~DFGla~~~~~~~~~~~~~~~~GT--~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 477 (611)
+..+||+|||+|+........... .-.|+ ..|||||.+....|+.|+|||||||+||||+| |..||.+-.... .
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~--~ 530 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE--E 530 (609)
T ss_pred CCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--H
Confidence 999999999999866554433211 12222 34999999999999999999999999999999 899996622111 1
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+..+. ..|.-.+. +..-...+..++..||+.+|++||++.++.+.+..
T Consensus 531 l~~~l----~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 531 LLEFL----KEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHHH----hcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 12221 12211110 11113345567777999999999999999998875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=269.66 Aligned_cols=267 Identities=29% Similarity=0.409 Sum_probs=202.7
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCcceeEEeeEEEecC----ce
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----NL 333 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~--l~HpnIv~l~g~~~~~~----~~ 333 (611)
....+..+.+.||+|.||.||+|.+ .|..||||++...+ ...+.+|.+|.+. |+|+||+.+++.=..++ .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4456778899999999999999988 67889999997533 3567889998885 58999999998765443 58
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCcEEeeccCccceeeCCCCceEEee
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS-----GSAQRVIHRDVKSSNILLSDDFEPQLSD 408 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~-----~~~~gIiHrDIKp~NILLd~~~~vKL~D 408 (611)
+||.+|.+.|||+|+|... .++-+..++++.-+|.||+|||. .+...|.|||||+.|||+..++..-|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 9999999999999999864 48889999999999999999996 3345799999999999999999999999
Q ss_pred cCccccccCCCCC--ccccccccccccCChhhhccCC----C--CCcceehhhhHHHHHHHhC----------CCCCCCC
Q 007256 409 FGLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYGK----V--NDKIDVYAFGVVLLELLTG----------RKPISND 470 (611)
Q Consensus 409 FGla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~----~--s~ksDVwSlGvvL~ELltG----------~~Pf~~~ 470 (611)
+|||......... ......+||..|||||++...- + -..+||||||.|+||++.. +.||.+-
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999877665332 2334478999999999986431 1 1259999999999999752 4577654
Q ss_pred CCcchhhHHHhhccccccCccccccCcccCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 471 HPKGQESLVMWAKPILSSGKVTQLLDPALGNN-YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 471 ~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~-~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
-+.+.....|. ...-..+ +.|.++.. ...+.+..|..++..||..+|..|-|+-.+-+.|....
T Consensus 440 Vp~DPs~eeMr--kVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 440 VPSDPSFEEMR--KVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCCCHHHHh--cceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 43332222111 1111111 22222222 24567888999999999999999999988877765433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=266.97 Aligned_cols=200 Identities=23% Similarity=0.377 Sum_probs=175.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~----~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~ 334 (611)
..++|.+.++||+|+|..|..+.++ +.+.||+|++++ .+.+.+-...|-.+..+. +||.+|-++.+|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3468999999999999999999865 678899999985 345556666787777766 5999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+|.||++||+|--.++... .++++.++.+..+|+.||.|||+ +|||.||||.+|+|||..|++||+|+|+++.
T Consensus 328 fvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhc
Confidence 9999999999987777654 48899999999999999999999 9999999999999999999999999999985
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCC
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 469 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 469 (611)
.-... .++.+++|||.|+|||++.+..|...+|+|+|||+++||+.|+.||+.
T Consensus 401 ~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 401 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 43322 123458999999999999999999999999999999999999999973
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=267.68 Aligned_cols=209 Identities=30% Similarity=0.466 Sum_probs=173.4
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--------C
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFED--------N 331 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--------~ 331 (611)
.|.-..+||+|.||.||+|..+ +|+.||+|++.- ....-....+|+++|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555678999999999999864 688889886532 223445678999999999999999999988532 2
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
.+|+||++|+. +|.-+|.... ..++..++.+++.++..||.|+|. ..|+|||+|+.|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 48999999987 8888886553 368999999999999999999999 8899999999999999999999999999
Q ss_pred cccccCCCC--CccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH
Q 007256 412 AKWASTSSS--HITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479 (611)
Q Consensus 412 a~~~~~~~~--~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv 479 (611)
++.+..... ...++..+-|.+|.+||.+.+ ..|+++.|||..|||+.||.||.+-+.++....+..++
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I 241 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI 241 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH
Confidence 976654322 223455677999999998875 47999999999999999999999999887776665555
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=281.58 Aligned_cols=205 Identities=22% Similarity=0.318 Sum_probs=155.7
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-----------------CCCCEEEEEEecCChh-HHHH--------------HHHH
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-----------------PDGKELAVKILKPSED-VIKE--------------FVLE 308 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-----------------~~g~~vAVK~l~~~~~-~~~~--------------f~~E 308 (611)
..++|.+.++||+|+||+||+|.+ .+++.||||.++.... ..++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 2456899999875322 2222 3346
Q ss_pred HHHHHhcCCcce-----eEEeeEEEe--------cCceEEEEeeCCCCChhhhhccCCC--------------------C
Q 007256 309 IEIITTLHHKNI-----ISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKK--------------------D 355 (611)
Q Consensus 309 i~iL~~l~HpnI-----v~l~g~~~~--------~~~~~LV~Ey~~ggsL~~~L~~~~~--------------------~ 355 (611)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776554 677787753 3568999999999999999875321 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccccccccccccCC
Q 007256 356 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435 (611)
Q Consensus 356 ~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~A 435 (611)
...++|..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......... ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 1235678899999999999999999 89999999999999999999999999999765432211 1112345899999
Q ss_pred hhhhccCC----------------------CCCcceehhhhHHHHHHHhCCC-CCCC
Q 007256 436 PEYFMYGK----------------------VNDKIDVYAFGVVLLELLTGRK-PISN 469 (611)
Q Consensus 436 PE~l~~~~----------------------~s~ksDVwSlGvvL~ELltG~~-Pf~~ 469 (611)
||.+.... ...+.||||+|||+|+|++|.. ||..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99876432 1235799999999999999875 6643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=244.26 Aligned_cols=215 Identities=23% Similarity=0.344 Sum_probs=178.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+|.-.++||+|.||+||+|+.. +++.||+|.++..+ .......+||-+|+.++|.|||++++....++.+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3445578999999999999865 68889999998543 3456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
|.. +|..+...... .++.+..+.++.|+++||.++|+ +++.|||+||.|.||+.+|++||+|||+++.++-..
T Consensus 83 cdq-dlkkyfdslng---~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 976 88888765443 47888999999999999999999 899999999999999999999999999998776533
Q ss_pred CCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 487 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~ 487 (611)
... ...+-|.+|.+|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+-..+...+-|....+.
T Consensus 156 rcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ 223 (292)
T KOG0662|consen 156 RCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223 (292)
T ss_pred Eee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCc
Confidence 221 224579999999998765 48899999999999999998 7777877776666665655544333
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=237.39 Aligned_cols=210 Identities=35% Similarity=0.606 Sum_probs=182.7
Q ss_pred EeecCcEEEEEEEeCC-CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChhh
Q 007256 271 IGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEE 347 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~ 347 (611)
||+|.+|.||++...+ |+.+++|++..... ....+.+|+.+++.+.|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 89999999986544 36789999999999999999999999999899999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-CCceEEeecCccccccCCCCCccccc
Q 007256 348 NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTD 426 (611)
Q Consensus 348 ~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-~~~vKL~DFGla~~~~~~~~~~~~~~ 426 (611)
++.... ..+++..+..++.+++.+|.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 987542 247899999999999999999999 89999999999999999 89999999999986655431 1223
Q ss_pred cccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCCh
Q 007256 427 VAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505 (611)
Q Consensus 427 ~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~ 505 (611)
..+...|++||.+... .++.+.|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 5678899999999877 888999999999999999
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHh
Q 007256 506 DQMERMVLASILCIRRDPRARPQMSLVLKLL 536 (611)
Q Consensus 506 ~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L 536 (611)
..+..++..|++.+|.+||++.++++.+
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3455566679999999999999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=248.78 Aligned_cols=203 Identities=27% Similarity=0.386 Sum_probs=170.3
Q ss_pred ceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecC--ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeC
Q 007256 265 FLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~--~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
...+..||+|++|.|-+-++ .+|...|+|.++. ..+..++.++|+++..+. .+|++|.+||.+......++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34456799999999977665 5899999999975 346667888899987665 5999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
+- +|+.+...--......++..+-+|+..+.+||.|||+ ...+||||+||+||||+.+|++|+||||++-.+..+-.
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 76 8888776555555678899999999999999999998 36899999999999999999999999999977665432
Q ss_pred CccccccccccccCChhhhcc----CCCCCcceehhhhHHHHHHHhCCCCCCCCCCc
Q 007256 421 HITCTDVAGTFGYLAPEYFMY----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 473 (611)
. +...|-..|||||.+.. ..|+-|+||||||++++||.+++.||......
T Consensus 205 k---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 205 K---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred H---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 2 22468889999998863 37899999999999999999999999875543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=275.09 Aligned_cols=236 Identities=26% Similarity=0.321 Sum_probs=198.7
Q ss_pred CchhHHhHhhhhcCcccccCHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHH
Q 007256 235 LPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIIT 313 (611)
Q Consensus 235 ~~~el~~~~~~~~~~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~ 313 (611)
.+.+...+++.+....-.|.+.-.+...+.|.+....|+|-|++|.+|.+. -|..||||++...+...+.=+.|++||+
T Consensus 404 ~~~~~~~L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLk 483 (752)
T KOG0670|consen 404 VPRVNPGLQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILK 483 (752)
T ss_pred ccccCCccccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHH
Confidence 345555666667666666666666667889999999999999999999875 5889999999999988888899999999
Q ss_pred hcCC------cceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Q 007256 314 TLHH------KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387 (611)
Q Consensus 314 ~l~H------pnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIi 387 (611)
+|+. -|+++|+..|...+++|||||-+.- +|.++|...+.. ..|....+..++.|++.||..|-. .||+
T Consensus 484 KL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~---c~vl 558 (752)
T KOG0670|consen 484 KLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKK---CGVL 558 (752)
T ss_pred HhhccCchhhhHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHh---cCee
Confidence 9973 4899999999999999999998855 999999877653 457888899999999999999998 8899
Q ss_pred eeccCccceeeCCC-CceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCC
Q 007256 388 HRDVKSSNILLSDD-FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466 (611)
Q Consensus 388 HrDIKp~NILLd~~-~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~P 466 (611)
|.||||.|||+++. ..+||||||.|........ +...-+..|.|||++.+-.|+...|+||.||+||||.||+..
T Consensus 559 HaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 559 HADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred ecccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 99999999999865 5689999999977665322 123456789999999999999999999999999999999999
Q ss_pred CCCCCCcchhhHH
Q 007256 467 ISNDHPKGQESLV 479 (611)
Q Consensus 467 f~~~~~~~~~~lv 479 (611)
|.+........+.
T Consensus 635 FpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 635 FPGRTNNQMLRLF 647 (752)
T ss_pred cCCCCcHHHHHHH
Confidence 9876655444443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=257.49 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=197.9
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----CceE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NNLL 334 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~~~ 334 (611)
+.+.++.||-|+||.||.+.++ +|+.||.|.+..- -...+.+.+|+.+|..++|.|++..++...-. .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3456788999999999999875 8999999988642 24567889999999999999999988776433 2578
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
++.|+|.. +|.++|-. +..++-..+.-++.||++||.|||+ .+|+||||||.|.|++.+..+||||||+|+.
T Consensus 134 V~TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccc
Confidence 89999876 77777653 3467888888889999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc-------
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL------- 486 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~------- 486 (611)
...+.... ++..+-|..|.|||++++. .|+.++||||.|||+.||+..+..|....+..+..++.-.....
T Consensus 206 ee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 66554432 3345679999999999965 69999999999999999999999999888877665553211100
Q ss_pred -ccCccccccC-----cccCCCC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 487 -SSGKVTQLLD-----PALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 487 -~~g~l~~lld-----~~l~~~~----~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
-+|.-..++. |.+..-+ ....-..-+.+..+++..||++|.+..+.+..+-
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 0111111111 1110000 0111223344445688999999999888776543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=282.23 Aligned_cols=247 Identities=26% Similarity=0.405 Sum_probs=186.1
Q ss_pred ceeeeeEeecCcEE-EEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeeCCC
Q 007256 265 FLAENLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 265 f~~~~~LG~G~fG~-Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
|...+++|.|..|+ ||+|.. .|+.||||++-. ....-..+|+..|+.-. |||||++++.-.+...+||..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 34456689999986 599988 678999998863 33445668999999885 99999999998899999999999976
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC---C--CceEEeecCccccccC
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---D--FEPQLSDFGLAKWAST 417 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---~--~~vKL~DFGla~~~~~ 417 (611)
+|.+++.....+.....-...+.++.|++.||++||+ .+||||||||.||||+. + ..++|+|||+++.+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9999998642211112224457788999999999999 89999999999999975 2 4689999999998876
Q ss_pred CCCCc-cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhC-CCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 418 SSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 418 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
+.... ......||-||+|||++....-+.++||||||||+|+.++| .+||.+....+ .+++. .+..+..+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~------~~~~L~~L- 735 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILT------GNYTLVHL- 735 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhc------Cccceeee-
Confidence 54432 23447899999999999988888899999999999999995 99997643321 11111 01111111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
....+. ....++..|++.+|..||++.+|+.
T Consensus 736 ----~~~~d~----eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 ----EPLPDC----EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ----ccCchH----HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111111 2334555699999999999999985
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=237.22 Aligned_cols=198 Identities=35% Similarity=0.503 Sum_probs=173.3
Q ss_pred ceeeeeEeecCcEEEEEEEeCC-CCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 265 FLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
|.+.+.||.|++|.||++...+ ++.+|+|.+..... ..+.+.+|++.+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5677899999999999999864 89999999986542 56789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++..... .+++..+..++.+++.+|.+||+ .+++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999976432 17889999999999999999999 89999999999999999999999999999877654311
Q ss_pred ccccccccccccCChhhh-ccCCCCCcceehhhhHHHHHHHhCCCCCCC
Q 007256 422 ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTGRKPISN 469 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l-~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 469 (611)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11235688899999998 666788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=267.69 Aligned_cols=197 Identities=24% Similarity=0.368 Sum_probs=171.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHH---------HHHHHHHHHhcC---CcceeEEeeEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKE---------FVLEIEIITTLH---HKNIISLLGFCF 328 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~---------f~~Ei~iL~~l~---HpnIv~l~g~~~ 328 (611)
..+|...+.+|+|+||.|+++.++ +...|+||.+.+++-..+. .-.||.||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346899999999999999999976 5778999999876433332 445999999998 999999999999
Q ss_pred ecCceEEEEeeCC-CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 329 EDNNLLLVYDFLS-RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 329 ~~~~~~LV~Ey~~-ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
+++.+||+||.-. |-+|+++|.... .+++.++..|+.||+.|+++||+ ++|||||||-+||.++.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp----~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP----RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC----ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence 9999999999764 558999997654 48899999999999999999999 999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhccCCCC-CcceehhhhHHHHHHHhCCCCCCC
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISN 469 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~ELltG~~Pf~~ 469 (611)
|||.|.....+. ...++||.+|.|||++.+.+|- ..-|||++|++||-++....||.+
T Consensus 713 dfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999987665543 3447999999999999988874 458999999999999999999854
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=252.24 Aligned_cols=264 Identities=23% Similarity=0.337 Sum_probs=211.5
Q ss_pred HHHHHHhhcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeE
Q 007256 255 YQDLLSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGF 326 (611)
Q Consensus 255 ~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~ 326 (611)
.+++....+++....++-+|.||.||+|.+. +.+.|-||.++. +.-....+..|.-.+..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 4566667778888899999999999999643 345677888875 34556788999999999999999999999
Q ss_pred EEec-CceEEEEeeCCCCChhhhhccCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC
Q 007256 327 CFED-NNLLLVYDFLSRGSLEENLHGNKK----DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 401 (611)
Q Consensus 327 ~~~~-~~~~LV~Ey~~ggsL~~~L~~~~~----~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~ 401 (611)
+.++ ...+.+|.++.-|+|..++...+. ....++-.+...++.|++.|++|||+ ++|||.||-..|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence 8764 568999999999999999973221 23456677788899999999999999 999999999999999999
Q ss_pred CceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 007256 402 FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVM 480 (611)
Q Consensus 402 ~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~ 480 (611)
.++||+|=.+++.+-....+...+.--....||+||.+.+..|+.++|||||||+||||+| |+.|+..-+|.+....+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 9999999999987666555544444445678999999999999999999999999999999 999999888877665544
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 481 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 481 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
-...+ .+- .+-..++..++.-||...|++||+.++++.=|.
T Consensus 513 dGyRl------aQP----------~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 513 DGYRL------AQP----------FNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred cccee------cCC----------CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 33221 111 111223455555699999999999999987664
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=252.47 Aligned_cols=276 Identities=20% Similarity=0.329 Sum_probs=201.6
Q ss_pred cccccCHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----C---cc
Q 007256 249 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-----H---KN 319 (611)
Q Consensus 249 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-----H---pn 319 (611)
........+.. ...+|.+.++||-|-|++||++.+. +.+.||+|+.+......+..+.||.+|++++ | .+
T Consensus 65 GYHpV~IGD~F-~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 65 GYHPVRIGDVF-NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred CCceeeccccc-cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 33343444432 2468999999999999999999875 5678999999988888888999999999985 2 47
Q ss_pred eeEEeeEEEe----cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccc
Q 007256 320 IISLLGFCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 395 (611)
Q Consensus 320 Iv~l~g~~~~----~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~N 395 (611)
||+|+++|.. +.+++||+|++ |.+|..+|....-. .++...+.+|+.||+.||.|||..| ||||.||||+|
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPEN 218 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPEN 218 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcce
Confidence 9999999975 45899999999 55899988765543 4788999999999999999999964 79999999999
Q ss_pred eeeCCC--------------------------------------------------------------------------
Q 007256 396 ILLSDD-------------------------------------------------------------------------- 401 (611)
Q Consensus 396 ILLd~~-------------------------------------------------------------------------- 401 (611)
|||..+
T Consensus 219 vLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~ 298 (590)
T KOG1290|consen 219 VLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEP 298 (590)
T ss_pred eeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccc
Confidence 998300
Q ss_pred --------------------------------------------------------------------------------
Q 007256 402 -------------------------------------------------------------------------------- 401 (611)
Q Consensus 402 -------------------------------------------------------------------------------- 401 (611)
T Consensus 299 ~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~ 378 (590)
T KOG1290|consen 299 NQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNP 378 (590)
T ss_pred cccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccc
Confidence
Q ss_pred ------------CceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCC
Q 007256 402 ------------FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 469 (611)
Q Consensus 402 ------------~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 469 (611)
-.+||+|||-|.|.... .+...-|..|.|||++.+..|+..+||||++|++|||+||...|+.
T Consensus 379 ~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFeP 453 (590)
T KOG1290|consen 379 LVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEP 453 (590)
T ss_pred ccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecC
Confidence 00244455544443321 1223468889999999999999999999999999999999999975
Q ss_pred CCCcc----hhh--HHH-----hhcccc-----------ccCccccc-------cCcccCC--CCChHHHHHHHHHHHHh
Q 007256 470 DHPKG----QES--LVM-----WAKPIL-----------SSGKVTQL-------LDPALGN--NYDYDQMERMVLASILC 518 (611)
Q Consensus 470 ~~~~~----~~~--lv~-----~~~~~~-----------~~g~l~~l-------ld~~l~~--~~~~~~~~~l~~la~~C 518 (611)
..... ..+ +++ .-+.+. ..|.+..+ +...|.. ++..++...+..+.+=|
T Consensus 454 hsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~Pm 533 (590)
T KOG1290|consen 454 HSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPM 533 (590)
T ss_pred CCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHH
Confidence 43222 111 111 001111 11222211 1122222 23456777888888889
Q ss_pred cccCCCCCCCHHHHHHH
Q 007256 519 IRRDPRARPQMSLVLKL 535 (611)
Q Consensus 519 L~~dP~~RPtm~eVL~~ 535 (611)
|+.+|++|||+.+.|+.
T Consensus 534 Lef~PeKR~tA~~cl~h 550 (590)
T KOG1290|consen 534 LEFDPEKRPTAAQCLKH 550 (590)
T ss_pred HhcCccccccHHHHhcC
Confidence 99999999999998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=266.92 Aligned_cols=252 Identities=27% Similarity=0.402 Sum_probs=203.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.....+|.|.+|.|||+++. +++..|||+++-.. ++..-..+|+-+++..+|||||.++|.+.....++++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 467888999999999999999975 79999999998653 5667788899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
|.||+|.+..+... ++++.++..++++.++||.|||+ ++-+|||||-.|||+++.|.+|++|||.+-.+....
T Consensus 94 cgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999988654 58889999999999999999999 889999999999999999999999999987666543
Q ss_pred CCccccccccccccCChhhh---ccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 420 SHITCTDVAGTFGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l---~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.. ...+.||+.|||||+. ..+.|..++|||++|+...|+-.-++|...-.+.....+. -+..+. .
T Consensus 167 ~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--TkS~~q--------p 234 (829)
T KOG0576|consen 167 AK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--TKSGFQ--------P 234 (829)
T ss_pred hh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--hccCCC--------C
Confidence 32 2358999999999976 4678999999999999999999988887665543322221 111111 1
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+.+.+...+ ...+-.++..|+.++|++||+++.+|.
T Consensus 235 p~lkDk~kw--s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDKTKW--SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCCccc--hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 222222222 223334555699999999999987664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-28 Score=233.25 Aligned_cols=196 Identities=23% Similarity=0.436 Sum_probs=167.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEec--CceEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFED--NNLLLV 336 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~--~~~~LV 336 (611)
..++|++.+++|+|.++.||.|.. .++..++||++++-+ .+.+.+|+.||..|. ||||++|++...+. ....||
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 457899999999999999999984 578899999998643 467889999999998 99999999998764 467899
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC-CceEEeecCccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKWA 415 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~-~~vKL~DFGla~~~ 415 (611)
+||+.+.+...+.. .++...+..++.+++.||.|+|+ +||+|||+||.|++||.. -.++|+|+|+|.++
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999987776653 36667788899999999999999 999999999999999865 46999999999998
Q ss_pred cCCCCCccccccccccccCChhhhc-cCCCCCcceehhhhHHHHHHHhCCCCCCCCC
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDH 471 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 471 (611)
...... ...+.+..|--||.+. .+.|+..-|+|||||+|..|+..+.||-...
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 765433 2256788899999875 5678999999999999999999999986543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=240.24 Aligned_cols=199 Identities=26% Similarity=0.367 Sum_probs=166.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------Cc
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NN 332 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~------~~ 332 (611)
.+|.-.+.+|.|+- .|.-+.+. .++.||+|.+... ....++..+|..++..++|+||++++.+|.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46677788899988 66555543 6889999987542 34456788999999999999999999998643 35
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.|+|||||.. +|...++. .++-..+..|+.|++.|+.|||+ .||+||||||+||++..+..+||.|||+|
T Consensus 96 ~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhh
Confidence 8999999976 89888873 25567788999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcch
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 475 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~ 475 (611)
+....+ ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+.+...+
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ 225 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ 225 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence 866654 233457889999999999988899999999999999999999999986554333
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=270.96 Aligned_cols=196 Identities=21% Similarity=0.277 Sum_probs=138.5
Q ss_pred hcCC-cceeEEeeEE-------EecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc
Q 007256 314 TLHH-KNIISLLGFC-------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385 (611)
Q Consensus 314 ~l~H-pnIv~l~g~~-------~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g 385 (611)
.++| .||++++++| .+...+++++||+ +++|.++|.... ..+++.+++.++.||++||.|||+ ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 4456 6888888887 3345678889988 559999997432 358999999999999999999999 99
Q ss_pred EEeeccCccceeeCC-------------------CCceEEeecCccccccCCCC--------------Cccccccccccc
Q 007256 386 VIHRDVKSSNILLSD-------------------DFEPQLSDFGLAKWASTSSS--------------HITCTDVAGTFG 432 (611)
Q Consensus 386 IiHrDIKp~NILLd~-------------------~~~vKL~DFGla~~~~~~~~--------------~~~~~~~~GT~~ 432 (611)
|+||||||+||||+. ++.+||+|||+++....... .......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 34566666676653211000 000112468999
Q ss_pred cCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHH
Q 007256 433 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMV 512 (611)
Q Consensus 433 Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~ 512 (611)
|+|||++.+..|+.++|||||||+||||++|..|+..... ......... +.+... .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~~---------~~~~~~-----~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHRV---------LPPQIL-----LNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHhh---------cChhhh-----hcCHHHH
Confidence 9999999999999999999999999999999888753211 000010000 111100 0112234
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 007256 513 LASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 513 ~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.++..||+.+|.+||+|.+|++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 5566799999999999999986
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=235.48 Aligned_cols=201 Identities=27% Similarity=0.392 Sum_probs=166.0
Q ss_pred HHhhcCceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCce
Q 007256 259 LSATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNL 333 (611)
Q Consensus 259 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~ 333 (611)
....+.|..+++||+|.|++||++.+. ..+.||+|.+.... ....+.+|+++|..+. +.||+++.+++..++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 345567899999999999999999853 46789999887532 2346889999999997 89999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-CCceEEeecCcc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLA 412 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-~~~vKL~DFGla 412 (611)
.+|+||++.....+++.. ++..++..++..++.||.++|. +|||||||||+|+|.+. .+.-.|.|||+|
T Consensus 111 ~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred EEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence 999999999988888863 6678899999999999999999 99999999999999975 456789999999
Q ss_pred ccccCCC---------------------------------CCcc---------ccccccccccCChhhhc-cCCCCCcce
Q 007256 413 KWASTSS---------------------------------SHIT---------CTDVAGTFGYLAPEYFM-YGKVNDKID 449 (611)
Q Consensus 413 ~~~~~~~---------------------------------~~~~---------~~~~~GT~~Y~APE~l~-~~~~s~ksD 449 (611)
....... +... .-..+||+||.|||++. .+..++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7321100 0000 01146999999999876 557889999
Q ss_pred ehhhhHHHHHHHhCCCCCCCC
Q 007256 450 VYAFGVVLLELLTGRKPISND 470 (611)
Q Consensus 450 VwSlGvvL~ELltG~~Pf~~~ 470 (611)
|||.|||++-+++++.||...
T Consensus 261 iws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eeeccceeehhhccccccccC
Confidence 999999999999999998643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=224.96 Aligned_cols=250 Identities=22% Similarity=0.369 Sum_probs=184.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeE-EEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGF-CFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~-~~~~~~~~LV~E 338 (611)
.+.|.+.+.||+|.||.+-++.++ +.+.+++|.+.......++|.+|...--.|. |.||+.-|+. |+..+.+++++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 356888999999999999999875 6778999999988888899999998766664 8999988865 566678889999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC--CCCceEEeecCcccccc
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd--~~~~vKL~DFGla~~~~ 416 (611)
|++.|+|...+... .+.+....+++.|++.||.|+|+ +++||||||.+||||- +...+||||||+....+
T Consensus 103 ~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999988654 36778888999999999999999 8999999999999993 33479999999986554
Q ss_pred CCCCCccccccccccccCChhhhcc---C--CCCCcceehhhhHHHHHHHhCCCCCCCCCCcch--hhHHHhhccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMY---G--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ--ESLVMWAKPILSSG 489 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~---~--~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--~~lv~~~~~~~~~g 489 (611)
.... ..--+..|.+||.... + ...+.+|||.||+++|..+||+.||.......+ .....|......
T Consensus 175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 4222 1234667999997652 2 357789999999999999999999985443332 222334332111
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+...+.+ + .+...+|. ..-|.++|++|=...++-++
T Consensus 248 ~~P~~F~~-----f-s~~a~r~F---kk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ALPKKFNP-----F-SEKALRLF---KKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCchhhcc-----c-CHHHHHHH---HHhcCCcccccchhHHHHHH
Confidence 11111111 1 12223332 33678888888555555444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=209.14 Aligned_cols=166 Identities=23% Similarity=0.217 Sum_probs=123.9
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++.... ..+++..++.|+.||+.||.|||+ ++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997543 258999999999999999999998 55 999999999999999 99998665422
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
..||+.|+|||++.++.++.++|||||||++|||++|+.||........... .+...... . ++.- ..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~------~-~~~~-~~ 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE-ILLNGMPA------D-DPRD-RS 130 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH-HHHHHhcc------C-Cccc-cc
Confidence 2589999999999999999999999999999999999999975443221111 11110000 0 0000 00
Q ss_pred CChHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 503 YDYDQM--ERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 503 ~~~~~~--~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
...... ..+..++..||..+|.+||++.++++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 011111 246778888999999999999999997753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-23 Score=205.79 Aligned_cols=258 Identities=30% Similarity=0.433 Sum_probs=195.4
Q ss_pred ceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCc-ceeEEeeEEEecCceEEEEee
Q 007256 265 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHK-NIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~Hp-nIv~l~g~~~~~~~~~LV~Ey 339 (611)
|.+.+.||.|+||.||++... ..+++|.+.... .....+.+|+.++..+.|+ +++++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999886 889999987643 2467899999999999988 799999999777778999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-ceEEeecCccccccCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTS 418 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-~vKL~DFGla~~~~~~ 418 (611)
+.+++|.+++...... ..+.......++.+++.++.|+|+ .+++|||+||+||+++..+ .++++|||++......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777644321 257888999999999999999999 8899999999999999988 7999999999866554
Q ss_pred CCCc----cccccccccccCChhhhcc---CCCCCcceehhhhHHHHHHHhCCCCCCCCCCc---chhhHHHhhcccccc
Q 007256 419 SSHI----TCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK---GQESLVMWAKPILSS 488 (611)
Q Consensus 419 ~~~~----~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~---~~~~lv~~~~~~~~~ 488 (611)
.... ......||..|+|||.+.. ..++...|+||+|++++++++|..||...... .......+.....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 3321 2345789999999999987 57888999999999999999999997665431 1111111111100
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 489 g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
....................+...|+..+|..|.++......
T Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001122344555666899999999998876653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=224.39 Aligned_cols=164 Identities=20% Similarity=0.186 Sum_probs=129.4
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC--CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeE-EeeEEEecC
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIIS-LLGFCFEDN 331 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vAVK~l~~~------~~~~~~f~~Ei~iL~~l~HpnIv~-l~g~~~~~~ 331 (611)
..++|.+.+.||+|+||+||+|.+. +++.+|||++... ......|.+|+++|++++|+|+++ ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 3467999999999999999999864 5777899986532 234567899999999999999985 4432 4
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeecc-CccceeeCCCCceEEeecC
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDI-Kp~NILLd~~~~vKL~DFG 410 (611)
..++||||++|++|... ... . ...++.++++||.|||+ +||+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~-------~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPH-------G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-Ccc-------c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 68999999999999732 110 0 13578899999999999 99999999 9999999999999999999
Q ss_pred ccccccCCCCCcc------ccccccccccCChhhhccC
Q 007256 411 LAKWASTSSSHIT------CTDVAGTFGYLAPEYFMYG 442 (611)
Q Consensus 411 la~~~~~~~~~~~------~~~~~GT~~Y~APE~l~~~ 442 (611)
+|+.+........ .....+++.|+|||++...
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9987655321111 1346789999999998643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=214.94 Aligned_cols=257 Identities=24% Similarity=0.267 Sum_probs=190.2
Q ss_pred CceeeeeEeecCcEEEEEEEeCCC--CEEEEEEecCChhH-HHHHHHHHHHHHhcCC----cceeEEeeEE-EecCceEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLPDG--KELAVKILKPSEDV-IKEFVLEIEIITTLHH----KNIISLLGFC-FEDNNLLL 335 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~~g--~~vAVK~l~~~~~~-~~~f~~Ei~iL~~l~H----pnIv~l~g~~-~~~~~~~L 335 (611)
+|.+.+.||+|+||.||++..... ..+|+|........ ...+..|+.++..+.. .++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 899999999999999999997653 58899988754221 2267789999998873 6899999988 47778899
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC-----CceEEeecC
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFG 410 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~-----~~vKL~DFG 410 (611)
||+.+ |.+|.++..... ...++..+...|+.|++.+|.+||+ .|++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99987 669999886554 3579999999999999999999999 999999999999999865 368999999
Q ss_pred ccc--cccCCCCC----c-c-ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 007256 411 LAK--WASTSSSH----I-T-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 411 la~--~~~~~~~~----~-~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 482 (611)
+++ .+...... . . ...+.||..|.++....+...+.+.|+||++.++.|++.|..|+...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 33222211 1 1 12356999999999999999999999999999999999999999665433221111111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.. ...... .......+...+ ...+-..+...+|....+...|+.
T Consensus 253 ~~-------~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~Pdy~~~~~~l~~ 296 (322)
T KOG1164|consen 253 PR-------KLLTDR--FGDLKPEEFAKI---LEYIDSLDYEDKPDYEKLAELLKD 296 (322)
T ss_pred hh-------hhcccc--ccCCChHHHHHH---HHHhhccCCcCCCCHHHHHHHHHH
Confidence 00 000000 111122233332 223445789999999998888654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-22 Score=228.76 Aligned_cols=253 Identities=21% Similarity=0.224 Sum_probs=186.8
Q ss_pred eeeeeEeecCcEEEEEEEeC-CCCEEEEEEec----CCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 266 LAENLIGKGGSSQVYKGCLP-DGKELAVKILK----PSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 266 ~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~----~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
...+++|.|++|.|+..... ..+..+.|.++ ... .....+..|+.+-..++|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 35678999999977776532 33334444332 221 22223667888888999999998888887777766779
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
|||++ +|..++.... .+...++..++.|++.|+.|||. .||.|||+|++|+++..+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999987652 47778899999999999999999 9999999999999999999999999999987765
Q ss_pred CCCC--ccccccccccccCChhhhccCCCCCc-ceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 418 SSSH--ITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 418 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~s~k-sDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
.... .....++|+..|+|||++....|++. .||||.|++++.|++|+.||.......+....+. ...+.
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~--------~~~~~ 544 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN--------YSDQR 544 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc--------ccccc
Confidence 5443 44556899999999999999999875 9999999999999999999976655433220000 00000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
-...-..........+...++..+|+.+|.+|-|+++|++
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000000111223344555666799999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-21 Score=195.09 Aligned_cols=169 Identities=14% Similarity=0.178 Sum_probs=133.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh----hHHHH------HHHHHHHHHhcCCcceeEEeeEEEec-
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE----DVIKE------FVLEIEIITTLHHKNIISLLGFCFED- 330 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~----~~~~~------f~~Ei~iL~~l~HpnIv~l~g~~~~~- 330 (611)
.++|...++||.|+||.||++.. ++..+|||++.+.. ..... +.+|+..+.+++|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999755 67789999997532 22222 57899999999999999999886643
Q ss_pred -------CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc
Q 007256 331 -------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE 403 (611)
Q Consensus 331 -------~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~ 403 (611)
+..+|||||++|.+|.++.. ++. ....+++.+|..||+ .|++|||+||+||+++.++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence 35899999999999988732 222 245689999999999 9999999999999999988
Q ss_pred eEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHH
Q 007256 404 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 461 (611)
Q Consensus 404 vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELl 461 (611)
++|+|||........... ..++....|+.++|+|+|||++..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987644321110 11455566778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=188.70 Aligned_cols=138 Identities=20% Similarity=0.221 Sum_probs=108.1
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChh---H-------H-----------------HHHHHHHHHHHhcCCcce
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---V-------I-----------------KEFVLEIEIITTLHHKNI 320 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~---~-------~-----------------~~f~~Ei~iL~~l~HpnI 320 (611)
.+.||+|+||.||+|...+|+.||||+++.... . . .....|+.++..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999988999999999975421 0 1 122349999999988776
Q ss_pred eEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCcEEeeccCccceeeC
Q 007256 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHRDVKSSNILLS 399 (611)
Q Consensus 321 v~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yL-H~~~~~gIiHrDIKp~NILLd 399 (611)
.....+.. ...+|||||++|+++...+... ..+++..+..++.|++.+|.|| |+ .||+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 44333322 2348999999998776543222 2578899999999999999999 67 8999999999999998
Q ss_pred CCCceEEeecCccccc
Q 007256 400 DDFEPQLSDFGLAKWA 415 (611)
Q Consensus 400 ~~~~vKL~DFGla~~~ 415 (611)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-21 Score=189.64 Aligned_cols=206 Identities=23% Similarity=0.312 Sum_probs=170.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEE-eCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC-cceeEEeeEEEecCceEEEEe
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~LV~E 338 (611)
....|.+++.||.|+||.+|.|. ..+|.+||||+-... ...-++..|..+...|++ ..|..+..|..+...-.+|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 35689999999999999999998 468999999987643 223467789999999985 678888888888899999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC---CceEEeecCccccc
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKWA 415 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~---~~vKL~DFGla~~~ 415 (611)
.+ |.+|++++.-... .++..+.+-++-|++.-++|+|. +++|||||||+|+|+.-+ ..+.|+|||+|+.+
T Consensus 92 LL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 88 6699998865433 58899999999999999999999 899999999999999643 46899999999977
Q ss_pred cCCCCC-----ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc
Q 007256 416 STSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474 (611)
Q Consensus 416 ~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 474 (611)
....+. .......||..|.+--...+...+.+.|+-|+|.+|.++..|..||.+-....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 553322 12234679999998877777778889999999999999999999998765443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.7e-21 Score=221.83 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=182.5
Q ss_pred CceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
+|...+.||.+.|=+|.+|.++.|. |+||++-+.. ...++-..|+. ...++|||.+++.-+-..+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777899999999999999998888 9999986533 22334444555 566789999999988888888899999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc--c
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA--S 416 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~--~ 416 (611)
|+.+ +|+|.|..+. .+...+...|+.|++.||.-+|+ .||+|||||.+||||+.-+.+.|+||...+.. +
T Consensus 102 yvkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9977 9999997654 47778889999999999999999 99999999999999999999999999876532 2
Q ss_pred CCCCC---ccccccccccccCChhhhccC----------C-CCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 007256 417 TSSSH---ITCTDVAGTFGYLAPEYFMYG----------K-VNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 481 (611)
Q Consensus 417 ~~~~~---~~~~~~~GT~~Y~APE~l~~~----------~-~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 481 (611)
.++.. ...++...-..|+|||.|... . .+++.||||+|||++||++ |++||.-. .+..+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH
Confidence 22111 111222334579999988542 2 6788999999999999998 78888531 12221
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 482 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 482 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.. +. .......+ .++... .+..+++.|+++||.+|-++++.|+.-+|..
T Consensus 248 r~-----~~-~~~~e~~L-e~Ied~---~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 248 RS-----GN-ADDPEQLL-EKIEDV---SLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred hc-----cC-ccCHHHHH-HhCcCc---cHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 11 10 00000011 111111 3344556699999999999999998766654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=191.73 Aligned_cols=201 Identities=22% Similarity=0.288 Sum_probs=170.1
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
-+|.+.++||+|.||..+.|.. -+++.||||.-... ...-++..|.+..+.|. .++|...|-|..++-+-.||+|++
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 3789999999999999999984 48999999976432 23346677888888886 689999998888888999999988
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC-----CceEEeecCccccc
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-----FEPQLSDFGLAKWA 415 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~-----~~vKL~DFGla~~~ 415 (611)
|.+|++++.-.+. .|+..++..|+.|++.-++|+|+ +.+|.|||||+|+||... ..+.|+|||+|+.+
T Consensus 107 -GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 6699999875543 69999999999999999999999 889999999999999743 35889999999988
Q ss_pred cCCCCCc-----cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCC
Q 007256 416 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 471 (611)
Q Consensus 416 ~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 471 (611)
....+.. ......||..||+--...+...+.+-|+-|||-|+++.|.|..||.+-.
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 6644321 1233679999999988888899999999999999999999999998644
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=184.27 Aligned_cols=188 Identities=15% Similarity=0.101 Sum_probs=144.3
Q ss_pred eeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHH-----HHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEee
Q 007256 266 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----EFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 266 ~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~-----~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.+...|++|+||+||.+.. .+..++.+.+........ .|.+|+++|++|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997765 778888888876554333 5789999999996 5889999886 457999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeecc-CccceeeCCCCceEEeecCccccccCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV-KSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDI-Kp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
+.|.+|.+.+.. . ...++.+++.+|.++|+ +||+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR----------G-DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh----------h-hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998754321 0 13477889999999999 99999999 799999999999999999999855443
Q ss_pred CCC---cc--------ccccccccccCChhhhccC-CCC-CcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 419 SSH---IT--------CTDVAGTFGYLAPEYFMYG-KVN-DKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 419 ~~~---~~--------~~~~~GT~~Y~APE~l~~~-~~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
... .. ..-...++.|++|+...-- ..+ ...++++-|+.+|.++|++.|+..+..
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 210 00 0012368889999864421 222 567999999999999999999866543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=179.72 Aligned_cols=141 Identities=23% Similarity=0.229 Sum_probs=110.8
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhH---------------------------HHHHHHHHHHHHhcCCcce
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---------------------------IKEFVLEIEIITTLHHKNI 320 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~---------------------------~~~f~~Ei~iL~~l~HpnI 320 (611)
.+.||+|+||.||+|.+.+|+.||||+++..... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999889999999998864210 1224578999999999987
Q ss_pred eEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC
Q 007256 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD 400 (611)
Q Consensus 321 v~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~ 400 (611)
.....+... ..+|||||++|+++....... ..++......++.+++.++.+||+ ..||+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 554444332 348999999998654432221 246778889999999999999997 25899999999999999
Q ss_pred CCceEEeecCccccccC
Q 007256 401 DFEPQLSDFGLAKWAST 417 (611)
Q Consensus 401 ~~~vKL~DFGla~~~~~ 417 (611)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999976654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=9e-21 Score=188.47 Aligned_cols=246 Identities=20% Similarity=0.369 Sum_probs=183.7
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCC
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 344 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggs 344 (611)
..+|.+...|..|+|+++ |..+++|+++.. ....++|..|.-.|+-+.||||+.+++.|....++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 345788889999999984 455777887643 3445678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccc
Q 007256 345 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424 (611)
Q Consensus 345 L~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~ 424 (611)
|+..+++... ...+-.++.+++.++++|++|||+-. .-|.---|.+..+++|++..++|+= +-+++.- ..
T Consensus 274 lynvlhe~t~--vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfsf------qe 343 (448)
T KOG0195|consen 274 LYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF------QE 343 (448)
T ss_pred HHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceeee------ec
Confidence 9999987653 34566788899999999999999843 2233345888999999998887751 1111111 11
Q ss_pred cccccccccCChhhhccCCCC---CcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 425 TDVAGTFGYLAPEYFMYGKVN---DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 425 ~~~~GT~~Y~APE~l~~~~~s---~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
....-.|.|++||.++..+-+ .++|+|||.++|+||.|...||.+-.+.+.--.+.. ..+.-
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---------------eglrv 408 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---------------EGLRV 408 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh---------------ccccc
Confidence 123457889999999866543 469999999999999999999988766543222211 01122
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.+++.-...|..++..|+..||.+||.+..|+-+|++.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 23333445566677779999999999999998887653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-20 Score=204.07 Aligned_cols=185 Identities=30% Similarity=0.373 Sum_probs=157.4
Q ss_pred eEeecCcEEEEEEE----eCCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeeCC
Q 007256 270 LIGKGGSSQVYKGC----LPDGKELAVKILKPSE---DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~----~~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.+|+|.||.|+++. .+.|.-||+|++++.. ........|..++..++ ||.+|++.-.++.+..++++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999865 2457889999987532 11114556888888888 9999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
||.|...+.... .+.......+...++-+++++|+ .+|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 81 gg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV----MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccCC----chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999998887654 36677777788889999999999 9999999999999999999999999999986654322
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 469 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 469 (611)
.+||..|||||++. .....+|+||||++++||+||..||..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999998 667789999999999999999999976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=180.00 Aligned_cols=233 Identities=22% Similarity=0.320 Sum_probs=147.7
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCC----------cceeEEeeEE-
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHH----------KNIISLLGFC- 327 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~----~~~~~~~f~~Ei~iL~~l~H----------pnIv~l~g~~- 327 (611)
.....+.||.|+++.||.+.+. +|+.+|||++.. .....+++.+|.-....+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3566789999999999999986 689999998753 23456777777655554322 1222222221
Q ss_pred --------EecC--------ceEEEEeeCCCCChhhhhc---cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEe
Q 007256 328 --------FEDN--------NLLLVYDFLSRGSLEENLH---GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 388 (611)
Q Consensus 328 --------~~~~--------~~~LV~Ey~~ggsL~~~L~---~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiH 388 (611)
.... +.+++|+-+.+ +|.+++. ........+....+..+..|+++.+++||. .|++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 1111 34678887754 8887753 222222235556677888999999999999 99999
Q ss_pred eccCccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccC--------CCCCcceehhhhHHHHHH
Q 007256 389 RDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG--------KVNDKIDVYAFGVVLLEL 460 (611)
Q Consensus 389 rDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--------~~s~ksDVwSlGvvL~EL 460 (611)
+||||+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999887655442111 2345789999977532 578899999999999999
Q ss_pred HhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC
Q 007256 461 LTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR 526 (611)
Q Consensus 461 ltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~R 526 (611)
.+|+.||....+..... | .+. ... +..+.+..++..+|++||++|
T Consensus 244 WC~~lPf~~~~~~~~~~---~----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE---W----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG---G----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc---c----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999997654332211 0 111 111 233344455556899999887
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.8e-19 Score=205.42 Aligned_cols=201 Identities=22% Similarity=0.260 Sum_probs=162.9
Q ss_pred HHHHHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCc
Q 007256 256 QDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNN 332 (611)
Q Consensus 256 ~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~~ 332 (611)
.++......|.+.+.||+|+||+||+|...+|+.||+|+-++.... +|.--..++.+|+ -+.|..+...+.-.+.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3444456679999999999999999999888999999999875322 1222233444444 2345555666667788
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC-------CCCceE
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-------DDFEPQ 405 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd-------~~~~vK 405 (611)
-+||+||.+-|+|.+++...+ .++|...+.++.|++..+++||. .+|||+||||+|.||. +..-++
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceE
Confidence 899999999999999998544 48899999999999999999999 9999999999999994 234589
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCC
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK 465 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~ 465 (611)
|+|||.+.-+.--........+++|-++-.+|+..+..++..+|.|.|.-+++-||.|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999976654443344556789999999999999999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.1e-18 Score=168.73 Aligned_cols=133 Identities=20% Similarity=0.248 Sum_probs=103.2
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCC-hhHHHHHHHHHHHHHhc-----CCcceeEEeeEEEecC---c-eEEE
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEIEIITTL-----HHKNIISLLGFCFEDN---N-LLLV 336 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l-----~HpnIv~l~g~~~~~~---~-~~LV 336 (611)
-...||+|+||.||. ++.....+||++... ....+.+.+|+.+++.+ .||||++++|++.++. . +.+|
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 346899999999996 443333479988753 33456789999999999 5799999999998864 3 3378
Q ss_pred Eee--CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCcEEeeccCccceeeCC----CCceEEeec
Q 007256 337 YDF--LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL-EYLHSGSAQRVIHRDVKSSNILLSD----DFEPQLSDF 409 (611)
Q Consensus 337 ~Ey--~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL-~yLH~~~~~gIiHrDIKp~NILLd~----~~~vKL~DF 409 (611)
+|| +.+|+|.+++... .+.+. ..++.+++.++ +|||+ ++|+||||||+|||++. ++.++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 5589999999652 24444 34577788777 99999 99999999999999973 347999995
Q ss_pred Cc
Q 007256 410 GL 411 (611)
Q Consensus 410 Gl 411 (611)
+.
T Consensus 154 ~G 155 (210)
T PRK10345 154 IG 155 (210)
T ss_pred CC
Confidence 43
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.1e-18 Score=171.39 Aligned_cols=144 Identities=19% Similarity=0.179 Sum_probs=112.3
Q ss_pred hcCceeeeeEeecCcEEEEEEE--eCCCCEEEEEEecCChh-------------------------HHHHHHHHHHHHHh
Q 007256 262 TSNFLAENLIGKGGSSQVYKGC--LPDGKELAVKILKPSED-------------------------VIKEFVLEIEIITT 314 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~--~~~g~~vAVK~l~~~~~-------------------------~~~~f~~Ei~iL~~ 314 (611)
...|.+.+.||+|+||.||+|. ..+|+.||||+++.... ....+.+|+.++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458889999999999999998 56899999999874321 11235689999999
Q ss_pred cCCc--ceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc-EEeecc
Q 007256 315 LHHK--NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-VIHRDV 391 (611)
Q Consensus 315 l~Hp--nIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g-IiHrDI 391 (611)
+.+. .+.+++++ ...++||||++|++|........ .+.......++.+++.+|.+||+ .+ |+||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Di 175 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYK---EGELVHGDL 175 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCC
Confidence 9763 33444443 24589999999988876543222 24555677899999999999999 88 999999
Q ss_pred CccceeeCCCCceEEeecCccccccC
Q 007256 392 KSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 392 Kp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+||+++ ++.++|+|||.+.....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999999 78999999999865433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=164.98 Aligned_cols=133 Identities=23% Similarity=0.392 Sum_probs=113.7
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~---------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+.||+|++|.||+|.. +|..++||+..... .....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 77789999876421 1124578899999999999988888888788889999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
++|++|.+++.... + .+..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886421 2 778899999999999999 8999999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=163.10 Aligned_cols=144 Identities=20% Similarity=0.185 Sum_probs=112.7
Q ss_pred HHHHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChh-----------------------HHHHHHHHHHHHH
Q 007256 257 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----------------------VIKEFVLEIEIIT 313 (611)
Q Consensus 257 el~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~-----------------------~~~~f~~Ei~iL~ 313 (611)
++......|.+.+.||+|+||.||++...+|+.||||++..... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444445888899999999999999988999999998764320 1123667899999
Q ss_pred hcCCcc--eeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeecc
Q 007256 314 TLHHKN--IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 391 (611)
Q Consensus 314 ~l~Hpn--Iv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDI 391 (611)
.+.|++ +...++ ....++||||++|++|...... .....++.+++.++.++|+ .+|+||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCCC
Confidence 998874 444443 2456899999999999765431 2345688899999999999 89999999
Q ss_pred CccceeeCCCCceEEeecCccccccC
Q 007256 392 KSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 392 Kp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999864443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.3e-18 Score=183.38 Aligned_cols=214 Identities=21% Similarity=0.387 Sum_probs=158.1
Q ss_pred HHhcCCcceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcE-Eeec
Q 007256 312 ITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV-IHRD 390 (611)
Q Consensus 312 L~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gI-iHrD 390 (611)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.... ..++|.-...++.+|+.||.|||+ -.| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHN---SPIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhc---Ccceeeee
Confidence 456889999999999999999999999999999999997633 368899999999999999999998 333 9999
Q ss_pred cCccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCC-------CCCcceehhhhHHHHHHHhC
Q 007256 391 VKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK-------VNDKIDVYAFGVVLLELLTG 463 (611)
Q Consensus 391 IKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~s~ksDVwSlGvvL~ELltG 463 (611)
+++.|.+++..+.+||+|||+.................-..-|.|||.+.... .+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987664311111111122345699999987541 46679999999999999999
Q ss_pred CCCCCCCCCcch-hhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 464 RKPISNDHPKGQ-ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 464 ~~Pf~~~~~~~~-~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+.||........ ..++..... .....+-|.+.... +....+..++..||..+|.+||++..|-..+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 999987443322 223332211 11111222222111 122257777788999999999999998776654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.6e-17 Score=159.89 Aligned_cols=129 Identities=21% Similarity=0.349 Sum_probs=107.2
Q ss_pred eEeecCcEEEEEEEeCCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 270 LIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~---------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
+||+|+||.||+|.. +|..+++|+..... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999865321 11356778999999999887666666666777789999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+|++|.+.+.... . .++.+++.+|.+||+ .+++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 0 688999999999999 9999999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=184.64 Aligned_cols=139 Identities=19% Similarity=0.320 Sum_probs=113.2
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEe-cCC---h-----hHHHHHHHHHHHHHhcCCcceeEEeeEEEec
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKIL-KPS---E-----DVIKEFVLEIEIITTLHHKNIISLLGFCFED 330 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l-~~~---~-----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~ 330 (611)
.....|...+.||+|+||+||+|.+.+.. +++|+. ... . ...+.+.+|++++..++|++++....++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 34455677899999999999999875443 444432 211 1 1235688999999999999999888888887
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
...++||||++|++|.+++. ....++.+++.+|.|||+ .+++||||||+|||+ .++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCc
Confidence 88899999999999998875 346789999999999999 899999999999999 67799999999
Q ss_pred ccccc
Q 007256 411 LAKWA 415 (611)
Q Consensus 411 la~~~ 415 (611)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 98653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-17 Score=190.28 Aligned_cols=171 Identities=30% Similarity=0.444 Sum_probs=128.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.++|..+++|-.|++|.||...++ +.+.+|+|+-+. ....+. |+.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~lilRn------ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLILRN------ILTFAGNPFVV------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-chhhhc------cccccCCccee-------------------
Confidence 358899999999999999999876 467788855432 221111 33344445444
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
|+-...+...+. ++. +++.+++|||+ .+|+|||+||+|.+|..-|++|++|||+.+.......
T Consensus 136 --gDc~tllk~~g~----lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP----LPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcccCCC----Ccc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 455555554433 221 23678999999 9999999999999999999999999999875432111
Q ss_pred -------------CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcch
Q 007256 421 -------------HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 475 (611)
Q Consensus 421 -------------~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~ 475 (611)
......++|||.|+|||++..+.|...+|+|++|+|+||.+-|..||.++.+.+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel 266 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL 266 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH
Confidence 1112346899999999999999999999999999999999999999998876553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-17 Score=179.28 Aligned_cols=124 Identities=31% Similarity=0.505 Sum_probs=107.2
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
.+|+.|++|...+|.++|.+... ....++.....++.|++.|+.| ++.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 58899999999999999975443 2356888899999999999999 6789999999999999999999999999
Q ss_pred cccccCCC----CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh
Q 007256 412 AKWASTSS----SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT 462 (611)
Q Consensus 412 a~~~~~~~----~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt 462 (611)
........ .....+...||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87766554 1122334689999999999999999999999999999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.1e-16 Score=140.59 Aligned_cols=136 Identities=23% Similarity=0.255 Sum_probs=115.1
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--cceeEEeeEEEecCceEEEEeeCCCCC
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGS 344 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~~~~~~LV~Ey~~ggs 344 (611)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+.++..++| .++.+++.++...+..+++|||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 35789999999999998754 7899999876544 5678899999999987 589999998888888999999999977
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 345 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 345 L~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
+... +......++.+++.+|.+||.....+++|+|++|+||+++..+.++++|||.+...
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7654 34566778899999999999854457999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=159.12 Aligned_cols=145 Identities=27% Similarity=0.361 Sum_probs=109.6
Q ss_pred CCcceeEEeeEEEe---------------------------cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHH
Q 007256 316 HHKNIISLLGFCFE---------------------------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVA 368 (611)
Q Consensus 316 ~HpnIv~l~g~~~~---------------------------~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~ 368 (611)
+|||||++.++|.+ +..+|+||.-.+. +|.+++-.+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 59999999988753 2247899988766 8999886543 4445566689
Q ss_pred HHHHHHHHHHhcCCCCcEEeeccCccceee--CCCC--ceEEeecCccccccCCCCC----ccccccccccccCChhhhc
Q 007256 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDF--EPQLSDFGLAKWASTSSSH----ITCTDVAGTFGYLAPEYFM 440 (611)
Q Consensus 369 ~qIa~gL~yLH~~~~~gIiHrDIKp~NILL--d~~~--~vKL~DFGla~~~~~~~~~----~~~~~~~GT~~Y~APE~l~ 440 (611)
.|+++|+.|||+ +||.|||+|++|||| ++|+ .+.|+|||.+-.-....-. ....+.-|.-.-||||+..
T Consensus 348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999999 999999999999999 4443 4679999987432221000 1111245777889999986
Q ss_pred cCC------CCCcceehhhhHHHHHHHhCCCCCCC
Q 007256 441 YGK------VNDKIDVYAFGVVLLELLTGRKPISN 469 (611)
Q Consensus 441 ~~~------~s~ksDVwSlGvvL~ELltG~~Pf~~ 469 (611)
..+ --.|+|.|+.|.+.||+++...||..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 432 23489999999999999999999986
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.5e-16 Score=148.92 Aligned_cols=137 Identities=21% Similarity=0.262 Sum_probs=99.1
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhH---HHH----------------------HHHHHHHHHhcCCcc--e
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---IKE----------------------FVLEIEIITTLHHKN--I 320 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~---~~~----------------------f~~Ei~iL~~l~Hpn--I 320 (611)
.+.||+|+||+||+|.+.+|+.||||+++..... ... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998753211 111 134666666665433 4
Q ss_pred eEEeeEEEecCceEEEEeeCCCCChhhh-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC
Q 007256 321 ISLLGFCFEDNNLLLVYDFLSRGSLEEN-LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 399 (611)
Q Consensus 321 v~l~g~~~~~~~~~LV~Ey~~ggsL~~~-L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd 399 (611)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. ..+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 444443 346999999999654321 21111 11 5567899999999999996 26799999999999999
Q ss_pred CCCceEEeecCccccccC
Q 007256 400 DDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 400 ~~~~vKL~DFGla~~~~~ 417 (611)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 88999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=146.90 Aligned_cols=134 Identities=15% Similarity=0.182 Sum_probs=104.3
Q ss_pred eeEe-ecCcEEEEEEEeCCCCEEEEEEecCCh--------------hHHHHHHHHHHHHHhcCCcce--eEEeeEEEecC
Q 007256 269 NLIG-KGGSSQVYKGCLPDGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNI--ISLLGFCFEDN 331 (611)
Q Consensus 269 ~~LG-~G~fG~Vyk~~~~~g~~vAVK~l~~~~--------------~~~~~f~~Ei~iL~~l~HpnI--v~l~g~~~~~~ 331 (611)
..|| .||.|+||++... +..++||++.... .....+.+|++++..++|++| +..+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4688 8999999998774 7789999885311 123467889999999998774 67777654432
Q ss_pred c----eEEEEeeCCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEE
Q 007256 332 N----LLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 406 (611)
Q Consensus 332 ~----~~LV~Ey~~g-gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL 406 (611)
. .++||||++| .+|.+++... .++.. .+.+|+.+|.+||+ .||+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 3599999997 6898887542 23433 35689999999999 99999999999999999889999
Q ss_pred eecCccccc
Q 007256 407 SDFGLAKWA 415 (611)
Q Consensus 407 ~DFGla~~~ 415 (611)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=8.6e-16 Score=174.42 Aligned_cols=204 Identities=27% Similarity=0.346 Sum_probs=165.0
Q ss_pred CceeeeeEeecCcEEEEEEEeCC--CCEEEEEEecCC---hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLPD--GKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.|.+.+.||+|+|+.|-...... ...+|+|.+... ....+....|..+-..+. |.|++.+++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 35556679999999998876533 445666666543 344455556888888887 999999999999999999999
Q ss_pred eeCCCCChhhhh-ccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCcEEeeccCccceeeCCCC-ceEEeecCcccc
Q 007256 338 DFLSRGSLEENL-HGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKW 414 (611)
Q Consensus 338 Ey~~ggsL~~~L-~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH-~~~~~gIiHrDIKp~NILLd~~~-~vKL~DFGla~~ 414 (611)
+|..|+++.+.+ +... ...+....-.++.|+..++.|+| . .++.||||||+|.+++..+ .++++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 4332 13445566778999999999999 7 8899999999999999999 999999999998
Q ss_pred ccC-CCCCcccccccc-ccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCc
Q 007256 415 AST-SSSHITCTDVAG-TFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473 (611)
Q Consensus 415 ~~~-~~~~~~~~~~~G-T~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 473 (611)
+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 877 444455556788 9999999998874 5567899999999999999999998765443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.3e-13 Score=151.57 Aligned_cols=173 Identities=20% Similarity=0.277 Sum_probs=114.1
Q ss_pred CchhHHhHhhhhcCcccccCHHHHHHhhc------------CceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChh-H
Q 007256 235 LPKELEGLHEKYSATCRLFNYQDLLSATS------------NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-V 301 (611)
Q Consensus 235 ~~~el~~~~~~~~~~~~~f~~~el~~~t~------------~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~-~ 301 (611)
+|++...-..+.......++++++..... .|. .+.||.|++|.||+|.+++|+.||||+.++.-. .
T Consensus 78 lp~~~~~~L~~Lqd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~ 156 (437)
T TIGR01982 78 LPADIAEELSLLQDRVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKT 156 (437)
T ss_pred CCHHHHHHHHHHhcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHH
Confidence 34444444444445555566555543332 222 467999999999999999999999999876310 0
Q ss_pred ------------------------------HH----------HHHHHHHHHHhcC----CcceeEEeeEE-EecCceEEE
Q 007256 302 ------------------------------IK----------EFVLEIEIITTLH----HKNIISLLGFC-FEDNNLLLV 336 (611)
Q Consensus 302 ------------------------------~~----------~f~~Ei~iL~~l~----HpnIv~l~g~~-~~~~~~~LV 336 (611)
.+ +|.+|...+.+++ |.+-+.+-..+ ......+||
T Consensus 157 i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLv 236 (437)
T TIGR01982 157 IAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLT 236 (437)
T ss_pred HHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEE
Confidence 00 2344555555542 22223332232 224567999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE-ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~-gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
|||++|++|.+....... .. .+..++..++. .+..+|. .|++|+|+||.||+++.++.++|+|||++..+
T Consensus 237 mE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 237 MEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred EEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999987653211 11 23456666665 4678888 89999999999999999999999999998765
Q ss_pred cC
Q 007256 416 ST 417 (611)
Q Consensus 416 ~~ 417 (611)
..
T Consensus 308 ~~ 309 (437)
T TIGR01982 308 SE 309 (437)
T ss_pred CH
Confidence 43
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-13 Score=154.07 Aligned_cols=172 Identities=16% Similarity=0.202 Sum_probs=105.4
Q ss_pred CchhHHhHhhhhcCcccccCHHHHHHhh------------cCceeeeeEeecCcEEEEEEEeCC-CCEEEEEEecCCh--
Q 007256 235 LPKELEGLHEKYSATCRLFNYQDLLSAT------------SNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSE-- 299 (611)
Q Consensus 235 ~~~el~~~~~~~~~~~~~f~~~el~~~t------------~~f~~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~-- 299 (611)
+|+++..-..+.......|++++..... .+|.. +.||.|++|.||+|.+++ |+.||||++++.-
T Consensus 80 lP~~~~~eL~~Lqd~vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~ 158 (537)
T PRK04750 80 FPPDIADELALLQDRVPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILP 158 (537)
T ss_pred CCHHHHHHHHHHHcCCCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHH
Confidence 3444433333444455566655544332 24665 789999999999999987 9999999998541
Q ss_pred ---------------------------------hHHHH------HHHHHHHHHhcC----CcceeEEeeEEEe-cCceEE
Q 007256 300 ---------------------------------DVIKE------FVLEIEIITTLH----HKNIISLLGFCFE-DNNLLL 335 (611)
Q Consensus 300 ---------------------------------~~~~~------f~~Ei~iL~~l~----HpnIv~l~g~~~~-~~~~~L 335 (611)
+..+. |.+|+..+.+++ +.+.+.+-.++.+ ....+|
T Consensus 159 ~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VL 238 (537)
T PRK04750 159 VIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVM 238 (537)
T ss_pred HHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceE
Confidence 01111 223333333332 3333333333322 356789
Q ss_pred EEeeCCCCChhhh--hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC----ceEEeec
Q 007256 336 VYDFLSRGSLEEN--LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 409 (611)
Q Consensus 336 V~Ey~~ggsL~~~--L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~----~vKL~DF 409 (611)
||||++|+.|.+. +...+.....+.......++.| ++. .|++|+|+||.||+++.++ .++++||
T Consensus 239 vmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if~---~GffHaDpHPGNIlv~~~g~~~~~i~llDF 308 (537)
T PRK04750 239 VMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VFR---DGFFHADMHPGNIFVSYDPPENPRYIALDF 308 (537)
T ss_pred EEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HHh---CCeeeCCCChHHeEEecCCCCCCeEEEEec
Confidence 9999999999874 2222211111222222223333 334 7899999999999999888 9999999
Q ss_pred CccccccC
Q 007256 410 GLAKWAST 417 (611)
Q Consensus 410 Gla~~~~~ 417 (611)
|++..++.
T Consensus 309 Givg~l~~ 316 (537)
T PRK04750 309 GIVGSLNK 316 (537)
T ss_pred ceEEECCH
Confidence 99876654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-12 Score=123.25 Aligned_cols=130 Identities=22% Similarity=0.198 Sum_probs=97.2
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEEEeeCCCCChh
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv-~l~g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
.+.|+.|.++.||++... |..|++|+..........+..|+.+++.+.+.+++ +++.+. ....++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 367899999999998864 77899999876543334567899999998765544 444433 33468999999998876
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 347 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 347 ~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~--~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
..- . ....++.+++++|..||... ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 430 0 01235678999999999832 22369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.6e-12 Score=130.72 Aligned_cols=155 Identities=21% Similarity=0.301 Sum_probs=118.5
Q ss_pred HHHHhcCCcceeEEeeEEEec-----CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 007256 310 EIITTLHHKNIISLLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384 (611)
Q Consensus 310 ~iL~~l~HpnIv~l~g~~~~~-----~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~ 384 (611)
+-|-++-|.|||+++.|+.+. ....++.|||..|+|..+|++.......+......+++.||+.||.|||+.. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345566799999999988643 3578999999999999999877666667778888899999999999999855 7
Q ss_pred cEEeeccCccceeeCCCCceEEeecCccccccCCC---CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHH
Q 007256 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS---SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELL 461 (611)
Q Consensus 385 gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~---~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELl 461 (611)
.|+|+++..+-|++..++-+|+.--.- ....... .........+-++|.|||+=.....+..+|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 899999999999999998888752111 0000000 000011134678999999877777888999999999999998
Q ss_pred hCCCC
Q 007256 462 TGRKP 466 (611)
Q Consensus 462 tG~~P 466 (611)
-|..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 87653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.9e-12 Score=139.04 Aligned_cols=247 Identities=21% Similarity=0.233 Sum_probs=177.5
Q ss_pred CceeeeeEee--cCcEEEEEEEe---CCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceE
Q 007256 264 NFLAENLIGK--GGSSQVYKGCL---PDGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 264 ~f~~~~~LG~--G~fG~Vyk~~~---~~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~ 334 (611)
.|.+...+|. |.+|.||.+.. .++..+|+|.-+. .......-.+|+...++++ |+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999865 4688899987442 2233344456777777776 999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCcEEeeccCccceeeCCC-CceEEeec
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE----ALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDF 409 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~----gL~yLH~~~~~gIiHrDIKp~NILLd~~-~~vKL~DF 409 (611)
+-.|++. .+|..+.+.... .++....+.++.+... ||.++|. .+++|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence 9999986 588888775543 2455556666666666 9999999 889999999999999999 88999999
Q ss_pred CccccccCCCCCccc---cccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 007256 410 GLAKWASTSSSHITC---TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486 (611)
Q Consensus 410 Gla~~~~~~~~~~~~---~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 486 (611)
|+...+......... ....|..-|++||... +-++.+.|+|++|.++++..+|..+....... .|..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~--- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQ--- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cccc---
Confidence 999877665422211 1235788899999876 67889999999999999999987765433111 1211
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 487 ~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+.... +..++...-...+.....++++.+|..|++.+.+..
T Consensus 338 ----~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ----LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 01111 111111111122333566799999999999887654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=9e-11 Score=115.46 Aligned_cols=136 Identities=18% Similarity=0.206 Sum_probs=99.3
Q ss_pred eeeEeecCcEEEEEEEeCC-------CCEEEEEEecCC-------------h----------hHHHHHH----HHHHHHH
Q 007256 268 ENLIGKGGSSQVYKGCLPD-------GKELAVKILKPS-------------E----------DVIKEFV----LEIEIIT 313 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~-------g~~vAVK~l~~~-------------~----------~~~~~f~----~Ei~iL~ 313 (611)
...||.|--+.||.|...+ +..+|||+.+.+ + ...+.+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 479999998641 0 0122233 7999999
Q ss_pred hcCC--cceeEEeeEEEecCceEEEEeeCCCCChhh-hhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCcEEee
Q 007256 314 TLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLEE-NLHGNKKDPAAFGWSERYKVAMGVAEALEYL-HSGSAQRVIHR 389 (611)
Q Consensus 314 ~l~H--pnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~-~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yL-H~~~~~gIiHr 389 (611)
++.. -++.+++++ ..-+|||||+.+..+.. .+.. ..++......+..+++.+|..| |+ .+|||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 9863 456666654 46789999998754422 2221 1244455667889999999999 78 899999
Q ss_pred ccCccceeeCCCCceEEeecCcccccc
Q 007256 390 DVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 390 DIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
||++.|||+++ +.+.|+|||.+....
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999974 689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.1e-10 Score=114.88 Aligned_cols=140 Identities=20% Similarity=0.281 Sum_probs=110.4
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCChh--HHHHHHHHHHHHHhcCC--cceeEEeeEEEec---CceEEEEeeCC
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHH--KNIISLLGFCFED---NNLLLVYDFLS 341 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~--~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~~---~~~~LV~Ey~~ 341 (611)
+.||.|.++.||++...+|+.+++|+...... ....+..|+++++.+++ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999875443 45678899999999976 3456777776553 26689999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 382 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~--------------------------------------- 382 (611)
|.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876532 13666777788888888888888521
Q ss_pred --------------CCcEEeeccCccceeeCC--CCceEEeecCccc
Q 007256 383 --------------AQRVIHRDVKSSNILLSD--DFEPQLSDFGLAK 413 (611)
Q Consensus 383 --------------~~gIiHrDIKp~NILLd~--~~~vKL~DFGla~ 413 (611)
...++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 246799999999999998 6678999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.7e-10 Score=105.84 Aligned_cols=130 Identities=24% Similarity=0.341 Sum_probs=100.4
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCC-----h----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPS-----E----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~-----~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
..+++|+-+.+|.+... |..+++|.=.+. . -...+-.+|+.++.+++--.|.-.+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999998663 444666653321 1 1234567899999999866666666667788888999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
++|..|.+.+... ...++..+-.-+.-||. .||+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 13466777777889999 8999999999999998774 99999999863
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-10 Score=127.68 Aligned_cols=194 Identities=23% Similarity=0.187 Sum_probs=146.9
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe--CCCCEEEEEEecCChh-HHH--HHHHHHHHHHhcC-CcceeEEeeEEEecCceE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSED-VIK--EFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~--~~g~~vAVK~l~~~~~-~~~--~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~ 334 (611)
.+.+|..+..||.|.|+.|++... .++..|++|.+...-. ... .-..|+-+...+. |.+++.++..+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 456788999999999999998764 4688999998875321 111 1234665555554 889999888888888889
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC-CceEEeecCccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAK 413 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~-~~vKL~DFGla~ 413 (611)
+--||++++++...+... ..+....++.+..+++.++.++|+ ..++|+|+||+||++..+ +.-++.|||...
T Consensus 343 ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccc
Confidence 999999999888766322 246777888999999999999999 899999999999999886 788999999886
Q ss_pred cccCCCCCccccccccccccC--ChhhhccCCCCCcceehhhhHHHHHHHhCCCC
Q 007256 414 WASTSSSHITCTDVAGTFGYL--APEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~--APE~l~~~~~s~ksDVwSlGvvL~ELltG~~P 466 (611)
.+.-.. ....++-++. +|+......+..+.|+||||.-+.+.++|..-
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 422111 1122333344 55555566788899999999999999998654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.1e-09 Score=102.05 Aligned_cols=141 Identities=22% Similarity=0.291 Sum_probs=105.8
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCC---------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS---------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~---------~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
...+|-+|+-+.|+++.. .|+.++||.-... .-...+..+|+++|.+++--.|.-..-+|.+.+.-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999877 6777777753221 123456788999999998666666666777888889999
Q ss_pred eeCCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC---ceEEeecCccc
Q 007256 338 DFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAK 413 (611)
Q Consensus 338 Ey~~g-gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~---~vKL~DFGla~ 413 (611)
||++| .++.+++....... ........++..|-+.+.-||. .+|||+||.++||+|..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99988 46777775443211 1222226778888889999999 8899999999999996554 35899999874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.8e-09 Score=120.24 Aligned_cols=165 Identities=24% Similarity=0.292 Sum_probs=125.6
Q ss_pred eCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHH
Q 007256 284 LPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWS 362 (611)
Q Consensus 284 ~~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~ 362 (611)
..++.+|.|...+.+. .......+-+..|+.++||||++++..+......|||+|-+. .|..++... +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 4478888888887543 334556778889999999999999999999999999999885 466666543 345
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccC
Q 007256 363 ERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442 (611)
Q Consensus 363 ~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 442 (611)
.....+.||+.||.|||+. .+++|++|.-+.|+++..|+.||++|-++.......... ....---.|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCcc
Confidence 5667889999999999964 569999999999999999999999998875544432211 111122346777755432
Q ss_pred CCCCcceehhhhHHHHHHHhC
Q 007256 443 KVNDKIDVYAFGVVLLELLTG 463 (611)
Q Consensus 443 ~~s~ksDVwSlGvvL~ELltG 463 (611)
. -..|.|-|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.4e-10 Score=131.90 Aligned_cols=207 Identities=23% Similarity=0.295 Sum_probs=149.9
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChh----HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED----VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~----~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
..+.|.+.+-+-.|.++.++.+.-. .|...++|+...... ..+....+-.++-..++|.++...--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4456777788889999999877533 344445555443221 22233334344444556777766655666778999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
+++|+.+++|...++.... .+.+-.+..+..+..+++|||. ..+.|||++|.|+|+..+++.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999987652 3444445566678889999998 67999999999999999999999999843321
Q ss_pred cCC---------------------C---CC-----ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCC
Q 007256 416 STS---------------------S---SH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466 (611)
Q Consensus 416 ~~~---------------------~---~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~P 466 (611)
... . .. .......||+.|++||...+......+|+|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 0 00 001225689999999999999999999999999999999999999
Q ss_pred CCCCCCcc
Q 007256 467 ISNDHPKG 474 (611)
Q Consensus 467 f~~~~~~~ 474 (611)
|....+..
T Consensus 1035 ~na~tpq~ 1042 (1205)
T KOG0606|consen 1035 FNAETPQQ 1042 (1205)
T ss_pred CCCcchhh
Confidence 98876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.1e-09 Score=101.08 Aligned_cols=125 Identities=23% Similarity=0.306 Sum_probs=83.6
Q ss_pred EEEEEEeCCCCEEEEEEecCC---------------h------------hHHHHHHHHHHHHHhcCCc--ceeEEeeEEE
Q 007256 278 QVYKGCLPDGKELAVKILKPS---------------E------------DVIKEFVLEIEIITTLHHK--NIISLLGFCF 328 (611)
Q Consensus 278 ~Vyk~~~~~g~~vAVK~l~~~---------------~------------~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~~~ 328 (611)
.||.|...+|..+|||+.+.. . .......+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 389999999999999998641 0 1123456799999999865 456666442
Q ss_pred ecCceEEEEeeCC--CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 329 EDNNLLLVYDFLS--RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY-LHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 329 ~~~~~~LV~Ey~~--ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~y-LH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|. .||+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 4589999999 65555433321 1133445677777775555 577 899999999999999988 999
Q ss_pred EeecCcccccc
Q 007256 406 LSDFGLAKWAS 416 (611)
Q Consensus 406 L~DFGla~~~~ 416 (611)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.2e-08 Score=100.69 Aligned_cols=138 Identities=18% Similarity=0.171 Sum_probs=99.5
Q ss_pred eEeecCcEEEEEEEeCCCCEEEEEEecCCh--hHHH----------HHHHHHHHHHhcCCc--ceeEEeeEEEe-----c
Q 007256 270 LIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIK----------EFVLEIEIITTLHHK--NIISLLGFCFE-----D 330 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~----------~f~~Ei~iL~~l~Hp--nIv~l~g~~~~-----~ 330 (611)
.+-.-....|++... +|+.|.||...... ...+ .+.+|...+..+..- .+..++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344344445667655 67889999875432 1122 377999999888533 34445555543 2
Q ss_pred CceEEEEeeCCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-------CC
Q 007256 331 NNLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-------DF 402 (611)
Q Consensus 331 ~~~~LV~Ey~~gg-sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-------~~ 402 (611)
...+||||++++. +|.+++..... ...+...+..++.+++..+.-||. .||+|+|++++|||++. ++
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence 3478999999986 89988853221 234556777899999999999999 99999999999999975 46
Q ss_pred ceEEeecCccc
Q 007256 403 EPQLSDFGLAK 413 (611)
Q Consensus 403 ~vKL~DFGla~ 413 (611)
.+.|+||+.+.
T Consensus 183 ~~~LIDl~r~~ 193 (268)
T PRK15123 183 KLSVIDLHRAQ 193 (268)
T ss_pred eEEEEECCccc
Confidence 89999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=8e-08 Score=104.48 Aligned_cols=170 Identities=21% Similarity=0.290 Sum_probs=128.5
Q ss_pred CcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEE----ecCceEEEEeeCCC-CChhh
Q 007256 275 GSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF----EDNNLLLVYDFLSR-GSLEE 347 (611)
Q Consensus 275 ~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----~~~~~~LV~Ey~~g-gsL~~ 347 (611)
.-.+.||+..+ ||..|++|++...+ ........-+++++++.|.|||++.++|. .+..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34677999854 89999999995332 22223445678999999999999999886 34568999999985 47777
Q ss_pred hhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 348 NLHGNK-----------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 348 ~L~~~~-----------~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
...... ..+...++..+|.++.|+..||.++|+ .|+.-+-|.+.+||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 654322 123456788999999999999999999 889899999999999999999999888766554
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~P 466 (611)
.+... | +.. -.+-|.=.||.+++.|.||..-
T Consensus 445 ~d~~~--------------~--le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTE--------------P--LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCc--------------c--hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 43311 1 111 1256788899999999999654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.3e-08 Score=108.15 Aligned_cols=173 Identities=20% Similarity=0.258 Sum_probs=106.6
Q ss_pred CchhHHhHhhhhcCcccccCHHHHHHhhc------------CceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh---
Q 007256 235 LPKELEGLHEKYSATCRLFNYQDLLSATS------------NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--- 299 (611)
Q Consensus 235 ~~~el~~~~~~~~~~~~~f~~~el~~~t~------------~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--- 299 (611)
+|++......+..+....|++++.....+ +|. .+.|+.++-|.||+|.+++|+.||||+.++.-
T Consensus 86 ~p~e~~~eL~~LQD~vpp~~~~~~~~iie~eLG~~iee~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~ 164 (517)
T COG0661 86 VPPEYAEELAKLQDRVPPFPFEEAERIIEEELGRPIEELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRER 164 (517)
T ss_pred cCHHHHHHHHHhhcCCCCCCHHHHHHHHHHHhCCCHHHHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHH
Confidence 44444444444445555666555443322 222 26789999999999999999999999987630
Q ss_pred ----------------------------hHHHH----------HHHHHHHHHhcC-----CcceeEEeeEEEecCceEEE
Q 007256 300 ----------------------------DVIKE----------FVLEIEIITTLH-----HKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 300 ----------------------------~~~~~----------f~~Ei~iL~~l~-----HpnIv~l~g~~~~~~~~~LV 336 (611)
...++ +.+|..-+.+++ .+++.-..=|..-.+..+|+
T Consensus 165 i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLt 244 (517)
T COG0661 165 IEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLT 244 (517)
T ss_pred HHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEE
Confidence 01111 223333344332 24433333333335678999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHH-HHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA-LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~g-L~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
|||++|-.+.+....... .++... ++..++++ +..+-. .|++|.|..|.||+++.+|.+-+.|||+....
T Consensus 245 mE~i~Gi~i~d~~~l~~~---g~d~k~---ia~~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 245 MEWIDGIKISDIAALKSA---GIDRKE---LAELLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred EEeeCCEecccHHHHHhc---CCCHHH---HHHHHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 999999999887432211 233222 33333322 222222 67999999999999999999999999998765
Q ss_pred cC
Q 007256 416 ST 417 (611)
Q Consensus 416 ~~ 417 (611)
+.
T Consensus 316 ~~ 317 (517)
T COG0661 316 DP 317 (517)
T ss_pred CH
Confidence 54
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.2e-06 Score=93.36 Aligned_cols=193 Identities=18% Similarity=0.212 Sum_probs=124.6
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCChh-HHHHHHHHHHHHHhc-CCcceeEEeeE------EEec-CceEEEE
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-VIKEFVLEIEIITTL-HHKNIISLLGF------CFED-NNLLLVY 337 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~-~~~~f~~Ei~iL~~l-~HpnIv~l~g~------~~~~-~~~~LV~ 337 (611)
..+.||+|+.+.+|-.- .-...+-|++..... ...+... .|... .||-+-.=+.+ .-.. ....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45679999999999532 222235577764332 2222221 22222 34422210111 0112 2266778
Q ss_pred eeCCCC-Chhhhhc--cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 338 DFLSRG-SLEENLH--GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 338 Ey~~gg-sL~~~L~--~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
..+.|. .+..++. ...+.-....|.-.++++..++.+.+.||. .|.+-+|++++|+|+++++.+.|.|-.....
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 877765 2222222 112233457999999999999999999999 8899999999999999999999998543222
Q ss_pred ccCCCCCccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhC-CCCCCCC
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTG-RKPISND 470 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG-~~Pf~~~ 470 (611)
...+.. ....+|...|.+||.-. +-.-+...|-|.|||++|+||.| ++||.+.
T Consensus 167 ~~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 167 NANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 222211 12257899999999754 33456789999999999999986 9999753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.7e-07 Score=94.01 Aligned_cols=132 Identities=20% Similarity=0.228 Sum_probs=95.1
Q ss_pred ceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC----------h-------------hHHHHHHHHHHHHHhcCCc--c
Q 007256 265 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----------E-------------DVIKEFVLEIEIITTLHHK--N 319 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~----------~-------------~~~~~f~~Ei~iL~~l~Hp--n 319 (611)
..+.+.||-|--+.||.|..+.|.++|||.=+.. . -......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567889999999999999999999999975421 0 1123456799999999754 6
Q ss_pred eeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC
Q 007256 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 399 (611)
Q Consensus 320 Iv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd 399 (611)
+.+.+++ +.-.+||||++|-.|...-- .....-.|+..|++-+.-+-. .||||+|+.+-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 6666654 56689999999977665431 111122233333333333334 7899999999999999
Q ss_pred CCCceEEeecCcc
Q 007256 400 DDFEPQLSDFGLA 412 (611)
Q Consensus 400 ~~~~vKL~DFGla 412 (611)
++|.+.++||--+
T Consensus 237 ~dg~~~vIDwPQ~ 249 (304)
T COG0478 237 EDGDIVVIDWPQA 249 (304)
T ss_pred cCCCEEEEeCccc
Confidence 9999999999654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.49 E-value=7.3e-07 Score=88.48 Aligned_cols=123 Identities=19% Similarity=0.169 Sum_probs=90.9
Q ss_pred CCCEEEEEEecCC--h------hHHHHHHHHHHHHHhcCC--cceeEEeeEEEecC----ceEEEEeeCCCC-Chhhhhc
Q 007256 286 DGKELAVKILKPS--E------DVIKEFVLEIEIITTLHH--KNIISLLGFCFEDN----NLLLVYDFLSRG-SLEENLH 350 (611)
Q Consensus 286 ~g~~vAVK~l~~~--~------~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~~~----~~~LV~Ey~~gg-sL~~~L~ 350 (611)
.++.+-+|.+... . -......+|...+..|.. -.+.+.+++..... ..+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 4566666654321 1 123467788888888863 34556666665432 358999999985 7999887
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC---ceEEeecCccccc
Q 007256 351 GNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWA 415 (611)
Q Consensus 351 ~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~---~vKL~DFGla~~~ 415 (611)
.... .+......++.+++..+.-||. .||+|+|+++.|||++.+. .+.|+||+-++..
T Consensus 111 ~~~~----~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ----LDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc----cchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 5332 4456677899999999999999 9999999999999998887 8999999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=7e-08 Score=108.16 Aligned_cols=152 Identities=20% Similarity=0.329 Sum_probs=98.2
Q ss_pred HHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccc--c-----ccccccccCChhhhcc
Q 007256 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC--T-----DVAGTFGYLAPEYFMY 441 (611)
Q Consensus 369 ~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~--~-----~~~GT~~Y~APE~l~~ 441 (611)
.+++.||.|+|. ..++||++|.|++|.++.++.+||+.|+++.-.......... + -..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 445689999998 367999999999999999999999999987654442111110 0 0124567999999999
Q ss_pred CCCCCcceehhhhHHHHHHHhCCCC-CCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcc
Q 007256 442 GKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIR 520 (611)
Q Consensus 442 ~~~s~ksDVwSlGvvL~ELltG~~P-f~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~ 520 (611)
...+.++|+||+||++|.+..|..+ +................ +.... ....+.+. ++..-....+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~------~~~~~---~~s~~~p~----el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL------NAGAF---GYSNNLPS----ELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc------ccccc---cccccCcH----HHHHHHHHHhc
Confidence 8889999999999999999955554 43332221111111000 00000 00012222 23333344789
Q ss_pred cCCCCCCCHHHHHHH
Q 007256 521 RDPRARPQMSLVLKL 535 (611)
Q Consensus 521 ~dP~~RPtm~eVL~~ 535 (611)
.++.-||++.+++..
T Consensus 251 ~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLSI 265 (700)
T ss_pred CCcccCcchhhhhcc
Confidence 999999988877653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.6e-06 Score=83.62 Aligned_cols=136 Identities=19% Similarity=0.153 Sum_probs=101.2
Q ss_pred EeecCcEEEEEEEeCCCCEEEEEEecCC-------hhHHHHHHHHHHHHHhcCC--cceeEEeeEEEe-----cCceEEE
Q 007256 271 IGKGGSSQVYKGCLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHH--KNIISLLGFCFE-----DNNLLLV 336 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~~g~~vAVK~l~~~-------~~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~-----~~~~~LV 336 (611)
-|+||-+.|++... +|+.+-+|.-... .-....|.+|+..|..|.. -.+.++. ++.. ....+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 47799999998765 4457888876521 2245689999999999863 2344444 3321 1236899
Q ss_pred EeeCCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc--eEEeecCccc
Q 007256 337 YDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLAK 413 (611)
Q Consensus 337 ~Ey~~g-gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~--vKL~DFGla~ 413 (611)
+|-++| -+|.+++..... ...+...+..++.+++..+.-||+ .|+.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998864 388888755332 235667788999999999999999 99999999999999986666 9999997654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.40 E-value=4e-06 Score=84.55 Aligned_cols=138 Identities=17% Similarity=0.245 Sum_probs=86.3
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc--eeEEeeEEEecCceEEEEeeCCCCC-h
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLSRGS-L 345 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~l~g~~~~~~~~~LV~Ey~~ggs-L 345 (611)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56899999999984 35568889887533 3345688999999987433 4677777777777899999999963 2
Q ss_pred hhh---------------------hccCCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHhc-CCCCcEEeecc
Q 007256 346 EEN---------------------LHGNKKDPAAFGWSERY-KVAM----------GVAE-ALEYLHS-GSAQRVIHRDV 391 (611)
Q Consensus 346 ~~~---------------------L~~~~~~~~~l~~~~~~-~I~~----------qIa~-gL~yLH~-~~~~gIiHrDI 391 (611)
... +|..... ........ .+.. .+.. ...+|.. .....++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 111 1211000 11111100 0000 0011 1222221 12246799999
Q ss_pred CccceeeCCCCceEEeecCccc
Q 007256 392 KSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 392 Kp~NILLd~~~~vKL~DFGla~ 413 (611)
.|.||++++++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.2e-06 Score=95.77 Aligned_cols=171 Identities=21% Similarity=0.283 Sum_probs=108.3
Q ss_pred CchhHHhHhhhhcCcccccCHHHHHHhhcC---------c--eeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC-----
Q 007256 235 LPKELEGLHEKYSATCRLFNYQDLLSATSN---------F--LAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----- 298 (611)
Q Consensus 235 ~~~el~~~~~~~~~~~~~f~~~el~~~t~~---------f--~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~----- 298 (611)
+|++.-.......+.+..|+++|+...-+. | -..+.||.-..|.||+|.+++|+.||||+-++.
T Consensus 122 lP~Eyv~~L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~ 201 (538)
T KOG1235|consen 122 LPKEYVKTLSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLI 201 (538)
T ss_pred CcHHHHHHHHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHH
Confidence 566655555566667777887776654331 1 123679999999999999999999999998763
Q ss_pred ---------------------------hhHHHH------HHHHHHHH----HhcCCcc------eeEEeeEEEecCceEE
Q 007256 299 ---------------------------EDVIKE------FVLEIEII----TTLHHKN------IISLLGFCFEDNNLLL 335 (611)
Q Consensus 299 ---------------------------~~~~~~------f~~Ei~iL----~~l~Hpn------Iv~l~g~~~~~~~~~L 335 (611)
++..+. |.+|.+-. +.+.|-+ |.+++-. -....+|
T Consensus 202 ~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVL 279 (538)
T KOG1235|consen 202 MLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVL 279 (538)
T ss_pred HHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEE
Confidence 011112 22333322 2233444 3333322 2347899
Q ss_pred EEeeCCCCChhhhh--ccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC----CCCceEEeec
Q 007256 336 VYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS----DDFEPQLSDF 409 (611)
Q Consensus 336 V~Ey~~ggsL~~~L--~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd----~~~~vKL~DF 409 (611)
+||||+|..+.+.- ...+ ++... |+..+.++ |++.-...|++|+|-.|.||++. .++.+.+-||
T Consensus 280 tME~~~G~~i~Dl~~i~~~g-----i~~~~---i~~~l~~~--~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDh 349 (538)
T KOG1235|consen 280 TMEYVDGIKINDLDAIDKRG-----ISPHD---ILNKLVEA--YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDH 349 (538)
T ss_pred EEEecCCccCCCHHHHHHcC-----CCHHH---HHHHHHHH--HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcc
Confidence 99999999887753 3332 33333 33333332 22222126799999999999998 3678999999
Q ss_pred CccccccC
Q 007256 410 GLAKWAST 417 (611)
Q Consensus 410 Gla~~~~~ 417 (611)
|+......
T Consensus 350 Gl~~~is~ 357 (538)
T KOG1235|consen 350 GLYAVISH 357 (538)
T ss_pred cccccccH
Confidence 99876654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.6e-06 Score=82.26 Aligned_cols=144 Identities=21% Similarity=0.269 Sum_probs=86.9
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc--ceeEEeeEEEe---cCceEEEEeeCCC
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFE---DNNLLLVYDFLSR 342 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~~~~---~~~~~LV~Ey~~g 342 (611)
++.|+.|..+.||+....+ ..+++|+.... .....+..|..++..+... .+.+++.++.. ....+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4679999999999998877 69999998765 5667788899998888633 34566664432 2346899999999
Q ss_pred CChhh----------------hh---ccCCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHhc-
Q 007256 343 GSLEE----------------NL---HGNKKDPAAFGWSER---------YKV------------AMGVAE-ALEYLHS- 380 (611)
Q Consensus 343 gsL~~----------------~L---~~~~~~~~~l~~~~~---------~~I------------~~qIa~-gL~yLH~- 380 (611)
..+.. .+ +........+.+... ... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 11 111101111111110 000 111222 2333332
Q ss_pred ---CCCCcEEeeccCccceeeC-CCCceEEeecCccc
Q 007256 381 ---GSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAK 413 (611)
Q Consensus 381 ---~~~~gIiHrDIKp~NILLd-~~~~vKL~DFGla~ 413 (611)
.....++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2346799999999999999 56666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.6e-06 Score=82.65 Aligned_cols=136 Identities=15% Similarity=0.160 Sum_probs=91.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHH----------HHHHHHHHHhcCC---cceeEEeeEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKE----------FVLEIEIITTLHH---KNIISLLGFC 327 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~----------f~~Ei~iL~~l~H---pnIv~l~g~~ 327 (611)
..++|...+++-......|.+-.. +|+.+++|..+......++ ..+++..+..++. -....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346888889998888888887655 6788999998753221111 1223333333332 2222222222
Q ss_pred -----EecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC
Q 007256 328 -----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402 (611)
Q Consensus 328 -----~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~ 402 (611)
......+|+|||++|..|.+... +.. .++..+.+++.-||+ .|++|+|..|+|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-
Confidence 22345679999999988876542 111 245567788999999 999999999999999865
Q ss_pred ceEEeecCccc
Q 007256 403 EPQLSDFGLAK 413 (611)
Q Consensus 403 ~vKL~DFGla~ 413 (611)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 59999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.1e-07 Score=103.42 Aligned_cols=183 Identities=22% Similarity=0.198 Sum_probs=136.6
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc-eeEEeeEEEecCceEEEEeeCCCC-Chh
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYDFLSRG-SLE 346 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~~~LV~Ey~~gg-sL~ 346 (611)
.-+++|+.+.+||.+..-.+....+.+... ....-++++|.+++||| .+..++-+..+...+++++++.++ +..
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 446899999999987554555556666543 34556899999999999 777788887788899999999887 222
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccccc
Q 007256 347 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 426 (611)
Q Consensus 347 ~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~ 426 (611)
..... ....+..-+...+...-+++|+|||+ ..-+|+| ||+..+ +..+..||+....+.... ....
T Consensus 324 ~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t 389 (829)
T KOG0576|consen 324 LEMTV---SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRT 389 (829)
T ss_pred ccCCh---hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cccc
Confidence 21111 11224444455667777889999998 3348888 888776 588999999987666543 2334
Q ss_pred cccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCC
Q 007256 427 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 469 (611)
Q Consensus 427 ~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 469 (611)
..+|+.++|||+...+.+..+.|+|++|+--.+|--|-+|-..
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 7899999999999999999999999999988888888777544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.9e-05 Score=79.89 Aligned_cols=151 Identities=24% Similarity=0.252 Sum_probs=98.4
Q ss_pred CHHHHHHhhcCceeeee---EeecCcEEEEEEEeCCCCEEEEEEecCChhH--------------------H-----HHH
Q 007256 254 NYQDLLSATSNFLAENL---IGKGGSSQVYKGCLPDGKELAVKILKPSEDV--------------------I-----KEF 305 (611)
Q Consensus 254 ~~~el~~~t~~f~~~~~---LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~--------------------~-----~~f 305 (611)
+...+....+...+..+ |..|--+.||+|...++..+|||+++.+... . .-.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 44555555555555544 5578888999999888999999999753111 0 112
Q ss_pred HHHHHHHHhcC--CcceeEEeeEEEecCceEEEEeeCCCCCh-hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 007256 306 VLEIEIITTLH--HKNIISLLGFCFEDNNLLLVYDFLSRGSL-EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382 (611)
Q Consensus 306 ~~Ei~iL~~l~--HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL-~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 382 (611)
..|+.-|+++. +-.+.+.+++. .-.|||||+....+ .-.|... .+...+...+..++++.+.-|-..
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-----~~e~~e~~~~~~~~v~~~~~l~~~- 185 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-----PLELEEAEGLYEDVVEYMRRLYKE- 185 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC-----CcCchhHHHHHHHHHHHHHHHHHh-
Confidence 34666677764 34455555554 45899999976411 1111111 122224556666777776666542
Q ss_pred CCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 383 ~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
.++||+||..-|||+. ++.+.|+|||-|....
T Consensus 186 -a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 -AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 5799999999999999 7899999999886444
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.9e-05 Score=79.86 Aligned_cols=140 Identities=19% Similarity=0.159 Sum_probs=85.7
Q ss_pred EeecCc-EEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeeCCCCChhhh
Q 007256 271 IGKGGS-SQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEEN 348 (611)
Q Consensus 271 LG~G~f-G~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~ 348 (611)
|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++...++..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444555 888998664 4788899886543 345678999988885 34466777777666678999999999877643
Q ss_pred h-------------------ccCCCCCCCCC--HHHHHHHHH--------------------HHHHHHHHHhc----CCC
Q 007256 349 L-------------------HGNKKDPAAFG--WSERYKVAM--------------------GVAEALEYLHS----GSA 383 (611)
Q Consensus 349 L-------------------~~~~~~~~~l~--~~~~~~I~~--------------------qIa~gL~yLH~----~~~ 383 (611)
. |........+. ......... .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11111010111 000000000 01111222211 112
Q ss_pred CcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 384 ~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 568999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.05 E-value=2.1e-05 Score=77.21 Aligned_cols=105 Identities=25% Similarity=0.266 Sum_probs=83.5
Q ss_pred HHHHHHHHhcCC-cceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 007256 306 VLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384 (611)
Q Consensus 306 ~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~ 384 (611)
..|.-+++.+.+ +++.+++|+| ..++|.||...+++...... -..-...+|..|.+|+.++++.+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888999986 6999999999 34789999998776532100 00112368999999999999999999987656
Q ss_pred cEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 385 gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
.+.-.|++++|+-+++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6888999999999999999999999876433
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.03 E-value=4.1e-05 Score=76.81 Aligned_cols=142 Identities=20% Similarity=0.235 Sum_probs=83.3
Q ss_pred eeeEeecCcEEEEEEEeCC--CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEeeCCCCC
Q 007256 268 ENLIGKGGSSQVYKGCLPD--GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGS 344 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~--g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~LV~Ey~~ggs 344 (611)
.+.|..|-...+|+....+ ++.|++|+........-...+|+.++..+...++ .++++.+. -.+||||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 3567888889999987664 6789999876543222233478888888864333 34444332 248999999976
Q ss_pred hhhh-----------------hccCCCCC--------CCCCHHHHHHHHH----------------------HHH---HH
Q 007256 345 LEEN-----------------LHGNKKDP--------AAFGWSERYKVAM----------------------GVA---EA 374 (611)
Q Consensus 345 L~~~-----------------L~~~~~~~--------~~l~~~~~~~I~~----------------------qIa---~g 374 (611)
+... +|...... ....|..+..+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6321 11111110 1111222212111 111 11
Q ss_pred H-HHHhcC-CCCcEEeeccCccceeeCC-CCceEEeecCccc
Q 007256 375 L-EYLHSG-SAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 413 (611)
Q Consensus 375 L-~yLH~~-~~~gIiHrDIKp~NILLd~-~~~vKL~DFGla~ 413 (611)
| ..+-.. ....++|+|+.+.|||++. ++.+.|+||..|.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1 111111 2357999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00012 Score=72.48 Aligned_cols=127 Identities=24% Similarity=0.397 Sum_probs=93.9
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCCh-----------------hHHHHHHHHHHHHHhcC------CcceeEEe
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----------------DVIKEFVLEIEIITTLH------HKNIISLL 324 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~-----------------~~~~~f~~Ei~iL~~l~------HpnIv~l~ 324 (611)
...||+|+.=.||. +++.....||+..... ...+++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35689999999994 6777788999987654 33567778887777666 78999999
Q ss_pred eEEEecCceEEEEeeCCCC------ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 325 GFCFEDNNLLLVYDFLSRG------SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 325 g~~~~~~~~~LV~Ey~~gg------sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
|+...+-...+|+|.+.+. +|.+++.... ++. ...+.+. +-..||-. ..|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQALD---EFKRYLLD---HHIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHHHH---HHHHHHHH---cCCeecCCCcccEEE
Confidence 9999999999999987532 6777774332 443 3333333 34556666 779999999999999
Q ss_pred CCC---C-ceEEee
Q 007256 399 SDD---F-EPQLSD 408 (611)
Q Consensus 399 d~~---~-~vKL~D 408 (611)
... . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 532 2 577887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.96 E-value=9.5e-05 Score=88.13 Aligned_cols=148 Identities=15% Similarity=0.302 Sum_probs=92.5
Q ss_pred eeeEeecCcEEEEEEEeCCC---CEEEEEEecCCh--hHHHHHHHHHHHHHhcC-Ccce--eEEeeEEEec---CceEEE
Q 007256 268 ENLIGKGGSSQVYKGCLPDG---KELAVKILKPSE--DVIKEFVLEIEIITTLH-HKNI--ISLLGFCFED---NNLLLV 336 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g---~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~-HpnI--v~l~g~~~~~---~~~~LV 336 (611)
.+.|+.|.++.+|+....++ ..+++|+..... .....+.+|+++|+.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 57789999999999876554 467888765432 22356789999999996 6654 7788887654 467899
Q ss_pred EeeCCCCChhhh-----------------------hccCCCCC-------CCCCH--HHHHHHH---------------H
Q 007256 337 YDFLSRGSLEEN-----------------------LHGNKKDP-------AAFGW--SERYKVA---------------M 369 (611)
Q Consensus 337 ~Ey~~ggsL~~~-----------------------L~~~~~~~-------~~l~~--~~~~~I~---------------~ 369 (611)
|||++|..+.+. ||...... .+..+ ..+..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999998653221 12111000 00111 0111110 1
Q ss_pred HHHHHHHHHhcCCC--------CcEEeeccCccceeeCCC-Cc-eEEeecCccccc
Q 007256 370 GVAEALEYLHSGSA--------QRVIHRDVKSSNILLSDD-FE-PQLSDFGLAKWA 415 (611)
Q Consensus 370 qIa~gL~yLH~~~~--------~gIiHrDIKp~NILLd~~-~~-vKL~DFGla~~~ 415 (611)
.+...+.+|..+-+ ..+||+|+++.|||++.+ +. .-|.||+++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344567744221 359999999999999853 33 569999987644
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=5.7e-05 Score=76.16 Aligned_cols=73 Identities=15% Similarity=0.219 Sum_probs=47.5
Q ss_pred eeEeecCcE-EEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc---ceeEEeeEEEec---CceEEEEeeCC
Q 007256 269 NLIGKGGSS-QVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCFED---NNLLLVYDFLS 341 (611)
Q Consensus 269 ~~LG~G~fG-~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hp---nIv~l~g~~~~~---~~~~LV~Ey~~ 341 (611)
+.|+.||.. .||+. +..+++|+... ......+.+|.+++..+... .+.++++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 567777776 58975 34578887664 23345788899999887632 334444443322 23488999999
Q ss_pred CCChh
Q 007256 342 RGSLE 346 (611)
Q Consensus 342 ggsL~ 346 (611)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=7.1e-05 Score=72.15 Aligned_cols=130 Identities=21% Similarity=0.268 Sum_probs=90.0
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChh
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
+.+.||+|.+|.||+|.+. |..+|+|+-+. +.....+..|+++|..+.-.++.+=+-++- .-++.|||+.|-.|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcchh
Confidence 4567999999999999874 45889998764 344567889999999998766654332221 234559999998887
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCc-cceeeCCCCceEEeecCccccc
Q 007256 347 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS-SNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 347 ~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp-~NILLd~~~~vKL~DFGla~~~ 415 (611)
+.-.... .+-+..+++.-.-|.. .||-|+.|.- ..++|.++..+.|+||.-|...
T Consensus 101 ~~~~~~~-----------rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 101 KLEIGGD-----------RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhccc-----------HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 7654321 1233446666455555 8899998864 4444444559999999988643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00021 Score=70.63 Aligned_cols=124 Identities=22% Similarity=0.333 Sum_probs=90.8
Q ss_pred cCceeeeeEeecCc-EEEEEEEeCCCCEEEEEEecC---C------------h-------hHHHHHHHHHHHHHhcC---
Q 007256 263 SNFLAENLIGKGGS-SQVYKGCLPDGKELAVKILKP---S------------E-------DVIKEFVLEIEIITTLH--- 316 (611)
Q Consensus 263 ~~f~~~~~LG~G~f-G~Vyk~~~~~g~~vAVK~l~~---~------------~-------~~~~~f~~Ei~iL~~l~--- 316 (611)
.+++..+.||.|.. |.||++.. +|+.||+|+++. . . ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 99999988 677999999431 0 0 12345788888877775
Q ss_pred Ccce--eEEeeEEEec------------------CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 007256 317 HKNI--ISLLGFCFED------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376 (611)
Q Consensus 317 HpnI--v~l~g~~~~~------------------~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~ 376 (611)
+.++ |+.+||..-. ..+.||.||++... .+... -+.+|.+-+.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHHH
Confidence 4456 8999987422 12467888876643 12222 3455667778
Q ss_pred HHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 377 yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.+|. .||+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 8999 99999999999987 4589999854
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00011 Score=75.16 Aligned_cols=137 Identities=14% Similarity=0.172 Sum_probs=79.6
Q ss_pred EeecCcEEEEEEEeCCCCEEEEEEecCChhHH-HHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEeeCCCCChhhh
Q 007256 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVI-KEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSLEEN 348 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~-~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~LV~Ey~~ggsL~~~ 348 (611)
+..|-.+.+|+.. .+|..+++|+........ -...+|.++++.+....+ .+++..+ .-++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcccccc
Confidence 4567788999876 467789999866433221 235779999998864333 3334332 13789999998765421
Q ss_pred -----------------hccCCCCCCCCCHHHH-HHHHHHH---------HHHHHHHhcC-----CCCcEEeeccCccce
Q 007256 349 -----------------LHGNKKDPAAFGWSER-YKVAMGV---------AEALEYLHSG-----SAQRVIHRDVKSSNI 396 (611)
Q Consensus 349 -----------------L~~~~~~~~~l~~~~~-~~I~~qI---------a~gL~yLH~~-----~~~gIiHrDIKp~NI 396 (611)
+|........++.... ..+..++ ...+..+-.. ....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 2222111112222211 1111111 1112222111 124689999999999
Q ss_pred eeCCCCceEEeecCccc
Q 007256 397 LLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 397 LLd~~~~vKL~DFGla~ 413 (611)
++++++ +.|+||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899998774
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00013 Score=76.33 Aligned_cols=142 Identities=24% Similarity=0.330 Sum_probs=86.4
Q ss_pred eeeEeecCcEEEEEEEeCC-------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEee
Q 007256 268 ENLIGKGGSSQVYKGCLPD-------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~-------g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~LV~Ey 339 (611)
++.|..|-...+|+....+ ++.+++|+............+|.+++..+...++ .++++++. + .+|+||
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 3556777788999987655 5889999987654444456788888888864333 34455443 2 368999
Q ss_pred CCCCChhhh-----------------hccCCCCC-------CCCCHHHHHH--------------------------HHH
Q 007256 340 LSRGSLEEN-----------------LHGNKKDP-------AAFGWSERYK--------------------------VAM 369 (611)
Q Consensus 340 ~~ggsL~~~-----------------L~~~~~~~-------~~l~~~~~~~--------------------------I~~ 369 (611)
++|..+... +|...... ...-|..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776431 12111110 0011111111 111
Q ss_pred HHHHHHHHHhc------CCCCcEEeeccCccceeeCCC----CceEEeecCccc
Q 007256 370 GVAEALEYLHS------GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAK 413 (611)
Q Consensus 370 qIa~gL~yLH~------~~~~gIiHrDIKp~NILLd~~----~~vKL~DFGla~ 413 (611)
.+...+.+|-. .....++|+|+.+.|||++++ +.+.|+||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222334432 234689999999999999985 789999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00046 Score=72.47 Aligned_cols=77 Identities=10% Similarity=0.013 Sum_probs=57.9
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC---cceeEEeeEEEe---cCceEEEEeeC
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH---KNIISLLGFCFE---DNNLLLVYDFL 340 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H---pnIv~l~g~~~~---~~~~~LV~Ey~ 340 (611)
-.+.||.|..+.||+....+++ +++|..+. ......|..|.+.|+.+.. -.+.+++++|.. .+..+||||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 3467999999999998765664 77787543 2233578899999998863 367888888754 35689999999
Q ss_pred CCCCh
Q 007256 341 SRGSL 345 (611)
Q Consensus 341 ~ggsL 345 (611)
+|+++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00017 Score=74.98 Aligned_cols=143 Identities=16% Similarity=0.180 Sum_probs=86.5
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc--ceeEEeeE------EEecCceEEEEee
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF------CFEDNNLLLVYDF 339 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~------~~~~~~~~LV~Ey 339 (611)
.+.|..|....+|+....+ ..+++|+... ........|++++..+.+. .+.+++.. ...++..++||+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 4567888889999986544 4688998875 2345566788888877532 24444431 2234567899999
Q ss_pred CCCCChhh--------------hhccCCC---C----CCCCCHHHHH----------HHHHHHHHHHHHHhc----CCCC
Q 007256 340 LSRGSLEE--------------NLHGNKK---D----PAAFGWSERY----------KVAMGVAEALEYLHS----GSAQ 384 (611)
Q Consensus 340 ~~ggsL~~--------------~L~~~~~---~----~~~l~~~~~~----------~I~~qIa~gL~yLH~----~~~~ 384 (611)
++|..+.. .+|.... . .....|.... .....+..++.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99976532 0111100 0 0111222211 011113334444443 1235
Q ss_pred cEEeeccCccceeeCCCCceEEeecCccc
Q 007256 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 385 gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
+++|+|+.|.|||++++..+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999998777899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00082 Score=73.35 Aligned_cols=75 Identities=19% Similarity=0.233 Sum_probs=56.0
Q ss_pred eeeEeecCcEEEEEEEeCCC-CEEEEEEecCC--------hhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEE
Q 007256 268 ENLIGKGGSSQVYKGCLPDG-KELAVKILKPS--------EDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g-~~vAVK~l~~~--------~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~~~~L 335 (611)
.+.||.|.+..||++...+| +.++||.-.+. ....+++..|.+.|..+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 36789999999999998877 58999985421 224567778888888864 2456777766 4456789
Q ss_pred EEeeCCCCC
Q 007256 336 VYDFLSRGS 344 (611)
Q Consensus 336 V~Ey~~ggs 344 (611)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998754
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0013 Score=69.14 Aligned_cols=142 Identities=18% Similarity=0.220 Sum_probs=77.3
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc--ceeEEee------EEEecCceEEEEeeC
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLG------FCFEDNNLLLVYDFL 340 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g------~~~~~~~~~LV~Ey~ 340 (611)
+.|+.|....+|+....+| .+++|++.. ...+....|+.++..|... .+.+.+. +....+..+++++|+
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 4567788889999876555 688998762 1223334455555555321 1233332 122355679999999
Q ss_pred CCCChhh-----------h---hccCCCC-------CCCC-CHHHHHH------------HH-HHHHHHHHHHhcC----
Q 007256 341 SRGSLEE-----------N---LHGNKKD-------PAAF-GWSERYK------------VA-MGVAEALEYLHSG---- 381 (611)
Q Consensus 341 ~ggsL~~-----------~---L~~~~~~-------~~~l-~~~~~~~------------I~-~qIa~gL~yLH~~---- 381 (611)
+|..+.. . +|..... ...+ .|..... .+ ..+...+..+...
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 9975421 1 1111100 0011 1211111 11 1111222333211
Q ss_pred CCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 382 ~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
-+.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23689999999999999976556799998763
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.002 Score=67.67 Aligned_cols=144 Identities=17% Similarity=0.196 Sum_probs=83.3
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc--ceeEEeeE------EEecCceEEEEe
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF------CFEDNNLLLVYD 338 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~------~~~~~~~~LV~E 338 (611)
..+.++.|....+|+....+| .+++|+..... .......|++++..|... .+.+++.. ...++..+++++
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred eccccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 356677888889999876555 57889876531 123445667777776422 23444331 112456789999
Q ss_pred eCCCCChhh--------------hhccCCCC---C--C---CCCHHHHHH------------HHHHHHHHHHHHhc----
Q 007256 339 FLSRGSLEE--------------NLHGNKKD---P--A---AFGWSERYK------------VAMGVAEALEYLHS---- 380 (611)
Q Consensus 339 y~~ggsL~~--------------~L~~~~~~---~--~---~l~~~~~~~------------I~~qIa~gL~yLH~---- 380 (611)
|++|..+.. .+|..... + . .-.|..... ....+...++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 11211110 0 0 012221110 01123334555542
Q ss_pred CCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 381 ~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
..+.+++|+|+.+.||+++.++.+.|+||+.+
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 23478999999999999998877789999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00029 Score=73.80 Aligned_cols=145 Identities=21% Similarity=0.237 Sum_probs=98.9
Q ss_pred ccCHHHHHHhhc---CceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC----------hhH-------------HHHH
Q 007256 252 LFNYQDLLSATS---NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS----------EDV-------------IKEF 305 (611)
Q Consensus 252 ~f~~~el~~~t~---~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~----------~~~-------------~~~f 305 (611)
-+.|--|....+ -+.+.+.||-|.-+-||.+-+..|++.++|+-+.. .+. .-..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 344444444333 36788999999999999999999999999974321 100 1124
Q ss_pred HHHHHHHHhcCC--cceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 007256 306 VLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383 (611)
Q Consensus 306 ~~Ei~iL~~l~H--pnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~ 383 (611)
.+|...|+.|.. --+.+.+++ +.-++|||++.|..|...-+- .+...++.-+.+ -+.-|-.
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~---~Iv~la~--- 220 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMG---LIVRLAN--- 220 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CChHHHHHHHHH---HHHHHHH---
Confidence 467778887753 234444544 466899999999888765432 122333333333 3445555
Q ss_pred CcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 384 ~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
+|+||+|..-=||++++++.++++||--..
T Consensus 221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cCceecccchheeEEecCCCEEEeechHhh
Confidence 899999999999999999999999996543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0014 Score=78.16 Aligned_cols=195 Identities=18% Similarity=0.178 Sum_probs=128.3
Q ss_pred HHHHHHHHhcCCcceeEEeeEEEecCceE----EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 007256 306 VLEIEIITTLHHKNIISLLGFCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381 (611)
Q Consensus 306 ~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~----LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 381 (611)
.-|++.+.+..|+|++.++.|..+....- +..+++...++...+.... ..+....+.+..++.+||.|+|.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~----~i~~~~~r~~~~~~~~GL~~~h~- 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG----SIPLETLRILHQKLLEGLAYLHS- 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc----ccCHHHHHHHHHHHhhhHHHHHH-
Confidence 34667788889999999999987654333 3457788888888776544 46778888899999999999998
Q ss_pred CCCcEEeeccCcc---ceeeCCCCceEEe--ecCccccccCCCCCccccccccccccCChhhhccCCCCCc--ceehhhh
Q 007256 382 SAQRVIHRDVKSS---NILLSDDFEPQLS--DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK--IDVYAFG 454 (611)
Q Consensus 382 ~~~gIiHrDIKp~---NILLd~~~~vKL~--DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~k--sDVwSlG 454 (611)
....|.-+..+ +--.+..+...++ ||+..+.+........ ..-+..+.+||......+..+ .|+|.+|
T Consensus 305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred --hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHH
Confidence 43444444333 3334555666666 8888776654332221 234556788887776655544 7999999
Q ss_pred HHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 455 VVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 455 vvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..+..+..|..+-..... ...+++..... .+......|+..++++|+++.+++.
T Consensus 380 ll~~~~~~~~~i~~~~~~------------------~~~~l~~~~~~--------~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV------------------PVSLLDVLSTS--------ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCcccccccc------------------hhhhhccccch--------hhhhhhhhhcchhhhhccchhhhhh
Confidence 999999988665322110 01111111100 1223334599999999999999987
Q ss_pred Hh
Q 007256 535 LL 536 (611)
Q Consensus 535 ~L 536 (611)
+.
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 54
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0037 Score=67.09 Aligned_cols=143 Identities=15% Similarity=0.223 Sum_probs=84.2
Q ss_pred eeeeEeecCcEEEEEEEeCC-----CCEEEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEEEeeC
Q 007256 267 AENLIGKGGSSQVYKGCLPD-----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv-~l~g~~~~~~~~~LV~Ey~ 340 (611)
....|-.|-...+|+....+ ++.|++|+........-.-.+|..+++.+..-++. ++++++.. . .|++|+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi 115 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI 115 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence 34456668889999986432 36899998875432222336789998888644433 44555532 2 589999
Q ss_pred CCCChhhh-----------------hccCCCC--CCCCCHHHHHHHHHHH-----------------HHHHHHH----hc
Q 007256 341 SRGSLEEN-----------------LHGNKKD--PAAFGWSERYKVAMGV-----------------AEALEYL----HS 380 (611)
Q Consensus 341 ~ggsL~~~-----------------L~~~~~~--~~~l~~~~~~~I~~qI-----------------a~gL~yL----H~ 380 (611)
++.+|... +|..... .....|..+.++..++ ...+..| ..
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 88776421 2221110 1112233333332211 1112222 21
Q ss_pred -CCCCcEEeeccCccceeeCC-CCceEEeecCccc
Q 007256 381 -GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAK 413 (611)
Q Consensus 381 -~~~~gIiHrDIKp~NILLd~-~~~vKL~DFGla~ 413 (611)
.....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22357899999999999986 4679999998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0087 Score=62.23 Aligned_cols=70 Identities=17% Similarity=0.106 Sum_probs=42.7
Q ss_pred EeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--cc-eeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KN-IISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H--pn-Iv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
.++|....||.....+|..+++|.-+ .......+.+|.++|+.+.. +- +.+++.. ..-+++|+++.|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~-~~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~----~~~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPR-RPDVSERAAAEKRVLALVRKHLPVQVPDWRVH----TPELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecC-CHHHHHHHHHHHHHHHHHHhcCCCCCCceeee----cCceEEEeccCCCcc
Confidence 34555556666555578899999876 33445678899999998863 21 1222211 123567777777544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0064 Score=64.99 Aligned_cols=138 Identities=24% Similarity=0.308 Sum_probs=95.0
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCC--------------------------hhHHH-HHHHHHHHHHhcCCcc
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPS--------------------------EDVIK-EFVLEIEIITTLHHKN 319 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~--------------------------~~~~~-~f~~Ei~iL~~l~Hpn 319 (611)
+...|..|--+.||.+...+|..+|||+++.+ ...++ -...|++-|++++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 44568889999999999999999999998742 01111 2345888888887544
Q ss_pred eeEEeeEEEecCceEEEEeeCCCCChh-hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 320 IISLLGFCFEDNNLLLVYDFLSRGSLE-ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 320 Iv~l~g~~~~~~~~~LV~Ey~~ggsL~-~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
|.-.--.... .-+|||+|+.+.... -.|. ...++...+..+-.+++.-+.-|.+.| ++||.||.--|+|+
T Consensus 228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCceeee--cceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 4322222222 347999999642111 1111 234666778888888888888888754 59999999999998
Q ss_pred CCCCceEEeecCcccc
Q 007256 399 SDDFEPQLSDFGLAKW 414 (611)
Q Consensus 399 d~~~~vKL~DFGla~~ 414 (611)
.+ |.+.|+|-+-+..
T Consensus 299 hd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVE 313 (520)
T ss_pred EC-CEEEEEEcccccc
Confidence 65 5899999887643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.00021 Score=86.49 Aligned_cols=162 Identities=11% Similarity=-0.034 Sum_probs=118.1
Q ss_pred HHHHHHHHHHhcCCcceeEEeeEEE--ecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-
Q 007256 304 EFVLEIEIITTLHHKNIISLLGFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS- 380 (611)
Q Consensus 304 ~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~- 380 (611)
-...|.+.++...|+++.....-.. +..+.+.+++|+.+|.+...|-+.......+...-......+...+..-+|.
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3445666667778998877665443 2446789999999999999886554443344444444333443445555554
Q ss_pred -CCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHH
Q 007256 381 -GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 459 (611)
Q Consensus 381 -~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~E 459 (611)
+...-.+|+++|+-|.+|..+..+|+.++|+.+....... ..+...+++.|++|++...-+++.++|+|..|+-+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 2235579999999999999999999999999984333222 2234678889999999998899999999999999999
Q ss_pred HHhCCCCC
Q 007256 460 LLTGRKPI 467 (611)
Q Consensus 460 LltG~~Pf 467 (611)
+..|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 99888876
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.007 Score=64.56 Aligned_cols=141 Identities=19% Similarity=0.289 Sum_probs=81.4
Q ss_pred eeeEeecCcEEEEEEEeCC----CCEEEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEEEeeCCC
Q 007256 268 ENLIGKGGSSQVYKGCLPD----GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv-~l~g~~~~~~~~~LV~Ey~~g 342 (611)
.+.|..|-...+|+....+ +..|++|+........-.-.+|..+++.+..-++. ++++++. +. +|.+|++|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 3455558888899886543 34799998875433333345788999888755543 4555552 22 58999987
Q ss_pred CChhh-----------------hhccCCCC--CCCCCHHHHHHHHHHH----------------------HHHHHHH---
Q 007256 343 GSLEE-----------------NLHGNKKD--PAAFGWSERYKVAMGV----------------------AEALEYL--- 378 (611)
Q Consensus 343 gsL~~-----------------~L~~~~~~--~~~l~~~~~~~I~~qI----------------------a~gL~yL--- 378 (611)
..|.. .+|..... ...-.|..+.++..++ ..-+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 76532 11221110 1111233333332221 1111111
Q ss_pred h-c-CCCCcEEeeccCccceeeCC-CCceEEeecCcc
Q 007256 379 H-S-GSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLA 412 (611)
Q Consensus 379 H-~-~~~~gIiHrDIKp~NILLd~-~~~vKL~DFGla 412 (611)
. . ....-++|.|+.+.|||+++ ++.++++||..|
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 1 1 11234799999999999975 568999999876
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.018 Score=60.35 Aligned_cols=74 Identities=22% Similarity=0.287 Sum_probs=49.4
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
-.+.|+.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+++++....+..+|||||++.+
T Consensus 21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeEecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 34678989999999976 678899999887 333456778888888884 456778888887777889999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.026 Score=59.87 Aligned_cols=148 Identities=16% Similarity=0.268 Sum_probs=83.1
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCC--cceeEEeeEEEecC--ceEEEEee
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDN--NLLLVYDF 339 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~~~--~~~LV~Ey 339 (611)
+.+.+-.|....+|..... ++.+++. ... .-.......+|+.+|+.+.- --+...++.|.++. ..+.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3444444444445554443 7888888 332 11334556678888888753 33445567776665 67999999
Q ss_pred CCCCChhhhhccCCC---------------------CC-------------CCCCHHHHHHHH--------HHHHHHHHH
Q 007256 340 LSRGSLEENLHGNKK---------------------DP-------------AAFGWSERYKVA--------MGVAEALEY 377 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~---------------------~~-------------~~l~~~~~~~I~--------~qIa~gL~y 377 (611)
++|..+...+..... .. ....|...+..+ -....-..+
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 999533332211100 00 000111111000 011122334
Q ss_pred HhcC-----CCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 378 LHSG-----SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 378 LH~~-----~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|+.+ ....++|+|+.+.||+++.+.-+=|.||+++....
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 4431 12468999999999999998889999999886443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.0032 Score=62.35 Aligned_cols=123 Identities=23% Similarity=0.250 Sum_probs=62.5
Q ss_pred CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEeeCCCCChhhh-h---------------
Q 007256 287 GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGSLEEN-L--------------- 349 (611)
Q Consensus 287 g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~LV~Ey~~ggsL~~~-L--------------- 349 (611)
++.|+|++........-.-..|..+++.+..-++ .++++++.. .+|++|++|..|... +
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~ 77 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLAK 77 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHHH
Confidence 4678999988765555666789999988875444 445555422 367799977664321 1
Q ss_pred -ccCC---CCCCCCCHHHHHHH----------------------HHHHHHHHHHHhc-----CCCCcEEeeccCccceee
Q 007256 350 -HGNK---KDPAAFGWSERYKV----------------------AMGVAEALEYLHS-----GSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 350 -~~~~---~~~~~l~~~~~~~I----------------------~~qIa~gL~yLH~-----~~~~gIiHrDIKp~NILL 398 (611)
|... .....-.|.....+ +..+..-+..+.+ .....++|+|+.+.|||+
T Consensus 78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~ 157 (211)
T PF01633_consen 78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI 157 (211)
T ss_dssp HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence 1100 01111112222222 0111111222211 112468999999999999
Q ss_pred -CCCCceEEeecCccc
Q 007256 399 -SDDFEPQLSDFGLAK 413 (611)
Q Consensus 399 -d~~~~vKL~DFGla~ 413 (611)
+.++.++|+||..|.
T Consensus 158 ~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 158 NNKDGEVKLIDFEYAG 173 (211)
T ss_dssp TSSSSCEEE--GTT-E
T ss_pred ccCCCeEEEecHHHHh
Confidence 888999999998774
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.039 Score=57.54 Aligned_cols=28 Identities=36% Similarity=0.453 Sum_probs=25.0
Q ss_pred CcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 384 ~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.+++|+|+.+.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 68999999999999987 57899999865
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.021 Score=61.46 Aligned_cols=73 Identities=18% Similarity=0.205 Sum_probs=50.1
Q ss_pred eEeecCcEEEEEEEeCCC-CEEEEEEecC-------C-hhHHHHHHHHHHHHHhcC--Cc-ceeEEeeEEEecCceEEEE
Q 007256 270 LIGKGGSSQVYKGCLPDG-KELAVKILKP-------S-EDVIKEFVLEIEIITTLH--HK-NIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~~~~g-~~vAVK~l~~-------~-~~~~~~f~~Ei~iL~~l~--Hp-nIv~l~g~~~~~~~~~LV~ 337 (611)
.||.|....||++..++| +.|+||.-.+ + +-..++...|.+.|+... -| .+.+++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998755 6899998542 1 233455667888887764 34 34444433 556677999
Q ss_pred eeCCCCC
Q 007256 338 DFLSRGS 344 (611)
Q Consensus 338 Ey~~ggs 344 (611)
|+++...
T Consensus 80 EdL~~~~ 86 (370)
T TIGR01767 80 EDLSHHK 86 (370)
T ss_pred hhCccch
Confidence 9996543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.051 Score=57.77 Aligned_cols=73 Identities=14% Similarity=0.156 Sum_probs=48.2
Q ss_pred ecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc--ceeEEe---e--EEEecCceEEEEeeCCCCCh
Q 007256 273 KGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLL---G--FCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 273 ~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~---g--~~~~~~~~~LV~Ey~~ggsL 345 (611)
.+.-..||+....+|..+++|+.++.......+..|++.+..|... .++... | ....++..+.++++++|...
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 4456789998888888999999876544556677788877766421 122211 1 12234567889999988753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.051 Score=59.56 Aligned_cols=80 Identities=16% Similarity=0.158 Sum_probs=55.1
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecC-----Ch---hHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEE
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKP-----SE---DVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~-----~~---~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~~~~L 335 (611)
..+.||.|....||+.... +..++||+-.+ +. -...+-..|.+.|+.+. ..++.+++.++. +..++
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 3567899999999998764 55699998652 21 13445555677777664 247888888876 45688
Q ss_pred EEeeCCC--CChhhhh
Q 007256 336 VYDFLSR--GSLEENL 349 (611)
Q Consensus 336 V~Ey~~g--gsL~~~L 349 (611)
+|||+++ ..+.+-+
T Consensus 113 vME~L~~~~~ilr~~L 128 (418)
T PLN02756 113 GMRYLEPPHIILRKGL 128 (418)
T ss_pred EEeecCCcceehhhhh
Confidence 9999987 2444433
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.045 Score=58.46 Aligned_cols=140 Identities=22% Similarity=0.357 Sum_probs=83.1
Q ss_pred EeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc------eeEEeeEE--Eec--CceEEEEeeC
Q 007256 271 IGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFC--FED--NNLLLVYDFL 340 (611)
Q Consensus 271 LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hpn------Iv~l~g~~--~~~--~~~~LV~Ey~ 340 (611)
|.+ .-..+|+....+|+. ++|+..+. ....++..|+..|..|.-.+ +..+=|-. .-. ...+-+++|+
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l 110 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYL 110 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEec
Confidence 444 567789888777776 99999876 55566777888777774211 12221211 112 3678899999
Q ss_pred CCCChhh-h--------------hccCCC-----CC---CCCCHHH-------------HHHHHHHHHHHHHHHhc----
Q 007256 341 SRGSLEE-N--------------LHGNKK-----DP---AAFGWSE-------------RYKVAMGVAEALEYLHS---- 380 (611)
Q Consensus 341 ~ggsL~~-~--------------L~~~~~-----~~---~~l~~~~-------------~~~I~~qIa~gL~yLH~---- 380 (611)
+|..+.. . +|.... .+ ....|.. ......++...+..+..
T Consensus 111 ~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~ 190 (331)
T COG2334 111 PGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPA 190 (331)
T ss_pred CCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchh
Confidence 9988873 0 111000 11 1233431 01122333444444443
Q ss_pred CCCCc---EEeeccCccceeeCCCCc-eEEeecCccc
Q 007256 381 GSAQR---VIHRDVKSSNILLSDDFE-PQLSDFGLAK 413 (611)
Q Consensus 381 ~~~~g---IiHrDIKp~NILLd~~~~-vKL~DFGla~ 413 (611)
.-... +||+|+.|.||+++.+.. .-++|||-+.
T Consensus 191 ~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 191 HLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11123 999999999999999875 8899998763
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.018 Score=62.80 Aligned_cols=74 Identities=16% Similarity=0.099 Sum_probs=51.8
Q ss_pred eeeEeecCcEEEEEEEeCC-CCEEEEEEecC----C---hhHHHHHHHHHHHHHhcC--Cc-ceeEEeeEEEecCceEEE
Q 007256 268 ENLIGKGGSSQVYKGCLPD-GKELAVKILKP----S---EDVIKEFVLEIEIITTLH--HK-NIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~----~---~~~~~~f~~Ei~iL~~l~--Hp-nIv~l~g~~~~~~~~~LV 336 (611)
.+.||.|.-..||++.+.+ ++.|+||.-.+ . .-..++..-|.++|+... .| .+.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5678999999999998753 67899997542 1 234566777888888764 34 34445544 55567788
Q ss_pred EeeCCCC
Q 007256 337 YDFLSRG 343 (611)
Q Consensus 337 ~Ey~~gg 343 (611)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9888654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.044 Score=57.64 Aligned_cols=31 Identities=16% Similarity=0.226 Sum_probs=27.9
Q ss_pred CCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 383 ~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
..+++|+|+.+.|||+++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4689999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.087 Score=57.45 Aligned_cols=76 Identities=17% Similarity=0.282 Sum_probs=47.2
Q ss_pred eeeeEeecCcEEEEEEEeCCC--CE-----EEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEe
Q 007256 267 AENLIGKGGSSQVYKGCLPDG--KE-----LAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g--~~-----vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~LV~E 338 (611)
..+.|..|-...+|++...++ .. |.+++........-.-.+|+.+++.+...++ .++++.+. -++|+|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 345666688899999875433 22 4444432222222233568999999975544 44555553 269999
Q ss_pred eCCCCChh
Q 007256 339 FLSRGSLE 346 (611)
Q Consensus 339 y~~ggsL~ 346 (611)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.17 Score=62.01 Aligned_cols=142 Identities=25% Similarity=0.308 Sum_probs=79.6
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhc-------CCcceeEEe-e----EEEe-cC--ce
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-------HHKNIISLL-G----FCFE-DN--NL 333 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-------~HpnIv~l~-g----~~~~-~~--~~ 333 (611)
+.|+ |..-.+|+....+|..+++|+.+... .......|...|..| .-|.+++-. | .... ++ ..
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 45688899888888899999998643 222333344455433 234444332 1 1111 12 46
Q ss_pred EEEEeeCCCCChhhhhc-----------------c----CC--CCCCCCCHHH-----------------HHHHHHHHHH
Q 007256 334 LLVYDFLSRGSLEENLH-----------------G----NK--KDPAAFGWSE-----------------RYKVAMGVAE 373 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~-----------------~----~~--~~~~~l~~~~-----------------~~~I~~qIa~ 373 (611)
+-+|+|++|..|.+... . .. .....+.|.. .+.++.+++.
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 77899999987765111 0 00 0011223321 1222223332
Q ss_pred HHH-----HHhcCCCCcEEeeccCccceeeCCCC--ceE-EeecCccc
Q 007256 374 ALE-----YLHSGSAQRVIHRDVKSSNILLSDDF--EPQ-LSDFGLAK 413 (611)
Q Consensus 374 gL~-----yLH~~~~~gIiHrDIKp~NILLd~~~--~vK-L~DFGla~ 413 (611)
.+. .|. .-..++||+|+.+.|||++.++ .+. |+|||-+.
T Consensus 189 ~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 189 RFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 222 122 2236799999999999999875 555 99999764
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.097 Score=53.82 Aligned_cols=78 Identities=21% Similarity=0.141 Sum_probs=56.7
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC-CCCChhh
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL-SRGSLEE 347 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~-~ggsL~~ 347 (611)
..+..|..+.|+.+...+|.+.++|+..+......+...+ ..|+..+-...|++++.- ...-.|++|.+ ++.+|.+
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~~L~~ 84 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAAD--PERGALLLERLDPGRSLAS 84 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeeccc--cccchhhhhhccCCCchhh
Confidence 4466799999999999999999999998655433332222 448888888899999874 34567888998 4457765
Q ss_pred hh
Q 007256 348 NL 349 (611)
Q Consensus 348 ~L 349 (611)
..
T Consensus 85 ~~ 86 (253)
T PF04655_consen 85 LP 86 (253)
T ss_pred cc
Confidence 54
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.096 Score=52.70 Aligned_cols=152 Identities=17% Similarity=0.175 Sum_probs=91.2
Q ss_pred cCcEEEEEEEeCCCCEEEEEEecCChh--HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCCChhhhhcc
Q 007256 274 GGSSQVYKGCLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHG 351 (611)
Q Consensus 274 G~fG~Vyk~~~~~g~~vAVK~l~~~~~--~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~ 351 (611)
|+.++.-++..+=|. ..+|.+...+- ....|..+.+++.+++ .|+++..- .+..+.++.|+|.....
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 344444444332232 44555554331 3345678899999887 47777733 34457788898843110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccccccccc
Q 007256 352 NKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431 (611)
Q Consensus 352 ~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~ 431 (611)
.. .-.|..+ +.+|.-.|+.+ .+.+|+|..|+||+-|..|.+||.|=+... .. +.
T Consensus 142 -------~~---~N~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~------------~V 195 (308)
T PF07387_consen 142 -------NF---SNFITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--EN------------QV 195 (308)
T ss_pred -------ch---hHHHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhh--hh------------ee
Confidence 00 0112222 45678889755 789999999999999999999999976431 11 11
Q ss_pred ccCChhhhccCCCCCcceehhhhHHHHHHHhCCC
Q 007256 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK 465 (611)
Q Consensus 432 ~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~ 465 (611)
-|.--| +...+.++.+=+|=.-++++.....
T Consensus 196 ~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~ 226 (308)
T PF07387_consen 196 NMVNIE---YESLTQEAEVKVFVKSCLKLVEKQR 226 (308)
T ss_pred eEEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence 122211 2345667777777777777766443
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.19 Score=55.94 Aligned_cols=76 Identities=20% Similarity=0.212 Sum_probs=50.6
Q ss_pred eeeeEeecCcEEEEEEEeCC---------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEE
Q 007256 267 AENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLV 336 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~---------g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv-~l~g~~~~~~~~~LV 336 (611)
..+.|..|-...+|+....+ ++.|.+++.-......-.-..|..+++.+...+|- ++++.+. -+.|
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 55677788888999987542 46899999865443333445688888888654443 3445442 3568
Q ss_pred EeeCCCCChh
Q 007256 337 YDFLSRGSLE 346 (611)
Q Consensus 337 ~Ey~~ggsL~ 346 (611)
.||++|.+|.
T Consensus 185 ~efi~g~~l~ 194 (442)
T PTZ00296 185 EEWLYGDPLR 194 (442)
T ss_pred EEeeCCccCC
Confidence 9999987543
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=93.84 E-value=0.65 Score=48.17 Aligned_cols=30 Identities=37% Similarity=0.447 Sum_probs=24.9
Q ss_pred CcEEeeccCccceeeCCC--C---ceEEeecCccc
Q 007256 384 QRVIHRDVKSSNILLSDD--F---EPQLSDFGLAK 413 (611)
Q Consensus 384 ~gIiHrDIKp~NILLd~~--~---~vKL~DFGla~ 413 (611)
.-++|||+++.|||+..+ | .+++.||-+++
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeecccccc
Confidence 568999999999999654 3 58999998765
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=91.75 E-value=2.1 Score=43.55 Aligned_cols=74 Identities=15% Similarity=0.259 Sum_probs=51.2
Q ss_pred eEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEEEEeeCCCCChh
Q 007256 270 LIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
.+-.|.--..|... .+..++-||+-. ......|..|+.-|..|. --++.+++.+-.+..+.|+|+||++-+.+.
T Consensus 23 ~v~gG~inea~~v~-dg~~~~FvK~n~--~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 23 EVSGGDINEAWRLR-DGTDPFFVKCNQ--REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ccCCccccceeEee-cCCcceEEEecc--hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 34444444455433 356778888754 334456777887766664 456778888888899999999999987665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 611 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-55 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-33 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-22 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-12 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-12 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-12 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-12 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-12 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 8e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 410 bits (1055), Expect = e-140
Identities = 115/314 (36%), Positives = 181/314 (57%), Gaps = 5/314 (1%)
Query: 240 EGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE 299
E E + + F+ ++L A+ NF +N++G+GG +VYKG L DG +AVK LK
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 300 D--VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 357
+F E+E+I+ H+N++ L GFC LLVY +++ GS+ L +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 358 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417
W +R ++A+G A L YLH ++IHRDVK++NILL ++FE + DFGLAK
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 477
+H+T T V GT G++APEY GK ++K DV+ +GV+LLEL+TG++ +
Sbjct: 187 KDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 478 --LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535
L+ W K +L K+ L+D L NY +++E+++ ++LC + P RP+MS V+++
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 536 LRGDADVTKWARLQ 549
L GD +W Q
Sbjct: 306 LEGDGLAERWEEWQ 319
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 385 bits (990), Expect = e-130
Identities = 109/315 (34%), Positives = 174/315 (55%), Gaps = 6/315 (1%)
Query: 227 STDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD 286
S +T + DL AT+NF + LIG G +VYKG L D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 287 GKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSL 345
G ++A+K P S I+EF EIE ++ H +++SL+GFC E N ++L+Y ++ G+L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 346 EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405
+ +L+G+ + W +R ++ +G A L YLH+ + +IHRDVKS NILL ++F P+
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 406 LSDFGLAKWA-STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 464
++DFG++K +H++ T V GT GY+ PEYF+ G++ +K DVY+FGVVL E+L R
Sbjct: 180 ITDFGISKKGTELDQTHLS-TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 465 KPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPR 524
I P+ +L WA ++G++ Q++DP L + + + + ++ C+
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298
Query: 525 ARPQMSLVLKLLRGD 539
RP M VL L
Sbjct: 299 DRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 353 bits (908), Expect = e-118
Identities = 95/311 (30%), Positives = 159/311 (51%), Gaps = 23/311 (7%)
Query: 244 EKYSATCRLFNYQDLLSATSNF------LAENLIGKGGSSQVYKGCLPDGKELAVKILKP 297
E F++ +L + T+NF + N +G+GG VYKG + + +AVK L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 298 SEDV-----IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN 352
D+ ++F EI+++ H+N++ LLGF + ++L LVY ++ GSL + L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 353 KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412
P W R K+A G A + +LH IHRD+KS+NILL + F ++SDFGLA
Sbjct: 125 DGTPP-LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 413 KWAST-SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 471
+ + + + +T + + GT Y+APE + G++ K D+Y+FGVVLLE++TG + D
Sbjct: 181 RASEKFAQTVMT-SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV--DE 236
Query: 472 PKGQESLVMWAKPILSS-GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 530
+ + L+ + I + +D + + D +E M + C+ RP +
Sbjct: 237 HREPQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 531 LVLKLLRGDAD 541
V +LL+
Sbjct: 296 KVQQLLQEMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 2e-78
Identities = 73/318 (22%), Positives = 121/318 (38%), Gaps = 28/318 (8%)
Query: 241 GLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED 300
G H + ++ ++L + + +G V+K + +AVKI +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDK 60
Query: 301 VIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDP 356
+ E+ + + H+NI+ +G + L L+ F +GSL + L N
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS- 119
Query: 357 AAFGWSERYKVAMGVAEALEYLHS-------GSAQRVIHRDVKSSNILLSDDFEPQLSDF 409
W+E +A +A L YLH G + HRD+KS N+LL ++ ++DF
Sbjct: 120 ----WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGR 464
GLA S GT Y+APE +ID+YA G+VL EL +
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 465 KPISNDHPKGQESL--VMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASIL-C 518
+ + P L + V + P L + + M+ +I C
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 519 IRRDPRARPQMSLVLKLL 536
D AR V + +
Sbjct: 296 WDHDAEARLSAGCVGERI 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-62
Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
E ++G+G V K K++A+K ++ SE K F++E+ ++ ++H NI+ L G C
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
N + LV ++ GSL LHG + P + + + ++ + YLHS + +I
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 388 HRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 446
HRD+K N+LL ++ DFG A T T+ G+ ++APE F ++
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 447 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 506
K DV+++G++L E++T RKP + V P L N
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDE----------IGGPAFRIMWAVHNGTRPPLIKNLPKP 232
Query: 507 QMERMVLASIL--CIRRDPRARPQMSLVLKLLR 537
+ S++ C +DP RP M ++K++
Sbjct: 233 ------IESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-61
Identities = 65/319 (20%), Positives = 110/319 (34%), Gaps = 43/319 (13%)
Query: 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEII 312
+ N LIG+G VYKG L D + +AVK+ + + F+ E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIY 59
Query: 313 TT--LHHKNIISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY 365
+ H NI + LLV ++ GSL + L + D W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSC 114
Query: 366 KVAMGVAEALEYLHSGSAQR------VIHRDVKSSNILLSDDFEPQLSDFGLAK------ 413
++A V L YLH+ + + HRD+ S N+L+ +D +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 414 WASTSSSHITCTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKP 466
GT Y+APE ++D+YA G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 467 ISNDHPKGQESL----VMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASIL-- 517
+ + + + P + + P + + + L +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 518 CIRRDPRARPQMSLVLKLL 536
C +D AR + +
Sbjct: 295 CWDQDAEARLTAQXAEERM 313
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-60
Identities = 85/280 (30%), Positives = 134/280 (47%), Gaps = 37/280 (13%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKNIISLL 324
+ IG G V++ G ++AVKIL + + EF+ E+ I+ L H NI+ +
Sbjct: 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
G + NL +V ++LSRGSL LH R +A VA+ + YLH+
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
++HR++KS N+L+ + ++ DFGL++ AST S AGT ++APE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPEVLRDEP 215
Query: 444 VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA------KPILSSGKVTQLLDP 497
N+K DVY+FGV+L EL T ++P N +P Q V+ A + + L+P
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNP-AQ---VVAAVGFKCKRLEIPRN-----LNP 266
Query: 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ +E C +P RP + ++ LLR
Sbjct: 267 QV-----AAIIEG-------CWTNEPWKRPSFATIMDLLR 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 9e-58
Identities = 82/290 (28%), Positives = 120/290 (41%), Gaps = 52/290 (17%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSED-----VIKEFVLEIEIITTLHHKNIIS 322
E +IG GG +VY+ G E+AVK + D I+ E ++ L H NII+
Sbjct: 12 EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
L G C ++ NL LV +F G L L G + A+ +A + YLH +
Sbjct: 71 LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP-----PDILVNWAVQIARGMNYLHDEA 125
Query: 383 AQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGTFGYL 434
+IHRD+KSSNIL+ E ++DFGLA+ ++ AG + ++
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWM 181
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------PILS 487
APE + DV+++GV+L ELLTG P V + PI S
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-LA---VAYGVAMNKLALPIPS 237
Query: 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ ME C DP +RP + +L L
Sbjct: 238 T------CPEPF-----AKLMED-------CWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 9e-57
Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 46/289 (15%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--------VIKEFVLEIEIITTLHHK 318
E IGKGG V+KG + D +A+K L + +EF E+ I++ L+H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
NI+ L G N +V +F+ G L L WS + ++ + +A +EY+
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYM 138
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTFGY 433
+ ++HRD++S NI L E ++DFGL++ + S + + G F +
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-----SGLLGNFQW 192
Query: 434 LAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK- 490
+APE +K D Y+F ++L +LTG P + + I G
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLR 248
Query: 491 --VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ + P L + +E C DP+ RP S ++K L
Sbjct: 249 PTIPEDCPPRL-----RNVIEL-------CWSGDPKKRPHFSYIVKELS 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-54
Identities = 76/279 (27%), Positives = 125/279 (44%), Gaps = 38/279 (13%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IG G VYKG ++AVK+L + ++ F E+ ++ H NI+ +G+
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
L +V + SL +LH ++ F + +A A ++YLH+ + +I
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE---YFMYGKV 444
HRD+KS+NI L +D ++ DFGLA S S ++G+ ++APE
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 445 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA------KPILSSGKVTQLLDPA 498
+ + DVYAFG+VL EL+TG+ P SN + + Q ++ P LS KV
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLS--KVRSNCPKR 257
Query: 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ M C+++ RP +L +
Sbjct: 258 M-----KRLMAE-------CLKKKRDERPSFPRILAEIE 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-53
Identities = 54/284 (19%), Positives = 108/284 (38%), Gaps = 46/284 (16%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 324
+ + S +++KG G ++ VK+LK S ++F E + H N++ +L
Sbjct: 15 LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73
Query: 325 GFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
G C + L+ ++ GSL LH S+ K A+ +A + +LH+
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHT-L 130
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 440
+ + S ++++ +D ++S + ++APE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPEALQKK 183
Query: 441 -YGKVNDKIDVYAFGVVLLELLTGRKPISNDHP------KGQESLVMWAKPILSSGKVTQ 493
D+++F V+L EL+T P ++ E L +P + G
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----RPTIPPG---- 235
Query: 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ P + M+ C+ DP RP+ +++ +L
Sbjct: 236 -ISPHV-----SKLMKI-------CMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 7e-53
Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 49/290 (16%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 324
LIGKG QVY G E+A++++ +ED +K F E+ H+N++ +
Sbjct: 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
G C +L ++ +L + K ++ ++A + + + YLH+ +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAK---WASTSSSHITCTDVAGTFGYLAPEYFMY 441
++H+D+KS N+ D+ + ++DFGL G +LAPE
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 442 GKV---------NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-----KPILS 487
+ DV+A G + EL P ++W KP LS
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAIIWQMGTGMKPNLS 264
Query: 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ + D + C + RP + ++ +L
Sbjct: 265 QIGM----GKEI-----SDILLF-------CWAFEQEERPTFTKLMDMLE 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 6e-51
Identities = 68/295 (23%), Positives = 115/295 (38%), Gaps = 34/295 (11%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 325
IGKG +V+ G G+++AVK+ +E+ + E EI T + H+NI+ +
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 326 FCFEDN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
+ L L+ D+ GSL + L D K+A L +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLD-----AKSMLKLAYSSVSGLCHLHTE 153
Query: 382 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGYL 434
+ HRD+KS NIL+ + ++D GLA + T+ I GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 435 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISN----DHPKGQESLVMWAKP 484
PE + + D+Y+FG++L E+ P +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLLR 537
+ + L P+ N + D+ R + ++ C +P +R V K L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLR-QMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-50
Identities = 62/287 (21%), Positives = 116/287 (40%), Gaps = 40/287 (13%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNIISLLG 325
++GKG Q K G+ + +K L + E+ + F+ E++++ L H N++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
++D L + +++ G+L + + WS+R A +A + YLHS
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAK------------WASTSSSHITCTDVAGTFGY 433
+IHRD+ S N L+ ++ ++DFGLA+ + V G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 434 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK---PILSSGK 490
+APE ++K+DV++FG+VL E++ + P+ + +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN- 247
Query: 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
P+ + R C DP RP + L
Sbjct: 248 ----CPPSF-----FPITVR-------CCDLDPEKRPSFVKLEHWLE 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-49
Identities = 68/294 (23%), Positives = 114/294 (38%), Gaps = 34/294 (11%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 325
+GKG +V++G G+ +AVKI ++ K + E E+ T L H+NI+ +
Sbjct: 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIA 69
Query: 326 FC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L L+ + GSL + L D ++ + +A L +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-----TVSCLRIVLSIASGLAHLHIE 124
Query: 382 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLA--KWASTSSSHITCTDVAGTFGYL 434
+ HRD+KS NIL+ + + ++D GLA ST+ + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 435 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH----PKGQESLVMWAKP 484
APE ++D++AFG+VL E+ P +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLL 536
+ P + N + D LA ++ C ++P AR + K L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLT-SLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 76/295 (25%), Positives = 120/295 (40%), Gaps = 34/295 (11%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLG 325
+ IGKG +V++G G+E+AVKI E+ + + E EI T L H+NI+ +
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIA 103
Query: 326 FCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHME 158
Query: 382 SAQR-----VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH--ITCTDVAGTFGYL 434
+ HRD+KS NIL+ + ++D GLA +++ I GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 435 APE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISND----HPKGQESLVMWAKP 484
APE + + + D+YA G+V E+ P +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKLLR 537
+ Q L P + N + + R V+A I+ C + AR + K L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALR-VMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 33/283 (11%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHH 317
+NF E IG+G S+VY+ CL DG +A+K ++ + + EI+++ L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 375
N+I EDN L +V + G L + KK ER K + + AL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI--PERTVWKYFVQLCSAL 149
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
E++HS +RV+HRD+K +N+ ++ +L D GL ++ S+ ++ + GT Y++
Sbjct: 150 EHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMS 204
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ-L 494
PE N K D+++ G +L E+ + P D SL K+ Q
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCK---------KIEQCD 254
Query: 495 LDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 535
P ++Y + L ++ CI DP RP ++ V +
Sbjct: 255 YPPLPSDHYSEE------LRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 73/300 (24%), Positives = 133/300 (44%), Gaps = 35/300 (11%)
Query: 243 HEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPS 298
H +S+ L + ++ IG+G + DG++ +K + + S
Sbjct: 4 HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63
Query: 299 EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA 358
+E E+ ++ + H NI+ E+ +L +V D+ G L + ++ K
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL-- 121
Query: 359 FGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416
+ E + + AL+++H ++++HRD+KS NI L+ D QL DFG+A+ +
Sbjct: 122 --FQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176
Query: 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 476
++ GT YL+PE N+K D++A G VL EL T + K
Sbjct: 177 STVEL-ARA-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--- 231
Query: 477 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLK 534
+LV+ K+ P + +Y YD L S++ +R+PR RP ++ +L+
Sbjct: 232 NLVL---------KIISGSFPPVSLHYSYD------LRSLVSQLFKRNPRDRPSVNSILE 276
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 41/291 (14%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNII 321
++L +G+GG S V L DG A+K IL + +E E ++ +H NI+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 322 SLLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
L+ +C + L+ F RG+L + K + + +G+ LE
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS----TSSSHITCTDVA---GT 430
+H+ + HRD+K +NILL D+ +P L D G A S +T D A T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 431 FGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 487
Y APE F + ++++ DV++ G VL ++ G P KG +S+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL------- 258
Query: 488 SGKVTQLLDPALGNNYDYDQMERM--VLASIL--CIRRDPRARPQMSLVLK 534
A+ N Q R L +L + DP RP + L+L
Sbjct: 259 ----------AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-38
Identities = 65/292 (22%), Positives = 119/292 (40%), Gaps = 55/292 (18%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII 321
+F LIG GG QV+K DGK +K +K + + + E++ + L H NI+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER---EVKALAKLDHVNIV 67
Query: 322 SLLGFCFED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER 364
G C++ L + +F +G+LE+ + + + +
Sbjct: 68 HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK----LDKV 122
Query: 365 Y--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422
++ + + ++Y+HS +++I+RD+K SNI L D + ++ DFGL
Sbjct: 123 LALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482
GT Y++PE ++D+YA G++L ELL +
Sbjct: 180 R---SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE----TSKFFTDLR 232
Query: 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
I+S +D+ E+ +L + + P RP S +L+
Sbjct: 233 DGIISDI---------------FDKKEKTLLQK--LLSKKPEDRPNTSEILR 267
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-37
Identities = 59/297 (19%), Positives = 117/297 (39%), Gaps = 47/297 (15%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKN 319
++F +G+GG V++ D A+K L E ++ + E++ + L H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 320 IISLLGFCFEDNN------------LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 367
I+ E N L + + +L++ ++G S +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-RERSVCLHI 123
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK----------WAST 417
+ +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL +
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 477
++ T GT Y++PE + K+D+++ G++L ELL +P +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------YPFSTQM 231
Query: 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ + + K L E +++ + P RP+ +++
Sbjct: 232 ERVRTLTDVRNLKFPPLFT-------QKYPCEYVMVQD--MLSPSPMERPEAINIIE 279
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 65/267 (24%), Positives = 108/267 (40%), Gaps = 33/267 (12%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLG 325
IG+G VYKG E+A L K ++ + F E E++ L H NI+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 326 FCF----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
++LV + ++ G+L+ L K + + L++LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 382 SAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+ +IHRD+K NI ++ ++ D GLA S V GT ++APE +
Sbjct: 149 TPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE 203
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500
K ++ +DVYAFG+ +LE+ T P S Q ++SG D
Sbjct: 204 -EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR------RVTSGVKPASFDKVA- 255
Query: 501 NNYDYDQMERMVLASILCIRRDPRARP 527
+ ++ CIR++ R
Sbjct: 256 -----IPEVKEIIE--GCIRQNKDERY 275
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 72/264 (27%), Positives = 119/264 (45%), Gaps = 37/264 (14%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IGKG +V+KG K +A+KI L+ +ED I++ EI +++ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 385
+D L ++ ++L GS + L E + + + L+YLHS ++
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLHS---EK 139
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
IHRD+K++N+LLS+ E +L+DFG+ + T T GT ++APE
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAY 196
Query: 445 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KPILSSGKVTQLLDPALGNNY 503
+ K D+++ G+ +EL G P S HP M I + P L NY
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNNP------PTLEGNY 243
Query: 504 DYDQMERMVLASILCIRRDPRARP 527
++ V C+ ++P RP
Sbjct: 244 S-KPLKEFV---EACLNKEPSFRP 263
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 14/202 (6%)
Query: 271 IGKGGSSQVYKGCL-PDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IG+G +V+ G L D +AVK + D+ +F+ E I+ H NI+ L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
+ + +V + + G L ++ A +EYL S + I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVN 445
HRD+ + N L+++ ++SDFG+++ + + APE YG+ +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV--YAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 446 DKIDVYAFGVVLLELLT-GRKP 466
+ DV++FG++L E + G P
Sbjct: 294 SESDVWSFGILLWETFSLGASP 315
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 7e-35
Identities = 53/251 (21%), Positives = 95/251 (37%), Gaps = 25/251 (9%)
Query: 237 KELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSS--QVYKG-CLPDGKELAVK 293
H + + ++ + +IGKG V P G+ + V+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVR 58
Query: 294 IL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLH 350
+ S +++ E+ + +H NI+ DN L +V F++ GS ++ +
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118
Query: 351 GNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 408
+ D G +E + GV +AL+Y+H +HR VK+S+IL+S D + LS
Sbjct: 119 THFMD----GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSG 171
Query: 409 FGLAKWASTS-----SSHITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELL 461
+ H +L+PE + K D+Y+ G+ EL
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 462 TGRKPISNDHP 472
G P +
Sbjct: 232 NGHVPFKDMPA 242
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-35
Identities = 64/286 (22%), Positives = 107/286 (37%), Gaps = 30/286 (10%)
Query: 260 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTL 315
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 316 HHKNIISLLG-FCFEDNNLL-LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 373
H NI+ N L +V ++ G L + K+ +V +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 374 ALEYLHS--GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
AL+ H V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTP 180
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491
Y++PE N+K D+++ G +L EL P + Q+ L K+
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG---------KI 228
Query: 492 TQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARPQMSLVLKL 535
+ + Y + L I+ + RP + +L+
Sbjct: 229 REGKFRRIPYRYSDE------LNEIITRMLNLKDYHRPSVEEILEN 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 269 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 323
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 324 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 374
+ D + +V +L + S++ W + EA
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 139
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 140 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 435 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 466
PE K++ K DV++ G +L + G+ P
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 72/271 (26%), Positives = 114/271 (42%), Gaps = 27/271 (9%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IG G ++ V C P +++A+K L+ + + E + EI+ ++ HH NI+S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGW--SERY--KVAMGVAEALEYLHSGSA 383
+ L LV LS GS+ + + E + V E LEYLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--- 139
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC---TDVAGTFGYLAPEYFM 440
IHRDVK+ NILL +D Q++DFG++ + +T GT ++APE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 441 YGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499
+ + K D+++FG+ +EL TG P P M + L
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPP-------MKVLMLTLQNDPPSLETGVQ 252
Query: 500 GNNYDYD---QMERMVLASILCIRRDPRARP 527
+M+ LC+++DP RP
Sbjct: 253 DKEMLKKYGKSFRKMI---SLCLQKDPEKRP 280
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 63/271 (23%), Positives = 121/271 (44%), Gaps = 39/271 (14%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 324
+G GG S VY ++A+K + E+ +K F E+ + L H+NI+S++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
ED+ LV +++ +L E + + + + +++ H
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYFMYGK 443
R++HRD+K NIL+ + ++ DFG+AK + S + +T T+ V GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 444 VNDKIDVYAFGVVLLELLTGRKPISNDHPKG------QESLVMWAKPILSSGKVTQLLDP 497
++ D+Y+ G+VL E+L G P + + Q+S+ P +++ V + +
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-----PNVTT-DVRKDIPQ 242
Query: 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 528
+L ++L +D R +
Sbjct: 243 SL---------SNVILR---ATEKDKANRYK 261
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 15/205 (7%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 322
L+G+GG VY+ + +A+K++ + E L +++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
+ F D L + ++ L L + + + AL+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH--- 151
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA-GTFGYLAPEYFMY 441
A HRDVK NIL+S D L DFG+A +T+ +T GT Y+APE F
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 442 GKVNDKIDVYAFGVVLLELLTGRKP 466
+ D+YA VL E LTG P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 69/301 (22%), Positives = 125/301 (41%), Gaps = 50/301 (16%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 320
S+F ++G+G QV K D + A+K ++ +E+ + + E+ ++ +L+H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 321 ISLLGFCFEDNN-------------LLLVYDFLSRGSLEENLH-GNKKDPAAFGWSERYK 366
+ E N L + ++ G+L + +H N W +
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----R 120
Query: 367 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-- 424
+ + EAL Y+HS Q +IHRD+K NI + + ++ DFGLAK S +
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 425 ----------TDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473
T GT Y+A E G N+KID+Y+ G++ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST------- 230
Query: 474 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 533
G E + + K L S + P +N + + ++ ++ DP RP +L
Sbjct: 231 GMERVNILKK--LRSVSIE--FPPDFDDNKMKVE--KKIIRLLID--HDPNKRPGARTLL 282
Query: 534 K 534
Sbjct: 283 N 283
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 47/223 (21%), Positives = 86/223 (38%), Gaps = 43/223 (19%)
Query: 269 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 323
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 324 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 374
+ D + +V +L + S++ W + EA
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 120
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
+ +H ++H D+K +N L+ D +L DFG+A ++ + GT Y+
Sbjct: 121 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 435 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 466
PE K++ K DV++ G +L + G+ P
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 61/272 (22%), Positives = 100/272 (36%), Gaps = 38/272 (13%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE---FVLEIEIITTL-HH 317
+F + +G G +V+K DG+ AVK K+ + E+ + H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
+ L E L L + SL+++ + A+ ++ + AL +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAH 172
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LHS Q ++H DVK +NI L +L DFGL T+ + G Y+APE
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE 226
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497
G DV++ G+ +LE+ + W + L G L P
Sbjct: 227 LLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEG--------WQQ--LRQGY----LPP 271
Query: 498 ALGNNYDYDQMERMVLASIL--CIRRDPRARP 527
+ L S+L + DP+ R
Sbjct: 272 EFTAGLSSE------LRSVLVMMLEPDPKLRA 297
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 269 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISL 323
+GKG VY LA+K+L ++ V + E+EI + L H NI+ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 380
G+ + + L+ ++ G++ L K A +E +A AL Y HS
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-------LANALSYCHS 127
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+RVIHRD+K N+LL E +++DFG + A +S C GT YL PE
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIE 180
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473
++K+D+++ GV+ E L G+ P + +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLL 324
++G GG S+V+ L D +++AVK+L+ F E + L+H I+++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 325 GFCFEDNNLL----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
+ +V +++ +L + +H +V +AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH- 133
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYF 439
+IHRDVK +NI++S ++ DFG+A+ + S + +T T V GT YL+PE
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
V+ + DVY+ G VL E+LTG P + D P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 57/293 (19%), Positives = 101/293 (34%), Gaps = 57/293 (19%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---PSEDVIKEFVLEIEIITTL-H 316
T+ F IG G V+K DG A+K K + + E+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 317 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376
H +++ ED+++L+ ++ + GSL + + N + + F +E + + V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-------------------LSDFGLAKWAST 417
Y+HS ++H D+K SNI +S P + D G S+
Sbjct: 130 YIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 418 SSSHITCTDVAGTFGYLAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQE 476
G +LA E + K D++A + ++ N
Sbjct: 187 PQVEE------GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235
Query: 477 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--CIRRDPRARP 527
W + + G++ P + + +L I DP RP
Sbjct: 236 ---QWHE--IRQGRL-----PRIPQVLSQE------FTELLKVMIHPDPERRP 272
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 46/223 (20%), Positives = 85/223 (38%), Gaps = 43/223 (19%)
Query: 269 NLIGKGGSSQVYKGCLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKN--IISL 323
IG GGSS+V++ + A+K + + + + EI + L + II L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 324 LGFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 374
+ D + +V +L + S++ W + EA
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWE-------RKSYWKN-------MLEA 167
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
+ +H ++H D+K +N L+ D +L DFG+A ++ + G Y+
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 435 APEYFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 466
PE K++ K DV++ G +L + G+ P
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 16/215 (7%)
Query: 262 TSNFLAENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI 320
F +G+G VYK G+ +A+K + D ++E + EI I+ ++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHV 86
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 378
+ G F++ +L +V ++ GS+ + + K +E + + LEYL
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYL 141
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPE 437
H R IHRD+K+ NILL+ + +L+DFG+ + T + T V GT ++APE
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPE 195
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
N D+++ G+ +E+ G+ P ++ HP
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 34/282 (12%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 322
+F ++++G G + + D +++AVK + P + E++++ H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVIR 82
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
+ + + L +L+E + ++ A E + L +LHS
Sbjct: 83 YFCTEKDRQFQYIAIE-LCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 383 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKW-ASTSSSHITCTDVAGTFGYLAP 436
++HRD+K NIL+S +SDFGL K A S + V GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 437 EYF---MYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492
E +D+++ G V +++ G P +++ ++ L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQANILLGACSLDCLHPE 253
Query: 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ D + +E+M I DP+ RP VLK
Sbjct: 254 KHEDVIA-----RELIEKM-------IAMDPQKRPSAKHVLK 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 65/321 (20%), Positives = 123/321 (38%), Gaps = 50/321 (15%)
Query: 265 FLAENLIGKGGSSQVYKGCL-PDGKELAVKI--LKPSEDVIKEFVLEIEIITTLHHKNII 321
F + +G G V+K P G +A K+ L+ + + + E++++ + I+
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 379
G + D + + + + GSL++ L + P E+ KV++ V + L YL
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP------EQILGKVSIAVIKGLTYLR 148
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
+++HRDVK SNIL++ E +L DFG++ S GT Y++PE
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 202
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499
+ + D+++ G+ L+E+ GR PI K E + ++ + P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 500 GNNYDYDQMERM-----VLASIL----------------------CIRRDPRARP----- 527
N +L I+ C+ ++P R
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322
Query: 528 -QMSLVLKLLRGDADVTKWAR 547
+ + + + D W
Sbjct: 323 MVHAFIKRSDAEEVDFAGWLC 343
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-32
Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 25/229 (10%)
Query: 257 DLLSATSNFLAE---------NLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDV 301
+L+ A + + +IG+G VY G L DGK++ AVK L
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 302 IKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFG 360
+ +F+ E I+ H N++SLLG C + + L+V ++ G L + +P
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-- 127
Query: 361 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420
+ + VA+ ++YL ++++ +HRD+ + N +L + F +++DFGLA+
Sbjct: 128 -KDLIGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 421 HITCTDVAGTF--GYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ ++A E K K DV++FGV+L EL+T G P
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 63/243 (25%), Positives = 105/243 (43%), Gaps = 26/243 (10%)
Query: 268 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 321
+ +GKG V L D AVK L+ D ++F EI+I+ LH I+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 322 SLLGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
G + +L LV ++L G L + L ++ A S + + + +EYL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG 144
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 434
S +R +HRD+ + NIL+ + +++DFGLAK + G
Sbjct: 145 S---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV----VREPGQSPIFWY 197
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493
APE + + DV++FGVVL EL T K S ++ + + + ++ +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP--SAEFLRMMGCERDVPALSRLLE 255
Query: 494 LLD 496
LL+
Sbjct: 256 LLE 258
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-32
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 328 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 310
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKV 444
+HRD+ + N+L+S+D ++SDFGL K + T G APE K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 445 NDKIDVYAFGVVLLELLT-GRKP 466
+ K DV++FG++L E+ + GR P
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP 386
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 28/254 (11%)
Query: 224 SPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGC 283
P + D++ L ++L+ + +Y +Q +G+G +V++
Sbjct: 31 GPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR------------VGRGSFGEVHRMK 78
Query: 284 -LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342
G + AVK + E E E+ L I+ L G E + + + L
Sbjct: 79 DKQTGFQCAVKKV-RLEVFRVE---ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134
Query: 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD- 401
GSL + + K E LEYLH+ +R++H DVK+ N+LLS D
Sbjct: 135 GSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDG 187
Query: 402 FEPQLSDFGLAK---WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLL 458
L DFG A S +T + GT ++APE M + K+D+++ ++L
Sbjct: 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMML 247
Query: 459 ELLTGRKPISNDHP 472
+L G P +
Sbjct: 248 HMLNGCHPWTQYFR 261
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-32
Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 8/201 (3%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEK---KNF 339
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 446
IHR++ + N L+ ++ +++DFGL++ T ++ + APE Y K +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 447 KIDVYAFGVVLLELLT-GRKP 466
K DV+AFGV+L E+ T G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 62/294 (21%), Positives = 117/294 (39%), Gaps = 40/294 (13%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 326
+G+G V K +P G+ +AVK + K +++++I T+ ++ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 384
F + ++ + + + SL++ E K+A+ + +ALE+LHS
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTI--PEDILGKIAVSIVKALEHLHS--KL 129
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
VIHRDVK SN+L++ + ++ DFG++ + + AG Y+APE
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELN 186
Query: 445 ND----KIDVYAFGVVLLELLTGRKPISN-DHPKGQESLVMWAKPILSSGKVTQLLDPAL 499
K D+++ G+ ++EL R P + P Q V+ P L
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS------------PQL 234
Query: 500 GNNYDYDQMERMVLASILCIRRDPRARP------QMSLVLKLLRGDADVTKWAR 547
+ + C++++ + RP Q DV + +
Sbjct: 235 PADKFSAEFVDFTSQ---CLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVK 285
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
+IG+G VY G L DGK++ AVK L + +F+ E I+ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 322 SLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
SLLG C + + L+V ++ G L + +P + + VA+ +++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFL-- 208
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----A 435
++++ +HRD+ + N +L + F +++DFGLA+ T L A
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMA 264
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
E K K DV++FGV+L EL+T G P
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 15/207 (7%)
Query: 268 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 320
++G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
LLG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED 135
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+R++HRD+ + N+L+ +++DFGLAK ++A E +
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 441 YGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ + DV+++GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 324
L+GKG + VY+ + G E+A+K++ +++ E++I L H +I+ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 325 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHS 380
FED N + LV + G + L K + A R+ + + + YLHS
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA-----RHFMHQ-IITGMLYLHS 130
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEY 438
++HRD+ SN+LL+ + +++DFGLA + C GT Y++PE
Sbjct: 131 ---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEI 183
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKP 466
+ DV++ G + LL GR P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-31
Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 26/227 (11%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKN 319
F L+G G QVYKG + G+ A+K++ + D +E EI ++ HH+N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 320 IISLLG------FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGV 371
I + G D+ L LV +F GS+ + + K + E + + +
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL----KEEWIAYICREI 138
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGT 430
L +LH +VIHRD+K N+LL+++ E +L DFG+ A+ T T GT
Sbjct: 139 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGT 192
Query: 431 FGYLAPEYFMYGKVND-----KIDVYAFGVVLLELLTGRKPISNDHP 472
++APE + D K D+++ G+ +E+ G P+ + HP
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 21/212 (9%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCF 328
+G G +VYK G A K+++ SE+ ++++++EIEI+ T H I+ LLG +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 386
D L ++ +F G+++ + + G +E V + EAL +LHS +R+
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHS---KRI 138
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGL-AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 445
IHRD+K+ N+L++ + + +L+DFG+ AK T + GT ++APE M +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETMK 195
Query: 446 D-----KIDVYAFGVVLLELLTGRKPISNDHP 472
D K D+++ G+ L+E+ P +P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 326
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 327 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 381
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
++HR++K NI+ + Q L+DFG A+ + GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 438 YFMYGKVND--------KIDVYAFGVVLLELLTGRKP 466
+ + +D+++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G G V G ++AVK++K EF E + + L H ++ G C
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
++ + +V +++S G L L + K S+ ++ V E + +L + + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 441
HRD+ + N L+ D ++SDFG+ ++ + + G APE F Y
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRY-------VLDDQYVSSVGTKFPVKWSAPEVFHY 179
Query: 442 GKVNDKIDVYAFGVVLLELLT-GRKP 466
K + K DV+AFG+++ E+ + G+ P
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IGKG V G G ++AVK +K + F+ E ++T L H N++ LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 328 FEDN-NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKV 444
+HRD+ + N+L+S+D ++SDFGL K AS++ G APE K
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-------TGKLPVKWTAPEALREKKF 191
Query: 445 NDKIDVYAFGVVLLELLT-GRKP 466
+ K DV++FG++L E+ + GR P
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVP 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 68/285 (23%), Positives = 112/285 (39%), Gaps = 47/285 (16%)
Query: 268 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 321
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 322 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 131
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 434
+ +R IHRD+ + NIL+ ++ ++ DFGL K G
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK----VKEPGESPIFWY 184
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494
APE K + DV++FGVVL EL T + + + + + + + +L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 495 LD------------PALGNNYDYDQMERMVLASILCIRRDPRARP 527
L + Y M C + RP
Sbjct: 245 LKNNGRLPRPDGCPDEI-----YMIMTE-------CWNNNVNQRP 277
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 23/242 (9%)
Query: 268 ENLIGKGGSSQVYKGC---LPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNII 321
+GKG V L D AVK L+ +E+ +++F EIEI+ +L H NI+
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 322 SLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
G C+ L L+ ++L GSL + L +K+ + + + + +EYL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG 162
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL----- 434
+ +R IHRD+ + NIL+ ++ ++ DFGL K + G
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK----VKEPGESPIFWY 215
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494
APE K + DV++FGVVL EL T + + + + + + + +L
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 495 LD 496
L
Sbjct: 276 LK 277
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLL 324
+GKG VY + +A+K+L S+ V + EIEI + L H NI+ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSG 381
+ + + L+ +F RG L + L + + +A E +A+AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-------LADALHYCHE- 132
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
++VIHRD+K N+L+ E +++DFG + A + C GT YL PE
Sbjct: 133 --RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEG 186
Query: 442 GKVNDKIDVYAFGVVLLELLTGRKP 466
++K+D++ GV+ E L G P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 16/206 (7%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 328
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 386
+ L +V ++L+ GSL + + E V +ALE+LHS +V
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHS---NQV 137
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 446
IHRD+KS NILL D +L+DFG A + + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 447 KIDVYAFGVVLLELLTGRKPISNDHP 472
K+D+++ G++ +E++ G P N++P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENP 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 16/209 (7%)
Query: 266 LAENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 320
+A+ +G G V +G K++ A+K+LK + +E + E +I+ L + I
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
+ L+G C + L+LV + G L + L G +++ S ++ V+ ++YL
Sbjct: 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL-- 126
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEY 438
+ +HRD+ + N+LL + ++SDFGL+K S+ T AG + + APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPEC 184
Query: 439 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ K + + DV+++GV + E L+ G+KP
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-31
Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 45/296 (15%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 326
+G G QV+K G +AVK +++ K +++++++ + I+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 384
+ ++ + + + + + P ER K+ + + +AL YL
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIP------ERILGKMTVAIVKALYYLKE--KH 144
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
VIHRDVK SNILL + + +L DFG++ AG Y+APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDP 201
Query: 445 ND-----KIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQLLDPA 498
+ DV++ G+ L+EL TG+ P N + V+ +P P
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP------------PL 249
Query: 499 LGNNYDY-DQMERMVLASILCIRRDPRARP------QMSLVLKLLRGDADVTKWAR 547
L + + + V C+ +D R RP + S + + + DV W +
Sbjct: 250 LPGHMGFSGDFQSFVKD---CLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFK 302
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 76/284 (26%), Positives = 117/284 (41%), Gaps = 53/284 (18%)
Query: 271 IGKGGSSQVYKGCL---PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 323
+G+G +V C DG AVK LK + EI+I+ TL+H++II
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 324 LGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
G C + +L LV +++ GSL + L + G ++ A + E + YLH+
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHA- 152
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 436
Q IHRD+ + N+LL +D ++ DFGLAK + G AP
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAP 206
Query: 437 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495
E K DV++FGV L ELLT S P L+ A+ ++ ++T+LL
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELIGIAQGQMTVLRLTELL 264
Query: 496 D------------PALGNNYDYDQMERMVLASILCIRRDPRARP 527
+ + Y M+ C + RP
Sbjct: 265 ERGERLPRPDKCPAEV-----YHLMKN-------CWETEASFRP 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 32/221 (14%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKEL----AVKILKP---SEDVIKEFVLEIEIITTLHHKNI 320
++G+G V +G L AVK +K S+ I+EF+ E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 321 ISLLGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG--VAE 373
I LLG C E + +++ F+ G L L ++ + + + +A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGTF 431
+EYL S + +HRD+ + N +L DD ++DFGL+K I D G
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK-------IYSGDYYRQGRI 208
Query: 432 GYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ A E K DV+AFGV + E+ T G P
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 70/318 (22%), Positives = 137/318 (43%), Gaps = 55/318 (17%)
Query: 271 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 322
+G+G VY+G + D E A+K + S EF+ E ++ + +++
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALE 376
LLG + L++ + ++RG L+ L + A ++A +A+ +
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--VAGTFGYL 434
YL +A + +HRD+ + N ++++DF ++ DFG+ + I TD G G L
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-------IYETDYYRKGGKGLL 202
Query: 435 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISNDHPKGQESLVMWAKPI 485
+PE G DV++FGVVL E+ T +P +SN ++ L
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRF----- 252
Query: 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKW 545
+ G + L P + ++ M C + +P+ RP ++ ++ + + +
Sbjct: 253 VMEGGL--LDKPDNCPDMLFELMRM-------CWQYNPKMRPSFLEIISSIKEEME-PGF 302
Query: 546 ARLQVNASEESEMLDDES 563
+ SEE+++ + E
Sbjct: 303 REVSFYYSEENKLPEPEE 320
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 53/284 (18%), Positives = 93/284 (32%), Gaps = 32/284 (11%)
Query: 210 DSGAIVPVGNEIVSSPLSTDHDST---ELPKELEGLHEKYSATCRLFNYQ---DLLSATS 263
S V N IV +P L K + + C+L + + +
Sbjct: 6 SSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65
Query: 264 NFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVL---EIEIITT 314
+L+G+G +QVY+ + ++ +K+ KP+ EF + +E +
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP 123
Query: 315 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDP-AAFGWSERYKVAMGVAE 373
+ N +LV + S G+L ++ K P AM +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEP-----------QLSDFGLAKWASTSSSHI 422
+E +H +IH D+K N +L + F L D G +
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
T T G+ E N +ID + + +L G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
+ +IGKG VY G D + A+K L ++ F+ E ++ L+H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 322 SLLGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
+L+G + ++ ++ G L + + +++P + + VA +EYL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYL-- 140
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPEY 438
+ Q+ +HRD+ + N +L + F +++DFGLA+ + + A E
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 439 FMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ K DV++FGV+L ELLT G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 33/293 (11%), Positives = 71/293 (24%), Gaps = 51/293 (17%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLHHKNIISLL 324
+ G S V+ + ++ A+K+ + S ++ L ++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 325 GFC--------------------------FEDNNLLLVYDFL--SRGSLEENLHGNKKDP 356
+ N LL+ L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 357 AAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416
G + + + L S + ++H N+ + D L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 417 TSSSHITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474
T + Y E+ ++ + G+ + + P P
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 527
+ S + + + A G+ + ++ L D R R
Sbjct: 301 KGSWKRPSLRVPGTD------SLAFGSCTPLPDFVKTLIGRFL--NFDRRRRL 345
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 249 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 447
HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+ K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 448 IDVYAFGVVLLELLT-GRKP 466
DV++FG++L EL T GR P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 1e-30
Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
IG G V+ G + ++A+K ++ ++F+ E E++ L H ++ L G C
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
E + LV +F+ G L + L + F + + V E + YL VI
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVN 445
HRD+ + N L+ ++ ++SDFG+ ++ + F +PE F + + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 446 DKIDVYAFGVVLLELLT-GRKP 466
K DV++FGV++ E+ + G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 33/219 (15%)
Query: 271 IGKGGSSQVYKGCL--PDGKEL--AVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 323
+GKG V + L DG + AVK+LK + I+EF+ E + H ++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 324 LGFCFED------NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEAL 375
+G +++ F+ G L L ++P + + +A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGTFGY 433
EYL S++ IHRD+ + N +L++D ++DFGL++ I D G
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK-------IYSGDYYRQGCASK 200
Query: 434 L-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
L A E DV+AFGV + E++T G+ P
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 54/268 (20%), Positives = 95/268 (35%), Gaps = 49/268 (18%)
Query: 270 LIGKGGSSQVYKG--CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHKNIISLLG 325
I GG +Y +G+ + +K L S D + E + + + H +I+ +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 326 FCFEDNNLL-----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
F + +V +++ SL+ + +E + + AL YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH- 199
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+ +++ D+K NI+L+++ + +L D G S + + GT G+ APE
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGFQAPEIVR 250
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500
D+Y G L L + + G DP L
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LPEDDPVLK 292
Query: 501 NNYDYDQMERMVLASILCIRRDPRARPQ 528
YD R++ I DPR R
Sbjct: 293 ---TYDSYGRLLRR---AIDPDPRQRFT 314
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 51/287 (17%)
Query: 268 ENLIGKGGSSQVYKGCLP-----DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 320
+G+G +V G+++AVK LKP + I + EIEI+ L+H+NI
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 321 ISLLGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
+ G C ED + L+ +FL GSL+E L NK ++ K A+ + + ++YL
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKGMDYL 142
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL---- 434
S ++ +HRD+ + N+L+ + + ++ DFGL K T + T
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFW 195
Query: 435 -APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492
APE M K DV++FGV L ELLT S ++ ++ ++
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP--MALFLKMIGPTHGQMTVTRLV 253
Query: 493 QLLD------------PALGNNYDYDQMERMVLASILCIRRDPRARP 527
L + Y M + C P R
Sbjct: 254 NTLKEGKRLPCPPNCPDEV-----YQLMRK-------CWEFQPSNRT 288
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
E +IG G S +V G L P +++ A+K LK +E ++F+ E I+ H NII
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L G ++V +++ GSL+ L + F + + GV + YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ---FTIMQLVGMLRGVGAGMRYL--- 167
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 436
S +HRD+ + N+L+ + ++SDFGL++ T G + AP
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD----AAYTTTGGKIPIRWTAP 223
Query: 437 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
E + + DV++FGVV+ E+L G +P
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP----SEDVIKEFVLEIEIITTLHHKN 319
+G G V +G P GK + AVK LKP + + +F+ E+ + +L H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
+I L G + +V + GSL + L ++ F + A+ VAE + YL
Sbjct: 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYL- 137
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPE 437
++R IHRD+ + N+LL+ ++ DFGL + + H + + APE
Sbjct: 138 --ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HRKVPFAWCAPE 194
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ D + FGV L E+ T G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G G V G ++A+K++K EF+ E +++ L H+ ++ L G C
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
+ + ++ ++++ G L L + F + ++ V EA+EYL +++ +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 441
HRD+ + N L++D ++SDFGL+++ + + + G PE MY
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRY-------VLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 442 GKVNDKIDVYAFGVVLLELLT-GRKP 466
K + K D++AFGV++ E+ + G+ P
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 17/212 (8%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKI--LKPSEDVIKEFVLEIEII-TTLHHKNIISLLGF 326
IG+G V K P G+ +AVK E K+ +++++++ + I+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 384
F + + + + +S S ++ E K+ + +AL +L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDD-VIPEEILGKITLATVKALNHLKE--NL 145
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
++IHRD+K SNILL +L DFG++ S I T AG Y+APE
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSAS 202
Query: 445 ND----KIDVYAFGVVLLELLTGRKPISNDHP 472
+ DV++ G+ L EL TGR P +
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 266 LAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP---SEDVIKEFVLEIEIITTLHHKN 319
L + +G G V KG K + AVKILK + E + E ++ L +
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYL- 133
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF--GYLAPE 437
+HRD+ + N+LL ++SDFGL+K ++ G + + APE
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPE 190
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
Y K + K DV++FGV++ E + G+KP
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 55/214 (25%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
E +G G +V+ ++AVK +KP ++ F+ E ++ TL H ++ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
++ + ++ +F+++GSL + L ++ + + +AE + ++ + I
Sbjct: 253 TKE-PIYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWAS----TSSSH----ITCTDVAGTFGYLAPEYF 439
HRD++++NIL+S +++DFGLA+ T+ I T APE
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT---------APEAI 357
Query: 440 MYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 469
+G K DV++FG++L+E++T GR P +SN
Sbjct: 358 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 67/261 (25%), Positives = 120/261 (45%), Gaps = 30/261 (11%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFCF 328
IG+G + V G+++AVK++ + +E + E+ I+ H N++ +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 386
L ++ +FL G+L + + + +E V V +AL YLH+ Q V
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLHA---QGV 162
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 446
IHRD+KS +ILL+ D +LSDFG A S + GT ++APE
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRSLYAT 220
Query: 447 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 506
++D+++ G++++E++ G P +D P +++ + S P L N++
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSP--VQAMKR----LRDSPP------PKLKNSHKVS 268
Query: 507 QMERMVLASILCIRRDPRARP 527
+ R L + RDP+ R
Sbjct: 269 PVLRDFLE--RMLVRDPQERA 287
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 268 ENLIGKGGSSQVYKGCLPDGK-ELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
++ +G G +VY+G +AVK LK ++EF+ E ++ + H N++ LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
C + ++ +F++ G+L + L + + +A ++ A+EYL +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----APEYFMY 441
IHRD+ + N L+ ++ +++DFGL++ + T A APE Y
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPESLAY 186
Query: 442 GKVNDKIDVYAFGVVLLELLT-GRKP 466
K + K DV+AFGV+L E+ T G P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 40/229 (17%)
Query: 271 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 323
+G+G +V+ P ++ AVK LK + K+F E E++T L H++I+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAMGV 371
G C + + L++V++++ G L + L + D + +A +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--VAG 429
A + YL ++Q +HRD+ + N L+ + ++ DFG+++ + TD G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-------DVYSTDYYRVG 192
Query: 430 TFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 469
L PE MY K + DV++FGV+L E+ T G++P +SN
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 241
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 324
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 325 GFCFED-NNLLLVYDFLSRGSLEENLHGNKK--DPAAFGWSERYKVAMGVAEALEYLHSG 381
G FED + + +V + R SL E K +P A RY + + +YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 133
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYF 439
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+APE
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVL 187
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKP 466
+ ++DV++ G ++ LL G+ P
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-30
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 36/220 (16%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
++G+G ++ V++G G A+K+ + + E E++ L+HKNI+ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 327 CFED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 381
E+ + +L+ +F GSL L A+G E V V + +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSN---AYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
++HR++K NI+ + Q L+DFG A+ + GT YL P+
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 438 YFM-----------YGKVNDKIDVYAFGVVLLELLTGRKP 466
+ YG +D+++ GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGA---TVDLWSIGVTFYHAATGSLP 222
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 39/228 (17%)
Query: 271 IGKGGSSQVYKG----CLPDGKEL--AVKILKP-SEDVIKEFVLEIEIITTLHHKNIISL 323
+G+G +V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 324 LGFCFEDNNLLLVYDFLSRGSL-----------EENLHGNKKDPAAFGWSERYKVAMGVA 372
G C E LL+V++++ G L + G P G + VA VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV--AGT 430
+ YL + +HRD+ + N L+ ++ DFG+++ I TD G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYSTDYYRVGG 218
Query: 431 FGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 469
L PE +Y K + DV++FGVVL E+ T G++P +SN
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 8e-30
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++ L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
E+ + +V +++S+GSL + L G + +A +A + Y+ +
Sbjct: 332 SEE-PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 447
HRD++++NIL+ ++ +++DFGLA+ + + + APE +YG+ K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 448 IDVYAFGVVLLELLT-GRKP 466
DV++FG++L EL T GR P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 41/233 (17%)
Query: 268 ENLIGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKN 319
+G+ +VYKG P + A+K LK + +EF E + L H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDPAAFGWSERYKV 367
++ LLG +D L +++ + S G L E L ++ +A + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 426
+A +EYL S+ V+H+D+ + N+L+ D ++SD GL + + D
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-------EVYAADY 183
Query: 427 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 469
L APE MYGK + D++++GVVL E+ + G +P SN
Sbjct: 184 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-29
Identities = 61/245 (24%), Positives = 116/245 (47%), Gaps = 16/245 (6%)
Query: 230 HDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGK 288
+P + +S L + + L + +A+ +G G V +G K
Sbjct: 303 DKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK 362
Query: 289 EL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGS 344
++ A+K+LK + +E + E +I+ L + I+ L+G C + L+LV + G
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 421
Query: 345 LEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 404
L + L G +++ S ++ V+ ++YL + +HR++ + N+LL +
Sbjct: 422 LHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYA 475
Query: 405 QLSDFGLAKWASTSSSHITCTDVAGTFGY--LAPEYFMYGKVNDKIDVYAFGVVLLELLT 462
++SDFGL+K S+ T AG + APE + K + + DV+++GV + E L+
Sbjct: 476 KISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
Query: 463 -GRKP 466
G+KP
Sbjct: 535 YGQKP 539
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 324
+GKGG ++ ++ + A KI+ ++ +EI I +L H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 325 GFCFED-NNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
G FED + + +V + R SL E +P A RY + + +YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----RYYL-RQIVLGCQYLHR- 159
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS--HITCTDVAGTFGYLAPEYF 439
RVIHRD+K N+ L++D E ++ DFGLA + C GT Y+APE
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEVL 213
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKP 466
+ ++DV++ G ++ LL G+ P
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 271 IGKGGSSQVYKGCL-PDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNIISL 323
+G G VYKG P+G+++ A+K L+ S KE + E ++ ++ + ++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
LG C + L+ + G L + + +K + G + +A+ + YL
Sbjct: 83 LGICLTST-VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED--- 135
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK 443
+R++HRD+ + N+L+ +++DFGLAK ++A E ++
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 444 VNDKIDVYAFGVVLLELLT-GRKP 466
+ DV+++GV + EL+T G KP
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 44/226 (19%), Positives = 93/226 (41%), Gaps = 33/226 (14%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVKILK------------------PSEDVIKEFVLEIEII 312
+ +G +++ C D K A+K + + +F E++II
Sbjct: 39 LNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 313 TTLHHKNIISLLGFCFED-NNLLLVYDFLSRGSL----EENLHGNKKDPAAFGWSERYKV 367
T + ++ ++ G + + + ++Y+++ S+ E +K +
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 427
V + Y+H+ + + HRDVK SNIL+ + +LSDFG +++ +
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--- 211
Query: 428 AGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKPISNDH 471
GT+ ++ PE+F K+D+++ G+ L + P S
Sbjct: 212 -GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
++GKG VY G L + +A+K I + + EI + L HKNI+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 385
E+ + + + + GSL L + +E+ + E L+YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142
Query: 386 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
++HRD+K N+L+ + ++SDFG +K + + GT Y+APE G
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQYMAPEIIDKGPR 200
Query: 445 --NDKIDVYAFGVVLLELLTGRKPISN-DHP 472
D+++ G ++E+ TG+ P P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPPFYELGEP 231
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G G +V+ G ++AVK LK F+ E ++ L H+ ++ L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
++ + ++ +++ GSL + L ++ +A +AE + ++ + I
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 388 HRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------APEYFMY 441
HRD++++NIL+SD +++DFGLA+ I + G APE Y
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARL-------IEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 442 GKVNDKIDVYAFGVVLLELLT-GRKP---ISN 469
G K DV++FG++L E++T GR P ++N
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKEL---AVKILKP--SEDVIKEFVLEIEIITTLHHKNI 320
+ +IG G +VYKG L GK+ A+K LK +E +F+ E I+ H NI
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
I L G + ++++ +++ G+L++ L + F + + G+A ++YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL-- 163
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----A 435
+ +HRD+ + NIL++ + ++SDFGL++ + G + A
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE----ATYTTSGGKIPIRWTA 218
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
PE Y K DV++FG+V+ E++T G +P
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL----KPSEDVIKEFVLEIEIITTLH 316
F IG G VY + + + +A+K + K S + ++ + E+ + L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 317 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 374
H N I G ++ LV ++ GS + L +KK E V G +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQG 166
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
L YLHS +IHRDVK+ NILLS+ +L DFG AS + + GT ++
Sbjct: 167 LAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGS---ASIMAPANS---FVGTPYWM 217
Query: 435 APEYFMYGKV---NDKIDVYAFGVVLLELLTGRKPISNDHP 472
APE + + K+DV++ G+ +EL + P+ N +
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
+ ++G G +V G L P KE+ A+K LK +E ++F+ E I+ H NII
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L G + +++V +++ GSL+ L + F + + G+A ++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYL--- 163
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL-----AP 436
S +HRD+ + NIL++ + ++SDFGL + G + +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE----AAYTTRGGKIPIRWTSP 219
Query: 437 EYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
E Y K DV+++G+VL E+++ G +P
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 22/230 (9%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 323
+G G +V E A+KI+ S + + E+ ++ L H NI+ L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 381
F + N LV + G L + + K ++E + V + YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHK- 154
Query: 382 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
++HRD+K N+LL D ++ DFGL+ + GT Y+APE
Sbjct: 155 --HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEV 209
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 488
K ++K DV++ GV+L LL G P + V K S
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
IG+G V++G P+ L A+K K S+ V ++F+ E + H +I+
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL--- 132
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL------A 435
++R +HRD+ + N+L+S + +L DFGL+++ + + A
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMA 185
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
PE + + DV+ FGV + E+L G KP
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-29
Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLLG 325
+GKG +V G+E AVK++ + + + E++++ L H NI+ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSA 383
F + LV + + G L + + K+ +SE ++ V + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSGITYMHK--- 144
Query: 384 QRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+++HRD+K N+LL S D ++ DFGL+ S D GT Y+APE
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLH 201
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKP 466
G ++K DV++ GV+L LL+G P
Sbjct: 202 -GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 50/207 (24%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 268 ENLIGKGGSSQVYKGCL-PDGKEL----AVKILK--PSEDVIKEFVLEIEIITTLHHKNI 320
++G G V+KG P+G+ + +K+++ + + I +L H +I
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
+ LLG C + L LV +L GSL +++ ++ G + +A+ + YL
Sbjct: 78 VRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYL-- 131
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
++HR++ + N+LL + Q++DFG+A + ++ ++A E
Sbjct: 132 -EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 441 YGKVNDKIDVYAFGVVLLELLT-GRKP 466
+GK + DV+++GV + EL+T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 271 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 322
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDPAAFGWSERYKVAMGVAEALEYLH 379
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAKWASTSSSHITCTD--VAGTFGYL 434
IHRD+ + N LL+ ++ DFG+A+ I G L
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKGGCAML 207
Query: 435 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
PE FM G K D ++FGV+L E+ + G P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 67/307 (21%), Positives = 119/307 (38%), Gaps = 61/307 (19%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI-ITTLHHKNII 321
+ ++E ++G G S V G+ +AVK + D ++EI++ + H N+I
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALMEIKLLTESDDHPNVI 72
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
D L + + L +L+ E+ + + ++ + +A + +L
Sbjct: 73 RYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQ-------------LSDFGLAK--WASTSSSHIT 423
HS ++IHRD+K NIL+S +SDFGL K + SS
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 424 CTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 476
+ +GT G+ APE ++ ID+++ G V +L+ K HP G +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK-----HPFGDK 243
Query: 477 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL---------CIRRDPRARP 527
I+ + D+M+ + S++ I DP RP
Sbjct: 244 YSRESN--IIR-------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288
Query: 528 QMSLVLK 534
VL+
Sbjct: 289 TAMKVLR 295
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 50/224 (22%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKEL--------AVKILKP-SEDVIKEFVLEIEIITTLHHK 318
+G+G ++++KG + + +K+L + + F +++ L HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
+++ G C + +LV +F+ GSL+ L NK + +VA +A A+ +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMHFL 129
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQ--------LSDFGLAKWASTSSSHITCTDVAGT 430
+IH +V + NILL + + + LSD G++ V
Sbjct: 130 ---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------------TVLPK 174
Query: 431 FGY------LAPEYFMYGKV-NDKIDVYAFGVVLLELLT-GRKP 466
+ PE K N D ++FG L E+ + G KP
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 271 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 322
+G G +VY+G D L AVK L SE +F++E II+ +H+NI+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLH 379
+G + ++ + ++ G L+ L + P++ + VA +A +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQL---SDFGLAKWASTSSSHITCTD--VAGTFGYL 434
IHRD+ + N LL+ ++ DFG+A+ I G L
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRAGYYRKGGCAML 248
Query: 435 -----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
PE FM G K D ++FGV+L E+ + G P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 65/211 (30%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKI-----LKPSEDVIKEFVL-EIEIITTLHHKNIISL 323
IGKG S V + G++ AVKI S + E + E I L H +I+ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 381
L D L +V++F+ L + K+ A F +SE + EAL Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI--VKRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE- 437
+IHRDVK +LL+ L FG+A S GT ++APE
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEV 204
Query: 438 --YFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
YGK +DV+ GV+L LL+G P
Sbjct: 205 VKREPYGK---PVDVWGCGVILFILLSGCLP 232
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 63/231 (27%), Positives = 111/231 (48%), Gaps = 42/231 (18%)
Query: 268 ENLIGKGGSSQVYKGCL-PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 321
+++IG+G QV K + DG + A+K +K S+D ++F E+E++ L HH NII
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVAM 369
+LLG C L L ++ G+L + L ++ ++ A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD--V 427
VA ++YL S ++ IHRD+ + NIL+ +++ +++DFGL++ + V
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYV 196
Query: 428 AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 469
T G L A E Y DV+++GV+L E+++ G P ++
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 25/222 (11%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIISLL 324
++ +GG + VY+ + G+E A+K +L E+ + + E+ + L H NI+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 325 GFCF-------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
L+ L +G L E L + K+ A+++
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--------- 428
+H +IHRD+K N+LLS+ +L DFG A S +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 429 -GTFGYLAPEYF-MYGK--VNDKIDVYAFGVVLLELLTGRKP 466
T Y PE +Y + +K D++A G +L L + P
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-28
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISL 323
++GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSG 381
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK- 139
Query: 382 SAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+APE
Sbjct: 140 --HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEV 194
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKP 466
G ++K DV++ GV+L LL+G P
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-28
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
IG+G V++G P+ + A+K K S+ V ++F+ E + H +I+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L+G +N + ++ + + G L L K + A ++ AL YL
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYL--- 507
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV-AGTFGYL-----A 435
++R +HRD+ + N+L+S + +L DFGL+++ + + + G L A
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKGKLPIKWMA 560
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
PE + + DV+ FGV + E+L G KP
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 268 ENLIGKGGSSQVYKGCL--PDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
++G+G +VY+G G+++ AVK K + D ++F+ E I+ L H +I+
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L+G E+ ++ + G L L NK ++ + +A+ YL
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV---LTLVLYSLQICKAMAYL--- 129
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYL-----A 435
+ +HRD+ NIL++ +L DFGL+++ I D + L +
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRY-------IEDEDYYKASVTRLPIKWMS 182
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
PE + + DV+ F V + E+L+ G++P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-28
Identities = 63/253 (24%), Positives = 104/253 (41%), Gaps = 46/253 (18%)
Query: 249 TCRLFNYQDLLSATSNFLAENL---------IGKGGSSQVYKGC-LPDGKELAVKILKPS 298
++F + DL + + L +G G +V K++A++I+
Sbjct: 112 RNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKR 171
Query: 299 EDVIKEFVL---------EIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENL 349
+ I EIEI+ L+H II + F F+ + +V + + G L + +
Sbjct: 172 KFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV 230
Query: 350 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ-- 405
GNK+ E + A++YLH +IHRD+K N+LLS E
Sbjct: 231 VGNKR------LKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 281
Query: 406 -LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE------YFMYGKVNDKIDVYAFGVVLL 458
++DFG +K +S + GT YLAPE Y + +D ++ GV+L
Sbjct: 282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNR---AVDCWSLGVILF 335
Query: 459 ELLTGRKPISNDH 471
L+G P S
Sbjct: 336 ICLSGYPPFSEHR 348
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 9e-28
Identities = 44/313 (14%), Positives = 97/313 (30%), Gaps = 48/313 (15%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKEFVLEIEIITTL----HHKNI 320
++G+ + G+ V + +P + IK+ E+ + L + K
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 321 ISLLGFCFEDN-----------------------NLLLVYDFL--SRGSLEENLHGNKKD 355
L F F + + +Y + + + E L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 356 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 416 STSSSHITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISND 470
S+ A + + D + G+ + + P ++D
Sbjct: 262 GASAV-SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 471 HPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 530
G + + + V LL+ L Y + +R++ + + R ++S
Sbjct: 321 AALGGSEWIFRSCKNIPQP-VRALLEGFL----RYPKEDRLLPLQAMETPEYEQLRTELS 375
Query: 531 LVLKLLRGDADVT 543
L L + D + T
Sbjct: 376 AALPLYQTDGEPT 388
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 59/219 (26%), Positives = 89/219 (40%), Gaps = 33/219 (15%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKILK--------------PSEDVIKEFVLEIEII 312
+G G +V E A+K++K E +E EI ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 313 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMG 370
+L H NII L + LV +F G L E + K + E +
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQ 154
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDV 427
+ + YLH ++HRD+K NILL + ++ DFGL+ + S D
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDR 208
Query: 428 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
GT Y+APE K N+K DV++ GV++ LL G P
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 49/238 (20%)
Query: 271 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 322
IG+G +V++ LP AVK+LK S D+ +F E ++ + NI+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------------- 365
LLG C + L++++++ G L E L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 366 ---KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422
+A VA + YL S ++ +HRD+ + N L+ ++ +++DFGL++ +I
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-------NI 224
Query: 423 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 469
D A + PE Y + + DV+A+GVVL E+ + G +P +++
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 271 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTLHHKNIIS 322
+G+G +V K K AVK+LK S +++ + E ++ ++H ++I
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG------------ 370
L G C +D LLL+ ++ GSL L ++K + S + +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 371 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422
+++ ++YL + +++HRD+ + NIL+++ + ++SDFGL++ +
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD-------V 200
Query: 423 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISN 469
D V + G + A E + DV++FGV+L E++T G P I
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 40/317 (12%), Positives = 93/317 (29%), Gaps = 71/317 (22%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKIL----KPSEDVIKE-------------------- 304
++G+ + G+ V + +P + IK+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 305 -----FVLEIEIITTLHHKNIISLLGFC--FEDNNLLLVYDFL--SRGSLEENLHGNKKD 355
F+ +++ K +I + + +Y + + + E L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 356 PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 416 STSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGR 464
+ + G+ PE + D +A G+V+ +
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 465 KPISNDHPKGQESLVMWAKPILSSGK---VTQLLDPALGNNYDYDQMERMVLASILCIRR 521
PI+ D G + + + + L + +R++ +
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--------PKEDRLLPLQAM---E 359
Query: 522 DP---RARPQMSLVLKL 535
P + R ++S L L
Sbjct: 360 TPEYEQLRTELSAALPL 376
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 51/226 (22%), Positives = 94/226 (41%), Gaps = 37/226 (16%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHK 318
+G G +V + + AVK+LK D + + E++I++ L H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY----------KVA 368
NI++LLG C +L++ ++ G L L + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-- 426
VA+ + +L +++ IHRDV + N+LL++ ++ DFGLA+ I
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-------DIMNDSNY 220
Query: 427 VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
+ L APE + DV+++G++L E+ + G P
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 328
IG G S + E AVKI+ S+ E EIEI+ H NII+L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEILLRYGQHPNIITLKDVYD 86
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRV 386
+ + +V + + G L + + K +SER V + + +EYLH+ Q V
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKF------FSEREASAVLFTITKTVEYLHA---QGV 137
Query: 387 IHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 440
+HRD+K SNIL D+ + DFG AK + T ++APE
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQ 195
Query: 441 -YGKVNDKIDVYAFGVVLLELLTGRKP 466
Y D+++ GV+L +LTG P
Sbjct: 196 GYDA---ACDIWSLGVLLYTMLTGYTP 219
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-27
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 23/223 (10%)
Query: 264 NFLAENLIGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNI 320
+ + +G GG V + G+++A+K + S + + LEI+I+ L+H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 321 ISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVA 372
+S ++ LL ++ G L + L+ + G E + ++
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTLLSDIS 131
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAG 429
AL YLH R+IHRD+K NI+L + + D G AK CT+ G
Sbjct: 132 SALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVG 185
Query: 430 TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472
T YLAPE K +D ++FG + E +TG +P +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 7e-27
Identities = 59/248 (23%), Positives = 89/248 (35%), Gaps = 58/248 (23%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILK------PSEDVIKEFVLEIEIITTLHHKNIISL 323
IG+G V A+KI+ + ++ E+ ++ LHH NI L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 324 LGFCFEDNNLLLVYDFLSRGSL----------------------------------EENL 349
++ + LV + G L
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 350 HGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQ 405
++ F E+ + + AL YLH+ Q + HRD+K N L S FE +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 406 LSDFGLAKW--ASTSSSHITCTDVAGTFGYLAPE-----YFMYGKVNDKIDVYAFGVVLL 458
L DFGL+K + + T AGT ++APE YG K D ++ GV+L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP---KCDAWSAGVLLH 267
Query: 459 ELLTGRKP 466
LL G P
Sbjct: 268 LLLMGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 268 ENLIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLG 325
++G G S+V+ GK A+K +K S + EI ++ + H+NI++L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 326 FCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 374
+E + LV +S RG E KD + V V A
Sbjct: 74 I-YESTTHYYLVMQLVSGGELFDRILERGVYTE------KDAS--------LVIQQVLSA 118
Query: 375 LEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
++YLH ++HRD+K N+L ++ + ++DFGL+K + GT
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTP 171
Query: 432 GYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 466
GY+APE Y K +D ++ GV+ LL G P
Sbjct: 172 GYVAPEVLAQKPYSK---AVDCWSIGVITYILLCGYPP 206
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 271 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 319
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 367
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 426
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+ I D
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD-------INNIDY 258
Query: 427 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
T G L APE + DV++FGV++ E+ T G P
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 41/227 (18%)
Query: 271 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 319
+G+G QV + AVK+LK +E + + V E+E++ + HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KV 367
II+LLG C +D L ++ ++ S+G+L E L + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 426
+A +EYL ++Q+ IHRD+ + N+L++++ +++DFGLA+ I D
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-------DINNIDY 212
Query: 427 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
T G L APE + DV++FGV++ E+ T G P
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 17/204 (8%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKIL--KPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G G V+ G E +K + S+ +++ EIE++ +L H NII +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 385
+ +N+ +V + G L E + + A SE Y ++ + AL Y HS Q
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKAL--SEGYVAELMKQMMNALAYFHS---QH 144
Query: 386 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
V+H+D+K NIL S ++ DFGLA+ + T+ AGT Y+APE F
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-R 200
Query: 443 KVNDKIDVYAFGVVLLELLTGRKP 466
V K D+++ GVV+ LLTG P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 53/227 (23%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 266 LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISL 323
L++ ++G G + +V + G++ A+K+L S +E ++ +I+ +
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASGGPHIVCI 87
Query: 324 LGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 376
L +E+ LL++ + + G L + ++ AF +ER ++ + A++
Sbjct: 88 LDV-YENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAF--TEREAAEIMRDIGTAIQ 142
Query: 377 YLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 433
+LHS + HRDVK N+L D +L+DFG AK + ++ C T Y
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYY 195
Query: 434 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480
+APE K + D+++ GV++ LL G P ++ + +
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 271 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 327
+G G V++ C+ G+ K + + K V EI I+ LHH +I+L
Sbjct: 59 LGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 328 FED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 384
FED ++L+ +FLS G L + + +D + SE E L+++H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRI--AAED---YKMSEAEVINYMRQACEGLKHMHE---H 168
Query: 385 RVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
++H D+K NI+ + DFGLA + T + APE
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVDRE 225
Query: 443 KVNDKIDVYAFGVVLLELLTGRKP 466
V D++A GV+ LL+G P
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
+GKG +V K +E AVK++ + E+E++ L H NI+ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 384
+ ++ +V + + G L + + K+ +SE ++ V + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK---H 140
Query: 385 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 440
++HRD+K NILL D + ++ DFGL+ ++ D GT Y+APE
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG 197
Query: 441 -YGKVNDKIDVYAFGVVLLELLTGRKP 466
Y + K DV++ GV+L LL+G P
Sbjct: 198 TYDE---KCDVWSAGVILYILLSGTPP 221
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 64/234 (27%), Positives = 112/234 (47%), Gaps = 44/234 (18%)
Query: 271 IGKGGSSQVYKGCLPDGKEL--------AVKILKP--SEDVIKEFVLEIEIITTL-HHKN 319
+G+G QV + AVK+LK +E + + + E+E++ + HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK----------VAM 369
II+LLG C +D L ++ ++ S+G+L E L + + ++ + V+
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 370 G--VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD- 426
VA +EYL ++++ IHRD+ + N+L+++D +++DFGLA+ I D
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-------DIHHIDY 246
Query: 427 -VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP---ISND 470
T G L APE + DV++FGV+L E+ T G P + +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 62/234 (26%), Positives = 110/234 (47%), Gaps = 40/234 (17%)
Query: 260 SATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEII 312
S + F L E+++G+G ++V L +E AVKI++ I+ V E+E++
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 313 TTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVA 368
H+N++ L+ F FE+ + LV++ + GS+ ++H + ++E V
Sbjct: 65 YQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASVVV 117
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAK-----WASTSSS 420
VA AL++LH+ + + HRD+K NIL + ++ DF L + S
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 421 HITCTDVAGTFGYLAPE--------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
G+ Y+APE +Y K + D+++ GV+L LL+G P
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDK---RCDLWSLGVILYILLSGYPP 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 266 LAENLIGKGGSSQVYKGC-LPDGKELAVK-ILKPSEDVIKEFVLEIEIITTL-HHKNIIS 322
L + +G+G S K + AVK I K E ++ EI + H NI+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVK 70
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 380
L + + LV + L+ G L E + K +SE + + A+ ++H
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHD 124
Query: 381 GSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
V+HRD+K N+L +D+ E ++ DFG A+ + + T Y APE
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--TPCFTLHYAAPE 179
Query: 438 YFM---YGKVNDKIDVYAFGVVLLELLTGRKP 466
Y + D+++ GV+L +L+G+ P
Sbjct: 180 LLNQNGYDE---SCDLWSLGVILYTMLSGQVP 208
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 271 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 321
+G+G QV + + AVK+LK + + + E++I+ + HH N++
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 322 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY------------KVA 368
+LLG C + L+++ +F G+L L + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV- 427
VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+ I
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD-------IYKDPDY 204
Query: 428 -AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
L APE + DV++FGV+L E+ + G P
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 38/227 (16%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPS----------EDVIKEFVLEIEIITTL-HHK 318
+G+G SS V + P KE AVKI+ + +++ + + E++I+ + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALE 376
NII L + LV+D + +G L + L SE+ K+ + E +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVIC 138
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
LH ++HRD+K NILL DD +L+DFG + +V GT YLAP
Sbjct: 139 ALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAP 192
Query: 437 EYFM---------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474
E YGK ++D+++ GV++ LL G P +
Sbjct: 193 EIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPFWHRKQML 236
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 60/206 (29%), Positives = 86/206 (41%), Gaps = 26/206 (12%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 328
IG+G +V A K I K + + F EIEI+ +L H NII L F
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-F 75
Query: 329 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 385
ED ++ LV + + G L E + + + E ++ V A+ Y H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHK---LN 126
Query: 386 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 440
V HRD+K N L S D +L DFGLA GT Y++P+
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL 183
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKP 466
YG + D ++ GV++ LL G P
Sbjct: 184 YGP---ECDEWSAGVMMYVLLCGYPP 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 43/205 (20%), Positives = 83/205 (40%), Gaps = 24/205 (11%)
Query: 271 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 328
+G+G V++ C+ K K +K EI I+ H+NI+ L
Sbjct: 13 LGRGEFGIVHR-CVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 329 EDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
L+++++F+S + N+++ ++ V EAL++LHS
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSY--------VHQVCEALQFLHS--- 120
Query: 384 QRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
+ H D++ NI+ + +FG A+ + + Y APE +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQH 177
Query: 442 GKVNDKIDVYAFGVVLLELLTGRKP 466
V+ D+++ G ++ LL+G P
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVL---------EIEIITTLHHKNI 320
+G G +V K++A+KI+ + I EIEI+ L+H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYL 378
I + F F+ + +V + + G L + + GNK+ E + A++YL
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLLAVQYL 130
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
H +IHRD+K N+LLS E ++DFG +K +S + GT YLA
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLA 184
Query: 436 PE------YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 471
PE Y + +D ++ GV+L L+G P S
Sbjct: 185 PEVLVSVGTAGYNR---AVDCWSLGVILFICLSGYPPFSEHR 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 54/228 (23%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 265 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 322
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 119
Query: 323 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 375
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 120 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 174
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEP---QLSDFGLAKWASTSSSHITCTDVAGTFG 432
+YLHS + HRDVK N+L + +L+DFG AK ++ + + T T
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPY 228
Query: 433 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480
Y+APE K + D+++ GV++ LL G P ++H +
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 384
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 124
Query: 385 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 440
++HR++K N+LL+ + L+DFGLA + S AGT GYL+PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 181
Query: 441 --YGKVNDKIDVYAFGVVLLELLTGRKP 466
Y K +D++A GV+L LL G P
Sbjct: 182 DPYSK---PVDIWACGVILYILLVGYPP 206
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 264 NFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNI 320
++G G QV+K C G +LA KI+K KE V EI ++ L H N+
Sbjct: 90 TVSKTEILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 321 ISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 377
I L FE N+++LV +++ G L + + + + +E + E + +
Sbjct: 149 IQLYDA-FESKNDIVLVMEYVDGGELFDRI--IDES---YNLTELDTILFMKQICEGIRH 202
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLA 435
+H ++H D+K NIL + Q+ DFGLA+ GT +LA
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLA 256
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
PE Y V+ D+++ GV+ LL+G P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 271 IGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 327
+G G V++ G A K + + KE V EI+ ++ L H +++L
Sbjct: 165 LGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 328 FEDNNLLLVYDFLSRGSL-----EENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
+DN ++++Y+F+S G L +E+ ++ + + V + L ++H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--------MRQVCKGLCHMHE-- 273
Query: 383 AQRVIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+H D+K NI+ + +L DFGL S GT + APE
Sbjct: 274 -NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAE 329
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKP 466
V D+++ GV+ LL+G P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 51/232 (21%), Positives = 94/232 (40%), Gaps = 46/232 (19%)
Query: 271 IGKGGSSQVYKGCLPDGKEL------AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 321
+G G +V + AVK+LK + + E++++T L H+NI+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 370
+LLG C + L++++ G L L ++ + + +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 371 --------VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422
VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+ I
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-------DI 222
Query: 423 TCTD--VAGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
V L APE G K DV+++G++L E+ + G P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 41/227 (18%)
Query: 271 IGKGGSSQVYKG----CLPDGKEL--AVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 321
+G G +V + + + AVK+LKP + + E+++++ L +H NI+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG----------- 370
+LLG C L++ ++ G L L + S
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 371 ---VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 427
VA+ + +L +++ IHRD+ + NILL+ ++ DFGLA+ I
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-------DIKNDSN 200
Query: 428 --AGTFGYL-----APEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
L APE + DV+++G+ L EL + G P
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 54/240 (22%), Positives = 100/240 (41%), Gaps = 27/240 (11%)
Query: 243 HEKYSATCRLFNYQDLLSATSNF-----LAENLIGKGGSSQVYKG-CLPDGKELAVKIL- 295
H +S+ L + NF L +G+G + V + G+E A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 296 --KPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHG 351
+ +D E + EI ++ +I+L +E+ + ++L+ ++ + G +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-YENTSEIILILEYAAGGEIFSLCL- 121
Query: 352 NKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ---L 406
+ SE ++ + E + YLH ++H D+K NILLS + +
Sbjct: 122 -PELAEMV--SENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKI 175
Query: 407 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
DFG+++ + ++ GT YLAPE Y + D++ G++ LLT P
Sbjct: 176 VDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
+GKG S V + G E A KI+ K S ++ E I L H NI+ L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 384
E++ LV+D ++ G L E++ + +SE + E++ Y HS
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---N 147
Query: 385 RVIHRDVKSSNILLSDDFEPQ---LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 440
++HR++K N+LL+ + L+DFGLA + S AGT GYL+PE
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKK 204
Query: 441 --YGKVNDKIDVYAFGVVLLELLTGRKP 466
Y K +D++A GV+L LL G P
Sbjct: 205 DPYSK---PVDIWACGVILYILLVGYPP 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
+GKG S V + + G+E A I+ K S ++ E I L H NI+ L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQ 384
E+ + L++D ++ G L E++ + +SE + EA+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQILEAVLHCHQ---M 129
Query: 385 RVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM- 440
V+HR++K N+LL +L+DFGLA AGT GYL+PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPEVLRK 187
Query: 441 --YGKVNDKIDVYAFGVVLLELLTGRKP 466
YGK +D++A GV+L LL G P
Sbjct: 188 DPYGK---PVDLWACGVILYILLVGYPP 212
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILK---------PSEDVIKEFVLEIEIITTLH-HKN 319
IG+G SS V + G E AVKI++ E+V + E I+ + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEY 377
II+L+ + + LV+D + +G L + L SE+ + + EA+ +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA------LSEKETRSIMRSLLEAVSF 215
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LH+ ++HRD+K NILL D+ + +LSDFG + ++ GT GYLAPE
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPE 269
Query: 438 ---------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
+ YGK ++D++A GV+L LL G P
Sbjct: 270 ILKCSMDETHPGYGK---EVDLWACGVILFTLLAGSPP 304
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 271 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 321
+G G + V K C G E A K +K V +E + E+ I+ + H N+I
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 379
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
+ +++ H D+K NI+L D P L DFGLA ++ GT ++A
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
PE Y + + D+++ GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 270 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNI 320
++G+G S V +E A+KIL+ +IK +V E ++++ L H
Sbjct: 37 ILGEGSFSTVVLARELA---TSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 321 ISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALE 376
+ L F F+D+ L + G L + + F +E + ALE
Sbjct: 93 VKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE-------IVSALE 144
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
YLH + +IHRD+K NILL++D Q++DFG AK S S GT Y++P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 437 EYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 466
E K D++A G ++ +L+ G P
Sbjct: 202 ELLTEKSACKS---SDLWALGCIIYQLVAGLPP 231
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 49/247 (19%), Positives = 93/247 (37%), Gaps = 32/247 (12%)
Query: 298 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 357
S + ++I + KN + L L + + +L++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLE 159
Query: 358 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417
+ + +AEA+E+LHS + ++HRD+K SNI + D ++ DFGL
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 418 SSSHITC----------TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
T T GT Y++PE + K+D+++ G++L ELL
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST- 275
Query: 468 SNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 527
E + + + + K L E M++ +L P RP
Sbjct: 276 ------QMERVRIITD--VRNLKFPLLFT-------QKYPQEHMMVQDMLS--PSPTERP 318
Query: 528 QMSLVLK 534
+ + +++
Sbjct: 319 EATDIIE 325
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 328
+G+G +S VY+ K A+K+LK + D K EI ++ L H NII L F
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSHPNIIKLKEI-F 117
Query: 329 ED-NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHSGSAQR 385
E + LV + ++ G L + + +SER + EA+ YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGY------YSERDAADAVKQILEAVAYLHE---NG 168
Query: 386 VIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-- 440
++HRD+K N+L + D +++DFGL+K V GT GY APE
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGC 225
Query: 441 -YGKVNDKIDVYAFGVVLLELLTGRKP 466
YG ++D+++ G++ LL G +P
Sbjct: 226 AYGP---EVDMWSVGIITYILLCGFEP 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHKNIIS 322
+G G + V K GKE A K +K +E E+ I+ + H NII+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLHS 380
L +++L+ + +S G L + L + +E + + + + YLHS
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKES------LTEDEATQFLKQILDGVHYLHS 126
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
+R+ H D+K NI+L D P L DFG+A + ++ GT ++AP
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAP 180
Query: 437 EYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
E Y + + D+++ GV+ LL+G P
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 28/211 (13%)
Query: 271 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 321
+G G + V K C G E A K +K V +E + E+ I+ + H NII
Sbjct: 20 LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEALEYLH 379
+L +++L+ + +S G L + L SE + + + YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
+ +++ H D+K NI+L D P L DFGLA ++ GT ++A
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVA 186
Query: 436 PEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
PE Y + + D+++ GV+ LL+G P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 53/220 (24%), Positives = 96/220 (43%), Gaps = 46/220 (20%)
Query: 271 IGKGGSSQVYKGCL--PDGKELAVKILK------PSEDVIKEFVL-EIEIITTLHHKNII 321
+G G + V K C G + A K +K V +E + E+ I+ + H N+I
Sbjct: 19 LGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 322 SLLGFCFED-NNLLLVYDFLS----------RGSLEENLHGNKKDPAAFGWSERYKVAMG 370
+L +E+ +++L+ + ++ + SL E ++ F
Sbjct: 78 TLHEV-YENKTDVILILELVAGGELFDFLAEKESLTE------EEATEF--------LKQ 122
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTD 426
+ + YLHS ++ H D+K NI+L D P+ + DFGLA + +
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KN 176
Query: 427 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
+ GT ++APE Y + + D+++ GV+ LL+G P
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 38/215 (17%)
Query: 270 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFV----LEIEIITTLHHKNIISLL 324
IGKG +V D K++ A+K + + V + V E++I+ L H +++L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 325 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAE---ALEY 377
+ F+D ++ +V D L G L +L N + + + E AL+Y
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-----F-----ICELVMALDY 130
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
L + QR+IHRD+K NILL + ++DF +A + T +AGT Y+APE
Sbjct: 131 LQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGTKPYMAPE 184
Query: 438 YFM------YGKVNDKIDVYAFGVVLLELLTGRKP 466
F Y +D ++ GV ELL GR+P
Sbjct: 185 MFSSRKGAGYSFA---VDWWSLGVTAYELLRGRRP 216
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 40/279 (14%), Positives = 84/279 (30%), Gaps = 57/279 (20%)
Query: 270 LIGKGGSSQVYKGCLPD---GKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 322
G Q ++ D +++A+ + P +DV++E + ++ + +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
+L L+V +++ GSL+E + A + +A A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAH--- 146
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
V S + +S D G +
Sbjct: 147 RAGVALSIDHPSRVRVSID--------GDVV--------------LAYPATMPD------ 178
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502
N + D+ G L LL R P+ + + Q ++PA +
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-------RDTAGQPIEPADIDR 230
Query: 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541
Q+ + ++ D R +L+ + + A
Sbjct: 231 DIPFQISAVAAR---SVQGDGGIRSASTLLNLMQQATAV 266
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 56/267 (20%), Positives = 102/267 (38%), Gaps = 44/267 (16%)
Query: 223 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKG 282
SS H S +P+ +L ++ S + L+G GG VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 283 C-LPDGKELAVKILK-------PSEDVIKEFVLEIEIITTLHHK--NIISLLGFCFEDNN 332
+ D +A+K ++ +E+ ++ + +I LL + ++
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 333 LLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
+L+ +DF+ RG+L+E V EA+ + H+
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEE--------------LARSFFWQVLEAVRHCHN- 167
Query: 382 SAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
V+HRD+K NIL+ + E +L DFG + GT Y PE+
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 221
Query: 441 YGKVN-DKIDVYAFGVVLLELLTGRKP 466
Y + + V++ G++L +++ G P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 36/233 (15%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKNII 321
++F +IG+GG +VY D ++ A+K L + IK + L+ + ++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKM---KQGETLALNERIML 243
Query: 322 SL-----------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYK 366
SL + + F L + D ++ G L +L + F +E
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE--- 300
Query: 367 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD 426
+ LE++H+ + V++RD+K +NILL + ++SD GLA S H +
Sbjct: 301 ----IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-- 351
Query: 427 VAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESL 478
GT GY+APE G D D ++ G +L +LL G P K + +
Sbjct: 352 --GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 8e-21
Identities = 50/222 (22%), Positives = 86/222 (38%), Gaps = 46/222 (20%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKIL------KPSEDVIKEFV-LEIEIITTLH----H 317
L+GKGG V+ G L D ++A+K++ S LE+ ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 318 KNIISLLGFCFEDNNLLLV----------YDFL-SRGSLEENLHGNKKDPAAFGWSERYK 366
+I LL + +LV +D++ +G L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG--------------PSRC 143
Query: 367 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 425
V A+++ HS + V+HRD+K NIL+ +L DFG
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 426 DVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKP 466
GT Y PE+ + + V++ G++L +++ G P
Sbjct: 200 ---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-20
Identities = 59/208 (28%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 270 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 322
++G+GG +V+ + +L A K L + +K+ ++E +I+ +H + I+S
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN--KKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 323 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSE---RYKVAMGVAEALEYL 378
L + FE +L LV ++ G + +++ +D F E + A + LE+L
Sbjct: 250 LA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF--QEPRAIFYTAQ-IVSGLEHL 305
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
H + +I+RD+K N+LL DD ++SD GLA + T AGT G++APE
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKG-YAGTPGFMAPEL 360
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKP 466
+ + + +D +A GV L E++ R P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 56/226 (24%), Positives = 91/226 (40%), Gaps = 44/226 (19%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK---------PSEDVIKEFVLEIEIIT 313
+ + +G G V+ KE+ VK +K + + + LEI I++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 314 TLHHKNIISLLGFCFEDNNLLLV----------YDFLSRGSLEENLHGNKKDPAAFGWSE 363
+ H NII +L LV + F+ R H +P A
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-------HPRLDEPLA----- 132
Query: 364 RYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HI 422
Y + A+ YL + +IHRD+K NI++++DF +L DFG A + +
Sbjct: 133 SYIFRQ-LVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 423 TCTDVAGTFGYLAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 466
C GT Y APE M G ++++++ GV L L+ P
Sbjct: 189 FC----GTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 64/225 (28%), Positives = 99/225 (44%), Gaps = 33/225 (14%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIK----EFVL-EIEIITTLH 316
F +G G +V + A+KIL + V+K E L E I+ ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVN 99
Query: 317 HKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVA 372
++ L F F+DN NL +V ++++ G + +L + A F Y A +
Sbjct: 100 FPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-----Y--AAQIV 151
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 432
EYLHS +I+RD+K N+L+ Q++DFG AK T T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWT-LCGTPE 203
Query: 433 YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474
LAPE + Y K +D +A GV++ E+ G P D P
Sbjct: 204 ALAPEIILSKGYNKA---VDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 56/229 (24%)
Query: 264 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHKN 319
L ++G+G +V+ K D ++L A+K+LK K + + + T ++
Sbjct: 27 ELLK--VLGQGSFGKVFLVKKISGSDARQLYAMKVLK------KATLKVRDRVRTKMERD 78
Query: 320 IISL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKV 367
I+ L + F+ + L L+ DFL G L L + F Y
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF-----Y-- 131
Query: 368 AMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424
+AE AL++LHS +I+RD+K NILL ++ +L+DFGL+K I
Sbjct: 132 ---LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDH 179
Query: 425 TDVAGTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 466
A +F G Y+APE + + D ++FGV++ E+LTG P
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLP 225
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKILK-----PSEDVIKEFVLEIEIITTLHHKNIISL 323
L+G+G +V + AVKILK + EI+++ L HKN+I L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 324 LGFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA--------E 373
+ + E + +V ++ G E + + A +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE-----------MLDSVPEKRFPVCQAHGYFCQLID 120
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 433
LEYLHS Q ++H+D+K N+LL+ ++S G+A+ ++ TC G+ +
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 434 LAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 466
PE K+D+++ GV L + TG P
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKIL---KPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
IGKG ++V + G+E+A+KI+ + + +++ E+ I+ L+H NI+ L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 327 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
+ L L+ ++ S G + + L HG K+ A R + A++Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----R-SKFRQIVSAVQYCHQ---K 133
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYGK 443
R++HRD+K+ N+LL D +++DFG + + C G Y APE F GK
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC----GAPPYAAPELFQ-GK 188
Query: 444 VND--KIDVYAFGVVLLELLTGRKP 466
D ++DV++ GV+L L++G P
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 71/277 (25%), Positives = 109/277 (39%), Gaps = 56/277 (20%)
Query: 226 LSTDHDSTELPKE--LEGLHEKYSATCRLFNYQDLLSATSNFLAENLIGKGGSSQVY--- 280
L D D L K ++ +Y T +DL ++ +IG+G +V
Sbjct: 32 LVYDLDFPALRKNKNIDNFLSRYKDTIN--KIRDLRMKAEDYEVVKVIGRGAFGEVQLVR 89
Query: 281 -KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIITTLHHKNIISLLGFCFEDN-NL 333
K K A+K+L E +IK F E +I+ + ++ L + F+D+ L
Sbjct: 90 HKS---TRKVYAMKLLSKFE-MIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYL 144
Query: 334 LLVYDF---------LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
+V ++ +S + E A F +E V AL+ +HS
Sbjct: 145 YMVMEYMPGGDLVNLMSNYDVPE-------KWARFYTAE-------VVLALDAIHS---M 187
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE------- 437
IHRDVK N+LL +L+DFG + T V GT Y++PE
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGG 246
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474
YG+ D ++ GV L E+L G P D G
Sbjct: 247 DGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVG 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 66/236 (27%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 321
+L L+GKG +V A+KILK KE ++ E+ TL ++
Sbjct: 151 EYLK--LLGKGTFGKVILVKEKATGRYYAMKILK------KEVIVAKDEVAHTLTENRVL 202
Query: 322 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 369
L + F+ + L V ++ + G L +L + D A F +E
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------ 256
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
+ AL+YLHS + V++RD+K N++L D +++DFGL K I
Sbjct: 257 -IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMK 307
Query: 430 TF----GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP-ISNDHPKGQESLVM 480
TF YLAPE +D + GVV+ E++ GR P + DH K E ++M
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-19
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 270 LIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE------FVLEIEIITTLHHKNIIS 322
++GKGG +V + ++ A K L+ + IK+ + E +I+ ++ + ++S
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 323 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDP-----AAFGWSERYKVAMGVAEALE 376
L + +E + L LV ++ G L+ +++ + A F +E + LE
Sbjct: 249 L-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-------ICCGLE 300
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
LH +R+++RD+K NILL D ++SD GLA V GT GY+AP
Sbjct: 301 DLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRV-GTVGYMAP 354
Query: 437 EYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
E + D +A G +L E++ G+ P
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 48/228 (21%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 321
++L L+GKG +V A+KIL+ KE ++ E+ T+ ++
Sbjct: 8 DYLK--LLGKGTFGKVILVREKATGRYYAMKILR------KEVIIAKDEVAHTVTESRVL 59
Query: 322 SL--------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 369
L + F+ + L V ++ + G L +L + + A F +E
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------ 113
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
+ ALEYLHS + V++RD+K N++L D +++DFGL K I+
Sbjct: 114 -IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMK 163
Query: 430 TF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISND 470
TF G YLAPE YG+ +D + GVV+ E++ GR P N
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 259 LSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILK-PSEDVIKEFVL-EIEIITTL 315
+S++S F +G G + VYKG G +A+K +K SE+ + EI ++ L
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 316 HHKNIISLLGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDPAAFGWSERYKVAMGVA 372
H+NI+ L +N L LV++F+ + ++ P + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS--RTVGNTPRGLELNLVKYFQWQLL 118
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 432
+ L + H +++HRD+K N+L++ + +L DFGLA+ + + V T
Sbjct: 119 QGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 433 YLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 464
Y AP+ M Y ID+++ G +L E++TG+
Sbjct: 174 YRAPDVLMGSRTYST---SIDIWSCGCILAEMITGK 206
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 8e-19
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 271 IGKGGSSQVYKGC---LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+G+G VYK D K+ A+K ++ + EI ++ L H N+ISL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 328 FE--DNNLLLVYDFLS---RGSLEENLHGNKKDPAA-FGWSERYKVAMGVAEALEYLHSG 381
D + L++D+ ++ + + + + + YLH+
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA- 146
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWAST---SSSHITCTDVAGTFGYL 434
V+HRD+K +NIL+ + + ++D G A+ ++ + + V TF Y
Sbjct: 147 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYR 202
Query: 435 APEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 467
APE + Y K ID++A G + ELLT +PI
Sbjct: 203 APELLLGARHYTK---AIDIWAIGCIFAELLT-SEPI 235
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 55/235 (23%), Positives = 97/235 (41%), Gaps = 53/235 (22%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKIL---------------------------KPSEDV 301
IGKG V D A+K+L
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 302 IKEFVLEIEIITTLHHKNIISLLGFCFE------DNNLLLVYDFLSRGSL-EENLHGNKK 354
I++ EI I+ L H N++ L E +++L +V++ +++G + E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL----VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135
Query: 355 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414
+ A + + +EYLH Q++IHRD+K SN+L+ +D +++DFG++
Sbjct: 136 EDQAR------FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVN---DKIDVYAFGVVLLELLTGRKP 466
S + ++ T GT ++APE + +DV+A GV L + G+ P
Sbjct: 187 FKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 47/232 (20%)
Query: 263 SNFLAENLIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIK----EFVL-EIEIIT 313
+F +G G +V+ + +G+ A+K+LK E V++ E E +++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLS 61
Query: 314 TLHHKNIISLLGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAM 369
+ H II + F+D + ++ D++ G L L +++ A F +E
Sbjct: 62 IVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE------ 114
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
V ALEYLHS + +I+RD+K NILL + +++DFG AK DV
Sbjct: 115 -VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---------YVPDVTY 161
Query: 430 TF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474
T G Y+APE Y K ID ++FG+++ E+L G P + +
Sbjct: 162 TLCGTPDYIAPEVVSTKPYNKS---IDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 52/228 (22%)
Query: 264 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEIE-------II 312
L ++GKGG +V+ K + ++ A+K+LK + +I + I+
Sbjct: 20 ELLR--VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNIL 75
Query: 313 TTLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 368
+ H I+ L+ + F+ L L+ ++LS G L L D A F Y
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-----Y--- 126
Query: 369 MGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCT 425
+AE AL +LH + +I+RD+K NI+L+ +L+DFGL K I
Sbjct: 127 --LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK------ESIHDG 175
Query: 426 DVAGTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 466
V TF G Y+APE M + + +D ++ G ++ ++LTG P
Sbjct: 176 TVTHTFCGTIEYMAPEILMRSGHNRA---VDWWSLGALMYDMLTGAPP 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 50/228 (21%), Positives = 94/228 (41%), Gaps = 48/228 (21%)
Query: 265 FLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIIS 322
+ ++G G + +V + ++ A+K+L+ +E +E+ +I+
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVR 75
Query: 323 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEAL 375
++ +E+ LL+V + L G L + + AF +ER ++ + EA+
Sbjct: 76 IVDV-YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAI 130
Query: 376 EYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 432
+YLHS + HRDVK N+L + +L+DFG AK + G
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK------------ETTGE-- 173
Query: 433 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480
Y K D+++ GV++ LL G P ++H +
Sbjct: 174 -------KYDK---SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHH 317
+ IG+G V+K + +A+K ++ +D E V EI ++ L H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKH 60
Query: 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
KNI+ L D L LV++F + L++ + + L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
HS + V+HRD+K N+L++ + E +L++FGLA+ + V T Y P+
Sbjct: 117 CHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPD 171
Query: 438 YFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 467
Y ID+++ G + EL +P+
Sbjct: 172 VLFGAKLYST---SIDMWSAGCIFAELANAGRPL 202
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLLGF 326
IG+G V+K G+ +A+K SED VIK+ L EI ++ L H N+++LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
L LV+++ ++ L + + +A+ + H
Sbjct: 71 FRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK---HNC 123
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM----YG 442
IHRDVK NIL++ +L DFG A+ + D T Y +PE + YG
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 443 KVNDKIDVYAFGVVLLELLTGR 464
+DV+A G V ELL+G
Sbjct: 182 P---PVDVWAIGCVFAELLSGV 200
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 49/225 (21%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 321
F+ ++GKG +V + + +L AVK+LK K+ +L+ ++ T+ K I+
Sbjct: 26 EFIR--VLGKGSFGKVMLARVKETGDLYAVKVLK------KDVILQDDDVECTMTEKRIL 77
Query: 322 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 368
SL L CF+ + L V +F++ G L ++ +++ A F +E
Sbjct: 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE----- 132
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 428
+ AL +LH + +I+RD+K N+LL + +L+DFG+ K I
Sbjct: 133 --IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK------EGICNGVTT 181
Query: 429 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 466
TF G Y+APE YG +D +A GV+L E+L G P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPA---VDWWAMGVLLYEMLCGHAP 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 41/220 (18%)
Query: 270 LIGKGGSSQVY----KGCLPDGKELAVKILKPSEDVIKE----FVLEIEIITTLHHKNII 321
+IG+G S+V K G+ A+KI+ + + + F E +++ + I
Sbjct: 68 VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 322 SLLGFCFEDN-NLLLVYDFLSRGSLEENL--HGNK--KDPAAFGWSERYKVAMGVAEALE 376
L F F+D L LV ++ G L L G + + A F +E + A++
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE-------IVMAID 176
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
+H +HRD+K NILL +L+DFG + + V GT YL+P
Sbjct: 177 SVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSP 232
Query: 437 E----------YFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
E YG D +A GV E+ G+ P
Sbjct: 233 EILQAVGGGPGTGSYGPE---CDWWALGVFAYEMFYGQTP 269
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 43/222 (19%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 321
+FL +IGKG +V + AVK+L+ K+ +L+ E + +N++
Sbjct: 41 HFLK--VIGKGSFGKVLLARHKAEEVFYAVKVLQ------KKAILKKKEEKHIMSERNVL 92
Query: 322 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 368
L F F+ + L V D+++ G L +L + A F +E
Sbjct: 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE----- 147
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 428
+A AL YLHS +++RD+K NILL L+DFGL K +I
Sbjct: 148 --IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNSTT 196
Query: 429 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
TF G YLAPE + +D + G VL E+L G P
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 33/222 (14%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKE----FVLEIEIITTLHH 317
+F +IG+G +V L + ++ A+KIL E + + F E +++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 318 KNIISLLGFCFED-NNLLLVYDFLSRGSLEENLHGNKK----DPAAFGWSERYKVAMGVA 372
K I +L + F+D NNL LV D+ G L L + + A F +E +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE-------MV 185
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 432
A++ +H +HRD+K NIL+ + +L+DFG + + V GT
Sbjct: 186 IAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPD 241
Query: 433 YLAPEYFM--------YGKVNDKIDVYAFGVVLLELLTGRKP 466
Y++PE YG D ++ GV + E+L G P
Sbjct: 242 YISPEILQAMEGGKGRYGPE---CDWWSLGVCMYEMLYGETP 280
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 3e-18
Identities = 86/435 (19%), Positives = 154/435 (35%), Gaps = 56/435 (12%)
Query: 65 MNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVPV 124
MN+ + V G+ ++ ++ + L+ V
Sbjct: 138 MNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYV 197
Query: 125 QNVEAASTSITMLVRQLPESRPGWPLLRRAIFPDRRAPDRSSLRKISVVQWALRLPTR-- 182
+ + P + D+ + + W L
Sbjct: 198 KLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFM 257
Query: 183 -QPSYLANSDVKQITYDPGDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEG 241
S+ + K S VP + L + ++ + +
Sbjct: 258 GSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKA 317
Query: 242 LHEKYSATCRLFNYQDLLSATS----NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILK 296
EK + T F+ NFL ++GKG +V EL AVKILK
Sbjct: 318 PEEKTANTISKFDNNGNRDRMKLTDFNFLM--VLGKGSFGKVMLSERKGTDELYAVKILK 375
Query: 297 PSEDVIKEFVLEI-EIITTLHHKNIISL---------LGFCFE-DNNLLLVYDFLSRGSL 345
K+ V++ ++ T+ K +++L L CF+ + L V ++++ G L
Sbjct: 376 ------KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429
Query: 346 EENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402
++ + A F +E +A L +L S + +I+RD+K N++L +
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAE-------IAIGLFFLQS---KGIIYRDLKLDNVMLDSEG 479
Query: 403 EPQLSDFGLAKWASTSSSHITCTDVAGTF-G---YLAPE---YFMYGKVNDKIDVYAFGV 455
+++DFG+ K +I TF G Y+APE Y YGK +D +AFGV
Sbjct: 480 HIKIADFGMCK------ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS---VDWWAFGV 530
Query: 456 VLLELLTGRKPISND 470
+L E+L G+ P +
Sbjct: 531 LLYEMLAGQAPFEGE 545
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 49/225 (21%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 321
+ L +IG+G ++V L + A+K++K KE V + +I K++
Sbjct: 12 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMKVVK------KELVNDDEDIDWVQTEKHVF 63
Query: 322 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 368
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 118
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 428
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 119 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 167
Query: 429 GTF-G---YLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKP 466
TF G Y+APE YG +D +A GV++ E++ GR P
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFS---VDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 4e-18
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 43/226 (19%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 321
++GKG +V+ + A+K LK K+ VL ++ T+ K ++
Sbjct: 20 ILHK--MLGKGSFGKVFLAEFKKTNQFFAIKALK------KDVVLMDDDVECTMVEKRVL 71
Query: 322 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 368
SL + F+ NL V ++L+ G L ++ K A F +E
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE----- 126
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 428
+ L++LHS + +++RD+K NILL D +++DFG+ K ++
Sbjct: 127 --IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKT 175
Query: 429 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISND 470
TF G Y+APE + K N +D ++FGV+L E+L G+ P
Sbjct: 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 269 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVL-EIEIITTLHHKNIISLL 324
L+G+G V K G+ +A+K S+D ++K+ + EI+++ L H+N+++LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
C + LV++F+ + + + + P + K + + + HS
Sbjct: 91 EVCKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS--- 142
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--- 440
+IHRD+K NIL+S +L DFG A+ + ++ D T Y APE +
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 441 -YGKVNDKIDVYAFGVVLLELLTGR 464
YGK +DV+A G ++ E+ G
Sbjct: 201 KYGK---AVDVWAIGCLVTEMFMGE 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 324
IG G V + +A+K + +P ++ K E+ ++ ++HKNII LL
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 325 ------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEY 377
F+D + +V + + + NL + ER + + +++
Sbjct: 93 FTPQKSLEEFQD--VYIVMELM-----DANLCQVIQME---LDHERMSYLLYQMLCGIKH 142
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LHS +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPE 196
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGR 464
+ + +D+++ G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 67/222 (30%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 257 DLLSATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFV----L-EI 309
D+ S + + +G+G + VYK + +A+K I K+ + L EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 310 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 369
+++ L H NII LL +N+ LV+DF+ LE + K + S +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYML 119
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
+ LEYLH ++HRD+K +N+LL ++ +L+DFGLAK + + T V
Sbjct: 120 MTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-- 174
Query: 430 TFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 467
T Y APE YG +D++A G +L ELL R P
Sbjct: 175 TRWYRAPELLFGARMYGV---GVDMWAVGCILAELLL-RVPF 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 46/227 (20%)
Query: 264 NFLAENLIGKGGSSQVY---KGCLPDGKEL-AVKILKPSEDVIKEFVLEI--EIITTLHH 317
L ++G G +V+ K D +L A+K+LK K +++ T
Sbjct: 57 ELLK--VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK------KATIVQKAKTTEHTRTE 108
Query: 318 KNIISL---------LGFCFEDN-NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSER 364
+ ++ L + F+ L L+ D+++ G L +L ++
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI----- 163
Query: 365 YKVAMGVAE---ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421
Y V E ALE+LH +I+RD+K NILL + L+DFGL+K +
Sbjct: 164 Y-----VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 422 ITCTDVAGTFGYLAPEYFMYGKV--NDKIDVYAFGVVLLELLTGRKP 466
GT Y+AP+ G + +D ++ GV++ ELLTG P
Sbjct: 216 RAYD-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 324
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 325 GFCFE----DNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYL 378
++ + +V +++S G L + + HG ++ A R ++ + A++Y
Sbjct: 77 ---YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-----R-RLFQQILSAVDYC 127
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPE 437
H V+HRD+K N+LL +++DFGL+ S +C G+ Y APE
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPE 180
Query: 438 YFMYGKVND--KIDVYAFGVVLLELLTGRKPISNDH 471
G++ ++D+++ GV+L LL G P ++H
Sbjct: 181 VIS-GRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-18
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 43/222 (19%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 321
NFL ++GKG +V EL AVKILK K+ V++ ++ T+ K ++
Sbjct: 23 NFLM--VLGKGSFGKVMLSERKGTDELYAVKILK------KDVVIQDDDVECTMVEKRVL 74
Query: 322 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 368
+L L CF+ + L V ++++ G L ++ + A F +E
Sbjct: 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE----- 129
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 428
+A L +L S + +I+RD+K N++L + +++DFG+ K +I
Sbjct: 130 --IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK------ENIWDGVTT 178
Query: 429 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
TF G Y+APE Y +D +AFGV+L E+L G+ P
Sbjct: 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 56/222 (25%), Positives = 102/222 (45%), Gaps = 43/222 (19%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVKILKPSEDVIKEFVLEI-EIITTLHHKNII 321
+ L +IG+G ++V L + A++++K KE V + +I K++
Sbjct: 55 DLLR--VIGRGSYAKVLLVRLKKTDRIYAMRVVK------KELVNDDEDIDWVQTEKHVF 106
Query: 322 SL---------LGFCFE-DNNLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVA 368
L CF+ ++ L V ++++ G L ++ +K + A F +E
Sbjct: 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 161
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 428
++ AL YLH + +I+RD+K N+LL + +L+D+G+ K + D
Sbjct: 162 --ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDTT 210
Query: 429 GTF-G---YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKP 466
TF G Y+APE +D +A GV++ E++ GR P
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 260 SATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITT 314
+ +G+G VYK G+ +A+K ++ + E + EI ++
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKE 75
Query: 315 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 374
LHH NI+SL+ + L LV++F+ + L++ L ++ S+ +
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRG 131
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYL 434
+ + H R++HRD+K N+L++ D +L+DFGLA+ T V T Y
Sbjct: 132 VAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYR 186
Query: 435 APEYFM----YGKVNDKIDVYAFGVVLLELLTGR 464
AP+ M Y +D+++ G + E++TG+
Sbjct: 187 APDVLMGSKKYST---SVDIWSIGCIFAEMITGK 217
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 56/206 (27%), Positives = 84/206 (40%), Gaps = 24/206 (11%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 327
IG G + +AVK + I E V EI +L H NI+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 328 FEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
+L ++ ++ S G L E + G + A R+ ++ + Y HS +
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEA-----RFFFQQLLS-GVSYCHS---MQ 136
Query: 386 VIHRDVKSSNILLSDDFEPQL--SDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMYG 442
+ HRD+K N LL P+L DFG +K + S T GT Y+APE +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLL-R 191
Query: 443 KVND--KIDVYAFGVVLLELLTGRKP 466
+ D DV++ GV L +L G P
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 326
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 327 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYLAPEYFM 440
+ HRD+K N+LL + ++SDFGLA ++ + C GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELLK 180
Query: 441 YGKVND--KIDVYAFGVVLLELLTGRKP 466
+ +DV++ G+VL +L G P
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 324
IG G V + +A+K + +P ++ K E+ ++ ++HKNIISLL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 325 ----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVAEALEYLH 379
E ++ LV + + + NL + ER + + +++LH
Sbjct: 130 FTPQKTLEEFQDVYLVMELM-----DANLCQVIQMEL---DHERMSYLLYQMLCGIKHLH 181
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 235
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGR 464
+ + +D+++ G ++ E++ +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKEL-AVK--ILKPSEDVIKEFVLEIEIITTLHHKNI 320
++ + +G+G + VYKG L A+K L+ E + E+ ++ L H NI
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-VAEALEYLH 379
++L + +L LV+++L +++L D K+ + + L Y H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
Q+V+HRD+K N+L+++ E +L+DFGLA+ S + V T Y P+
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172
Query: 440 M----YGKVNDKIDVYAFGVVLLELLTGR 464
+ Y +ID++ G + E+ TGR
Sbjct: 173 LGSTDYST---QIDMWGVGCIFYEMATGR 198
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 317
+++ +G G V G+++A+K + +P + I K E+ ++ + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 318 KNIISLL------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-G 370
+N+I LL + LV F+ + +L + E+ + +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFS---EEKIQYLVYQ 134
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGT 430
+ + L+Y+HS V+HRD+K N+ +++D E ++ DFGLA+ A T T
Sbjct: 135 MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVT 186
Query: 431 FGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGR 464
Y APE + + N +D+++ G ++ E+LTG+
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 7e-17
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 23/210 (10%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFV-----LEIEIITTLHHK 318
+ IG+G VYK G+ A+K ++ ++ E + EI I+ L H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHS 60
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
NI+ L L+LV++ L + L++ L + + + Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
H +RV+HRD+K N+L++ + E +++DFGLA+ T V T Y AP+
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDV 171
Query: 439 FM----YGKVNDKIDVYAFGVVLLELLTGR 464
M Y ID+++ G + E++ G
Sbjct: 172 LMGSKKYST---TIDIWSVGCIFAEMVNGT 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 44/230 (19%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKN 319
F E + G+G V G G +A+K +++ +E + ++ + LHH N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 320 IISLLGF-------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSER 364
I+ L + D L +V ++ + + LH P
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 365 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHIT 423
+++ + LH S V HRD+K N+L+ D +L DFG AK S S ++
Sbjct: 136 FQLIRSIG----CLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 424 --CTDVAGTFGYLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
C+ Y APE Y +D+++ G + E++ G +PI
Sbjct: 191 YICSRY-----YRAPELIFGNQHYTT---AVDIWSVGCIFAEMMLG-EPI 231
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 25/208 (12%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGF 326
+G+G +V + +AVKI+ D + EI I L+H+N++ G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 327 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
E N L ++ S G L + + +P A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-GVVYLHG---I 124
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS----HITCTDVAGTFGYLAPEYFM 440
+ HRD+K N+LL + ++SDFGLA ++ + C GT Y+APE
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAPELLK 180
Query: 441 YGKVND--KIDVYAFGVVLLELLTGRKP 466
+ +DV++ G+VL +L G P
Sbjct: 181 -RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 48/229 (20%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 319
++ +IG G VY+ G+ +A+K K +D K F E++I+ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQD--KRFKNRELQIMRKLDHCN 108
Query: 320 IISLLGF------CFEDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERY 365
I+ L F ++ L LV D+ + E ++ + P + Y
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDY-----VPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 366 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHIT- 423
++ +A Y+HS + HRD+K N+LL D +L DFG AK +++
Sbjct: 164 QLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 424 -CTDVAGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 467
C+ Y APE Y IDV++ G VL ELL G+ PI
Sbjct: 217 ICSRY-----YRAPELIFGATDYTS---SIDVWSAGCVLAELLLGQ-PI 256
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 45/217 (20%), Positives = 85/217 (39%), Gaps = 30/217 (13%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-----EIEIITTLH 316
+ +G+G +VYK + +A+K ++ + +E V E+ ++ L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQ 91
Query: 317 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376
H+NII L ++ L L++++ E +L + +
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSHITCTDVAGTF 431
+ HS +R +HRD+K N+LLS + + DFGLA+ T + T
Sbjct: 147 FCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TL 201
Query: 432 GYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 464
Y PE + Y +D+++ + E+L
Sbjct: 202 WYRPPEILLGSRHYST---SVDIWSIACIWAEMLMKT 235
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 50/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 324
+G+G +V +++A+K + D+ EI + L H +II L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 325 GFCFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 375
++++V +D++ + + E+ E + + A+
Sbjct: 76 DVITTPTDIVMVIEYAGGELFDYIVEKKRMTED--------------EGRRFFQQIICAI 121
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYL 434
EY H +++HRD+K N+LL D+ +++DFGL+ + + +C G+ Y
Sbjct: 122 EYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYA 174
Query: 435 APEYFMYGKVND--KIDVYAFGVVLLELLTGRKP 466
APE GK+ ++DV++ G+VL +L GR P
Sbjct: 175 APEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 50/207 (24%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCF 328
+G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII+L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLAD-IV 100
Query: 329 ED---NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
+D LV++ ++ ++ F E K AL+Y HS
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCHS---MG 150
Query: 386 VIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE----YFM 440
++HRDVK N+++ + + +L D+GLA++ + + + PE Y M
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQM 207
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKPI 467
Y +D+++ G +L ++ ++P
Sbjct: 208 YDY---SLDMWSLGCMLASMIFRKEPF 231
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 39/224 (17%)
Query: 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVLEIEIITTLHHKNI 320
+ +IG G V++ L + E+A+K +L+ +E ++I+ + H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNV 94
Query: 321 ISLLGFCF------EDNNLLLVYDFLSRGSLEENLH--------GNKKDPAAFGWSERYK 366
+ L F + ++ L LV ++ + E ++ + P Y+
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 367 VAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCT 425
+ +A Y+HS + HRD+K N+LL +L DFG AK +
Sbjct: 150 LLRSLA----YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNV 199
Query: 426 DVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPI 467
+ Y APE ++G ID+++ G V+ EL+ G +P+
Sbjct: 200 SYICSRYYRAPE-LIFGATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHK 318
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 319 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM 369
NII + + ++ +V D + E +L+ + +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSN------DHICYFL 134
Query: 370 -GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC-TDV 427
+ L+Y+HS + V+HRD+K SN+LL+ + ++ DFGLA+ A H T+
Sbjct: 135 YQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 428 AGTFGYLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 464
T Y APE Y K ID+++ G +L E+L+ R
Sbjct: 192 VATRWYRAPEIMLNSKGYTK---SIDIWSVGCILAEMLSNR 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 41/221 (18%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKE-F----VLEIEIITTLHHKNIISLL 324
IG+G +V+K G+++A+K + + KE F + EI+I+ L H+N+++L+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLI 82
Query: 325 GFCFED--------NNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 374
C ++ LV+DF L N+ F SE +V +
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNG 136
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW----ASTSSSHITCTDVAGT 430
L Y+H +++HRD+K++N+L++ D +L+DFGLA+ ++ + T V T
Sbjct: 137 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV--T 191
Query: 431 FGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGRKPI 467
Y PE + YG ID++ G ++ E+ T R PI
Sbjct: 192 LWYRPPELLLGERDYGP---PIDLWGAGCIMAEMWT-RSPI 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 39/212 (18%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 324
+G G V G ++A+K + +P + + K E+ ++ + H+N+I LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 325 ------GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDPAAFGWSERYKVAM-GVAEALE 376
F D LV F+ +L K + +R + + + + L
Sbjct: 93 FTPDETLDDFTD--FYLVMPFM-----GTDLGKLMKHEKLG---EDRIQFLVYQMLKGLR 142
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAP 436
Y+H+ +IHRD+K N+ +++D E ++ DFGLA+ A + T T Y AP
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAP 194
Query: 437 E----YFMYGKVNDKIDVYAFGVVLLELLTGR 464
E + Y + +D+++ G ++ E++TG+
Sbjct: 195 EVILNWMRYTQ---TVDIWSVGCIMAEMITGK 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKILK----PSEDVIKEFVLEIEIITTLHHKNIISLL 324
+G G +V G G ++AVKIL S DV+ + EI+ + H +II L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
+++ +V +++S G L + + +G + + R ++ ++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-----RRLFQQILS-GVDYCHR-- 134
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS-HITCTDVAGTFGYLAPEYFMY 441
V+HRD+K N+LL +++DFGL+ S +C G+ Y APE
Sbjct: 135 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVIS- 188
Query: 442 GKVND--KIDVYAFGVVLLELLTGRKP 466
G++ ++D+++ GV+L LL G P
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 35/210 (16%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHHKNIISLL-- 324
+G G V G +AVK + +P + +I K E+ ++ + H+N+I LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 325 ----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEAL 375
E N++ LV + +L+ K + + + + L
Sbjct: 97 FTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTD------DHVQFLIYQILRGL 145
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
+Y+HS +IHRD+K SN+ +++D E ++ DFGLA+ + T T Y A
Sbjct: 146 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-----TGYVATRWYRA 197
Query: 436 PEYFM-YGKVNDKIDVYAFGVVLLELLTGR 464
PE + + N +D+++ G ++ ELLTGR
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 270 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NII 321
+IGKG QV K + +A+K+++ + ++ EI I+ L + N+I
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 322 SLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
+L F F N++ + ++ LS +L E + NK F K A + + L+ LH
Sbjct: 163 HMLENFTFR-NHICMTFELLSM-NLYELIKKNKFQG--FSLPLVRKFAHSILQCLDALHK 218
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
R+IH D+K NILL + DFG + T + F Y APE
Sbjct: 219 ---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF-YRAPEV 270
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGR 464
+ + ID+++ G +L ELLTG
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 48/216 (22%), Positives = 82/216 (37%), Gaps = 36/216 (16%)
Query: 271 IGKGGSSQVYKGCLPDGKELAVK-ILKPSEDVIKEFVL-----------EIEIITTLHHK 318
I G V G +G +A+K + D +L EI ++ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 319 NIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM-GVA 372
NI+ L + L LV + + +L D + + M +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYHIL 144
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 432
L LH V+HRD+ NILL+D+ + + DF LA+ + ++ T
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVTHRW 198
Query: 433 YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 464
Y APE + + K +D+++ G V+ E+ +
Sbjct: 199 YRAPELVMQFKGFTK---LVDMWSAGCVMAEMFNRK 231
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 41/218 (18%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 270 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH----------- 316
+G G S V+ + + +A+KI++ + + EI+++ ++
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 317 HKNIISLLG-FCFEDNN---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 372
+I+ LL F + N +++V++ L +L + + +++ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRG--IPLIYVKQISKQLL 141
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ------LSDFGLAKWASTSSSHITCTD 426
L+Y+H +IH D+K N+L+ P+ ++D G A W T+
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY-----DEHYTN 194
Query: 427 VAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR 464
T Y +PE + D+++ ++ EL+TG
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 76.8 bits (188), Expect = 9e-15
Identities = 89/526 (16%), Positives = 154/526 (29%), Gaps = 152/526 (28%)
Query: 64 VMNLEQALVKARSDCSGSAAKRNCSICGPVRNLPDGSCSQSEEESPSDGGAGDESLAIVP 123
+ L QAL++ R +N I G G+G +A+
Sbjct: 137 YLKLRQALLELRPA-------KNVLIDG-------------------VLGSGKTWVALDV 170
Query: 124 VQNVEAASTS------ITMLVRQLPES--RPGWPLLRRAIFPDRRAPDRSS---LRKISV 172
+ + + + PE+ LL + D SS LR S+
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 173 VQWALRLPTRQP---SYLANSDVKQITYDPGDNESINLN-------GDSGAIVPVGNEIV 222
RL +P L +V + + NL+ +
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNV----QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 223 SSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDL--LSATSNFLAENLIG---KGGSS 277
+ H T P E++ L KY CR QDL T+N ++I + G +
Sbjct: 287 THISLDHHSMTLTPDEVKSLLLKY-LDCRP---QDLPREVLTTNPRRLSIIAESIRDGLA 342
Query: 278 --QVYKGCLPDGK----ELAVKILKPSE-------------DV-IKEFVLEI-------- 309
+K D E ++ +L+P+E I +L +
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS 402
Query: 310 ---EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYK 366
++ LH SL+ + + + Y
Sbjct: 403 DVMVVVNKLHKY---SLV---EKQPKESTIS-----------IPS------------IY- 432
Query: 367 VAMGVAEALEYLHSGSAQRVIHRD-VKSSNILL---SDDFEPQLSDFGLAKWASTSSSHI 422
LE + +HR V NI SDD P D + S H+
Sbjct: 433 --------LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD---QYFYSHIGHHL 481
Query: 423 TCTDVAGTFGYLAPEY----FMYGKV-NDKIDVYAFGVV---LLELLTGRKPISNDHPKG 474
+ + F+ K+ +D A G + L +L + I ++ PK
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY 541
Query: 475 QESL------VMWAKPILSSGKVTQLLDPALGNNYD--YDQMERMV 512
+ + + + L K T LL AL + +++ + V
Sbjct: 542 ERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 6e-12
Identities = 57/498 (11%), Positives = 130/498 (26%), Gaps = 152/498 (30%)
Query: 185 SYLANSDVKQITYDPGDNESINL-------NGDSGAIVPVGNEIVSSPLSTDHD------ 231
S L+ ++ I + + V L ++
Sbjct: 44 SILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMV-----QKFVEEVLRINYKFLMSPI 98
Query: 232 STELPKELEGLHEKYSATC-RLFN---------------YQDLLSATSNFLAENLI---G 272
TE ++ + Y RL+N Y L A + G
Sbjct: 99 KTE-QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 273 KGGSSQVYKGCLPDGKE-LAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 331
GS GK +A+ + S V + +I + L C
Sbjct: 158 VLGS----------GKTWVALDVCL-SYKVQCKMDFKIFWLN----------LKNCNSPE 196
Query: 332 NLL-----LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR- 385
+L L+Y + + + L S +
Sbjct: 197 TVLEMLQKLLYQI--DPNWTSRSDHSSNIKLRIHSIQAEL--------RRLLKSKPYENC 246
Query: 386 -VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
++ +V+++ + F + C + T + +V
Sbjct: 247 LLVLLNVQNAKAW--NAF-----NLS-------------CKILLTT---------RFKQV 277
Query: 445 NDKIDVYAFGVVLLELLTGRKPISNDHPKG---QESLVMWAK-----------------P 484
D + + L+ H E + K P
Sbjct: 278 TDFLSAATTTHISLD----------HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP 327
Query: 485 ILSSGKVTQLLD-PALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540
S + D A +N+ + D++ ++ +S+ + +P +M L + A
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL--EPAEYRKMFDRLSVFPPSA 385
Query: 541 DVTK------WARLQVNASEESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMS-SIEQS 593
+ W + + ++ ++ S ++ + + + + +E
Sbjct: 386 HIPTILLSLIWFDVI---KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE 442
Query: 594 VSLEDYLLGRWSRSSSFD 611
+L ++ ++ +FD
Sbjct: 443 YALHRSIVDHYNIPKTFD 460
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 53/226 (23%), Positives = 93/226 (41%), Gaps = 31/226 (13%)
Query: 260 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVIKEFVL-----EIEII 312
ATS + IG G VYK G +A+K + P+ + E+ ++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 313 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 362
L H N++ L+ + + LV++ + + + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA------ 119
Query: 363 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421
E K M L++LH+ ++HRD+K NIL++ +L+DFGLA+ S
Sbjct: 120 ETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQ 173
Query: 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
+ T V T Y APE + +D+++ G + E+ RKP+
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 48/219 (21%), Positives = 94/219 (42%), Gaps = 42/219 (19%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVI--KEFVLEIEIITTLHHKNIISLL--- 324
+G+G V P G+ +A+K ++P + + + EI+I+ H+NII++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 325 --GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEY 377
N + ++ + + + +LH + + + A++
Sbjct: 79 RPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSD------DHIQYFIYQTLRAVKV 127
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG----- 432
LH + VIHRD+K SN+L++ + + ++ DFGLA+ S++ + +
Sbjct: 128 LHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 433 ---YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGR 464
Y APE Y + +DV++ G +L EL R
Sbjct: 185 TRWYRAPEVMLTSAKYSR---AMDVWSCGCILAELFLRR 220
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 260 SATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPSEDVIKEFV----L-EIEII 312
A + IG+G +V+K G+ +A+K ++ +E + + E+ ++
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVL 65
Query: 313 TTLH---HKNIISLL-----GFCFEDNNLLLVYDFLSR--GSLEENLHGNKKDPAAFGWS 362
L H N++ L + L LV++ + + + + +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT------ 119
Query: 363 ERYKVAMG-VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421
E K M + L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S
Sbjct: 120 ETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 173
Query: 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
+ T V T Y APE + +D+++ G + E+ RKP+
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 52/249 (20%), Positives = 86/249 (34%), Gaps = 56/249 (22%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKN 319
+ + +G G V + + GK A+K K +D + E++I+ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQD--PRYKNRELDIMKVLDHVN 61
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER--------------- 364
II L+ + + + + N +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 365 ---YKVAMGVAE-------------------ALEYLHSGSAQRVIHRDVKSSNILL-SDD 401
+KV A+ ++HS + HRD+K N+L+ S D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 402 FEPQLSDFGLAKWASTSSSHIT--CTDVAGTFGYLAPE-YFMYGKVNDKIDVYAFGVVLL 458
+L DFG AK S + C+ Y APE + ID+++ G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 459 ELLTGRKPI 467
EL+ G KP+
Sbjct: 234 ELILG-KPL 241
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 269 NLIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNI 320
+LIGKG QV K + + +A+KI+K + + + +E+ ++ + I
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 321 ISLLG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
+ L F F N+L LV++ LS +L + L + K A + AL +L
Sbjct: 119 VHLKRHFMFR-NHLCLVFEMLSY-NLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLA 174
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
+ +IH D+K NILL + + DFG +S + F Y +PE
Sbjct: 175 TPEL-SIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQRIYQYIQSRF-YRSPE 228
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGR 464
+ + ID+++ G +L+E+ TG
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 58/289 (20%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLHH 317
N++ ++LIG+G VY K +A+K + + ED+I K + EI I+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 318 KNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG-V 371
II L + + L +V + + +L K P E K + +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLT-EEHIKTILYNL 138
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
++H +IHRD+K +N LL+ D ++ DFGLA+ ++ D+
Sbjct: 139 LLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 432 G--------------------YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
Y APE Y K ID+++ G + ELL +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK---SIDIWSTGCIFAELLNMLQSH 252
Query: 468 SNDHPKGQESLVMWAKPI---LSSGKVTQLLDPALGNNYDY-DQMERMV 512
ND P+ S ++ + + DQ+ +
Sbjct: 253 INDPTNR--------FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIF 293
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 44/221 (19%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLL---- 324
+G GG+ V+ K +A+K + ++ + L EI+II L H NI+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 325 ----------GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM- 369
G E N++ +V +++ E +L E ++ M
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLE------EHARLFMY 127
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITC-TDV 427
+ L+Y+HS + V+HRD+K +N+ + ++D ++ DFGLA+ SH ++
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 428 AGTFGYLAPEYFM----YGKVNDKIDVYAFGVVLLELLTGR 464
T Y +P + Y K ID++A G + E+LTG+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTK---AIDMWAAGCIFAEMLTGK 222
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 60/315 (19%), Positives = 112/315 (35%), Gaps = 64/315 (20%)
Query: 200 GDNESINLNGDSGAIVPVGNEIVSSPLSTDHDSTELPKELEGLHEKYSATCRLFNYQDLL 259
+ +SG V H S++ + H + R Y+
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR---YEIR- 58
Query: 260 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTL 315
+LIG G V + + + +A+K IL+ ED+I K + EI I+ L
Sbjct: 59 ---------HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 316 HHKNIISLL-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM- 369
+H +++ +L + + L +V + + + + P K +
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLT-ELHIKTLLY 163
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG 429
+ ++Y+HS ++HRD+K +N L++ D ++ DFGLA+ + + ++
Sbjct: 164 NLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 430 TFG-------------------------YLAPEYFM----YGKVNDKIDVYAFGVVLLEL 460
Y APE + Y + IDV++ G + EL
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTE---AIDVWSIGCIFAEL 277
Query: 461 LTGRKPISNDHPKGQ 475
L K H
Sbjct: 278 LNMIKENVAYHADRG 292
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 31/100 (31%), Positives = 55/100 (55%), Gaps = 4/100 (4%)
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 427
+ VA+ +E+L ++++ IHRD+ + NILLS+ ++ DFGLA+ ++ D
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 428 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKP 466
++APE + DV++FGV+L E+ + G P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 23/99 (23%), Positives = 48/99 (48%), Gaps = 10/99 (10%)
Query: 271 IGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNII 321
+G+G QV + + +AVK+LK + + + E++I+ + HH N++
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 322 SLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAF 359
+LLG C + L+++ +F G+L L + + +
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 53/232 (22%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVK-ILKPSEDVI--KEFVLEIEIITTLH-HKNIISLLG 325
+GKG V+K G+ +AVK I ++ + EI I+T L H+NI++LL
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 326 FCFEDNN--LLLVYDFLSRGSLEENLH----GNKKDPAAFGWSERYKVAM-GVAEALEYL 378
DN+ + LV+D++ E +LH N +P + + + + ++YL
Sbjct: 77 VLRADNDRDVYLVFDYM-----ETDLHAVIRANILEP------VHKQYVVYQLIKVIKYL 125
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 432
HSG ++HRD+K SNILL+ + +++DFGL++ ++
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 433 -------------YLAPE----YFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467
Y APE Y K ID+++ G +L E+L KPI
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTK---GIDMWSLGCILGEIL-CGKPI 230
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 40/222 (18%)
Query: 270 LIGKGGSSQVYKGCL---PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK------NI 320
+G+G +V + C+ G+ +AVKI+K + + EI+++ L+
Sbjct: 21 TLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 321 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
+ +L FE ++ +V++ L S + + N P F K+A + +++ +LH
Sbjct: 80 VQMLE-WFEHHGHICIVFELLGL-STYDFIKENGFLP--FRLDHIRKMAYQICKSVNFLH 135
Query: 380 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 432
S ++ H D+K NIL D+ + + + I D FG
Sbjct: 136 S---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD----FGSATYDD 188
Query: 433 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 463
Y APE + + DV++ G +L+E G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 46/222 (20%), Positives = 84/222 (37%), Gaps = 40/222 (18%)
Query: 270 LIGKGGSSQVYKGC--LPDGKEL-AVKILKPSEDVIKEFVLEIEIITTLHHK------NI 320
+G+G +V + C GK A+KI++ + LEI ++ + K
Sbjct: 26 NLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 321 ISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
+ + F ++ + ++ L + + E L N P + +A + AL +LH
Sbjct: 85 VLMSD-WFNFHGHMCIAFELLGK-NTFEFLKENNFQP--YPLPHVRHMAYQLCHALRFLH 140
Query: 380 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFG------ 432
++ H D+K NIL + +FE ++ + S ++ I D FG
Sbjct: 141 E---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD----FGSATFDH 193
Query: 433 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 463
Y PE + DV++ G +L E G
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 36/222 (16%)
Query: 270 LIGKGGSSQVYKGC--LPDGKELAVKILKPSEDVIKEFVLEIEIITTL-----HHKNIIS 322
+G G +V C + + K AVK+++ + + +E +I+ + ++ NI+
Sbjct: 42 KMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 323 LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
G F +++ L+++ L SL E + N + F + + + +AL YL
Sbjct: 101 YHG-KFMYYDHMCLIFEPLGP-SLYEIITRNNYNG--FHIEDIKLYCIEILKALNYLRK- 155
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA--------GTFG- 432
+ H D+K NILL D + + TF
Sbjct: 156 --MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213
Query: 433 -----------YLAPEYFMYGKVNDKIDVYAFGVVLLELLTG 463
Y APE + + D+++FG VL EL TG
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 41/180 (22%), Positives = 65/180 (36%), Gaps = 21/180 (11%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNII 321
NF IG G ++ G L + +A+K+ + LE L I
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLGSGDGIP 68
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
+ F +V + L SLE+ +L F +A+ + +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRT-----FSLKTVLMIAIQLISRMEYVH 122
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 432
S + +I+RDVK N L+ + DF LAK + HI + G
Sbjct: 123 S---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 45/257 (17%), Positives = 90/257 (35%), Gaps = 74/257 (28%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNII 321
+G G S V+ + K +A+K++K +E + + EI ++ ++ + ++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 322 SLLGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376
LL F+ ++ +V++ L L + + + K+ V + L+
Sbjct: 105 QLLD-DFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGLD 160
Query: 377 YLHSGSAQRVIHRDVKSSNILL-------------------------------------- 398
YLH+ R+IH D+K NILL
Sbjct: 161 YLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 399 -----------SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDK 447
++ + +++D G A W + T Y + E + N
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTP 273
Query: 448 IDVYAFGVVLLELLTGR 464
D+++ + EL TG
Sbjct: 274 ADIWSTACMAFELATGD 290
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 38/173 (21%), Positives = 69/173 (39%), Gaps = 21/173 (12%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 328
IG+G +++G L + +++A+K +P + E L I ++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 329 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
E + +LV D L SLE+ +L G K F A + ++ +H + +
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHE---KSL 127
Query: 387 IHRDVKSSNILLSDDFEPQ-----LSDFGLAK--WASTSSSHITCTDVAGTFG 432
++RD+K N L+ + DFG+ K + HI + G
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 7e-09
Identities = 42/273 (15%), Positives = 76/273 (27%), Gaps = 71/273 (26%)
Query: 259 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDV---------IKEFVLEI 309
T IG+G +V++ D +A+KI+ +E + EI
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 310 EIITTLH---------HKNIISLLGFC------------------------------FED 330
I L + I L F+D
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRD 390
+ L +V +F G E + + + + +L ++ R HRD
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSS-----LATAKSILHQLTASLAVAE--ASLRFEHRD 187
Query: 391 VKSSNILLSDDFEPQLSDFGLAKWAS--TSSSHITCTD-----------VAGTFGYLAPE 437
+ N+LL +L K ++ + ++ D V + +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 438 YFMYGKVNDKIDVY-AFGVVLLELLTGRKPISN 469
F G + + D+Y P SN
Sbjct: 248 LFT-GDGDYQFDIYRLMKKENNNRWGEYHPYSN 279
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 33/184 (17%), Positives = 67/184 (36%), Gaps = 33/184 (17%)
Query: 264 NFLAENLIGKGGSSQVYKGC---------LPDGKELAVKILKPSEDVIKEF--------V 306
+ ++ + +Y+ P ++ ++K+ + E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 307 LEIEIITTLH---HKNIISLLGF-CFEDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFG 360
L++ L+ I + +GF +D LV L R SL+ ++
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHV----LS 157
Query: 361 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTS 418
+VA + +ALE+LH +H +V + NI + + + Q L+ +G A S
Sbjct: 158 ERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 419 SSHI 422
H+
Sbjct: 215 GKHV 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 34/177 (19%), Positives = 65/177 (36%), Gaps = 34/177 (19%)
Query: 270 LIGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEI-----------ITTLHH 317
IG GG +Y ++ A ++K + + L E+ I
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK--VEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 318 KNIISLLGF----------CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 367
+ + LG + +V + L L++ N F S ++
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT----FKKSTVLQL 156
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHI 422
+ + + LEY+H +H D+K++N+LL Q L+D+GL+ + +H
Sbjct: 157 GIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 19/171 (11%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCF 328
IG G +Y G + G+E+A+K+ + + + +E +I + I ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 329 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
E + ++V + L SLE+ N K F +A + +EY+HS +
Sbjct: 76 EGDYNVMVMELLGP-SLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHS---KNF 126
Query: 387 IHRDVKSSNILL---SDDFEPQLSDFGLAK--WASTSSSHITCTDVAGTFG 432
IHRDVK N L+ + DFGLAK + + HI + G
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 177
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 32/170 (18%), Positives = 64/170 (37%), Gaps = 35/170 (20%)
Query: 270 LIGKGGSSQVYKGCLPDGKELAVKI-----LKPSED-------------VIKEFVLEIEI 311
IG+GG +Y + + + ++PS++ E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 312 ITTLHHKNIISLLGFCFEDNNLL----LVYDFLSRGSLEE--NLHGNKKDPAAFGWSERY 365
L + + G D N ++ D L++ + + F
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANAKR-----FSRKTVL 155
Query: 366 KVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAK 413
++++ + + LEY+H +H D+K+SN+LL+ Q L D+GLA
Sbjct: 156 QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 42/171 (24%), Positives = 71/171 (41%), Gaps = 19/171 (11%)
Query: 271 IGKGGSSQVYKGC-LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCF 328
IG G ++Y G + +E+A+K+ + + E +I L I ++ F
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 329 EDNNLLLVYDFLSRGSLEE--NLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
E + +LV D L SLE+ N K +A + +E++HS +
Sbjct: 74 EGDYNVLVMDLLGP-SLEDLFNFCSRK-----LSLKTVLMLADQMINRVEFVHS---KSF 124
Query: 387 IHRDVKSSNILLSDDFEPQ---LSDFGLAK--WASTSSSHITCTDVAGTFG 432
+HRD+K N L+ + DFGLAK +++ HI + G
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.38 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.21 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.81 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.38 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.38 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.95 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.65 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.85 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.35 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.16 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.82 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.05 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-54 Score=446.57 Aligned_cols=257 Identities=25% Similarity=0.457 Sum_probs=211.3
Q ss_pred cCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
++|.+.+.||+|+||+||+|.+. ++..||||+++.. ....++|.+|+++|++++|||||+++|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57899999999999999999853 4788999999864 4556789999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEE
Q 007256 336 VYDFLSRGSLEENLHGNK---------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 406 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~---------~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL 406 (611)
|||||++|+|.++|+... .....++|.+++.|+.||+.||.|||+ ++||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997643 234569999999999999999999999 89999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccc
Q 007256 407 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||...........+....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-- 247 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-- 247 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC--
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Confidence 99999987765444434444679999999999999999999999999999999999 999998765433322222111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
... .+... ...+..++..||+.||++|||+.+|++.|+.
T Consensus 248 -----~~~-----~p~~~----~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~ 286 (299)
T 4asz_A 248 -----VLQ-----RPRTC----PQEVYELMLGCWQREPHMRKNIKGIHTLLQN 286 (299)
T ss_dssp -----CCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCC-----CCccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 100 11111 2345667778999999999999999998864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=447.12 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=204.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
++|.+.+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|++++|||||+++++|.+++.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 57888999999999999999853 4788999999864 4556789999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCce
Q 007256 336 VYDFLSRGSLEENLHGNKK-----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 404 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~-----------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~v 404 (611)
|||||++|+|.++++.... ...+++|.+++.|+.||+.||.|||+ ++||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 9999999999999976432 22469999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 007256 405 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 483 (611)
||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...........+....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~ 277 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987765544444445789999999999999999999999999999999999 999998765433322222111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 484 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
. +..+...+ ..+..++..||+.||++||||.+|++.|+..
T Consensus 278 ~------------~~~p~~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l 317 (329)
T 4aoj_A 278 E------------LERPRACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317 (329)
T ss_dssp C------------CCCCTTCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred C------------CCCccccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 1 01111122 3455677789999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=443.84 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=210.5
Q ss_pred cCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
+++.+.+.||+|+||+||+|.+ .+++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++.++
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4567889999999999999985 25788999999753 345678999999999999999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC
Q 007256 335 LVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~ 402 (611)
||||||++|+|.++|..... ....++|..+..|+.||+.||.|||+ ++||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 99999999999999965431 12468999999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 007256 403 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 481 (611)
Q Consensus 403 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 481 (611)
.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||...........+..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~ 262 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 262 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999999987755444334445789999999999999999999999999999999998 8999987654332222211
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 482 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 482 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+.... ..... ...+..++..||+.||.+||||.+|++.|+.
T Consensus 263 -------~~~~~-----~p~~~----~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 263 -------RQVLP-----CPDDC----PAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -------TCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -------CCCCC-----Ccccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111 11111 2345667778999999999999999999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=441.05 Aligned_cols=257 Identities=28% Similarity=0.461 Sum_probs=200.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||+||+|.+++ .||||+++. +....+.|.+|+.+|++++|||||+++++|.+ +.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3577889999999999999998754 599999874 34566789999999999999999999999864 57899999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
||+||+|.++|+... ..++|.++..|+.||+.||+|||+ ++||||||||+||||++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999997543 259999999999999999999999 89999999999999999999999999999877654
Q ss_pred CCCccccccccccccCChhhhcc---CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
.........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||................ . .
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~--~--------~ 255 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRG--Y--------A 255 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTT--C--------C
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcC--C--------C
Confidence 43334445789999999999964 468999999999999999999999998655433222111110 0 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.|.+. .........+..++..||+.||.+||||.+|++.|+.
T Consensus 256 ~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 256 SPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp CCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred CCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111 0111112345566778999999999999999988753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=442.48 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=201.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.|.+|+++|++++|||||+++++|.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999864 7999999999753 3556789999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
||+||+|.++|..... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999975432 357889999999999999999999 99999999999999999999999999999876432
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...........+... ... .
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-------~~~-----~ 244 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG-------SFP-----P 244 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-------CCC-----C
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-------CCC-----C
Confidence 1 1223468999999999999999999999999999999999999999876544332222211 111 1
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+...++ ..+..++..||+.||.+|||+.|+++.
T Consensus 245 ~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 245 VSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCccCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 234556677999999999999999873
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=437.71 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=208.3
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||++.+. ....+.+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999864 7999999999753 234577999999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||++||+|.+++...+ .+++.++..++.||+.||.|||+ ++||||||||+||||+.++++||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999997654 48999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
..........+||+.|||||++.+..|+.++|||||||+||||++|+.||...+.......+.....
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY------------- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 5444444568999999999999999999999999999999999999999987654333222221111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 533 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL 533 (611)
.+...+. ..+..++..||+.||.+|||+.|++
T Consensus 252 ~~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 1111122 2344566779999999999998864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=437.73 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=206.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..|.+.+.||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+++|+.++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999975 79999999996432 33456889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
+||+|.+++... .+++.++..++.||+.||+|||+ ++||||||||+||||+.++++||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999999753 48999999999999999999999 9999999999999999999999999999987765433
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
. ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.........+....+ +.+.
T Consensus 226 ~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~------------~~~~ 291 (346)
T 4fih_A 226 R--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP------------PRLK 291 (346)
T ss_dssp C--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC------------CCCS
T ss_pred c--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC------------CCCC
Confidence 2 2347899999999999999999999999999999999999999987654433332221110 0110
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. .......+..++..||+.||.+|||+.|++++
T Consensus 292 ~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 N--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp C--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred c--cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 01111234556677999999999999998863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=435.60 Aligned_cols=251 Identities=23% Similarity=0.260 Sum_probs=203.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.+.|.+.+.||+|+||+||+|.+. +|+.||||+++.... +.+|+.+++.++|||||+++++|.+++.+|||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 356888999999999999999975 799999999975432 246999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-ceEEeecCccccccCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWASTSS 419 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-~vKL~DFGla~~~~~~~ 419 (611)
+||+|.++|...+ .+++..+..++.||+.||+|||+ ++||||||||+||||+.++ ++||+|||+|+......
T Consensus 133 ~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999997653 58999999999999999999999 8999999999999999887 69999999998775432
Q ss_pred CC---ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 420 SH---ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 420 ~~---~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.. .....++||+.|||||++.+..|+.++|||||||+||||+||+.||...........+....+. +.+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~--- 277 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-----IRE--- 277 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-----GGG---
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-----chh---
Confidence 21 1223468999999999999999999999999999999999999999876654433333221110 001
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
+...+ ...+..++..||+.||.+|||+.|+++.|.
T Consensus 278 --~~~~~----s~~~~~li~~~L~~dP~~R~sa~el~~~l~ 312 (336)
T 4g3f_A 278 --IPPSC----APLTAQAIQEGLRKEPVHRASAMELRRKVG 312 (336)
T ss_dssp --SCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cCccC----CHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 11111 123445666799999999999999998875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=428.46 Aligned_cols=265 Identities=27% Similarity=0.321 Sum_probs=201.0
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC----ceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~----~~~LV~E 338 (611)
++|.+.+.||+|+||+||+|.+ +|+.||||+++........+..|+..+.+++|||||+++++|.+++ .++||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4688899999999999999987 6899999999765443333445666667899999999999998764 5799999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~-----~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
||++|+|.++++.. .++|..+.+++.|++.||+|||+.+ ..+||||||||+||||+.++.+||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999754 4899999999999999999999831 2389999999999999999999999999998
Q ss_pred cccCCCCCc--cccccccccccCChhhhccC------CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhh--------
Q 007256 414 WASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-------- 477 (611)
Q Consensus 414 ~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-------- 477 (611)
......... .....+||+.|||||++.+. .++.++|||||||+||||+||+.||..........
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 776543321 22346899999999999754 46789999999999999999988875433211100
Q ss_pred -HHHhhccccccCccccccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 478 -LVMWAKPILSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 478 -lv~~~~~~~~~g~l~~lld~~l~~~~-~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
....... -....++|.++... ..+....+..++..||+.||.+||||.+|++.|+.
T Consensus 237 ~~~~~~~~-----~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 237 SVEEMRKV-----VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHH-----HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHH-----HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0000000 01111223222221 22445677788899999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=418.81 Aligned_cols=245 Identities=27% Similarity=0.381 Sum_probs=195.7
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceEEE
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLV 336 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~LV 336 (611)
|.+.+.||+|+||+||+|.+. ++..||||++.. .....+.|.+|+++|++++|||||+++++|.. ++.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 367788999999999999875 689999999864 34556789999999999999999999999875 3458999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--EEeeccCccceeeC-CCCceEEeecCccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLAK 413 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g--IiHrDIKp~NILLd-~~~~vKL~DFGla~ 413 (611)
||||+||+|.+++.... .+++..+..++.||+.||+|||+ ++ ||||||||+||||+ .++.+||+|||+|+
T Consensus 108 mEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999997643 58999999999999999999998 66 99999999999997 47899999999998
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
..... .....+||+.|||||++. ++|+.++|||||||+||||+||+.||........... .. ..+....
T Consensus 181 ~~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~--~i----~~~~~~~ 249 (290)
T 3fpq_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR--RV----TSGVKPA 249 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH--HH----TTTCCCG
T ss_pred eCCCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH--HH----HcCCCCC
Confidence 65432 223478999999999887 5799999999999999999999999976543322111 11 1111111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.++ ... .+ .+..++..||+.||.+|||+.+++++
T Consensus 250 ~~~----~~~-~~---~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 SFD----KVA-IP---EVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGG----GCC-CH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCC----ccC-CH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 111 12 34456677999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=439.53 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=207.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.+.|.+.+.||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999975 79999999997533 3445688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
|+||+|.+++... .+++..+..|+.||+.||+|||+ ++||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 9999999999653 48999999999999999999999 999999999999999999999999999998776543
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+.... .+.+
T Consensus 302 ~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------~~~~ 367 (423)
T 4fie_A 302 PR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------PPRL 367 (423)
T ss_dssp CC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------CCCC
T ss_pred cc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------CCCC
Confidence 32 234789999999999999999999999999999999999999998765544333322111 0111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
... ......+..++..||+.||.+|||+.|++++
T Consensus 368 ~~~--~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 KNL--HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCT--TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 100 0111234456667999999999999998863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=417.16 Aligned_cols=244 Identities=20% Similarity=0.329 Sum_probs=189.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||++... ....+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999864 7999999999753 234567999999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+ +|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 679999987654 58999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
... ....+||+.|+|||++.+..| +.++|||||||++|||+||+.||...........+.....
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~------------ 229 (275)
T 3hyh_A 165 GNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVY------------ 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------------
T ss_pred CCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 332 234789999999999998876 5799999999999999999999976543322222211110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+....+ ..+..++..||+.||.+|||+.|+++
T Consensus 230 -~~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -TLPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0111111 23445666799999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=432.73 Aligned_cols=260 Identities=24% Similarity=0.382 Sum_probs=210.4
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCC-cceeEEeeEEEec-
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHH-KNIISLLGFCFED- 330 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~H-pnIv~l~g~~~~~- 330 (611)
..++|.+.+.||+|+||+||+|.+. .++.||||+++.. ....+.|.+|+++|.+++| ||||+++|+|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 3468999999999999999999853 2468999999754 3456789999999999965 8999999999764
Q ss_pred CceEEEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
+.++||||||++|+|.++|+.... ....++|..+..++.|||.||.|||+ ++||||||||+||||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceee
Confidence 568999999999999999975421 13458999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhh
Q 007256 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 477 (611)
Q Consensus 399 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 477 (611)
+.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||..........
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999998766555555556789999999999999999999999999999999998 999998755433211
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
... ..+.. +..+...+ ..+..++..||+.||.+|||+.+|+++|..
T Consensus 299 ~~i------~~g~~-----~~~p~~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 299 RRL------KEGTR-----MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp HHH------HHTCC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH------HcCCC-----CCCCccCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 111 11110 11111111 245556678999999999999999998863
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=424.17 Aligned_cols=246 Identities=26% Similarity=0.350 Sum_probs=195.6
Q ss_pred cCceeeeeEeecCcEEEEEEEe----CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
++|.+.+.||+|+||+||+|.. .+++.||||+++... .....+.+|+++|++++|||||+++++|.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999985 257899999997532 233468889999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
|||||+||+|.+++.... .+++.++..++.||+.||+|||+ ++||||||||+|||++.++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999997654 48999999999999999999999 99999999999999999999999999999865
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
...... ....+||+.|||||++.+..|+.++|||||||+||||+||+.||...+.......+.....
T Consensus 177 ~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~----------- 243 (304)
T 3ubd_A 177 IDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL----------- 243 (304)
T ss_dssp ----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred cCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----------
Confidence 443322 2347899999999999999999999999999999999999999987655443332221111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQM-----SLVLK 534 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm-----~eVL~ 534 (611)
.+...++ ..+..++..||+.||.+|||+ +|+++
T Consensus 244 --~~p~~~s----~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 --GMPQFLS----PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --CCCTTSC----HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --CCCCcCC----HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 0111111 234456667999999999994 56665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=410.44 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=186.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-------
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------- 332 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~------- 332 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||+++. .....+.+.+|+++|++++|||||+++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999865 799999999864 33456789999999999999999999999976553
Q ss_pred -----eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 333 -----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 333 -----~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
+|+|||||+||+|.+++...... ....+..++.|+.||+.||+|||+ ++||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 79999999999999999765432 235667788999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCC----------ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhh
Q 007256 408 DFGLAKWASTSSSH----------ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 477 (611)
Q Consensus 408 DFGla~~~~~~~~~----------~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~ 477 (611)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||..... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHH
Confidence 99999876543221 11234689999999999999999999999999999999996 7753211 111
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..... ......... .........++..||+.||.+|||+.++++
T Consensus 236 ~~~~~----~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDV----RNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHH----HTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHH----hcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11110 011111100 011122345667899999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=398.74 Aligned_cols=283 Identities=37% Similarity=0.680 Sum_probs=246.6
Q ss_pred cCHHHHHHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC
Q 007256 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 331 (611)
Q Consensus 253 f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~ 331 (611)
+.+.++...+++|.+.+.||+|+||+||+|.+.+|+.||||++... ....+.+.+|+.+++.++||||++++++|...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 4455566688999999999999999999999888999999998754 355678999999999999999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++||||+++|+|.+++.........+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997665544569999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
++...............||+.|+|||++.++.++.++|||||||++|||++|+.||....+........|.......+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98765433332333467999999999999999999999999999999999999999887776666666666555556677
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
...+++.+...........+..++..||+.||.+|||+.+|++.|+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 78888887777788888889999999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=399.12 Aligned_cols=297 Identities=37% Similarity=0.712 Sum_probs=254.0
Q ss_pred cccccCHHHHHHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeE
Q 007256 249 TCRLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGF 326 (611)
Q Consensus 249 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~ 326 (611)
..+.|++.++...+++|.+.+.||+|+||+||+|...+|+.||||+++... .....+.+|+++++.++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 346789999999999999999999999999999998889999999998643 223368899999999999999999999
Q ss_pred EEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEE
Q 007256 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQL 406 (611)
Q Consensus 327 ~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL 406 (611)
|...+..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999999877665567999999999999999999999932229999999999999999999999
Q ss_pred eecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCC--CcchhhHHHhhcc
Q 007256 407 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH--PKGQESLVMWAKP 484 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~--~~~~~~lv~~~~~ 484 (611)
+|||++.......... .....||+.|+|||++.++.++.++|||||||++|+|++|+.||.... .........|...
T Consensus 176 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999998775543332 234569999999999999999999999999999999999999996321 1122344556666
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCccchhhH
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWA 546 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~~~~~~~ 546 (611)
......+..+.+..+...+.......+..++..||+.||.+|||+.+|+++|++.....+|.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~ 316 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhh
Confidence 67777888888888888888888899999999999999999999999999999876655543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=409.84 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=203.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe------cC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------~~ 331 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.+.+|+++|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 468999999999999999999874 7999999999753 3455678899999999999999999998764 35
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
.+|||||||+ |+|.+++.... .+++..+..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999996 57999997543 59999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCC--CccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 007256 412 AKWASTSSS--HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 488 (611)
Q Consensus 412 a~~~~~~~~--~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 488 (611)
|+.+..... .......+||+.|+|||++.+. .|+.++||||+|||+|||++|+.||.+.+...+...+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 987644321 1223457899999999998865 5699999999999999999999999887655544443322111110
Q ss_pred Ccc--------ccccCcccCC--CCChH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 489 GKV--------TQLLDPALGN--NYDYD-----QMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 489 g~l--------~~lld~~l~~--~~~~~-----~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
... ...+. .+.. ..+.. ....+..++..||+.||.+|||+.|+|++
T Consensus 285 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000 0000 00111 11244566778999999999999998863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=399.71 Aligned_cols=201 Identities=26% Similarity=0.412 Sum_probs=172.8
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceE
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~ 334 (611)
...+.|.+.+.||+|+||+||+|..+ +++.||||++.... ...++.+|+++|+.+ +|||||+++++|.+++.+|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 34678999999999999999999753 47889999987653 345678999999998 6999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC-CceEEeecCccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAK 413 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~-~~vKL~DFGla~ 413 (611)
|||||++||+|.+++. .+++.++..++.||+.||+|||+ +|||||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999984 38899999999999999999999 999999999999999876 799999999998
Q ss_pred cccCCCCC--------------------------ccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCC
Q 007256 414 WASTSSSH--------------------------ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKP 466 (611)
Q Consensus 414 ~~~~~~~~--------------------------~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~P 466 (611)
........ ......+||+.|+|||++.+. .|+.++||||+|||+|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432211 112235799999999999875 589999999999999999999999
Q ss_pred CCCCC
Q 007256 467 ISNDH 471 (611)
Q Consensus 467 f~~~~ 471 (611)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=418.10 Aligned_cols=252 Identities=22% Similarity=0.284 Sum_probs=207.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||+||+|.++ +|+.||||+++.. ....+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999875 7999999998754 34566788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC--CceEEeecCccccccC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWAST 417 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~--~~vKL~DFGla~~~~~ 417 (611)
|+||+|.++|.... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999986443 258999999999999999999999 999999999999999854 8999999999998765
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.........+......+. .
T Consensus 310 ~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~---------~ 377 (573)
T 3uto_A 310 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD---------D 377 (573)
T ss_dssp TSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---------S
T ss_pred CCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC---------c
Confidence 332 2346899999999999999999999999999999999999999987665443333222111100 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.....+. ..+..++..||+.||.+|||+.|++++
T Consensus 378 ~~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 SAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111111 234456677999999999999999984
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=416.45 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=198.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----h---HHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----D---VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~---~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.++||+|+||+||+|... +|+.||||++++.. . .......++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999875 79999999996431 1 122233446677778999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
|||||||+||+|.++|.... .+++..+..++.||+.||.|||+ ++||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999997654 48999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
....... ...+||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+...... .
T Consensus 341 ~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~----~--- 409 (689)
T 3v5w_A 341 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----M--- 409 (689)
T ss_dssp ECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH----C---
T ss_pred ecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC----C---
Confidence 7765432 24689999999999975 4799999999999999999999999976544332222111100 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 535 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~~ 535 (611)
...+...+. ..+..++..||+.||.+|++ +.+|+++
T Consensus 410 ---~~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 410 ---AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---CCCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---CCCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 001111111 23445666799999999998 6777653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=377.38 Aligned_cols=269 Identities=25% Similarity=0.317 Sum_probs=210.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc----eEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----LLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~----~~LV~ 337 (611)
.++|.+.+.||+|+||+||+|.+. ++.||||+++........+..|+.++++++||||+++++++..... +++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 468999999999999999999875 7899999998776666677789999999999999999999987553 69999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------cEEeeccCccceeeCCCCceEEe
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ----------RVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~----------gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
||+++|+|.+++... .+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+
T Consensus 102 e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999753 38999999999999999999998 7 99999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhccC-----CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 482 (611)
|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||...............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999877654443333446899999999999863 5667899999999999999999999765443221111110
Q ss_pred ccccccCcc-----ccccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 483 KPILSSGKV-----TQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 483 ~~~~~~g~l-----~~lld~~l~~~~-~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
........+ .....+.+.... .......+..++..||+.||.+|||+.+|++.|+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000000000 000111111111 123345677788889999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=362.34 Aligned_cols=283 Identities=31% Similarity=0.560 Sum_probs=230.2
Q ss_pred cccccCHHHHHHhhcCceee------eeEeecCcEEEEEEEeCCCCEEEEEEecCC-----hhHHHHHHHHHHHHHhcCC
Q 007256 249 TCRLFNYQDLLSATSNFLAE------NLIGKGGSSQVYKGCLPDGKELAVKILKPS-----EDVIKEFVLEIEIITTLHH 317 (611)
Q Consensus 249 ~~~~f~~~el~~~t~~f~~~------~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~-----~~~~~~f~~Ei~iL~~l~H 317 (611)
....|++.++..++++|... +.||+|+||.||+|.. +++.||||++... ....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45779999999999999887 8999999999999987 6889999998642 3456789999999999999
Q ss_pred cceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCcccee
Q 007256 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 397 (611)
Q Consensus 318 pnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NIL 397 (611)
|||+++++++...+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+ ++|+||||||+|||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 9999999999999999999999999999999864322 2358999999999999999999999 89999999999999
Q ss_pred eCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhh
Q 007256 398 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES 477 (611)
Q Consensus 398 Ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~ 477 (611)
++.++.+||+|||++................||+.|+|||++. +.++.++|||||||++|+|++|+.||..........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 244 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 244 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH
Confidence 9999999999999998766543333334467999999999886 468999999999999999999999998654433211
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.+... .......+...+++.+. .........+..++..||+.||.+|||+.+|++.|+..
T Consensus 245 ~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKEE-IEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHH-HHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHH-hhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11100 00112234444554442 33455667788888899999999999999999998743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=357.39 Aligned_cols=258 Identities=22% Similarity=0.380 Sum_probs=213.3
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..++|.+.+.||+|+||.||+|...++..||||+++......+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 34689999999999999999999988889999999877666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999997543 258999999999999999999999 8999999999999999999999999999987655432
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
. ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+...... ..+
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------~~~-- 227 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL---------YRP-- 227 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---------CCC--
T ss_pred h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC---------CCC--
Confidence 2 2223457788999999999899999999999999999999 99999765543322222111110 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~~ 541 (611)
.... ..+..++..||+.||.+|||+.++++.|+...+
T Consensus 228 --~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 228 --HLAS---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --TTSC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --CcCh---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1111 245566677999999999999999999976543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=375.89 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=211.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEe--------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 330 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~--------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~ 330 (611)
.++|.+.+.||+|+||.||+|.+ .++..||||+++.. ....+.+.+|+.+++.+ +||||++++++|...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46899999999999999999985 24567999999864 34567899999999999 899999999999999
Q ss_pred CceEEEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
+.+++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 999999999999999999976532 12358999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhh
Q 007256 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 477 (611)
Q Consensus 399 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 477 (611)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987665443333334568899999999999999999999999999999999 999997755433222
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.+.... . +.. +......+..++..||+.||.+||++.++++.|+...
T Consensus 317 ~~~~~~-------~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 317 LLKEGH-------R-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHTTC-------C-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCC-------C-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 211110 0 001 1111234556677799999999999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=365.52 Aligned_cols=259 Identities=25% Similarity=0.453 Sum_probs=208.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC-ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~-~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||+|++.. .....+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467999999999999999999975 699999998865 456677899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999976432 58999999999999999999999 899999999999999999999999999998765433
Q ss_pred CCcc------------ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc
Q 007256 420 SHIT------------CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 487 (611)
Q Consensus 420 ~~~~------------~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~ 487 (611)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..|+............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~-------- 234 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL-------- 234 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--------
Confidence 2211 11357999999999999999999999999999999999999998765443221110
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 488 ~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.....++.......+ ..+..++..||+.||.+|||+.++++.|+...
T Consensus 235 --~~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 235 --NVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp --CHHHHHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --hhhccccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001111111111111 23455667799999999999999999887543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=362.30 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=206.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++.... ...+.+.+|+.+++.++||||++++++|..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999986 579999999986533 3456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++|+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999754 38899999999999999999999 899999999999999999999999999998766543
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... ..+..
T Consensus 171 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-------~~~~~--- 238 (297)
T 3fxz_A 171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-------PELQN--- 238 (297)
T ss_dssp CC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-------CCCSC---
T ss_pred cc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------CCCCC---
Confidence 32 2346799999999999999999999999999999999999999977654333222211110 00000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......+..++..||+.||.+|||+.++++.
T Consensus 239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11112335556677999999999999999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=357.71 Aligned_cols=255 Identities=24% Similarity=0.416 Sum_probs=210.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.++|.+.+.||+|+||+||+|.+.+++.||||++.......+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 36799999999999999999999889999999998776666789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 89 ~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999997543 258999999999999999999999 89999999999999999999999999999866442211
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.... .....
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~ 229 (269)
T 4hcu_A 163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------RLYKP 229 (269)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------------CCCCC
T ss_pred -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc------------cCCCC
Confidence 1223467889999999999999999999999999999999 999997655433222111110 00011
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
... ...+..++..||+.||.+||++.++++.|+..
T Consensus 230 ~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 230 RLA----STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcC----CHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 111 23455666779999999999999999998743
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=369.62 Aligned_cols=248 Identities=24% Similarity=0.402 Sum_probs=206.2
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
..++|.+.+.||+|+||.||+|.+ .+|+.||||++... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999997 58999999999653 35567789999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999997643 48899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCCC-CcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+..... .
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-----~----- 232 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY-----R----- 232 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----C-----
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----C-----
Confidence 432 22346899999999999988875 789999999999999999999987654333222221110 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+ +......+..++..||+.||.+|||+.++++.
T Consensus 233 ---~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 ---I----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---C----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---C----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 11111234556677999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=366.07 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=206.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||+||+|.+. .+..||||+++. .....+.|.+|+.+++.++||||++++++|.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467999999999999999999874 345699999986 34556789999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999996543 258999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 416 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 416 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--------- 272 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR--------- 272 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC---------
Confidence 5533221 2223456889999999999999999999999999999999 9999976554332222211100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
... +......+..++..||+.||.+|||+.+|++.|+..
T Consensus 273 ---~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 273 ---LPA----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ---CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCC----CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 111123455667779999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=366.42 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=208.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||+|+++........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 578999999999999999999875 6889999999877777778999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC--CCceEEeecCccccccCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~--~~~vKL~DFGla~~~~~~ 418 (611)
++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++......
T Consensus 84 ~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999996543 258999999999999999999999 89999999999999987 789999999999877543
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......+ +..
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~---------~~~ 225 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF---------DEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC---------CHH
T ss_pred Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC---------Chh
Confidence 32 233679999999999998889999999999999999999999998765433222222111100 000
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
....+ ...+..++..||..||.+|||+.++++.
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00011 2345566778999999999999999973
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=369.50 Aligned_cols=269 Identities=23% Similarity=0.371 Sum_probs=213.3
Q ss_pred cCHHHHHHhhcCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEE
Q 007256 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISL 323 (611)
Q Consensus 253 f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l 323 (611)
+.........++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 33444445678999999999999999999973 35688999999863 34556799999999999 79999999
Q ss_pred eeEEEecCc-eEEEEeeCCCCChhhhhccCCCC-----------------------------------------------
Q 007256 324 LGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKD----------------------------------------------- 355 (611)
Q Consensus 324 ~g~~~~~~~-~~LV~Ey~~ggsL~~~L~~~~~~----------------------------------------------- 355 (611)
+++|.+.+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 89999999999999999765421
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 356 ---------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 356 ---------------~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1228999999999999999999999 8999999999999999999999999999987655444
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.................. ...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-----------MRA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC-----------CCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC-----------CCC
Confidence 444445678999999999999999999999999999999998 99999776543322111111000 001
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.... ...+..++..||+.||.+|||+.+|+++|+..
T Consensus 318 ~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 318 PDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1111 12355566779999999999999999998743
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=361.58 Aligned_cols=261 Identities=24% Similarity=0.343 Sum_probs=211.7
Q ss_pred cccCHHHHHHhhcC----------ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCc
Q 007256 251 RLFNYQDLLSATSN----------FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHK 318 (611)
Q Consensus 251 ~~f~~~el~~~t~~----------f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~Hp 318 (611)
..|+++++..+++. |...+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45677777777764 788889999999999999976 79999999997543 4456788999999999999
Q ss_pred ceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 319 nIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
||++++++|...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEE
Confidence 9999999999999999999999999999998643 48999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhH
Q 007256 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESL 478 (611)
Q Consensus 399 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~l 478 (611)
+.++.+||+|||++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999876553322 2346799999999999999999999999999999999999999976544322211
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 479 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 479 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+... ..+.+.. .......+..++..||+.||.+|||+.++++.
T Consensus 253 ~~~~------------~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 253 LRDS------------PPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHS------------SCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhcC------------CCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 0011100 01111235556667999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=362.52 Aligned_cols=257 Identities=30% Similarity=0.488 Sum_probs=200.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
..++|.+.+.||+|+||+||+|.. +|+.||||++... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356899999999999999999977 6889999999753 345678999999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--EEeeccCccceeeCCCCceEEeecCccccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g--IiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|||+++..
T Consensus 114 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp ECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred ecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999975431 1238899999999999999999999 78 999999999999999999999999999765
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~---------- 257 (309)
T 3p86_A 190 ASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR---------- 257 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC----------
T ss_pred ccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC----------
Confidence 44322 123467999999999999999999999999999999999999999876543332222111100
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
..+...++ ..+..++..||+.||.+|||+.+|++.|+..
T Consensus 258 -~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 258 -LEIPRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp -CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 01111111 2455667779999999999999999988643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=358.87 Aligned_cols=258 Identities=25% Similarity=0.424 Sum_probs=211.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++||||+++++++.+++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 56899999999999999999985 34588999999753 35567899999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCc
Q 007256 334 LLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 393 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~--------------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp 393 (611)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999976543 12348999999999999999999999 8999999999
Q ss_pred cceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCC
Q 007256 394 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 472 (611)
Q Consensus 394 ~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 472 (611)
+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987765444333334567899999999999999999999999999999999 9999987655
Q ss_pred cchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 473 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 473 ~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
......+..... ...... ....+..++..||+.||.+||++.++++.|+.
T Consensus 259 ~~~~~~~~~~~~------------~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 259 ERLFNLLKTGHR------------MERPDN----CSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp GGHHHHHHTTCC------------CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhhcCCc------------CCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 433222221110 001111 12345566777999999999999999998864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=356.90 Aligned_cols=254 Identities=22% Similarity=0.398 Sum_probs=207.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.++|.+.+.||+|+||+||+|.+.++..||||+++......+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 102 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence 46799999999999999999999888899999999776666789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 103 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 103 NGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999997533 248999999999999999999999 89999999999999999999999999999866442211
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..... ....
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------~~~~ 243 (283)
T 3gen_A 177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------LYRP 243 (283)
T ss_dssp -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC------------CCCC
T ss_pred -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC------------CCCC
Confidence 1122457889999999999999999999999999999998 9999976554332222211100 0001
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
... ...+..++..||+.||.+|||+.++++.|..
T Consensus 244 ~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 244 HLA----SEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp TTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 111 1345566777999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=364.88 Aligned_cols=262 Identities=24% Similarity=0.428 Sum_probs=211.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
..++|.+.+.||+|+||.||+|.+. +++.||||+++.. ....+.+.+|+.+++.++||||++++++|..++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4678999999999999999999874 3588999999853 3456789999999999999999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccC
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKD--------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 392 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~--------------------~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIK 392 (611)
.++||||+++|+|.+++...... ...+++.+++.++.||+.||.|||+ ++|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 99999999999999999764321 1468999999999999999999999 899999999
Q ss_pred ccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCC
Q 007256 393 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH 471 (611)
Q Consensus 393 p~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~ 471 (611)
|+|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654333223334678999999999999999999999999999999999 999997654
Q ss_pred CcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 007256 472 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541 (611)
Q Consensus 472 ~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~~ 541 (611)
.......+.. +.... +...+ ...+..++..||+.||.+||++.+|++.|+....
T Consensus 282 ~~~~~~~~~~-------~~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 HEEVIYYVRD-------GNILA-----CPENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HHHHHHHHHT-------TCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hHHHHHHHhC-------CCcCC-----CCCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 3322211111 11111 11111 1345566777999999999999999999986543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=368.82 Aligned_cols=213 Identities=25% Similarity=0.354 Sum_probs=188.7
Q ss_pred cccCHHHHHHhhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----CcceeEEe
Q 007256 251 RLFNYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----HKNIISLL 324 (611)
Q Consensus 251 ~~f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-----HpnIv~l~ 324 (611)
..|++++.....++|.+.+.||+|+||+||+|.+ .+++.||||+++........+..|+++++.+. ||||++++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 4556666667789999999999999999999987 47899999999987777788899999999997 99999999
Q ss_pred eEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC----
Q 007256 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---- 400 (611)
Q Consensus 325 g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---- 400 (611)
+++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence 9999999999999999 8899999976543 248899999999999999999999 89999999999999975
Q ss_pred ---------------------CCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHH
Q 007256 401 ---------------------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLE 459 (611)
Q Consensus 401 ---------------------~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~E 459 (611)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7899999999998655422 23579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCcc
Q 007256 460 LLTGRKPISNDHPKG 474 (611)
Q Consensus 460 LltG~~Pf~~~~~~~ 474 (611)
|++|+.||.......
T Consensus 252 ll~g~~pf~~~~~~~ 266 (360)
T 3llt_A 252 LYTGSLLFRTHEHME 266 (360)
T ss_dssp HHHSSCSCCCSSHHH
T ss_pred HHHCCCCCCCCcHHH
Confidence 999999998755433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=365.39 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=203.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||+||+|.+. +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 79999999986543 334678899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999997543 48999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... ..+...... ..+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~~~~-------~~~ 230 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKEKKTY-------LNP 230 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-HHHHTTCTT-------STT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHHhccccc-------CCc
Confidence 33333344689999999999987776 778999999999999999999997655432221 112111000 000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......+..++..||+.||.+|||+.++++.
T Consensus 231 ------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00112234556777999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=357.86 Aligned_cols=259 Identities=22% Similarity=0.360 Sum_probs=203.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~----~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.+. +++.||+|++.. .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999865 789999999853 345567899999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999997653 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .. ..... .
T Consensus 163 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~------~~~~~-~ 233 (294)
T 4eqm_A 163 ETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QD------SVPNV-T 233 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH-SS------CCCCH-H
T ss_pred ccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-hc------cCCCc-c
Confidence 43222 2233679999999999999999999999999999999999999997654332211110 00 00000 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhCCc
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLRGDA 540 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-tm~eVL~~L~~~~ 540 (611)
..+...+ ...+..++..||+.||.+|| ++.++.+.|....
T Consensus 234 ~~~~~~~----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 234 TDVRKDI----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHSCTTS----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred hhcccCC----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 0111111 23455667779999999999 7999998887543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=358.64 Aligned_cols=264 Identities=22% Similarity=0.329 Sum_probs=203.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||+||+|.+.+|+.||||+++... .....+.+|+++++.++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46899999999999999999999889999999997532 345678899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++ +|.+.+.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9986 8888886543 258999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc---
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL--- 494 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l--- 494 (611)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...............
T Consensus 173 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 VRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred ccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 322 223578999999999876 56899999999999999999999999876554433222111110000000000
Q ss_pred ---cCcccC--CCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 495 ---LDPALG--NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 495 ---ld~~l~--~~~~~-----~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+.... ..... .....+..++..||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 00000 11234556777899999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=374.54 Aligned_cols=257 Identities=23% Similarity=0.395 Sum_probs=207.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
..++|.+.+.||+|+||.||+|.+. +++.||||+++.. ......|.+|++++++++||||++++++|..++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3468999999999999999999986 7999999999754 344567899999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 192 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999997543 258899999999999999999999 8999999999999999999999999999986543
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
...........+++.|+|||++.++.++.++|||||||++|||++ |..||...........+..... +
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~------~----- 334 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR------L----- 334 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC------C-----
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------C-----
Confidence 221111112346788999999999999999999999999999998 9999976554332222211100 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
...... ...+..++..||+.||.+|||+.+|++.|+..
T Consensus 335 -~~~~~~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 335 -PCPELC----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 001111 12455567779999999999999999998643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=367.95 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=205.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
..+.|.+.+.||+|+||+||+|... +|+.||||+++... ...+.+.+|+.+|+.++||||++++++|.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3568999999999999999999875 69999999997532 135788999999999999999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC----ceEEee
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSD 408 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~----~vKL~D 408 (611)
.++||||++||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999999996543 58999999999999999999999 8999999999999998776 799999
Q ss_pred cCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 007256 409 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 488 (611)
Q Consensus 409 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 488 (611)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....
T Consensus 163 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---- 235 (361)
T 2yab_A 163 FGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY---- 235 (361)
T ss_dssp CSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC----
T ss_pred cCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----
Confidence 999987655332 2346799999999999999999999999999999999999999977654332222111100
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 489 g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. +++...... ...+..++..||..||.+|||+.+++++
T Consensus 236 -~----~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 -D----FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -C----CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -C----CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000000111 1234556677999999999999999874
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.04 Aligned_cols=256 Identities=22% Similarity=0.382 Sum_probs=201.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCE----EEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~----vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
.++|.+.+.||+|+||+||+|.+. +|+. ||+|.++.. ....+.|.+|+.++++++||||++++++|..+ ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 357999999999999999999864 4544 588887643 34567899999999999999999999999865 588
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+|+||+.+|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 99999999999999976542 58999999999999999999999 8999999999999999999999999999988
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
..............||+.|+|||++.++.++.++|||||||++|||++ |+.||...........+.......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------- 239 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------- 239 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC-------
Confidence 766544444344567889999999999999999999999999999999 999998765544333222111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
........+..++..||+.||.+||++.+|++.|+...
T Consensus 240 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 240 ---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 01111234566777899999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=365.29 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=204.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||+||+|... +|+.||||+++.. ......+.+|+.+++.++||||++++++|...+.+++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999875 7999999999753 23456788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999987543 48899999999999999999999 899999999999999999999999999998643
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 157 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------ 222 (337)
T 1o6l_A 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------ 222 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred cCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 3222 22346899999999999999999999999999999999999999976544322222211100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
.+...+ ...+..++..||+.||.+|| ++.+++++
T Consensus 223 -~~p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 -RFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 011111 12345566679999999999 89998874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=353.49 Aligned_cols=262 Identities=24% Similarity=0.379 Sum_probs=202.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCcceeEEeeEEEec----CceE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFED----NNLL 334 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~--l~HpnIv~l~g~~~~~----~~~~ 334 (611)
..++|.+.+.||+|+||+||+|.. +|+.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 356899999999999999999987 7899999999754 34556677777776 7899999999997653 4589
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCcEEeeccCccceeeCCCCceEE
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEPQL 406 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH--------~~~~~gIiHrDIKp~NILLd~~~~vKL 406 (611)
+||||+++|+|.+++... .+++..++.++.|++.||.||| + ++|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEE
Confidence 999999999999999542 4899999999999999999999 6 89999999999999999999999
Q ss_pred eecCccccccCCCCCcc--ccccccccccCChhhhccC------CCCCcceehhhhHHHHHHHhC----------CCCCC
Q 007256 407 SDFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTG----------RKPIS 468 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~--~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSlGvvL~ELltG----------~~Pf~ 468 (611)
+|||+++.......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99999987655433221 2235799999999999876 455799999999999999999 88886
Q ss_pred CCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 469 NDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 469 ~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.............. ..........+.. ..........+..++..||+.||.+|||+.+|++.|+.
T Consensus 235 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 235 DVVPNDPSFEDMRK-VVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TTSCSSCCHHHHHH-HHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCcchhhhhH-HHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 54433221111110 0000111111100 01122345677788888999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=372.35 Aligned_cols=259 Identities=24% Similarity=0.382 Sum_probs=208.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||+||+|... +++.||||+++. .......+.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357899999999999999999842 567899999975 345566799999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC---ceEEe
Q 007256 334 LLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLS 407 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~---~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~---~vKL~ 407 (611)
++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999975432 23458999999999999999999999 8999999999999999554 59999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhcccc
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 486 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 486 (611)
|||+++...............||+.|+|||++.++.++.++|||||||++|||++ |+.||...........+.....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~-- 304 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-- 304 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--
Confidence 9999986543322222334578999999999999999999999999999999998 9999977654332222211110
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 487 ~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
....... ...+..++..||+.||.+||++.+|++.|+..
T Consensus 305 ----------~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 305 ----------MDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp ----------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCccC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0001111 12455667779999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=367.53 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=211.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 330 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~ 330 (611)
.++|.+.+.||+|+||+||+|.+. ++..||||+++.. ......+.+|+++++.+ +||||++++++|..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 468999999999999999999852 3467999999864 35567899999999999 899999999999999
Q ss_pred CceEEEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEE
Confidence 999999999999999999976542 12358999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhh
Q 007256 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 477 (611)
Q Consensus 399 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 477 (611)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987765443333344578899999999999999999999999999999999 999997654333222
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.+..... ....... ...+..++..||+.||.+|||+.+|++.|+...
T Consensus 305 ~~~~~~~------------~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 305 LLKEGHR------------MDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHTTCC------------CCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHcCCC------------CCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 2111100 0001111 234556677799999999999999999987543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=355.06 Aligned_cols=271 Identities=21% Similarity=0.291 Sum_probs=210.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC--ceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~--~~~LV 336 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++... ...+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999975 59999999997533 34577889999999999999999999998765 78999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee----CCCCceEEeecCcc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLA 412 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL----d~~~~vKL~DFGla 412 (611)
|||+++++|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 999999999999975432 2248999999999999999999999 899999999999999 78888999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhc--------cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHH----
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFM--------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM---- 480 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~--------~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~---- 480 (611)
+........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||...........+.
T Consensus 164 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 877654332 2357999999999986 5789999999999999999999999997544322211111
Q ss_pred hhccccccCcccccc------Cccc--CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 481 WAKPILSSGKVTQLL------DPAL--GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 481 ~~~~~~~~g~l~~ll------d~~l--~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
...+......+.... .+.+ ...........+..++..||+.||.+|||+.++++....+
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111100000000000 0011 1123344555667778889999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=363.41 Aligned_cols=261 Identities=23% Similarity=0.395 Sum_probs=209.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~ 332 (611)
.++|.+.+.||+|+||.||+|.+ .++..||||+++.. ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46899999999999999999985 24668999999753 23456799999999999 89999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKD-------------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKS 393 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~-------------------~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp 393 (611)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 99999999999999999765321 1247999999999999999999999 8999999999
Q ss_pred cceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCC
Q 007256 394 SNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHP 472 (611)
Q Consensus 394 ~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~ 472 (611)
+|||++.++.+||+|||++................||+.|+|||++.++.++.++|||||||++|||+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999987765544444445678999999999999999999999999999999998 9999977654
Q ss_pred cchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 473 KGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 473 ~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.......... + ..... +......+..++..||+.||.+|||+.+|++.|+...
T Consensus 281 ~~~~~~~~~~------~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 281 DANFYKLIQN------G-----FKMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp SHHHHHHHHT------T-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHhc------C-----CCCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 3321111110 0 00001 1111234556677799999999999999999997543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=359.25 Aligned_cols=262 Identities=23% Similarity=0.368 Sum_probs=194.6
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeCC-C---CEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLPD-G---KELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~~-g---~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
...++|.+.+.||+|+||+||+|.+.. + ..||||+++.. ....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345789999999999999999998754 3 27999999753 3556789999999999999999999999987765
Q ss_pred e------EEEEeeCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCce
Q 007256 333 L------LLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 404 (611)
Q Consensus 333 ~------~LV~Ey~~ggsL~~~L~~~~--~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~v 404 (611)
. ++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCE
Confidence 5 99999999999999985432 223358999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 007256 405 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 483 (611)
||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+....
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 256 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence 9999999987655443333334567889999999999999999999999999999999 999998765443322221111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 484 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.. .. .......+..++..||+.||.+|||+.++++.|+...
T Consensus 257 ~~------------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 257 RL------------KQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp CC------------CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC------------CC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00 1111234566777899999999999999999887543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.94 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=211.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSE--DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~ 332 (611)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++... ...+.+.+|+.+++++ +||||++++++|..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46799999999999999999974 357889999998643 4467899999999999 89999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKD--------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~--------------~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 99999999999999999765421 2358999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhh
Q 007256 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 477 (611)
Q Consensus 399 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 477 (611)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 9999999999999987766554434444678899999999999999999999999999999999 999997655433221
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
...... ........ ....+..++..||+.||.+|||+.++++.|+.
T Consensus 259 ~~~~~~-----------~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 304 (313)
T 1t46_A 259 KMIKEG-----------FRMLSPEH----APAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (313)
T ss_dssp HHHHHT-----------CCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhccC-----------CCCCCccc----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence 111100 00001111 12345566777999999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=359.69 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=204.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+++.++||||++++++|...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356999999999999999999975 69999999987532 1367899999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC----ceEEeec
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 409 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~----~vKL~DF 409 (611)
++||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999996543 58999999999999999999999 8999999999999998887 7999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+......
T Consensus 163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---- 235 (326)
T 2y0a_A 163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE---- 235 (326)
T ss_dssp TTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCC----
T ss_pred CCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCC----
Confidence 99987654332 22367999999999999999999999999999999999999999765443322221111100
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. ........ ...+..++..||+.||.+|||+.++++.
T Consensus 236 -~----~~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 -F----EDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -C----CHHHHTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -c----CccccccC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00000111 1234556677999999999999999984
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=359.98 Aligned_cols=271 Identities=24% Similarity=0.339 Sum_probs=200.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-----CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~ 333 (611)
.++|.+.+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|++++++++||||++++++|.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46799999999999999999973 36889999999864 4556789999999999999999999999865 3568
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++|+|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 999999999999999976532 58999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC-ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+.......................+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 76543322 12223457888999999999999999999999999999999999986432110000000000000000000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..+........+......+..++..||+.||.+|||+.+|++.|+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~ 288 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0000000001111122345667778999999999999999998864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=365.29 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=204.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467999999999999999999875 6899999999753 345677899999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC---CceEEeecCcccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 414 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~---~~vKL~DFGla~~ 414 (611)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999987543 48999999999999999999999 899999999999999865 4599999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~------- 250 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP------- 250 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 654332 2236799999999999998999999999999999999999999976554322222111110000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.. ......+..++..||+.||.+||++.++++.
T Consensus 251 -~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 -SPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -TTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -cccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0111345556677999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=347.59 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=209.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.++|.+.+.||+|+||.||+|...+++.||+|+++......+.+.+|+++++.++||||+++++++.+++..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 36799999999999999999999889999999998776666789999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 87 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999997653 258899999999999999999999 8999999999999999999999999999986643211
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
.......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..... ....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~------------~~~~ 227 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------LYKP 227 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC------------CCCC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc------------CCCC
Confidence 11123467889999999999999999999999999999999 8999976543322211111000 0001
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.. ....+..++..||+.||.+||++.++++.|+..
T Consensus 228 ~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 228 RL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 123455667779999999999999999998743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=352.28 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=200.2
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||+|+||+||+|...+|+.||||+++... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5799999999999999999999889999999997543 2346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++ +|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 9999887543 258899999999999999999999 899999999999999999999999999998765432
Q ss_pred CCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc---ccc--
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK---VTQ-- 493 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~---l~~-- 493 (611)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+........... ...
T Consensus 155 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 RK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 21 2235789999999999754 589999999999999999999999977554332221111000000000 000
Q ss_pred ccCcccCC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 494 LLDPALGN-------NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 494 lld~~l~~-------~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..++.+.. .........+..++..||+.||.+|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00111100 0001112345567778999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=369.24 Aligned_cols=256 Identities=24% Similarity=0.399 Sum_probs=196.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||.||+|.+. ++..||||+++.. ....+.|.+|+.++++++||||++++++|.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999864 5778999999853 4556789999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCc-cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 416 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 416 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
....... ......+|+.|+|||++.++.++.++|||||||++|||++ |+.||...........+.....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~--------- 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR--------- 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 5432221 1122346788999999999999999999999999999998 9999976544332222111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
..........+..++..||+.||.+||++.+|++.|+..
T Consensus 269 -------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 -------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 000111223466677789999999999999999998754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=369.01 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=200.1
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~ 334 (611)
..++|.+.+.||+|+||+||+|... +|+.||||+++.. ....+.+.+|..++..+ +||||++++++|.+.+.++
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999875 6899999999753 23456788999999988 6999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 9999999999999997653 48999999999999999999999 8999999999999999999999999999985
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 174 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------- 241 (353)
T 3txo_A 174 GICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------- 241 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred cccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 433222 22346899999999999988999999999999999999999999987654433222221110
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQM------SLVLKL 535 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm------~eVL~~ 535 (611)
.+... ....+..++..||+.||.+||++ .+++++
T Consensus 242 ---~~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 242 ---VYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ---CCCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ---CCCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 01111 11234556677999999999998 677653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=353.06 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=214.3
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
..++|.+.+.||+|+||+||+|.+. ++..||||+++......+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4678999999999999999999976 588999999998777788999999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++..... ..+++..++.++.+++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999976433 358999999999999999999999 899999999999999999999999999998766543
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+..... ..
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~------------~~ 232 (288)
T 3kfa_A 166 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------ME 232 (288)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------------CC
T ss_pred cc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC------------CC
Confidence 22 2233567889999999999999999999999999999999 9999977654433222211100 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
....+ ...+..++..||+.||.+|||+.++++.|+..
T Consensus 233 ~~~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 233 RPEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11111 23455667779999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=349.56 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=199.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 6899999999743 3455788899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++ +|.+.+.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9987 5666554432 258999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCccccccccccccCChhhhccCC-CCCcceehhhhHHHHHHHhCCCCCCCCCCcc-hhhHHHhhccccccCcc---cc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKPILSSGKV---TQ 493 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~-~~~lv~~~~~~~~~g~l---~~ 493 (611)
... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||....... ....+............ ..
T Consensus 155 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 222 23357899999999998765 8999999999999999999988864433222 11111111000000000 00
Q ss_pred ccCc---------ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 494 LLDP---------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 494 lld~---------~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+. .............+..++..||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 00000111122345566777999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=363.33 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=195.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCC--cceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||++.+.+++.||||++... ....+.+.+|+.+|..++| |||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999989999999998743 3456788999999999986 9999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|| +.+++|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 56789999998653 48899999999999999999999 8999999999999997 5789999999998776
Q ss_pred CCCCCccccccccccccCChhhhcc-----------CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
............||+.|+|||++.+ +.++.++|||||||++|||++|+.||........ .+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~---- 233 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHAI---- 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHHHH----
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-HHHHH----
Confidence 5444333345689999999999875 6789999999999999999999999975432211 11111
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+++.....++......+..++..||+.||.+|||+.++++.
T Consensus 234 ---------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 234 ---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111111111112345566777999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=364.84 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=201.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+.+++.++||||++++++|.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46999999999999999999875 79999999986422 235789999999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc---eEEeecCcc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLA 412 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~---vKL~DFGla 412 (611)
||||+++++|.+.+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998876543333458999999999999999999999 89999999999999986654 999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... ... ...
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i-~~~-------~~~ 250 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGI-IKG-------KYK 250 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHH-HHT-------CCC
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHH-HcC-------CCC
Confidence 87755332 22346799999999999999999999999999999999999999976421111111 000 000
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.++.....+ ...+..++..||+.||.+|||+.++++
T Consensus 251 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000111 134556677799999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=346.22 Aligned_cols=249 Identities=31% Similarity=0.479 Sum_probs=193.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.+ .|+.||||+++... ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999987 48899999987532 3356789999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc---EEeeccCccceeeCC--------CCceE
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR---VIHRDVKSSNILLSD--------DFEPQ 405 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g---IiHrDIKp~NILLd~--------~~~vK 405 (611)
|||+++++|.+++... .+++..++.++.|++.||.|||+ ++ |+||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceE
Confidence 9999999999998632 48999999999999999999999 66 999999999999986 67899
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
|+|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....
T Consensus 157 l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~- 231 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL- 231 (271)
T ss_dssp ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCC-
T ss_pred EccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCC-
Confidence 999999986654322 235799999999999999999999999999999999999999976543322221111100
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
....... ....+..++..||+.||.+|||+.++++.|+.
T Consensus 232 ----------~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 ----------ALPIPST----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp ----------CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred ----------CCCCCcc----cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0001111 12345566777999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=378.72 Aligned_cols=257 Identities=22% Similarity=0.406 Sum_probs=210.2
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..++|.+.+.||+|+||.||+|.++++..||||+++......+.|.+|+.+|+.++||||+++++++. .+..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45689999999999999999999988999999999977667789999999999999999999999986 66899999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 265 ~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp TTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999975321 247889999999999999999999 8999999999999999999999999999987643211
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.......+|+.|+|||++..+.++.++|||||||+||||++ |+.||...........+...... ..
T Consensus 340 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------~~ 406 (454)
T 1qcf_A 340 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM------------PR 406 (454)
T ss_dssp -HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC------------CC
T ss_pred -eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC------------CC
Confidence 11122456789999999999999999999999999999999 99999765543322222111000 00
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.... ...+..++..||+.||.+|||+.+|++.|+...
T Consensus 407 ~~~~----~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 407 PENC----PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 1111 234556677899999999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=372.85 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=204.4
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
..++|.+.+.||+|+||+||+|.+. +|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3568999999999999999999864 78999999987543 4456789999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC---CCCceEEeecCccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAK 413 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd---~~~~vKL~DFGla~ 413 (611)
|||++||+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999987653 48999999999999999999999 8999999999999998 56789999999998
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........
T Consensus 162 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~------ 233 (444)
T 3soa_A 162 EVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP------ 233 (444)
T ss_dssp CCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC------
T ss_pred EecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC------
Confidence 76553322 2346899999999999999999999999999999999999999977654332222221111000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.. ... ...+..++..||+.||.+|||+.++++.
T Consensus 234 --~~~~-~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 --SPEW-DTV----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --TTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --cccc-ccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 011 1234556667999999999999999974
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=347.93 Aligned_cols=261 Identities=18% Similarity=0.208 Sum_probs=207.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... ..+.+.+|+.+++.+ +|+|++++++++..+...++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 46899999999999999999986 579999999987543 334678899999999 799999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc-----eEEeecCcccc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 414 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~-----vKL~DFGla~~ 414 (611)
+ +++|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++..
T Consensus 88 ~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 9999999976532 58999999999999999999999 89999999999999987766 99999999987
Q ss_pred ccCCCCC-----ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 415 ASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 415 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7654322 11234679999999999999999999999999999999999999998765433322221110000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.... +...+ ...+..++..||+.||.+||++.+|++.|+..
T Consensus 241 ~~~~-----~~~~~----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 241 PLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp CHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cHHH-----HHhhC----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0011 11111 13455667779999999999999999998743
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.06 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=208.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEe--------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL--------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 330 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~--------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~ 330 (611)
.++|.+.+.||+|+||.||+|.+ .++..||||+++.. ....+.+.+|+.+++.+ +||||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46899999999999999999986 35778999999853 35567899999999999 899999999999999
Q ss_pred CceEEEEeeCCCCChhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~------------~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 9999999999999999999765421 1348999999999999999999999 899999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhh
Q 007256 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 477 (611)
Q Consensus 399 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 477 (611)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999987665433323333567899999999998999999999999999999999 999997654332222
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.+..... ....... ...+..++..||+.||.+||++.++++.|+...
T Consensus 271 ~~~~~~~------------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 271 LLKEGHR------------MDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HHHHTCC------------CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcCCC------------CCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1111100 0011111 234556677799999999999999999987544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=356.59 Aligned_cols=245 Identities=26% Similarity=0.345 Sum_probs=203.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||++... +|+.||||+++... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999875 79999999997532 3456788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||++||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999997653 48899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------ 220 (318)
T 1fot_A 158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL------------ 220 (318)
T ss_dssp SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC------------
T ss_pred Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 42 2236899999999999999999999999999999999999999976554332222111100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
.+...+ ...+..++..||+.||.+|| ++.+++++
T Consensus 221 -~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 -RFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -CCCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 011111 12345566679999999999 88888764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=357.79 Aligned_cols=259 Identities=21% Similarity=0.223 Sum_probs=206.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.... ..+.+.+|+.+++.+ +||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 46899999999999999999986 578999999987542 234688999999999 899999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc-----eEEeecCcccc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-----PQLSDFGLAKW 414 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~-----vKL~DFGla~~ 414 (611)
+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 899999997642 258999999999999999999999 89999999999999998887 99999999987
Q ss_pred ccCCCCCc-----cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 415 ASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 415 ~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~---- 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT---- 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH----
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh----
Confidence 65433211 123468999999999999999999999999999999999999999876544332221111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..... ...+.... . .+..++..|++.||.+||++.+|++.|+.
T Consensus 236 ~~~~~-~~~~~~~~--p---~~~~li~~~l~~~p~~RP~~~~l~~~l~~ 278 (330)
T 2izr_A 236 KRATP-IEVLCENF--P---EMATYLRYVRRLDFFEKPDYDYLRKLFTD 278 (330)
T ss_dssp HHHSC-HHHHTTTC--H---HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred hccCC-HHHHhccC--h---HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence 00000 00011111 1 55666777999999999999999998863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=352.13 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=194.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChh---------------------------HHHHHHHHHHHHH
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED---------------------------VIKEFVLEIEIIT 313 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~---------------------------~~~~f~~Ei~iL~ 313 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999864 688999999875321 2356889999999
Q ss_pred hcCCcceeEEeeEEEe--cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeecc
Q 007256 314 TLHHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDV 391 (611)
Q Consensus 314 ~l~HpnIv~l~g~~~~--~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDI 391 (611)
.++||||+++++++.+ ++..++||||+++++|.+++.. ..+++..++.++.||+.||.|||+ ++|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 9999999999999986 5679999999999999886543 258999999999999999999999 89999999
Q ss_pred CccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCC---CCCcceehhhhHHHHHHHhCCCCCC
Q 007256 392 KSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPIS 468 (611)
Q Consensus 392 Kp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSlGvvL~ELltG~~Pf~ 468 (611)
||+|||++.++.+||+|||++......... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999876543322 23467999999999998665 4778999999999999999999997
Q ss_pred CCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 469 NDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 469 ~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..........+.... .. + +. ...+ ...+..++..||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~-------~~-~--~~-~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMCLHSKIKSQA-------LE-F--PD-QPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHHHHHHHHHCC-------CC-C--CS-SSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHHHHHHhccc-------CC-C--CC-cccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 654322111111100 00 0 00 0111 134556677799999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=347.44 Aligned_cols=254 Identities=23% Similarity=0.369 Sum_probs=195.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||.||+|.+. .+..||||+++.. ....+.+.+|+.++++++||||+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 468999999999999999999864 2457999998753 34567899999999999999999999998 4567899
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999997543 258999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
....... .....+|+.|+|||++....++.++|||||||++|||++ |..||...........+......
T Consensus 167 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~--------- 236 (281)
T 1mp8_A 167 EDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--------- 236 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---------
T ss_pred Ccccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---------
Confidence 5433221 223457889999999999999999999999999999997 99999876544332222111100
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.+.... ...+..++..||+.||.+|||+.++++.|+..
T Consensus 237 ---~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 ---PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111 23455667779999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=359.72 Aligned_cols=256 Identities=22% Similarity=0.408 Sum_probs=204.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCE----EEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~----vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
.++|.+.+.||+|+||+||+|.+. +|+. ||+|.+... ......+.+|+.+++.++||||++++++|. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 357999999999999999999864 4544 788887543 233456788999999999999999999985 56799
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999997543 258899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
..............||+.|+|||++.++.++.++|||||||++|||++ |+.||...........+......... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~ 240 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP----Q 240 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC----T
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC----C
Confidence 766554444445678899999999999999999999999999999999 99999876554433333222111110 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
... ..+..++..||+.||.+||++.++++.|+...
T Consensus 241 ~~~------------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 241 ICT------------IDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp TBC------------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred cCc------------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011 12344666799999999999999999997654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=375.39 Aligned_cols=264 Identities=22% Similarity=0.238 Sum_probs=209.2
Q ss_pred cCHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEE
Q 007256 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFC 327 (611)
Q Consensus 253 f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~ 327 (611)
+.+.++...+++|.+.++||+|+||+||+|.+. +++.||||+++... .....+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 346667777899999999999999999999976 57899999997532 1223488999999999999999999999
Q ss_pred EecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 328 ~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
.+++.+++||||++||+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 99999999999999999999997643 258999999999999999999999 999999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 482 (611)
|||+++........ .....+||+.|+|||++. .+.++.++|||||||++|||++|+.||...........+...
T Consensus 218 DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 218 DFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296 (437)
T ss_dssp CCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence 99999876543332 223468999999999997 567999999999999999999999999876554433322211
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKL 535 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~--RPtm~eVL~~ 535 (611)
...+ .+ +...... . ..+..++..||..+|++ ||++.+++++
T Consensus 297 ~~~~---~~-----p~~~~~~-s---~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 KERF---QF-----PTQVTDV-S---ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHC---CC-----CSSCCCS-C---HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccc---cC-----CcccccC-C---HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1000 00 0000011 1 23344555678777777 9999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=380.33 Aligned_cols=258 Identities=23% Similarity=0.387 Sum_probs=212.9
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
..++|.+.+.||+|+||.||+|.+. ++..||||+++......+.|.+|+.+|++++||||++++++|...+..++||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3467899999999999999999976 488999999987766778899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999976432 358999999999999999999999 899999999999999999999999999998765432
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
. .......+|+.|+|||++.++.++.++|||||||+||||++ |+.||...........+..... .
T Consensus 373 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------~- 438 (495)
T 1opk_A 373 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------M- 438 (495)
T ss_dssp E-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC------------C-
T ss_pred e-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------C-
Confidence 2 12223456789999999999999999999999999999999 9999977654332222211100 0
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
..+......+..++..||+.||.+|||+.+|++.|+...
T Consensus 439 ---~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ---CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 011111234556677899999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=348.14 Aligned_cols=254 Identities=23% Similarity=0.400 Sum_probs=207.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.++|.+.+.||+|+||.||+|...++..||||+++......+.+.+|+++++.++||||+++++++. .+..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 4689999999999999999999888889999999876666788999999999999999999999986 456899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+++|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 91 ~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 91 NGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999964321 248899999999999999999999 89999999999999999999999999999876543221
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......+|+.|+|||++.++.++.++|||||||++|||++ |+.||...........+.... .....
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~------------~~~~~ 232 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------RMVRP 232 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------CCCCC
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc------------CCCCc
Confidence 1223467889999999999999999999999999999999 999997654332211111100 00111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..+ ...+..++..||+.||.+|||+.++++.|+.
T Consensus 233 ~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 266 (279)
T 1qpc_A 233 DNC----PEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (279)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccc----cHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 111 2345566777999999999999999998864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.79 Aligned_cols=267 Identities=24% Similarity=0.373 Sum_probs=212.4
Q ss_pred HHHHHHhhcCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEee
Q 007256 255 YQDLLSATSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLG 325 (611)
Q Consensus 255 ~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g 325 (611)
........++|.+.+.||+|+||+||+|.+ .+++.||||+++.. ....+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334444567899999999999999999974 35789999999864 34556799999999999 6999999999
Q ss_pred EEEecC-ceEEEEeeCCCCChhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccC
Q 007256 326 FCFEDN-NLLLVYDFLSRGSLEENLHGNKKD------------PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 392 (611)
Q Consensus 326 ~~~~~~-~~~LV~Ey~~ggsL~~~L~~~~~~------------~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIK 392 (611)
+|...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+ ++|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCc
Confidence 987755 489999999999999999765431 1237899999999999999999999 899999999
Q ss_pred ccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCC
Q 007256 393 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDH 471 (611)
Q Consensus 393 p~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~ 471 (611)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987765544444445678999999999999999999999999999999998 999997655
Q ss_pred CcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 472 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 472 ~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
........... +.. ....... ...+..++..||+.||.+|||+.+|++.|+..
T Consensus 256 ~~~~~~~~~~~------~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 256 IDEEFCRRLKE------GTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CSHHHHHHHHH------TCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHHHhcc------Ccc-----CCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 33221111100 000 0011111 12455666779999999999999999998743
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=355.81 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=197.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------ 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~------ 332 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++. .....+.+.+|+.++++++||||++++++|.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457999999999999999999976 899999999874 33456789999999999999999999999876542
Q ss_pred ---------------------------------------------------eEEEEeeCCCCChhhhhccCCCCCCCCCH
Q 007256 333 ---------------------------------------------------LLLVYDFLSRGSLEENLHGNKKDPAAFGW 361 (611)
Q Consensus 333 ---------------------------------------------------~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~ 361 (611)
.++||||+++++|.+++..... .....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 7999999999999999986543 234577
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC----------cccccccccc
Q 007256 362 SERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH----------ITCTDVAGTF 431 (611)
Q Consensus 362 ~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~----------~~~~~~~GT~ 431 (611)
..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 7889999999999999999 89999999999999999999999999999877654221 1123357999
Q ss_pred ccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHH
Q 007256 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERM 511 (611)
Q Consensus 432 ~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l 511 (611)
.|+|||++.+..++.++|||||||++|||++|..|+... ........ ....... .......+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~----~~~~~~~---------~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVR----NLKFPLL---------FTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHH----TTCCCHH---------HHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhh----ccCCCcc---------cccCChhH
Confidence 999999999999999999999999999999987764211 11111000 0000000 01112334
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 007256 512 VLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 512 ~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..++..||+.||.+|||+.++++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 566778999999999999999873
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=358.52 Aligned_cols=244 Identities=23% Similarity=0.267 Sum_probs=191.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||++... ......+..|+..+..+ +||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 7999999998653 23444556666666655 8999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 669998887543 258999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
... .....||++|+|||++.+ .++.++|||||||++|||++|..|+..... ..... .+.. .+
T Consensus 210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~-----~~~~----~~ 271 (311)
T 3p1a_A 210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQQLR-----QGYL----PP 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HHHHT-----TTCC----CH
T ss_pred CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHh-----ccCC----Cc
Confidence 332 223579999999998875 799999999999999999999877654211 10000 0100 11
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.... ...+..++..||+.||.+|||+.++++.
T Consensus 272 ~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 EFTAGL----SSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccCC----CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111111 2345666777999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=342.11 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=204.2
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
..++|.+.+.||+|+||.||+|.+. +|+.||+|++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999875 6899999998653 34567788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc---eEEeecCccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAK 413 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~---vKL~DFGla~ 413 (611)
|||+++++|.+.+.... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++. +||+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 99999999999887543 48999999999999999999999 89999999999999976655 9999999997
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+......
T Consensus 157 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 225 (284)
T 3kk8_A 157 EVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-------- 225 (284)
T ss_dssp ECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred EcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc--------
Confidence 66543322 2367999999999999999999999999999999999999999765543322222111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
...+.. ... ...+..++..||+.||.+|||+.++++
T Consensus 226 ~~~~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPSPEW-DTV----TPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCTTTT-TTS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCchhh-ccc----CHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 011 123555667799999999999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=350.46 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=200.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC------hhHHHHHHHHHHHHHhcC---CcceeEEeeEEEec
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS------EDVIKEFVLEIEIITTLH---HKNIISLLGFCFED 330 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~------~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~ 330 (611)
.+++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ......+.+|+.+++.++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467999999999999999999996 47999999998632 122345667777777665 99999999999876
Q ss_pred C-----ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 331 N-----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 331 ~-----~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
. ..++||||+.+ +|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence 5 48999999975 99999976543 248999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
|+|||++......... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......
T Consensus 161 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999876543322 3467999999999999999999999999999999999999999876654433322211111
Q ss_pred cccCccccc---cCcccCCCC-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 486 LSSGKVTQL---LDPALGNNY-------DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 486 ~~~g~l~~l---ld~~l~~~~-------~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.....+... ....+.... .......+..++..||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 111111000 000000000 00112345567778999999999999999863
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=357.17 Aligned_cols=263 Identities=25% Similarity=0.273 Sum_probs=202.2
Q ss_pred HHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe
Q 007256 257 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNIISLLGFCFE 329 (611)
Q Consensus 257 el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~------~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~ 329 (611)
++....++|.+.+.||+|+||+||+|... +++.||||++... ....+.+.+|+.+++.++||||++++++|.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34456678999999999999999999874 7889999998643 3456789999999999999999999999999
Q ss_pred cCceEEEEeeCCCCChhhhhccCCCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 007256 330 DNNLLLVYDFLSRGSLEENLHGNKKD------------------------------------PAAFGWSERYKVAMGVAE 373 (611)
Q Consensus 330 ~~~~~LV~Ey~~ggsL~~~L~~~~~~------------------------------------~~~l~~~~~~~I~~qIa~ 373 (611)
.+..++||||+++|+|.+++...... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521110 112456778899999999
Q ss_pred HHHHHhcCCCCcEEeeccCccceeeCCCC--ceEEeecCccccccCCCCC--ccccccccccccCChhhhcc--CCCCCc
Q 007256 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDF--EPQLSDFGLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMY--GKVNDK 447 (611)
Q Consensus 374 gL~yLH~~~~~gIiHrDIKp~NILLd~~~--~vKL~DFGla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~--~~~s~k 447 (611)
||.|||+ ++|+||||||+|||++.++ .+||+|||++......... .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 9999999 8999999999999998776 8999999999866442221 12234679999999999975 678999
Q ss_pred ceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC
Q 007256 448 IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP 527 (611)
Q Consensus 448 sDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP 527 (611)
+|||||||++|||++|+.||...........+........ .+.. ......+..++..||+.||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE--------NPNY-----NVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT--------SGGG-----GGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC--------Cccc-----ccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999976654332222211111000 0000 00113455566779999999999
Q ss_pred CHHHHHHH
Q 007256 528 QMSLVLKL 535 (611)
Q Consensus 528 tm~eVL~~ 535 (611)
++.++++.
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999873
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=366.93 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=195.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcC--CcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLH--HKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~--HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||++.+.+|+.||||++... ....+.+.+|+.+|+.++ ||||+++++++..++.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 469999999999999999999888999999998643 355678999999999997 599999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
| +.+++|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56889999997654 47889999999999999999999 8999999999999996 57999999999987765
Q ss_pred CCCCccccccccccccCChhhhcc-----------CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 486 (611)
..........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ .+...
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~~~~~----- 280 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-KLHAI----- 280 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHH-----
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-HHHHH-----
Confidence 443333344689999999999875 4689999999999999999999999975432211 11111
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 487 ~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+++.....++......+..++..||+.||.+|||+.++++.
T Consensus 281 --------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 --------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111101111112345566777999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=364.37 Aligned_cols=253 Identities=22% Similarity=0.275 Sum_probs=194.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.++|.+.+.||+|+||+||++... +|+.||||++.......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 468999999999999999999976 7999999999876655677889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc--eEEeecCccccccCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKWASTS 418 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~--vKL~DFGla~~~~~~ 418 (611)
++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999987543 48999999999999999999999 89999999999999987765 999999999744332
Q ss_pred CCCccccccccccccCChhhhccCCCCCc-ceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~k-sDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.. .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............... +.. ...
T Consensus 172 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~--~~~-~~~------ 239 (361)
T 3uc3_A 172 SQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR--ILS-VKY------ 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH--HHT-TCC------
T ss_pred CC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH--Hhc-CCC------
Confidence 21 223579999999999998888766 89999999999999999999865443222111100 000 000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.... .....+..++..||+.||.+|||+.+++++
T Consensus 240 ~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SIPDDI--RISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCTTS--CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCcC--CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000000 011345566777999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.48 Aligned_cols=258 Identities=29% Similarity=0.462 Sum_probs=193.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||+||+|.... .||||+++.. ....+.|.+|+.+++.++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4679999999999999999998643 5999999753 45567899999999999999999999965 5667899999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999996543 358999999999999999999999 89999999999999999999999999999866543
Q ss_pred CCCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
..........||+.|+|||++. ...++.++|||||||++|+|++|+.||............... +.....+
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~ 247 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR------GSLSPDL 247 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHH------TSCCCCT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcc------cccCcch
Confidence 3333334467999999999986 667888999999999999999999999765443322111111 0110000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.. + .......+..++..||+.||.+|||+.++++.|+..
T Consensus 248 ~~-~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 248 SK-V----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp TS-S----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hh-c----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 00 0 111123456667779999999999999999998754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=373.36 Aligned_cols=263 Identities=22% Similarity=0.241 Sum_probs=208.9
Q ss_pred cCHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEE
Q 007256 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFC 327 (611)
Q Consensus 253 f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~ 327 (611)
+.+++.....++|.+.+.||+|+||.||++..+ +|+.||||+++... ...+.+.+|..++..++||||++++++|
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 455666677899999999999999999999975 79999999997532 2234578999999999999999999999
Q ss_pred EecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 328 ~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
.+.+.+|+||||++||+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999997543 258999999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhc-------cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-------~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~ 480 (611)
|||+++........ .....+||+.|+|||++. .+.++.++|||||||++|||++|+.||...........+.
T Consensus 205 DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 205 DFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred echhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999876553321 223468999999999997 4578999999999999999999999998765543322222
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 007256 481 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR---PQMSLVLKL 535 (611)
Q Consensus 481 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~R---Ptm~eVL~~ 535 (611)
....... -+.+...++ ..+..++..||. +|.+| |++.+++++
T Consensus 284 ~~~~~~~--------~p~~~~~~s----~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 284 HYKEHLS--------LPLVDEGVP----EEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp THHHHCC--------CC----CCC----HHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred hcccCcC--------CCccccCCC----HHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1110000 011111111 234555667998 99988 689998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=365.43 Aligned_cols=249 Identities=27% Similarity=0.371 Sum_probs=203.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||++... +|+.||||++.... ...+.+.+|+.+|+.++||||++++++|.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357999999999999999999865 68999999997532 3456788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+.||+|.+++.... .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999997643 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhcc---CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
.... ....+||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+........
T Consensus 167 ~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------- 236 (384)
T 4fr4_A 167 RETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------- 236 (384)
T ss_dssp TTCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-------
T ss_pred CCCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-------
Confidence 4332 234689999999999974 458999999999999999999999997655443332222111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLK 534 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-m~eVL~ 534 (611)
.. ++......+..++..||+.||.+||+ +.+|++
T Consensus 237 ---~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ---VT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---cC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 11111234556677799999999999 777665
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=364.49 Aligned_cols=265 Identities=18% Similarity=0.214 Sum_probs=202.9
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCC------CCEEEEEEecCChhH------------HHHHHHHHHHHHhcCCcceeE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSEDV------------IKEFVLEIEIITTLHHKNIIS 322 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~------g~~vAVK~l~~~~~~------------~~~f~~Ei~iL~~l~HpnIv~ 322 (611)
..++|.+.+.||+|+||+||+|.+.+ ++.||||++...... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999998754 478999998764321 112345666777888999999
Q ss_pred EeeEEEec----CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 323 LLGFCFED----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 323 l~g~~~~~----~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
+++++... ...+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 99999875 4589999999 999999997643 358999999999999999999999 899999999999999
Q ss_pred C--CCCceEEeecCccccccCCCCCc-----cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCC
Q 007256 399 S--DDFEPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDH 471 (611)
Q Consensus 399 d--~~~~vKL~DFGla~~~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 471 (611)
+ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 88999999999998765432211 1123569999999999999999999999999999999999999998543
Q ss_pred CcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 472 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 472 ~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
...... ...... ....+..++++.+....... .+..++..|++.+|.+||++.+|++.|+.
T Consensus 266 ~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~li~~cl~~~p~~RP~~~~l~~~l~~ 326 (364)
T 3op5_A 266 KDPKYV--RDSKIR-YRENIASLMDKCFPAANAPG---EIAKYMETVKLLDYTEKPLYENLRDILLQ 326 (364)
T ss_dssp TCHHHH--HHHHHH-HHHCHHHHHHHHSCTTCCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred cCHHHH--HHHHHH-hhhhHHHHHHHhcccccCHH---HHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence 322211 111100 01133444444443222233 34455667999999999999999998864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=362.82 Aligned_cols=252 Identities=21% Similarity=0.243 Sum_probs=205.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++.... .....+.+|+.+++.++||||++++++|.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999875 78999999997643 4456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC--CCceEEeecCccccccC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWAST 417 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~--~~~vKL~DFGla~~~~~ 417 (611)
+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999987543 258999999999999999999999 89999999999999974 57899999999987755
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...... +++
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~---------~~~ 271 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---------FDE 271 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC---------CCS
T ss_pred Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------CCc
Confidence 332 22357999999999999999999999999999999999999999875433222211111000 011
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..... ....+..++..||+.||.+|||+.++++.
T Consensus 272 ~~~~~----~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 DAFSS----VSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp STTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11111 12345566778999999999999999974
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=354.05 Aligned_cols=264 Identities=21% Similarity=0.375 Sum_probs=211.5
Q ss_pred HHhhcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec
Q 007256 259 LSATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED 330 (611)
Q Consensus 259 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~ 330 (611)
....++|.+.+.||+|+||.||+|.+. +++.||||++... ......+.+|+.+++.++||||+++++++.++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345678999999999999999999754 4788999999754 34456789999999999999999999999999
Q ss_pred CceEEEEeeCCCCChhhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCce
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 404 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~------~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~v 404 (611)
+..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeE
Confidence 99999999999999999986532 111357899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 007256 405 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 483 (611)
||+|||++................||+.|+|||++.++.++.++|||||||++|+|++ |+.||...........+..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-- 255 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME-- 255 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT--
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc--
Confidence 9999999986654433333334567899999999999999999999999999999999 8999976543322211111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 007256 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541 (611)
Q Consensus 484 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~~ 541 (611)
+.... ..... ...+..++..||+.||.+|||+.++++.|+....
T Consensus 256 -----~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 -----GGLLD-----KPDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -----TCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----CCcCC-----CCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11100 01111 2345556677999999999999999999986543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=349.25 Aligned_cols=264 Identities=25% Similarity=0.295 Sum_probs=199.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 68999999999999999999975 69999999986542 345678899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999886543 48999999999999999999999 89999999999999999999999999999876543
Q ss_pred CCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc--------ccC
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL--------SSG 489 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~--------~~g 489 (611)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....... ...
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 322 223579999999999976 578999999999999999999999998765443332221110000 000
Q ss_pred -ccc--cccCcccCCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 -KVT--QLLDPALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 -~l~--~lld~~l~~~~---~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
... .+.++...... .......+..++..||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000000000 00112345667778999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=360.71 Aligned_cols=245 Identities=23% Similarity=0.292 Sum_probs=204.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||++... +|+.||||+++... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 468999999999999999999975 79999999997532 3456788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999997643 48999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~------------ 255 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------------ 255 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 42 2236899999999999999999999999999999999999999987654332222211110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~~ 535 (611)
.+...+ ...+..++..||+.||.+||+ +.+|+++
T Consensus 256 -~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 -RFPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 011111 123555667799999999998 7887764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=364.21 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=203.1
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 333 (611)
...++|.+.+.||+|+||.||+|..+ +|+.||||+++.. ......+..|..++..+ +||||+++++++.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 35679999999999999999999975 6899999999753 23456788899999987 899999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||++||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999997643 48999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....+
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------- 235 (345)
T 1xjd_A 167 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--------- 235 (345)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred hcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 6533222 22347899999999999999999999999999999999999999987654332222221111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLK 534 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~-eVL~ 534 (611)
.+...+ ...+..++..||+.||.+||++. +|++
T Consensus 236 ----~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 ----FYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ----CCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111111 12345566779999999999987 5553
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=371.86 Aligned_cols=260 Identities=23% Similarity=0.294 Sum_probs=208.5
Q ss_pred CHHHHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEE
Q 007256 254 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCF 328 (611)
Q Consensus 254 ~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~ 328 (611)
.+.++....++|.+.+.||+|+||+||+|.+. +|+.||||+++... .....+.+|+.+++.++||||++++++|.
T Consensus 60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 34566667889999999999999999999975 68999999997532 22335789999999999999999999999
Q ss_pred ecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEee
Q 007256 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 408 (611)
Q Consensus 329 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~D 408 (611)
+++.+++||||++||+|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+|
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~D 211 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLAD 211 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEec
Confidence 999999999999999999999753 38899999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccccccCChhhhccCC----CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 007256 409 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGK----VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 484 (611)
Q Consensus 409 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 484 (611)
||+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+.....
T Consensus 212 FG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 212 FGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN 290 (410)
T ss_dssp CTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred cceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc
Confidence 999987654322 1223478999999999998665 88999999999999999999999987665443332221110
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRA--RPQMSLVLKL 535 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~--RPtm~eVL~~ 535 (611)
.+. + +. ...+ ...+..++..||+.+|.+ ||++.+|+++
T Consensus 291 ~~~------~--p~-~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 SLT------F--PD-DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HCC------C--CT-TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccc------C--CC-cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000 0 00 0011 123445556699989988 9999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.60 Aligned_cols=252 Identities=25% Similarity=0.324 Sum_probs=188.7
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
..++|.+.+.||+|+||+||+|.+. +++.||||+++... ..+.+.+|+.++++++||||++++++|...+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4578999999999999999999976 68899999998643 346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC---CCceEEeecCcccccc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGLAKWAS 416 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---~~~vKL~DFGla~~~~ 416 (611)
+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 130 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999997543 48999999999999999999999 89999999999999975 8899999999998665
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... .... ... ....
T Consensus 203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~i~~-----~~~-~~~~ 272 (349)
T 2w4o_A 203 HQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR-RILN-----CEY-YFIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHH-HHHT-----TCC-CCCT
T ss_pred cccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHH-HHHh-----CCC-ccCC
Confidence 4321 2236799999999999999999999999999999999999999976544321111 0000 000 0001
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+. .......+..++..||+.||.+|||+.++++.
T Consensus 273 ~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 PW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ch-----hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 01112345566778999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=360.08 Aligned_cols=208 Identities=23% Similarity=0.304 Sum_probs=180.1
Q ss_pred hhcCceeeeeEeec--CcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 261 ATSNFLAENLIGKG--GSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 261 ~t~~f~~~~~LG~G--~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
..++|.+.+.||+| +||+||+|.+. +|+.||||+++.. ....+.+.+|+.+++.++||||++++++|.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35689999999999 99999999976 7999999999753 355677889999999999999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+++|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999976532 248999999999999999999999 8999999999999999999999999999865
Q ss_pred ccCCCC-----CccccccccccccCChhhhcc--CCCCCcceehhhhHHHHHHHhCCCCCCCCCCc
Q 007256 415 ASTSSS-----HITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473 (611)
Q Consensus 415 ~~~~~~-----~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 473 (611)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 432111 111122479999999999987 57999999999999999999999999765543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=357.61 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=209.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-C-----CCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-D-----GKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~-----g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~ 332 (611)
.++|.+.+.||+|+||.||+|... + ++.||||+++.. ....+.+.+|+.+++.+ +||||++++++|..++.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 468999999999999999999864 2 347999999864 34567899999999999 89999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC
Q 007256 333 LLLVYDFLSRGSLEENLHGNKK----------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF 402 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~----------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~ 402 (611)
.++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 9999999999999999864321 12357899999999999999999999 8999999999999999999
Q ss_pred ceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHh
Q 007256 403 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMW 481 (611)
Q Consensus 403 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~ 481 (611)
.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||..............
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 999999999987655444433344668899999999999999999999999999999999 9999976554332211111
Q ss_pred hccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 482 AKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 482 ~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
... ........ ...+..++..||+.||.+|||+.+|++.|+..
T Consensus 282 ~~~-----------~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 282 DGY-----------QMAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HTC-----------CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC-----------CCCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 100 00001111 23455667779999999999999999998743
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=345.03 Aligned_cols=251 Identities=30% Similarity=0.508 Sum_probs=200.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChh-----H---HHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED-----V---IKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~-----~---~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
.++|.+.+.||+|+||+||+|.+. +++.||||++..... . .+.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 468999999999999999999874 799999999864321 1 167899999999999999999999986544
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--EEeeccCccceeeCCCCc-----eE
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFE-----PQ 405 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g--IiHrDIKp~NILLd~~~~-----vK 405 (611)
++||||+++|+|.+.+.... ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999886543 258999999999999999999999 77 999999999999988776 99
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhc--cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~ 483 (611)
|+|||+++..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||................
T Consensus 170 l~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 170 VADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp ECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred eCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 9999999754332 23367999999999983 4567899999999999999999999997665443322211111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 484 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.. ..+.+.... ...+..++..||+.||.+|||+.++++.|+.
T Consensus 245 ~~---------~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 245 EG---------LRPTIPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SC---------CCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred cC---------CCCCCCccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 10 011111111 2345666777999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=355.20 Aligned_cols=263 Identities=23% Similarity=0.367 Sum_probs=190.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||+||+|... +|+.||||+++... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 468999999999999999999875 68999999987532 344678899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 339 FLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 339 y~~ggsL~~~L~~~~--~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|+++ +|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9985 9999886432 223458999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC------
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG------ 489 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g------ 489 (611)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..........
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 43222 223578999999999976 468999999999999999999999998765443322221110000000
Q ss_pred ---------------ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 490 ---------------KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 490 ---------------~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+.+.+.+...... ...+..++..||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00111111111111 234566777899999999999999886
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.07 Aligned_cols=248 Identities=25% Similarity=0.346 Sum_probs=194.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEe----CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
.++|.+.+.||+|+||.||++.. .+|+.||||+++... .....+.+|+.+++.++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 479999999998642 344567889999999999999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999997543 48899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 169 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------- 238 (327)
T 3a62_A 169 KESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-------- 238 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------
T ss_pred cccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 75443222 12346799999999999999999999999999999999999999986554332221111100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
.+.... ...+..++..||+.||.+|| ++.+++++
T Consensus 239 -----~~p~~~----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 -----NLPPYL----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -----CCCTTS----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -----CCCCCC----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 011111 23445566779999999999 77888774
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=341.32 Aligned_cols=250 Identities=20% Similarity=0.344 Sum_probs=202.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~LV 336 (611)
.++|.+.+.||+|+||+||+|.+. |+.||||+++.. ....+.|.+|+.++++++||||+++++++... +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 357999999999999999999984 889999999854 35567899999999999999999999999877 788999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--EEeeccCccceeeCCCCceEEeecCcccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g--IiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
|||+++|+|.+++..... ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999976432 358999999999999999999998 77 99999999999999999999999988754
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCC---cceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVND---KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~---ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||...........+....
T Consensus 163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------- 227 (271)
T 3kmu_A 163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG-------- 227 (271)
T ss_dssp TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC--------
T ss_pred ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC--------
Confidence 322 2357899999999998765554 7999999999999999999997654433211111110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
..+.+.... ...+..++..||+.||.+|||+.++++.|+..
T Consensus 228 ---~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 ---LRPTIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ---CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 011111111 22455666679999999999999999998753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=342.77 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=205.9
Q ss_pred hcCceeee-eEeecCcEEEEEEEeC---CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~-~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+ .||+|+||.||+|.+. ++..||||+++.. ....+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35666666 9999999999999853 6788999999863 45677899999999999999999999999 5667999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999996433 358999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 416 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 416 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~-------~~-- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-------KR-- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-------CC--
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC-------Cc--
Confidence 5433221 1222457899999999998999999999999999999998 99999776543322222111 00
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
+.+.... ...+..++..||+.||.+||++.++++.|+..
T Consensus 232 ---~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 ---MECPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ---CCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCc----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111111 23455667779999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=355.94 Aligned_cols=252 Identities=18% Similarity=0.223 Sum_probs=200.9
Q ss_pred hhcCceeeeeEeecCcEEEEEEE------eCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecC
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDN 331 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~------~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~ 331 (611)
..++|.+.+.||+|+||+||+|. ..+++.||||+++... ..++..|+.++..++ |+||+++++++..++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 45789999999999999999994 4578999999998643 456788888888887 999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC----------
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKK-DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---------- 400 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~-~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---------- 400 (611)
..++||||+++|+|.+++..... ....+++..++.|+.||+.||.|||+ ++|+||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999974321 22469999999999999999999999 89999999999999998
Q ss_pred -CCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH
Q 007256 401 -DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479 (611)
Q Consensus 401 -~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv 479 (611)
++.+||+|||+++..............+||++|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 89999999999986654333334455789999999999999999999999999999999999999995432211
Q ss_pred HhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHhhC
Q 007256 480 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR-PQMSLVLKLLRG 538 (611)
Q Consensus 480 ~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~R-Ptm~eVL~~L~~ 538 (611)
+ . +...+......+. +..+...|++.+|.+| |++.++.+.|+.
T Consensus 293 -~--------~----~~~~~~~~~~~~~---~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 -C--------K----PEGLFRRLPHLDM---WNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp -E--------E----ECSCCTTCSSHHH---HHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred -e--------e----echhccccCcHHH---HHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 0 0 1111111112233 3344556999999998 567777776653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=349.64 Aligned_cols=268 Identities=25% Similarity=0.365 Sum_probs=199.8
Q ss_pred HHHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhc--CCcceeEEeeEEEec----C
Q 007256 258 LLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL--HHKNIISLLGFCFED----N 331 (611)
Q Consensus 258 l~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l--~HpnIv~l~g~~~~~----~ 331 (611)
.....++|.+.+.||+|+||.||+|... |+.||||++..... ..+..|.+++..+ +||||+++++++... .
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 3345578999999999999999999875 89999999975443 3445566666554 899999999999887 6
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCcEEeeccCccceeeCCCCceEE
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEPQL 406 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~-----~~gIiHrDIKp~NILLd~~~~vKL 406 (611)
..++||||+++|+|.+++... .+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 799999999999999999654 4899999999999999999999820 129999999999999999999999
Q ss_pred eecCccccccCCCCCcc--ccccccccccCChhhhccCCCCCc------ceehhhhHHHHHHHhC----------CCCCC
Q 007256 407 SDFGLAKWASTSSSHIT--CTDVAGTFGYLAPEYFMYGKVNDK------IDVYAFGVVLLELLTG----------RKPIS 468 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~s~k------sDVwSlGvvL~ELltG----------~~Pf~ 468 (611)
+|||+++.......... .....||+.|+|||++.+..++.+ +|||||||++|||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999976654332211 123579999999999987776665 9999999999999999 56665
Q ss_pred CCCCcchhhHHHhhccccccCccccccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 469 NDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 469 ~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~-~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.............. ...... ..+.+.... .......+..++..||+.||.+|||+.+|++.|+..
T Consensus 264 ~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 264 DLVPSDPSYEDMRE--IVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTSCSSCCHHHHHH--HHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhcCCCCchhhhHH--HHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 43322211110000 000000 111111111 123455677888889999999999999999999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=367.58 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=204.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-ceEEEEee
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN-NLLLVYDF 339 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~-~~~LV~Ey 339 (611)
..++|.+.+.||+|+||.||+|... |+.||||+++... ..+.|.+|+.++++++||||+++++++.+.. ..++||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 3568999999999999999999874 7899999998654 5578999999999999999999999987765 79999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999976432 247899999999999999999999 899999999999999999999999999998543321
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
....+|+.|+|||++.++.++.++|||||||++|||++ |+.||...........+..... ..
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------~~ 406 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------MD 406 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC------------CC
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------CC
Confidence 12357889999999999999999999999999999998 9999987654433222211100 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..... ...+..++..||+.||.+|||+.+|++.|+.
T Consensus 407 ~p~~~----~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 407 APDGC----PPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111 2345566677999999999999999998864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=373.02 Aligned_cols=257 Identities=24% Similarity=0.409 Sum_probs=204.4
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..++|.+.+.||+|+||.||+|.++++..||||+++......+.|.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 346789999999999999999999888889999998766566789999999999999999999999866 6789999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.+++..... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 261 ~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 261 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp TTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred cCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 99999999974321 248899999999999999999999 8999999999999999999999999999987654322
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
. ......+|+.|+|||++.++.++.++|||||||++|||++ |+.||...........+..... ...
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------~~~ 402 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------MPC 402 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------CCC
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------CCC
Confidence 1 1223457889999999999999999999999999999999 9999976554332222111100 000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
... ....+..++..||+.||.+|||+.+|++.|+...
T Consensus 403 ~~~----~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 403 PPE----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111 1234556677899999999999999999997654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=355.01 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=194.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce---
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL--- 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~--- 333 (611)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++.. ......+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999996 57899999999753 34456789999999999999999999998876543
Q ss_pred -EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 334 -LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 334 -~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999997543 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 413 KWASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 413 ~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...................
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----- 238 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----- 238 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC-----
Confidence 876543222 12233579999999999999999999999999999999999999997765433221111110000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
. ......+ ...+..++..||+.||.+||++.+++.
T Consensus 239 ~----~~~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 239 P----SARHEGL----SADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp H----HHHSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred c----ccccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 0 0000111 134555667799999999998776664
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.14 Aligned_cols=261 Identities=25% Similarity=0.386 Sum_probs=197.3
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN- 331 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~- 331 (611)
...++|.+.+.||+|+||.||+|... ++..||||+++.. ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34678999999999999999999753 3458999999753 455678999999999999999999999998755
Q ss_pred ----ceEEEEeeCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 332 ----NLLLVYDFLSRGSLEENLHGNK--KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 332 ----~~~LV~Ey~~ggsL~~~L~~~~--~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEE
Confidence 3599999999999999985332 223468999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhcc
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKP 484 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~ 484 (611)
|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...........+.....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 999999987655433223333567889999999999999999999999999999999 8999977654432222111100
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
+.....+ ...+..++..||+.||.+|||+.++++.|+..
T Consensus 268 ------------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 268 ------------LKQPEDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp ------------CCCBTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------------CCCCccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011111 23456667779999999999999999998743
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=363.85 Aligned_cols=249 Identities=20% Similarity=0.325 Sum_probs=195.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||+||+|... +++.||||+++.. ....+.+.+|..++.++ +||||++++++|.+.+.+++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999875 6889999999753 23345678899999887 89999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||++||+|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999997643 48999999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhh--HHHhhccccccCcccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES--LVMWAKPILSSGKVTQ 493 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~--lv~~~~~~~~~g~l~~ 493 (611)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........+..+.
T Consensus 204 ~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 278 (396)
T 4dc2_A 204 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 278 (396)
T ss_dssp CCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred ccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence 33222 2234789999999999999999999999999999999999999996432211000 0000000000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 529 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm 529 (611)
..+... ....+..++..||+.||.+||++
T Consensus 279 ---~~~p~~----~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 ---IRIPRS----LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---CCCCTT----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ---cCCCCc----CCHHHHHHHHHHhcCCHhHcCCC
Confidence 011111 12344556677999999999995
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=353.82 Aligned_cols=256 Identities=22% Similarity=0.376 Sum_probs=199.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCE----EEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKE----LAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~----vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
.++|.+.+.||+|+||+||+|.+. +++. ||+|.+.. .....+.+.+|+.+++.++||||++++++|..+ ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 468999999999999999999864 4554 57777754 234567899999999999999999999999865 488
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+|+||+.+|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999976543 58999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
..............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------- 239 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP------- 239 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 755444333334567889999999999999999999999999999999 999998765544333222111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
........+..++..||+.||.+||++.++++.|+...
T Consensus 240 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 240 ---------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01111224556677799999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=347.48 Aligned_cols=252 Identities=27% Similarity=0.380 Sum_probs=198.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||.||++... +|..+|+|++.... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357999999999999999999874 68999999987543 346789999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee---CCCCceEEeecCccccc
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL---d~~~~vKL~DFGla~~~ 415 (611)
|+++|+|.+.+.........+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999886443223468999999999999999999999 899999999999999 45678999999999866
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
..... .....||+.|+|||++. +.++.++|||||||++|||++|+.||.............+..+... .
T Consensus 178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-----~-- 246 (285)
T 3is5_A 178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA-----V-- 246 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----C--
T ss_pred CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-----c--
Confidence 54322 22367999999999986 5789999999999999999999999977554332222222111100 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..... ...+..++..||+.||.+|||+.++++
T Consensus 247 ---~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ---ECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---ccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001 123455667799999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=360.40 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=196.2
Q ss_pred eeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 266 LAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 266 ~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
...+.||+|+||.||+|... +|+.||||+++... ...+.+.+|++++++++||||++++++|...+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 34678999999999999864 79999999998643 55678999999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee--CCCCceEEeecCccccccCCCCC
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--SDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL--d~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++........
T Consensus 172 ~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp EEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 9999886543 258999999999999999999999 899999999999999 66789999999999876543322
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
....||+.|+|||++.++.++.++|||||||++|||++|+.||...........+...... +..... .
T Consensus 246 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~--------~~~~~~-~ 313 (373)
T 2x4f_A 246 ---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD--------LEDEEF-Q 313 (373)
T ss_dssp ---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------SCSGGG-T
T ss_pred ---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC--------CChhhh-c
Confidence 2357999999999999999999999999999999999999999876543322221111000 000000 1
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+ ...+..++..||+.||.+|||+.++++.
T Consensus 314 ~~----~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 DI----SEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cC----CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11 1345566778999999999999999973
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=359.94 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=202.3
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~ 334 (611)
..++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+..|..++..+ +||||+++++++...+.+|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999976 58899999997532 3456788999999988 7999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999999999997543 48999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 171 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------- 238 (353)
T 2i0e_A 171 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------- 238 (353)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred cccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 433222 22346899999999999999999999999999999999999999987654332222211110
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 534 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~ 534 (611)
.+...+ ...+..++..||+.||.+||+ +.++++
T Consensus 239 ---~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ---AYPKSM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---CCCTTS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---CCCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011111 234555667799999999996 466665
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=355.06 Aligned_cols=249 Identities=20% Similarity=0.329 Sum_probs=196.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ....+.+.+|+.++.++ +||||++++++|.+.+.+++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999975 6889999999753 34566788999999988 89999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999997543 48999999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchh--hHHHhhccccccCcccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE--SLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~--~lv~~~~~~~~~g~l~~ 493 (611)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........+..+.
T Consensus 161 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--- 235 (345)
T 3a8x_A 161 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--- 235 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---
T ss_pred cCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---
Confidence 33222 223468999999999999999999999999999999999999999653211100 00000000000000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQM 529 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm 529 (611)
..+...+ ...+..++..||+.||.+||++
T Consensus 236 ---~~~p~~~----s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 ---IRIPRSL----SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---CCCCTTS----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---CCCCCCC----CHHHHHHHHHHhcCCHhHCCCC
Confidence 0111111 2345556677999999999995
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=349.06 Aligned_cols=251 Identities=23% Similarity=0.312 Sum_probs=205.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457999999999999999999975 68999999987532 1367899999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC----ceEEeec
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 409 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~----~vKL~DF 409 (611)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999997543 58999999999999999999999 8999999999999999887 7999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....
T Consensus 164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~----- 235 (321)
T 2a2a_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY----- 235 (321)
T ss_dssp TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-----
T ss_pred ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc-----
Confidence 99987655332 2235799999999999999999999999999999999999999976543322211111000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..++.+.... ...+..++..||+.||.+|||+.++++.
T Consensus 236 ----~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 ----DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ----CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ----ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011111111 1345566778999999999999999974
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=350.59 Aligned_cols=266 Identities=27% Similarity=0.390 Sum_probs=202.8
Q ss_pred cCceeeeeEeecCcEEEEEEEe-----CCCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEec--Cce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~ 333 (611)
+.|.+.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.+++.++||||+++++++... +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588999999999999999983 478999999997543 3457889999999999999999999999876 678
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996543 258999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC-ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC---
Q 007256 414 WASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG--- 489 (611)
Q Consensus 414 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g--- 489 (611)
........ .......||..|+|||++.+..++.++|||||||++|+|++|+.|+...... ......+.....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccCHH
Confidence 77654332 1223356889999999999999999999999999999999999986432100 000000000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.+...+...............+..++..||+.||.+|||+.++++.|+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 0000000000011111222456667778999999999999999999863
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=341.16 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=204.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999975 7999999998643 3456788999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999987543 58999999999999999999999 89999999999999999999999999999866543
Q ss_pred CCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
..........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......... ...+...... ..+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~-------~~~ 230 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTY-------LNP 230 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTTCTT-------STT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhcccc-------cCc
Confidence 32222334679999999999987765 77899999999999999999999765543221 1112111000 000
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......+..++..||+.||.+|||+.++++.
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00111244556777999999999999998863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=342.79 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=200.7
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
+.++|.+.+.||+|+||+||+|.+. ++..||||++.... .....+.+|+.+++.++||||++++++|.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3568999999999999999999865 67899999986432 235678899999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 999999999999987543 48899999999999999999999 89999999999999999999999999998654
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 224 (279)
T 3fdn_A 160 PSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF----------- 224 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------
T ss_pred Cccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC-----------
Confidence 4322 2235799999999999999999999999999999999999999976554332222211110
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.... ...+..++..||+.||.+|||+.++++.
T Consensus 225 --~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 --TFPDFV----TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --CCCTTS----CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCCcC----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 011111 1234556677999999999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=363.91 Aligned_cols=207 Identities=29% Similarity=0.430 Sum_probs=168.7
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecC--ce
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDN--NL 333 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~--~~ 333 (611)
..++|.+.+.||+|+||.||+|.+. +|+.||||++.. .......+.+|+.+++.+. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999864 799999999864 3455677889999999998 999999999997654 68
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
|+||||+++ +|.+++... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCSE-EHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccCc-CHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 999999984 899988753 48899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCC-------------------CCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCc
Q 007256 414 WASTSS-------------------SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPK 473 (611)
Q Consensus 414 ~~~~~~-------------------~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~ 473 (611)
...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 654311 1112234689999999999986 67899999999999999999999999876654
Q ss_pred chh
Q 007256 474 GQE 476 (611)
Q Consensus 474 ~~~ 476 (611)
.+.
T Consensus 238 ~~~ 240 (388)
T 3oz6_A 238 NQL 240 (388)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=340.09 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=202.2
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
..++|.+.+.||+|+||.||+|.+. ++..+|+|++... ....+.+.+|+++++.++||||++++++|.+++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 3467999999999999999999875 5789999998753 3446789999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee---CCCCceEEeecCccccc
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL---d~~~~vKL~DFGla~~~ 415 (611)
|+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999999999887543 48999999999999999999999 899999999999999 78899999999999876
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
...... ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+........
T Consensus 160 ~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 227 (277)
T 3f3z_A 160 KPGKMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP-------- 227 (277)
T ss_dssp CTTSCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------
T ss_pred cCccch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 543322 23579999999999875 599999999999999999999999976554332222111110000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.... .. ....+..++..||+.||.+|||+.++++
T Consensus 228 ~~~~-~~----~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EKDW-LN----VSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHH-TT----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhh-hc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 1134556677799999999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=346.44 Aligned_cols=261 Identities=27% Similarity=0.429 Sum_probs=196.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecC----ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~----~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++. .......+.+|+.+++.++||||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999986 4799999999975 235567889999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.........+++..++.++.+++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986533233468999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......... +..... ........
T Consensus 188 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~----~~~~~~~~- 259 (310)
T 2wqm_A 188 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCKKIE----QCDYPPLP- 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-HHHHHH----TTCSCCCC-
T ss_pred CCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-HHHHhh----cccCCCCc-
Confidence 43222 12357999999999999999999999999999999999999999765432211 111110 01111100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
...+ ...+..++..||+.||.+||++.+|++.|+...
T Consensus 260 ---~~~~----~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 260 ---SDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ---TTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cccc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0111 124556667799999999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=360.05 Aligned_cols=246 Identities=22% Similarity=0.336 Sum_probs=200.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999996 579999999987432 2245788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+ +|+|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 679999886543 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+ ..+.
T Consensus 160 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------~~~~----- 224 (336)
T 3h4j_B 160 DGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------NSCV----- 224 (336)
T ss_dssp TSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-------CSSC-----
T ss_pred CCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-------HcCC-----
Confidence 4332 233679999999999987776 68999999999999999999999765432211100 0000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+.... ...+..++..||+.||.+|||+.++++.
T Consensus 225 -~~~p~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 -YVMPDFL----SPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCCTTS----CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCcccC----CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0011111 1234556777999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.89 Aligned_cols=266 Identities=27% Similarity=0.363 Sum_probs=203.9
Q ss_pred ceeeeeEeecCcEEEEEEEe-----CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--CceEE
Q 007256 265 FLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED--NNLLL 335 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~--~~~~L 335 (611)
|.+.+.||+|+||+||++.. .+|+.||||+++.. ....+.+.+|+++++.++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999999864 26889999999864 35567899999999999999999999999874 57899
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999754 38899999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....+.........+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHH
Confidence 6543221 12235688899999999999999999999999999999999999865321100 000000000000001111
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
++..............+..++..||+.||.+|||+.++++.|+..
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111111111122234566677789999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=340.79 Aligned_cols=256 Identities=22% Similarity=0.356 Sum_probs=203.1
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
..++|.+.+.||+|+||+||+|.+.+ +..||||+++.. ....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35689999999999999999998542 346999999864 3556789999999999999999999999864 5679
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999997543 258899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.......
T Consensus 163 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~------- 234 (281)
T 3cc6_A 163 IEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP------- 234 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC-------
T ss_pred ccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC-------
Confidence 6543322 1223567889999999999999999999999999999998 999997655443322222111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
..... ...+..++..||+.||.+||++.++++.|+...
T Consensus 235 -----~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 235 -----KPDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp -----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 00111 134556667799999999999999999987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=348.10 Aligned_cols=254 Identities=29% Similarity=0.499 Sum_probs=197.3
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
++|.+.+.||+|+||+||+|.. .++.||||++... ...+.|.+|+.++++++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 5789999999999999999987 4788999999754 45678999999999999999999999886 458999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc-eEEeecCccccccCCCCC
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE-PQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~-vKL~DFGla~~~~~~~~~ 421 (611)
|+|.+++..... ...+++..++.++.|++.||.|||+.+.++|+||||||+|||++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 84 GSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp CBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 999999976542 124788999999999999999999855568999999999999988876 7999999997554321
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... +.+... .+.. +.+..
T Consensus 161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~---~~~~-----~~~~~ 227 (307)
T 2eva_A 161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAVH---NGTR-----PPLIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHHH---TTCC-----CCCBT
T ss_pred ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHHh---cCCC-----CCccc
Confidence 2346999999999999999999999999999999999999999764432211 111110 0110 11111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
..+ ..+..++..||+.||.+|||+.++++.|+...
T Consensus 228 ~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 228 NLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred ccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 111 24556677799999999999999999987543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=343.54 Aligned_cols=251 Identities=21% Similarity=0.351 Sum_probs=200.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CC-------CEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DG-------KELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g-------~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
.++|.+.+.||+|+||+||+|.+. ++ ..||+|++... ....+.+.+|+.++++++||||+++++++..++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 468999999999999999999865 33 57999999754 3556789999999999999999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc--------e
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--------P 404 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~--------v 404 (611)
.++||||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999976532 48899999999999999999999 89999999999999998877 9
Q ss_pred EEeecCccccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 007256 405 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~ 483 (611)
||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+................
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc
Confidence 9999999865432 123568999999999987 679999999999999999999655544332222111111100
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 007256 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541 (611)
Q Consensus 484 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~~ 541 (611)
. .+.. .. ...+..++..||+.||.+|||+.++++.|+....
T Consensus 235 ~-----~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 235 H-----QLPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp C-----CCCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred C-----CCCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0 0000 00 1124456667999999999999999999986654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.15 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=199.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEE-ecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCF-EDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~-~~~~~~ 334 (611)
..+|.+.+.||+|+||+||+|.+.+ +..+|+|.++.. ....+.+.+|+.++++++||||++++++|. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3468999999999999999998642 235899998753 345678999999999999999999999865 456789
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999997543 357899999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCC--ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 415 ASTSSSH--ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 415 ~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
....... .......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........+......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------ 251 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------ 251 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC------
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC------
Confidence 6443211 12223567889999999999999999999999999999999 55566554433322221111100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
...... . ..+..++..||+.||.+|||+.++++.|+..
T Consensus 252 ------~~~~~~-~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 252 ------LQPEYC-P---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp ------CCCTTC-C---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCccC-C---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001111 1 2455667779999999999999999998753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=356.03 Aligned_cols=272 Identities=24% Similarity=0.314 Sum_probs=207.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-----CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEE--ecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~~ 333 (611)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++||||+++++++. ..+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35799999999999999999983 468899999997653 45667999999999999999999999987 45568
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999975432 48999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc-cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... .+.........+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLL 254 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHH
Confidence 775443221 22235688999999999999999999999999999999999999864322110000 0000000000001
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
..+...............+..++..||+.||.+|||+.+|++.|+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111112222344566777799999999999999999997654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=355.85 Aligned_cols=263 Identities=21% Similarity=0.320 Sum_probs=196.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhH--HHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDV--IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~--~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||+|+||+||+|... +|+.||||+++..... ...+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999975 7899999999754322 22456799999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++ +|.+++..... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 985 89998876532 58999999999999999999999 899999999999999999999999999998655432
Q ss_pred CCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc-
Q 007256 420 SHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP- 497 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~- 497 (611)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+......
T Consensus 155 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 155 KT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 22 223578999999999876 56899999999999999999999999876654433332221111111111111110
Q ss_pred --------ccCCCC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 498 --------ALGNNY----DYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 498 --------~l~~~~----~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
...... .......+..++..||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 0011234556777899999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=343.74 Aligned_cols=258 Identities=23% Similarity=0.305 Sum_probs=205.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~L 335 (611)
.++|.+.+.||+|+||.||++... +|+.||+|++... ....+.+.+|+.++++++||||+++++++.. +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 7899999999753 3556789999999999999999999998854 567999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc-----EEeeccCccceeeCCCCceEEeecC
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR-----VIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g-----IiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
||||+++++|.+++.........+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997644334468999999999999999999999 66 9999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.. +.
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-------~~ 232 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-------GK 232 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TC
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-------cc
Confidence 9987654322 12235789999999999999999999999999999999999999976543222111111 11
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 491 l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.. .+...+ ...+..++..||+.||.+||++.+|++.+....
T Consensus 233 ~~-----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 233 FR-----RIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CC-----CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred cc-----cCCccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 11 111111 234556677799999999999999998765443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=340.15 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=199.9
Q ss_pred CceeeeeEeecCcEEEEEEEeC-C---CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce-EEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-D---GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL-LLV 336 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~---g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~-~LV 336 (611)
.|...+.||+|+||+||+|.+. + +..||+|++... ....+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 5677899999999999999853 2 337999999753 34567899999999999999999999999876665 999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997643 358899999999999999999999 899999999999999999999999999997654
Q ss_pred CCC--CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCC-CCCCCcchhhHHHhhccccccCcccc
Q 007256 417 TSS--SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI-SNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 417 ~~~--~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf-~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
... .........||+.|+|||.+.+..++.++|||||||++|+|++|..|+ ...........+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-------- 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-------- 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC--------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC--------
Confidence 322 111222356899999999999999999999999999999999965554 433332222222111110
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
...... ...+..++..||+.||.+|||+.++++.|+..
T Consensus 248 ----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 248 ----PQPEYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCccc----hHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 001111 13455667779999999999999999998643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=350.28 Aligned_cols=259 Identities=24% Similarity=0.396 Sum_probs=203.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||.||+|.+ .++..||||++.. .......+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999983 3578999999964 345567899999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC---CCceEEe
Q 007256 334 LLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLS 407 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~---~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---~~~vKL~ 407 (611)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976542 22458999999999999999999999 89999999999999984 4569999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhcccc
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPIL 486 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~ 486 (611)
|||++................||+.|+|||++.++.++.++|||||||++|+|++ |+.||...........+....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--- 262 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG--- 262 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC---
Confidence 9999986654433333334578999999999999999999999999999999998 999997654332222111110
Q ss_pred ccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 487 SSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 487 ~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
. ....... ...+..++..||+.||.+||++.+|++.|...
T Consensus 263 ----~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 263 ----R-----MDPPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ----C-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----C-----CCCCCCC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0 0011111 13455667779999999999999999988643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=340.85 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=182.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999987 479999999997432 2346789999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999997543 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+ .. . +
T Consensus 164 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~-~------~ 228 (278)
T 3cok_A 164 MPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------VL-A------D 228 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------CS-S------C
T ss_pred CCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------hh-c------c
Confidence 43221 12357999999999999889999999999999999999999999765433211100 00 0 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..+...+ ...+..++..||+.||.+|||+.++++
T Consensus 229 ~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 YEMPSFL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCcccc----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0111111 234556677799999999999999886
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=368.74 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=194.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||++++++|...+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999864 7999999999742 34456788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ .++|+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997543 48999999999999999999995 1679999999999999999999999999998644
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..... .
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-----~------ 367 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-----R------ 367 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----C------
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-----C------
Confidence 3322 22347899999999999999999999999999999999999999977654333222221110 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
+...++ ..+..++..||+.||.+|| ++.+++++
T Consensus 368 --~p~~~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 --FPRTLG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp --CCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCccCC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111111 2345566779999999999 99999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=339.50 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=200.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999976 79999999987532 2367899999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC----ceEEeec
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 409 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~----~vKL~DF 409 (611)
++||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE----SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence 99999999999999997543 48999999999999999999999 8999999999999998877 8999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....
T Consensus 157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 228 (283)
T 3bhy_A 157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY----- 228 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----
T ss_pred ccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc-----
Confidence 99987654332 2235799999999999999999999999999999999999999976543322111111100
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
. .++...... ...+..++..||+.||.+||++.++++
T Consensus 229 ~----~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 D----FDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C----CCHHHHTTC----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CcchhcccC----CHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 000000111 134556677899999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=365.86 Aligned_cols=262 Identities=22% Similarity=0.239 Sum_probs=197.7
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC-----
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----- 331 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~----- 331 (611)
..++|.+.+.||+|+||+||+|.+. +|+.||||++.. .....+.+.+|+.+++.++||||++++++|....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999865 689999999975 3455678899999999999999999999997553
Q ss_pred -ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 332 -NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 332 -~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 56999999987 46666642 37899999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc----
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL---- 486 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~---- 486 (611)
+++....... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...+...+.......
T Consensus 210 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 210 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9987654322 234689999999999999999999999999999999999999998765443332221110000
Q ss_pred ------------------ccCccccccCcccCCCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 487 ------------------SSGKVTQLLDPALGNNYD---YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 487 ------------------~~g~l~~lld~~l~~~~~---~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
....+...+...+..... ......+..++..||+.||.+|||+.+++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011111111100000 0113456677788999999999999999974
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=351.90 Aligned_cols=268 Identities=23% Similarity=0.344 Sum_probs=195.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHH--HHhcCCcceeEEeeEEEe-----cCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEI--ITTLHHKNIISLLGFCFE-----DNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~i--L~~l~HpnIv~l~g~~~~-----~~~~~ 334 (611)
.++|.+.+.||+|+||+||+|.. +++.||||++..... ..+..|.++ +..++||||+++++++.. ...++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46899999999999999999976 789999999975433 344444444 456899999999986643 22578
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------cEEeeccCccceeeCCCCceE
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ---------RVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~---------gIiHrDIKp~NILLd~~~~vK 405 (611)
+||||+++|+|.+++.... .++..++.++.||+.||.|||+ . +|+||||||+|||++.++.+|
T Consensus 89 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEE
Confidence 9999999999999997543 5889999999999999999998 6 999999999999999999999
Q ss_pred EeecCccccccCCCC------CccccccccccccCChhhhcc-------CCCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 406 LSDFGLAKWASTSSS------HITCTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 406 L~DFGla~~~~~~~~------~~~~~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 111223579999999999986 4567789999999999999999877654332
Q ss_pred cchhh-HHH-hhccccccCcc-----ccccCcccCCCC--ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 473 KGQES-LVM-WAKPILSSGKV-----TQLLDPALGNNY--DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 473 ~~~~~-lv~-~~~~~~~~g~l-----~~lld~~l~~~~--~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
..... ... ..........+ .....+.+.... .......+..++..||+.||.+|||+.+|++.|+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 21110 000 00000000000 000011111111 1234456777888899999999999999999987543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=348.13 Aligned_cols=257 Identities=24% Similarity=0.406 Sum_probs=199.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCC-----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPD-----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~-----g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
.++|.+.+.||+|+||.||+|.... +..||||+++.. ......+.+|+.+++.++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4578899999999999999998642 246999999853 345567899999999999999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999997643 258999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCc-cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 415 ASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 415 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.... ..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~------~~- 269 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------RL- 269 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------CC-
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC------cC-
Confidence 65432211 1122456889999999999999999999999999999999 999997654332221111100 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
.. .......+..++..||+.||.+||++.++++.|+...
T Consensus 270 -----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 270 -----PT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -----CC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 1111234556677899999999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=341.04 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=203.9
Q ss_pred hcCceeee-eEeecCcEEEEEEEe---CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 262 TSNFLAEN-LIGKGGSSQVYKGCL---PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~-~LG~G~fG~Vyk~~~---~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
.++|.+.+ .||+|+||+||+|.+ .+++.||||+++.. ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45788888 999999999999954 35788999999754 23467899999999999999999999999 667899
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999997643 48899999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCcc-ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 415 ASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 415 ~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
......... .....||+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------~- 238 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-------R- 238 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------C-
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------C-
Confidence 655433211 122456789999999998899999999999999999999 999998755433222221110 0
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
+.+... ....+..++..||+.||.+||++.+|++.|+...
T Consensus 239 ----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 ----MGCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ----CCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011111 1234556677799999999999999999997543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.00 Aligned_cols=262 Identities=22% Similarity=0.289 Sum_probs=199.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEE-EecCceEEEEe
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYD 338 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~-~~~~~~~LV~E 338 (611)
..++|.+.+.||+|+||+||+|.+ .+++.||||++.... ....+.+|+.+++.++|++++..+.++ ..++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 457899999999999999999986 578999999876432 224578899999999988877766665 56677899999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee---CCCCceEEeecCccccc
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL---d~~~~vKL~DFGla~~~ 415 (611)
|+ +++|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 8899999975432 58999999999999999999999 899999999999999 78899999999999876
Q ss_pred cCCCCCc-----cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 416 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 416 ~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~ 234 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----H
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc----c
Confidence 6543311 123467999999999999999999999999999999999999999865443222211110000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 491 l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.... .+.+...++ ..+..++..||+.||.+|||+.+|++.|+..
T Consensus 235 ~~~~-~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 235 MSTP-IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHSC-HHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred ccch-hhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0000 000111111 3456667779999999999999999998743
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=357.43 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=190.6
Q ss_pred hcCceee-eeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHH-hcCCcceeEEeeEEEe----cCceE
Q 007256 262 TSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIIT-TLHHKNIISLLGFCFE----DNNLL 334 (611)
Q Consensus 262 t~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~-~l~HpnIv~l~g~~~~----~~~~~ 334 (611)
.++|.+. +.||+|+||+||++.+. +|+.||||+++.. ..+.+|++++. ..+||||++++++|.. ...++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 4567776 78999999999999875 7899999999754 34667888874 4589999999999875 56789
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC---CCceEEeecCc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 411 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---~~~vKL~DFGl 411 (611)
+||||++||+|.+++..... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999976432 358999999999999999999999 89999999999999987 78999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcch----hhHHHhhccccc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ----ESLVMWAKPILS 487 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~----~~lv~~~~~~~~ 487 (611)
++....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+......
T Consensus 211 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~-- 285 (400)
T 1nxk_A 211 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE-- 285 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC--
T ss_pred ccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc--
Confidence 986654322 2346799999999999999999999999999999999999999976554321 1111111000
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 488 ~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+..+.. . .....+..++..||+.||.+|||+.++++.
T Consensus 286 ------~~~~~~-~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 ------FPNPEW-S----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ------CCTTTT-T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCccc-c----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000 0 112345566778999999999999999984
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=344.52 Aligned_cols=264 Identities=28% Similarity=0.375 Sum_probs=206.6
Q ss_pred HHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHh--cCCcceeEEeeEEEecC----c
Q 007256 259 LSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITT--LHHKNIISLLGFCFEDN----N 332 (611)
Q Consensus 259 ~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~--l~HpnIv~l~g~~~~~~----~ 332 (611)
....++|.+.+.||+|+||.||+|.. +|+.||||++... ....+.+|++++.. ++||||+++++++.... .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 34457899999999999999999987 5899999999743 34677889999988 78999999999998876 7
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCcEEeeccCccceeeCCCCce
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--------SGSAQRVIHRDVKSSNILLSDDFEP 404 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH--------~~~~~gIiHrDIKp~NILLd~~~~v 404 (611)
.++||||+++|+|.+++... .+++..++.++.|++.||.||| + ++|+||||||+|||++.++.+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCE
T ss_pred eEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCE
Confidence 99999999999999999753 4899999999999999999999 6 899999999999999999999
Q ss_pred EEeecCccccccCCCCCc--cccccccccccCChhhhccC------CCCCcceehhhhHHHHHHHhC----------CCC
Q 007256 405 QLSDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTG----------RKP 466 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSlGvvL~ELltG----------~~P 466 (611)
||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998766543221 12335799999999999865 234689999999999999999 778
Q ss_pred CCCCCCcchhhHHHhhccccccCccccccCcccCCC-CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 467 ISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN-YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 467 f~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~-~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
|........... .+...+. . ..+.+.+... ........+..++..||+.||.+|||+.+|++.|+..
T Consensus 267 ~~~~~~~~~~~~-~~~~~~~-~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPSDPSVE-EMRKVVC-E----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCSSCCHH-HHHHHHT-T----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcCcccHH-HHHHHHH-H----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 865443221111 0110000 0 0111111111 1234556777888889999999999999999998753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.42 Aligned_cols=263 Identities=21% Similarity=0.314 Sum_probs=207.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEe--CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc------eeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~--~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hpn------Iv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||.||+|.+ .+|+.||||+++......+.+.+|+.+++.++|++ ++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 46899999999999999999986 36889999999987777788999999999998765 99999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-------------
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD------------- 400 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~------------- 400 (611)
++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 8899999976543 358899999999999999999999 89999999999999987
Q ss_pred ------CCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc
Q 007256 401 ------DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474 (611)
Q Consensus 401 ------~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 474 (611)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6689999999998654422 23579999999999999999999999999999999999999998765443
Q ss_pred hhhHHHhhcccccc--------Cc------------------cccccCcccC-CCCChHHHHHHHHHHHHhcccCCCCCC
Q 007256 475 QESLVMWAKPILSS--------GK------------------VTQLLDPALG-NNYDYDQMERMVLASILCIRRDPRARP 527 (611)
Q Consensus 475 ~~~lv~~~~~~~~~--------g~------------------l~~lld~~l~-~~~~~~~~~~l~~la~~CL~~dP~~RP 527 (611)
....+......+.. .. ......+... ..........+..++..||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 22222111000000 00 0000000000 011223345677788889999999999
Q ss_pred CHHHHHHH
Q 007256 528 QMSLVLKL 535 (611)
Q Consensus 528 tm~eVL~~ 535 (611)
|+.++++.
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99998863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=351.47 Aligned_cols=265 Identities=19% Similarity=0.278 Sum_probs=194.7
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
..++|.+.+.||+|+||+||+|.+. +|+.||||+++... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3468999999999999999999864 78999999997543 3345678999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee-----CCCCceEEeecCc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL-----SDDFEPQLSDFGL 411 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL-----d~~~~vKL~DFGl 411 (611)
|||+++ +|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999985 9999997654 48999999999999999999999 899999999999999 4555699999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
+......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...........
T Consensus 184 a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 9876543222 2235789999999999864 589999999999999999999999987654433222211111111100
Q ss_pred cc------cccC--cccCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 491 VT------QLLD--PALGNNY-----DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 491 l~------~lld--~~l~~~~-----~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.. .+.. +...... .......+..++..||+.||.+|||+.++++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00 0000 0000000 00012345567778999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=351.93 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=204.8
Q ss_pred HHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---------hHHHHHHHHHHHHHhc-CCcceeEEee
Q 007256 257 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTL-HHKNIISLLG 325 (611)
Q Consensus 257 el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---------~~~~~f~~Ei~iL~~l-~HpnIv~l~g 325 (611)
......++|.+.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+.+++++ +||||+++++
T Consensus 88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 167 (365)
T 2y7j_A 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167 (365)
T ss_dssp HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 34445678999999999999999999985 79999999987532 2245688999999999 7999999999
Q ss_pred EEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 326 ~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
++...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+|
T Consensus 168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 168 SYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEBSSEEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEE
T ss_pred EEeeCCEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999997543 48999999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhcc------CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv 479 (611)
|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 241 l~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999987654332 233689999999999863 35889999999999999999999999765432222111
Q ss_pred HhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 480 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 480 ~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
...... ...+.. ... ...+..++..||+.||.+|||+.++++.
T Consensus 318 ~~~~~~--------~~~~~~-~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 MEGQYQ--------FSSPEW-DDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHTCCC--------CCHHHH-SSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCCCC--------CCCccc-ccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111000 000000 001 1235566777999999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=347.86 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=201.3
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEE--EEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKEL--AVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~v--AVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV 336 (611)
++|.+.+.||+|+||.||+|.+. +|..+ |||.++.. ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999865 56644 99998753 34556789999999999 899999999999999999999
Q ss_pred EeeCCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCce
Q 007256 337 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 404 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~------------~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~v 404 (611)
|||+++|+|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997654 223468999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhc
Q 007256 405 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~ 483 (611)
||+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.
T Consensus 182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~--- 255 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 255 (327)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG---
T ss_pred EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh---
Confidence 9999999874432211 122457889999999998899999999999999999998 999997654332211111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 484 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.+ ....... .....+..++..||+.||.+|||+.++++.|..
T Consensus 256 ----~~-----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 297 (327)
T 1fvr_A 256 ----QG-----YRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297 (327)
T ss_dssp ----GT-----CCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----cC-----CCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 00 0000111 112345667778999999999999999998864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=339.34 Aligned_cols=246 Identities=22% Similarity=0.304 Sum_probs=197.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||+||+|.+. +++.||||+++.. ......+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 568999999999999999999976 7999999999753 34567788999999999 899999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC---------------
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--------------- 401 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~--------------- 401 (611)
|||+++++|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997643222358999999999999999999999 899999999999999844
Q ss_pred ----CceEEeecCccccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchh
Q 007256 402 ----FEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 476 (611)
Q Consensus 402 ----~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~ 476 (611)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+..... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~ 237 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W 237 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence 479999999998765432 24589999999999866 566899999999999999999987643321 1
Q ss_pred hHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 477 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 477 ~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+ . .+... .+...++ ..+..++..||+.||.+|||+.++++.
T Consensus 238 ~~~--~-----~~~~~-----~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 HEI--R-----QGRLP-----RIPQVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHH--H-----TTCCC-----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHH--H-----cCCCC-----CCCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111 0 11111 1111111 345566677999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=354.39 Aligned_cols=251 Identities=29% Similarity=0.406 Sum_probs=198.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||.||++.++ +|+.||||+++.... .+.+|++++.++ +||||+++++++.+++..++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 467999999999999999999875 689999999976542 245688888888 799999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC----CceEEeecCccccc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 415 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~----~~vKL~DFGla~~~ 415 (611)
++||+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+..+ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999997543 48999999999999999999999 899999999999998433 35999999999876
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+..... .+...
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~~~~--- 241 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----SGKFS--- 241 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----HCCCC---
T ss_pred cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----cCCcc---
Confidence 554322 234689999999999998889999999999999999999999997643322222221110 01100
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+...........+..++..||+.||.+||++.++++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000011111234455667799999999999999886
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.90 Aligned_cols=261 Identities=22% Similarity=0.296 Sum_probs=202.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEE-EecCceEEEEe
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC-FEDNNLLLVYD 338 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~-~~~~~~~LV~E 338 (611)
..++|.+.+.||+|+||.||+|.+ .+|+.||||++.... ....+.+|+.+++.++|++++..+.++ ..++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 357899999999999999999996 579999999987543 234688999999999988876666655 56677899999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee---CCCCceEEeecCccccc
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL---d~~~~vKL~DFGla~~~ 415 (611)
|+ +++|.+++..... .+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 8899999974432 58999999999999999999999 899999999999999 48889999999999876
Q ss_pred cCCCCCc-----cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 416 STSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 416 ~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~ 234 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----H
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc----c
Confidence 6543321 123467999999999999999999999999999999999999999865433221111110000 0
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 491 l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
... ..+.+...++ ..+..++..||+.||.+|||+.+|++.|+.
T Consensus 235 ~~~-~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 235 MST-PIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHS-CHHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred cCC-chHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 000 0001111111 345666777999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=349.67 Aligned_cols=267 Identities=25% Similarity=0.302 Sum_probs=198.8
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
...++|.+.+.||+|+||.||+|.+. +|+.||||+++... ...+.+.+|+.+++.++||||++++++|...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999975 69999999997532 123468899999999999999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999987 8888886543 358889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
+........ .....||+.|+|||++.+. .++.++|||||||++|||++|..||...........+............
T Consensus 160 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 160 KSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp STTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 876543322 2336799999999999754 5899999999999999999999999876543332222111111111111
Q ss_pred c---cccCcccC---CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 492 T---QLLDPALG---NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 492 ~---~lld~~l~---~~~~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. .+.+.... .... ......+..++..||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 11000000 0001 1112456667778999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=339.35 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=204.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
+.|.+.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56899999999999999999864 7899999999754 34567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998642 48999999999999999999999 899999999999999999999999999998765433
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... . .+.+
T Consensus 174 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~-----~~~~ 239 (303)
T 3a7i_A 174 IK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-------N-----PPTL 239 (303)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------C-----CCCC
T ss_pred cc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-------C-----CCCC
Confidence 22 23367999999999999999999999999999999999999999765433222111111 0 0111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
...++ ..+..++..||+.||.+|||+.++++.
T Consensus 240 ~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11222 245566677999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=355.42 Aligned_cols=263 Identities=19% Similarity=0.276 Sum_probs=204.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC--------CcceeEEeeEEE----
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH--------HKNIISLLGFCF---- 328 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~--------HpnIv~l~g~~~---- 328 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++......+.+.+|+.+++.++ |+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 478999999999999999999864 6889999999987777888999999999996 788999999987
Q ss_pred ecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-cEEeeccCccceeeCCCC-----
Q 007256 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDF----- 402 (611)
Q Consensus 329 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~-gIiHrDIKp~NILLd~~~----- 402 (611)
.+...++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+ + +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 556799999999 5566666654322 358999999999999999999999 7 899999999999999775
Q ss_pred --------------------------------------------ceEEeecCccccccCCCCCccccccccccccCChhh
Q 007256 403 --------------------------------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438 (611)
Q Consensus 403 --------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~ 438 (611)
.+||+|||++....... ....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCChh
Confidence 79999999998765432 23579999999999
Q ss_pred hccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhh----H---HHhhcc--------------cc-ccCccccccC
Q 007256 439 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES----L---VMWAKP--------------IL-SSGKVTQLLD 496 (611)
Q Consensus 439 l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~----l---v~~~~~--------------~~-~~g~l~~lld 496 (611)
+.+..++.++|||||||++|||++|+.||.......... + ...... .+ ..+.+..+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999997655332110 0 000000 00 0001111100
Q ss_pred cc-------c--CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 497 PA-------L--GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 497 ~~-------l--~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.. + ...........+..++..||+.||.+|||+.++++.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 0 011234455677788889999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=367.27 Aligned_cols=246 Identities=23% Similarity=0.381 Sum_probs=203.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 468999999999999999999975 79999999997532 3456789999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999997543 58999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+... ..
T Consensus 168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~-------~~---- 233 (476)
T 2y94_A 168 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG-------IF---- 233 (476)
T ss_dssp TTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT-------CC----
T ss_pred cccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-------Cc----
Confidence 4332 223679999999999998766 67999999999999999999999865543322211110 00
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
......+ ..+..++..||+.||.+|||+.++++
T Consensus 234 --~~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 --YTPQYLN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCccCC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0011111 23455667799999999999999997
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=350.20 Aligned_cols=267 Identities=23% Similarity=0.324 Sum_probs=202.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEe--------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 329 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------- 329 (611)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++.... .....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999997 579999999986432 334578899999999999999999999987
Q ss_pred cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeec
Q 007256 330 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409 (611)
Q Consensus 330 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DF 409 (611)
.+..++||||+++ +|.+.+..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999986 77777765432 58999999999999999999999 89999999999999999999999999
Q ss_pred CccccccCCCCC--ccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 007256 410 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486 (611)
Q Consensus 410 Gla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 486 (611)
|+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999876532211 12234678999999999876 468999999999999999999999998766544333322211111
Q ss_pred ccCccccc-----cCc---ccCCCCCh-HH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 487 SSGKVTQL-----LDP---ALGNNYDY-DQ------MERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 487 ~~g~l~~l-----ld~---~l~~~~~~-~~------~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
........ .+. ........ .. ...+..++..||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11111100 000 00000011 11 1235567778999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=351.73 Aligned_cols=264 Identities=24% Similarity=0.377 Sum_probs=200.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.+++.++||||++++++|...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999975 5999999998643 344567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988876443 48999999999999999999999 8999999999999999999999999999976654
Q ss_pred CCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh--------------
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-------------- 482 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~-------------- 482 (611)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...
T Consensus 177 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PGEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred Cccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 3222 2235799999999999875 7899999999999999999999999876543322211110
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+......+..+................+..++..||+.||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000111111000000000111345667777899999999999999987
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=360.64 Aligned_cols=250 Identities=26% Similarity=0.327 Sum_probs=193.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHH-HHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEI-ITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~i-L~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||.||+|..+ +++.||||+++... .....+.+|..+ ++.++||||++++++|.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999975 68899999997532 334556777776 577899999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999997643 48899999999999999999999 89999999999999999999999999999864
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+... +.
T Consensus 190 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~---------- 256 (373)
T 2r5t_A 190 IEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-PL---------- 256 (373)
T ss_dssp BCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS-CC----------
T ss_pred ccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc-cc----------
Confidence 43222 223478999999999999999999999999999999999999999765543322222111 00
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.+...+. ..+..++..||+.||.+||++.+.++.+.
T Consensus 257 --~~~~~~~----~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 257 --QLKPNIT----NSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp --CCCSSSC----HHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred --CCCCCCC----HHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 0111111 23455666799999999999864444333
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=354.32 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=175.9
Q ss_pred eeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeeCCCCChh
Q 007256 269 NLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
+.||+|+||+||+|.+. +|+.||||++... ....+.+|+.+++.+. ||||++++++|.++...++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 78999999999999875 6899999999643 4467788999999997 999999999999999999999999999999
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC---ceEEeecCccccccCCCCCcc
Q 007256 347 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLSDFGLAKWASTSSSHIT 423 (611)
Q Consensus 347 ~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~---~vKL~DFGla~~~~~~~~~~~ 423 (611)
+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++........
T Consensus 95 ~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 95 ERIKKKK----HFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp HHHHHCS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 9997653 58999999999999999999999 8999999999999997665 8999999999866543322
Q ss_pred ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhh-HHHhhccccccCccccccCcccCCC
Q 007256 424 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVMWAKPILSSGKVTQLLDPALGNN 502 (611)
Q Consensus 424 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-lv~~~~~~~~~g~l~~lld~~l~~~ 502 (611)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ....... +..+... +...
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-i~~~~~~------~~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDFS------FEGE 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH-HTTTCCC------CCSH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH-HHcCCCC------CCcc
Confidence 233678999999999999999999999999999999999999997654321100 0000000 0111100 0000
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 503 ~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
........+..++..||+.||.+|||+.++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00011234556677799999999999998875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.79 Aligned_cols=270 Identities=20% Similarity=0.294 Sum_probs=208.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC--ceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~--~~~LV 336 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 457999999999999999999975 59999999997533 34577889999999999999999999998765 68999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee----CCCCceEEeecCcc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLSDFGLA 412 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL----d~~~~vKL~DFGla 412 (611)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999975432 2238999999999999999999999 899999999999999 77888999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhcc--------CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH----H
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMY--------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV----M 480 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv----~ 480 (611)
+....... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+ .
T Consensus 164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 87654322 223679999999999875 56788999999999999999999999754332211111 1
Q ss_pred hhccccccCcccccc------Cccc--CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 481 WAKPILSSGKVTQLL------DPAL--GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 481 ~~~~~~~~g~l~~ll------d~~l--~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
...+......+.... ...+ ...........+..++..||+.||++||++.++++.+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 111100000000000 0011 112334455666778888999999999999999987754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.02 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=201.7
Q ss_pred HHhhcCceee-eeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCc
Q 007256 259 LSATSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNN 332 (611)
Q Consensus 259 ~~~t~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~ 332 (611)
....+.|.+. +.||+|+||+||+|... +|+.||||+++.. ......+.+|+.++..+. ||||++++++|...+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445567777 89999999999999875 6999999999753 344678899999999995 6999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC---CCceEEeec
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDF 409 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---~~~vKL~DF 409 (611)
.++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999865422 358999999999999999999999 89999999999999987 789999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........
T Consensus 179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-- 253 (327)
T 3lm5_A 179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS-- 253 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--
T ss_pred ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccC--
Confidence 99987654322 2236799999999999999999999999999999999999999977554332222211110000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..........+..++..||+.||.+|||+.++++.
T Consensus 254 -----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 254 -----------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -----------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -----------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00001112345556677999999999999999864
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=353.72 Aligned_cols=264 Identities=17% Similarity=0.207 Sum_probs=197.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecCChh------------HHHHHHHHHHHHHhcCCcceeEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPSED------------VIKEFVLEIEIITTLHHKNIISLLG 325 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~~~------------~~~~f~~Ei~iL~~l~HpnIv~l~g 325 (611)
.++|.+.+.||+|+||.||+|.+. ++..+|||++..... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 678899999876431 1134667889999999999999999
Q ss_pred EEEe----cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC
Q 007256 326 FCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD 401 (611)
Q Consensus 326 ~~~~----~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~ 401 (611)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence 9988 67899999999 999999997654 58999999999999999999999 899999999999999887
Q ss_pred C--ceEEeecCccccccCCCCC-----ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc
Q 007256 402 F--EPQLSDFGLAKWASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474 (611)
Q Consensus 402 ~--~vKL~DFGla~~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 474 (611)
+ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876432211 11134679999999999999999999999999999999999999996533222
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 475 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
......... . . ..+...+........ ....+..++..||+.||.+||++.+|++.|+..
T Consensus 268 ~~~~~~~~~-~-~-~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAKTN-L-L-DELPQSVLKWAPSGS---SCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHH-H-H-HTTTHHHHHHSCTTS---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHHh-h-c-ccccHHHHhhccccc---cHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 111111000 0 0 011111111111101 123455566679999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.44 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=203.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||++.+. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999976 6889999998643 34567789999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999887543 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+....
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 231 (294)
T 2rku_A 167 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE------------- 231 (294)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-------------
T ss_pred cCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc-------------
Confidence 43222 223679999999999998899999999999999999999999997654332211111110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..+....+ ..+..++..||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 YSIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCccccC----HHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00111111 23455667799999999999999886
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=352.63 Aligned_cols=241 Identities=22% Similarity=0.355 Sum_probs=199.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~ 331 (611)
.++|.+.+.||+|+||+||+|.+ .+|+.||||+++... .....+.+|+.+++.++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46899999999999999999986 478999999997642 13346778999999999999999999999999
Q ss_pred ceEEEEeeCCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 332 NLLLVYDFLSRG-SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 332 ~~~LV~Ey~~gg-sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
..++||||+.+| +|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 9999997654 48999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
++......... ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...... .. ..
T Consensus 176 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~---~~---- 240 (335)
T 3dls_A 176 SAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----VE---AA---- 240 (335)
T ss_dssp TCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----TT---TC----
T ss_pred cceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----Hh---hc----
Confidence 99877654322 23679999999999998877 78999999999999999999999642110 00 00
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+ ...+ ...+..++..||+.||.+|||+.++++.
T Consensus 241 -----~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 -----IHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----CCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----cCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0011 1235566677999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=376.46 Aligned_cols=257 Identities=24% Similarity=0.421 Sum_probs=208.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..++|.+.+.||+|+||.||+|.+.++..||||+++......+.|.+|+.+|++++||||+++++++.+ +..+|||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 356789999999999999999999888889999998766666789999999999999999999999866 6799999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp TTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred cCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999974321 248899999999999999999999 8999999999999999999999999999986643211
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.......+|..|+|||++.++.++.++|||||||+||||++ |+.||...........+.... .+ ..
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~------~~------~~ 485 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------RM------PC 485 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC------CC------CC
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------CC------CC
Confidence 11122457789999999999999999999999999999999 999997654433222211110 00 00
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
...+ ...+..++..||+.||.+|||+.+|++.|+...
T Consensus 486 ~~~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 PPEC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111 234556677899999999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=352.70 Aligned_cols=271 Identities=20% Similarity=0.238 Sum_probs=193.4
Q ss_pred HHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc----
Q 007256 258 LLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 332 (611)
Q Consensus 258 l~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~---- 332 (611)
.....++|.+.+.||+|+||+||+|.+. +|+.||||++.........+.+|+..+..++||||++++++|...+.
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 3445689999999999999999999975 79999999997766556677889999999999999999999976544
Q ss_pred ---eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCcEEeeccCccceeeCC-CCceEE
Q 007256 333 ---LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH--SGSAQRVIHRDVKSSNILLSD-DFEPQL 406 (611)
Q Consensus 333 ---~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH--~~~~~gIiHrDIKp~NILLd~-~~~vKL 406 (611)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEE
Confidence 8899999987 555444332222346889999999999999999999 7 89999999999999996 899999
Q ss_pred eecCccccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 407 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
+|||++......... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......
T Consensus 174 ~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 999999876654332 235789999999998755 4899999999999999999999999876544332222111000
Q ss_pred ccc---------CccccccC------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 486 LSS---------GKVTQLLD------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 486 ~~~---------g~l~~lld------~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
... .......+ ..............+..++..||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 00000000 000001111234566777788999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=337.88 Aligned_cols=245 Identities=26% Similarity=0.391 Sum_probs=202.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|... +++.||||++.... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999875 67889999986432 2346788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 99999999999997643 48899999999999999999999 899999999999999999999999999987654
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+... +
T Consensus 166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------~ 228 (284)
T 2vgo_A 166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-------------D 228 (284)
T ss_dssp SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------------C
T ss_pred ccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-------------c
Confidence 422 22357999999999999999999999999999999999999999765433222111110 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..+...+ ...+..++..||+.||.+||++.++++
T Consensus 229 ~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 LKFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0111111 134456677799999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=347.62 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=195.1
Q ss_pred hcCceee-eeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAE-NLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~-~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.+.|.+. +.||+|+||+||+|.+. +|+.||||++.... .....+.+|+.++.++ +||||+++++++.+++..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999864 79999999997543 4467889999999985 7999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc---eEEeecCcccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDFGLAKW 414 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~---vKL~DFGla~~ 414 (611)
||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999997643 48899999999999999999999 89999999999999988776 99999999876
Q ss_pred ccCCCC-----CccccccccccccCChhhhcc-----CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHH-----
Q 007256 415 ASTSSS-----HITCTDVAGTFGYLAPEYFMY-----GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV----- 479 (611)
Q Consensus 415 ~~~~~~-----~~~~~~~~GT~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv----- 479 (611)
...... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 543211 111123569999999999975 56899999999999999999999999875433210000
Q ss_pred ----HhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 480 ----MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 480 ----~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..... +..+.. .+..... .. ....+..++..||+.||.+|||+.++++.
T Consensus 244 ~~~~~~~~~-i~~~~~-~~~~~~~-~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 244 ACQNMLFES-IQEGKY-EFPDKDW-AH----ISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHH-HHHCCC-CCCHHHH-TT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHH-HhccCc-ccCchhc-cc----CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000 000000 0000000 00 12345667778999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=366.25 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=201.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--------------hHHHHHHHHHHHHHhcCCcceeEEee
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--------------DVIKEFVLEIEIITTLHHKNIISLLG 325 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--------------~~~~~f~~Ei~iL~~l~HpnIv~l~g 325 (611)
..++|.+.+.||+|+||+||+|... +++.||||+++... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3578999999999999999999975 68899999997532 33567899999999999999999999
Q ss_pred EEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC---
Q 007256 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF--- 402 (611)
Q Consensus 326 ~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~--- 402 (611)
+|.+....++||||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999887543 48999999999999999999999 8999999999999998775
Q ss_pred ceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 007256 403 EPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 403 ~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 482 (611)
.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|+.||...........+...
T Consensus 187 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 262 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262 (504)
T ss_dssp SEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 699999999987755432 23367999999999987 57999999999999999999999999876544332222211
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
..... ....... ...+..++..||+.||.+|||+.++++
T Consensus 263 ~~~~~---------~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 263 KYYFD---------FNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCCC---------HHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCC---------ccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11000 0000011 134556667799999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=355.75 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=193.1
Q ss_pred cCceeeeeEeecCcEEEEEEEeC--CC--CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~--~g--~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~~L 335 (611)
..|.+.+.||+|+||+||+|.+. ++ ..||||.++.. ....+.|.+|+.++++++||||++++++|.. ++..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35788899999999999999863 32 36899998753 3566789999999999999999999998764 457899
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 169 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999975432 57899999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCCCc--cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 416 STSSSHI--TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 416 ~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
....... ......+|+.|+|||++.++.++.++|||||||++|||++ |..||...........+......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~------- 315 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------- 315 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC-------
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 4432211 1223567889999999999999999999999999999999 67778665544332222111110
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.. .... ...+..++..||+.||.+||++.++++.|+..
T Consensus 316 --~~---p~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 316 --LQ---PEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp --CC---CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CC---CCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 1111 12455667779999999999999999998743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=353.88 Aligned_cols=200 Identities=25% Similarity=0.435 Sum_probs=178.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||+|++... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 468999999999999999999875 7899999999754 4556789999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-cEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~-gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
|+++++|.+++.... .+++..+..++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999997643 48899999999999999999998 5 799999999999999999999999999976543
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 185 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 185 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp HC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred cc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 21 1235799999999999999999999999999999999999999976543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=351.27 Aligned_cols=245 Identities=28% Similarity=0.409 Sum_probs=198.3
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
+.|...+.||+|+||+||+|.. .+|+.||||++... ....+.+.+|++++++++||||++++++|..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999986 57899999998643 234567899999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9998 58888775432 258999999999999999999999 8999999999999999999999999999976643
Q ss_pred CCCCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||...........+... .
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~-------~---- 269 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------E---- 269 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------C----
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-------C----
Confidence 2 2357999999999985 568999999999999999999999999765433221111110 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.+...... ..+..++..||+.||.+|||+.++++.
T Consensus 270 -~~~~~~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 -SPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -CCCCCCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCCCCC---HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111111111 234456667999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=359.85 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=191.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEec
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFED 330 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~ 330 (611)
..++|.+.+.||+|+||+||+|.+. +++.||||++.... .....+.+|+.+|++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4678999999999999999999865 68999999987532 12235789999999999999999999985 5
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC---ceEEe
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF---EPQLS 407 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~---~vKL~ 407 (611)
+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEe
Confidence 56899999999999999887543 58999999999999999999999 8999999999999997544 59999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 484 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 484 (611)
|||+++....... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||..............
T Consensus 285 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~--- 358 (419)
T 3i6u_A 285 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT--- 358 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---
T ss_pred ecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---
Confidence 9999987654322 23467999999999985 36788899999999999999999999976543322111110
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.... .+..... ....+..++..||+.||.+|||+.+++++
T Consensus 359 ---~~~~~~--~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 359 ---SGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ---TTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---cCCCCC--Cchhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 0000001 12345566778999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=342.72 Aligned_cols=253 Identities=22% Similarity=0.318 Sum_probs=185.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh--h-HHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE--D-VIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~--~-~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
..++|.+.+.||+|+||+||+|.+ .+|+.||||+++... . ..+.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999997 478999999997542 2 233344555568888999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-cEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~-gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
|||+++ +|.+++.........+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 8888775432223468999999999999999999999 7 8999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccCChhhh----ccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
...... ....||+.|+|||++ ....++.++|||||||++|+|++|+.||................. .
T Consensus 161 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------~ 231 (290)
T 3fme_A 161 VDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP------S 231 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC------C
T ss_pred cccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC------C
Confidence 553322 224799999999996 456789999999999999999999999975433222111111110 0
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+..... .....+..++..||+.||.+|||+.++++
T Consensus 232 -----~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -----PQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCcccc---cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 000000 11234556677799999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=358.10 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=196.9
Q ss_pred HhhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec--------
Q 007256 260 SATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-------- 330 (611)
Q Consensus 260 ~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~-------- 330 (611)
...++|.+.+.||+|+||+||+|.+ .+|+.||||++...... ..+|+.+++.++||||++++++|...
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 4567899999999999999999986 57999999998754322 34799999999999999999998543
Q ss_pred ------------------------------CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 007256 331 ------------------------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380 (611)
Q Consensus 331 ------------------------------~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 380 (611)
...++||||+++ +|.+.+.........+++..+..++.||+.||.|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 348899999985 8887775432223468999999999999999999999
Q ss_pred CCCCcEEeeccCccceeeC-CCCceEEeecCccccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHH
Q 007256 381 GSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLL 458 (611)
Q Consensus 381 ~~~~gIiHrDIKp~NILLd-~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ 458 (611)
++|+||||||+|||++ .++.+||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|
T Consensus 160 ---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 160 ---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp ---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred ---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 8999999999999997 6889999999999876544332 235789999999998865 4899999999999999
Q ss_pred HHHhCCCCCCCCCCcchhhHHHhhccc------------cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCC
Q 007256 459 ELLTGRKPISNDHPKGQESLVMWAKPI------------LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRAR 526 (611)
Q Consensus 459 ELltG~~Pf~~~~~~~~~~lv~~~~~~------------~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~R 526 (611)
||++|+.||.......+...+...... .....+..+........++......+..++..||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999876544332222111000 00000111100000000111112345667778999999999
Q ss_pred CCHHHHHH
Q 007256 527 PQMSLVLK 534 (611)
Q Consensus 527 Ptm~eVL~ 534 (611)
||+.++++
T Consensus 314 ~t~~e~l~ 321 (383)
T 3eb0_A 314 INPYEAMA 321 (383)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=346.28 Aligned_cols=263 Identities=24% Similarity=0.358 Sum_probs=202.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecC-ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~-~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~L 335 (611)
.++|.+.+.||+|+||.||++.. .+|+.||||++.. .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999997 5799999998864 34566789999999999999999999999973 347899
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999987643334468999999999999999999999 89999999999999999999999999998765
Q ss_pred cCCCCCc-------cccccccccccCChhhhccCC---CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 416 STSSSHI-------TCTDVAGTFGYLAPEYFMYGK---VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 416 ~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~---~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
....... ......||+.|+|||++.... ++.++|||||||++|||++|+.||..................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 3211110 011245799999999987553 789999999999999999999999532111111111111000
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~~ 541 (611)
. +. ........+..++..||+.||.+|||+.+|++.|+....
T Consensus 265 ----~--------~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 265 ----S--------IP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -------------CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ----C--------CC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 00 001112345667777999999999999999999976543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=340.02 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=200.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-----------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 329 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----------- 329 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||+++... +.+.+|+++++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 457999999999999999999976 79999999998654 356789999999999999999998864
Q ss_pred -----cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCce
Q 007256 330 -----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 404 (611)
Q Consensus 330 -----~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~v 404 (611)
....++||||+++++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 4458999999999999999975422 358899999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 007256 405 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 484 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 484 (611)
||+|||++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..|+.... .....
T Consensus 162 kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~~~--- 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KFFTD--- 230 (284)
T ss_dssp EECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHHHH---
T ss_pred EECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHHHH---
Confidence 99999999876554322 23579999999999999999999999999999999999998874211 11000
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
...+. +...++ ..+..++..||+.||.+|||+.++++.|...
T Consensus 231 -~~~~~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 231 -LRDGI--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp -HHTTC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -hhccc--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00111 111122 2345566779999999999999999988643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.48 Aligned_cols=258 Identities=21% Similarity=0.277 Sum_probs=197.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999975 7889999999753 23457889999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999997543 48999999999999999999999 899999999999999999999999999997665
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.. .. ....
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~----~~~~--- 255 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ--AI----PRPS--- 255 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS--CC----CCGG---
T ss_pred ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc--CC----CCcc---
Confidence 43222 12235799999999999999999999999999999999999999976543211111110 00 0000
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhhCCcc
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLRGDAD 541 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-tm~eVL~~L~~~~~ 541 (611)
.....++ ..+..++..||+.||.+|| ++.++++.|+....
T Consensus 256 -~~~~~~~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 256 -TVRPGIP----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp -GTSTTCC----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred -ccCCCCC----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 0111111 2345566779999999999 89999999876544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=360.34 Aligned_cols=202 Identities=27% Similarity=0.372 Sum_probs=179.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhc------CCcceeEEeeEEEecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTL------HHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l------~HpnIv~l~g~~~~~~~~~ 334 (611)
..+|.+.+.||+|+||+||+|.+. +++.||||+++........+.+|+.+++.+ +|+||++++++|...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 457999999999999999999865 689999999998877778889999999888 5679999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc--eEEeecCcc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE--PQLSDFGLA 412 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~--vKL~DFGla 412 (611)
+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999996 599999876543 248999999999999999999999 89999999999999999887 999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 474 (611)
....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 7654322 23579999999999999999999999999999999999999998765443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=346.76 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=204.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||++.+. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999975 5889999998643 34567789999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999887543 48999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.....
T Consensus 193 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 258 (335)
T 2owb_A 193 YDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY------------ 258 (335)
T ss_dssp STTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------------
T ss_pred cCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC------------
Confidence 43222 2236799999999999999999999999999999999999999976543322211111100
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+...++ ..+..++..||+.||.+||++.++++
T Consensus 259 -~~~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -SIPKHIN----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111111 23455667799999999999999886
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=355.04 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=201.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEe----CCCCEEEEEEecCCh-----hHHHHHHHHHHHHHhc-CCcceeEEeeEEEecC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPSE-----DVIKEFVLEIEIITTL-HHKNIISLLGFCFEDN 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~~-----~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~ 331 (611)
.++|.+.+.||+|+||.||++.. .+|+.||||+++... ...+.+.+|+.+++.+ +||||+++++++..++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999987 478999999987532 3345677899999999 6999999999999999
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999997543 48899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccC--CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
++........ ......||+.|+|||++.++ .++.++|||||||++|||++|+.||...........+.. .+...
T Consensus 206 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~- 281 (355)
T 1vzo_A 206 SKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--RILKS- 281 (355)
T ss_dssp EEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH--HHHHC-
T ss_pred CeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH--HHhcc-
Confidence 9866433222 22346799999999999853 578999999999999999999999976543322211110 00000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHh
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKLL 536 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~L 536 (611)
.+.+... ....+..++..||+.||.+|| ++.++++..
T Consensus 282 ------~~~~~~~----~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 ------EPPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCCCcc----cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0111111 123445566779999999999 999998754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=369.78 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=205.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.+++.++||||++++++|...+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 478999999999999999999975 79999999997532 3356788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||++||+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997655444569999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..+.. +.
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~--~~i~~-~~------ 409 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--QRVLE-QA------ 409 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH--HHHHH-CC------
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH--HHHhh-cc------
Confidence 44322 233689999999999999999999999999999999999999998754322111111 00000 00
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQM-----SLVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm-----~eVL~ 534 (611)
..+...+ ...+..++..||+.||.+||++ .+|++
T Consensus 410 ~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 VTYPDKF----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cCCCccc----CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0011111 2344556667999999999975 55554
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=335.71 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=202.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----------hHHHHHHHHHHHHHhcC-CcceeEEeeEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCF 328 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----------~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~ 328 (611)
..++|.+.+.||+|+||.||+|.+. +|+.||||+++... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3568999999999999999999975 68999999997532 33567889999999996 999999999999
Q ss_pred ecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEee
Q 007256 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 408 (611)
Q Consensus 329 ~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~D 408 (611)
.++..++||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999997543 48999999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccccccCChhhhc------cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 007256 409 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 409 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 482 (611)
||++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||...........+...
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 999987654332 22357999999999985 457889999999999999999999999765433222211111
Q ss_pred ccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 483 ~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.... ..+. .......+..++..||+.||.+|||+.++++
T Consensus 245 ~~~~--------~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQF--------GSPE-----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCCC--------CTTT-----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Cccc--------Cccc-----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1000 0000 0111234566777799999999999999886
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=365.54 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=203.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++++++||||++++++|.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999975 7999999998643 34567899999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee---CCCCceEEeecCccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAK 413 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL---d~~~~vKL~DFGla~ 413 (611)
|||+.+|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++.
T Consensus 105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999987543 48999999999999999999999 899999999999999 567899999999998
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.........
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 248 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL----- 248 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-----
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC-----
Confidence 7755432 223579999999999875 7999999999999999999999999876543332222211110000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+.. ......+..++..||+.||.+|||+.++++
T Consensus 249 ---~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 249 ---PQW-----KKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ---GGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000 011234556677799999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=373.06 Aligned_cols=254 Identities=24% Similarity=0.303 Sum_probs=205.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
..++|.+.+.||+|+||.||+|... +|+.||||++.... .....+.+|+.+|+.++||||++++++|.+.+.+++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 4568999999999999999999875 79999999997532 334568899999999999999999999999999999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||++||+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999976432 348999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... .. .
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~~-~------ 404 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--KE-V------ 404 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--HH-C------
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--hc-c------
Confidence 54332 223689999999999999999999999999999999999999998754332211111000 00 0
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
...+...+ ...+..++..||+.||.+|| ++.+|+++
T Consensus 405 ~~~~p~~~----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 PEEYSERF----SPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCCCTTS----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cccCCccC----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00111111 23455566679999999999 78888764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.88 Aligned_cols=271 Identities=21% Similarity=0.269 Sum_probs=199.2
Q ss_pred HHHHHHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC------------hhHHHHHHHHHHHHHhcCCcceeE
Q 007256 255 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS------------EDVIKEFVLEIEIITTLHHKNIIS 322 (611)
Q Consensus 255 ~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~------------~~~~~~f~~Ei~iL~~l~HpnIv~ 322 (611)
..++....++|.+.+.||+|+||.||+|.+.+|+.||||++... ....+.+.+|+++++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 56777889999999999999999999999888999999998642 223478999999999999999999
Q ss_pred EeeEEEec-----CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCcccee
Q 007256 323 LLGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 397 (611)
Q Consensus 323 l~g~~~~~-----~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NIL 397 (611)
+++++... ...++||||++ |+|.+.+.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEE
Confidence 99998543 35799999998 58888887543 358999999999999999999999 89999999999999
Q ss_pred eCCCCceEEeecCccccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchh
Q 007256 398 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 476 (611)
Q Consensus 398 Ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~ 476 (611)
++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999975544322 223579999999999886 67899999999999999999999999876533322
Q ss_pred hHHHhhcccc--------ccCccccccCcccCCCC-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 477 SLVMWAKPIL--------SSGKVTQLLDPALGNNY-------DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 477 ~lv~~~~~~~--------~~g~l~~lld~~l~~~~-------~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+....... ........+...+.... .......+..++..||+.||.+|||+.++++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 2111000000 00000001100000000 00112345567778999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=350.07 Aligned_cols=271 Identities=25% Similarity=0.346 Sum_probs=204.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-----CCCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC--ce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-----PDGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN--NL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-----~~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~--~~ 333 (611)
.++|.+.+.||+|+||.||++.. .+|+.||||++... ....+.+.+|+++++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35789999999999999999983 46899999999764 355678999999999999999999999987644 78
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 99999999999999997653 258999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCcc-ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcc-ccccCcc
Q 007256 414 WASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP-ILSSGKV 491 (611)
Q Consensus 414 ~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~-~~~~g~l 491 (611)
.......... .....+|..|+|||++.+..++.++|||||||++|||++|..|+........ ........ ......+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-RMIGNDKQGQMIVFHL 272 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH-HHHCTTCCTHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH-HhhccccchhhhHHHH
Confidence 7765433211 1224578889999999998999999999999999999999999853210000 00000000 0000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.+.+...............+..++..||+.||.+|||+.+|++.|+..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000000000001111123456677789999999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.42 Aligned_cols=250 Identities=29% Similarity=0.431 Sum_probs=195.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-CceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~-~~~~LV~Ey~ 340 (611)
.++|.+.+.||+|+||+||+|.. +|+.||||+++... ..+.+.+|+.+++.++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 46799999999999999999987 58899999998643 557899999999999999999999997654 4789999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++++|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999975421 237889999999999999999999 899999999999999999999999999987654422
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+.. +. ....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-------~~-----~~~~ 235 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------GY-----KMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-------TC-----CCCC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-------CC-----CCCC
Confidence 12467899999999999999999999999999999998 9999976543322211110 00 0111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.... ...+..++..||+.||.+||++.++++.|+..
T Consensus 236 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 PDGC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1111 23455666779999999999999999988753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=360.75 Aligned_cols=242 Identities=13% Similarity=0.184 Sum_probs=188.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecC----ChhHHHHHHHHHH---HHHhcCCcceeEEe-------eE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKP----SEDVIKEFVLEIE---IITTLHHKNIISLL-------GF 326 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~----~~~~~~~f~~Ei~---iL~~l~HpnIv~l~-------g~ 326 (611)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++.. .....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 56899999999999999999996 4799999999863 3456678999994 55566899999998 66
Q ss_pred EEecC-----------------ceEEEEeeCCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcE
Q 007256 327 CFEDN-----------------NLLLVYDFLSRGSLEENLHGNKK---DPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386 (611)
Q Consensus 327 ~~~~~-----------------~~~LV~Ey~~ggsL~~~L~~~~~---~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gI 386 (611)
+...+ ..++||||+ +|+|.+++..... ....+++..++.|+.||+.||.|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 389999999 6799999975321 11234568888999999999999999 899
Q ss_pred EeeccCccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccC-----------CCCCcceehhhhH
Q 007256 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-----------KVNDKIDVYAFGV 455 (611)
Q Consensus 387 iHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~s~ksDVwSlGv 455 (611)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985433 2234578 999999999987 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 456 VLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 456 vL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
++|||++|+.||...........+. .. ...++ ..+..++..||+.||.+|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~---------------~~--~~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIF---------------RS--CKNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGG---------------SS--CCCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhhhh---------------hh--ccCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999997654332211110 00 01111 24555667799999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.63 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=200.4
Q ss_pred CHHHHHHhhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe--
Q 007256 254 NYQDLLSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE-- 329 (611)
Q Consensus 254 ~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~-- 329 (611)
++.++....++|.+.+.||+|+||.||+|.+ .+|+.||||++.......+.+.+|+.+++++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3444455678999999999999999999997 4799999999987666667899999999999 79999999999987
Q ss_pred ----cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 330 ----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 330 ----~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
.+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEE
Confidence 4678999999999999999976432 358899999999999999999999 8999999999999999999999
Q ss_pred EeecCccccccCCCCCccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHH
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~ 480 (611)
|+|||++......... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+.
T Consensus 170 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred EeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 9999999766543221 22357999999999997 5678999999999999999999999997654332221111
Q ss_pred hhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 481 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 481 ~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.. ...... ...+ ...+..++..||..||.+||++.++++
T Consensus 248 ~~-------~~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RN-------PAPRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HS-------CCCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cC-------ccccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 10 000110 1111 124555667799999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=350.02 Aligned_cols=209 Identities=24% Similarity=0.330 Sum_probs=180.3
Q ss_pred HHHHhhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-Cc-----ceeEEeeEEEe
Q 007256 257 DLLSATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HK-----NIISLLGFCFE 329 (611)
Q Consensus 257 el~~~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-Hp-----nIv~l~g~~~~ 329 (611)
......++|.+.+.||+|+||+||+|.+. +|+.||||+++........+..|+.+++.++ |+ +|+++++++..
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 33445689999999999999999999875 6889999999987777788889999999885 44 59999999999
Q ss_pred cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC--CCCceEEe
Q 007256 330 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLS 407 (611)
Q Consensus 330 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd--~~~~vKL~ 407 (611)
.+..++||||+++ +|.+++..... ..+++..+..++.|++.||.|||... .+|+||||||+|||++ .++.+||+
T Consensus 128 ~~~~~lv~e~~~~-~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-NLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CCceEEEEecCCC-CHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999965 99999976542 24899999999999999999999522 7899999999999994 57789999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 474 (611)
|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 204 DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 204 DFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp CCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999998765422 23679999999999999999999999999999999999999998765443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=374.62 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=200.3
Q ss_pred hcCceeee-eEeecCcEEEEEEEeC---CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAEN-LIGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~-~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.+++.+.+ .||+|+||.||+|.+. ++..||||+++.. ....+.|.+|+++|++++||||++++++|.. +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34555555 8999999999999864 5667999999863 3457889999999999999999999999975 57999
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 413 v~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999999999999997543 358999999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCCcc-ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 416 STSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 416 ~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
........ .....+|+.|+|||++.++.++.++|||||||+||||++ |+.||...........+..... .
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------~- 558 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------M- 558 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-------C-
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------C-
Confidence 54332211 112346789999999999999999999999999999998 9999987655433222221110 0
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..... ....+..++..||+.||.+||++.+|++.|+.
T Consensus 559 ----~~p~~----~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 559 ----ECPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp ----CCCTT----CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred ----CCCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 01111 12345567778999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=351.95 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=195.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~------ 331 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999874 799999999964 3345678899999999999999999999997653
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++||||+ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 78999998753 48899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC-
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG- 489 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g- 489 (611)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+...+...+..........
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9876542 223578999999999887 689999999999999999999999998765443332221111000000
Q ss_pred -------c-------cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 -------K-------VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 -------~-------l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. +.......+.. ........+..++..||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 00000000000 001112345556677999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=364.32 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=198.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.+.|.+.+.||+|+||+||+|... ++..||||+++.. ......+.+|+.+++.++||||++++++|.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456999999999999999999975 7899999999753 233567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC---CceEEeecCcccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 414 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~---~~vKL~DFGla~~ 414 (611)
||+++|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.. +.+||+|||++..
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999886543 48899999999999999999999 899999999999999764 4599999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
...... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||...........+......+.
T Consensus 189 ~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------- 257 (494)
T 3lij_A 189 FENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD------- 257 (494)
T ss_dssp CBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------
T ss_pred CCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 654332 23367999999999986 5799999999999999999999999987654433322222111110
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+.. ... ...+..++..||+.||.+|||+.++++
T Consensus 258 -~~~~-~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 -SPEW-KNV----SEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -SGGG-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -chhc-ccC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0100 011 123455667799999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.51 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=197.9
Q ss_pred cCHHHHHHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcC--CcceeEEeeEE
Q 007256 253 FNYQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLH--HKNIISLLGFC 327 (611)
Q Consensus 253 f~~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~--HpnIv~l~g~~ 327 (611)
+.++.+....++|.+.+.||+|+||.||++.+.+|+.||||++.. .....+.+.+|+.++.+++ |+||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 334444455678999999999999999999998899999999964 3455678999999999997 49999999999
Q ss_pred EecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 328 ~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
..++..++||| +.+++|.+++.... .+++..++.++.|++.||.|||+ ++|+||||||+|||+++ +.+||+
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEEC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEe
Confidence 99999999999 66789999997653 58899999999999999999999 89999999999999965 799999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhcc-----------CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchh
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY-----------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE 476 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~ 476 (611)
|||++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 247 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS- 247 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-
Confidence 9999987655433333334679999999999875 4788899999999999999999999975433211
Q ss_pred hHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 477 SLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 477 ~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.... ++.....+.......+..++..||+.||.+||++.++++.
T Consensus 248 ~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 KLHAII-------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHH-------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHH-------------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111111 1110001111112345556677999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.46 Aligned_cols=258 Identities=20% Similarity=0.315 Sum_probs=199.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEe--cCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~--~~~~~LV~ 337 (611)
.++|.+.+.||+|+||+||+|.+ .+|+.||||+++... .+.+.+|+.+++.++ ||||+++++++.. ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 46899999999999999999986 579999999998543 467889999999997 9999999999987 66789999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-ceEEeecCcccccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAS 416 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-~vKL~DFGla~~~~ 416 (611)
||+++++|.+++. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999885 27889999999999999999999 8999999999999999776 89999999998765
Q ss_pred CCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcc-----------
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP----------- 484 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~----------- 484 (611)
..... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +......
T Consensus 183 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHH
T ss_pred CCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHH
Confidence 54322 23579999999999986 67899999999999999999999999654332111 1100000
Q ss_pred ---ccccCccccc--------cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 485 ---ILSSGKVTQL--------LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 485 ---~~~~g~l~~l--------ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.........+ ................+..++..||+.||.+|||+.+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000000 00011111111123456667778999999999999999873
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=363.87 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=201.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||++... ......+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999875 7999999998642 234578899999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC---CCCceEEeecCcccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKW 414 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd---~~~~vKL~DFGla~~ 414 (611)
||+.+|+|.+.+.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++..
T Consensus 101 e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999886543 48999999999999999999999 8999999999999995 556799999999986
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+.........
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 243 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL------ 243 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS------
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC------
Confidence 654322 233679999999999875 6999999999999999999999999876543332222211110000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+.. ......+..++..||+.||.+|||+.++++.
T Consensus 244 --~~~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 --PQW-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --GGG-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --ccc-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0111245566777999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=364.11 Aligned_cols=194 Identities=23% Similarity=0.362 Sum_probs=155.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~ 332 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||++... ....+.+.+|+.+|+.++||||++++++|... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999865 7899999998753 34567899999999999999999999999543 56
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 69999987543 58999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC-------------------------ccccccccccccCChhhh-ccCCCCCcceehhhhHHHHHHHhC
Q 007256 413 KWASTSSSH-------------------------ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTG 463 (611)
Q Consensus 413 ~~~~~~~~~-------------------------~~~~~~~GT~~Y~APE~l-~~~~~s~ksDVwSlGvvL~ELltG 463 (611)
+........ ...+..+||+.|+|||++ ....|+.++||||||||||||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 876532211 122346789999999986 456799999999999999999993
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=340.39 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=201.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
..++|.+.+.||+|+||.||++... +|+.||||+++... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999975 79999999998653 334568899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee---CCCCceEEeecCccccc
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL---d~~~~vKL~DFGla~~~ 415 (611)
|+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 999999999986543 48899999999999999999999 899999999999999 78889999999998754
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... .+
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--------~~- 226 (304)
T 2jam_A 160 QNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY--------EF- 226 (304)
T ss_dssp CCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCC--------CC-
T ss_pred CCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC--------CC-
Confidence 4321 2235799999999999999999999999999999999999999976543322211111100 00
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
....... ....+..++..||+.||.+|||+.++++
T Consensus 227 ~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ESPFWDD----ISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CTTTTTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred Ccccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001111 1234556677799999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=337.67 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=197.4
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLL 334 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~ 334 (611)
..|.+.+.||+|+||+||+|.+. ++..||+|++.. .....+.+.+|+.+++.++||||++++++|.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 45888999999999999999874 688999999874 34556789999999999999999999999875 34589
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--EEeeccCccceeeC-CCCceEEeecCc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGL 411 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g--IiHrDIKp~NILLd-~~~~vKL~DFGl 411 (611)
+||||+++++|.+++.... .+++..++.++.+|+.||.|||+ ++ |+||||||+|||++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999997643 48899999999999999999999 77 99999999999997 789999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
+....... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||............. . .+..
T Consensus 179 ~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--~----~~~~ 247 (290)
T 1t4h_A 179 ATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--T----SGVK 247 (290)
T ss_dssp GGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH--T----TTCC
T ss_pred cccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH--h----ccCC
Confidence 97554432 22357999999999887 569999999999999999999999997654332221111 0 0000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.. .+.... ...+..++..||+.||.+|||+.++++.
T Consensus 248 ~~----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 PA----SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CG----GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cc----ccCCCC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 111111 1245566777999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=341.75 Aligned_cols=265 Identities=27% Similarity=0.425 Sum_probs=187.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
..++|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999864 7899999998754 344567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 338 DFLSRGSLEENLHGN----KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~----~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
||+++++|.+++... ......+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988631 1122358999999999999999999999 899999999999999999999999999997
Q ss_pred cccCCCCC---ccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 414 WASTSSSH---ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 414 ~~~~~~~~---~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
........ .......||+.|+|||++.. ..++.++|||||||++|||++|+.||................+. .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~ 246 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP---S 246 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC---C
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC---c
Confidence 66543211 11223579999999999875 56899999999999999999999999876543322211111100 0
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
......++.....++ ..+..++..||+.||.+||++.++++.
T Consensus 247 ~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000111111111222 345566677999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=348.02 Aligned_cols=261 Identities=21% Similarity=0.250 Sum_probs=193.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~------ 331 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999865 6899999999752 345677889999999999999999999997655
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 68999999986 78888752 37899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc--------
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------- 483 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-------- 483 (611)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+....
T Consensus 174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98665432 1223679999999999999999999999999999999999999998765433222111000
Q ss_pred --------------cccccCccccccCcccCCCCC---hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 484 --------------PILSSGKVTQLLDPALGNNYD---YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 484 --------------~~~~~g~l~~lld~~l~~~~~---~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+......+..++......... ......+..++..||+.||.+|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000011111111100000 1123456677888999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.84 Aligned_cols=262 Identities=16% Similarity=0.234 Sum_probs=202.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCC---------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeE----------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS---------- 322 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~---------g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~---------- 322 (611)
.++|.+.+.||+|+||.||+|.+.. ++.||||++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 4689999999999999999998763 789999999755 46788999999999999988
Q ss_pred -----EeeEEEe-cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccce
Q 007256 323 -----LLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNI 396 (611)
Q Consensus 323 -----l~g~~~~-~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NI 396 (611)
+++++.. ++..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHE
Confidence 6777776 67899999999 999999998652 1358999999999999999999999 8999999999999
Q ss_pred eeCCCC--ceEEeecCccccccCCCCCc-----cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCC
Q 007256 397 LLSDDF--EPQLSDFGLAKWASTSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISN 469 (611)
Q Consensus 397 LLd~~~--~vKL~DFGla~~~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~ 469 (611)
|++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 89999999998765432211 11235799999999999999999999999999999999999999986
Q ss_pred CCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 470 DHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 470 ~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
........... .... ......+.+........ ...+..++..||+.||.+||++.+|++.|+..
T Consensus 271 ~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNTEDIMKQ-KQKF--VDKPGPFVGPCGHWIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCHHHHHHH-HHHH--HHSCCCEECTTSCEECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCHHHHHHH-HHhc--cCChhhhhhhccccCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 54322211111 1000 00111111111110011 13455566779999999999999999998753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=336.50 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=198.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-----hHHHHHHHHHHHHHhcCCcceeEEeeEEE--ecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-----DVIKEFVLEIEIITTLHHKNIISLLGFCF--EDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~--~~~~~ 333 (611)
.++|.+.+.||+|+||.||++.+. +++.||||+++... .....+.+|+.+++.++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999974 78999999997532 34578999999999999999999999984 45689
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||++++ |.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999986 7777765432 358999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCChhhhccCC--CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
...............||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------- 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------- 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-------
Confidence 765443333334567999999999998644 37799999999999999999999986543322221111100
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+...+ ...+..++..||+.||.+|||+.++++.
T Consensus 231 ------~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ------AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011111 1244556677999999999999999973
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=355.99 Aligned_cols=199 Identities=25% Similarity=0.362 Sum_probs=168.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~ 332 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.+.+|+.+|+.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 568999999999999999999875 6889999999753 34567899999999999999999999999776 57
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.|+||||+.+ +|.+++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~-~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIADS-DLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCSE-EHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCCc-CHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 9999999875 9999997543 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCC--------------------ccccccccccccCChhhh-ccCCCCCcceehhhhHHHHHHHhCCCCCC
Q 007256 413 KWASTSSSH--------------------ITCTDVAGTFGYLAPEYF-MYGKVNDKIDVYAFGVVLLELLTGRKPIS 468 (611)
Q Consensus 413 ~~~~~~~~~--------------------~~~~~~~GT~~Y~APE~l-~~~~~s~ksDVwSlGvvL~ELltG~~Pf~ 468 (611)
+........ ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 876543221 112457899999999986 45679999999999999999998655554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=338.58 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=199.1
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
..++|.+.+.||+|+||.||+|.+. +|+.||||++.... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 3568999999999999999999875 69999999997543 346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+++++|.+++.... ..+++..++.++.+++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 106 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 106 CGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999986332 258999999999999999999999 899999999999999999999999999997765432
Q ss_pred CCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.... ...+..
T Consensus 180 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~--- 247 (314)
T 3com_A 180 AK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-------PPTFRK--- 247 (314)
T ss_dssp SC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------CCCCSS---
T ss_pred cc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-------CcccCC---
Confidence 22 223579999999999999999999999999999999999999997654332211111100 000000
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.......+..++..||+.||.+|||+.++++
T Consensus 248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0111234556677799999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.01 Aligned_cols=253 Identities=13% Similarity=0.080 Sum_probs=180.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc--CCcceeEEe-------eEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL--HHKNIISLL-------GFC 327 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l--~HpnIv~l~-------g~~ 327 (611)
..+|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345899999999999999999965 7899999999863 24456677886555555 699988865 444
Q ss_pred Eec-----------------CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCC
Q 007256 328 FED-----------------NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSER------YKVAMGVAEALEYLHSGSAQ 384 (611)
Q Consensus 328 ~~~-----------------~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~------~~I~~qIa~gL~yLH~~~~~ 384 (611)
... ...++||||++ |+|.+++..... .+.+..+ +.++.||+.||.|||+ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 332 33899999999 799999975422 2455566 7788999999999999 8
Q ss_pred cEEeeccCccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhcc--CCCCCcceehhhhHHHHHHHh
Q 007256 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLT 462 (611)
Q Consensus 385 gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELlt 462 (611)
+|+||||||+|||++.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999998664321 13467799999999987 679999999999999999999
Q ss_pred CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 463 GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 463 G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
|+.||....+..... +...............+. .......+..++..||+.||.+|||+.++++
T Consensus 289 g~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGS---WKRPSLRVPGTDSLAFGS-----CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTC---CCBCCTTSCCCCSCCCTT-----SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccc---hhhhhhhhccccccchhh-----ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999998764432211 111000000000000000 0111234556667799999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=360.07 Aligned_cols=263 Identities=23% Similarity=0.273 Sum_probs=194.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------ceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------NLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~------~~~L 335 (611)
.+|.+.+.||+|+||.||+|.+. +|+.||||++..... .+.+|+++|+.++||||++++++|.... .+++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 36889999999999999999975 699999999875432 2347999999999999999999986422 3679
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC-CceEEeecCcccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-FEPQLSDFGLAKW 414 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~-~~vKL~DFGla~~ 414 (611)
||||+++ +|.+.+.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999987 6666654322223468999999999999999999999 899999999999999965 5789999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc------
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS------ 487 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~------ 487 (611)
....... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......+...+........
T Consensus 207 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 207 LVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6543322 235789999999999765 799999999999999999999999987654333222211100000
Q ss_pred -cCccccccCcccCCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 488 -SGKVTQLLDPALGNN-----YDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 488 -~g~l~~lld~~l~~~-----~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
......+.-+.+... +.......+..++..||+.||.+|||+.+++++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 001111111111000 111112456667778999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=333.95 Aligned_cols=247 Identities=23% Similarity=0.366 Sum_probs=194.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999976 79999999997532 3356788999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++++|.+++.... .+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999997543 48899999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
.... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+.....
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 228 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF----------- 228 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------
Confidence 4322 123578999999999987765 5899999999999999999999976543222111111000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.... ...+..++..||+.||.+|||+.++++.
T Consensus 229 --~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 --YIPEYL----NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --cCchhc----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011111 1235566777999999999999999973
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=341.19 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=195.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDN 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~---------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~ 331 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+++++.++||||+++++++..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 467999999999999999999875 68899999987532 2234588999999999999999999998655
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc---eEEee
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSD 408 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~---vKL~D 408 (611)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred ceEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4899999999999999987543 58999999999999999999999 89999999999999987654 99999
Q ss_pred cCccccccCCCCCccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchh-hHHHhhcc
Q 007256 409 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKP 484 (611)
Q Consensus 409 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~ 484 (611)
||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......... ..+...
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-- 235 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-- 235 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT--
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC--
Confidence 99998765421 122357999999999974 567899999999999999999999999765433211 111110
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
... ..+..... ....+..++..||+.||.+||++.++++.
T Consensus 236 -----~~~--~~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 236 -----KYN--FIPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -----CCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----ccc--cCchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 000 00000011 12345667778999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=345.47 Aligned_cols=266 Identities=22% Similarity=0.325 Sum_probs=203.1
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~ 332 (611)
..++|.+.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4568999999999999999999865 7889999999753 34557899999999999999999999999765 36
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.++||||+.+ +|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccCc-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 8999999985 999988653 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc-cccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 413 KWASTSSSHI-TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 413 ~~~~~~~~~~-~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 8765432221 1234689999999998764 4589999999999999999999999987665443332211100000000
Q ss_pred cccccC--------cc-cCCCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 491 VTQLLD--------PA-LGNNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 491 l~~lld--------~~-l~~~~~~-----~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+..+.+ .. ....... .....+..++..||+.||.+|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00 0000010 112345667778999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=335.33 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=194.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-----------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----------- 329 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----------- 329 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++......+.+.+|+.+++.++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 567999999999999999999974 79999999998777777889999999999999999999999865
Q ss_pred --cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 330 --DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 330 --~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 356899999999999999997543 257889999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCC------------CccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcc
Q 007256 408 DFGLAKWASTSSS------------HITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474 (611)
Q Consensus 408 DFGla~~~~~~~~------------~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 474 (611)
|||++........ ........||+.|+|||++.+. .++.++|||||||++|||++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 9999986643211 1112235799999999999854 78999999999999999998 5532211
Q ss_pred hhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 475 ~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......... . ...+...+.......+..++..||+.||.+|||+.++++.
T Consensus 234 ~~~~~~~~~~----~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 RVNILKKLRS----V------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHHS----T------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHhccc----c------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111111000 0 0111112222223445567777999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=337.73 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=196.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC--CCC--EEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP--DGK--ELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~--~g~--~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||+||+|.+. +++ .||||+++.. ....+.+.+|+.+++.++||||+++++++..++ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357999999999999999999853 333 6899998753 345678999999999999999999999997654 8
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 99999999999999997543 258899999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCCc-cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 414 WASTSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 414 ~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+..... .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----~- 243 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-----R- 243 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-----C-
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC-----C-
Confidence 775543321 1223567889999999998899999999999999999999 9999976654322211111000 0
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
...... ....+..++..||+.||.+|||+.++++.|+...
T Consensus 244 -----~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 -----LPRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp -----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----CCCCcC----cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 000111 1234556677799999999999999999987544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=355.54 Aligned_cols=264 Identities=20% Similarity=0.266 Sum_probs=194.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc------eEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN------LLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~------~~L 335 (611)
..+|.+.+.||+|+||+||+|.+..+..+|+|++...... ..+|+.+++.++||||++++++|..... +++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 3469999999999999999999877777999988654322 2369999999999999999999976543 889
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC-CCCceEEeecCcccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKW 414 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd-~~~~vKL~DFGla~~ 414 (611)
||||++++.+. .+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++.
T Consensus 116 v~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPETVYR-ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEEHHH-HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCccHHH-HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999885443 332211122358999999999999999999999 8999999999999998 799999999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc----------
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK---------- 483 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~---------- 483 (611)
....... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.......+...+....
T Consensus 192 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 192 LIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6544332 235789999999998765 58999999999999999999999998765443322221110
Q ss_pred --cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 484 --PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 484 --~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+......+.......+...+.......+..++..||+.||.+|||+.+++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000011111100000000111112355667778999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=338.30 Aligned_cols=262 Identities=19% Similarity=0.260 Sum_probs=203.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CC-CEEEEEEecCChhHHHHHHHHHHHHHhcCCcc------eeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DG-KELAVKILKPSEDVIKEFVLEIEIITTLHHKN------IISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g-~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hpn------Iv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||+||+|.+. ++ +.||||+++......+.+.+|+.+++.++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 468999999999999999999874 44 68999999987777788999999999998776 99999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee---------------
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL--------------- 398 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL--------------- 398 (611)
++||||+ +++|.+.+..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 5577777765432 358999999999999999999999 899999999999999
Q ss_pred ----CCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc
Q 007256 399 ----SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474 (611)
Q Consensus 399 ----d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~ 474 (611)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 567899999999998654422 23579999999999999999999999999999999999999998755433
Q ss_pred hhhHHHhhccccccC------ccccccC--------------------cccC-CCCChHHHHHHHHHHHHhcccCCCCCC
Q 007256 475 QESLVMWAKPILSSG------KVTQLLD--------------------PALG-NNYDYDQMERMVLASILCIRRDPRARP 527 (611)
Q Consensus 475 ~~~lv~~~~~~~~~g------~l~~lld--------------------~~l~-~~~~~~~~~~l~~la~~CL~~dP~~RP 527 (611)
....+.......... ....... +... ..........+..++..||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 222111110000000 0000000 0000 001122344667788889999999999
Q ss_pred CHHHHHH
Q 007256 528 QMSLVLK 534 (611)
Q Consensus 528 tm~eVL~ 534 (611)
|+.++++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=342.96 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=182.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcC-CcceeEEeeEEEe--------c
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--------D 330 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~--------~ 330 (611)
..+|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 457999999999999999999964 7999999988643 455678899999999996 9999999999953 3
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--EEeeccCccceeeCCCCceEEee
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLSDDFEPQLSD 408 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g--IiHrDIKp~NILLd~~~~vKL~D 408 (611)
...++||||+. |+|.+++..... ...+++..++.++.||+.||.|||+ ++ |+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 34899999996 699988864221 1358999999999999999999999 77 99999999999999999999999
Q ss_pred cCccccccCCCCCc----------cccccccccccCChhhh---ccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcch
Q 007256 409 FGLAKWASTSSSHI----------TCTDVAGTFGYLAPEYF---MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ 475 (611)
Q Consensus 409 FGla~~~~~~~~~~----------~~~~~~GT~~Y~APE~l---~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~ 475 (611)
||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 99998765432211 01134699999999998 566789999999999999999999999965432211
Q ss_pred hhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 476 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 476 ~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.... ... ..... .. ..+..++..||+.||.+|||+.++++.|+..
T Consensus 262 ---~~~~--------~~~----~~~~~-~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 262 ---VNGK--------YSI----PPHDT-QY---TVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ---------------CCC----CTTCC-SS---GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ---hcCc--------ccC----Ccccc-cc---hHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0000 000 00000 11 1244566679999999999999999998644
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=372.55 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=196.4
Q ss_pred eeeEeecCcEEEEEEEe---CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 268 ENLIGKGGSSQVYKGCL---PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~---~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
.+.||+|+||.||+|.+ .+++.||||+++.. ....+.|.+|+.+|++++|||||+++++|. .+..++||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccC
Confidence 35899999999999965 35688999999853 244678999999999999999999999995 556899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+|+|.+++.... .+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 453 ~g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 453 LGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp TEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999997543 48999999999999999999999 89999999999999999999999999999877554322
Q ss_pred -ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCccc
Q 007256 422 -ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 422 -~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l 499 (611)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+..... . ..
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------~-----~~ 593 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------M-----GC 593 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------C-----CC
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------C-----CC
Confidence 12223457889999999999999999999999999999998 9999987654432222221110 0 01
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.... ...+..++..||+.||.+||++.+|++.|+.
T Consensus 594 p~~~----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 594 PAGC----PREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111 2345566777999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.24 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=195.9
Q ss_pred CceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCC
Q 007256 264 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
+|....+||+|+||.||+|.+ .+++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 445556899999999999996 478899999987643 456779999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-CCceEEeecCccccccCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-~~~vKL~DFGla~~~~~~~~ 420 (611)
+++|.+++..... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999976432 2356788999999999999999999 89999999999999987 89999999999987654322
Q ss_pred CccccccccccccCChhhhccCC--CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGK--VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~--~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
. .....||+.|+|||++.++. ++.++||||||+++|+|++|+.||........... .... . ...+.
T Consensus 179 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~--~-------~~~~~ 246 (295)
T 2clq_A 179 C--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGM--F-------KVHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-HHHH--H-------CCCCC
T ss_pred c--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-hhcc--c-------ccccc
Confidence 1 22357999999999997654 88999999999999999999999965432211110 0000 0 00111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+...+ ...+..++..||+.||.+||++.++++
T Consensus 247 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 IPESM----SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 234555667799999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=376.90 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=203.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~ 334 (611)
..++|.+.+.||+|+||.||+|.+. +++.||||+++.. ....+.+..|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999975 6889999999753 23456788899999987 6999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
|||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++||||||||+||||+.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999997653 48999999999999999999999 8999999999999999999999999999986
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
...... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.......+.....
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------- 559 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV---------- 559 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC----------
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC----------
Confidence 443222 23347899999999999999999999999999999999999999987654433222221110
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQM-----SLVLK 534 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm-----~eVL~ 534 (611)
.+... ....+..++..||+.||.+||++ .+|++
T Consensus 560 ---~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ---AYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CCCTT----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CCCcc----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 01111 12345556677999999999997 66654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=338.87 Aligned_cols=264 Identities=22% Similarity=0.341 Sum_probs=199.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe--CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhc---CCcceeEEeeEEE----
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL--PDGKELAVKILKPSE---DVIKEFVLEIEIITTL---HHKNIISLLGFCF---- 328 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~--~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~---- 328 (611)
..++|.+.+.||+|+||.||+|.+ .+|+.||||+++... .....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 468899999986422 2223566788777766 8999999999987
Q ss_pred -ecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEe
Q 007256 329 -EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLS 407 (611)
Q Consensus 329 -~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~ 407 (611)
.....++||||++ |+|.+++..... ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999998 599999876543 248999999999999999999999 899999999999999999999999
Q ss_pred ecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc
Q 007256 408 DFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 487 (611)
Q Consensus 408 DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~ 487 (611)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+........
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999997654322 22346799999999999999999999999999999999999999987654332222211100000
Q ss_pred cCcccc-------ccC----cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 488 SGKVTQ-------LLD----PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 488 ~g~l~~-------lld----~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
...... .+. ..+ ..+.......+..++..||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 240 EEDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 000 000 0011111234556677799999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=337.18 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=197.9
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
..++|.+.+.||+|+||.||+|.+. +|+.||+|++... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3568999999999999999999975 6899999998754 3456789999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999886533 248999999999999999999999 89999999999999999999999999987543221
Q ss_pred CCCccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
.. ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+ ... ....
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~-----~~~~ 241 (302)
T 2j7t_A 171 LQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--AKS-----DPPT 241 (302)
T ss_dssp HH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHS-----CCCC
T ss_pred cc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH--hcc-----CCcc
Confidence 11 112357899999999984 667899999999999999999999999765433221111 110 0000
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
... .......+..++..||+.||.+|||+.++++.
T Consensus 242 ~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 242 LLT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp CSS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred cCC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 01112345566777999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=342.15 Aligned_cols=264 Identities=20% Similarity=0.284 Sum_probs=203.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChh------------------HHHHHHHHHHHHHhcCCcceeEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED------------------VIKEFVLEIEIITTLHHKNIISL 323 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~------------------~~~~f~~Ei~iL~~l~HpnIv~l 323 (611)
.++|.+.+.||+|+||.||+|.. +|+.||||++..... ..+.+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 999999999874321 12789999999999999999999
Q ss_pred eeEEEecCceEEEEeeCCCCChhhh------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCcccee
Q 007256 324 LGFCFEDNNLLLVYDFLSRGSLEEN------LHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNIL 397 (611)
Q Consensus 324 ~g~~~~~~~~~LV~Ey~~ggsL~~~------L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NIL 397 (611)
++++.+.+..++||||+++|+|.++ +.... ...+++..++.++.|++.||.|||+ .++|+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence 9999999999999999999999998 54321 2468999999999999999999996 267999999999999
Q ss_pred eCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccC-CCCC-cceehhhhHHHHHHHhCCCCCCCCCCcc-
Q 007256 398 LSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVND-KIDVYAFGVVLLELLTGRKPISNDHPKG- 474 (611)
Q Consensus 398 Ld~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~-ksDVwSlGvvL~ELltG~~Pf~~~~~~~- 474 (611)
++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876543 22346799999999999877 6666 9999999999999999999998765422
Q ss_pred hhhHHHhhccccccCccccccCcccCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 475 QESLVMWAKPILSSGKVTQLLDPALGN---NYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 475 ~~~lv~~~~~~~~~g~l~~lld~~l~~---~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
....+........ ........+.... .........+..++..||+.||.+|||+.++++.
T Consensus 261 ~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 LFNNIRTKNIEYP-LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHTSCCCCCC-CSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHhccCcCCc-cchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111100000 0000011110000 0001112345566777999999999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.96 Aligned_cols=266 Identities=21% Similarity=0.293 Sum_probs=199.9
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~ 332 (611)
..++|.+.+.||+|+||.||+|.+. +|+.||||+++.. ......+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999975 6899999999753 34566788999999999999999999988754 67
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.++||||+. ++|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999998 4899988753 48999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCc--------cccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc
Q 007256 413 KWASTSSSHI--------TCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK 483 (611)
Q Consensus 413 ~~~~~~~~~~--------~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~ 483 (611)
.......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 8765432111 1223578999999998764 678999999999999999999999998765433222211100
Q ss_pred cccc-cCcc--------ccccCcccC-CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 484 PILS-SGKV--------TQLLDPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 484 ~~~~-~g~l--------~~lld~~l~-~~~~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.... .... .+.+..... .... ......+..++..||+.||.+|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000 000000000 0000 0112345567778999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.03 Aligned_cols=260 Identities=23% Similarity=0.311 Sum_probs=184.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------C
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED------N 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~------~ 331 (611)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999986 47899999999753 34567888999999999999999999998654 5
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
..++||||+ +++|.+++... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 689999999 67999888642 48999999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccc---
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS--- 487 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~--- 487 (611)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+...+...+........
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 223679999999999986 6899999999999999999999999987665443332221110000
Q ss_pred -----cCccccccCcccC-CCCChH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 488 -----SGKVTQLLDPALG-NNYDYD-----QMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 488 -----~g~l~~lld~~l~-~~~~~~-----~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
......++..... ...... ....+..++..||+.||.+|||+.++++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000000 001111 11335566777999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=340.63 Aligned_cols=263 Identities=18% Similarity=0.305 Sum_probs=201.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----------CcceeEEeeEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFE 329 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-----------HpnIv~l~g~~~~ 329 (611)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++.......+.+.+|+.++++++ ||||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 46899999999999999999986 47899999999987777788999999999887 8999999999986
Q ss_pred cC----ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-cEEeeccCccceeeC-----
Q 007256 330 DN----NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLS----- 399 (611)
Q Consensus 330 ~~----~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~-gIiHrDIKp~NILLd----- 399 (611)
.+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+ + +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCC
Confidence 54 789999999 8899999976443 248899999999999999999999 7 999999999999994
Q ss_pred -CCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcch---
Q 007256 400 -DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ--- 475 (611)
Q Consensus 400 -~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~--- 475 (611)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 44589999999998765432 235799999999999999999999999999999999999999986542211
Q ss_pred -hh---HHHhhccc--------------ccc-CccccccC-------ccc--CCCCChHHHHHHHHHHHHhcccCCCCCC
Q 007256 476 -ES---LVMWAKPI--------------LSS-GKVTQLLD-------PAL--GNNYDYDQMERMVLASILCIRRDPRARP 527 (611)
Q Consensus 476 -~~---lv~~~~~~--------------~~~-g~l~~lld-------~~l--~~~~~~~~~~~l~~la~~CL~~dP~~RP 527 (611)
.. ++...... +.. +.+..+.. ..+ ...+.......+..++..||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 00 00000000 000 00000000 000 0123345566777888899999999999
Q ss_pred CHHHHHHH
Q 007256 528 QMSLVLKL 535 (611)
Q Consensus 528 tm~eVL~~ 535 (611)
|+.++++.
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=329.33 Aligned_cols=249 Identities=24% Similarity=0.364 Sum_probs=200.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|++++++++||||+++++++...+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 468999999999999999999975 7999999998643 245678999999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC---CceEEeecCcccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD---FEPQLSDFGLAKW 414 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~---~~vKL~DFGla~~ 414 (611)
||+++++|.+.+.... .+++..++.++.||+.||.|||+ ++|+||||||+||+++.+ +.+||+|||++..
T Consensus 101 e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 9999999999886543 48999999999999999999999 899999999999999754 4799999999986
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
....... ....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+.... ....
T Consensus 174 ~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~ 242 (287)
T 2wei_A 174 FQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK-------YAFD 242 (287)
T ss_dssp BCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------CCCC
T ss_pred ecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------CCCC
Confidence 6543221 23568999999999874 58999999999999999999999997654332221111110 0000
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
. +.. ..+ ...+..++..||+.||.+|||+.++++
T Consensus 243 ~-~~~-~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 L-PQW-RTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp S-GGG-TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-hhh-hhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 000 111 134556677799999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.77 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=193.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC-hhHHHHHHHHHHHHHhcCCcceeEEeeEEE-----------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS-EDVIKEFVLEIEIITTLHHKNIISLLGFCF----------- 328 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~-~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~----------- 328 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999976 5899999998754 456678999999999999999999999873
Q ss_pred ---ecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC-CCCce
Q 007256 329 ---EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEP 404 (611)
Q Consensus 329 ---~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd-~~~~v 404 (611)
+.+..++||||++ |+|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999998 5999998642 48899999999999999999999 8999999999999997 56799
Q ss_pred EEeecCccccccCCCCC-ccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh
Q 007256 405 QLSDFGLAKWASTSSSH-ITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA 482 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~ 482 (611)
||+|||++......... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999876532221 11223568999999998875 67899999999999999999999999876543332222211
Q ss_pred ccccccCcccccc-------CcccC-CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 483 KPILSSGKVTQLL-------DPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 483 ~~~~~~g~l~~ll-------d~~l~-~~~~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+........++. ..... .... ......+..++..||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111110000000 00000 0000 011234566777899999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=357.18 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=204.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC-cceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++..... ...+.+|+++++.++| +++..+..++...+..+|||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 47899999999999999999986 5799999999875332 2457889999999987 5666666777788889999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee---CCCCceEEeecCcccccc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL---SDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL---d~~~~vKL~DFGla~~~~ 416 (611)
+ +++|.+++..... .+++..++.|+.||+.||.|||+ ++|+||||||+|||| +.++.+||+|||+++...
T Consensus 85 ~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred C-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9 8899999975432 58999999999999999999999 899999999999999 588999999999998776
Q ss_pred CCCCCc-----cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 417 TSSSHI-----TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 417 ~~~~~~-----~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
...... ......||+.|+|||++.+..++.++||||||||||||++|+.||...........+...... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----KV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----HH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----cc
Confidence 543321 122468999999999999999999999999999999999999999876544332222211100 00
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
...+.. +...+ ...+..++..||+.+|.+||++.+|++.|+..
T Consensus 234 ~~~~~~-l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATSIEA-LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSCHHH-HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccHHH-HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111110 11111 13456677779999999999999999988653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.97 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=196.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce----
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL---- 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~---- 333 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||++... ....+.+.+|+.+++.++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 568999999999999999999865 7899999999753 34567889999999999999999999999877655
Q ss_pred --EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 334 --LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 334 --~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
++||||+. ++|.+.+.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 488887742 38899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 9865442 223578999999999987 6889999999999999999999999987654332221111000000000
Q ss_pred c--------ccccCcccC-CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 491 V--------TQLLDPALG-NNYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 491 l--------~~lld~~l~-~~~~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. ......... .... ......+..++..||+.||.+|||+.++++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000000000 0000 0112345667778999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=338.10 Aligned_cols=258 Identities=22% Similarity=0.314 Sum_probs=195.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-----
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~----- 332 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999875 7999999999753 3456788999999999999999999999987654
Q ss_pred -eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 333 -LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 333 -~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
.++||||+. ++|.+++.. .+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999998 488887742 38899999999999999999999 8999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc--
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS-- 488 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~-- 488 (611)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9765432 223578999999999986 67899999999999999999999999876543322211110000000
Q ss_pred ------C-------ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 489 ------G-------KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 489 ------g-------~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. .+.....+.+. .........+..++..||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00000000000 0111123455666777999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=336.89 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=172.4
Q ss_pred hhcCceeee-eEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceE
Q 007256 261 ATSNFLAEN-LIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLL 334 (611)
Q Consensus 261 ~t~~f~~~~-~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~ 334 (611)
..++|.+.+ +||+|+||+||+|.+. +|+.||||++........++ ...++.+.||||+++++++.. +...+
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 356888854 6999999999999976 79999999998654433332 234667789999999999976 44589
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC---CCceEEeecCc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 411 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---~~~vKL~DFGl 411 (611)
+||||+++|+|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999976542 358999999999999999999999 89999999999999976 45599999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
+....... .....||+.|+|||++....++.++|||||||++|+|++|+.||............. .....+..
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~ 250 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLGQY 250 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhcccc
Confidence 98665432 123578999999999998899999999999999999999999997654332111000 00000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. +...........+..++..||+.||.+|||+.++++.
T Consensus 251 -~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 251 -G-----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -C-----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -c-----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0000001112345566677999999999999999973
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.47 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=188.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+++..++||||+.
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 445667899999999998777778999999998753 345678999999986 89999999999999999999999996
Q ss_pred CCChhhhhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC-------------CceE
Q 007256 342 RGSLEENLHGNKKDPAA---FGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD-------------FEPQ 405 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~---l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~-------------~~vK 405 (611)
|+|.+++......... ..+..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 5999999765432211 1334567899999999999999 899999999999999654 4899
Q ss_pred EeecCccccccCCCCCc--cccccccccccCChhhhcc-------CCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcch
Q 007256 406 LSDFGLAKWASTSSSHI--TCTDVAGTFGYLAPEYFMY-------GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQ 475 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~ 475 (611)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 99999998776543221 1224679999999999975 678999999999999999999 999997544322
Q ss_pred hhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 476 ESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 476 ~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+... ...... +...........+..++..||+.||.+|||+.+|++.
T Consensus 248 ~~i~~~---~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 SNIIRG---IFSLDE--------MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHHT---CCCCCC--------CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhcC---CCCccc--------ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111111 100000 0111123344567778888999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=335.55 Aligned_cols=257 Identities=21% Similarity=0.346 Sum_probs=197.5
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
..++|.+.+.||+|+||.||+|...+ .+|+|+++.. ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35789999999999999999998754 4999998753 233456788999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++++|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ ++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999997543 358899999999999999999999 8999999999999998 67999999999876532
Q ss_pred CCC---CccccccccccccCChhhhcc---------CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 418 SSS---HITCTDVAGTFGYLAPEYFMY---------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 418 ~~~---~~~~~~~~GT~~Y~APE~l~~---------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...........+..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---- 257 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT---- 257 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT----
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc----
Confidence 211 111223569999999999874 4578899999999999999999999976543322111110
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~~ 541 (611)
+........ .++ ..+..++..||..||.+|||+.++++.|+....
T Consensus 258 ---~~~~~~~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 258 ---GMKPNLSQI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp ---TCCCCCCCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ---CCCCCCCcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 000111000 111 134556677999999999999999999986553
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=343.81 Aligned_cols=204 Identities=26% Similarity=0.422 Sum_probs=156.3
Q ss_pred cCcee-eeeEeecCcEEEEEEEeC---CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEEE
Q 007256 263 SNFLA-ENLIGKGGSSQVYKGCLP---DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLLV 336 (611)
Q Consensus 263 ~~f~~-~~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~LV 336 (611)
+.|.+ .++||+|+||+||+|... +++.||||++.... ....+.+|+.+|+.++||||++++++|.. +...++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 34665 458999999999999864 57899999997543 23468899999999999999999999965 6689999
Q ss_pred EeeCCCCChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee----CCCCceEEe
Q 007256 337 YDFLSRGSLEENLHGNK-----KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL----SDDFEPQLS 407 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~-----~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL----d~~~~vKL~ 407 (611)
|||+.+ +|.+++.... .....+++..++.++.||+.||.|||+ ++|+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 8887775221 122358999999999999999999999 899999999999999 677899999
Q ss_pred ecCccccccCCCCC-ccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCC
Q 007256 408 DFGLAKWASTSSSH-ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDH 471 (611)
Q Consensus 408 DFGla~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~ 471 (611)
|||+++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999876543221 222346899999999999874 58999999999999999999999997654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=364.06 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=202.6
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC----CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP----DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~----~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
..++|.+.+.||+|+||.||+|.+. .+..||||+++.. ....+.|.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 3467999999999999999999864 2567999998753 345678999999999999999999999984 56789
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 467 lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999997543 258999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 415 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||...........+......
T Consensus 541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-------- 611 (656)
T 2j0j_A 541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------- 611 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC--------
T ss_pred cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 6543322 2223467889999999999999999999999999999997 99999865543322222111100
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.+.... ...+..++..||+.||.+|||+.+|++.|+..
T Consensus 612 ----~~~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 ----PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ----CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 011111 13455667789999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=335.16 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=176.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHH-HHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIE-IITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~-iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ......+..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 368999999999999999999975 7899999999754 344456666666 777889999999999999999999999
Q ss_pred eeCCCCChhhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-cEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 338 DFLSRGSLEENLHGNK-KDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~-~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~-gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||+++ +|.+++.... .....+++..+..++.+++.||.|||+ . +|+||||||+|||++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 8877765211 112358999999999999999999999 7 9999999999999999999999999999866
Q ss_pred cCCCCCccccccccccccCChhhh----ccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYF----MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
...... ....||+.|+|||++ .+..++.++|||||||++|+|++|+.||........ ...... .+..
T Consensus 177 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~-~~~~ 247 (327)
T 3aln_A 177 VDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV-KGDP 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-CSCC
T ss_pred cccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh-cCCC
Confidence 543221 224799999999998 456789999999999999999999999975432111 000010 1111
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.. +...........+..++..||+.||.+||++.++++
T Consensus 248 ~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11 111111111234566677799999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=331.45 Aligned_cols=241 Identities=23% Similarity=0.365 Sum_probs=189.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChh-------HHHHHHHHHHHHHhc----CCcceeEEeeEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSED-------VIKEFVLEIEIITTL----HHKNIISLLGFCF 328 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~-------~~~~f~~Ei~iL~~l----~HpnIv~l~g~~~ 328 (611)
..++|.+.+.||+|+||.||+|.+ .+|+.||||++..... ....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 457899999999999999999986 4789999999975431 233466799999999 8999999999999
Q ss_pred ecCceEEEEee-CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC-CCCceEE
Q 007256 329 EDNNLLLVYDF-LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQL 406 (611)
Q Consensus 329 ~~~~~~LV~Ey-~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd-~~~~vKL 406 (611)
..+..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+||+++ .++.+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 99999999999 78999999997643 48999999999999999999999 8999999999999998 8899999
Q ss_pred eecCccccccCCCCCccccccccccccCChhhhccCCCC-CcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 407 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN-DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s-~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
+|||++....... .....||+.|+|||++.+..+. .++|||||||++|||++|+.||.... .... ...
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~-~~~- 250 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EILE-AEL- 250 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-TCC-
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHhh-hcc-
Confidence 9999998765432 2235799999999999877765 48999999999999999999996421 1111 000
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.... ...+..++..||+.||.+|||+.++++.
T Consensus 251 ------------~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 ------------HFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ------------CCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------------CCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111 1245566777999999999999999974
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=325.19 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=177.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hH-HHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DV-IKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~-~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++.... .. .+.+..+..+++.++||||+++++++..++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467999999999999999999975 79999999997542 22 233445556788889999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-cEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ-RVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~-gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
||+ ++.+..+..... ..+++..++.++.+++.||.|||+ + +|+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 556655554322 258899999999999999999998 6 89999999999999999999999999997665
Q ss_pred CCCCCccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
..... ....||+.|+|||++. ...++.++|||||||++|||++|+.||......... +...... .
T Consensus 177 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~-----~- 246 (318)
T 2dyl_A 177 DDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKVLQE-----E- 246 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHHHHS-----C-
T ss_pred CCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HHHHhcc-----C-
Confidence 43221 2357999999999994 567899999999999999999999999764332111 1110000 0
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+.+.... .....+..++..||+.||.+||++.++++
T Consensus 247 ----~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 ----PPLLPGHM--GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCCCSSS--CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCCccC--CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00111000 01124555667799999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=335.99 Aligned_cols=243 Identities=22% Similarity=0.364 Sum_probs=197.6
Q ss_pred HHhhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcC--CcceeEEeeEEE
Q 007256 259 LSATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFCF 328 (611)
Q Consensus 259 ~~~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-------~~~~~f~~Ei~iL~~l~--HpnIv~l~g~~~ 328 (611)
....++|.+.+.||+|+||.||+|.+ .+|+.||||+++... .....+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999986 478999999997532 12345778999999997 599999999999
Q ss_pred ecCceEEEEeeCCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC-CCCceEE
Q 007256 329 EDNNLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS-DDFEPQL 406 (611)
Q Consensus 329 ~~~~~~LV~Ey~~g-gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd-~~~~vKL 406 (611)
..+..++||||+.+ ++|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999986 89999987643 48899999999999999999999 8999999999999998 7889999
Q ss_pred eecCccccccCCCCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccc
Q 007256 407 SDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485 (611)
Q Consensus 407 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~ 485 (611)
+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .... .. .
T Consensus 192 ~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~-~~-~ 260 (320)
T 3a99_A 192 IDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EIIR-GQ-V 260 (320)
T ss_dssp CCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHHH-CC-C
T ss_pred eeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhhc-cc-c
Confidence 9999998765432 223579999999999987766 678999999999999999999996431 1110 00 0
Q ss_pred cccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 486 ~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+...++ ..+..++..||+.||.+|||+.+|++.
T Consensus 261 ------------~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 ------------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------------cccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111 245566777999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=341.10 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=186.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
..+|.+.+.||+|+||+||.....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.+....++||||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 456899999999999997665566899999999975322 2356899999999 7999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-----CCceEEeecCccccc
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKWA 415 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-----~~~vKL~DFGla~~~ 415 (611)
.+ +|.+++..... .+.+..++.++.||+.||.|||+ ++|+||||||+|||++. ...+||+|||+++..
T Consensus 101 ~g-~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 AA-TLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp SE-EHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 74 99999976543 34445667899999999999999 89999999999999953 336889999999876
Q ss_pred cCCCCC-ccccccccccccCChhhhc---cCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 416 STSSSH-ITCTDVAGTFGYLAPEYFM---YGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 416 ~~~~~~-~~~~~~~GT~~Y~APE~l~---~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
...... .......||+.|+|||++. ...++.++|||||||++|||++ |..||........... .. ...
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--~~-----~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--LG-----ACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--TT-----CCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--hc-----cCC
Confidence 543221 2223467999999999997 4577889999999999999999 9999965432221111 00 000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 491 l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
. .... ........+..++..||+.||.+|||+.+|+++
T Consensus 247 ~-~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 L-DCLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp C-TTSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c-cccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 0 0000 011223345567778999999999999999863
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=352.97 Aligned_cols=237 Identities=21% Similarity=0.301 Sum_probs=190.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC--CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc-----
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP--DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN----- 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~--~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~----- 332 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||++... ......+.+|+.++++++||||++++++|...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 6899999998653 3456678999999999999999999999988766
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.||||||++|++|.+++.. .+++..++.|+.||+.||.|||+ ++||||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999987753 48999999999999999999999 899999999999999986 9999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
+..... ....||++|+|||++.++. +.++|||||||++|+|++|..||....... +.
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~------ 285 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP------ 285 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CC------
T ss_pred hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------cc------
Confidence 876543 2357999999999998654 889999999999999999998886421110 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHhhC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-MSLVLKLLRG 538 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-m~eVL~~L~~ 538 (611)
...........+..++..||+.||.+||+ ++++.+.|.+
T Consensus 286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00000111234566777899999999996 5556555543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=308.22 Aligned_cols=230 Identities=16% Similarity=0.188 Sum_probs=181.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.+. +|+.||||++... ....+.+.+|+.++.+++||||+++++++..++..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999975 5899999999864 34557899999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||++|++|.+++... ....++..|+.|++.||.|||+ +||+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 9999999999999532 3455788899999999999999 899999999999999999999998543
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
|++ .++.++|||||||++|||++|+.||........... ...... +.... .
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~-~~~~~--~ 225 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTA-GQPIE--P 225 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTT-SCBCC--H
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhc-cCCCC--h
Confidence 333 368899999999999999999999987654321100 000000 00000 0
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCc
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDA 540 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~ 540 (611)
..+.... ...+..++..||+.||.+| |+.++++.|+...
T Consensus 226 ~~~~~~~----~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 226 ADIDRDI----PFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHCTTS----CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhcccCC----CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0011111 1335566777999999999 9999999997543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=349.94 Aligned_cols=259 Identities=23% Similarity=0.331 Sum_probs=197.8
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe------cCc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DNN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------~~~ 332 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.+.+|+++++.++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999874 6899999998753 4556789999999999999999999998765 677
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCc---eEEeec
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFE---PQLSDF 409 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~---vKL~DF 409 (611)
.++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+ .+|+||||||+|||++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999976432 2358899999999999999999999 89999999999999987665 999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
|++......... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..|........
T Consensus 169 G~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~ 240 (676)
T 3qa8_A 169 GYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKS 240 (676)
T ss_dssp CCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC---
T ss_pred cccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhccc
Confidence 999876554322 3367999999999999999999999999999999999999999754221 11211111100
Q ss_pred cccccc----------Cc--ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 007256 490 KVTQLL----------DP--ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 532 (611)
Q Consensus 490 ~l~~ll----------d~--~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eV 532 (611)
...... .. .............+..++..||..||.+|||+.++
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000 00 01122333445667778888999999999999764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=330.24 Aligned_cols=243 Identities=14% Similarity=0.189 Sum_probs=179.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCC-cce--------------
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH-KNI-------------- 320 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~H-pnI-------------- 320 (611)
.+.+|...+.||+|+||+||+|.+ .+|+.||||+++.. ....+.|.+|+.+++.++| +|.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345688899999999999999995 47999999999832 2335778999999999976 211
Q ss_pred -eE------EeeEEEe-----cCceEEEEeeCCCCChhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc
Q 007256 321 -IS------LLGFCFE-----DNNLLLVYDFLSRGSLEENLHGN---KKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385 (611)
Q Consensus 321 -v~------l~g~~~~-----~~~~~LV~Ey~~ggsL~~~L~~~---~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g 385 (611)
+. +..++.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||.|||+ ++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Confidence 11 1111111 22456777765 57999888421 1122357889999999999999999999 99
Q ss_pred EEeeccCccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhh----------ccCCCCCcceehhhhH
Q 007256 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF----------MYGKVNDKIDVYAFGV 455 (611)
Q Consensus 386 IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l----------~~~~~s~ksDVwSlGv 455 (611)
|+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999998865443 234578 999999999 5556888999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 456 VLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 456 vL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
++|||++|+.||........... . +... ..++ ..+..++..||+.||.+||++.++++
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~------~---------~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEW------I---------FRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGG------G---------GSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhhHHH------H---------Hhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999976543221111 0 0000 0111 34556667799999999999998875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.02 Aligned_cols=232 Identities=22% Similarity=0.370 Sum_probs=176.3
Q ss_pred hcCceee-eeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHH-HhcCCcceeEEeeEEEe----cCceE
Q 007256 262 TSNFLAE-NLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEII-TTLHHKNIISLLGFCFE----DNNLL 334 (611)
Q Consensus 262 t~~f~~~-~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL-~~l~HpnIv~l~g~~~~----~~~~~ 334 (611)
.++|.+. +.||+|+||.||+|.+ .+|+.||||+++.. ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3567776 7899999999999987 47899999999754 3566788887 56689999999999987 67799
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC---CCceEEeecCc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 411 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---~~~vKL~DFGl 411 (611)
+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999986542 358999999999999999999999 89999999999999998 78899999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
+..... ..++.++|||||||++|||++|+.||........... .......+..
T Consensus 167 a~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~ 219 (299)
T 3m2w_A 167 AKETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQY 219 (299)
T ss_dssp CEECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSSCTTCC
T ss_pred cccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHHhhccc
Confidence 864321 3567799999999999999999999976543221000 0000000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+..+. ... ....+..++..||+.||.+|||+.++++.
T Consensus 220 -~~~~~~-~~~----~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 220 -EFPNPE-WSE----VSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -SSCHHH-HTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -cCCchh-ccc----CCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 001 12345566777999999999999999873
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.52 Aligned_cols=190 Identities=21% Similarity=0.234 Sum_probs=160.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcC---------CcceeEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLH---------HKNIISL 323 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~---------~~~~~f~~Ei~iL~~l~---------HpnIv~l 323 (611)
.++|.+.+.||+|+||+||+|.+ +|+.||||+++... ...+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45788999999999999999988 78999999997532 23478899999999886 6666666
Q ss_pred eeEE-----------------Ee-------------cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHH
Q 007256 324 LGFC-----------------FE-------------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 373 (611)
Q Consensus 324 ~g~~-----------------~~-------------~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~ 373 (611)
++.+ .+ .+..++||||+++|++.+.+.. ..+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 6553 32 6789999999999987776643 24789999999999999
Q ss_pred HHHHHh-cCCCCcEEeeccCccceeeCCCC--------------------ceEEeecCccccccCCCCCccccccccccc
Q 007256 374 ALEYLH-SGSAQRVIHRDVKSSNILLSDDF--------------------EPQLSDFGLAKWASTSSSHITCTDVAGTFG 432 (611)
Q Consensus 374 gL~yLH-~~~~~gIiHrDIKp~NILLd~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~~GT~~ 432 (611)
||.||| + ++|+||||||+|||++.++ .+||+|||+|+..... ..+||+.
T Consensus 173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~ 242 (336)
T 2vuw_A 173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV 242 (336)
T ss_dssp HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence 999999 8 8999999999999999887 8999999999876542 2479999
Q ss_pred cCChhhhccCCCCCcceehhhhHH-HHHHHhCCCCCC
Q 007256 433 YLAPEYFMYGKVNDKIDVYAFGVV-LLELLTGRKPIS 468 (611)
Q Consensus 433 Y~APE~l~~~~~s~ksDVwSlGvv-L~ELltG~~Pf~ 468 (611)
|+|||++.+.. +.++||||||++ .+++++|..||.
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 99999998655 889999998777 788889999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-31 Score=295.71 Aligned_cols=185 Identities=17% Similarity=0.101 Sum_probs=131.8
Q ss_pred eEeecCcEEEEEEE-eCCCCEEEEEEecCC-----------hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEE
Q 007256 270 LIGKGGSSQVYKGC-LPDGKELAVKILKPS-----------EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 270 ~LG~G~fG~Vyk~~-~~~g~~vAVK~l~~~-----------~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV 336 (611)
..+.|++|.+..+. .-.|+.||||++... +...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777666554 236889999999643 23456799999999999 699999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||++|++|.++|.... .++.. +|+.||+.||+|||+ +|||||||||+||||+.+|.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999997654 35443 588999999999999 999999999999999999999999999998776
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf 467 (611)
..... ....+||++|+|||++.+ .+..++|+||+|+++++|.+|..++
T Consensus 391 ~~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 54332 234789999999999874 5778899999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=268.24 Aligned_cols=185 Identities=17% Similarity=0.212 Sum_probs=148.0
Q ss_pred eeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh---------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 266 LAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE---------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 266 ~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~---------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
...++||+|+||+||+|. ..++.+++|+..... ...+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 446789999999999994 467889999865321 1245689999999999999999777777788889999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||++|++|.+++.. +..++.|++.||.|||+ ++|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999975 34799999999999999 89999999999999998 99999999998775
Q ss_pred CCCCCc-----cccccccccccCChhhhcc--CCCCCcceehhhhHHHHHHHhCCCCCC
Q 007256 417 TSSSHI-----TCTDVAGTFGYLAPEYFMY--GKVNDKIDVYAFGVVLLELLTGRKPIS 468 (611)
Q Consensus 417 ~~~~~~-----~~~~~~GT~~Y~APE~l~~--~~~s~ksDVwSlGvvL~ELltG~~Pf~ 468 (611)
...... ......||+.|+|||++.. ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 532211 1134689999999999986 578889999999999999998887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.8e-24 Score=219.48 Aligned_cols=152 Identities=16% Similarity=0.124 Sum_probs=125.0
Q ss_pred HHHHHHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh-------------------hHHHHHHHHHHHHHhc
Q 007256 255 YQDLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTL 315 (611)
Q Consensus 255 ~~el~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~-------------------~~~~~f~~Ei~iL~~l 315 (611)
...+......|.+.+.||+|+||.||+|.+.+|+.||||+++... .....+.+|+.+++.+
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 445555667788889999999999999999789999999997432 1356789999999999
Q ss_pred CCcceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccc
Q 007256 316 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 395 (611)
Q Consensus 316 ~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~N 395 (611)
+ | +++.+++. .+..++||||++|++|.+ +.. .....++.|++.||.|||+ +||+||||||+|
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHH
Confidence 9 5 66677554 456799999999999998 421 1234699999999999999 999999999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhc
Q 007256 396 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440 (611)
Q Consensus 396 ILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 440 (611)
||++ ++.+||+|||+|+ .+..|.|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSV---------------EVGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence 9999 9999999999985 344578999885
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.2e-20 Score=185.94 Aligned_cols=137 Identities=19% Similarity=0.180 Sum_probs=108.3
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCE--EEEEEecCChhH-------------------------HHHHHHHHHHHHh
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKE--LAVKILKPSEDV-------------------------IKEFVLEIEIITT 314 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~--vAVK~l~~~~~~-------------------------~~~f~~Ei~iL~~ 314 (611)
.-|.+.+.||+|+||.||+|.+ .+|+. ||||+++..... ...+.+|+.+|..
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3467889999999999999998 68999 999997653211 1367889999999
Q ss_pred cCCcce--eEEeeEEEecCceEEEEeeCCC-C----ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCcE
Q 007256 315 LHHKNI--ISLLGFCFEDNNLLLVYDFLSR-G----SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH-SGSAQRV 386 (611)
Q Consensus 315 l~HpnI--v~l~g~~~~~~~~~LV~Ey~~g-g----sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH-~~~~~gI 386 (611)
++|+++ ..++++ +..+|||||+.+ | +|.+.... .++..+..++.|++.||.||| + .+|
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~gi 192 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AEL 192 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCE
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCE
Confidence 998764 333332 367899999942 4 66665432 224566789999999999999 8 899
Q ss_pred EeeccCccceeeCCCCceEEeecCccccc
Q 007256 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 387 iHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=3.4e-17 Score=175.43 Aligned_cols=138 Identities=14% Similarity=0.149 Sum_probs=101.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChh---------------HHH--------HHHHHHHHHHhcCCc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSED---------------VIK--------EFVLEIEIITTLHHK 318 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~---------------~~~--------~f~~Ei~iL~~l~Hp 318 (611)
..-|.+.+.||.|+||.||+|...+|+.||||+++.... ... ...+|...|.++.+.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 344999999999999999999999999999999864210 011 123466677777554
Q ss_pred ceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 319 nIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
++.-..-+.. ...+|||||++|++|.++... .....++.||+.+|.|||+ .|||||||||.|||+
T Consensus 174 gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 174 GFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILI 238 (397)
T ss_dssp TCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEE
T ss_pred CCCCCeeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEE
Confidence 4322211111 234799999999988765431 1235678999999999999 899999999999999
Q ss_pred CCCC----------ceEEeecCcccc
Q 007256 399 SDDF----------EPQLSDFGLAKW 414 (611)
Q Consensus 399 d~~~----------~vKL~DFGla~~ 414 (611)
++++ .+.|+||+-+..
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred eCCCCcccccccccceEEEEeCCccc
Confidence 8776 389999997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=5.3e-12 Score=126.61 Aligned_cols=143 Identities=17% Similarity=0.115 Sum_probs=112.8
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEe
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~E 338 (611)
...+|.+...++.|+++.||++... |..+++|+..... .....+.+|+++++.+. +..+.++++++...+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3457888889999999999998754 6899999987421 22345888999999985 6778899999988889999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS------------------------------------ 382 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~------------------------------------ 382 (611)
|++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876421 1123467889999999999811
Q ss_pred --------------------CCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 383 --------------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 383 --------------------~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.28 E-value=5.9e-12 Score=124.97 Aligned_cols=136 Identities=16% Similarity=0.088 Sum_probs=101.3
Q ss_pred CceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc--eeEEeeEEEecCceEEEEeeCC
Q 007256 264 NFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGFCFEDNNLLLVYDFLS 341 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~l~g~~~~~~~~~LV~Ey~~ 341 (611)
+|.+..+.+.|..+.||++...+|..+++|+.... ....+.+|+.+++.+.+.+ +.++++++..++..++||||++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 45544444456669999998777888999998754 2345778999999986544 5568888887778999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 382 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~--------------------------------------- 382 (611)
|.+|. ... .. ...++.++++.|..||+..
T Consensus 99 G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 99 GQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 98884 211 11 1256777888888888632
Q ss_pred ----------------CCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 383 ----------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 383 ----------------~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
...++|+|++|.|||++++..+.|+|||.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.10 E-value=4.1e-10 Score=118.46 Aligned_cols=142 Identities=14% Similarity=0.254 Sum_probs=107.6
Q ss_pred eeeeeEeecCcEEEEEEEeCCCCEEEEEEec--CCh--hHHHHHHHHHHHHHhcC--CcceeEEeeEEEec---CceEEE
Q 007256 266 LAENLIGKGGSSQVYKGCLPDGKELAVKILK--PSE--DVIKEFVLEIEIITTLH--HKNIISLLGFCFED---NNLLLV 336 (611)
Q Consensus 266 ~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~--~~~--~~~~~f~~Ei~iL~~l~--HpnIv~l~g~~~~~---~~~~LV 336 (611)
...+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|+.+++.+. +..+.+++.++.+. +..++|
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 346788999999999987654 678899876 432 22456788999999997 45688889888766 348999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS---------------------------------- 382 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~---------------------------------- 382 (611)
|||++|..+.+... ..++...+..++.++++.|..||+..
T Consensus 120 me~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 99999987754221 13677888899999999999999721
Q ss_pred ---------------------CCcEEeeccCccceeeCCCCc--eEEeecCcccc
Q 007256 383 ---------------------AQRVIHRDVKSSNILLSDDFE--PQLSDFGLAKW 414 (611)
Q Consensus 383 ---------------------~~gIiHrDIKp~NILLd~~~~--vKL~DFGla~~ 414 (611)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999987753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=2.6e-10 Score=117.29 Aligned_cols=186 Identities=17% Similarity=0.187 Sum_probs=123.2
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-Ccc--eeEEeeEEEecC---ceEEEEeeCC
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKN--IISLLGFCFEDN---NLLLVYDFLS 341 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-Hpn--Iv~l~g~~~~~~---~~~LV~Ey~~ 341 (611)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+++.+....+ ..|+||++++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999852 56899987633 45567889999998884 322 344444443333 3588999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--------------------------------------- 382 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~--------------------------------------- 382 (611)
|.+|.+.... .++..++..++.+++..|..||+..
T Consensus 100 G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9888754321 2566777788888888888888511
Q ss_pred ----------------CCcEEeeccCccceeeCC--CCceEEeecCccccccCCCCCccc-------------ccccccc
Q 007256 383 ----------------AQRVIHRDVKSSNILLSD--DFEPQLSDFGLAKWASTSSSHITC-------------TDVAGTF 431 (611)
Q Consensus 383 ----------------~~gIiHrDIKp~NILLd~--~~~vKL~DFGla~~~~~~~~~~~~-------------~~~~GT~ 431 (611)
...++|+|++|.||++++ +..+.|+||+.+....... .... ..+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHHc
Confidence 135899999999999988 4567899999986543210 0000 0000111
Q ss_pred ccCC-hhhhccCCCCCcceehhhhHHHHHHHhCCCCC
Q 007256 432 GYLA-PEYFMYGKVNDKIDVYAFGVVLLELLTGRKPI 467 (611)
Q Consensus 432 ~Y~A-PE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf 467 (611)
++.. |+.... .....+.|++|.+++.+.+|..+|
T Consensus 253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1222 332221 112368999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=7.6e-07 Score=91.83 Aligned_cols=137 Identities=20% Similarity=0.202 Sum_probs=95.7
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc---ceeEEeeEEE-ecCceEEEEeeCCCC
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK---NIISLLGFCF-EDNNLLLVYDFLSRG 343 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hp---nIv~l~g~~~-~~~~~~LV~Ey~~gg 343 (611)
.+.++.|....||+. |..+++|+.. .......+.+|.++|+.+.+. .+.+++.++. ..+..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456899999999987 5678999854 334567889999999999752 3556666664 345678999999998
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG------------------------------------------ 381 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~------------------------------------------ 381 (611)
+|.+..-. .++...+..++.++++.|..||+.
T Consensus 99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88763211 123344444555555555555531
Q ss_pred ---------------CCCcEEeeccCccceeeCC---CCc-eEEeecCccccc
Q 007256 382 ---------------SAQRVIHRDVKSSNILLSD---DFE-PQLSDFGLAKWA 415 (611)
Q Consensus 382 ---------------~~~gIiHrDIKp~NILLd~---~~~-vKL~DFGla~~~ 415 (611)
....++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2246799999999999987 455 489999987543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=2.7e-06 Score=85.13 Aligned_cols=134 Identities=19% Similarity=0.123 Sum_probs=96.1
Q ss_pred eEeecCcE-EEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceEEEEeeCCCCChh
Q 007256 270 LIGKGGSS-QVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 270 ~LG~G~fG-~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
.+..|..| .||+.... ++..+++|+-... ....+.+|..+|+.+. +--+.++++++.+++..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 34555554 68987764 5678999987643 3456788999998885 334677888998889999999999998887
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q 007256 347 ENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-------------------------------------------- 382 (611)
Q Consensus 347 ~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~-------------------------------------------- 382 (611)
+..... ......+..+++..|.-||...
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 655321 1222345556666666666411
Q ss_pred -----------CCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 383 -----------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 383 -----------~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987777799999774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=1.6e-06 Score=90.54 Aligned_cols=81 Identities=12% Similarity=0.103 Sum_probs=57.9
Q ss_pred eeeeE-eecCcEEEEEEEeC-------CCCEEEEEEecCChh----HHHHHHHHHHHHHhcCC---cceeEEeeEEEec-
Q 007256 267 AENLI-GKGGSSQVYKGCLP-------DGKELAVKILKPSED----VIKEFVLEIEIITTLHH---KNIISLLGFCFED- 330 (611)
Q Consensus 267 ~~~~L-G~G~fG~Vyk~~~~-------~g~~vAVK~l~~~~~----~~~~f~~Ei~iL~~l~H---pnIv~l~g~~~~~- 330 (611)
..+.| +.|..+.+|+.... ++..+++|+...... ....+.+|+.+++.+.. -.+.+++.++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 34677 88989999998654 267899998764331 12457788988888853 3567788877655
Q ss_pred --CceEEEEeeCCCCChhh
Q 007256 331 --NNLLLVYDFLSRGSLEE 347 (611)
Q Consensus 331 --~~~~LV~Ey~~ggsL~~ 347 (611)
+..++||||++|..+.+
T Consensus 104 ~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TTSSCEEEEECCCCBCCCB
T ss_pred ccCCceEEEEecCCCChhh
Confidence 35689999999977654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=5.9e-06 Score=87.83 Aligned_cols=75 Identities=16% Similarity=0.122 Sum_probs=51.2
Q ss_pred eeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChh--------HHHHHHHHHHHHHhcCC--c-ceeEEeeEEEecCceE
Q 007256 267 AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSED--------VIKEFVLEIEIITTLHH--K-NIISLLGFCFEDNNLL 334 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~--------~~~~f~~Ei~iL~~l~H--p-nIv~l~g~~~~~~~~~ 334 (611)
..+.||.|.++.||++... +++.++||...+... ....+..|.++|+.+.. + .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3568999999999999764 578899998754211 23456789999988742 3 34455543 455678
Q ss_pred EEEeeCCCC
Q 007256 335 LVYDFLSRG 343 (611)
Q Consensus 335 LV~Ey~~gg 343 (611)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.21 E-value=6.1e-06 Score=84.88 Aligned_cols=142 Identities=19% Similarity=0.283 Sum_probs=81.4
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--cceeEEee------EEEecCceEEEEee
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLG------FCFEDNNLLLVYDF 339 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H--pnIv~l~g------~~~~~~~~~LV~Ey 339 (611)
.+.|+.|..+.||+....+| .+++|+..... ..+..|+.++..+.. -.+.+++. +...++..++||+|
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34566677899999877555 49999998643 233345555555431 12333332 12345678999999
Q ss_pred CCCCChh--------------hhhccCCC-C--C-------CCCCHHHHH------------------------------
Q 007256 340 LSRGSLE--------------ENLHGNKK-D--P-------AAFGWSERY------------------------------ 365 (611)
Q Consensus 340 ~~ggsL~--------------~~L~~~~~-~--~-------~~l~~~~~~------------------------------ 365 (611)
++|..+. ..+|.... . + ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987542 11221100 0 0 012332211
Q ss_pred -HHHHHHHHHHHHHhc----------CCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 366 -KVAMGVAEALEYLHS----------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 366 -~I~~qIa~gL~yLH~----------~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123345666653 123789999999999999888899999998763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=9.9e-05 Score=76.55 Aligned_cols=140 Identities=15% Similarity=0.195 Sum_probs=94.3
Q ss_pred eeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcC---CcceeEEeeEEEecCceEEEEeeCCCC
Q 007256 267 AENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLH---HKNIISLLGFCFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~---HpnIv~l~g~~~~~~~~~LV~Ey~~gg 343 (611)
..+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.|. ...+.+++.++...+..++||||++|.
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 456799999999999876 5778999987643 3567888999998885 356888888888778899999999998
Q ss_pred Chhh-----------hhccCCC-CC-----------------CCCCHHHHHH---HH----------------HHHHHH-
Q 007256 344 SLEE-----------NLHGNKK-DP-----------------AAFGWSERYK---VA----------------MGVAEA- 374 (611)
Q Consensus 344 sL~~-----------~L~~~~~-~~-----------------~~l~~~~~~~---I~----------------~qIa~g- 374 (611)
.+.. .||.... .. -.-+|...+. +. ..++..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 2333221 00 0124554321 11 111111
Q ss_pred HHHHhc-CCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 375 LEYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 375 L~yLH~-~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
...|.. .....++|+|+.+.||+++.++ +.|+||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223421 1236799999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00014 Score=78.08 Aligned_cols=76 Identities=16% Similarity=0.193 Sum_probs=46.0
Q ss_pred CcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcccccccc--ccccCChhhhccCC---CCCcceehhhhHHHH
Q 007256 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAG--TFGYLAPEYFMYGK---VNDKIDVYAFGVVLL 458 (611)
Q Consensus 384 ~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~G--T~~Y~APE~l~~~~---~s~ksDVwSlGvvL~ 458 (611)
..++|+|++|.|||++.++ +.|+||+.+.+...... .. ...+ ...|++|+...... -....++..+...++
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D-la--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD-IG--AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH-HH--HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH-HH--HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 7899999999999998876 99999998865432100 00 0011 13456665543111 111244556777777
Q ss_pred HHHhC
Q 007256 459 ELLTG 463 (611)
Q Consensus 459 ELltG 463 (611)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.66 E-value=7e-05 Score=76.44 Aligned_cols=139 Identities=14% Similarity=0.125 Sum_probs=77.3
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEeeC-CCCCh
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFL-SRGSL 345 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~LV~Ey~-~ggsL 345 (611)
.+.|+.|....+|+. ..+++|+............+|+.+++.+...++ .+++++ ..+.-++|+||+ +|.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 678999999999998 568999887532222223468888877753333 344443 344467899999 66544
Q ss_pred hh------------------hhccCCC-CCCCCC-HHHHHHHHH--------------HHHHHH----HHHhc-CCCCcE
Q 007256 346 EE------------------NLHGNKK-DPAAFG-WSERYKVAM--------------GVAEAL----EYLHS-GSAQRV 386 (611)
Q Consensus 346 ~~------------------~L~~~~~-~~~~l~-~~~~~~I~~--------------qIa~gL----~yLH~-~~~~gI 386 (611)
.. .+|.... ....+. +.....+.. .+...+ ..|.. .....+
T Consensus 96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l 175 (301)
T 3dxq_A 96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA 175 (301)
T ss_dssp CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence 31 1121111 000011 111111110 011111 11211 223568
Q ss_pred EeeccCccceeeCCCCceEEeecCcccc
Q 007256 387 IHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 387 iHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+|+|+.+.||+ ..++.+.|+||..+..
T Consensus 176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 176 CHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp ECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eccCCCcCCEE-ECCCCEEEEecccccC
Confidence 99999999999 5566789999987753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00034 Score=70.82 Aligned_cols=79 Identities=19% Similarity=0.180 Sum_probs=58.1
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCC---cceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLHH---KNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~H---pnIv~l~g~~~~~~~~~LV~E 338 (611)
........+|.|..+.||+....||+.|++|+..... .....|..|+..|+.|.. -.+.+++++. .-++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 4566778899999999999999999999999876432 223457789999998852 1244444432 3478999
Q ss_pred eCCCCCh
Q 007256 339 FLSRGSL 345 (611)
Q Consensus 339 y~~ggsL 345 (611)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00034 Score=71.56 Aligned_cols=144 Identities=17% Similarity=0.171 Sum_probs=80.9
Q ss_pred eeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc--eeEEeeE------EEecCceEEEEee
Q 007256 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN--IISLLGF------CFEDNNLLLVYDF 339 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hpn--Iv~l~g~------~~~~~~~~LV~Ey 339 (611)
.+.|+.|....+|+....+| .+++|+.... .....+..|+.++..+...+ +.+++.. ....+..+++|+|
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 45677888899999887666 6889998752 12234556777777664222 2333321 1234567899999
Q ss_pred CCCCChhh--------------hhccCC---CCC--CC---CCHHHHHH------------HHHHHHHHHHHHhc----C
Q 007256 340 LSRGSLEE--------------NLHGNK---KDP--AA---FGWSERYK------------VAMGVAEALEYLHS----G 381 (611)
Q Consensus 340 ~~ggsL~~--------------~L~~~~---~~~--~~---l~~~~~~~------------I~~qIa~gL~yLH~----~ 381 (611)
++|..+.. .+|... ..+ .. ..|...+. +...+...+.+|+. .
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865421 122110 000 00 12322111 00113444555553 1
Q ss_pred CCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 382 ~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
...+++|+|+.+.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23579999999999999887556899998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00016 Score=78.20 Aligned_cols=74 Identities=16% Similarity=0.218 Sum_probs=51.7
Q ss_pred eeeeEeecCcEEEEEEEeCC--------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEE
Q 007256 267 AENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~LV~ 337 (611)
..+.|+.|....||+....+ +..+++|+.... .....+..|..+++.+...++ .++++.+.. .+||
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 45678889999999998653 578999998542 112455679999888864333 566665532 3899
Q ss_pred eeCCCCCh
Q 007256 338 DFLSRGSL 345 (611)
Q Consensus 338 Ey~~ggsL 345 (611)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00062 Score=69.84 Aligned_cols=142 Identities=18% Similarity=0.239 Sum_probs=83.4
Q ss_pred eeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc--ceeEEeeE-----EEecCceEEEEeeCC
Q 007256 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK--NIISLLGF-----CFEDNNLLLVYDFLS 341 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hp--nIv~l~g~-----~~~~~~~~LV~Ey~~ 341 (611)
..|+ |....||+....+|+.+++|+..+.......+..|..++..+... .+.+++.. ...++..++||+|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 4566 888999998777788899999975433345667788888877522 23444432 222455688999999
Q ss_pred CCChhh--------------hhccC----CC-CCCCCCHHHH----HHHH---------------HHHHHHHHHHhc---
Q 007256 342 RGSLEE--------------NLHGN----KK-DPAAFGWSER----YKVA---------------MGVAEALEYLHS--- 380 (611)
Q Consensus 342 ggsL~~--------------~L~~~----~~-~~~~l~~~~~----~~I~---------------~qIa~gL~yLH~--- 380 (611)
|..+.. .+|.. .. ....+++... ..++ ..+...+..+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 864321 01110 00 0111222211 0010 011112223221
Q ss_pred -CCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 381 -GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 381 -~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
.....++|+|+++.|||++ + .+.|+||+.+.
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 1236789999999999999 4 89999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00067 Score=69.99 Aligned_cols=143 Identities=15% Similarity=0.124 Sum_probs=74.4
Q ss_pred eeEeecCcEE-EEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--cceeEEeeEEEecCceEEEEeeCCCCCh
Q 007256 269 NLIGKGGSSQ-VYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSL 345 (611)
Q Consensus 269 ~~LG~G~fG~-Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~~~~~~LV~Ey~~ggsL 345 (611)
+.|+.|+... +|+....+|..+++|....... ..+..|+.++..+.. -.+.+++.+.... -+++||++.+..+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 4566665554 6676654577888887654321 233456666666642 2345566653322 3789999987766
Q ss_pred hhhhccCC---------------------CCC-CCCCHHHHH-------H-H------------HHHHHHHHHHHh---c
Q 007256 346 EENLHGNK---------------------KDP-AAFGWSERY-------K-V------------AMGVAEALEYLH---S 380 (611)
Q Consensus 346 ~~~L~~~~---------------------~~~-~~l~~~~~~-------~-I------------~~qIa~gL~yLH---~ 380 (611)
.+.+.... ... ..+...... . + ...+...+..|. .
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 54432210 000 012111100 0 0 001112222221 1
Q ss_pred CCCCcEEeeccCccceeeCCC----CceEEeecCccccc
Q 007256 381 GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAKWA 415 (611)
Q Consensus 381 ~~~~gIiHrDIKp~NILLd~~----~~vKL~DFGla~~~ 415 (611)
.....++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 223689999999999999874 67899999987543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00021 Score=75.01 Aligned_cols=74 Identities=18% Similarity=0.183 Sum_probs=46.6
Q ss_pred eeeEeecCcEEEEEEEeCC---------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc-eeEEeeEEEecCceEEEE
Q 007256 268 ENLIGKGGSSQVYKGCLPD---------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~---------g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~~~LV~ 337 (611)
...|+.|....+|+....+ +..+++|+.............|..+++.+...+ +.++++.+ . -++||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4567888889999987654 278999998654332223457888888876333 34566543 2 37899
Q ss_pred eeCCCCCh
Q 007256 338 DFLSRGSL 345 (611)
Q Consensus 338 Ey~~ggsL 345 (611)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998644
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00035 Score=76.26 Aligned_cols=75 Identities=21% Similarity=0.179 Sum_probs=49.5
Q ss_pred eeeeEeecCcEEEEEEEeCC-CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEEeeCCCCC
Q 007256 267 AENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVYDFLSRGS 344 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~-g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~LV~Ey~~ggs 344 (611)
..+.|+.|-...+|+....+ +..+++|+........-...+|..++..|...++ .++++++. + .+||||++|.+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 45678889999999988765 5789999885432111112578999998875444 46666662 2 35999999855
Q ss_pred h
Q 007256 345 L 345 (611)
Q Consensus 345 L 345 (611)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0007 Score=72.07 Aligned_cols=142 Identities=19% Similarity=0.253 Sum_probs=84.0
Q ss_pred eeeEeecCcEEEEEEEeC--------CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc-eeEEeeEEEecCceEEEEe
Q 007256 268 ENLIGKGGSSQVYKGCLP--------DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~~~LV~E 338 (611)
.+.|..|-...+|+.... +++.+++|+..........+.+|..+++.+..-+ ..++++++.. .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 356777888999998764 3578999997543233456678999998886322 3556666543 39999
Q ss_pred eCCCCChhhh-----------------hccCCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHHH-
Q 007256 339 FLSRGSLEEN-----------------LHGNKK-DPAAF--GWSERYKVAMGVAE-------------------ALEYL- 378 (611)
Q Consensus 339 y~~ggsL~~~-----------------L~~~~~-~~~~l--~~~~~~~I~~qIa~-------------------gL~yL- 378 (611)
|++|.+|..- ||.... ..... -|.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 122111 01112 24455555443321 22333
Q ss_pred ---hc-CCCCcEEeeccCccceeeCCC----CceEEeecCccc
Q 007256 379 ---HS-GSAQRVIHRDVKSSNILLSDD----FEPQLSDFGLAK 413 (611)
Q Consensus 379 ---H~-~~~~gIiHrDIKp~NILLd~~----~~vKL~DFGla~ 413 (611)
.. .....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 223579999999999999876 689999998763
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0016 Score=67.86 Aligned_cols=67 Identities=18% Similarity=0.197 Sum_probs=44.3
Q ss_pred ecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC---cceeEEeeE------EEecCceEEEEeeCCCC
Q 007256 273 KGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH---KNIISLLGF------CFEDNNLLLVYDFLSRG 343 (611)
Q Consensus 273 ~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H---pnIv~l~g~------~~~~~~~~LV~Ey~~gg 343 (611)
.|....||+....+| .+++|+...... ..|+.++..|.. |++.+++.. ...++..++||+|++|.
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 333689999987777 899998876442 356666665532 224444432 23356789999999987
Q ss_pred Ch
Q 007256 344 SL 345 (611)
Q Consensus 344 sL 345 (611)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 65
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.026 Score=60.81 Aligned_cols=142 Identities=14% Similarity=0.181 Sum_probs=85.1
Q ss_pred eeeeEeecCcEEEEEEEeCC--------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcc-eeEEeeEEEecCceEEEE
Q 007256 267 AENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKN-IISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hpn-Iv~l~g~~~~~~~~~LV~ 337 (611)
..+.|..|-...+|+....+ +..|++|+........-...+|..+++.+..-+ ..++++.+ . -++||
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 34677888889999988653 688999997653322223357888888875322 34455433 2 37899
Q ss_pred eeCCCCChhhh-----------------hccC-------CC--CCCCCCHHHHHHHHHHH-------------------H
Q 007256 338 DFLSRGSLEEN-----------------LHGN-------KK--DPAAFGWSERYKVAMGV-------------------A 372 (611)
Q Consensus 338 Ey~~ggsL~~~-----------------L~~~-------~~--~~~~l~~~~~~~I~~qI-------------------a 372 (611)
||++|..|..- +|.. .. ...+..|..+.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99999764210 1110 00 11122344444333222 1
Q ss_pred HHHHHHhc---------------------CCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 373 EALEYLHS---------------------GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 373 ~gL~yLH~---------------------~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
..+.+|.. .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 22333321 12356899999999999 778899999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.35 E-value=0.081 Score=51.86 Aligned_cols=101 Identities=18% Similarity=0.127 Sum_probs=65.3
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCcc
Q 007256 344 SLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT 423 (611)
Q Consensus 344 sL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 423 (611)
+|.++|..... +++++++|.++.|.+.+|.-+-... .+ ..+=+-|..|+|..+|.+-+.+ +.+.
T Consensus 34 SL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 78999976654 7999999999999999887762100 11 1233456899999999887764 1110
Q ss_pred ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCC
Q 007256 424 CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK 465 (611)
Q Consensus 424 ~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~ 465 (611)
.....+.|||... ...+.+.=|||||+++|.-+-=..
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123466888764 345678899999999999886333
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.16 E-value=0.16 Score=53.78 Aligned_cols=29 Identities=34% Similarity=0.471 Sum_probs=24.3
Q ss_pred cEEeeccCccceee------CCCCceEEeecCccc
Q 007256 385 RVIHRDVKSSNILL------SDDFEPQLSDFGLAK 413 (611)
Q Consensus 385 gIiHrDIKp~NILL------d~~~~vKL~DFGla~ 413 (611)
.++|+|+.+.|||+ +++..+.++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 46799999999999 456679999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.82 E-value=3.2 Score=40.42 Aligned_cols=115 Identities=12% Similarity=0.093 Sum_probs=76.9
Q ss_pred CCcceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCcEEeeccCcc
Q 007256 316 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE-YLHSGSAQRVIHRDVKSS 394 (611)
Q Consensus 316 ~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~-yLH~~~~~gIiHrDIKp~ 394 (611)
.||++ -...-.+++.+.+.|+.-+++.=+..+. .++..++++++..|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 3444466777888887665543333443 3677899999999887666 5554 688899999
Q ss_pred ceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCC
Q 007256 395 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 468 (611)
Q Consensus 395 NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~ 468 (611)
||+++.++.++|.=.|+-..+.. .=+.+|-+ .-.+=+++..++.++..|.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~lpP--------------~e~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESLPP--------------DEWDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTBSS--------------CSCCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccCCC--------------CCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999999987775322111 11222222 1246688888888888774
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.05 E-value=2.3 Score=41.29 Aligned_cols=116 Identities=11% Similarity=0.177 Sum_probs=77.9
Q ss_pred CCcceeEEeeEEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccc
Q 007256 316 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSN 395 (611)
Q Consensus 316 ~HpnIv~l~g~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~N 395 (611)
.||+++.. ..-.+++.+.+.|+.-+.+.=+..+. .++...+++++..|+....+++. -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57888866 45556666777776554332222233 36778999999999988766664 4888999999
Q ss_pred eeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCC
Q 007256 396 ILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPIS 468 (611)
Q Consensus 396 ILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~ 468 (611)
|+++.++.+++.=.|+-..+... =+.+|-+ .-.+=+++..+++|+..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P~--------------~~~ee~f----------L~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDPL--------------PVSEAEF----------LTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSCC--------------CCCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCCCC--------------CCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999999877753222110 0122221 2246788899999988874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 611 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-54 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-47 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 3e-65
Identities = 74/281 (26%), Positives = 128/281 (45%), Gaps = 26/281 (9%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILK---PSEDVIKEFVLEIEIITTLHHKN 319
IG G VYKG ++AVK+L P+ ++ F E+ ++ H N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
I+ +G+ L +V + SL +LH + F + +A A+ ++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH 121
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
+ + +IHRD+KS+NI L +D ++ DFGLA S S ++G+ ++APE
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 440 MY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496
+ + DVYAFG+VL EL+TG+ P SN + + Q ++ +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-------L 231
Query: 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ +N M+R++ C+++ RP +L +
Sbjct: 232 SKVRSNCP-KAMKRLMAE---CLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-61
Identities = 56/274 (20%), Positives = 114/274 (41%), Gaps = 22/274 (8%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 322
+G G +V+ G ++AVK LK F+ E ++ L H+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
L + ++ +++ GSL + L ++ +A +AE + ++
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEE-- 127
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
+ IHRD++++NIL+SD +++DFGLA+ + + APE YG
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYG 185
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502
K DV++FG++L E++T + + V+ + + +N
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQ--------NLERGYRMVRPDN 234
Query: 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
+++ +++ LC + P RP + +L
Sbjct: 235 CP-EELYQLMR---LCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-61
Identities = 66/279 (23%), Positives = 119/279 (42%), Gaps = 22/279 (7%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 322
S IG G V+ G + ++A+K ++ ++F+ E E++ L H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
L G C E + LV++F+ G L + L F + + V E + YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
VIHRD+ + N L+ ++ ++SDFG+ ++ + + +PE F +
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFS 177
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502
+ + K DV++FGV++ E+ + K P S + I + + L P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI-----PYENRSNSEVVEDISTGFR---LYKPRLAST 229
Query: 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541
+ Y M C + P RP S +L+ L A+
Sbjct: 230 HVYQIMNH-------CWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 8e-61
Identities = 59/304 (19%), Positives = 119/304 (39%), Gaps = 40/304 (13%)
Query: 261 ATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHH 317
+F + +G G V+K P G +A K++ + + + E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
I+ G + D + + + + GSL++ L + KV++ V + L Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
L +++HRDVK SNIL++ E +L DFG++ S + GT Y++PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPI-SNDHPKGQESLVMWAKPILSSGKVTQLLD 496
+ + D+++ G+ L+E+ GR PI D + + + +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 497 PALGNNYDYDQMERMVLASIL--------------------------CIRRDPRARPQMS 530
++Y D M + +L C+ ++P R +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293
Query: 531 LVLK 534
++
Sbjct: 294 QLMV 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 8e-60
Identities = 72/292 (24%), Positives = 115/292 (39%), Gaps = 28/292 (9%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFC 327
+ IGKG +V++G G+E+AVKI E+ EI L H+NI+ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 328 FEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS--- 380
+DN L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHMEIV 121
Query: 381 --GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW--ASTSSSHITCTDVAGTFGYLAP 436
+ HRD+KS NIL+ + ++D GLA ++T + I GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 437 EYF------MYGKVNDKIDVYAFGVVLLELLTGRKPISND----HPKGQESLVMWAKPIL 486
E + + + D+YA G+V E+ P + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 487 SSGKVTQLLDPALGNNYDYDQMERMVLASIL-CIRRDPRARPQMSLVLKLLR 537
Q L P + N + + R++ + C + AR + K L
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-58
Identities = 69/277 (24%), Positives = 114/277 (41%), Gaps = 33/277 (11%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 317
+F +GKG VY LA+K+L + V + E+EI + L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
NI+ L G+ + + L+ ++ G++ L K F +A AL Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSY 121
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
HS +RVIHRD+K N+LL E +++DFG + A +S C GT YL PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPE 174
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497
++K+D+++ GV+ E L G+ P + + + + +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD-----FVTE 229
Query: 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
D + R ++ +P RP + VL+
Sbjct: 230 GA-----RDLISR-------LLKHNPSQRPMLREVLE 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-58
Identities = 60/276 (21%), Positives = 114/276 (41%), Gaps = 24/276 (8%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 322
+ +G G V G ++A+K++K EF+ E +++ L H+ ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
L G C + + ++ ++++ G L L + F + ++ V EA+EYL S
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
++ +HRD+ + N L++D ++SDFGL+++ + + PE MY
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS 176
Query: 443 KVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501
K + K D++AFGV++ E+ + G+ P + L P L +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---------LYRPHLAS 227
Query: 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
Y M C RP ++L +
Sbjct: 228 EKVYTIMYS-------CWHEKADERPTFKILLSNIL 256
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 9e-58
Identities = 62/283 (21%), Positives = 106/283 (37%), Gaps = 26/283 (9%)
Query: 260 SATSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTL 315
S ++ IG G + K DGK L K L +E + V E+ ++ L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 316 HHKNIISLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 373
H NI+ + + L +V ++ G L + K+ +V +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 374 ALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
AL+ H S V+HRD+K +N+ L +L DFGLA+ + +S GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTP 178
Query: 432 GYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491
Y++PE N+K D+++ G +L EL P + K + K +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ L + + R + RP + +L+
Sbjct: 239 SDEL---------NEIITR-------MLNLKDYHRPSVEEILE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-57
Identities = 58/274 (21%), Positives = 117/274 (42%), Gaps = 22/274 (8%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 322
+ E +G+G +V+ G +A+K LKP + F+ E +++ L H+ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
L + + +V +++S+GSL + L G + +A +A + Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVER-- 131
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
+HRD++++NIL+ ++ +++DFGLA+ + + APE +YG
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYG 189
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502
+ K DV++FG++L EL T + + + +V ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPG---------------MVNREVLDQVERGYRMP 234
Query: 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
+ E + C R++P RP + L
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (491), Expect = 2e-57
Identities = 69/304 (22%), Positives = 127/304 (41%), Gaps = 41/304 (13%)
Query: 253 FNYQDLLSATSNFLAE---------NLIGKGGSSQVYKGCLPDGKEL----AVKILKP-- 297
F ++D A F E +IG G +V G L + A+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 298 SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPA 357
+E ++F+ E I+ H N+I L G + ++++ +F+ GSL+ L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-- 124
Query: 358 AFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417
F + + G+A ++YL +HRD+ + NIL++ + ++SDFGL+++
Sbjct: 125 -FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 418 SSSHITCTDVAG---TFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 473
+S T T G + APE Y K DV+++G+V+ E+++ G +P + +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 474 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVL 533
V ++ D + + C ++D RP+ ++
Sbjct: 241 ----------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 534 KLLR 537
L
Sbjct: 285 NTLD 288
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-57
Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 31/290 (10%)
Query: 256 QDLLSATSNFLAENL-IGKGGSSQVYKGCL---PDGKELAVKILKP--SEDVIKEFVLEI 309
+ L N L ++ +G G V +G ++A+K+LK + +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 310 EIITTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAM 369
+I+ L + I+ L+G C + L+LV + G L + L G +++ S ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 370 GVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VA 428
V+ ++YL + +HRD+ + N+LL + ++SDFGL+K S+ T
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 429 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILS 487
+ APE + K + + DV+++GV + E L+ G+KP + + K +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ L Y M C RP V + +R
Sbjct: 234 PPECPPEL---------YALMSD-------CWIYKWEDRPDFLTVEQRMR 267
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 7e-57
Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 28/276 (10%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 322
IGKG V G G ++AVK +K ++ + F+ E ++T L H N++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 323 LLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
LLG E+ L +V +++++GSL + L + G K ++ V EA+EYL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEG- 121
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
+HRD+ + N+L+S+D ++SDFGL K AS+ T + APE
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALRE 174
Query: 442 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501
K + K DV++FG++L E+ + + P + L +V + +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVP------RVEKGYKMDAPD 223
Query: 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ ++ C D RP + + L
Sbjct: 224 GCP-PAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 1e-56
Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 36/274 (13%)
Query: 269 NLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISL 323
IG G VY + + + +A+K + S + ++ + E+ + L H N I
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 324 LGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSA 383
G ++ LV ++ + + K E V G + L YLHS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHS--- 133
Query: 384 QRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM--- 440
+IHRDVK+ NILLS+ +L DFG A + ++S + GT ++APE +
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPEVILAMD 187
Query: 441 YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500
G+ + K+DV++ G+ +EL + P+ N + + + PAL
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------PALQ 235
Query: 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ + + V + C+++ P+ RP ++LK
Sbjct: 236 SGHWSEYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 7e-56
Identities = 60/275 (21%), Positives = 109/275 (39%), Gaps = 25/275 (9%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP--SEDVIKEFVLEIEIITTLHHKNI 320
++ +G+G +V + +AVKI+ + D + EI I L+H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 321 ISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHS 380
+ G E N L ++ S G L + + + + + + + YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHG 121
Query: 381 GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFM 440
+ HRD+K N+LL + ++SDFGLA ++ + GT Y+APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 441 YGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499
+ + +DV++ G+VL +L G P QE K + + +D A
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN--PWKKIDSAP 236
Query: 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ + + +P AR + + K
Sbjct: 237 -----LALLHK-------ILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-55
Identities = 66/273 (24%), Positives = 125/273 (45%), Gaps = 29/273 (10%)
Query: 269 NLIGKGGSSQVYKG-CLPDGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGF 326
+G G +VYK A K++ SE+ ++++++EI+I+ + H NI+ LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
+ +NNL ++ +F + G+++ + ++ S+ V +AL YLH ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHD---NKI 131
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 446
IHRD+K+ NIL + D + +L+DFG++ + + GT ++APE M D
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKD 189
Query: 447 -----KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501
K DV++ G+ L+E+ P +P + ++P P L
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP------------PTLAQ 237
Query: 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ + L C+ ++ AR S +L+
Sbjct: 238 PSRWSSNFKDFLKK--CLEKNVDARWTTSQLLQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-55
Identities = 66/280 (23%), Positives = 112/280 (40%), Gaps = 32/280 (11%)
Query: 266 LAENLIGKGGSSQVYKGCLPD---GKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 319
L + +G G V KG K +AVKILK + E + E ++ L +
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
I+ ++G C E + +LV + G L + L N+ ++ V+ ++YL
Sbjct: 70 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLE 124
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEY 438
+HRD+ + N+LL ++SDFGL+K ++ + APE
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 439 FMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497
Y K + K DV++FGV++ E + G+KP +++ + + + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM-- 239
Query: 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
YD M C D RP + V LR
Sbjct: 240 -------YDLMNL-------CWTYDVENRPGFAAVELRLR 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (473), Expect = 5e-55
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 22/285 (7%)
Query: 254 NYQDLLSATSNFLAENLIGKGGSSQVYKGCLPD-GKELAVKILKPSEDVIKEFVLEIEII 312
NY ++ ++ +G G +VY+G +AVK LK ++EF+ E ++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 313 TTLHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVA 372
+ H N++ LLG C + ++ +F++ G+L + L + +A ++
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQIS 125
Query: 373 EALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFG 432
A+EYL + IHRD+ + N L+ ++ +++DFGL++ + +
Sbjct: 126 SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIK 181
Query: 433 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492
+ APE Y K + K DV+AFGV+L E+ T Q V
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VY 226
Query: 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+LL+ E++ C + +P RP + + +
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 6e-55
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 33/276 (11%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISL 323
+ IG+G VYKG E+A L+ ++ + F E E++ L H NI+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 324 LGFCFE----DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
++LV + ++ G+L+ L K + + L++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 380 SGSAQRVIHRDVKSSNILLSD-DFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
+ + +IHRD+K NI ++ ++ D GLA S + V GT ++APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEM 184
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498
+ K ++ +DVYAFG+ +LE+ T P S Q ++ +VT + PA
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYR-------RVTSGVKPA 232
Query: 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ +++ ++ CIR++ R + +L
Sbjct: 233 SFDKVAIPEVKEIIEG---CIRQNKDERYSIKDLLN 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 9e-55
Identities = 60/300 (20%), Positives = 114/300 (38%), Gaps = 40/300 (13%)
Query: 263 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPSEDV--IKEFVLEIEIITT 314
+ +G G +V + +AVK+LKPS + + + E+++++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 315 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--------------DPAAF 359
L +H NI++LLG C L++ ++ G L L + D A
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 360 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419
+ + VA+ + +L S + IHRD+ + NILL+ ++ DFGLA+ S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479
+++ + ++APE + DV+++G+ L EL + P +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256
Query: 480 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539
+++ M C DP RP +++L+
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-54
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 32/282 (11%)
Query: 264 NFLAENLIGKGGSSQVYKGCLPDGK----ELAVKILKPSEDV--IKEFVLEIEIITTLHH 317
+F +IG+G VY G L D AVK L D+ + +F+ E I+ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 318 KNIISLLGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376
N++SLLG C + + L+V ++ G L + +P + + VA+ ++
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT---VKDLIGFGLQVAKGMK 144
Query: 377 YLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS--SHITCTDVAGTFGYL 434
+L S ++ +HRD+ + N +L + F +++DFGLA+ S T ++
Sbjct: 145 FLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494
A E K K DV++FGV+L EL+T P P + +L + L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---L 253
Query: 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLL 536
L P Y D + ++L C RP S ++ +
Sbjct: 254 LQP----EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-54
Identities = 59/284 (20%), Positives = 119/284 (41%), Gaps = 29/284 (10%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKE-----LAVKILKP--SEDVIKEFVLEIEIITTL 315
S + +IG G +VYKG L +A+K LK +E +F+ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 316 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 375
H NII L G + ++++ +++ G+ ++ F + + G+A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI-TCTDVAGTFGYL 434
+YL + +HRD+ + NIL++ + ++SDFGL++ T + +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 435 APEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494
APE Y K DV++FG+V+ E++T + + + V +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKA 225
Query: 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538
++ D + + C +++ RP+ + ++ +L
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-54
Identities = 70/268 (26%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 269 NLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGF 326
IG+G S VY + G+E+A++ + + KE ++ EI ++ + NI++ L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
+ L +V ++L+ GSL + + D + V +ALE+LHS +V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLHS---NQV 137
Query: 387 IHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 446
IHRD+KS NILL D +L+DFG + S + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGP 195
Query: 447 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 506
K+D+++ G++ +E++ G P N++P L+ P L N
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT------------PELQNPEKLS 243
Query: 507 QMERMVLASILCIRRDPRARPQMSLVLK 534
+ R L C+ D R +L+
Sbjct: 244 AIFRDFLNR--CLDMDVEKRGSAKELLQ 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-54
Identities = 60/302 (19%), Positives = 118/302 (39%), Gaps = 45/302 (14%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPD------GKELAVKILKPSED--VIKEFVLEIEIITT 314
N ++G G +V ++AVK+LK D + + E++++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 315 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKK------------------- 354
L H+NI++LLG C + L++++ G L L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 355 DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414
D + + A VA+ +E+L + +HRD+ + N+L++ ++ DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474
+ S+++ + ++APE G K DV+++G++L E+ + P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+L+ + + E + + C D R RP +
Sbjct: 274 AN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 535 LL 536
L
Sbjct: 320 FL 321
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (460), Expect = 5e-53
Identities = 62/303 (20%), Positives = 126/303 (41%), Gaps = 46/303 (15%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKP--SEDVIKEFVLEIEIITT 314
+N IG+G +V++ P +AVK+LK S D+ +F E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 315 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD------------------- 355
+ NI+ LLG C + L++++++ G L E L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 356 -PAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414
P +E+ +A VA + YL ++ +HRD+ + N L+ ++ +++DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 415 ASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG 474
++ + + A ++ PE Y + + DV+A+GVVL E+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 247
Query: 475 QESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
E ++ + + G + + ++ ++ LC + P RP + +
Sbjct: 248 HEEVIYYVR----DGNILACPENCP------LELYNLMR---LCWSKLPADRPSFCSIHR 294
Query: 535 LLR 537
+L+
Sbjct: 295 ILQ 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-52
Identities = 61/269 (22%), Positives = 103/269 (38%), Gaps = 29/269 (10%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 318
+F ++G+G S V L +E A+KIL+ E+ + E ++++ L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
+ L +D L + G L + + F + + ALEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYL 124
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
H + +IHRD+K NILL++D Q++DFG AK S S GT Y++PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498
D++A G ++ +L+ G P + ++ + P
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK-----FFPK 236
Query: 499 LGNNYDYDQMERMVLASILCIRRDPRARP 527
D +E+ + D R
Sbjct: 237 A-----RDLVEK-------LLVLDATKRL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 3e-51
Identities = 64/293 (21%), Positives = 124/293 (42%), Gaps = 39/293 (13%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLPDGKEL---AVKILKP--SEDVIKEFVLEIEIITTL-H 316
++ +++IG+G QV K + A+K +K S+D ++F E+E++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 317 HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGN------------KKDPAAFGWSER 364
H NII+LLG C L L ++ G+L + L + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 365 YKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITC 424
A VA ++YL ++ IHRD+ + NIL+ +++ +++DFGL++
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 425 TDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 484
++A E Y DV+++GV+L E+++ P + +
Sbjct: 187 R---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEK 238
Query: 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ ++ + L+ D++ ++ C R P RP + +L L
Sbjct: 239 LPQGYRLEKPLNCD-------DEVYDLMR---QCWREKPYERPSFAQILVSLN 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 8e-51
Identities = 65/341 (19%), Positives = 140/341 (41%), Gaps = 46/341 (13%)
Query: 269 NLIGKGGSSQVYKG-CLPDGKEL----AVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
++G G VYKG +P+G+++ A+K L+ S KE + E ++ ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
LLG C + + L+ + G L + + +K + G + +A+ + YL
Sbjct: 75 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLED- 129
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
+R++HRD+ + N+L+ +++DFGLAK ++A E ++
Sbjct: 130 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 442 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501
+ DV+++GV + EL+T + P + ++ +L+
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGERL 232
Query: 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK-LLRGDADVTKWARLQVNASEESEMLD 560
+ + + C D +RP+ ++ + D ++ +Q +
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292
Query: 561 DESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLL 601
D + R+ L+D ED ++ V ++YL+
Sbjct: 293 DSNFYRA---------LMDEED-------MDDVVDADEYLI 317
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 175 bits (444), Expect = 4e-50
Identities = 56/275 (20%), Positives = 103/275 (37%), Gaps = 26/275 (9%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKIL-KPSEDVIKEFVLEIEIITTLHHKNII 321
++ +G G V++ G A K + P E + EI+ ++ L H ++
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
+L +DN ++++Y+F+S G L E + E + V + L ++H
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
+H D+K NI+ + + L DFGL S T GT + APE
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 197
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499
V D+++ GV+ LL+G P ++ V + + + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG- 256
Query: 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
D + + + DP R + L+
Sbjct: 257 -----KDFIRK-------LLLADPNTRMTIHQALE 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 5e-49
Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 39/297 (13%)
Query: 263 SNFLAENLIGKGGSSQVYKGC------LPDGKELAVKILKPS--EDVIKEFVLEIEIIT- 313
+G+G QV + + +AVK+LK + + E++I+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 314 TLHHKNIISLLGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDPA------------AFG 360
HH N+++LLG C + L+++ +F G+L L + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 361 WSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420
+ VA+ +E+L S ++ IHRD+ + NILLS+ ++ DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM 480
++ D ++APE + DV++FGV+L E+ + P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 481 WAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
L G + D Y +M + +L C +P RP S +++ L
Sbjct: 245 EFCRRLKEGTRMRAPD------YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 169 bits (428), Expect = 1e-48
Identities = 65/271 (23%), Positives = 114/271 (42%), Gaps = 30/271 (11%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIIS 322
++G GG S+V+ L +++AVK+L+ F E + L+H I++
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 323 LLGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
+ + +V +++ +L + +H +V +AL +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS 127
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHIT-CTDVAGTFGYLAPE 437
H +IHRDVK +NI++S ++ DFG+A+ + S + +T V GT YL+PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497
V+ + DVY+ G VL E+LTG P + D P + PI S + L
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244
Query: 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 528
+ + + ++P R Q
Sbjct: 245 L------DAVVLK-------ALAKNPENRYQ 262
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-48
Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 30/276 (10%)
Query: 271 IGKGGSSQVYKGCLP----DGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIIS 322
+G G V +G +AVK LKP + + +F+ E+ + +L H+N+I
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
L G + +V + GSL + L ++ F + A+ VAE + YL S
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLES-- 129
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTD-VAGTFGYLAPEYFMY 441
+R IHRD+ + N+LL+ ++ DFGL + + H + F + APE
Sbjct: 130 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 442 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501
+ D + FGV L E+ T + P + I G+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGE-----RLPRPE 238
Query: 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+ + +++ C P RP + L
Sbjct: 239 DCP-QDIYNVMV---QCWAHKPEDRPTFVALRDFLL 270
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 167 bits (424), Expect = 4e-48
Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 41/289 (14%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----------EDVIKEFVLEIEII 312
N+ + ++G+G SS V + P KE AVKI+ + +++ + + E++I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 313 TTLH-HKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGV 371
+ H NII L + LV+D + +G L + L E K+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRAL 119
Query: 372 AEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTF 431
E + LH ++HRD+K NILL DD +L+DFG + +V GT
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 432 GYLAPEYFM------YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPI 485
YLAPE + ++D+++ GV++ LL G P + ++M
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 486 LSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
S + D D + R + P+ R L
Sbjct: 234 FGSPEWDDYSDTV------KDLVSR-------FLVVQPQKRYTAEEALA 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (429), Expect = 5e-48
Identities = 56/269 (20%), Positives = 99/269 (36%), Gaps = 26/269 (9%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVL-EIEIITTLHHKNIISLLGFC 327
+G G V++ G+ K + + K V EI I+ LHH +I+L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 328 FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVI 387
+ ++L+ +FLS G L + + +E E L+++H ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HSIV 149
Query: 388 HRDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 445
H D+K NI+ + DFGLA + T T + APE V
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVG 206
Query: 446 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505
D++A GV+ LL+G P + + V + + A
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA------K 260
Query: 506 DQMERMVLASILCIRRDPRARPQMSLVLK 534
D ++ ++++PR R + L+
Sbjct: 261 DFIKN-------LLQKEPRKRLTVHDALE 282
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-48
Identities = 60/277 (21%), Positives = 113/277 (40%), Gaps = 31/277 (11%)
Query: 268 ENLIGKGGSSQVYKGCLPDGKE----LAVKILKP--SEDVIKEFVLEIEIITTLHHKNII 321
IG+G V++G + +A+K K S+ V ++F+ E + H +I+
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
L+G +N + ++ + + G L + + + A ++ AL YL S
Sbjct: 72 KLIGVI-TENPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLES- 126
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
+R +HRD+ + N+L+S + +L DFGL+++ S+ + + ++APE +
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINF 183
Query: 442 GKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500
+ DV+ FGV + E+L G KP + + + L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL----- 238
Query: 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
Y M + C DP RP+ + + L
Sbjct: 239 ----YSLMTK-------CWAYDPSRRPRFTELKAQLS 264
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-47
Identities = 51/268 (19%), Positives = 103/268 (38%), Gaps = 25/268 (9%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCF 328
+G+G V++ K K +K EI I+ H+NI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 329 EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIH 388
L+++++F+S + E ++ + + E V EAL++LHS + H
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 389 RDVKSSNILLSDDFEPQ--LSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVND 446
D++ NI+ + +FG A+ + Y APE + V+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVVST 182
Query: 447 KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYD 506
D+++ G ++ LL+G P + + +M A+ ++ A+ D
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM------D 236
Query: 507 QMERMVLASILCIRRDPRARPQMSLVLK 534
++R + ++ ++R S L+
Sbjct: 237 FVDR-------LLVKERKSRMTASEALQ 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-47
Identities = 53/293 (18%), Positives = 118/293 (40%), Gaps = 32/293 (10%)
Query: 263 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKP--SEDVIKEFVLEIEIITT 314
+G+G VY+G +A+K + S EF+ E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 315 LHHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFG------WSERYKVA 368
+ +++ LLG + L++ + ++RG L+ L + A S+ ++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 369 MGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVA 428
+A+ + YL++ + +HRD+ + N ++++DF ++ DFG+ + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 429 GTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 488
+++PE G DV++FGVVL E+ T + +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVME 250
Query: 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541
G + D D + ++ +C + +P+ RP ++ ++ + +
Sbjct: 251 GGLLDKPDNCP------DMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (420), Expect = 3e-47
Identities = 67/315 (21%), Positives = 123/315 (39%), Gaps = 37/315 (11%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLL 324
+++G G S+V K +A+K + E EI ++ + H NI++L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
+L L+ +S G L + + + + ++ V +A++YLH
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHD---L 126
Query: 385 RVIHRDVKSSNILLS---DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
++HRD+K N+L +D + +SDFGL+K S + GT GY+APE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQ 183
Query: 442 GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501
+ +D ++ GV+ LL G P +++ ++ A+ S + D A
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA--- 240
Query: 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLK--LLRGDADVTKWARLQVNASEESEML 559
D + + +DP R L+ + GD + K V+ +
Sbjct: 241 ---KDFIRH-------LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNF- 289
Query: 560 DDESCPRSNLQSHLN 574
+S + N
Sbjct: 290 -----AKSKWKQAFN 299
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 4e-47
Identities = 61/277 (22%), Positives = 113/277 (40%), Gaps = 32/277 (11%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHH 317
+F+ ++GKG +V+ + A+K LK +D ++ ++E +++ H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
+ + NL V ++L+ G L ++ K F S A + L++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQF 118
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LHS + +++RD+K NILL D +++DFG+ K GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPE 173
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497
+ K N +D ++FGV+L E+L G+ P + + P L+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW-----LEK 228
Query: 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
D + + R+P R + ++
Sbjct: 229 EA-----KDLLVK-------LFVREPEKRLGVRGDIR 253
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 165 bits (418), Expect = 3e-46
Identities = 62/273 (22%), Positives = 109/273 (39%), Gaps = 34/273 (12%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTL 315
+F +IG+GG +VY GK A+K L E + + + +++T
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 316 HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEAL 375
I+ + + L + D ++ G L +L + ++ A + L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGL 120
Query: 376 EYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
E++H+ + V++RD+K +NILL + ++SD GLA S H + GT GY+A
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173
Query: 436 PEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494
PE G D D ++ G +L +LL G P K + + + ++
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--ELPDS 231
Query: 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARP 527
P L +E ++RD R
Sbjct: 232 FSPEL-----RSLLEG-------LLQRDVNRRL 252
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 6e-46
Identities = 70/304 (23%), Positives = 125/304 (41%), Gaps = 41/304 (13%)
Query: 263 SNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKP--SEDVIKEFVLEIEII 312
+ +G+G QV ++AVK+LK +E + + + E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 313 TTL-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAA------------F 359
+ HKNII+LLG C +D L ++ ++ S+G+L E L +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 360 GWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419
+ A VA +EYL S ++ IHRD+ + N+L+++D +++DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 420 SHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLV 479
+ T+ ++APE + DV++FGV+L E+ T P V
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V 243
Query: 480 MWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539
+L G +++ M+ C P RP +++ L
Sbjct: 244 EELFKLLKEGHRMDKPSNCT------NELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 294
Query: 540 ADVT 543
+T
Sbjct: 295 VALT 298
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 5e-45
Identities = 55/279 (19%), Positives = 99/279 (35%), Gaps = 25/279 (8%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
IG G +Y G + G+E+A+K+ + +E +I + I + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 327 CFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRV 386
C + + ++ L SLE+ + + F +A + +EY+HS +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KNF 124
Query: 387 IHRDVKSSNILLSD---DFEPQLSDFGLAKWASTSSSHITC-----TDVAGTFGYLAPEY 438
IHRDVK N L+ + DFGLAK + +H ++ GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498
+ + + + D+ + G VL+ G P + K
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKMSTPIEV 239
Query: 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
L Y + + C +P S + +L R
Sbjct: 240 LCKGYP-SEFATYLNF---CRSLRFDDKPDYSYLRQLFR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (403), Expect = 1e-44
Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS----EDVIKEFVLEIEIITTLHH 317
+F +G G +V+ +G+ A+K+LK ++ E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
II + G + + ++ D++ G L L +++ P A V ALEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP----NPVAKFYAAEVCLALEY 119
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
LHS + +I+RD+K NILL + +++DFG AK+ + GT Y+APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE 171
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497
N ID ++FG+++ E+L G P + + ++ A+ +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-----FNE 226
Query: 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQ 528
+ D + R I RD R
Sbjct: 227 DV-----KDLLSR-------LITRDLSQRLG 245
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-44
Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 28/285 (9%)
Query: 269 NLIGKGGSSQVYKG-CLPDGKELAVKILKPS------EDVIKEFVLEIEIITTLHHKNII 321
+ +G+G + VYK + +A+K +K + + + + EI+++ L H NII
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
LL +N+ LV+DF+ + S + + LEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMY 441
++HRD+K +N+LL ++ +L+DFGLAK S S + T T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 442 GKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVM----------WAKPILSSGK 490
++ +D++A G +L ELL + D Q + + W
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 491 VTQLLDPALGNNYDYDQMERMVLASIL-CIRRDPRARPQMSLVLK 534
VT P + ++ + +L I +P AR + LK
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 8e-44
Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 31/296 (10%)
Query: 262 TSNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSED--VIKEFVLEIEIITTLHHK 318
+ + IG+G V + +A+K + P E + + EI+I+ H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 319 NIISLLGFC----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEA 374
NII + E + + L L + L +
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFLYQILRG 121
Query: 375 LEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK-WASTSSSHITCTDVAGTFGY 433
L+Y+HS V+HRD+K SN+LL+ + ++ DFGLA+ T+ T Y
Sbjct: 122 LKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 434 LAPEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492
APE + K ID+++ G +L E+L+ R H Q + ++ S +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 493 QLLD-PALGNNYDYDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 534
+++ A ++ + + +P R ++ L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (390), Expect = 3e-43
Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 25/282 (8%)
Query: 269 NLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 325
IG+G VYK G+ A+K ++ E + + EI I+ L H NI+ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
L+LV++ L + + + + + Y H +R
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 445
V+HRD+K N+L++ + E +++DFGLA+ ++ + K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMGSKKYS 179
Query: 446 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505
ID+++ G + E++ G Q + +S + + + ++
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK-YDPNF 238
Query: 506 DQMERMVLASIL-------------CIRRDPRARPQMSLVLK 534
E + S L ++ DP R L+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 59/333 (17%), Positives = 134/333 (40%), Gaps = 28/333 (8%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
++G G + +V + ++ A+K+L+ +E L +I+ ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDV 73
Query: 327 C----FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
LL+V + L G L + F E ++ + EA++YLHS
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHS-- 129
Query: 383 AQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYG 442
+ HRDVK N+L + + +A ++SH + T T Y+APE
Sbjct: 130 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 443 KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNN 502
K + D+++ GV++ LL G P ++H + + + + ++ Q P +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRMGQYEFPNPEWS 242
Query: 503 YDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASEESEMLDDE 562
++++ ++ ++ +P R ++ + + + ++ S +L ++
Sbjct: 243 EVSEEVKMLIRN---LLKTEPTQRMTITEFMN----HPWIMQSTKVPQTPLHTSRVLKED 295
Query: 563 SCPRSNLQSHLNLAL--LDVEDDSFSMSSIEQS 593
+++ + AL + V+ + + IE +
Sbjct: 296 KERWEDVKEEMTSALATMRVDYEQIKIKKIEDA 328
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 3e-42
Identities = 43/285 (15%), Positives = 95/285 (33%), Gaps = 27/285 (9%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 322
++ IG+G +++G L + +++A+K D + E L I
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIP 64
Query: 323 LLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS 382
+ + ++ ++ L SLE+ L + F A + ++ +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK---FSVKTVAMAAKQMLARVQSIHE-- 119
Query: 383 AQRVIHRDVKSSNILLSDDFEPQ-----LSDFGLAKWASTSSSH-----ITCTDVAGTFG 432
+ +++RD+K N L+ + DFG+ K+ + +++GT
Sbjct: 120 -KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 433 YLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492
Y++ + + + + D+ A G V + L G P + S +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537
+L + + + A P + L
Sbjct: 239 ELCA-------GFPEEFYKYMHY--ARNLAFDATPDYDYLQGLFS 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-42
Identities = 58/277 (20%), Positives = 108/277 (38%), Gaps = 35/277 (12%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNII 321
+G G + V K G + A K +K ++ E+ I+ + H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 322 SLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSG 381
+L +++L+ + ++ G L + L + E + + + YLHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHS- 131
Query: 382 SAQRVIHRDVKSSNILLSDDFEPQ----LSDFGLAKWASTSSSHITCTDVAGTFGYLAPE 437
++ H D+K NI+L D P+ + DFGLA + ++ GT ++APE
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 438 YFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497
Y + + D+++ GV+ LL+G P D + + V +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
A D + R + +DP+ R + L+
Sbjct: 247 A------KDFIRR-------LLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 35/293 (11%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKN 319
NF IG+G VYK G+ +A+K ++ +E V + EI ++ L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
I+ LL +N L LV++FL + + + + L + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFCH 119
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPE-Y 438
S RV+HRD+K N+L++ + +L+DFGLA+ T T Y APE
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEIL 174
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498
+ +D+++ G + E++T R D Q + + G +++ P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-----LFRIFRTLGTPDEVVWPG 229
Query: 499 LGNNYDYD----QMERMVLASIL-------------CIRRDPRARPQMSLVLK 534
+ + DY + R + ++ + DP R L
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 54/297 (18%), Positives = 107/297 (36%), Gaps = 32/297 (10%)
Query: 261 ATSNFLAENLIGKGGSSQVYKG--CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTL 315
A + IG+G +V+K G+ +A+K ++ E + + E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 316 ---HHKNIISLLGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKV 367
H N++ L C + L LV++ + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP---GVPTETIKDM 121
Query: 368 AMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDV 427
+ L++LHS RV+HRD+K NIL++ + +L+DFGLA+ S + T V
Sbjct: 122 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSV 175
Query: 428 AGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 487
T Y APE + +D+++ G + E+ + Q ++ +
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 488 SGKVTQLLDPALGNNYDYDQMERMVLASIL----------CIRRDPRARPQMSLVLK 534
+ + + + + C+ +P R L
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 63/302 (20%), Positives = 123/302 (40%), Gaps = 37/302 (12%)
Query: 263 SNFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHK 318
S + IG+G +V+K G+++A+K + E + EI+I+ L H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 319 NIISLLGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMG 370
N+++L+ C ++ LV+DF + K F SE +V
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 371 VAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS--SSHITCTDVA 428
+ L Y+H +++HRD+K++N+L++ D +L+DFGLA+ S + S T+
Sbjct: 126 LLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 429 GTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILS 487
T Y PE + + ID++ G ++ E+ T + + + Q +L+ ++
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 488 SGKVTQLLDPALGNNYDYDQMERMVLASIL---------------CIRRDPRARPQMSLV 532
+ + L + + ++ + L + DP R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 533 LK 534
L
Sbjct: 303 LN 304
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 76/352 (21%), Positives = 129/352 (36%), Gaps = 32/352 (9%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIIS 322
++ +IG G VY+ G+ +A+K + + E++I+ L H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKLDHCNIVR 77
Query: 323 LLGFCFE------DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALE 376
L F + + L LV D++ H ++ + +L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFRSLA 136
Query: 377 YLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLA 435
Y+HS + HRD+K N+LL D +L DFG AK +++ + Y A
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SRYYRA 190
Query: 436 PEYFMYGKVND-KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494
PE IDV++ G VL ELL G+ D Q LV K + + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR 248
Query: 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDADVTKWARLQVNASE 554
+ + Q++ + R P A +L +LL ARL +
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI---ALCSRLLEYTPT----ARLTPLEAC 301
Query: 555 ESEMLDDESCPRSNLQSHLNLALLDVEDDSFSMSSIEQSVSLEDYLLGRWSR 606
D+ P L + + L +F+ + + L L+ +R
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPAL----FNFTTQELSSNPPLATILIPPHAR 349
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-40
Identities = 51/277 (18%), Positives = 99/277 (35%), Gaps = 45/277 (16%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKN 319
L+G GG VY G + D +A+K ++ +E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 320 IISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
+I LL + ++ +L+ + + + A V EA+ + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 380 SGSAQRVIHRDVKSSNILLS-DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
+ V+HRD+K NIL+ + E +L DFG + TD GT Y PE+
Sbjct: 128 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 180
Query: 439 FMYGKVNDK-IDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497
Y + + + V++ G++L +++ G P +D ++ + +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQR-----VSS 229
Query: 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534
+ C+ P RP +
Sbjct: 230 EC-----QHLIRW-------CLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 7e-39
Identities = 59/283 (20%), Positives = 104/283 (36%), Gaps = 25/283 (8%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 325
+G G V G ++A+K L SE K E+ ++ + H+N+I LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
D L DF G G + + + L Y+H+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 445
+IHRD+K N+ +++D E ++ DFGLA+ A + + V + + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT----GYVVTRWYRAPEVILNWMRYT 197
Query: 446 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQL-LDPALGNNYD 504
+D+++ G ++ E++TG+ Q +M + V +L D A
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 505 YDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 534
++E+ ASIL + D R L
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 2e-38
Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 31/271 (11%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHK 318
+F L+GKG +V G+ A+KIL+ ++D + V E ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 319 NIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYL 378
+ +L + L V ++ + G L +L + F + ALEYL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYL 121
Query: 379 HSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
HS + V++RD+K N++L D +++DFGL K + + + GT YLAPE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 439 FMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498
+D + GVV+ E++ GR P N + L++ + L P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT-----LSPE 231
Query: 499 LGNNYDYDQMERMVLASILCIRRDPRARPQM 529
+ +++DP+ R
Sbjct: 232 A-----KSLLAG-------LLKKDPKQRLGG 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 8e-38
Identities = 57/287 (19%), Positives = 105/287 (36%), Gaps = 33/287 (11%)
Query: 269 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 324
IG+G V+K + +A+K ++ E V + EI ++ L HKNI+ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
D L LV++F + + N + + L + HS +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCHS---R 120
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
V+HRD+K N+L++ + E +L++FGLA+ + V + F
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLY 179
Query: 445 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 504
+ ID+++ G + EL +P+ G + + G T+ P++ D
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLF----PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 505 YDQMERMVLASIL-----------------CIRRDPRARPQMSLVLK 534
Y + L ++ +P R L+
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (355), Expect = 1e-37
Identities = 58/263 (22%), Positives = 99/263 (37%), Gaps = 34/263 (12%)
Query: 271 IGKGGSSQVYKG-CLPDGKELAVKILKP----SEDVIKEFVLEIEIITTLHHKNIISLLG 325
+G G +V G A+KIL I+ + E I+ ++ ++ L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR 385
+++NL +V ++++ G + +L + F A + EYLHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 386 VIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVN 445
+I+RD+K N+L+ Q++DFG AK + GT LAPE + N
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 446 DKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYDY 505
+D +A GV++ E+ G P D P ++ K S L
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-----FSSDL-----K 266
Query: 506 DQMERMVLASILCIRRDPRARPQ 528
D + ++ D R
Sbjct: 267 DLLRN-------LLQVDLTKRFG 282
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-34
Identities = 64/279 (22%), Positives = 115/279 (41%), Gaps = 33/279 (11%)
Query: 264 NFLAENLIGKGGSSQVYKG----CLPDGKELAVKILKPS-----EDVIKEFVLEIEIITT 314
NF ++G G +V+ GK A+K+LK + + E +++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 315 L-HHKNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAE 373
+ +++L + L L+ D+++ G L +L ++ F E +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVL 140
Query: 374 ALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 433
ALE+LH +I+RD+K NILL + L+DFGL+K + GT Y
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 196
Query: 434 LAPEYFMYGKVND--KIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491
+AP+ G +D ++ GV++ ELLTG P + D K ++ + + + S
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-RRILKSEPPY 255
Query: 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMS 530
Q + D ++R + +DP+ R
Sbjct: 256 PQEMSALA-----KDLIQR-------LLMKDPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 8e-33
Identities = 55/287 (19%), Positives = 120/287 (41%), Gaps = 27/287 (9%)
Query: 264 NFLAENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNII 321
++ +G+G S+V++ + + +++ VKILKP + K+ EI+I+ L NII
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNII 93
Query: 322 SLLGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
+L + LV++ ++ ++ + + +AL+Y H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCH 146
Query: 380 SGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEY 438
S ++HRDVK N+++ + + +L D+GLA++ + + PE
Sbjct: 147 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPEL 200
Query: 439 FM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497
+ Y + +D+++ G +L ++ ++P + H + LV AK + + +
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKY 259
Query: 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMS-----LVLKLLRGD 539
+ + ++ + + +S + KLLR D
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 58/284 (20%), Positives = 102/284 (35%), Gaps = 25/284 (8%)
Query: 269 NLIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLL 324
+ +G G V G +AVK L S K E+ ++ + H+N+I LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 325 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQ 384
+L D L N + + L+Y+HS
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 140
Query: 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV 444
+IHRD+K SN+ +++D E ++ DFGLA+ + T + +
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT----RWYRAPEIMLNWMHY 196
Query: 445 NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGNNYD 504
N +D+++ G ++ ELLTGR Q L++ + + ++ + N
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 505 -YDQMERMVLASIL-------------CIRRDPRARPQMSLVLK 534
QM +M A++ + D R + L
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 2e-30
Identities = 54/312 (17%), Positives = 106/312 (33%), Gaps = 47/312 (15%)
Query: 268 ENLIGKGGSSQVYKG-CLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGF 326
+G G S V+ + + +A+KI++ + + EI+++ ++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 327 C----------FEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERY--KVAMGVAEA 374
F V+ + L ENL K G Y +++ +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 375 LEYLHSGSAQRVIHRDVKSSNILL-SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGY 433
L+Y+H +IH D+K N+L+ D L +A + T+ T Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 434 LAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-----------QESLVMWA 482
+PE + D+++ ++ EL+TG D E L
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 483 KPILSSGKVTQLLDPALGNNYDYDQMERMVLASIL--------------------CIRRD 522
+L +GK T+ + G + +++ L +L ++ D
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315
Query: 523 PRARPQMSLVLK 534
PR R ++
Sbjct: 316 PRKRADAGGLVN 327
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 2e-30
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 31/288 (10%)
Query: 270 LIGKGGSSQVYKG-CLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLG 325
IG G V + +A+K L ++ K E+ ++ ++HKNIISLL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 326 FCF------EDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLH 379
E ++ LV + + + + + +++LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 380 SGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYF 439
S +IHRD+K SNI++ D ++ DFGLA+ A TS T T Y APE
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 190
Query: 440 MYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPAL 499
+ + +D+++ G ++ E++ + Q + V+ + +L
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 500 GNNYDYDQMERMVLASILCIRRDPRARPQ--------MSLVLKLLRGD 539
+ + + + P L+ K+L D
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 1e-20
Identities = 23/156 (14%), Positives = 45/156 (28%), Gaps = 22/156 (14%)
Query: 269 NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIK-----------EFVLEIEIITTLHH 317
L+G+G S V+ E VK K K F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 318 KNIISLLGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEY 377
+ + L G Y + L E + + + + E +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVAK 118
Query: 378 LHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413
+ + ++H D+ N+L+ + + DF +
Sbjct: 119 FYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 611 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.06 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.34 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.77 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=418.26 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=200.2
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
++|.+.+.||+|+||+||+|.+.+++.||||+++......++|.+|++++++++|||||+++|+|.+++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 57999999999999999999998899999999987766778899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 85 g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 85 GCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999987543 358999999999999999999999 899999999999999999999999999998775543322
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhC-CCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTG-RKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG-~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
.....||+.|+|||++.++.|+.++|||||||++|||+|| ++||...........+..... ...| .
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~---------~~~p---~ 225 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------LYKP---R 225 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC---------CCCC---T
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC---------CCCc---c
Confidence 2236799999999999999999999999999999999995 555544332222222211110 0111 1
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
. . ...+..++..||+.||.+||||++|++.|+..
T Consensus 226 ~-~---~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 L-A---STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp T-S---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-c---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1 1 23456677789999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=421.04 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=203.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... +..+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 367999999999999999999974 79999999987542 345678999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++|+|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999997543 58999999999999999999999 89999999999999999999999999999987654
Q ss_pred CCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.........+||+.|+|||++.+..+ +.++|||||||+||||++|+.||.................... .+
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~--------~~ 228 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--------NP 228 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS--------TT
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--------Cc
Confidence 43333445789999999999998876 5689999999999999999999976554332222111111000 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
...+ ...+..++..||+.||.+|||+.++++
T Consensus 229 --~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --WKKI----DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GGGS----CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccC----CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001 123445666799999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=418.68 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=200.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.++|.+.+.||+|+||+||+|..++ .||||+++. .....+.|.+|+.+|++++|||||++++++. ++.+++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 4678899999999999999998643 599999974 3456788999999999999999999999875 457899999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+++|+|.+++..... .+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999975432 58999999999999999999999 89999999999999999999999999999877654
Q ss_pred CCCccccccccccccCChhhhcc---CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
..........||+.|+|||++.+ +.|+.++|||||||+||||+||+.||................. ....+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~--~~p~~~~-- 233 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY--LSPDLSK-- 233 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS--CCCCGGG--
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC--CCCcchh--
Confidence 44444455789999999999974 3589999999999999999999999987654433222211110 0001111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+...+ ...+..++..||+.||.+|||+.+|++.|+.
T Consensus 234 ---~~~~~----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 234 ---VRSNC----PKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp ---SCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---ccccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 11111 2345566778999999999999999998863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-51 Score=415.73 Aligned_cols=253 Identities=23% Similarity=0.389 Sum_probs=205.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
++|.+.+.||+|+||+||+|.+++++.||||+++......+.|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 5789999999999999999999888999999998776677889999999999999999999998854 568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++..... ..++|..++.|+.||++||.|||+ ++|+||||||+||||+.++.+||+|||+|+........
T Consensus 92 g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~- 165 (272)
T d1qpca_ 92 GSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (272)
T ss_dssp CBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc-
Confidence 999998764432 248999999999999999999999 89999999999999999999999999999977653322
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCc-chhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPK-GQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~-~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
......||+.|+|||++.++.++.++|||||||++|||+||..|+...... .....+.. + ..+....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-------~-----~~~~~p~ 233 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------G-----YRMVRPD 233 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------T-----CCCCCCT
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------c-----CCCCCcc
Confidence 223467999999999999999999999999999999999966655433322 11111111 0 0111111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
..+ ..+..++..||+.||.+||||.+|++.|+.
T Consensus 234 ~~~----~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 234 NCP----EELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cCh----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 122 345567778999999999999999998863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=413.57 Aligned_cols=244 Identities=27% Similarity=0.429 Sum_probs=205.0
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||+|.++ +|+.||||++... ....+.+.+|+++++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999975 7899999998643 234567889999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+++|+|.+++.... .+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997643 48999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
... ....||+.|+|||++.+..|+.++|||||||+||||++|+.||...........+.....
T Consensus 159 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------- 221 (263)
T d2j4za1 159 SRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------- 221 (263)
T ss_dssp CCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-------------
T ss_pred Ccc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------
Confidence 322 236899999999999999999999999999999999999999976554333222221111
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+....+ ..+..++..||+.||.+|||+.|+++
T Consensus 222 ~~p~~~s----~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPDFVT----EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCC----HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111111 23445666799999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-50 Score=418.56 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=195.6
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCC---EEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGK---ELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~---~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
++|.+.++||+|+||+||+|.+. +|+ .||||.+.. .....+.|.+|+++|++++|||||+++++|.+++.+++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 56788899999999999999874 332 589999875 345567899999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++|+|.+++..... .++|.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+...
T Consensus 106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998875432 58999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCCCcc---ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 417 TSSSHIT---CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 417 ~~~~~~~---~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
....... .....||+.|+|||++.++.++.++|||||||+||||+| |+.||...........+.... ..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~------~~- 252 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY------RL- 252 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------CC-
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------CC-
Confidence 5433221 122468999999999999999999999999999999998 899997765433222222111 00
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
. .+......+..++..||+.||.+|||+.+|++.|+.
T Consensus 253 -----~----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 253 -----P----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp -----C----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -----C----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 0 011112345667778999999999999999998863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-51 Score=415.95 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=194.4
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--cCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE--DNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~--~~~~~L 335 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||++... +...+.+.+|++++++++|||||++++++.+ ++.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999999864 7999999998753 3456678999999999999999999999865 456899
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS--AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~--~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
||||+++|+|.+++.........+++..++.++.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998654333346999999999999999999999822 2359999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
........ .....||+.|+|||++.+..|+.++|||||||++|||+||+.||...........+.. +....
T Consensus 163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~-------~~~~~ 233 (269)
T d2java1 163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-------GKFRR 233 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------TCCCC
T ss_pred ecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-------CCCCC
Confidence 87653322 2347899999999999999999999999999999999999999976554332222211 11111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+...++ ..+..++..||+.||.+|||+.|+++
T Consensus 234 -----~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -----IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111122 24555667799999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-51 Score=420.13 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=211.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++.+....++|.+|+.+|++++|||||+++++|.+++..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 357889999999999999999875 6889999999877777788999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.+++..... ..+++..++.|+.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 96 ~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 96 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999975433 368999999999999999999999 8999999999999999999999999999987765433
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchh-hHHHhhccccccCccccccCccc
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE-SLVMWAKPILSSGKVTQLLDPAL 499 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~-~lv~~~~~~~~~g~l~~lld~~l 499 (611)
. ......||+.|+|||++.++.|+.++|||||||++|||++|..||......... ..+.. +. .+..
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~-------~~-----~~~~ 237 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-------DY-----RMER 237 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-------TC-----CCCC
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-------CC-----CCCC
Confidence 3 223456899999999999999999999999999999999987776544332221 11111 00 0111
Q ss_pred CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 500 GNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 500 ~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.... ...+..++..||+.||++|||+.+|++.|+..
T Consensus 238 ~~~~----~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 238 PEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred Cccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 23456677789999999999999999988643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-50 Score=413.45 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=205.3
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|++++++++|||||+++++|.+++.+|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999986 479999999987543 34577999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
+||+|.+++... .+++.++..++.||+.||.|||+ +||+||||||+|||++.++++||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988653 48999999999999999999999 8999999999999999999999999999987755433
Q ss_pred CccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 421 HITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
. ....+||+.|+|||++.++.|+.++|||||||++|||++|+.||...........+..... ..+..
T Consensus 172 ~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-------~~~~~---- 238 (293)
T d1yhwa1 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-------PELQN---- 238 (293)
T ss_dssp C--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-------CCCSS----
T ss_pred c--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-------CCCCC----
Confidence 2 2346899999999999999999999999999999999999999976654332222211110 00000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+......+..++..||+.||.+|||+.|+++
T Consensus 239 ---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 ---PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111133455667799999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-50 Score=406.60 Aligned_cols=253 Identities=23% Similarity=0.427 Sum_probs=213.1
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
++|.+.+.||+|+||+||+|.+++++.||||+++......++|.+|+.++++++||||++++|+|.+++.+++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 68999999999999999999998899999999988776778899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++..... .+++..+++++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 84 g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 84 GCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp EEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 999999765432 58899999999999999999999 89999999999999999999999999999876654333
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
......||+.|+|||++..+.++.++|||||||++|||+| |+.||...........+..... ...| .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~---------~~~p---~ 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---------LYRP---H 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC---------CCCC---T
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC---------CCCc---c
Confidence 2234679999999999999999999999999999999998 8999987654433222221110 0111 1
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.. ...+..++..||+.||++|||+++|++.|..
T Consensus 225 ~~----~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LA----SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cc----cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11 1345567778999999999999999998853
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=417.03 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=203.1
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.+.+|+++|++++||||++++++|.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999874 7999999999743 234567999999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||++||+|.+++...+ .+++..++.++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999987654 48999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
..........+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.......+.....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~------------- 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY------------- 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-------------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC-------------
Confidence 4444344457899999999999999999999999999999999999999987654332222211110
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+...+. ..+..++..||+.||.+|||++|++.
T Consensus 228 ~~p~~~s----~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEKFF----PKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTTCC----HHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCccCC----HHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1111121 23456677899999999999998754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=418.45 Aligned_cols=257 Identities=23% Similarity=0.392 Sum_probs=207.2
Q ss_pred cCceeeeeEeecCcEEEEEEEeCC-C-----CEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPD-G-----KELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~-g-----~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 333 (611)
++|.+.+.||+|+||+||+|.+.. + ..||||++... ......|.+|+.+|.++ +|||||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578999999999999999998642 2 36999998653 34456789999999998 899999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCcc
Q 007256 334 LLVYDFLSRGSLEENLHGNKK-------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSS 394 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~-------------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~ 394 (611)
++||||+++|+|.++|+.... ....+++..++.++.||+.||.|||+ ++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 999999999999999976432 12358999999999999999999999 89999999999
Q ss_pred ceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCc
Q 007256 395 NILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPK 473 (611)
Q Consensus 395 NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~ 473 (611)
|||++.++.+||+|||+|+...............||+.|+|||++.++.|+.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999988776655544455779999999999999999999999999999999998 89999876544
Q ss_pred chhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 474 GQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 474 ~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.....+... +. .+...... ...+..++..||+.||.+|||+++|+++|.
T Consensus 274 ~~~~~~~~~------~~-----~~~~p~~~----~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLIQN------GF-----KMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHT------TC-----CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhc------CC-----CCCCCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 322211111 00 00111111 234556777899999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=406.53 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=205.6
Q ss_pred hcCceeeee-EeecCcEEEEEEEeC---CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENL-IGKGGSSQVYKGCLP---DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~-LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+. ||+|+||+||+|.+. ++..||||+++.. ....++|.+|+++|++++|||||+++++|.. +.++|
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 456778875 999999999999753 4557999999753 4556789999999999999999999999864 57899
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999986543 258999999999999999999999 89999999999999999999999999999877
Q ss_pred cCCCCCc-cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 416 STSSSHI-TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 416 ~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
....... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...........+.. +...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~-------~~~~- 231 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------GKRM- 231 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-------TCCC-
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CCCC-
Confidence 6543322 2223578999999999999999999999999999999998 9999987654332222221 1111
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
.+....+ ..+..++..||+.||++|||+.+|++.|+
T Consensus 232 ----~~p~~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 232 ----ECPPECP----PELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp ----CCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCCCcCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 1111122 34556777899999999999999999886
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=409.52 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=203.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC-ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP-SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~-~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
+.|.+.+.||+|+||+||+|.+. +|+.||||+++. .....+.|.+|+++|++++|||||+++++|.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999974 799999999975 3455678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999876533 258999999999999999999999 899999999999999999999999999997654321
Q ss_pred CccccccccccccCChhhhc-----cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 421 HITCTDVAGTFGYLAPEYFM-----YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 421 ~~~~~~~~GT~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
.......||+.|+|||++. ...|+.++|||||||++|||+||+.||...........+....+ ..+.
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-------~~~~ 236 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------PTLA 236 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC-------CCCS
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-------CCCC
Confidence 1223468999999999984 45689999999999999999999999987655443222221110 0000
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
. +......+..++..||+.||.+|||+.|+++
T Consensus 237 ~-------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 Q-------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp S-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0111234455667799999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=418.84 Aligned_cols=202 Identities=25% Similarity=0.428 Sum_probs=179.7
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
..++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.+.+|+.+|++++|||||+++++|.+++.+++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999974 7899999998753 345678999999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||++||+|.+++.... .+++..++.++.|++.||.|||+. ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999997653 489999999999999999999961 3799999999999999999999999999987654
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCC
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHP 472 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~ 472 (611)
.. ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred Cc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 32 2246899999999999999999999999999999999999999976543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=406.02 Aligned_cols=256 Identities=24% Similarity=0.396 Sum_probs=198.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCCC-----CEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPDG-----KELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~g-----~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
.+.|...++||+|+||+||+|.++++ ..||||+++.. .....+|.+|++++++++|||||+++|+|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35789999999999999999986532 36999999753 345567999999999999999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+.+++|.+.+..... .++|.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999998865543 58999999999999999999999 8999999999999999999999999999987
Q ss_pred ccCCCCC-ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 415 ASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 415 ~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
....... .......||+.|+|||++.++.++.++|||||||++|||++|..|+........ +..... .+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i~----~~~--- 230 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAIN----DGF--- 230 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH----TTC---
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHHh----ccC---
Confidence 6543322 122335689999999999999999999999999999999997666554433221 111111 010
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.+. .+......+..++..||+.||++||||.+|++.|+.
T Consensus 231 --~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 231 --RLP----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp --CCC----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred --CCC----CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 011 111122346667788999999999999999998864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-49 Score=413.84 Aligned_cols=251 Identities=23% Similarity=0.340 Sum_probs=190.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh--hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE--DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~--~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.+.|.+.+.||+|+||+||+|.+. +|+.||||++.... .....+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999975 78999999997542 334568899999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC---CCCceEEeecCccccc
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWA 415 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd---~~~~vKL~DFGla~~~ 415 (611)
|++||+|.+++.... .+++.++..++.||+.||.|||+ ++|+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997543 58999999999999999999999 8999999999999994 5789999999999876
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
..... ....+||+.|+|||++.++.|+.++|||||||+||||++|+.||...........+.......
T Consensus 161 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~--------- 228 (307)
T d1a06a_ 161 DPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF--------- 228 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC---------
T ss_pred cCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC---------
Confidence 54332 223689999999999999999999999999999999999999998755433222222111100
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.......+ ...+..++..||+.||.+|||+.|++++
T Consensus 229 ~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DSPYWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CTTTTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00011111 1345566777999999999999999984
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-49 Score=402.42 Aligned_cols=245 Identities=26% Similarity=0.390 Sum_probs=197.4
Q ss_pred eeEeecCcEEEEEEEeC---CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 269 NLIGKGGSSQVYKGCLP---DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 269 ~~LG~G~fG~Vyk~~~~---~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
+.||+|+||+||+|.+. .++.||||+++.. ....+.|.+|+++|++++|||||+++++|. .+..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 57999999999999854 3568999999753 344678999999999999999999999985 4568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999997654 48999999999999999999999 899999999999999999999999999998765543322
Q ss_pred -cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 423 -TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 423 -~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
......||+.|+|||++.++.++.++|||||||++|||+| |+.||...........+..... +.+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~------------~~~p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------MGCP 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------CCCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC------------CCCC
Confidence 2233579999999999999999999999999999999998 8999987654332222221110 0111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
...+ ..+..++..||+.||.+|||+.+|++.|+
T Consensus 233 ~~~~----~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 233 AGCP----REMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp TTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred cccC----HHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 1112 34556677899999999999999998886
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-48 Score=411.38 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=206.7
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... ...+.+.+|+.+|++++|||||+++++|.+++.+||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 358999999999999999999874 79999999997643 4566788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC--CCCceEEeecCccccccC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd--~~~~vKL~DFGla~~~~~ 417 (611)
|+||+|.+++.... ..+++..++.|+.||+.||.|||+ ++||||||||+|||++ .++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999986443 259999999999999999999999 9999999999999995 467899999999987765
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.... ....||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+......+ ..
T Consensus 179 ~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~---- 246 (350)
T d1koaa2 179 KQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-----DD---- 246 (350)
T ss_dssp TSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-----CC----
T ss_pred cccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----Cc----
Confidence 4332 33689999999999999999999999999999999999999998665433322222111100 00
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.....+ ...+..++..||+.||.+|||+.|++++
T Consensus 247 ~~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFSGI----SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGGC----CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000011 1234556677999999999999999984
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=404.10 Aligned_cols=254 Identities=23% Similarity=0.388 Sum_probs=202.0
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeCCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFLSR 342 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~g 342 (611)
++|.+.+.||+|+||.||+|.+++++.||||+++......+.|.+|+.++++++|||||+++++|. ++..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 578999999999999999999988889999999877766788999999999999999999999985 4568999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCCc
Q 007256 343 GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSHI 422 (611)
Q Consensus 343 gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 422 (611)
|+|..++..... ..++|.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 96 g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 96 GSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp CBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 999998865432 258999999999999999999999 89999999999999999999999999999876543322
Q ss_pred cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcc-hhhHHHhhccccccCccccccCcccCC
Q 007256 423 TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKG-QESLVMWAKPILSSGKVTQLLDPALGN 501 (611)
Q Consensus 423 ~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~-~~~lv~~~~~~~~~g~l~~lld~~l~~ 501 (611)
......||+.|+|||++..+.++.++|||||||+||||++|..|+....... ....+..... .....
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~------------~~~~~ 237 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------MPCPP 237 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------CCCCT
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC------------CCCCc
Confidence 2234679999999999999999999999999999999999766654443322 2222221110 01111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 502 NYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 502 ~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.. ...+..++..||+.||++||++++|+++|+..
T Consensus 238 ~~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 238 EC----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred cc----CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 11 23466677889999999999999999988753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=397.03 Aligned_cols=244 Identities=26% Similarity=0.381 Sum_probs=194.5
Q ss_pred ceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe----cCceEEE
Q 007256 265 FLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE----DNNLLLV 336 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~----~~~~~LV 336 (611)
|.+.+.||+|+||+||+|.+. +++.||+|++... ....+.|.+|+++|++++|||||+++++|.. +..+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 367788999999999999975 6889999998643 3456779999999999999999999999875 3458999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCc--EEeeccCccceeeC-CCCceEEeecCccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQR--VIHRDVKSSNILLS-DDFEPQLSDFGLAK 413 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~g--IiHrDIKp~NILLd-~~~~vKL~DFGla~ 413 (611)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+ ++ |+||||||+||||+ +++.+||+|||+|+
T Consensus 91 mE~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp EECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EeCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999999999997643 48999999999999999999998 66 99999999999996 57899999999998
Q ss_pred cccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQ 493 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ 493 (611)
...... ....+||+.|+|||++. ++++.++|||||||++|||++|+.||.......... ... ..+....
T Consensus 164 ~~~~~~----~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~--~~i----~~~~~~~ 232 (270)
T d1t4ha_ 164 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--RRV----TSGVKPA 232 (270)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--HHH----TTTCCCG
T ss_pred eccCCc----cCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH--HHH----HcCCCCc
Confidence 654432 23468999999999987 469999999999999999999999997554332211 111 0111001
Q ss_pred ccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 494 LLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 494 lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
.+.... .+ .+..++..||+.||++|||+.|+++
T Consensus 233 ----~~~~~~-~~---~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ----SFDKVA-IP---EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGGGCC-CH---HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccCccC-CH---HHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111111 12 3445667799999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.4e-48 Score=409.97 Aligned_cols=251 Identities=20% Similarity=0.240 Sum_probs=206.6
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE-DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|+.+|++++|||||+++++|.+++.+||||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999997 479999999997643 44567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC--CCCceEEeecCccccccCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS--DDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd--~~~~vKL~DFGla~~~~~~ 418 (611)
+||+|.+.+.... ..+++.+++.|+.||+.||.|||+ +|||||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999998876543 358999999999999999999999 9999999999999997 6789999999999887654
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
... ....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.........+......+. ..
T Consensus 183 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------~~ 250 (352)
T d1koba_ 183 EIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------ED 250 (352)
T ss_dssp SCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---------SS
T ss_pred Cce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------cc
Confidence 322 336799999999999999999999999999999999999999987654433222221111000 00
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
....+ ...+..++..||+.||.+|||+.|++++
T Consensus 251 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111 1234556778999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=399.66 Aligned_cols=251 Identities=22% Similarity=0.300 Sum_probs=205.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC-------hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS-------EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~-------~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.+.|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ....+.|.+|+.+|++++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 46799999999999999999997 47999999998642 12467899999999999999999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC----ceEEeec
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF----EPQLSDF 409 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~----~vKL~DF 409 (611)
|||||||++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999997643 58999999999999999999999 9999999999999998776 5999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
|+|+........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus 162 G~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~----- 233 (293)
T d1jksa_ 162 GLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY----- 233 (293)
T ss_dssp TTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-----
T ss_pred hhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----
Confidence 999877554322 236799999999999999999999999999999999999999987654332222211110
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
... +...... ...+..++..||+.||.+|||+.+++++
T Consensus 234 ~~~----~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EFE----DEYFSNT----SALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCC----HHHHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCC----chhcCCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0000111 1234556778999999999999999873
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-48 Score=403.09 Aligned_cols=260 Identities=24% Similarity=0.417 Sum_probs=211.0
Q ss_pred hhcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN 332 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~ 332 (611)
..++|.+.+.||+|+||+||+|..+ +++.||||+++.. ....++|.+|+++|++++||||++++++|...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999853 4678999999753 3456789999999999999999999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccC
Q 007256 333 LLLVYDFLSRGSLEENLHGNKK--------------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVK 392 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~--------------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIK 392 (611)
.++||||+++|+|.+++..... ....+++..++.|+.|++.||+|||+ ++|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEc
Confidence 9999999999999999864321 12358999999999999999999999 899999999
Q ss_pred ccceeeCCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCC-CCCCCCC
Q 007256 393 SSNILLSDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR-KPISNDH 471 (611)
Q Consensus 393 p~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~-~Pf~~~~ 471 (611)
|+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998765544444444578999999999999999999999999999999999985 5676655
Q ss_pred CcchhhHHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 472 PKGQESLVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 472 ~~~~~~lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.......+.. +.... .....+ ..+..++..||+.+|.+||||.+|+++|+..
T Consensus 248 ~~e~~~~v~~-------~~~~~-----~p~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 248 HEEVIYYVRD-------GNILA-----CPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHHHHHHT-------TCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHHHHc-------CCCCC-----CCccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 4433222221 11111 111122 3466677889999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-48 Score=404.97 Aligned_cols=243 Identities=26% Similarity=0.390 Sum_probs=199.4
Q ss_pred CceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 264 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
.|...+.||+|+||+||+|.+ .+|+.||||+++.. ....+.+.+|+++|++++|||||+++++|.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 489999999999999999986 47889999998653 2445679999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
||.+|+|..++.... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999987765443 58999999999999999999999 89999999999999999999999999999865442
Q ss_pred CCCccccccccccccCChhhhcc---CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcccccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMY---GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLL 495 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~---~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~ll 495 (611)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||...........+... ....+.
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~-------~~~~~~ 235 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-------ESPALQ 235 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------CCCCCS
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-------CCCCCC
Confidence 23579999999999863 46899999999999999999999999765543322211111 111111
Q ss_pred CcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 DPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 d~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+ ..+ ...+..++..||+.||.+|||+.++++
T Consensus 236 ~----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 S----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----CCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1 111 124455666799999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=401.20 Aligned_cols=253 Identities=22% Similarity=0.385 Sum_probs=201.9
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCC----EEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGK----ELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~----~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
++|++.++||+|+||+||+|.+. +|+ .||||.++.. ....++|.+|++++++++|||||+++++|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46999999999999999999864 454 5899988753 3456789999999999999999999999976 46788
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
+|||+.+|+|.+.+.... ..+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887654 368999999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
.............||+.|+|||++.++.|+.++|||||||++|||+| |..||...........+.......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-------- 233 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-------- 233 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC--------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 66555444445679999999999999999999999999999999998 788887665444333332211110
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
. +......+..++..||+.||.+|||+.+|++.|..
T Consensus 234 ----~----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 234 ----Q----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ----C----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----C----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 0 11112345667778999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.2e-48 Score=402.11 Aligned_cols=244 Identities=26% Similarity=0.361 Sum_probs=204.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999974 7999999999743 234577899999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||++||+|..++.... .+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999987654 47888999999999999999999 9999999999999999999999999999987754
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
.. ...+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+.......+..... .
T Consensus 157 ~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~------- 219 (316)
T d1fota_ 157 VT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL-----R------- 219 (316)
T ss_dssp CB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC-----C-------
T ss_pred cc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----C-------
Confidence 32 246899999999999999999999999999999999999999987654433222221111 0
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
+....+ ..+..++..||+.||.+|| |+++++++
T Consensus 220 -~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -FPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111111 2345566679999999996 89998874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=404.85 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=206.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.. ....+.+.+|+.+|+.++||||++++++|.+++.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 46899999999999999999997 47999999999753 23467789999999999999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||++||+|.+++.... .+++..++.++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999998654 48899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
.... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.......+.....
T Consensus 157 ~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~------------ 222 (337)
T d1o6la_ 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------ 222 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred cCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC------------
Confidence 4332 22347899999999999999999999999999999999999999987664432222211110
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 535 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~~ 535 (611)
.+...+. ..+..++..||+.||.+||+ +.+++++
T Consensus 223 -~~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 -RFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1111122 23445666799999999995 7887763
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-48 Score=391.71 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=195.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeCC----CCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEE
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLPD----GKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~~----g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~L 335 (611)
.++|.+.+.||+|+||.||+|.+.. +..||||.++.. ....+.|.+|+.++++++|||||+++++|. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3579999999999999999998642 456899998753 455678999999999999999999999995 567899
Q ss_pred EEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccc
Q 007256 336 VYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWA 415 (611)
Q Consensus 336 V~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~ 415 (611)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+|+..
T Consensus 85 v~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999876543 258999999999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccc
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQL 494 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~l 494 (611)
....... .....||+.|+|||++.++.++.++|||||||++|||++ |..||...........+..... .
T Consensus 159 ~~~~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-------~-- 228 (273)
T d1mp8a_ 159 EDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------L-- 228 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------C--
T ss_pred cCCccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------C--
Confidence 5543322 234678999999999999999999999999999999998 8999987665443332221111 0
Q ss_pred cCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 495 LDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 495 ld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.+....+ ..+..++..||+.||.+|||+.+|++.|+.
T Consensus 229 ---~~~~~~~----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 ---PMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ---CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCCCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111122 345566778999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-47 Score=390.70 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=199.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCc----
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNN---- 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~---- 332 (611)
.++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ......|.+|+++++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999986 47999999999753 3456679999999999999999999999987553
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
+||||||++|++|.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence 799999999999999887654 48999999999999999999999 99999999999999999999999999998
Q ss_pred ccccCCCCC-ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 413 KWASTSSSH-ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 413 ~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
......... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||................+..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~----- 233 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP----- 233 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-----
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCC-----
Confidence 765443222 22334689999999999999999999999999999999999999998765433222221111110
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHhh
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARP-QMSLVLKLLR 537 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-tm~eVL~~L~ 537 (611)
..... ... ...+..++..||+.||.+|| |++++++.|.
T Consensus 234 ~~~~~----~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 234 PSARH----EGL----SADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp GGGTS----SSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred Cchhc----cCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 01111 111 13455566779999999999 7999887764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=399.16 Aligned_cols=251 Identities=19% Similarity=0.241 Sum_probs=207.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEeeC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDFL 340 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 340 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++........+.+|+++|+.++|||||+++++|.+++.+|||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 468999999999999999999875 7889999999887766677889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCC--CceEEeecCccccccCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDD--FEPQLSDFGLAKWASTS 418 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~--~~vKL~DFGla~~~~~~ 418 (611)
+||+|.+++.... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999997543 258999999999999999999999 999999999999999854 58999999999876543
Q ss_pred CCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.. .....||+.|+|||.+.+..|+.++|||||||++|+|++|+.||...........+......+ .. .
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~----~ 225 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-----DE----E 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-----CH----H
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----Ch----h
Confidence 32 233679999999999999999999999999999999999999998765443322222111100 00 0
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
....+ ...+..++..||..||.+|||+.|+++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011 123456677899999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=396.83 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=198.0
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec-C
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED-N 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~-~ 331 (611)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.. ....+.+.+|..++.++ +|+||+.+++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357999999999999999999853 3568999999753 34566788888888877 689999999998765 4
Q ss_pred ceEEEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 399 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd 399 (611)
.+++||||+++|+|.++++.... ....+++..+..++.||+.||.|||+ ++||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 68999999999999999975432 12358999999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCC-CCCCCCCCcchhhH
Q 007256 400 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR-KPISNDHPKGQESL 478 (611)
Q Consensus 400 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~-~Pf~~~~~~~~~~l 478 (611)
.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||...........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998776655554555578999999999999999999999999999999999974 57765543322111
Q ss_pred HHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 479 VMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 479 v~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
... .+.. +...... ...+..++..||+.||.+|||+.+|+++|+.
T Consensus 249 ~~~------~~~~-----~~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 249 RLK------EGTR-----MRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp HHH------HTCC-----CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHh------cCCC-----CCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 110 1110 1111111 1245567778999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.4e-47 Score=387.89 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=204.5
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh----------hHHHHHHHHHHHHHhcC-CcceeEEeeEEEec
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE----------DVIKEFVLEIEIITTLH-HKNIISLLGFCFED 330 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~----------~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~ 330 (611)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|+.++++++ ||||++++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999987 479999999986531 23456889999999997 99999999999999
Q ss_pred CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecC
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFG 410 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFG 410 (611)
+.+||||||+++|+|.+++.... .+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997543 58999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCCccccccccccccCChhhhcc------CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcc
Q 007256 411 LAKWASTSSSHITCTDVAGTFGYLAPEYFMY------GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKP 484 (611)
Q Consensus 411 la~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~ 484 (611)
+++........ ....||+.|+|||++.+ ..++.++||||+||+||||++|+.||...........+.....
T Consensus 156 ~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 156 FSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232 (277)
T ss_dssp TCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred heeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCC
Confidence 99887654322 34689999999999863 3578899999999999999999999987654433222221111
Q ss_pred ccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 485 ILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 485 ~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.... + ........+..++..||+.||.+|||+.||+++
T Consensus 233 ~~~~--------~-----~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 233 QFGS--------P-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CCCT--------T-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCC--------c-----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1000 0 001112345566778999999999999998763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.4e-47 Score=400.97 Aligned_cols=249 Identities=23% Similarity=0.332 Sum_probs=199.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh----hHHHHHH---HHHHHHHhcCCcceeEEeeEEEecCce
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE----DVIKEFV---LEIEIITTLHHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~----~~~~~f~---~Ei~iL~~l~HpnIv~l~g~~~~~~~~ 333 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... .....+. .|+.+++.++|||||+++++|.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999975 79999999986422 1222333 446677778899999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
|+||||++||+|.+++.... .+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999997653 47899999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 414 WASTSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 414 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
....... ...+||+.|+|||++.. ..|+.++|||||||+||||+||+.||..........+.......
T Consensus 156 ~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------- 224 (364)
T d1omwa3 156 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------- 224 (364)
T ss_dssp ECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-------
T ss_pred ecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-------
Confidence 7765432 23579999999999975 46899999999999999999999999876554433322211100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLKL 535 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~~ 535 (611)
...+...++ ..+..++..||+.||.+||| +++++++
T Consensus 225 ---~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 ---AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---CCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---CCCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 001111112 23455666799999999999 6888763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-47 Score=401.70 Aligned_cols=244 Identities=23% Similarity=0.290 Sum_probs=204.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~ 337 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||++... ....+.+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 68999999999999999999874 7999999998643 234567899999999999999999999999999999999
Q ss_pred eeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccC
Q 007256 338 DFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAST 417 (611)
Q Consensus 338 Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 417 (611)
||+.+|+|.+++.... .+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999997654 48999999999999999999999 9999999999999999999999999999987754
Q ss_pred CCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCc
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDP 497 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~ 497 (611)
. .....||+.|+|||++.+..|+.++|||||||++|||+||+.||...........+......
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~------------ 256 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR------------ 256 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------------
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC------------
Confidence 2 22468999999999999999999999999999999999999999876543332222211110
Q ss_pred ccCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007256 498 ALGNNYDYDQMERMVLASILCIRRDPRARP-----QMSLVLKL 535 (611)
Q Consensus 498 ~l~~~~~~~~~~~l~~la~~CL~~dP~~RP-----tm~eVL~~ 535 (611)
....++ ..+..++..||+.||.+|+ |+++++++
T Consensus 257 -~p~~~s----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 257 -FPSHFS----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCTTCC----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCccCC----HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111111 2345566679999999994 89998873
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=389.68 Aligned_cols=249 Identities=29% Similarity=0.438 Sum_probs=195.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEe-cCceEEEEeeCC
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFE-DNNLLLVYDFLS 341 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-~~~~~LV~Ey~~ 341 (611)
++|.+.+.||+|+||.||+|.+ .|+.||||+++.+ ...+.|.+|++++++++||||++++|+|.+ .+.+++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 5788999999999999999998 5788999999754 455789999999999999999999999965 456899999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCCC
Q 007256 342 RGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSSH 421 (611)
Q Consensus 342 ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 421 (611)
+|+|.+++..... ..++|..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 9999999965422 248999999999999999999999 899999999999999999999999999998655422
Q ss_pred ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccccccCcccC
Q 007256 422 ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPALG 500 (611)
Q Consensus 422 ~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~l~ 500 (611)
....+|+.|+|||++.++.++.++|||||||++|||+| |+.||...........+. .+. .+.+.
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-------~~~-----~~~~~ 222 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGY-----KMDAP 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TTC-----CCCCC
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC-----CCCCC
Confidence 23468999999999999999999999999999999998 688876654433222221 111 11111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 501 NNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 501 ~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
...+ ..+..++..||+.||.+|||+.+|+++|+..
T Consensus 223 ~~~~----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 223 DGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCC----HHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111 3455677789999999999999999998643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=394.68 Aligned_cols=270 Identities=26% Similarity=0.322 Sum_probs=200.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC----ceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~----~~~LV~E 338 (611)
.+|.+.+.||+|+||.||+|.+ +|+.||||+++........+..|+..+..++|||||+++++|.+.+ .+++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 5688899999999999999986 6889999999765433223334555556789999999999998764 5799999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-----AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~-----~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
|+++|+|.++++.. .++|..++.++.+++.||+|||+.. .++|+||||||+||||+.++.+||+|||+++
T Consensus 82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999764 4899999999999999999999731 2699999999999999999999999999998
Q ss_pred cccCCCCC--ccccccccccccCChhhhccC------CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhh-cc
Q 007256 414 WASTSSSH--ITCTDVAGTFGYLAPEYFMYG------KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWA-KP 484 (611)
Q Consensus 414 ~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~------~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~-~~ 484 (611)
........ .......||+.|+|||++... .++.++|||||||+||||+||..||............... .+
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 77554332 123346899999999998754 3677999999999999999999887543322111000000 00
Q ss_pred c---cccCccccccCcccCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 485 I---LSSGKVTQLLDPALGNNY-DYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 485 ~---~~~g~l~~lld~~l~~~~-~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
. .........++|.+.... ..+....+..++..||+.||.+|||+.||++.|+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0 000001111222222222 22345567788889999999999999999998864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=390.94 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=206.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC--------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEec
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP--------DGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFED 330 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~--------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~ 330 (611)
.++|.+.+.||+|+||.||+|... ++..||||+++.. .....++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 357899999999999999999853 2347999999754 34567899999999888 799999999999999
Q ss_pred CceEEEEeeCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceee
Q 007256 331 NNLLLVYDFLSRGSLEENLHGNKK------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILL 398 (611)
Q Consensus 331 ~~~~LV~Ey~~ggsL~~~L~~~~~------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILL 398 (611)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceee
Confidence 999999999999999999975532 12458999999999999999999999 999999999999999
Q ss_pred CCCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhh
Q 007256 399 SDDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES 477 (611)
Q Consensus 399 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~ 477 (611)
+.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |+.||..........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999998776655544555789999999999999999999999999999999998 788887655432222
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.+.. +. .+...... ...+..++..||+.||.+|||+.+|++.|+..
T Consensus 249 ~i~~-------~~-----~~~~p~~~----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 249 LLKE-------GH-----RMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HHHT-------TC-----CCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHc-------CC-----CCCCCccc----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 2111 10 01111111 23456677789999999999999999999643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=394.54 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=210.3
Q ss_pred cCceeeeeEeecCcEEEEEEEe------CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCce
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL------PDGKELAVKILKPS--EDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNL 333 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~------~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~ 333 (611)
++|.+.+.||+|+||.||+|.+ .+++.||||+++.. ......|.+|+.+++++ +|||||+++++|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788999999999999999974 35678999999854 34566799999999999 699999999999999999
Q ss_pred EEEEeeCCCCChhhhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC
Q 007256 334 LLVYDFLSRGSLEENLHGNKK--------------DPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS 399 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~--------------~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd 399 (611)
++||||+++|+|.++++.... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 999999999999999976432 22358999999999999999999999 8999999999999999
Q ss_pred CCCceEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhh-
Q 007256 400 DDFEPQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQES- 477 (611)
Q Consensus 400 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~- 477 (611)
.++.+||+|||+++...............||+.|+|||++..+.++.++|||||||++|||+| |.+||..........
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999998876665555566789999999999999999999999999999999999 555555444333221
Q ss_pred HHHhhccccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 478 LVMWAKPILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 478 lv~~~~~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
.+....+ +.. +......+..++..||+.||.+|||+.+|+++|+.
T Consensus 260 ~i~~~~~------------~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 260 MIKEGFR------------MLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp HHHHTCC------------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhcCCC------------CCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 2211111 011 11112346667778999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=389.66 Aligned_cols=260 Identities=25% Similarity=0.287 Sum_probs=196.5
Q ss_pred eeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh------hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 267 AENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE------DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~------~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.+++||+|+||+||+|.+. +|+.||||+++... ...+.+.+|+.+|++++|||||+++++|..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999975 79999999997532 1234688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+.++++..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9998777666533 258889999999999999999999 999999999999999999999999999998765543
Q ss_pred CCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccc---ccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVT---QLL 495 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~---~ll 495 (611)
.. ....+||+.|+|||++..+ .|+.++|||||||++|||++|+.||...........+............. ...
T Consensus 155 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 RA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred cc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 32 2236799999999998755 57999999999999999999999998766544333222110000000000 000
Q ss_pred Cc-ccC--CCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 496 DP-ALG--NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 496 d~-~l~--~~~~~-----~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.. ... ...+. .....+..++..||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 000 00011 112345667778999999999999999863
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=388.33 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=195.8
Q ss_pred cCceeeeeEeecCcEEEEEEEeC--CC--CEEEEEEecCC----hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP--DG--KELAVKILKPS----EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~--~g--~~vAVK~l~~~----~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
++|++.+.||+|+||.||+|... ++ ..||||+++.. ....++|.+|+.+|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57999999999999999999853 33 36899998753 3556789999999999999999999999965 5789
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKW 414 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~ 414 (611)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999886543 258999999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcc-ccccccccccCChhhhccCCCCCcceehhhhHHHHHHHh-CCCCCCCCCCcchhhHHHhhccccccCccc
Q 007256 415 ASTSSSHIT-CTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLT-GRKPISNDHPKGQESLVMWAKPILSSGKVT 492 (611)
Q Consensus 415 ~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELlt-G~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~ 492 (611)
......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...........+.. .+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~------~~~~- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------EGER- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------SCCC-
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh------CCCC-
Confidence 765543322 233568889999999999999999999999999999998 8999976554432222211 1100
Q ss_pred cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 493 QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 493 ~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
+......+ ..+..++..||+.||++|||+.+|++.|+.
T Consensus 234 ----~~~~~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 234 ----LPRPEDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 00111111 245567777999999999999999998864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=390.47 Aligned_cols=260 Identities=21% Similarity=0.375 Sum_probs=210.7
Q ss_pred cCceeeeeEeecCcEEEEEEEeC------CCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP------DGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~------~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~ 334 (611)
++|.+.+.||+|+||+||+|.+. +++.||||+++.. ......|.+|+.++++++|||||+++++|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 57889999999999999999863 3678999999753 344567899999999999999999999999999999
Q ss_pred EEEeeCCCCChhhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEee
Q 007256 335 LVYDFLSRGSLEENLHGNK------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 408 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~------~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~D 408 (611)
+||||+++|+|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 9999999999999886432 122357899999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCC-CCCCCCCCcchhhHHHhhccccc
Q 007256 409 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGR-KPISNDHPKGQESLVMWAKPILS 487 (611)
Q Consensus 409 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~-~Pf~~~~~~~~~~lv~~~~~~~~ 487 (611)
||+|+...............||+.|+|||.+.++.++.++|||||||++|||+||. .||...........+..
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~------ 250 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT------
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------
Confidence 99998776654444444567999999999999999999999999999999999985 66765443332222211
Q ss_pred cCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCCcc
Q 007256 488 SGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGDAD 541 (611)
Q Consensus 488 ~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~~~ 541 (611)
+..... .... ...+..++..||+.+|.+|||+.+|++.|+...+
T Consensus 251 -~~~~~~-----p~~~----~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 -GGLLDK-----PDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -TCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -CCCCCC-----cccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111 1111 1346667778999999999999999999986543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=390.58 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=200.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCC--EEEEEEecC--ChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEecCceEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGK--ELAVKILKP--SEDVIKEFVLEIEIITTL-HHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~--~vAVK~l~~--~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~~~~~~LV 336 (611)
++|.+.+.||+|+||+||+|.++ +|. .||||.++. .....+.|.+|+++|+++ +|||||+++++|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57899999999999999999875 444 477888754 334566899999999998 799999999999999999999
Q ss_pred EeeCCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCce
Q 007256 337 YDFLSRGSLEENLHGNK------------KDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEP 404 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~------------~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~v 404 (611)
|||+++|+|.++|+... .....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 99999999999997542 223569999999999999999999999 899999999999999999999
Q ss_pred EEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCC-CCCCCCCcchhhHHHhhc
Q 007256 405 QLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRK-PISNDHPKGQESLVMWAK 483 (611)
Q Consensus 405 KL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~-Pf~~~~~~~~~~lv~~~~ 483 (611)
||+|||+++........ ....||..|+|||.+.++.++.++|||||||++|||++|.. ||...........+.
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~--- 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--- 240 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG---
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH---
Confidence 99999999865543322 23568999999999999999999999999999999999765 665544322211111
Q ss_pred cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 484 PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 484 ~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.+. .+.. +......+..++..||+.||++||||.+|++.|+..
T Consensus 241 ----~~~-----~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 241 ----QGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp ----GTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----hcC-----CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 110 0111 111123455667789999999999999999988643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=395.94 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=203.0
Q ss_pred cCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC----hhHHHHHHHHHHHHH-hcCCcceeEEeeEEEecCceEEE
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS----EDVIKEFVLEIEIIT-TLHHKNIISLLGFCFEDNNLLLV 336 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~----~~~~~~f~~Ei~iL~-~l~HpnIv~l~g~~~~~~~~~LV 336 (611)
++|.+.+.||+|+||+||+|.+. +|+.||||+++.. ....+.+..|..++. .++|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999875 7999999999743 234556777887765 68999999999999999999999
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 416 (611)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999997654 48899999999999999999999 899999999999999999999999999998665
Q ss_pred CCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccC
Q 007256 417 TSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLD 496 (611)
Q Consensus 417 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld 496 (611)
..... .....||+.|+|||++.++.|+.++|||||||++|||++|+.||.+.........+....+
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~------------ 220 (320)
T d1xjda_ 155 LGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------------ 220 (320)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred ccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 43332 2346899999999999999999999999999999999999999987655443333322211
Q ss_pred cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 007256 497 PALGNNYDYDQMERMVLASILCIRRDPRARPQMS-LVLK 534 (611)
Q Consensus 497 ~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~-eVL~ 534 (611)
.+...++ ..+..++..||+.||.+||++. ++++
T Consensus 221 -~~p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 -FYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCccCC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111111 2345566679999999999985 6654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=393.99 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=196.9
Q ss_pred hcCceeee-eEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhc-CCcceeEEeeEEEe----cCceE
Q 007256 262 TSNFLAEN-LIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTL-HHKNIISLLGFCFE----DNNLL 334 (611)
Q Consensus 262 t~~f~~~~-~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l-~HpnIv~l~g~~~~----~~~~~ 334 (611)
.++|.+.+ .||+|+||+||+|.+ .+|+.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ +..+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 46888765 699999999999986 57999999999754 3466799987654 89999999999875 46789
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC---CCceEEeecCc
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD---DFEPQLSDFGL 411 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~---~~~vKL~DFGl 411 (611)
+|||||+||+|.+++..... ..+++.+++.|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccce
Confidence 99999999999999975432 359999999999999999999999 99999999999999975 56799999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
|+........ ....||+.|+|||++.+..|+.++|||||||+||+|+||+.||...........+.. ....+..
T Consensus 161 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~---~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---RIRMGQY 234 (335)
T ss_dssp CEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred eeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH---HHhcCCC
Confidence 9877654332 346899999999999999999999999999999999999999976543322111100 0000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+...........+..++..||+.||.+|||+.+++++
T Consensus 235 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000001112345667778999999999999999873
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-46 Score=383.95 Aligned_cols=265 Identities=26% Similarity=0.330 Sum_probs=199.4
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCCh---hHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSE---DVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~---~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++... ...+.+.+|+++|++++|||||+++++|.+++.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999997 579999999997532 335678999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
|+.++.+........ ..+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 998754443333322 358999999999999999999999 99999999999999999999999999999877543
Q ss_pred CCCccccccccccccCChhhhccCC-CCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC---ccccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---KVTQL 494 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---~l~~l 494 (611)
.. ......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+.......+.......... .....
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 32 223468999999999887665 5789999999999999999999998765433222211110000000 00000
Q ss_pred cC--cccCC--CCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 495 LD--PALGN--NYD-----YDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 495 ld--~~l~~--~~~-----~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+ ..+.. ... ......+..++..||+.||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 00000 000 0111345556778999999999999999863
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-46 Score=384.85 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=198.2
Q ss_pred eeeEeecCcEEEEEEEeCCC----CEEEEEEecC--ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-CceEEEEeeC
Q 007256 268 ENLIGKGGSSQVYKGCLPDG----KELAVKILKP--SEDVIKEFVLEIEIITTLHHKNIISLLGFCFED-NNLLLVYDFL 340 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~~g----~~vAVK~l~~--~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~-~~~~LV~Ey~ 340 (611)
.++||+|+||+||+|.+.++ ..||||+++. .....++|.+|+++|++++||||++++|+|.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999986432 2589999974 445668899999999999999999999998764 5789999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCCC
Q 007256 341 SRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSSS 420 (611)
Q Consensus 341 ~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 420 (611)
++|+|.+++..... .+.+..++.++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999876543 57788999999999999999999 8999999999999999999999999999987655432
Q ss_pred Cc--cccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCccccccCcc
Q 007256 421 HI--TCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKVTQLLDPA 498 (611)
Q Consensus 421 ~~--~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l~~lld~~ 498 (611)
.. ......||+.|+|||++..+.++.++||||||+++|||+||+.||......... ..+. ..+. ....|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~--~~~i----~~g~--~~~~p- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYL----LQGR--RLLQP- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C--HHHH----HTTC--CCCCC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH--HHHH----HcCC--CCCCc-
Confidence 22 223357899999999999999999999999999999999988887654332211 1111 0111 00111
Q ss_pred cCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhCC
Q 007256 499 LGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRGD 539 (611)
Q Consensus 499 l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~~ 539 (611)
.. .. ..+..++..||+.||++||+|.+|++.|+..
T Consensus 257 --~~-~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 257 --EY-CP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp --TT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cc-Cc---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 12 2455667789999999999999999998644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.8e-46 Score=379.25 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=200.5
Q ss_pred cCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEee
Q 007256 263 SNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~Ey 339 (611)
++|.+.+.||+|+||+||+|.+++|+.||||+++.. ....+.+.+|+.+|++++|||||+++++|..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999999999999999754 23357899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCCC
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTSS 419 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 419 (611)
+.++.+..+..... .+++..++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99877777665443 58999999999999999999999 899999999999999999999999999998765533
Q ss_pred CCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC---cccccc
Q 007256 420 SHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG---KVTQLL 495 (611)
Q Consensus 420 ~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g---~l~~ll 495 (611)
.. .....||+.|+|||.+... .++.++|||||||++|||++|+.||...........+.......... ......
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 RK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 22 2235789999999998754 56899999999999999999999997655433322211111000000 000000
Q ss_pred --CcccC-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 496 --DPALG-------NNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 496 --d~~l~-------~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
+..+. ..........+..++..||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0001111234556677799999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=382.32 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=196.5
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CC-CCEEEEEEecCC---hhHHHHHHHHHHHHHhc---CCcceeEEeeEEEe----
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PD-GKELAVKILKPS---EDVIKEFVLEIEIITTL---HHKNIISLLGFCFE---- 329 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~-g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l---~HpnIv~l~g~~~~---- 329 (611)
.++|.+.+.||+|+||+||+|.+ .+ ++.||||+++.. ......+.+|+.+|+.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999986 34 567999998642 22233566788777665 79999999999863
Q ss_pred -cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEee
Q 007256 330 -DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSD 408 (611)
Q Consensus 330 -~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~D 408 (611)
....+++|||+.++.+........ ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence 346899999999987765544332 358899999999999999999999 8999999999999999999999999
Q ss_pred cCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 007256 409 FGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 488 (611)
Q Consensus 409 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 488 (611)
||+++...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+.........
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99987654332 233478999999999999999999999999999999999999999876554433322211100000
Q ss_pred Ccc------c-----cccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 489 GKV------T-----QLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 489 g~l------~-----~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
... . ....... ..+.......+..++..||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0 0000000 00011112234456677999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=378.85 Aligned_cols=240 Identities=22% Similarity=0.359 Sum_probs=194.6
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCCh-------hHHHHHHHHHHHHHhcC--CcceeEEeeEEEecC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSE-------DVIKEFVLEIEIITTLH--HKNIISLLGFCFEDN 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~-------~~~~~f~~Ei~iL~~l~--HpnIv~l~g~~~~~~ 331 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++... ....++.+|+.+|++++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 368999999999999999999974 79999999986431 12244678999999997 899999999999999
Q ss_pred ceEEEEeeCCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-CCceEEeec
Q 007256 332 NLLLVYDFLSR-GSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-DFEPQLSDF 409 (611)
Q Consensus 332 ~~~LV~Ey~~g-gsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-~~~vKL~DF 409 (611)
..++||||+.+ +++.+++.... .+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~----~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcc
Confidence 99999999986 57778776543 58999999999999999999999 99999999999999985 479999999
Q ss_pred CccccccCCCCCccccccccccccCChhhhccCCC-CCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccccc
Q 007256 410 GLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKV-NDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSS 488 (611)
Q Consensus 410 Gla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~ 488 (611)
|+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... . +......
T Consensus 156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-i~~~~~~--- 222 (273)
T d1xwsa_ 156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-IIRGQVF--- 222 (273)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-HHHCCCC---
T ss_pred ccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-HhhcccC---
Confidence 9998665432 234689999999999987766 567899999999999999999996531 1 1111110
Q ss_pred CccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 489 GKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 489 g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+...++ ..+..++..||+.||.+|||+.|++++
T Consensus 223 ----------~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 223 ----------FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----------CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------CCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111122 234556677999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=373.05 Aligned_cols=267 Identities=22% Similarity=0.294 Sum_probs=197.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe--------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE-------- 329 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~-------- 329 (611)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++... +...+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999997 47999999998643 2345678899999999999999999998855
Q ss_pred cCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeec
Q 007256 330 DNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDF 409 (611)
Q Consensus 330 ~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DF 409 (611)
++..++||||+.++.+....... ..++...++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 34689999999987766554433 258889999999999999999999 99999999999999999999999999
Q ss_pred CccccccCCCCC--ccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhcccc
Q 007256 410 GLAKWASTSSSH--ITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPIL 486 (611)
Q Consensus 410 Gla~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~ 486 (611)
|+++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999866543221 122235799999999998765 68999999999999999999999998765444333322211111
Q ss_pred ccCccccccCc--------ccCCCCChH-H------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 487 SSGKVTQLLDP--------ALGNNYDYD-Q------MERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 487 ~~g~l~~lld~--------~l~~~~~~~-~------~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
........... ......... . ...+..++..||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11111110000 000000111 1 1123456778999999999999999974
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=377.77 Aligned_cols=262 Identities=24% Similarity=0.272 Sum_probs=192.6
Q ss_pred CceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcceeEEeeEEEec------CceEEE
Q 007256 264 NFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNIISLLGFCFED------NNLLLV 336 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~------~~~~LV 336 (611)
+|...++||+|+||+||+|.+. +|+.||||+++.... .+.+|+++|++++||||++++++|... ..++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 5788899999999999999975 799999999976543 234799999999999999999998643 247899
Q ss_pred EeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-ceEEeecCccccc
Q 007256 337 YDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWA 415 (611)
Q Consensus 337 ~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-~vKL~DFGla~~~ 415 (611)
|||++++.+..+.. .......+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99998764444332 11122368999999999999999999999 9999999999999999775 8999999999877
Q ss_pred cCCCCCccccccccccccCChhhhcc-CCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc-----------
Q 007256 416 STSSSHITCTDVAGTFGYLAPEYFMY-GKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK----------- 483 (611)
Q Consensus 416 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~----------- 483 (611)
...... ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 554332 23679999999998875 478999999999999999999999998765433322221100
Q ss_pred -cccccCccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 484 -PILSSGKVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 484 -~~~~~g~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+......+...................+..++..||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000001111100000000111112235556677999999999999999863
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=372.14 Aligned_cols=267 Identities=22% Similarity=0.293 Sum_probs=198.3
Q ss_pred hhcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC--hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC----ce
Q 007256 261 ATSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS--EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN----NL 333 (611)
Q Consensus 261 ~t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~--~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~----~~ 333 (611)
.+++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ....+.+.+|+++|+.++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356899999999999999999986 58999999999753 345678999999999999999999999997653 23
Q ss_pred EEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 334 LLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 334 ~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
+++++|+.+|+|.+++... .+++..++.++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+++
T Consensus 86 ~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 5556677899999999753 48999999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCC-ccccccccccccCChhhhc-cCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 414 WASTSSSH-ITCTDVAGTFGYLAPEYFM-YGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 414 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~-~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
........ ......+||+.|+|||++. ...++.++||||+||++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 76543322 1223467999999999985 456788999999999999999999999876543333222111110000000
Q ss_pred --------cccc-CcccCCCCChH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 492 --------TQLL-DPALGNNYDYD-----QMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 492 --------~~ll-d~~l~~~~~~~-----~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.... ........+.. ....+..++..||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000001111 01245567778999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=372.99 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=193.1
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecC---ChhHHHHHHHHHHHHHhcCCcceeEEeeEEEecC------
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKP---SEDVIKEFVLEIEIITTLHHKNIISLLGFCFEDN------ 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~---~~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~------ 331 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++. .....+.+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999964 799999999975 3355678899999999999999999999997654
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
.+++||||+ +.+|..+++.. .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence 579999999 55788777543 48999999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC-
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG- 489 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g- 489 (611)
|+...... +...||+.|+|||++.+. .++.++|||||||++|||++|+.||......................
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 98765432 236799999999998764 56899999999999999999999998765433222111110000000
Q ss_pred --------------ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 --------------KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 --------------~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
.+.......+.. ........+..++..||+.||.+|||+.|+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 000011234456677999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=359.05 Aligned_cols=264 Identities=21% Similarity=0.247 Sum_probs=202.7
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEecCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFEDNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~~~~~LV~E 338 (611)
++|++.+.||+|+||+||+|.+ .+|+.||||+++.. ......+.+|+.+|+.++||||++++++|......++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999997 47899999998643 3557789999999999999999999999999999999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCccccccCC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLAKWASTS 418 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 418 (611)
++.+++|..++.... .+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988876543 47899999999999999999999 89999999999999999999999999999877654
Q ss_pred CCCccccccccccccCChhhhccCC-CCCcceehhhhHHHHHHHhCCCCCCCCCCcch-hhHHHhhccccccCc---ccc
Q 007256 419 SSHITCTDVAGTFGYLAPEYFMYGK-VNDKIDVYAFGVVLLELLTGRKPISNDHPKGQ-ESLVMWAKPILSSGK---VTQ 493 (611)
Q Consensus 419 ~~~~~~~~~~GT~~Y~APE~l~~~~-~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~-~~lv~~~~~~~~~g~---l~~ 493 (611)
.... ....+++.|+|||++.... ++.++|||||||++|||++|+.||........ ...+........... ...
T Consensus 155 ~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred Cccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 3322 2346788999999988665 68999999999999999999999754433221 111111100000000 000
Q ss_pred ccC---------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 494 LLD---------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 494 lld---------~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
..+ ..-...........+..++..||+.||.+|||++||+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000111112344556677999999999999998863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-43 Score=360.85 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=193.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCccee-EEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNII-SLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnIv-~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++.... ...++..|+++++.++|+|++ .+..++.+++..++||||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 35799999999999999999986 478999999987543 234678899999999876654 555566777889999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeC---CCCceEEeecCcccccc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLS---DDFEPQLSDFGLAKWAS 416 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd---~~~~vKL~DFGla~~~~ 416 (611)
+.+ +|.+.+.... ..+++..+..++.|++.||+|||+ ++||||||||+|||++ .+..+||+|||+|+...
T Consensus 85 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 LGP-SLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-BHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred cCC-chhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 954 6666665433 258999999999999999999999 9999999999999875 45579999999999876
Q ss_pred CCCCC-----ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCcc
Q 007256 417 TSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGKV 491 (611)
Q Consensus 417 ~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~l 491 (611)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 54322 1223468999999999999999999999999999999999999999775543332221111100000000
Q ss_pred ccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhh
Q 007256 492 TQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLR 537 (611)
Q Consensus 492 ~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~ 537 (611)
+.+...++ ..+..++..|++.+|.+||++.++.+.|+
T Consensus 238 -----~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 238 -----EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp -----HHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred -----hHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 11111112 23455666799999999999999988776
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.5e-43 Score=363.42 Aligned_cols=257 Identities=19% Similarity=0.309 Sum_probs=195.8
Q ss_pred cCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-CcceeEEeeEEEe--cCceEEEEe
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-HKNIISLLGFCFE--DNNLLLVYD 338 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~--~~~~~LV~E 338 (611)
++|.+.+.||+|+||+||+|.+ .+|+.||||+++... .+++.+|+++|+.++ ||||++++++|.. ...+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 6899999999999999999997 479999999998643 467889999999996 9999999999974 356999999
Q ss_pred eCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC-ceEEeecCccccccC
Q 007256 339 FLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF-EPQLSDFGLAKWAST 417 (611)
Q Consensus 339 y~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~-~vKL~DFGla~~~~~ 417 (611)
|+.+++|..+.. .+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987642 48899999999999999999999 9999999999999998655 699999999987765
Q ss_pred CCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhh-HHH----------hhc--
Q 007256 418 SSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQES-LVM----------WAK-- 483 (611)
Q Consensus 418 ~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~-lv~----------~~~-- 483 (611)
.... ....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+. +..
T Consensus 183 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4322 336799999999998765 47999999999999999999999997655432111 100 000
Q ss_pred cccccCccccccC--------cccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007256 484 PILSSGKVTQLLD--------PALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLK 534 (611)
Q Consensus 484 ~~~~~g~l~~lld--------~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~ 534 (611)
............. ..............+..++..||+.||.+|||++|+|+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000001100 00111011111234555677899999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.1e-43 Score=358.95 Aligned_cols=260 Identities=18% Similarity=0.213 Sum_probs=203.3
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCChhHHHHHHHHHHHHHhcCC-cceeEEeeEEEecCceEEEEee
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPSEDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNNLLLVYDF 339 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H-pnIv~l~g~~~~~~~~~LV~Ey 339 (611)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... ....+.+|+++++.++| +|++.+++++..+...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 468999999999999999999965 78999999986532 23457789999999975 8999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCC-----CCceEEeecCcccc
Q 007256 340 LSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSD-----DFEPQLSDFGLAKW 414 (611)
Q Consensus 340 ~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~-----~~~vKL~DFGla~~ 414 (611)
+ +++|.+++..... .+++.++..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 6799998876543 58999999999999999999999 99999999999999974 57899999999987
Q ss_pred ccCCCCC-----ccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC
Q 007256 415 ASTSSSH-----ITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG 489 (611)
Q Consensus 415 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g 489 (611)
....... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7543221 12234689999999999999999999999999999999999999998665543322211111000000
Q ss_pred ccccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHhhC
Q 007256 490 KVTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQMSLVLKLLRG 538 (611)
Q Consensus 490 ~l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~L~~ 538 (611)
...+ +...++ ..+..++..|+..+|++||+++.+.+.|+.
T Consensus 236 ~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111 111222 234455566999999999999988877753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=365.82 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=199.9
Q ss_pred cCceeeeeEeecCcEEEEEEEe----CCCCEEEEEEecCC-----hhHHHHHHHHHHHHHhcCC-cceeEEeeEEEecCc
Q 007256 263 SNFLAENLIGKGGSSQVYKGCL----PDGKELAVKILKPS-----EDVIKEFVLEIEIITTLHH-KNIISLLGFCFEDNN 332 (611)
Q Consensus 263 ~~f~~~~~LG~G~fG~Vyk~~~----~~g~~vAVK~l~~~-----~~~~~~f~~Ei~iL~~l~H-pnIv~l~g~~~~~~~ 332 (611)
++|.+.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999975 25899999998742 2345678899999999976 899999999999999
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.++||||+.+|+|.+++.... .+....+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999997654 36788899999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCccccccccccccCChhhhccC--CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccCc
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMYG--KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSGK 490 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g~ 490 (611)
+......... .....||+.|+|||.+... .++.++|||||||+||||++|+.||...........+.......
T Consensus 177 ~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~---- 251 (322)
T d1vzoa_ 177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS---- 251 (322)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----
T ss_pred hhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC----
Confidence 8765433322 2346799999999999754 46889999999999999999999998766544332222111000
Q ss_pred cccccCcccCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007256 491 VTQLLDPALGNNYDYDQMERMVLASILCIRRDPRARPQ-----MSLVLK 534 (611)
Q Consensus 491 l~~lld~~l~~~~~~~~~~~l~~la~~CL~~dP~~RPt-----m~eVL~ 534 (611)
.+.+.. .....+..++..||+.||.+||| ++|+++
T Consensus 252 -----~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -----EPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -----CCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -----CCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001111 11234555666799999999994 788876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=363.29 Aligned_cols=261 Identities=22% Similarity=0.240 Sum_probs=191.2
Q ss_pred hcCceeeeeEeecCcEEEEEEEeC-CCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEe------cC
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCLP-DGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFE------DN 331 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~------~~ 331 (611)
.++|.+.++||+|+||+||+|.+. +|+.||||+++.. ......+.+|+.+|++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 468999999999999999999975 7999999999753 4556678999999999999999999999964 35
Q ss_pred ceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCc
Q 007256 332 NLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGL 411 (611)
Q Consensus 332 ~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGl 411 (611)
.+|+||||+.++.+ +.+.. .+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~------~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHH-Hhhhc------CCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence 78999999977544 44432 47899999999999999999999 9999999999999999999999999999
Q ss_pred cccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhc--------
Q 007256 412 AKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAK-------- 483 (611)
Q Consensus 412 a~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~-------- 483 (611)
++....... .....||+.|+|||++.+..++.++||||+||+++||++|+.||...+.......+....
T Consensus 166 ~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 886655332 234679999999999999999999999999999999999999998665433222111000
Q ss_pred --------------cccccCccccccCcccCCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 484 --------------PILSSGKVTQLLDPALGNNY---DYDQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 484 --------------~~~~~g~l~~lld~~l~~~~---~~~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
+................... .......+..++..||+.||++|||++|+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000011111111111111 11223456677888999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=364.79 Aligned_cols=261 Identities=22% Similarity=0.286 Sum_probs=194.9
Q ss_pred hcCceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCC---hhHHHHHHHHHHHHHhcCCcceeEEeeEEEec-----Cc
Q 007256 262 TSNFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPS---EDVIKEFVLEIEIITTLHHKNIISLLGFCFED-----NN 332 (611)
Q Consensus 262 t~~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~---~~~~~~f~~Ei~iL~~l~HpnIv~l~g~~~~~-----~~ 332 (611)
.++|.+.+.||+|+||+||+|.+ .+|+.||||+++.. ....+.+.+|+++|+.++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999986 47999999999753 34556789999999999999999999998643 34
Q ss_pred eEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 333 LLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 333 ~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
.+++|+|+.+|+|.+++... .+++.+++.++.||+.||+|||+ +||+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence 57778888999999998643 48999999999999999999999 89999999999999999999999999998
Q ss_pred ccccCCCCCccccccccccccCChhhhccC-CCCCcceehhhhHHHHHHHhCCCCCCCCCCcchhhHHHhhccccccC--
Q 007256 413 KWASTSSSHITCTDVAGTFGYLAPEYFMYG-KVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQESLVMWAKPILSSG-- 489 (611)
Q Consensus 413 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~~lv~~~~~~~~~g-- 489 (611)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+..........
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 75543 22346799999999987765 46889999999999999999999998765433322221111000000
Q ss_pred ------ccccccCcccC-CCCCh-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007256 490 ------KVTQLLDPALG-NNYDY-----DQMERMVLASILCIRRDPRARPQMSLVLKL 535 (611)
Q Consensus 490 ------~l~~lld~~l~-~~~~~-----~~~~~l~~la~~CL~~dP~~RPtm~eVL~~ 535 (611)
........... ..... .....+..++..||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000 00000 011234556677999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-37 Score=326.94 Aligned_cols=264 Identities=18% Similarity=0.229 Sum_probs=190.9
Q ss_pred CceeeeeEeecCcEEEEEEEe-CCCCEEEEEEecCChhHHHHHHHHHHHHHhcC-----------CcceeEEeeEEEec-
Q 007256 264 NFLAENLIGKGGSSQVYKGCL-PDGKELAVKILKPSEDVIKEFVLEIEIITTLH-----------HKNIISLLGFCFED- 330 (611)
Q Consensus 264 ~f~~~~~LG~G~fG~Vyk~~~-~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~-----------HpnIv~l~g~~~~~- 330 (611)
+|.+.++||+|+||+||+|.+ .+|+.||||+++......+.+.+|+.+++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 599999999999999999997 47999999999987777778899999998875 47899999988643
Q ss_pred -CceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCC------c
Q 007256 331 -NNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDF------E 403 (611)
Q Consensus 331 -~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~------~ 403 (611)
...+++|+++..+.......... ....+.+..+..++.||+.||.|||+ ..||+||||||+||||+.++ .
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeecccccccccccccc-cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 45677777776554333322211 12357889999999999999999996 26899999999999997654 3
Q ss_pred eEEeecCccccccCCCCCccccccccccccCChhhhccCCCCCcceehhhhHHHHHHHhCCCCCCCCCCcchh----hHH
Q 007256 404 PQLSDFGLAKWASTSSSHITCTDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLTGRKPISNDHPKGQE----SLV 479 (611)
Q Consensus 404 vKL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~s~ksDVwSlGvvL~ELltG~~Pf~~~~~~~~~----~lv 479 (611)
++|+|||.+....... ...+||+.|+|||++....++.++||||+||++++|++|+.||......... .+.
T Consensus 171 ~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 9999999998665432 2367999999999999999999999999999999999999999765432111 010
Q ss_pred H--hhcc---------------ccccCccccccCc----------ccCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 007256 480 M--WAKP---------------ILSSGKVTQLLDP----------ALGNNYDYDQMERMVLASILCIRRDPRARPQMSLV 532 (611)
Q Consensus 480 ~--~~~~---------------~~~~g~l~~lld~----------~l~~~~~~~~~~~l~~la~~CL~~dP~~RPtm~eV 532 (611)
. +... ..........+.. .............+..++..||..||.+|||+.|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0 0000 0000000000000 00112234455667778888999999999999999
Q ss_pred HHH
Q 007256 533 LKL 535 (611)
Q Consensus 533 L~~ 535 (611)
|++
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=4.4e-24 Score=204.37 Aligned_cols=164 Identities=16% Similarity=0.160 Sum_probs=123.1
Q ss_pred ceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh-------------------hHHHHHHHHHHHHHhcCCcceeEEee
Q 007256 265 FLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-------------------DVIKEFVLEIEIITTLHHKNIISLLG 325 (611)
Q Consensus 265 f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~-------------------~~~~~f~~Ei~iL~~l~HpnIv~l~g 325 (611)
+.+.+.||+|+||+||+|.+.+|+.||||+++... .....+..|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35789999999999999999899999999876421 11234556889999999999998876
Q ss_pred EEEecCceEEEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCcEEeeccCccceeeCCCCceE
Q 007256 326 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGSAQRVIHRDVKSSNILLSDDFEPQ 405 (611)
Q Consensus 326 ~~~~~~~~~LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~~~gIiHrDIKp~NILLd~~~~vK 405 (611)
+. ..+++|||+++..+.+ +.......++.|++.+|.|||+ +||+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 53 3479999999865543 2334456789999999999999 899999999999999965 599
Q ss_pred EeecCccccccCCCCCccccccccccccCC------hhhhccCCCCCcceehhhhHHHH
Q 007256 406 LSDFGLAKWASTSSSHITCTDVAGTFGYLA------PEYFMYGKVNDKIDVYAFGVVLL 458 (611)
Q Consensus 406 L~DFGla~~~~~~~~~~~~~~~~GT~~Y~A------PE~l~~~~~s~ksDVwSlGvvL~ 458 (611)
|+|||+|........ ..|+. .+.+ ...|+.++|+||+.--++
T Consensus 143 liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred EEECCCcccCCCCCc----------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 999999875543211 11111 1222 357888999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=2.6e-07 Score=89.73 Aligned_cols=147 Identities=18% Similarity=0.145 Sum_probs=99.2
Q ss_pred HHHHhhcCceeeeeEeecCcEEEEEEEeCCCCEEEEEEecCCh-hHHHHHHHHHHHHHhcC-CcceeEEeeEEEecCceE
Q 007256 257 DLLSATSNFLAENLIGKGGSSQVYKGCLPDGKELAVKILKPSE-DVIKEFVLEIEIITTLH-HKNIISLLGFCFEDNNLL 334 (611)
Q Consensus 257 el~~~t~~f~~~~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~-~~~~~f~~Ei~iL~~l~-HpnIv~l~g~~~~~~~~~ 334 (611)
++......|.+.+..+.++.+.||+... ++..+++|+..... .....+.+|...+..+. +--+.+++.++..++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444455677666655555678998754 56678888876432 23345677888888775 333667788888888899
Q ss_pred EEEeeCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 007256 335 LVYDFLSRGSLEENLHGNKKDPAAFGWSERYKVAMGVAEALEYLHSGS-------------------------------- 382 (611)
Q Consensus 335 LV~Ey~~ggsL~~~L~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~-------------------------------- 382 (611)
+||++++|.++.+...... ....++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~~---------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ---------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS---------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEecccccccccccccc---------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 9999999988865542211 11224445555555555421
Q ss_pred ------------------------CCcEEeeccCccceeeCCCCceEEeecCccc
Q 007256 383 ------------------------AQRVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 383 ------------------------~~gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987667799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.06 E-value=2.6e-06 Score=81.96 Aligned_cols=75 Identities=16% Similarity=0.070 Sum_probs=54.9
Q ss_pred eEeecC-cEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCC--cceeEEeeEEEecCceEEEEeeCCCCChh
Q 007256 270 LIGKGG-SSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHH--KNIISLLGFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 270 ~LG~G~-fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~H--pnIv~l~g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
.+..|. .+.||+....++..+++|...... ...+..|...++.+.. -.+.+++.++.+++..++||+|++|.++.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344554 368999988888889999877543 2346678888777653 33567788888888899999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=4.2e-05 Score=79.13 Aligned_cols=76 Identities=17% Similarity=0.138 Sum_probs=50.7
Q ss_pred eeeEeecCcEEEEEEEeC-CCCEEEEEEecCC--------hhHHHHHHHHHHHHHhcC-C--cceeEEeeEEEecCceEE
Q 007256 268 ENLIGKGGSSQVYKGCLP-DGKELAVKILKPS--------EDVIKEFVLEIEIITTLH-H--KNIISLLGFCFEDNNLLL 335 (611)
Q Consensus 268 ~~~LG~G~fG~Vyk~~~~-~g~~vAVK~l~~~--------~~~~~~f~~Ei~iL~~l~-H--pnIv~l~g~~~~~~~~~L 335 (611)
.+.||.|....||+.... +|+.++||.-.+. .....+...|.+.|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 456899999999999875 4678999975431 112344566888887664 2 345555544 4566789
Q ss_pred EEeeCCCCCh
Q 007256 336 VYDFLSRGSL 345 (611)
Q Consensus 336 V~Ey~~ggsL 345 (611)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.34 E-value=0.00039 Score=69.53 Aligned_cols=138 Identities=16% Similarity=0.215 Sum_probs=82.2
Q ss_pred cCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce--eEEe-----eEEEecCceEEEEeeCCCCChh
Q 007256 274 GGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI--ISLL-----GFCFEDNNLLLVYDFLSRGSLE 346 (611)
Q Consensus 274 G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnI--v~l~-----g~~~~~~~~~LV~Ey~~ggsL~ 346 (611)
+.-..||++..++|..|++|+.++.....+++..|...+..|...++ +..+ ..+..++..+.++++++|..+.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 33478999999999999999998876666778889988888753222 1111 1234456788999999875332
Q ss_pred h-----------h---hcc----CC-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHh----cCCCC
Q 007256 347 E-----------N---LHG----NK-KDPAAFGWS-------------------ERYKVAMGVAEALEYLH----SGSAQ 384 (611)
Q Consensus 347 ~-----------~---L~~----~~-~~~~~l~~~-------------------~~~~I~~qIa~gL~yLH----~~~~~ 384 (611)
. . +|. .. .....+++. .+..+...+...+..+. .....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 0 110 00 001111111 11111112222233332 22346
Q ss_pred cEEeeccCccceeeCCCCceEEeecCccc
Q 007256 385 RVIHRDVKSSNILLSDDFEPQLSDFGLAK 413 (611)
Q Consensus 385 gIiHrDIKp~NILLd~~~~vKL~DFGla~ 413 (611)
++||+|+.+.|||++++ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 89999999999999754 4589998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.20 E-value=0.00043 Score=71.12 Aligned_cols=75 Identities=17% Similarity=0.224 Sum_probs=52.0
Q ss_pred eeeeEeecCcEEEEEEEeCC--------CCEEEEEEecCChhHHHHHHHHHHHHHhcCCcce-eEEeeEEEecCceEEEE
Q 007256 267 AENLIGKGGSSQVYKGCLPD--------GKELAVKILKPSEDVIKEFVLEIEIITTLHHKNI-ISLLGFCFEDNNLLLVY 337 (611)
Q Consensus 267 ~~~~LG~G~fG~Vyk~~~~~--------g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~HpnI-v~l~g~~~~~~~~~LV~ 337 (611)
..+.|+.|-.-.+|++..++ .+.|.+++.-..... -...+|..+++.+.-.++ .+++++|.. .+||
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 34678999999999988654 356778877643332 345679999988864344 467777632 6899
Q ss_pred eeCCCCChh
Q 007256 338 DFLSRGSLE 346 (611)
Q Consensus 338 Ey~~ggsL~ 346 (611)
||++|..|.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEeccccCC
Confidence 999886443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.77 E-value=0.002 Score=63.37 Aligned_cols=156 Identities=14% Similarity=0.058 Sum_probs=80.0
Q ss_pred HHHHHHhhcCceee-----eeEeecCcEEEEEEEeCCCCEEEEEEecCChhHHHHHHHHHHHHHhcCCc-----ceeEEe
Q 007256 255 YQDLLSATSNFLAE-----NLIGKGGSSQVYKGCLPDGKELAVKILKPSEDVIKEFVLEIEIITTLHHK-----NIISLL 324 (611)
Q Consensus 255 ~~el~~~t~~f~~~-----~~LG~G~fG~Vyk~~~~~g~~vAVK~l~~~~~~~~~f~~Ei~iL~~l~Hp-----nIv~l~ 324 (611)
.+++.....+|.+. +.|..|---+.|+...++|+ +++|+..... ..+++..|++++..|... ..+...
T Consensus 5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~ 82 (316)
T d2ppqa1 5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRK 82 (316)
T ss_dssp HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBT
T ss_pred HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceec
Confidence 34455555555443 33456767889998876665 8999986432 223445566666666432 221111
Q ss_pred ---eEEEecCceEEEEeeCCCCChhh--------------hhcc---CCCCC--CCC------------------CHHHH
Q 007256 325 ---GFCFEDNNLLLVYDFLSRGSLEE--------------NLHG---NKKDP--AAF------------------GWSER 364 (611)
Q Consensus 325 ---g~~~~~~~~~LV~Ey~~ggsL~~--------------~L~~---~~~~~--~~l------------------~~~~~ 364 (611)
.+.........++.++.+..... .++. ..... ... .....
T Consensus 83 ~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (316)
T d2ppqa1 83 DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGL 162 (316)
T ss_dssp TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTH
T ss_pred CCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhH
Confidence 01223445666777776643321 0000 00000 000 00011
Q ss_pred HHHHHHHHHHHHHHhc-CCCCcEEeeccCccceeeCCCCceEEeecCcc
Q 007256 365 YKVAMGVAEALEYLHS-GSAQRVIHRDVKSSNILLSDDFEPQLSDFGLA 412 (611)
Q Consensus 365 ~~I~~qIa~gL~yLH~-~~~~gIiHrDIKp~NILLd~~~~vKL~DFGla 412 (611)
...+..+...+.-.+. .-+.++||+|+.++||+++.+...-|+||+.+
T Consensus 163 ~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 163 REEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp HHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 1222223333333332 23478999999999999998877789999976
|